Citrus Sinensis ID: 023285
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 284 | 2.2.26 [Sep-21-2011] | |||||||
| Q54H46 | 642 | Probable serine/threonine | yes | no | 0.616 | 0.272 | 0.475 | 3e-43 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.676 | 0.209 | 0.408 | 8e-42 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.700 | 0.242 | 0.429 | 5e-41 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.616 | 0.253 | 0.447 | 1e-40 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.609 | 0.185 | 0.477 | 5e-39 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.612 | 0.446 | 0.402 | 2e-37 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.609 | 0.106 | 0.418 | 4e-35 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.619 | 0.106 | 0.412 | 6e-35 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.609 | 0.134 | 0.414 | 7e-35 | |
| Q99N57 | 648 | RAF proto-oncogene serine | yes | no | 0.623 | 0.273 | 0.417 | 2e-34 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 175 bits (444), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 86/181 (47%), Positives = 123/181 (67%), Gaps = 6/181 (3%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID Q+KI ++ G+YG++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C PP++CI TE+M RGS+Y LH Q Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 278 V 278
V
Sbjct: 541 V 541
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 8e-42, Method: Composition-based stats.
Identities = 80/196 (40%), Positives = 132/196 (67%), Gaps = 4/196 (2%)
Query: 87 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
++++S + +E P+ + EI +LKI K+ G++G +YKG + VAIK +K
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
E VN ++L+EF +E+ I+ ++RH N+V + ACT PPNLC +TE++ GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
+ K+AI +++GMNYLH + +IHRD+K+ NLL+DE+ VK+ DFG+++++++S
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813
Query: 263 VMTAETGTYRWMAPEV 278
MT G+ WM+PE+
Sbjct: 814 EMTKSIGSPIWMSPEL 829
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 5e-41, Method: Compositional matrix adjust.
Identities = 89/207 (42%), Positives = 135/207 (65%), Gaps = 8/207 (3%)
Query: 79 GVPMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
PM++ + + PN E+ DG D+ +I L I+ K+ +GS+G +++ + +V
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV 575
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
A+K+L + + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y
Sbjct: 576 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 635
Query: 197 FLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADF 252
LHK QL L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ VKV DF
Sbjct: 636 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDF 695
Query: 253 GVARVQAQSGVMT-AETGTYRWMAPEV 278
G++R++A + + + + GT WMAPEV
Sbjct: 696 GLSRLKASTFLSSKSAAGTPEWMAPEV 722
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (421), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 81/181 (44%), Positives = 122/181 (67%), Gaps = 6/181 (3%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID +Q+KI ++ G++G++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C P++CI TE+M RGS+Y LH +K + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 278 V 278
V
Sbjct: 558 V 558
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 161 bits (408), Expect = 5e-39, Method: Compositional matrix adjust.
Identities = 84/176 (47%), Positives = 112/176 (63%), Gaps = 3/176 (1%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
EI L I ++ GSYG++Y + EVA+K + + L EF EV IMR++R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H NVV F+GA TRPPNL IVTEF+ RGS+Y LH+ K +K+A+DV+ GMN LH
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLH 782
Query: 226 QN--NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRWMAPEV 278
+ I+HRDLKT NLL+D N VKV DFG++R++ + + + T GT WMAPEV
Sbjct: 783 TSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEV 838
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 156 bits (394), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 72/179 (40%), Positives = 118/179 (65%), Gaps = 5/179 (2%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK----PECVNTEMLKEFSQEVYI 160
W D QL I K ASG++ +Y+G Y + VA+K+++ E ++ ++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSK 219
+ ++ H N+VQFI AC +PP CI+TE+M++G++ +L+K++ + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
GM YLH +IHRDLK+ NLL+++ VKVADFG + ++ Q GTYRWMAPE+
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEM 257
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 148 bits (374), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 75/179 (41%), Positives = 115/179 (64%), Gaps = 6/179 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
WEID +L+I + +G YG++YK + EVA+K++ + V+ +M + F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV--AIDVSKGMN 222
RH NVV F+ A T+ PN+CIV EFM+ GS+YD L + + ++ LK+ A SKGM+
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNEL-IPEIPYALKIKMAYQASKGMH 897
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE---TGTYRWMAPEV 278
+LH + I+HRDLK+ NLL+D VKV+DFG+ +V+++ GT W+APE+
Sbjct: 898 FLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWIAPEI 956
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 75/182 (41%), Positives = 119/182 (65%), Gaps = 6/182 (3%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYI 160
+D WEID +L++ ++ +G++G+++KGT+ EVA+K++ P+ + ++ + F EV +
Sbjct: 776 SDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRV 835
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVS 218
M +RH NVV F+ A T+PP +CIV EFMA GS++D L K + + + LKV I S
Sbjct: 836 MTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFALKVKIAYQAS 894
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAP 276
KGM++LH + I HRDLK+ NLL+D VKV+DFG+ + ++ + E GT +W AP
Sbjct: 895 KGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTAP 954
Query: 277 EV 278
E+
Sbjct: 955 EI 956
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 73/176 (41%), Positives = 115/176 (65%), Gaps = 3/176 (1%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
WE+ ++ I ++ G YG +++G++ EVA+K+L + VN +++ + +EV ++ K+
Sbjct: 844 WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
RH N+V F+GACT P + CIVTE+++RGS+ + L + L++ D ++GM YL
Sbjct: 904 RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963
Query: 225 HQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H N IIHRDLKT NLL+D++ VKVADFG+A V++ + T GT W+APEV
Sbjct: 964 HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEV 1018
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99N57|RAF1_MOUSE RAF proto-oncogene serine/threonine-protein kinase OS=Mus musculus GN=Raf1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 145 bits (367), Expect = 2e-34, Method: Compositional matrix adjust.
Identities = 76/182 (41%), Positives = 116/182 (63%), Gaps = 5/182 (2%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
D + WEI+A ++ + ++ SGS+G +YKG + +VA+K+LK E L+ F EV
Sbjct: 337 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQLQAFRNEVA 395
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
++RK RH N++ F+G T+ NL IVT++ S+Y LH Q+ FQ+ L+ +A ++
Sbjct: 396 VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 454
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
GM+YLH NIIHRD+K+ N+ + E VK+ DFG+A V+++ SG E TG+ WMAP
Sbjct: 455 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 514
Query: 277 EV 278
EV
Sbjct: 515 EV 516
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation (By similarity). Regulates Rho signaling and migration, and is required for normal wound healing. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 284 | ||||||
| 449456851 | 579 | PREDICTED: mitogen-activated protein kin | 0.943 | 0.462 | 0.779 | 1e-125 | |
| 449495086 | 579 | PREDICTED: mitogen-activated protein kin | 0.943 | 0.462 | 0.779 | 1e-125 | |
| 357483963 | 574 | Dual specificity protein kinase pyk2 [Me | 0.943 | 0.466 | 0.787 | 1e-122 | |
| 217074650 | 538 | unknown [Medicago truncatula] | 0.943 | 0.498 | 0.787 | 1e-122 | |
| 356538347 | 571 | PREDICTED: serine/threonine-protein kina | 0.943 | 0.469 | 0.776 | 1e-122 | |
| 224117232 | 587 | predicted protein [Populus trichocarpa] | 0.943 | 0.456 | 0.798 | 1e-122 | |
| 116643258 | 581 | flag-tagged protein kinase domain of put | 0.940 | 0.459 | 0.794 | 1e-121 | |
| 297798344 | 570 | kinase family protein [Arabidopsis lyrat | 0.940 | 0.468 | 0.794 | 1e-121 | |
| 356496589 | 571 | PREDICTED: serine/threonine-protein kina | 0.943 | 0.469 | 0.776 | 1e-121 | |
| 22329194 | 570 | ACT-like protein tyrosine kinase family | 0.940 | 0.468 | 0.794 | 1e-121 |
| >gi|449456851|ref|XP_004146162.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1168), Expect = e-125, Method: Compositional matrix adjust.
Identities = 209/268 (77%), Positives = 241/268 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL K+Q
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S++QP+ + H++ +ES P+C+ IPTDGTDVWE+D QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEV 463
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495086|ref|XP_004159730.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 454 bits (1167), Expect = e-125, Method: Compositional matrix adjust.
Identities = 209/268 (77%), Positives = 241/268 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL K+Q
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S++QP+ + H++ +ES P+C+ IPTDGTDVWE+D QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEV 463
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357483963|ref|XP_003612268.1| Dual specificity protein kinase pyk2 [Medicago truncatula] gi|355513603|gb|AES95226.1| Dual specificity protein kinase pyk2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/268 (78%), Positives = 236/268 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK KDQ
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVKDQY 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +ESSP+CI+IP DG DVWEID QLK E KV SGS+GDL++G+
Sbjct: 254 LSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFGDLFRGS 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN +VKVA
Sbjct: 374 RGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENELVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEV 461
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074650|gb|ACJ85685.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-122, Method: Compositional matrix adjust.
Identities = 211/268 (78%), Positives = 236/268 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK KDQ
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVKDQY 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +ESSP+CI+IP DG DVWEID QLK E KV SGS+GDL++G+
Sbjct: 254 LSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFGDLFRGS 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN +VKVA
Sbjct: 374 RGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENELVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEV 461
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538347|ref|XP_003537665.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 443 bits (1139), Expect = e-122, Method: Compositional matrix adjust.
Identities = 208/268 (77%), Positives = 236/268 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +E SP+CI+IP+DG DVWEID QLK E KV SGS+GDLY+GT
Sbjct: 254 LSNQGIHYATNEQYQARMEPSPHCIQIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEV 461
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117232|ref|XP_002331754.1| predicted protein [Populus trichocarpa] gi|222874451|gb|EEF11582.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-122, Method: Compositional matrix adjust.
Identities = 214/268 (79%), Positives = 237/268 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW +ETE+L+N L KEILKSK+Q
Sbjct: 205 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLREETEELRNALEKEILKSKEQC 264
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
SK+ V +K +ES P+C+EIP+DGTDVWEID LK+E KVASGSYGDLY+GT
Sbjct: 265 FSKQLSVSLVGEQNKTGVESLPDCVEIPSDGTDVWEIDTSLLKVENKVASGSYGDLYRGT 324
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVLKPE V+ EML+EFS+EVYIMRK+RHKNVVQFIGAC R PNLCIVTEFMA
Sbjct: 325 YCSQEVAIKVLKPERVSGEMLREFSREVYIMRKVRHKNVVQFIGACDRSPNLCIVTEFMA 384
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+GS+Y+FLHKQKGVF+L L+KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 385 KGSLYNFLHKQKGVFKLPCLIKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 444
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 445 DFGVARVQTQSGVMTAETGTYRWMAPEV 472
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643258|gb|ABK06437.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1133), Expect = e-121, Method: Compositional matrix adjust.
Identities = 213/268 (79%), Positives = 233/268 (86%), Gaps = 1/268 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ +SGVMTAETGTYRWMAPEV
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEV 458
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
| >gi|297798344|ref|XP_002867056.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312892|gb|EFH43315.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 441 bits (1133), Expect = e-121, Method: Compositional matrix adjust.
Identities = 213/268 (79%), Positives = 233/268 (86%), Gaps = 1/268 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALTKEIRKLKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ +SGVMTAETGTYRWMAPEV
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEV 458
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496589|ref|XP_003517149.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 208/268 (77%), Positives = 235/268 (87%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +E SP+CI IP+DG DVWEID QLK E KV SGS+GDLY+GT
Sbjct: 254 MSNQGIHYATNEQYQARMEPSPHCILIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ QSGVMTAETGTYRWMAPEV
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEV 461
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22329194|ref|NP_195303.2| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|20260236|gb|AAM13016.1| putative protein [Arabidopsis thaliana] gi|22136520|gb|AAM91338.1| putative protein [Arabidopsis thaliana] gi|332661163|gb|AEE86563.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 213/268 (79%), Positives = 233/268 (86%), Gaps = 1/268 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ +SGVMTAETGTYRWMAPEV
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEV 458
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 284 | ||||||
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.940 | 0.468 | 0.794 | 2e-111 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.940 | 0.489 | 0.779 | 1.5e-108 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.933 | 0.460 | 0.714 | 9.4e-98 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.616 | 0.272 | 0.475 | 1.4e-41 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.637 | 0.440 | 0.470 | 5.9e-41 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.637 | 0.439 | 0.455 | 1.4e-39 | |
| DICTYBASE|DDB_G0289709 | 690 | drkB "DRK subfamily protein ki | 0.616 | 0.253 | 0.447 | 8.3e-39 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.676 | 0.209 | 0.408 | 1.1e-38 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.693 | 0.239 | 0.434 | 2.9e-38 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.647 | 0.178 | 0.442 | 3.2e-38 |
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1100 (392.3 bits), Expect = 2.0e-111, P = 2.0e-111
Identities = 213/268 (79%), Positives = 233/268 (86%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ +SGVMTAETGTYRWMAPEV
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEV 458
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1073 (382.8 bits), Expect = 1.5e-108, P = 1.5e-108
Identities = 209/268 (77%), Positives = 234/268 (87%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLLGE+GLNIQEAHAFSTVDGFSLDVFVVDGW +ET+ L++ L+KEILK KDQ
Sbjct: 186 LSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALSKEILKLKDQP 245
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
SK Q ++ H K E P CIEIPTDGTD WEID QLKIE KVASGSYGDL++GT
Sbjct: 246 GSK-QKSISFFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGT 304
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK LKP+ VN EML+EFSQEV+IMRK+RHKNVVQF+GACTR P LCIVTEFMA
Sbjct: 305 YCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMA 364
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHKQK F+L +LLKVA+DV+KGM+YLHQNNIIHRDLKTANLLMDE+G+VKVA
Sbjct: 365 RGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVA 424
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFGVARVQ +SGVMTAETGTYRWMAPEV
Sbjct: 425 DFGVARVQIESGVMTAETGTYRWMAPEV 452
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 9.4e-98, P = 9.4e-98
Identities = 190/266 (71%), Positives = 220/266 (82%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCS 72
+LT+LL E+GLNIQEAHAFST DG+SLDVFVVDGWPY+ETE L+ L KE K + QS S
Sbjct: 192 QLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLRISLEKEAAKIELQSQS 251
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC 132
P + + + IP DGTDVWEI+ K LK K+ASGSYGDLYKGTYC
Sbjct: 252 WPMQQSFSPEKENGQTGARTH-VPIPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYC 310
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
SQEVAIKVLKPE +++++ KEF+QEV+IMRK+RHKNVVQFIGACT+PP+LCIVTEFM G
Sbjct: 311 SQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGG 370
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
S+YD+LHKQKGVF+L +L KVAID+ KGM+YLHQNNIIHRDLK ANLLMDEN VVKVADF
Sbjct: 371 SVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADF 430
Query: 253 GVARVQAQSGVMTAETGTYRWMAPEV 278
GVARV+AQ+GVMTAETGTYRWMAPEV
Sbjct: 431 GVARVKAQTGVMTAETGTYRWMAPEV 456
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.4e-41, P = 1.4e-41
Identities = 86/181 (47%), Positives = 123/181 (67%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID Q+KI ++ G+YG++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C PP++CI TE+M RGS+Y LH Q Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 278 V 278
V
Sbjct: 541 V 541
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 435 (158.2 bits), Expect = 5.9e-41, P = 5.9e-41
Identities = 89/189 (47%), Positives = 126/189 (66%)
Query: 98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVL-KPECVNTE---M 150
PT+G D W ID ++L + A G++G LYKGTY ++VAIK+L +PE + M
Sbjct: 113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTS 209
++F QEV ++ ++H N+V+FIGAC +P CIVTE+ GS+ FL +Q L
Sbjct: 173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+K A+DV++GM Y+H N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT ETG
Sbjct: 233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 292
Query: 270 TYRWMAPEV 278
TYRWMAPE+
Sbjct: 293 TYRWMAPEM 301
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 422 (153.6 bits), Expect = 1.4e-39, P = 1.4e-39
Identities = 86/189 (45%), Positives = 125/189 (66%)
Query: 98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----M 150
PT+G + W ID ++L + A G++G LY+GTY ++VAIK+L+ N E +
Sbjct: 114 PTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQAL 173
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTS 209
++F QEV ++ ++H N+V+FIGAC +P CIVTE+ GS+ FL K Q L
Sbjct: 174 EQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKL 233
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+ A+DV++GM Y+H+ N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT ETG
Sbjct: 234 AVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETG 293
Query: 270 TYRWMAPEV 278
TYRWMAPE+
Sbjct: 294 TYRWMAPEM 302
|
|
| DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 8.3e-39, P = 8.3e-39
Identities = 81/181 (44%), Positives = 122/181 (67%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID +Q+KI ++ G++G++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C P++CI TE+M RGS+Y LH +K + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 278 V 278
V
Sbjct: 558 V 558
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 1.1e-38, P = 1.1e-38
Identities = 80/196 (40%), Positives = 132/196 (67%)
Query: 87 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
++++S + +E P+ + EI +LKI K+ G++G +YKG + VAIK +K
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
E VN ++L+EF +E+ I+ ++RH N+V + ACT PPNLC +TE++ GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
+ K+AI +++GMNYLH + +IHRD+K+ NLL+DE+ VK+ DFG+++++++S
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813
Query: 263 VMTAETGTYRWMAPEV 278
MT G+ WM+PE+
Sbjct: 814 EMTKSIGSPIWMSPEL 829
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 2.9e-38, P = 2.9e-38
Identities = 89/205 (43%), Positives = 135/205 (65%)
Query: 81 PMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAI 138
PM++ + + PN E+ DG D+ +I L I+ K+ +GS+G +++ + +VA+
Sbjct: 519 PMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAV 577
Query: 139 KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 198
K+L + + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y L
Sbjct: 578 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 637
Query: 199 HKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGV 254
HK QL L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ VKV DFG+
Sbjct: 638 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 697
Query: 255 ARVQAQSGVMT-AETGTYRWMAPEV 278
+R++A + + + + GT WMAPEV
Sbjct: 698 SRLKASTFLSSKSAAGTPEWMAPEV 722
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 420 (152.9 bits), Expect = 3.2e-38, P = 3.2e-38
Identities = 85/192 (44%), Positives = 127/192 (66%)
Query: 90 SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 149
S +C ++ +D +WE ++ + ++ GSYG++Y+G + EVA+K + + E
Sbjct: 731 SKSDCDDV-SDCEILWE----EITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGE 785
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
L+EF EV IM+K+RH N+V F+GA TRPPNL IVTEF+ RGS+Y +H+
Sbjct: 786 ALEEFRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERR 845
Query: 210 LLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
L++A+D ++GMNYLH N I+HRDLK+ NLL+D+N VVKV DFG++R++ + + +
Sbjct: 846 RLRMALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKS 905
Query: 268 T-GTYRWMAPEV 278
T GT WMAPEV
Sbjct: 906 TAGTAEWMAPEV 917
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01810006 | hypothetical protein (587 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 284 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-60 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-59 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-58 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-44 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-44 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-44 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-41 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-41 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-40 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-38 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-38 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-37 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-36 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-36 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-36 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-36 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-35 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-35 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-33 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-33 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-32 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-32 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-32 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-32 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-32 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-28 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-27 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-27 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 9e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-25 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-25 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-25 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-24 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-24 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-21 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-20 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-20 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 9e-20 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-17 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-16 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 7e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 0.002 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 3e-60
Identities = 69/182 (37%), Positives = 101/182 (55%), Gaps = 10/182 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L++ K+ G++G++YKGT +VA+K LK E +EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+V+ +G CT+ L IVTE+M G + DFL K L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVAFTF 282
N +HRDL N L+ EN VVK++DFG++R + G +WMAPE
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 283 FF 284
F
Sbjct: 180 KF 181
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 1e-59
Identities = 68/181 (37%), Positives = 98/181 (54%), Gaps = 9/181 (4%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L + K+ G++G++YKG EVA+K LK + + + ++EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H NVV+ +G CT L IV E+M G + +L K + L+ LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVAFTFF 283
N IHRDL N L+ EN VVK++DFG++R G RWMAPE
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 284 F 284
F
Sbjct: 180 F 180
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 5e-58
Identities = 69/182 (37%), Positives = 100/182 (54%), Gaps = 10/182 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L + K+ G++G++YKGT EVA+K LK + + + ++EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYL 224
H N+V+ +G CT L IV E+M G + D+L K + S LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVAFTF 282
N IHRDL N L+ EN VVK++DFG++R + G RWMAPE
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 283 FF 284
F
Sbjct: 180 KF 181
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 3e-53
Identities = 67/181 (37%), Positives = 96/181 (53%), Gaps = 17/181 (9%)
Query: 120 SGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
G++G++YKG + EVA+K LK E + E K+F +E +M+K+ H NVV+ +G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS--------LLKVAIDVSKGMNYLHQ 226
CT L +V E+M G + D+L K + VF LL AI ++KGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVAFTFF 283
+HRDL N L+ E+ VVK++DFG++R +TG RWMAPE
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 284 F 284
F
Sbjct: 184 F 184
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-52
Identities = 64/165 (38%), Positives = 101/165 (61%), Gaps = 4/165 (2%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ SGS+G +YK + + VA+K+LK ++ + +E+ I+R++ H N+V+ I
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
A +L +V E+ G ++D+L + G K+A+ + +G+ YLH N IIHRDL
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEV 278
K N+L+DENGVVK+ADFG+A+ +S +T GT +MAPEV
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 1e-49
Identities = 57/163 (34%), Positives = 98/163 (60%), Gaps = 5/163 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G +Y ++VAIK++K E ++ +L+E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+L +V E+ GS+ D L + +G +L++ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 238 NLLMDE-NGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
N+L+D NG VK+ADFG+++ + + ++ GT +MAPEV
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV 164
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-49
Identities = 56/168 (33%), Positives = 88/168 (52%), Gaps = 4/168 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+I K+ GS+G +Y + VAIKV+K + + + +E+ I++K++H N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNIV 60
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L +V E+ G ++D L K +G + + YLH I+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
HRDLK N+L+DE+G VK+ADFG+AR +T GT +MAPEV
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 4e-45
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 8/176 (4%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
+ + GS+G +Y + +A+K ++ + E L+ +E+ I+ ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 169 VVQFIGAC-TRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+V++ G+ N L I E+++ GS+ L K G + K + +G+ YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET---GTYRWMAPEVA 279
N I+HRD+K AN+L+D +GVVK+ADFG A+ GT WMAPEV
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 60/164 (36%), Positives = 95/164 (57%), Gaps = 4/164 (2%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G +G++YK + +EVAIKV+K E + E ++ E+ I++K +H N+V++ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L IV EF + GS+ D L + + V ++ KG+ YLH N IIHRD+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
K AN+L+ +G VK+ DFG++ + + GT WMAPEV
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEV 168
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-44
Identities = 69/180 (38%), Positives = 102/180 (56%), Gaps = 9/180 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEID +++ K+ +G +G++++G + + VA+K LKP T K+F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP---GTMDPKDFLAEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RH ++Q CT + IVTE M GS+ ++L G +L L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
YL N IHRDL N+L+ EN + KVADFG+ARV + + A G +W APE A
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 6e-44
Identities = 73/180 (40%), Positives = 108/180 (60%), Gaps = 9/180 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + LK+E K+ +G +G+++ GT+ + +VA+K LKP ++ E F QE IM+K
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKGMN 222
+RH +VQ C+ + IVTE+M++GS+ DFL +G L L+ +A +++GM
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
YL N IHRDL N+L+ EN V K+ADFG+AR+ TA G +W APE A
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-41
Identities = 71/186 (38%), Positives = 109/186 (58%), Gaps = 11/186 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
WE++ + ++ K+ G YG++Y+G + S VA+K LK + T ++EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMK 57
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGM 221
+I+H N+VQ +G CTR P I+TEFM G++ D+L + + LL +A +S M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE- 277
YL + N IHRDL N L+ EN +VKVADFG++R+ TA G +W APE
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176
Query: 278 VAFTFF 283
+A+ F
Sbjct: 177 LAYNKF 182
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-41
Identities = 68/176 (38%), Positives = 105/176 (59%), Gaps = 10/176 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W I++K+LK+ + G +GD+ G Y Q+VA+K LK ++ + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNY 223
RH N+VQ +G + L IVTE+MA+GS+ D+L + + V L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
L + N +HRDL N+L+ E+ V KV+DFG+A+ +A G ++G +W APE
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-40
Identities = 63/178 (35%), Positives = 109/178 (61%), Gaps = 5/178 (2%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WE ++ +E K+ SG +G++++G + VAIK+LK + + ++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RHK+++ C+ + I+TE M +GS+ FL +G V + SL+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-YRWMAPEVA 279
YL + N IHRDL N+L+ E+ V KVADFG+AR+ + ++++ Y+W APE A
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-39
Identities = 66/182 (36%), Positives = 104/182 (57%), Gaps = 13/182 (7%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID +L ++ SG +G ++ G + + +VAIK+++ ++ + +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+VQ G CT+ + IVTE+MA G + ++L ++KG LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVAF 280
N IHRDL N L+ E+ VVKV+DFG+AR + Q T+ GT +W PEV F
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEV-F 173
Query: 281 TF 282
+
Sbjct: 174 DY 175
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-38
Identities = 63/172 (36%), Positives = 101/172 (58%), Gaps = 6/172 (3%)
Query: 111 QLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
++ + G++G +YKG VAIK + E + E LK QE+ +++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQN 227
+V++IG+ +L I+ E+ GS+ + K+ G F SL+ V + V +G+ YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFP-ESLVAVYVYQVLQGLAYLHEQ 118
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEV 278
+IHRD+K AN+L ++GVVK+ADFGVA ++ S + GT WMAPEV
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEV 170
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-38
Identities = 68/180 (37%), Positives = 105/180 (58%), Gaps = 9/180 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
I +L + ++ SG +G ++ G + + +VAIK ++ ++ E +F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G CT +C+V EFM G + D+L Q+G F +LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVAFTF 282
+N+IHRDL N L+ EN VVKV+DFG+ R T+ TGT +W +PEV F+F
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEV-FSF 175
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 72/181 (39%), Positives = 112/181 (61%), Gaps = 10/181 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L++E K+ G +G+++ GT+ + VAIK LKP ++ E F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
+RH+ +VQ + P + IVTE+M++GS+ DFL + G + +L L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE A
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 F 280
Sbjct: 176 L 176
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 13/180 (7%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
+ LK ++ G +G + Y +VA+K L +F +E+ I+R
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62
Query: 164 IRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H+N+V++ G C +P +L ++ E++ GS+ D+L + + L LL + + KGM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMTAETGTYRWMAPE 277
+YL IHRDL N+L++ +VK++DFG+A+V + V W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 64/166 (38%), Positives = 95/166 (57%), Gaps = 5/166 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ SG+YGD+YK + VAIKV+K E + + QE+ ++++ RH N+V + G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ R L IV E+ GS+ D +G + V + KG+ YLH+ IHRD+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVA 279
K AN+L+ E+G VK+ADFGV A++ A + GT WMAPEVA
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 7e-36
Identities = 72/181 (39%), Positives = 110/181 (60%), Gaps = 10/181 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L+++ K+ G +G+++ GT+ + +VAIK LKP T M + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
+RH +V + P + IVTEFM +GS+ DFL + G + +L L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
Y+ + N IHRDL+ AN+L+ +N V K+ADFG+AR+ + TA G +W APE A
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 F 280
Sbjct: 176 L 176
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 9e-36
Identities = 60/166 (36%), Positives = 96/166 (57%), Gaps = 7/166 (4%)
Query: 117 KVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
K+ G++GD+YKG EVA+K + ++ ++F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C + + IV E + GS+ FL K+K + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPE 277
N L+ EN V+K++DFG++R + + G+ T G +W APE
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPE 165
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-35
Identities = 61/172 (35%), Positives = 91/172 (52%), Gaps = 15/172 (8%)
Query: 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
I K+ GSYG +YK + Q VAIKV+ E E++KE S I+++ +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS----ILKQCDSPYIVK 62
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNN 228
+ G+ + +L IV E+ GS+ D + ++ ++L KG+ YLH N
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---QTLKGLEYLHSNK 119
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
IHRD+K N+L++E G K+ADFGV+ Q + T GT WMAPEV
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEV 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-35
Identities = 69/181 (38%), Positives = 112/181 (61%), Gaps = 10/181 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L++ K+ +G +G+++ GT+ + +VA+K LKP ++ E F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RH +VQ + P + IVTE+M++GS+ DFL +G +L +L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
Y+ + N IHRDL++AN+L+ + V K+ADFG+AR+ + TA G +W APE A
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 F 280
Sbjct: 176 L 176
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 63/186 (33%), Positives = 99/186 (53%), Gaps = 10/186 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYIM 161
ID + IE + G +G++ +G +E VAIK LK + + L +F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N+++ G T+ + I+TE+M GS+ FL + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG--TYRWMAPE- 277
YL + N +HRDL N+L++ N V KV+DFG++R S T + G RW APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 278 VAFTFF 283
+A+ F
Sbjct: 180 IAYRKF 185
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 59/177 (33%), Positives = 103/177 (58%), Gaps = 8/177 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WE+ + LK+ K+ +G +G+++ G Y +VAIK LK ++ E F E +M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
++H +V+ T+ P + I+TE+M GS+ DFL +G+ + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
++ + N IHRDL+ AN+L+ E K+ADFG+AR+ + E + +W APE
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 18/178 (10%)
Query: 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
+ + + GS+G++YK +Q VAIKV+ E E+ ++ QE+ + + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ ++ G+ + L I+ E+ GS D L + G T + + +V G+ YLH+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-------GTYRWMAPEV 278
IHRD+K AN+L+ E G VK+ADFGV SG +T+ GT WMAPEV
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEV 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 65/175 (37%), Positives = 100/175 (57%), Gaps = 8/175 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ K+LK+ + G +GD+ G Y +VA+K +K N + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 165 RHKNVVQFIGACTRPP-NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
RH N+VQ +G L IVTE+MA+GS+ D+L + + V LLK ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
YL NN +HRDL N+L+ E+ V KV+DFG+ + +A S T + +W APE
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPV-KWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-32
Identities = 62/177 (35%), Positives = 106/177 (59%), Gaps = 7/177 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + +K+ K+ +G +G+++ G Y S +VA+K LKP T ++ F +E +M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKT 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
++H +V+ T+ + I+TE+MA+GS+ DFL +G L L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV + E + +W APE
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 1e-32
Identities = 64/177 (36%), Positives = 105/177 (59%), Gaps = 8/177 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + LK+E K+ +G +G+++ TY +VA+K +KP ++ E F E +M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
++H +V+ T+ P + I+TEFMA+GS+ DFL +G L L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
++ Q N IHRDL+ AN+L+ + V K+ADFG+ARV + E + +W APE
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 59/170 (34%), Positives = 90/170 (52%), Gaps = 14/170 (8%)
Query: 118 VASGSYGDLY------KGTYCSQEVAIKV--LKPECVNT-EMLKEFSQEVYIMRKIRHKN 168
+ SGS+G +Y G + A+K L + E +K+ QE+ ++ K++H N
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFF----AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+VQ++G NL I E + GS+ L K G F + + G+ YLH N
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+HRD+K AN+L+D NGVVK+ADFG+A+ + + G+ WMAPEV
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 58/173 (33%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 118 VASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNV 169
+ G++G +Y C +E+A+K + + + E KE + E+ +++ ++H+ +
Sbjct: 10 LGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
VQ+ G L I E+M GS+ D L K G T K + +G+ YLH N I
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA---QSGVMTAETGTYRWMAPEV 278
+HRD+K AN+L D G VK+ DFG + R+Q M + TGT WM+PEV
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-32
Identities = 61/175 (34%), Positives = 97/175 (55%), Gaps = 6/175 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
I+ +L ++ SG +G ++ G + +Q +VAIK + ++ E +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G CT+ L IVTEFM G + ++L +++G LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEV 278
+N+ IHRDL N L+ GVVKV+DFG+ R ++ + +W PEV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEV 172
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-32
Identities = 58/180 (32%), Positives = 87/180 (48%), Gaps = 9/180 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
+EI + + + + G +GD+Y+G Y S E VA+K K + K F QE Y
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IMR+ H ++V+ IG T P + IV E G + +L K L SL+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
+ YL +HRD+ N+L+ VK+ DFG++R A G +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 8e-32
Identities = 61/174 (35%), Positives = 105/174 (60%), Gaps = 8/174 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ ++L + + G +G + +G Y Q+VA+K +K C T + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTA--QAFLEETAVMTKL 56
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNY 223
HKN+V+ +G L IV E M++G++ +FL + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
L ++HRDL N+L+ E+GV KV+DFG+ARV + GV ++ +W APE
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPV-KWTAPE 167
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 44/169 (26%), Positives = 89/169 (52%), Gaps = 8/169 (4%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G L + + +K + ++ + ++ EV I++K+ H N++++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS---LLKVAIDVSKGMNYLHQNNIIH 231
+ LCIV E+ G + + KQK + +L + + + YLH I+H
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH 126
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
RD+K N+ + NG+VK+ DFG+++V + + + A+T GT +++PE+
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPEL 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-31
Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 12/179 (6%)
Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
++ + G+ +Y C +++VAIK + E T + E +EV M + H
Sbjct: 1 DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HK-QKGVFQLTSLLKVAIDVSKGMNYL 224
NVV++ + L +V +++ GS+ D + +G + V +V KG+ YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEV 278
H N IHRD+K N+L+ E+G VK+ADFGV+ A G T + GT WMAPEV
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 57/166 (34%), Positives = 91/166 (54%), Gaps = 8/166 (4%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+ G++YK T + +EVAIK ++ N E++ E+ IM+ +H N+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ L +V E+M GS+ D + + + V +V +G+ YLH N+IHRD+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
K+ N+L+ ++G VK+ADFG A Q + GT WMAPEV
Sbjct: 143 KSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 65/182 (35%), Positives = 101/182 (55%), Gaps = 8/182 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID K L ++ +G +G + G + Q +VAIK++K ++ + EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H+ +VQ G CT+ + IVTE+M+ G + ++L + FQ + LL++ DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVAFTF 282
IHRDL N L+D+ G VKV+DFG++R T+ G+ RW PEV
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYS 176
Query: 283 FF 284
F
Sbjct: 177 KF 178
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-29
Identities = 55/170 (32%), Positives = 89/170 (52%), Gaps = 6/170 (3%)
Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
L+ + GS G +YK + + A+K + + E K+ +E+ +R V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-N 228
V+ GA + + IV E+M GS+ D L K+ G L +A + KG++YLH +
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPE 277
IIHRD+K +NLL++ G VK+ADFG+++V + GT +M+PE
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 55/171 (32%), Positives = 90/171 (52%), Gaps = 12/171 (7%)
Query: 117 KVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
K+ GS+G + +G + + VA+K LK + + ++++ +F +E IM + H+N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
G P L +VTE GS+ D L K G F +++L A+ ++ GM YL I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAPE 277
HRDL N+L+ + VK+ DFG+ R Q+ VM + W APE
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTE 149
+P D WE+ +L + + G++G + K + VA+K+LK + +
Sbjct: 1 LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 150 MLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
L + E+ +M+ I +HKN++ +G CT+ L +V E+ A G++ DFL ++ +
Sbjct: 59 -LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 209 S---------------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
S L+ A V++GM +L IHRDL N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 254 VAR-VQAQSGVMTAETG--TYRWMAPEVAF 280
+AR + G +WMAPE F
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALF 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 51/179 (28%), Positives = 92/179 (51%), Gaps = 25/179 (13%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKE-FSQ----EVYIMRKIR 165
K+E K+ G+YG +YK + VA+K ++ + +E E+ ++++++
Sbjct: 3 KLE-KLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKELK 56
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+V+ + L +V E+ + +L K+ G + + + +G+ Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGT--YRWMAPEV 278
+ I+HRDLK N+L++ +GV+K+ADFG+AR G+ T E T YR APE+
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTYTHEVVTLWYR--APEI 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 59/164 (35%), Positives = 94/164 (57%), Gaps = 6/164 (3%)
Query: 118 VASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
+ G++G+++KGT + VA+K K E + E+ +F E I+++ H N+V+ IG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
T+ + IV E + G FL K+K + L+K A+D + GM YL N IHRDL
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTA---ETGTYRWMAPE 277
N L+ EN V+K++DFG++R Q G+ ++ + +W APE
Sbjct: 122 RNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPE 164
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 9e-28
Identities = 63/166 (37%), Positives = 93/166 (56%), Gaps = 6/166 (3%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ SG+YGD+YK + + AIKV+K E E QE+ +M+ +H N+V + G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ R L I EF GS+ D H G + + V+ + +G+ YLH +HRD+
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVA 279
K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEVA
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 56/178 (31%), Positives = 94/178 (52%), Gaps = 13/178 (7%)
Query: 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH-KNVV 170
+I K+ GS+G++Y + VA+KVL + ++ ++ F +E+ I+ + H N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ +L +V E++ GS+ D L K +KG + L + + + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 229 IIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-------MTAETGTYRWMAPEV 278
IIHRD+K N+L+D +G VVK+ DFG+A++ G + GT +MAPEV
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 54/174 (31%), Positives = 89/174 (51%), Gaps = 11/174 (6%)
Query: 120 SGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG++G +YKG + + VAIKVL+ E + + KE E Y+M + H +VV+ +
Sbjct: 17 SGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G C + ++T+ M G + D++ K LL + ++KGM+YL + ++HRD
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 234 LKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVAFTFFF 284
L N+L+ VK+ DFG+A+ + AE G +WMA E +
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 63/196 (32%), Positives = 97/196 (49%), Gaps = 31/196 (15%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
D T ++E+ +++ + G+YG +YK + Q VAIK++ + +E +E
Sbjct: 3 DPTGIFEL----VEV---IGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEE 52
Query: 158 VYIMRKI-RHKNVVQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
I+RK H N+ F GA L +V E GS+ D + KG+ +
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109
Query: 211 LKVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
LK + +G+ YLH+N +IHRD+K N+L+ +N VK+ DFGV+ Q S +
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLG 168
Query: 265 TAET--GTYRWMAPEV 278
T GT WMAPEV
Sbjct: 169 RRNTFIGTPYWMAPEV 184
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 53/161 (32%), Positives = 89/161 (55%), Gaps = 5/161 (3%)
Query: 120 SGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
+G+ G + K + + +A+K ++ E +N + K+ +E+ I+ K +V F GA
Sbjct: 11 AGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 236
++ I E+M GS+ L + +G L K+A+ V KG+ YLH ++ IIHRD+K
Sbjct: 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+N+L++ G +K+ DFGV+ S T GT +MAPE
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE 169
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 38/188 (20%)
Query: 121 GSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G++G +YKG + VAIK LK E ++ +EF QE +M ++H N+V +
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74
Query: 174 GACTRPPNLCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVS 218
G CT+ C++ E++A G +++FL K + L +AI ++
Sbjct: 75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETG 269
GM YL ++ +HRDL N L+ E VK++DFG++R VQ++S +
Sbjct: 135 AGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL------ 188
Query: 270 TYRWMAPE 277
RWM PE
Sbjct: 189 PVRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 34/199 (17%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VAIK + E + EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLT 208
+M++ +VV+ +G + +V E MA+G + +L ++ G L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+++A +++ GM YL +HRDL N ++ E+ VK+ DFG+ R ET
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYET 172
Query: 269 GTY----------RWMAPE 277
Y RWMAPE
Sbjct: 173 DYYRKGGKGLLPVRWMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 8e-27
Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 27/184 (14%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
+ K+ G+Y +YK + VAIK +K + K+ F+ +E+ ++++++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQELK 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS------- 218
H N++ + N+ +V EFM D + V + S++ D+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME----TDL----EKVIKDKSIVLTPADIKSYMLMTL 112
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM-AP 276
+G+ YLH N I+HRDLK NLL+ +GV+K+ADFG+AR MT + T RW AP
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAP 171
Query: 277 EVAF 280
E+ F
Sbjct: 172 ELLF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 9e-27
Identities = 60/189 (31%), Positives = 95/189 (50%), Gaps = 13/189 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
ID +KIE + +G +G++ +G VAIK LK + ++F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N++ G T+ + I+TEFM G++ FL + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWMA 275
YL + N +HRDL N+L++ N V KV+DFG++R T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 276 PE-VAFTFF 283
PE +A+ F
Sbjct: 180 PEAIAYRKF 188
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 46/169 (27%), Positives = 89/169 (52%), Gaps = 8/169 (4%)
Query: 117 KVASGSYGDLYKG-TYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G++G +Y + E+ A+K ++ + + + +KE + E+ ++ ++H N+V++ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ I E+ + G++ + L + + + + +G+ YLH + I+HRD+
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-----TGTYRWMAPEV 278
K AN+ +D NGV+K+ DFG A + E GT +MAPEV
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 55/167 (32%), Positives = 87/167 (52%), Gaps = 12/167 (7%)
Query: 120 SGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
G++G + KG Y + EVA+K LK E + KEF +E +M ++ H +V+ IG
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIG 63
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
C P L +V E G + +L K++ ++ L ++A V+ GM YL + +HRDL
Sbjct: 64 VCKGEP-LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPE 277
N+L+ K++DFG++R + A S A T +W APE
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 48/136 (35%), Positives = 73/136 (53%), Gaps = 6/136 (4%)
Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCIVTEFMARGS---IYDFLHKQ 201
N ++ K+ +E+ I + + +V++ GA ++ I E+ GS IY + K+
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
G L K+A V KG++YLH IIHRD+K +N+L+ G VK+ DFGV+ S
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158
Query: 262 GVMTAETGTYRWMAPE 277
T TGT +MAPE
Sbjct: 159 LAGTF-TGTSFYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 48/167 (28%), Positives = 90/167 (53%), Gaps = 9/167 (5%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQF 172
+ G+YG +Y+G + + VA+K++ + + + + + +EV ++ ++R N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITKY 67
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
G+ + P L I+ E+ GS+ + + S+ + +V + Y+H+ +IHR
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--IIREVLVALKYIHKVGVIHR 125
Query: 233 DLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV 278
D+K AN+L+ G VK+ DFGV A + S + GT WMAPEV
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 56/170 (32%), Positives = 89/170 (52%), Gaps = 13/170 (7%)
Query: 121 GSYGDLYKG-TYCSQEVAIK--VLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G+YG +Y G T Q +A+K L V + ++ +EV +++ ++H N+VQ++G
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C + I EF+ GSI L + G K + G+ YLH N ++HRD+K
Sbjct: 71 CLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129
Query: 236 TANLLMDENGVVKVADFGVARVQA-------QSGVMTAETGTYRWMAPEV 278
N+++ NG++K+ DFG AR A S ++ + GT WMAPEV
Sbjct: 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 30/163 (18%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+KVL+P+ + ++F +EV I+ ++ N+ + +G CT P LC++ E+M G +
Sbjct: 49 VAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 196 DFLHKQKGVFQLTS----------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
FL K + LL +A ++ GM YL N +HRDL T N L+ +N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY-----------RWMAPE 277
+K+ADFG++R + Y RWMA E
Sbjct: 168 TIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWE 202
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 35/182 (19%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ G+YG +YK + VA+K ++ E +E+ +++K+RH N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 174 GACTRPPNLCIVTEFMARGSIY--------DF--LHKQKGV-F---QLTSLLKVAIDVSK 219
IVT +GSIY D L V F Q+ +K + +
Sbjct: 65 ---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---E 111
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGT--YRWMA 275
G+ YLH N I+HRD+K +N+L++ +GV+K+ADFG+AR S T T YR
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169
Query: 276 PE 277
PE
Sbjct: 170 PE 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-25
Identities = 64/187 (34%), Positives = 94/187 (50%), Gaps = 11/187 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIM 161
IDA +KIE + +G +G++ G VAIK LK + ++F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N++ G T+ + IVTE+M GS+ FL K G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPE 277
YL +HRDL N+L++ N V KV+DFG++RV T G RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 278 -VAFTFF 283
+A+ F
Sbjct: 180 AIAYRKF 186
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 54/183 (29%), Positives = 93/183 (50%), Gaps = 12/183 (6%)
Query: 99 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
+ D+WEI + + G++G +YK + A K+++ E + E L++F
Sbjct: 1 VNPNDIWEIIGE-------LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMV 51
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E+ I+ + +H N+V A L I+ EF G++ + + + + V
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMA 275
+ + +N+LH + +IHRDLK N+L+ +G VK+ADFGV A+ ++ GT WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 276 PEV 278
PEV
Sbjct: 172 PEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 38/190 (20%)
Query: 118 VASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ G++G ++ G E VA+K LK N + K+F +E ++ +H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIV 71
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF---------QLT--SLLKVAIDV 217
+F G CT +V E+M G + FL H F +LT LL++A+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------ 271
+ GM YL + +HRDL T N L+ + VVK+ DFG++R V T T Y
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184
Query: 272 ----RWMAPE 277
RWM PE
Sbjct: 185 MLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 61/182 (33%), Positives = 89/182 (48%), Gaps = 23/182 (12%)
Query: 118 VASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+ SG++G++Y+GT VA+K L+ + E KEF +E ++M H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNI 61
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNY 223
V+ +G C I+ E M G + +L + + L LL + +DV+KG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 224 LHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGVMTAETG---TYRWMA 275
L Q + IHRDL N L+ E G VVK+ DFG+AR +S E RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 276 PE 277
PE
Sbjct: 182 PE 183
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 48/169 (28%), Positives = 86/169 (50%), Gaps = 6/169 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+YG +YK + VAIK +K + + K +E+ +++++ H N+++ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L +V EFM +Y + ++ + + + +G+ + H + I+HRDL
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWM-APEVAFT 281
K NLL++ GV+K+ADFG+AR T T RW APE+
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLG 172
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-25
Identities = 59/166 (35%), Positives = 95/166 (57%), Gaps = 6/166 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+V SG+YGD+YK + + A+K++K E + L QE++++++ +H N+V + G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFG 73
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ L I E+ GS+ D H + +L + V + +G+ YLH +HRD+
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLHSKGKMHRDI 132
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVA 279
K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEVA
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 1e-24
Identities = 59/188 (31%), Positives = 94/188 (50%), Gaps = 13/188 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE L + +G++G + + T +VA+K+LKP ++E S E
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-E 88
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAI 215
+ IM + H+N+V +GACT + ++TE+ G + +FL +++ F L LL +
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---R 272
V+KGM +L N IHRDL N+L+ +VK+ DFG+AR + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 273 WMAPEVAF 280
WMAPE F
Sbjct: 209 WMAPESIF 216
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-24
Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 6/173 (3%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
K+ K+ GSYG +YK S Q A+K + ++ + ++ E+ I+ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---FQLTSLLKVAIDVSKGMNYLH 225
++ + A LCIV E+ G + + K+K + ++ I + +G+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ I+HRDLK+AN+L+ N +VK+ D G+++V + + + GT +MAPEV
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEV 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 39/206 (18%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-------------------VAIKVLKPECV 146
E +QL+++ K+ G +G+++ C E VA+K+L+ + V
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56
Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
+F +E+ IM ++++ N+++ +G C LC++TE+M G + FL +++
Sbjct: 57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 207 LT-----------SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
T +LL +A+ ++ GM YL N +HRDL T N L+ + +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 256 RVQAQSGVMTAETG----TYRWMAPE 277
R SG G RWMA E
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWE 201
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 61/172 (35%), Positives = 96/172 (55%), Gaps = 14/172 (8%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
V +G+YG +YKG + Q AIKV+ V + +E QE+ +++K H+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
A + PP L +V EF GS+ D + KG + + + ++ +G+++LHQ+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV 278
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEV
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 33/181 (18%)
Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
V G+YG + K C + VAIK K E + E +K+ + EV ++R++RH+N+
Sbjct: 7 GVVGEGAYGVVLK---CRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG----------VFQLTSLLKVAIDVSK 219
V A R L +V E++ R ++ + L G ++QL +
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL----------Q 111
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWM-APE 277
+ Y H +NIIHRD+K N+L+ E+GV+K+ DFG AR ++A+ + RW APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 278 V 278
+
Sbjct: 172 L 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-24
Identities = 59/172 (34%), Positives = 93/172 (54%), Gaps = 14/172 (8%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
V +G+YG +YKG + Q AIKV+ V + +E E+ +++K H+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
A + PP L +V EF GS+ D + KG + + + ++ +G+ +LH +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV 278
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEV
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-24
Identities = 44/170 (25%), Positives = 84/170 (49%), Gaps = 6/170 (3%)
Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
I K+ GS+G ++K + + A+K + +N +E E ++ K+ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + L IV E+ G ++ L Q+G + + I + G+ +LH I+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
HRD+K+ NL +D VK+ D GVA++ + + A T GT +++PE+
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-24
Identities = 57/177 (32%), Positives = 101/177 (57%), Gaps = 17/177 (9%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-------MLKEFSQEVYIMRKIRHKN 168
+ SGS+G +Y G S + +A+K ++ V+ ML ++E+ ++++++H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+VQ++G+ +L I E++ GS+ L+ G F+ T + + KG+NYLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET------GTYRWMAPEV 278
IIHRD+K AN+L+D G +K++DFG++ +++A S G+ WMAPEV
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 8e-24
Identities = 55/169 (32%), Positives = 85/169 (50%), Gaps = 25/169 (14%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+LK E + +M +F +E +M + H N+V+ +G C +C++ E+MA G +
Sbjct: 38 VAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 196 DFLHKQ--KGVFQL-------------------TSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+FL + + L T L +A V+ GM YL + +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVAF 280
T N L+ EN VVK+ADFG++R + + +E RWM PE F
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-24
Identities = 50/167 (29%), Positives = 91/167 (54%), Gaps = 8/167 (4%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ G++G+++ G + VA+K + E + ++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
CT+ + IV E + G FL + ++ L+++ + + GM YL + IHRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPE 277
N L+ E V+K++DFG++R + + GV + G +W APE
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPE 166
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-24
Identities = 47/136 (34%), Positives = 78/136 (57%), Gaps = 7/136 (5%)
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
E+++ +E+ +M ++ H ++++ +GA + + E+MA GS+ L K G F+
Sbjct: 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEA 103
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAE 267
++ + +G++YLH+N IIHRD+K ANLL+D G +++ADFG A A G E
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 268 -----TGTYRWMAPEV 278
GT +MAPEV
Sbjct: 164 FQGQLLGTIAFMAPEV 179
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 10/181 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
EI + + + +G +G++++G VAIK LKP + ++F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASI 59
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + H N+++ G T+ I+TE+M G++ +L G F L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--SGVMTAETGT--YRWMAP 276
M YL N +HRDL N+L++ N KV+DFG++RV G T G RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 277 E 277
E
Sbjct: 180 E 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 60/167 (35%), Positives = 94/167 (56%), Gaps = 10/167 (5%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G+++KG Q VAIK++ E E +++ QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ + L I+ E++ GS D L FQ+ ++LK ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+K AN+L+ E G VK+ADFGVA Q + T GT WMAPEV
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-23
Identities = 55/165 (33%), Positives = 92/165 (55%), Gaps = 6/165 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G++YKG + VAIK++ E E +++ QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L I+ E++ GS D L + G + T + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVM-TAETGTYRWMAPEV 278
K AN+L+ E G VK+ADFGVA + + GT WMAPEV
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-23
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
VA+K L+ E L++F +E+ I++ ++H N+V++ G C NL +V E++ GS
Sbjct: 36 VAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ D+L K + LL A + KGM YL +HRDL T N+L++ VK+ DFG
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 254 VARV--QAQSGVMTAETGTYR--WMAPE 277
+ +V Q + E G W APE
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWYAPE 181
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 2e-23
Identities = 56/165 (33%), Positives = 92/165 (55%), Gaps = 6/165 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G+++KG + VAIK++ E E +++ QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L I+ E++ GS D L + G T + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
K AN+L+ E+G VK+ADFGVA + + GT WMAPEV
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 55/152 (36%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 121 GSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G++G++Y+G Y +VA+K L PE + + +F E IM K H+N+V+ I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLT--SLLKVAIDVSKGMNYLHQN 227
G I+ E MA G + FL + + LT LL A DV+KG YL +N
Sbjct: 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135
Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVAR 256
+ IHRD+ N L+ G V K+ADFG+AR
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-23
Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 16/175 (9%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----------MLKEFSQEVYIMRKIRHK 167
+ G+YG +Y + + V + E T M+K E+ ++ + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+VQ++G T L I E++ GSI L G F+ + V +G+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR----VQAQSGVMTAETGTYRWMAPEV 278
I+HRDLK NLL+D +G+ K++DFG+++ + M+ + G+ WMAPEV
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEV 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 8e-23
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 7/156 (4%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--V 185
+G ++VA+K LKPE + + +E+ I+R + H+N+V++ G CT I +
Sbjct: 28 EGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
EF+ GS+ ++L + K L LK A+ + KGM+YL +HRDL N+L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 246 VVKVADFGVAR-VQAQSGVMTAE---TGTYRWMAPE 277
VK+ DFG+ + ++ T + W APE
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 134 QEVAIKVL----KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189
+ VA+K + + + L+E + ++ +H VV+ + +V E+M
Sbjct: 26 ETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81
Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
+ + L ++ + + KG+ Y+H N I+HRDLK ANLL+ +GV+K+
Sbjct: 82 PS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140
Query: 250 ADFGVARVQA--QSGVMTAETGTYRWMAPEVAF 280
ADFG+AR+ + + + + + T + APE+ +
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 57/169 (33%), Positives = 92/169 (54%), Gaps = 12/169 (7%)
Query: 117 KVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVV 170
V GSYG + K C Q VAIK E + +M+K+ + +E+ +++++RH+N+V
Sbjct: 8 LVGEGSYGMVMK---CKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I R L +V EF+ ++ D L K + + K + +G+ + H +NII
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEV 278
HRD+K N+L+ ++GVVK+ DFG AR A G + + RW APE+
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-22
Identities = 58/181 (32%), Positives = 96/181 (53%), Gaps = 14/181 (7%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + + VAIK+L E + EF E
Sbjct: 6 ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM + H ++V+ +G C P + +VT+ M G + D++H+ K LL + ++K
Sbjct: 62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
GM YL + ++HRDL N+L+ VK+ DFG+AR ++ A+ G +WMA
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 277 E 277
E
Sbjct: 181 E 181
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 8e-22
Identities = 48/162 (29%), Positives = 90/162 (55%), Gaps = 4/162 (2%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180
G+YG +Y S +V I + + ++ ++ +E+ + ++H+N+VQ++G+ +
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
I E + GS+ L + G + +++ + +G+ YLH N I+HRD+K N
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 239 LLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
+L++ +GVVK++DFG ++ A T TGT ++MAPEV
Sbjct: 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 45/145 (31%), Positives = 73/145 (50%), Gaps = 7/145 (4%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ G +G +Y GT + A+K L + E +++F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 173 IGACTRPPNL-CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+G C +V +M G + +F+ + + L+ + V+KGM YL +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 232 RDLKTANLLMDENGVVKVADFGVAR 256
RDL N ++DE+ VKVADFG+AR
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-21
Identities = 60/170 (35%), Positives = 93/170 (54%), Gaps = 14/170 (8%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL--KPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++Y +E+A+K + P+ T + + E+ +++ +RH +VQ+ G
Sbjct: 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG- 71
Query: 176 CTRPP---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
C R P L I E+M GSI D L K G + + +G++YLH N I+HR
Sbjct: 72 CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNMIVHR 130
Query: 233 DLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEV 278
D+K AN+L D G VK+ DFG + R+Q SG + + TGT WM+PEV
Sbjct: 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 121 GSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G +G + +G +VA+K +K + ++EF E M+ H NV++ IG
Sbjct: 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69
Query: 176 C------TRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYL 224
C + P ++ FM G ++ FL L +LLK +D++ GM YL
Sbjct: 70 CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
N IHRDL N ++ E+ V VADFG+++
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 61/173 (35%), Positives = 95/173 (54%), Gaps = 14/173 (8%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
+ G++G +Y +E+A K ++ + + E KE S E+ +++ ++H+ +VQ+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 173 IGACTR---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
G C R L I E+M GS+ D L K G + K + +GM+YLH N I
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEV 278
+HRD+K AN+L D G VK+ DFG + R+Q SG + + TGT WM+PEV
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 6e-21
Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 24/216 (11%)
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL----KIECKVASGSYGDLYK 128
+R P+L VP+ L SS + + + AK L ++ ++ SG+ G +YK
Sbjct: 36 QRDPSLAVPL--PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVN-RIGSGAGGTVYK 92
Query: 129 GTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184
+ + A+KV+ N E + ++ +E+ I+R + H NVV+ + +
Sbjct: 93 VIHRPTGRLYALKVIYG---NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149
Query: 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+ EFM GS+ + + L VA + G+ YLH+ +I+HRD+K +NLL++
Sbjct: 150 LLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204
Query: 245 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPE 277
VK+ADFGV+R+ AQ+ M + GT +M+PE
Sbjct: 205 KNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-21
Identities = 56/181 (30%), Positives = 96/181 (53%), Gaps = 14/181 (7%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + + VAIK L+ E + + KE E Y
Sbjct: 6 ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M + + +V + +G C + ++T+ M G + D++ + K LL + ++K
Sbjct: 62 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
GMNYL + ++HRDL N+L+ VK+ DFG+A+ + A AE G +WMA
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 277 E 277
E
Sbjct: 181 E 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-21
Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
VA+K+LK + + L + E+ +M+ I +HKN++ +G CT+ L ++ E+ A+G++
Sbjct: 47 VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 195 YDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
+FL ++ L+ A V++GM YL IHRDL N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 240 LMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVAF 280
L+ E+ V+K+ADFG+AR + +WMAPE F
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-21
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
E+P D WE+ +L + + G +G + +VA+K+LK +
Sbjct: 6 ELPEDPR--WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT 63
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 64 EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ A V++GM YL IHRDL N+L+ E+ V+K+A
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVAF 280
DFG+AR T +WMAPE F
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 215
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 9e-21
Identities = 60/172 (34%), Positives = 92/172 (53%), Gaps = 12/172 (6%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
+ G++G +Y +E+A+K ++ + + E KE + E+ +++ + H+ +VQ+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 173 IGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
G P L I E M GSI D L K G K + +G++YLH N I+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 231 HRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEV 278
HRD+K AN+L D G VK+ DFG + R+Q SG M + TGT WM+PEV
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 21/191 (10%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
++ +K + + G++G + K + AIK +K E + + ++F+ E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62
Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
K+ H N++ +GAC L + E+ G++ DFL K +
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 267 ETGTYRWMAPE 277
RWMA E
Sbjct: 183 GRLPVRWMAIE 193
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-20
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 34/169 (20%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+L+P+ N +F +EV I+ +++ N+++ +G C LC++TE+M G +
Sbjct: 49 VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 196 DFLHK------------------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
FL +SLL VA+ ++ GM YL N +HRDL T
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 238 NLLMDENGVVKVADFGVA---------RVQAQSGVMTAETGTYRWMAPE 277
N L+ EN +K+ADFG++ R+Q ++ + RWMA E
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWE 210
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-20
Identities = 55/167 (32%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + ++ VAIK + + E ++ +EV ++++RH N +++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + + +G+ YLH + IHRD
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEV 278
+K N+L+ E G VK+ADFG A + A S V GT WMAPEV
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 45/123 (36%), Positives = 74/123 (60%), Gaps = 5/123 (4%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
VA+K LK EC + + +E+ I++ + H+N+V++ G C+ L ++ E++ GS
Sbjct: 36 VAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ D+L K K L LL A + +GM YLH + IHRDL N+L+D + +VK+ DFG
Sbjct: 95 LRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 254 VAR 256
+A+
Sbjct: 153 LAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 1e-20
Identities = 46/134 (34%), Positives = 76/134 (56%), Gaps = 11/134 (8%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG------ACTRPPNLCIVTE 187
Q+VA+K+LK + ++ ++EF +E M++ H NV++ IG A R P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 188 FMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
FM G ++ FL ++ L +L++ ID++ GM YL N IHRDL N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 243 ENGVVKVADFGVAR 256
EN V VADFG+++
Sbjct: 148 ENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 57/165 (34%), Positives = 87/165 (52%), Gaps = 7/165 (4%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + S+ VAIK + + E ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K N+L+ E G+VK+ DFG A + A + GT WMAPEV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 47/166 (28%), Positives = 83/166 (50%), Gaps = 28/166 (16%)
Query: 113 KIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKI 164
+IE + G+YG +YK +E AIK K + SQ E+ ++R++
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLREL 59
Query: 165 RHKNVVQFIGACTRPPNLCI--VTEFMARGSIYDFL-----HKQKGVFQL-TSLLKVAI- 215
+H+NVV + + + + ++ + +D H+Q + S++K +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV 257
+ G++YLH N ++HRDLK AN+L+ E GVVK+ D G+AR+
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-20
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 31/212 (14%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECVN 147
+P D WE+ +L + + G +G + + VA+K+LK + +
Sbjct: 1 LPADPK--WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--GV 204
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++ G+
Sbjct: 59 KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 205 -----------FQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
QLT L+ A V++GM YL IHRDL N+L+ E+ V+K+AD
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIAD 177
Query: 252 FGVARVQAQSGVMTAETG---TYRWMAPEVAF 280
FG+AR T +WMAPE F
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 122 SYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
++G +YKG +Q VAIK LK + N + EF QE +M ++ H N+V +G
Sbjct: 17 AFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75
Query: 176 CTRPPNLCIVTEFMARGSIYDFL-----HKQ-----------KGVFQLTSLLKVAIDVSK 219
T+ +C++ E++ +G +++FL H K L +AI ++
Sbjct: 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAP 276
GM YL + +H+DL N+L+ E VK++D G++R + + + RWM P
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195
Query: 277 E 277
E
Sbjct: 196 E 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G +G + + VA+K+LK +
Sbjct: 3 ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 204
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 61 EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 205 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ V++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVAF 280
DFG+AR T +WMAPE F
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALF 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 5e-20
Identities = 53/165 (32%), Positives = 87/165 (52%), Gaps = 7/165 (4%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + ++ VAIK + + E ++ +EV +++I+H N +++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + + +G+ YLH +N+IHRD
Sbjct: 92 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K N+L+ E G VK+ADFG A + + + GT WMAPEV
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEV 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 7e-20
Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 40/187 (21%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLK------PECVNTEMLKEFSQEVYIMRKI 164
K+ ++ G++G +Y + VAIK +K EC+N L+E V +RK+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LRE----VKSLRKL 54
Query: 165 -RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------VFQLTSLLK 212
H N+V+ L V E+M G++Y + +KG ++Q+
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--- 110
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
G+ ++H++ HRDLK NLL+ VVK+ADFG+AR T T R
Sbjct: 111 -------GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-R 162
Query: 273 WM-APEV 278
W APE+
Sbjct: 163 WYRAPEI 169
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-20
Identities = 32/52 (61%), Positives = 39/52 (75%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL 64
+L+SLLG++GLNI EAHAFST DG +LD+FVV GW ET L + L KEI
Sbjct: 17 QLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEID 68
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 9e-20
Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 8/179 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
E+D K +KIE + +G +G+L +G +E VAI L+ C + + F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALT 59
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ + H N+V+ G TR + IVTE+M+ G++ FL K +G L+ + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPE 277
M YL + +H+ L +L++ + V K++ F + + T +G W APE
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPE 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 52/165 (31%), Positives = 87/165 (52%), Gaps = 7/165 (4%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y T + ++ VA+K + T E ++ +EV +++++H N +++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G + +V E+ GS D L K Q + + +G+ YLH +N+IHRD
Sbjct: 88 GCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K N+L+ E G VK+ADFG A + + GT WMAPEV
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEV 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-19
Identities = 49/167 (29%), Positives = 92/167 (55%), Gaps = 6/167 (3%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G L K ++ IK + ++ + +E +EV ++ ++H N+VQ+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ NL IV ++ G +Y ++ Q+GV F +L + + + ++H I+HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+K+ N+ + ++G +K+ DFG+ARV S V A T GT +++PE+
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEI 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 32/185 (17%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNV 169
K+ G++G+++K Q VA+K V E KE F +E+ I++ ++H+NV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIY---DF--------LHKQKGVFQLTSLLKVAIDVS 218
V I C +GS Y +F L + F L+ + KV +
Sbjct: 74 VNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRW 273
G+ Y+H+N I+HRD+K AN+L+ ++G++K+ADFG+AR ++ T T +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 274 MAPEV 278
PE+
Sbjct: 190 RPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 61/193 (31%), Positives = 92/193 (47%), Gaps = 25/193 (12%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
WE +K E + G++G + + AIK+LK E + ++F+ E+ +
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55
Query: 161 MRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQ 206
+ K+ H N++ +GAC L I E+ G++ DFL K +
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 207 LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
LTS LL+ A DV+ GM YL + IHRDL N+L+ EN K+ADFG++R +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 265 TAETGTYRWMAPE 277
T RWMA E
Sbjct: 176 TMGRLPVRWMAIE 188
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 53/175 (30%), Positives = 91/175 (52%), Gaps = 10/175 (5%)
Query: 108 DAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKI 164
K + E K+ G+ G +Y + QEVAIK + + + KE E+ +MR+
Sbjct: 18 KKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+H N+V ++ + L +V E++A GS+ D + + + V + + + +L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 131
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
H N +IHRD+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 45/166 (27%), Positives = 91/166 (54%), Gaps = 6/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ G++G+ LY+ T V K + ++ + ++ E+ I+ ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L I E+ G++YD + +QKG +F+ +L + ++Y+H+ I+HRD+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
KT N+ + + G++K+ DFG++++ M AET GT +M+PE+
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 41/131 (31%), Positives = 74/131 (56%), Gaps = 11/131 (8%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+L+ + N +F +E+ IM +++ N+++ + C LC++TE+M G +
Sbjct: 49 VAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 196 DFL--HKQKG--------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
FL H+ + ++L+ +A ++ GM YL N +HRDL T N L+ +N
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 246 VVKVADFGVAR 256
+K+ADFG++R
Sbjct: 168 TIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-19
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 120 SGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G+YG ++ K AIKV+ K + + + + E I+ + + VV+ +
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
NL +V E++ G + L G ++ + YLH N IIHRDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 237 ANLLMDENGVVKVADFGVARV-----QAQSGVMTAET----GTYRWMAPEV 278
N+L+D NG +K+ DFG+++V Q E GT ++APEV
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 50/158 (31%), Positives = 85/158 (53%), Gaps = 11/158 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + VAIKVL+ E + + KE E Y
Sbjct: 6 ETELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M + V + +G C + +VT+ M G + D++ + K LL + ++K
Sbjct: 62 VMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
GM+YL + ++HRDL N+L+ VK+ DFG+AR+
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 54/164 (32%), Positives = 86/164 (52%), Gaps = 29/164 (17%)
Query: 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHK 167
+I K+ G++G++YK + + LK ++ E K+ F +E+ I++K++H
Sbjct: 11 EILGKLGEGTFGEVYKAR-QIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHP 67
Query: 168 NVVQFIG-ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---KVAIDVSK---- 219
NVV I A RP RGS+Y L+ LL V + S+
Sbjct: 68 NVVPLIDMAVERPDK-----SKRKRGSVYMVTPYM--DHDLSGLLENPSVKLTESQIKCY 120
Query: 220 ------GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
G+NYLH+N+I+HRD+K AN+L+D G++K+ADFG+AR
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 54/172 (31%), Positives = 90/172 (52%), Gaps = 16/172 (9%)
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPE---CVNTEMLKEFSQEVYIMRKIRHKNV 169
++ SG++G + KG Y + +VAIKVLK E V EM++E IM ++ + +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE----AEIMHQLDNPYI 57
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ IG C L +V E + G + FL +K +++++++ VS GM YL N
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPE 277
+HRDL N+L+ K++DFG+++ + A A + +W APE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 47/132 (35%), Positives = 78/132 (59%), Gaps = 7/132 (5%)
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
+ K+ +E+ IM + R +V F GA N+C+ EFM GS+ D ++K+ G +
Sbjct: 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVE 103
Query: 209 SLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
L K+A+ V +G+ YL+ + I+HRD+K +N+L++ G +K+ DFGV+ S A+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IAD 160
Query: 268 T--GTYRWMAPE 277
T GT +M+PE
Sbjct: 161 TFVGTSTYMSPE 172
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 52/157 (33%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 127 YKGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
YK T + AIK LK + E L + RH +V ++
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77
Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
C V E+ A G + +H VF + A V G+ YLH+N I++RDLK NLL+D
Sbjct: 78 CFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 243 ENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
G VK+ADFG+ + G T+ GT ++APEV
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEV 172
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 3e-18
Identities = 51/165 (30%), Positives = 83/165 (50%), Gaps = 11/165 (6%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+G + K T + A+KVL K + + + ++ E I+ +I H +V+ A
Sbjct: 4 GSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V E+ G ++ L K+ G F A ++ + YLH II+RDLK
Sbjct: 62 FQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
N+L+D +G +K+ DFG+A+ + S T GT ++APEV
Sbjct: 121 PENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 57/173 (32%), Positives = 90/173 (52%), Gaps = 9/173 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
KIE K+ G+YG +YKG Q VA+K ++ E + +E+ ++++++H N+
Sbjct: 3 TKIE-KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 170 VQFIGACTRPPNLCIVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
V + L ++ EF M D L KG + L+K + + +G+ + H
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
++HRDLK NLL+D GV+K+ADFG+AR V T E T + APEV
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-18
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K LK + ++F +E ++ ++H+++V+F G CT L +V E+M G +
Sbjct: 38 VAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
FL G L +L +A ++ GM YL + +HRDL T N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPE 277
+ VVK+ DFG++R + T RWM PE
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-18
Identities = 51/168 (30%), Positives = 92/168 (54%), Gaps = 7/168 (4%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G +Y K S+ IK + + + + +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L IV E+ G + +++Q+GV F +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 234 LKTANLLMDENGVV-KVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+K+ N+ + +NG+V K+ DFG+AR S + A T GT +++PE+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEI 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 12/179 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYI 160
+ WEI + + G++G +YK V A KV+ + + E L+++ E+ I
Sbjct: 5 EFWEIIGE-------LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ H N+V+ + A NL I+ EF A G++ + + + + V +
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEV 278
+NYLH+N IIHRDLK N+L +G +K+ADFGV+ ++ + GT WMAPEV
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K LK K+F +E ++ ++H+++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 196 DFLH---------------KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
FL + KG L+ +L +A ++ GM YL + +HRDL T N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPE 277
+ N +VK+ DFG++R + T RWM PE
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-18
Identities = 55/183 (30%), Positives = 90/183 (49%), Gaps = 24/183 (13%)
Query: 117 KVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
++ G++G ++ C ++ VA+K LK N K+F +E ++ ++H+++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHI 69
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF--------QLTS--LLKVAIDV 217
V+F G C L +V E+M G + FL H V +LT +L +A +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWM 274
+ GM YL + +HRDL T N L+ EN +VK+ DFG++R + T RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 275 APE 277
PE
Sbjct: 190 PPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-18
Identities = 38/165 (23%), Positives = 86/165 (52%), Gaps = 4/165 (2%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V G++G ++ + + V IK + E + + E +++ + H N++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L IV E+ G++ +++ K+ + ++L + + ++++H I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 235 KTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
KT N+L+D++ VVK+ DFG++++ + GT +++PE+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 51/169 (30%), Positives = 91/169 (53%), Gaps = 10/169 (5%)
Query: 117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ SG++G + KG Y + VA+K+LK + + + E +E +M+++ + +V+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
IG C + +V E G + FL K K V + ++ ++ VS GM YL + N +HR
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNFVHR 119
Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPE 277
DL N+L+ K++DFG+++ + A A+T G + +W APE
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 5/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V GSYG+ L + ++ IK L + K QE ++ +++H N+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 176 CTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYLHQNNIIHRD 233
L IV F G +Y L +QKG + +++ + ++ + YLH+ +I+HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV 278
LKT N+ + ++KV D G+ARV + Q + + GT +M+PE+
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 56/180 (31%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 118 VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172
+ G++G + K + AIK +K E + + ++F+ E+ ++ K+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDV 217
+GAC L + E+ G++ DFL K + LL A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 47/173 (27%), Positives = 89/173 (51%), Gaps = 14/173 (8%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF-- 172
++ G+YG +Y+ T + VA+K ++ + + +E+ ++ +RH N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 173 IGACTRPPNLCIVTEF----MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ ++ +V E+ +A L F + + + + + +G+ YLH+N
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS-----LLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVAF 280
IIHRDLK +NLL+ + G +K+ADFG+AR + MT + T + APE+
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.2 bits (197), Expect = 2e-17
Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 9/166 (5%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G ++ + QEVAIK + + + KE E+ +M+++++ N+V F+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + + +LH N +IHRD
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 40/152 (26%), Positives = 68/152 (44%), Gaps = 11/152 (7%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----R 165
K + GS+ + ++E AIK+L + E K + V I +++
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KV--KYVKIEKEVLTRLNG 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +++ NL V E+ G + ++ K G A ++ + YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
IIHRDLK N+L+D++ +K+ DFG A+V
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKV 151
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 66/195 (33%), Positives = 94/195 (48%), Gaps = 30/195 (15%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQE 157
D TD WEI IE + G+YG +YK T A+K+L P +++ +E E
Sbjct: 19 DPTDTWEI------IE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAE 68
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
I++ + H NVV+F G + L +V E GS+ + + KG+ L
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRL 125
Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
A+ G+ +LH N IIHRD+K N+L+ G VK+ DFGV+ Q S +
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLR 184
Query: 266 AET--GTYRWMAPEV 278
T GT WMAPEV
Sbjct: 185 RNTSVGTPFWMAPEV 199
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-17
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 12/174 (6%)
Query: 114 IECKVASGSYGDLY--KGTYCSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKN 168
++ ++ GS+G +Y K E +KVLK V N + +QE ++ K+ H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDF----LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+V+F + CI+TE+ G D L + + I + G++Y+
Sbjct: 64 IVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPE 277
HQ I+HRDLK N+ + N ++K+ DFGV+R+ S + T TGT +M+PE
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 3e-17
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 9/166 (5%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G +Y QEVAIK + + + KE E+ +MR+ ++ N+V ++
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + +++LH N +IHRD
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-17
Identities = 46/174 (26%), Positives = 89/174 (51%), Gaps = 9/174 (5%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNV 169
KIE K+ G + +YK + VA+K ++ E ++ + ++ +E+ +++++ H NV
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
++++ + L IV E G + + KQK + ++ K + + + ++H
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
I+HRD+K AN+ + GVVK+ D G+ R S A + GT +M+PE
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPER 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 43/157 (27%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 158
E + ++LK+ + SG +G ++KG + + +IK+ P + T + +E + +
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI--PVAIKTIQDRSGRQTFQEITDHM 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
M + H +V+ +G C +L +VT+ GS+ D + + + LL + ++
Sbjct: 61 LAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
KGM YL ++ ++HR+L N+L+ + +V++ADFGVA
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-17
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 41/196 (20%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEV 158
E+D K + I+ + G+YG CS ++VAIK + N K +E+
Sbjct: 2 EVDTKYVPIKP-IGRGAYG-----IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREI 55
Query: 159 YIMRKIRHKNVVQFIGACTRPPN------LCIVTEFMARGSIYDFL---------HKQKG 203
++R + H+NV+ I PP+ + IV E M ++ + H Q
Sbjct: 56 KLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262
++QL +G+ Y+H N++HRDLK +NLL++ N +K+ DFG+AR ++ G
Sbjct: 114 LYQLL----------RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
Query: 263 VMTAETGTYRWMAPEV 278
MT T + APE+
Sbjct: 164 FMTEYVVTRWYRAPEL 179
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 5e-17
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 21/179 (11%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQ 171
+ GS+G + K S + + K + + KE Q EV I+R+++H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63
Query: 172 FIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH- 225
+ N L IV E+ G + + K ++ + + ++ + + H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
N ++HRDLK AN+ +D N VK+ DFG+A++ A+T GT +M+PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQ 181
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 52/166 (31%), Positives = 88/166 (53%), Gaps = 9/166 (5%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS G + T + ++VA+K K + + + EV IMR H+NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V EF+ G++ D + H + Q+ + V + V + ++YLH +IHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 143
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+K+ ++L+ +G +K++DFG A+V + + GT WMAPEV
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEV 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-17
Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
G+ ++G ++ V +K L+ E L F QEV R++ H NV+Q +G C
Sbjct: 14 GEAHRGMSKAR-VVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 184 IVTEFMARGSIYDFLHKQKGVF----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
+V EF G + ++L +G+ Q L ++A +V+ G+ +LHQ + IH DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 240 LMDENGVVKVADFGVARVQ-AQSGVMTAETGTY--RWMAPEV 278
+ + VK+ D+G+A Q + +T + RW+APE+
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-17
Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 12/182 (6%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQE 157
D +VWEI + + G++G +YK A KV+ E + E L+++ E
Sbjct: 9 DPNEVWEIIGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
+ I+ H +V+ +GA L I+ EF G++ + + + + +
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 276
+ + YLH IIHRDLK N+L+ +G +K+ADFGV+ ++ + GT WMAP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 277 EV 278
EV
Sbjct: 180 EV 181
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-17
Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
L + + G +G + K T VA+K+LK E ++ L++ E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------------- 204
+ H +V++ GAC++ L ++ E+ GS+ FL + + V
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 205 ----FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
+ L+ A +S+GM YL + ++HRDL N+L+ E +K++DFG++R V
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 260 QSGVMTAETG--TYRWMAPEVAF 280
+ + G +WMA E F
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLF 202
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-17
Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 118 VASGSYGDLYKGTYCSQE----VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ G +G + +G + VA+K +K C +EM ++F E M++ H NV++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65
Query: 173 IGACTRP------PNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGM 221
IG C + P+ ++ FM G ++ FL L+K D++ GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
YL + IHRDL N +++EN V VADFG+++
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 1/140 (0%)
Query: 142 KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ 201
K +CV ++ E I++++ H +V + N+ +V + + G + L Q
Sbjct: 35 KQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQ 93
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
K F + ++ + YLH IIHRD+K N+L+DE G V + DF +A
Sbjct: 94 KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153
Query: 262 GVMTAETGTYRWMAPEVAFT 281
+ T+ +GT +MAPEV
Sbjct: 154 TLTTSTSGTPGYMAPEVLCR 173
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-16
Identities = 49/166 (29%), Positives = 87/166 (52%), Gaps = 9/166 (5%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G +Y QEVAI+ + + + KE E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + + +LH N +IHRD
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 10/166 (6%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFI 173
++ G++G +Y K AIKVL K + + + E IM V +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++ G + K G + +V G+ LHQ IIHRD
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
+K NLL+D+ G +K+ DFG++R G+ + GT ++APE
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPET 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 120 SGSYGD----LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+GS+G +KG+ + A+K+L K + V + ++ E I++ IRH +V G
Sbjct: 11 TGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ NL +V E++ G ++ L ++ G F A V + YLH +I++RDL
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
K NLL+D +G +K+ DFG A+ + T GT ++APE+
Sbjct: 128 KPENLLLDSDGYIKITDFGFAKR-VKGRTYTL-CGTPEYLAPEI 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 51/199 (25%), Positives = 92/199 (46%), Gaps = 34/199 (17%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VAIK + E + EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
+M++ +VV+ +G ++ ++ E M RG + +L + + L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+ R ET
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYET 172
Query: 269 GTY----------RWMAPE 277
Y RWM+PE
Sbjct: 173 DYYRKGGKGLLPVRWMSPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 51/164 (31%), Positives = 85/164 (51%), Gaps = 5/164 (3%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
K+ GS G + T S + V K + + + EV IMR +H+NVV+ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V EF+ G++ D + H + Q+ + V + V K ++ LH +IHRD+K
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQGVIHRDIK 143
Query: 236 TANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+ ++L+ +G VK++DFG A+V + + GT WMAPE+
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-16
Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 35/195 (17%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
+ + + G+YG + T+ +VAIK + P T + +E+ I+R+ +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62
Query: 167 KNVVQFIGACTRPPNLC------IVTEFMARGSIYDFL--------HKQKGVFQLTSLLK 212
+N++ I RPP+ IV E M +Y + H Q ++Q+ LK
Sbjct: 63 ENIIG-ILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ----SGVMTAET 268
Y+H N++HRDLK +NLL++ N +K+ DFG+AR+ +G +T
Sbjct: 121 ----------YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 269 GTYRWM-APEVAFTF 282
T RW APE+
Sbjct: 171 AT-RWYRAPEIMLNS 184
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 41/123 (33%), Positives = 68/123 (55%), Gaps = 3/123 (2%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
EV IMR +H N+V+ + L +V EF+ G++ D + + + V +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMA 275
V K +++LH +IHRD+K+ ++L+ +G VK++DFG A+V + + GT WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 276 PEV 278
PEV
Sbjct: 184 PEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-16
Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 9/159 (5%)
Query: 121 GSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G+ G +YK + +A+KV+ P + E+ K+ E+ I+ K ++ F GA
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
+ I TEFM GS+ + + V L ++A+ V KG+ YL I+HRD+K +N
Sbjct: 71 ENRISICTEFMDGGSLDVYRKIPEHV-----LGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+L++ G VK+ DFGV+ Q + + GT +MAPE
Sbjct: 126 MLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 39/194 (20%)
Query: 113 KIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
K + SG+YG CS ++VAIK + + K +E+ I+R +
Sbjct: 8 KPIENIGSGAYG-----VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 166 HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGV------FQLTSLLKVA 214
H N++ I RPP ++ +V + M ++ +H + + + L LL+
Sbjct: 63 HDNIIA-IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLR-- 118
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----GVMTAETG 269
G+ Y+H N+IHRDLK +NLL++E+ +++ DFG+AR + S MT
Sbjct: 119 -----GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 270 TYRWM-APEVAFTF 282
T RW APE+ +
Sbjct: 174 T-RWYRAPELLLSL 186
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-16
Identities = 46/173 (26%), Positives = 86/173 (49%), Gaps = 12/173 (6%)
Query: 117 KVASGSYGDLYKGT----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ +G +G + G Y +V +K L+ E +K F +E R ++H N++Q
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQC 60
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT----SLLKVAIDVSKGMNYLHQNN 228
+G CT +V EF G + +L + +T +L ++A +++ G+ +LH+NN
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEV 278
IH DL N L+ + VK+ D+G++ + + + RW+APE+
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 49/164 (29%), Positives = 81/164 (49%), Gaps = 8/164 (4%)
Query: 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEV-YIMRKIRHKNVVQFIGACT 177
G++G + K + +A+K ++ E K ++ +MR +V+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 178 RPPNLCIVTEFM--ARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRD 233
R + I E M + Y +++ K V L K+A+ K +NYL + IIHRD
Sbjct: 74 REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+K +N+L+D NG +K+ DFG++ S T + G +MAPE
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 7e-16
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 7/172 (4%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYI-MRKIRHKNV 169
L++ ++ G+YG + K + + V + VN++ K ++ I MR +
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLL-KVAIDVSKGMNYLHQ 226
V F GA R ++ I E M S+ F K KG+ +L K+A+ + K + YLH
Sbjct: 63 VTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 227 N-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
++IHRD+K +N+L++ NG VK+ DFG++ S T + G +MAPE
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-16
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 28/194 (14%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
D +D WEI IE + G+YG ++K + A+K+L P ++ +E E
Sbjct: 15 DPSDTWEI------IE-TIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAE 64
Query: 158 VYIMRKIR-HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
I++ + H NVV+F G + L +V E GS+ D + KG + +
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121
Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVM 264
+ I + G+ +LH N IHRD+K N+L+ G VK+ DFGV A++ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 265 TAETGTYRWMAPEV 278
GT WMAPEV
Sbjct: 182 NTSVGTPFWMAPEV 195
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 50/172 (29%), Positives = 89/172 (51%), Gaps = 18/172 (10%)
Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTE---MLKEFS-QEVYIMRKIRH 166
K+ GSYG ++K C Q VAIK + V +E ++K+ + +E+ ++++++H
Sbjct: 7 SKIGEGSYGVVFK---CRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
N+V I R L +V E+ + + +GV + + K+ + +N+ H+
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-LIKKIIWQTLQAVNFCHK 118
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APE 277
+N IHRD+K N+L+ + G +K+ DFG AR+ G + RW APE
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 35/183 (19%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ SG+YG + ++VAIK + + K +E+ ++R +RH+N++ +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 176 CTRPP------NLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
RPP ++ IVTE M H Q ++Q+ +G+
Sbjct: 68 -LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL----------RGL 116
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----AQSGVMTAETGT--YRWMA 275
YLH N+IHRDLK +N+L++ N +K+ DFG+AR + G +T T YR A
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--A 174
Query: 276 PEV 278
PE+
Sbjct: 175 PEL 177
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 24/176 (13%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFS-------QEVYIMRKIRHK 167
++ G+YG +Y+ VA+K LK M KE +E+ I+ K++H
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKLQHP 64
Query: 168 NVVQF--IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
N+V + + + +V E++ + + K F + + + + + G+ +LH
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--YRWMAPEV 278
N I+HRDLKT+NLL++ G++K+ DFG+AR + T T YR APE+
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APEL 177
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 26/191 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
VWE+ + + V SG+YG + T ++VAIK L + K +E+ ++
Sbjct: 10 VWEVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSL 210
+ + H+NV+ + T +L +VT M + + + QK F + +
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVYQI 127
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270
L+ G+ Y+H IIHRDLK +N+ ++E+ +K+ DFG+AR MT T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE-MTGYVAT 178
Query: 271 YRW-MAPEVAF 280
RW APE+
Sbjct: 179 -RWYRAPEIML 188
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 18/152 (11%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
V +KVL + ++ F + +M ++ HK++V+ G C R N+ +V E++ G +
Sbjct: 32 SVVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
FLH++K L L VA ++ ++YL ++H ++ N+L+ G+ +
Sbjct: 88 DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147
Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPE 277
K++D G+ V++ E R W+APE
Sbjct: 148 KLSDPGIPI-----TVLSREERVERIPWIAPE 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMAR 191
Q VAIK + + K +E+ +++ +RH+N++ P ++ VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 192 GSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
LH+ + + + +G+ Y+H ++HRDLK +N+L++EN +K+
Sbjct: 95 D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282
DFG+AR+Q MT T + APE+ T+
Sbjct: 150 CDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTW 180
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 42/160 (26%), Positives = 72/160 (45%), Gaps = 36/160 (22%)
Query: 121 GSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS----------------QEVYIMR 162
G+YG + K T + VAIK +K E+ + + +E+ IM
Sbjct: 20 GTYGKVEKAYDTLTGKIVAIKKVK----IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------ID 216
+I+H+N++ + + +V + MA D K V L + +
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMA----SDL----KKVVDRKIRLTESQVKCILLQ 127
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
+ G+N LH+ +HRDL AN+ ++ G+ K+ADFG+AR
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 18/179 (10%)
Query: 113 KIECKVASGSYGDLYK------GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
KI K+ G++ ++ K G Y AIK +K + E + E+ +R++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMKKHFKSLEQVNNLR-EIQALRRLSP 56
Query: 166 HKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
H N+++ I L +V E M ++Y+ + +K + + K +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVAFT 281
+H+N I HRD+K N+L+ ++ ++K+ADFG R T T RW APE T
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLT 172
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-15
Identities = 43/174 (24%), Positives = 93/174 (53%), Gaps = 9/174 (5%)
Query: 112 LKIECKVASGSYGDLYKGTYC---SQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHK 167
+IE K+ G + ++Y+ T C + VA+K ++ E ++ + ++ +E+ +++++ H
Sbjct: 4 FQIEKKIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
NV++++ + L IV E G + + KQK + ++ K + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPE 277
H ++HRD+K AN+ + GVVK+ D G+ R +++ + GT +M+PE
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 7e-15
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 1/122 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E +++ + H +V++ C+V +Y +L K+ + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +G+ YLH IIHRD+KT N+ +++ V + D G A+ + GT AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 277 EV 278
EV
Sbjct: 226 EV 227
|
Length = 357 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 43/176 (24%), Positives = 90/176 (51%), Gaps = 16/176 (9%)
Query: 111 QLKIECKVASGSYGDLYK------GTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
L+ V +G++G ++ Y A+KV+ PE + + + E ++++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYY----ALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +++ L ++ E++ G ++ +L + G F ++ L A ++ + Y
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEY 116
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
LH I++RDLK N+L+D+ G +K+ DFG A+ ++ ++ + GT ++APEV
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEV 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 9e-15
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 16/168 (9%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
GS+G + KGT + A+KVLK + + + E + +++ +H + Q
Sbjct: 6 GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLTQ 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
L V E++ G + + + G F A ++ G+ +LH+ II+
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
RDLK N+L+D G +K+ADFG+ + GV T+ GT ++APE+
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-15
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 8/166 (4%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G +G + S+ A+K + K V T + E I+ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ ++ E+ G ++ L +G+F + T+ +A V YLH II+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
LK NLL+D NG VK+ DFG A+ + +SG T GT ++APE+
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEI 163
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 46/153 (30%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 110 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLK---PECVNTEMLKEFSQEVYIMRKI 164
KQL+ K+ G+Y +YKG + VA+K + E + ++E S +M+++
Sbjct: 3 KQLE---KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKEL 55
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+H+N+V+ L +V E+M + Y H +G ++ + KG+ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
H+N ++HRDLK NLL+++ G +K+ADFG+AR
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 40/173 (23%), Positives = 87/173 (50%), Gaps = 7/173 (4%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKN 168
+IE K+ G + ++Y+ T V + + K + ++ + + +E+ +++++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
V+++ + L IV E G + + KQK + ++ K + + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPE 277
++HRD+K AN+ + GVVK+ D G+ R +++ + GT +M+PE
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 8/178 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
+ D L+ ++ SG+ G +YK + + V + N E K ++ ++ K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 164 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKG 220
H +V+ G ++ I E M+ + D L K+ +G L K+ + + K
Sbjct: 70 -SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 221 MNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
++YL + +IHRD+K +N+L+D +G VK+ DFG++ S T G +MAPE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 30/182 (16%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
K+E K+ G+YG +YK + VA+K ++ E V + ++E S +++++ H
Sbjct: 3 KVE-KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNH 57
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDF-LHK---QKGVFQLTSLL--KVAIDVSKG 220
N+V+ + L +V EF+ D L K + L L + +G
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAP 276
+ Y H + ++HRDLK NLL+D G +K+ADFG+AR GV T E T + AP
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAP 168
Query: 277 EV 278
E+
Sbjct: 169 EI 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 48/166 (28%), Positives = 87/166 (52%), Gaps = 9/166 (5%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEF-SQEVYIMRKIRHKNVVQFI 173
K+ GS G + + + ++VA+K++ + + +E EV IMR +H+NVV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L ++ EF+ G++ D + + + + V V + + YLH +IHRD
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEV 278
+K+ ++L+ +G VK++DFG A++ + GT WMAPEV
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 51/176 (28%), Positives = 92/176 (52%), Gaps = 18/176 (10%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHK 167
K+E K+ G+YG +YK + VA+K ++ ++TE S +E+ +++++ H
Sbjct: 4 KVE-KIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHP 59
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
N+V+ + L +V EF+ + + F+ L+K + + +G+ + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV 278
+ ++HRDLK NLL++ G +K+ADFG+AR GV T E T + APE+
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEI 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 34/199 (17%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VA+K + E + EF E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
+M+ +VV+ +G ++ +V E MA G + +L + + L
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
++++A +++ GM YL+ +HRDL N ++ + VK+ DFG+ R ET
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYET 172
Query: 269 GTYR----------WMAPE 277
YR WMAPE
Sbjct: 173 DYYRKGGKGLLPVRWMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-14
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 26/197 (13%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 158
EI+ ++ ++ +G +YKG +Q VAIK LK + + +EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQ----------KG 203
+ +++H N+V +G T+ L ++ + + +++FL H K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 261
+ + + ++ GM +L ++++H+DL T N+L+ + VK++D G+ R V A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 262 -GVMTAETGTYRWMAPE 277
+M RWM+PE
Sbjct: 180 YKLMGNSLLPIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 33/185 (17%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+E K+ G+YG ++K + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 4 KLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 171 QFIGACTRPPNLCIVTEFM----------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ L +V E+ G I D + +FQL KG
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLL----------KG 111
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWMA 275
+ + H +N++HRDLK NLL+++NG +K+ADFG+AR V+ S AE T +
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRP 167
Query: 276 PEVAF 280
P+V F
Sbjct: 168 PDVLF 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 1/123 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + +V A +LC+V M G + Y + + F + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+ G+ +LHQ I++RDLK N+L+D++G V+++D G+A + GT +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162
Query: 276 PEV 278
PEV
Sbjct: 163 PEV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 51/182 (28%), Positives = 95/182 (52%), Gaps = 15/182 (8%)
Query: 110 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+Q + ++ G+YG ++K + VA+K ++ + M +EV ++R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
H NVV+ CT R L +V E + + + +L K + GV T + +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET-IKDMMFQ 118
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +G+++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+ T + AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 277 EV 278
EV
Sbjct: 179 EV 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-14
Identities = 48/167 (28%), Positives = 87/167 (52%), Gaps = 9/167 (5%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
K+ GSY +YKG + VA+KV++ + E F+ +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
L +V E++ + ++ K G ++ + +G++Y+HQ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV 278
DLK NLL+ + G +K+ADFG+AR ++ S + E T + P+V
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-14
Identities = 44/165 (26%), Positives = 89/165 (53%), Gaps = 5/165 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V GS+G L + Q+ A+K ++ ++ +++ +E ++ K++H N+V F +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L IV E+ G + + Q+G +F ++L+ + + G+ ++H+ ++HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
K+ N+ + +NG VK+ DFG AR+ G GT ++ PE+
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-14
Identities = 49/167 (29%), Positives = 85/167 (50%), Gaps = 9/167 (5%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
K+ GSY +YKG Q VA+KV+ + TE F+ +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
L V E+M + ++ + G ++ + +G+ Y+H +I+HR
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV 278
DLK NLL+ G +K+ADFG+AR ++ S ++E T + P+V
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 28/175 (16%)
Query: 118 VASGSYGDL----YKGTYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ +GS+G + +KGT + AIK LK E + + ++ +QE I+ ++ H +V
Sbjct: 26 LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYL 224
+ + + + EF+ G ++ L K + DV+K YL
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYL 134
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEV 278
H +II+RDLK NLL+D G VKV DFG A +V ++ + GT ++APEV
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEV 186
|
Length = 329 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 28/179 (15%)
Query: 121 GSYGDLY----KGTYCSQE---VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G +G+++ KG V +K L+ + EF +E+ + RK+ HKNVV+ +
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAI--DVSKGMNYLH 225
G C ++ E+ G + FL K + L++ KVA+ ++ GM++L
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-------RWMAPE 277
+HRDL N L+ VKV+ +++ V +E RW+APE
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLRWLAPE 188
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 14/170 (8%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
+ G +G++Y C + K+ +C++ + +K E IM + F
Sbjct: 2 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 173 IGACT----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
I T P LC + + M G ++ L Q GVF + A ++ G+ ++H
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+++RDLK AN+L+DE+G V+++D G+A A GT+ +MAPEV
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 2/100 (2%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
P L + + M G ++ L Q GVF + A ++ G+ ++H +++RDLK AN
Sbjct: 69 PDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127
Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+L+DE+G V+++D G+A A GT+ +MAPEV
Sbjct: 128 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 29/62 (46%), Positives = 42/62 (67%), Gaps = 2/62 (3%)
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAP 276
+G+ YLH I+HRD+K NLL++ N V+K+ DFG+ARV+ +S MT E T + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 277 EV 278
E+
Sbjct: 174 EI 175
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 5/165 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G++G L + + A+K+LK E + + + E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ LC V E++ G ++ L +++ VF ++ ++YLH I++RDL
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 235 KTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEV 278
K NL++D++G +K+ DFG+ + + M GT ++APEV
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 5e-13
Identities = 43/165 (26%), Positives = 82/165 (49%), Gaps = 8/165 (4%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
++Y T ++ V +K LK + E EF Q+ R ++H N++Q +G C
Sbjct: 14 SEIYTDTGVARVV-VKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 184 IVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
+V E+ G + +L +++ QL L ++A +++ G+ ++H++N +H DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVAFTF 282
+ + VKV D+G+ + + + E RW+APE+ F
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 36/184 (19%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIK-VLKPEC---VNTEMLKEFSQEVYIMRKIR---HKN 168
+ G+YG +YK + VA+K V P + L+E + +++++ H N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA----LLKQLESFEHPN 62
Query: 169 VVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAI-DVSK- 219
+V+ + C P L +V E + + + +L K + G L I D+ +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG------LPPETIKDLMRQ 115
Query: 220 ---GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YRWM 274
G+++LH + I+HRDLK N+L+ +G VK+ADFG+AR+ + +T+ T YR
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR-- 173
Query: 275 APEV 278
APEV
Sbjct: 174 APEV 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-13
Identities = 43/181 (23%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 116 CKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+ G++G ++ G +EV +K +K + + QE ++ + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNI 70
Query: 170 VQFIGACTR---PPNLCIVTEFMARGSIYDFL----HKQKGVFQLTS---LLKVAIDVSK 219
+ + C PP + +M G++ FL + Q S L+ +AI ++
Sbjct: 71 LPILHVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR---WMAP 276
GM+YLH+ +IH+D+ N ++DE VK+ D ++R R WMA
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 277 E 277
E
Sbjct: 189 E 189
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQ 171
K+ GSY +YKG Q VA+K ++ + E F+ +E +++ ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 172 FIGACTRPPNLCIVTEFMAR---------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
L +V E++ G + + +FQL +G+
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----------RGLA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
Y HQ ++HRDLK NLL+ E G +K+ADFG+AR
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
L K + VA+K + + + E LK QE+ R+++H N++ ++ + L +V
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAI-----DVSKGMNYLHQNNIIHRDLKTANLL 240
+ MA GS D L K F L ++AI DV ++Y+H IHR +K +++L
Sbjct: 78 SPLMAYGSCEDLL---KTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133
Query: 241 MDENGVVKVADF 252
+ +G V ++
Sbjct: 134 LSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-13
Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 11/167 (6%)
Query: 121 GSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G YG +++ G + A+KVLK + N + E I+ ++H +V I
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI 66
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
A L ++ E+++ G + F+H +++G+F + ++S + +LHQ II+R
Sbjct: 67 YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
DLK N+L+D G VK+ DFG+ + G +T GT +MAPE+
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 9e-13
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 118 VASGSYGDLYKGTYCSQE---VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ +GS+G + TY +++ VAIK K + + + + E I+ I H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQN 227
G+ L +V EF+ G + FL + K G F ++ + YL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSL 150
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NI++RDLK NLL+D++G +K+ DFG A+V + T GT ++APE+
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEI 199
|
Length = 340 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 55/173 (31%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNVV 170
+ G+YG +YK + VA+K V + KE F +E+ I+R++ H+N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKK-----VRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 171 QFIGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVF------------------------ 205
NL IVT+ + DF K KG F
Sbjct: 70 ----------NLKEIVTD---KQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 206 -QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
+ S +K ++ G+NY H+ N +HRD+K +N+L++ G +K+ADFG+AR+
Sbjct: 116 DHIKSFMKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 32/192 (16%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 156
+WE+ + ++ +V SG+YG T CS +VAIK L + K +
Sbjct: 10 IWEVPDRYRDLK-QVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSI--YDFLHKQKGVFQ 206
E+ +++ ++H+NV+ + T +L +V FM G + ++ L + + F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
+ +LK G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR Q S MT
Sbjct: 124 VYQMLK-------GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTG 174
Query: 267 ETGTYRWMAPEV 278
T + APEV
Sbjct: 175 YVVTRWYRAPEV 186
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 52/190 (27%), Positives = 88/190 (46%), Gaps = 25/190 (13%)
Query: 111 QLKIECKVASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
+ KI+ + GSYG + T+ ++VAIK + + +E+ ++R +RH +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 169 VVQFIGACTRPPN------LCIVTEFMARG-----SIYDFLHKQKGVFQLTSLLKVAIDV 217
+V+ I PP+ + +V E M D L + F L LL+
Sbjct: 61 IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWM 274
+ Y+H N+ HRDLK N+L + + +K+ DFG+ARV + + + RW
Sbjct: 115 --ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 275 -APEVAFTFF 283
APE+ +FF
Sbjct: 173 RAPELCGSFF 182
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 4/145 (2%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+Y +YKG + VA+K ++ E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L +V E++ + + +L + ++ + +G+NY H+ ++HRDL
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 235 KTANLLMDENGVVKVADFGVARVQA 259
K NLL++E G +K+ADFG+AR ++
Sbjct: 131 KPQNLLINERGELKLADFGLARAKS 155
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 5/165 (3%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V G+YG + K + + VAIK K N E+ + +E+ ++R ++ +N+V+ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
R L +V E++ + ++ + L + + + K +++ H+N+I+HRD+K
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 236 TANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEV 278
NLL+ N V+K+ DFG AR + + T T + +PE+
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 3/144 (2%)
Query: 137 AIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+LK E + + + E +++ RH + + LC V E+ G ++
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L ++ VF ++ + YLH ++++RDLK NL++D++G +K+ DFG+
Sbjct: 84 FHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC 142
Query: 256 RVQAQSG-VMTAETGTYRWMAPEV 278
+ G M GT ++APEV
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 1/123 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + H + F+ + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
++ G+ LHQ I++RDLK N+L+D++G ++++D G+A + + GT +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169
Query: 276 PEV 278
PEV
Sbjct: 170 PEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 46/155 (29%), Positives = 70/155 (45%), Gaps = 18/155 (11%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
Q VAIK L N K +E+ +M+ + HKN++ + T +L +V E
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 188 FMARGSI----YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
M D H++ L G+ +LH IIHRDLK +N+++
Sbjct: 102 LMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKS 153
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ +K+ DFG+AR S +MT T + APEV
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 52/189 (27%), Positives = 86/189 (45%), Gaps = 27/189 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQ 156
VWE+ + + +V SG+YG + CS ++VAIK L + K +
Sbjct: 10 VWELPERYTSL-KQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGV-FQLTS 209
E+ +++ ++H+NV+ + T + +V +M L K G
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDK 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+ + + G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV 176
Query: 270 TYRWMAPEV 278
T + APEV
Sbjct: 177 TRWYRAPEV 185
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 3/144 (2%)
Query: 137 AIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+L+ E + + + E +++ RH + A LC V E+ G ++
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L +++ VF ++ + YLH ++++RD+K NL++D++G +K+ DFG+
Sbjct: 84 FHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 142
Query: 256 RVQAQSG-VMTAETGTYRWMAPEV 278
+ G M GT ++APEV
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-12
Identities = 44/170 (25%), Positives = 89/170 (52%), Gaps = 6/170 (3%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+K+E K+ G+Y ++KG E VA+K ++ E +EV +++ ++H N+
Sbjct: 9 IKLE-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V +L +V E++ + + ++ + + ++ + +G+ Y H+ +
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV 278
+HRDLK NLL++E G +K+ADFG+AR ++ + + E T + P+V
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-12
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 56/201 (27%)
Query: 110 KQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEF--------SQ--- 156
++ +I K+ G+YG ++K + VA+K K F +Q
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------------KIFDAFRNATDAQRTF 54
Query: 157 -EVYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGV 204
E+ ++++ H N+V+ + + N + +V E+M R +I + +HK+ +
Sbjct: 55 REIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM 113
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262
+QL LK Y+H N+IHRDLK +N+L++ + VK+ADFG+AR ++
Sbjct: 114 YQLLKALK----------YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 263 ----VMTAETGTYRWM-APEV 278
V+T T RW APE+
Sbjct: 164 PENPVLTDYVAT-RWYRAPEI 183
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
GS+G + KGT ++ AIK LK + V + + + + R++ H +
Sbjct: 6 GSFGKVMLAELKGT--NEFFAIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+L V E++ G D + + G F A ++ G+ +LH+ I
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
I+RDLK N+L+D++G +K+ADFG+ + +G A T GT ++APE+
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-12
Identities = 49/163 (30%), Positives = 83/163 (50%), Gaps = 9/163 (5%)
Query: 121 GSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G+YG +YK + V A+K ++ E ++ + E+ I+ K +V F GA
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 179 PPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDL 234
+ + E+M GS +Y +G+ + L ++ V KG+ +L ++NIIHRD+
Sbjct: 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHNIIHRDV 129
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
K N+L++ NG VK+ DFGV+ + + G +MAPE
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 40/166 (24%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G + + ++E A+KVL+ + + E S+ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +++ + YLH NI++RD
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEV 278
LK N+L+D G + + DFG+ + + +G + GT ++APEV
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 42/175 (24%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 120 SGSYGDLYKGTYCSQEVAIKVLK------PECVNTEMLKEFS-----QEVYIMRK-IRHK 167
SG++G +YK + + LK P + ++ S EV I+++ +RH
Sbjct: 10 SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
N+V++ L IV + + + + L ++K F + + + + + YL
Sbjct: 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 225 H-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H + I+HRDL N+++ E+ V + DFG+A+ + +T+ GT + PE+
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEI 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 14/183 (7%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+WE+ + + V SG+YG + T VA+K L + K +E+ ++
Sbjct: 12 IWEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ ++H+NV+ + T +L +VT M + + + QK L I
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR MT T + A
Sbjct: 130 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRA 185
Query: 276 PEV 278
PE+
Sbjct: 186 PEI 188
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 171
++ G+YG +YK + VA+K ++ + + +EV +++++ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 172 FIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMN 222
+ C R + +V E + + + +L K + L++ + +G++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGLD 122
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+LH N I+HRDLK N+L+ G VK+ADFG+AR+ + +T T + APEV
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-12
Identities = 36/123 (29%), Positives = 61/123 (49%), Gaps = 1/123 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + + F+ L A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
++ G+ LH+ N ++RDLK N+L+D+ G ++++D G+A + + GT +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169
Query: 276 PEV 278
PEV
Sbjct: 170 PEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 3/133 (2%)
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
+ + + +E+ ++ + +V F GA + I E M GS+ D + K+ G
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96
Query: 206 QLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
L K++I V +G+ YL + I+HRD+K +N+L++ G +K+ DFGV+ Q +
Sbjct: 97 PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA 155
Query: 265 TAETGTYRWMAPE 277
+ GT +M+PE
Sbjct: 156 NSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 23/174 (13%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPE------CVNTEMLKEFSQEVYIMRKIRHKN 168
K+ G+Y ++KG E VA+K ++ E C +EV +++ ++H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHAN 64
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLH 225
+V L +V E++ D L S+ V I + +G++Y H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV 278
+ I+HRDLK NLL++E G +K+ADFG+AR ++ + + E T + P+V
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 4/143 (2%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ G++G +Y G S+ A+KV+ K + +N M+ + E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ N+ +V E++ G + LH G F +K +V+ ++YLH++ IIHRDL
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 235 KTANLLMDENGVVKVADFGVARV 257
K N+L+ G +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 46/165 (27%), Positives = 83/165 (50%), Gaps = 9/165 (5%)
Query: 121 GSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+G ++ G Q A+KVLK + E I+ ++ H +V+ A
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L ++ +F+ G ++ L K+ +F + +++ +++LH II+RDLK
Sbjct: 67 FQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLK 125
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
N+L+DE G +K+ DFG+++ ++ A + GT +MAPEV
Sbjct: 126 PENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEV 169
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 45/166 (27%), Positives = 83/166 (50%), Gaps = 6/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G++G L K + A+K+LK E V + + E +++ RH +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
+ LC V E+ G ++ L +++ VF ++ ++YLH + N+++RD
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEV 278
LK NL++D++G +K+ DFG+ + + G M GT ++APEV
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
+ VAIK L N K +E+ +M+ + HKN++ + T +L IV E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
M ++ + + +++ LL + G+ +LH IIHRDLK +N+++ + +
Sbjct: 110 LM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
K+ DFG+AR S +MT T + APEV
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 42/193 (21%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN----------TEMLKEFSQEVYI 160
K+E K+ G+YG +YK + + VA+K + E +L+ S+ +YI
Sbjct: 5 KLE-KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFM-----------ARGSIYDFLHK--QKGVFQL 207
+R + ++V + G P+L +V E++ RG K + ++QL
Sbjct: 64 VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV-QAQSGVMT 265
KG+ + H++ ++HRDLK NLL+D + G++K+AD G+ R T
Sbjct: 120 L----------KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 266 AETGTYRWMAPEV 278
E T + APEV
Sbjct: 170 HEIVTLWYRAPEV 182
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 41/123 (33%), Positives = 68/123 (55%), Gaps = 3/123 (2%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+E+ ++ + +V F GA + I E M GS+ D + K+ G L KV+I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 110
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
V KG+ YL + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169
Query: 275 APE 277
+PE
Sbjct: 170 SPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 24/166 (14%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 177
C + VA+K K + + +K +E+ I+R++ H N+V+ +G+ T
Sbjct: 29 CDKRVAVK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
++ IV E+M + + L + + L + +G+ Y+H N++HRDLK A
Sbjct: 87 ELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLF--MYQLLRGLKYIHSANVLHRDLKPA 143
Query: 238 NLLMD-ENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV 278
N+ ++ E+ V+K+ DFG+AR+ + G ++ T + +P +
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRL 189
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 28/190 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
VWE+ + + V SG+YG + T Q+VA+K L + + +E+ ++
Sbjct: 10 VWEVPERYQNLT-PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSIYDFL-----HKQKGVFQLT 208
+ ++H+NV+ + T ++ +VT M +I H Q ++QL
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+G+ Y+H IIHRDLK +N+ ++E+ +++ DFG+AR QA MT
Sbjct: 129 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDE-MTGYV 176
Query: 269 GTYRWMAPEV 278
T + APE+
Sbjct: 177 ATRWYRAPEI 186
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 133 SQEVAIKVLKPECVNTEML-KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI-VTEFMA 190
EVAIK+L+ + E F +E + ++ H N+V + + PP L V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---V 247
++ + L G ++ + V + H I+HRDLK N+++ + GV
Sbjct: 63 GRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 248 KVADFGVARV-----QAQSGVMTAET---GTYRWMAPE 277
KV DFG+ + A +T T GT + APE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 3/124 (2%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + + F + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
+++ G+ LH+ I++RDLK N+L+D+ G ++++D G+A V+ G + GT +M
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYM 168
Query: 275 APEV 278
APEV
Sbjct: 169 APEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 57/196 (29%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+E K+ G+YG +YK ++ +A+K ++ E + + +E+ ++++++H N+V
Sbjct: 6 KVE-KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG---VFQLTSL-LKVAIDVS-------- 218
+ + D +H +K VF+ L LK +D S
Sbjct: 65 R----------------------LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR 102
Query: 219 ----------KGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR-----VQAQSG 262
+G+ Y H + ++HRDLK NLL+D +K+ADFG+AR V+
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--- 159
Query: 263 VMTAETGTYRWMAPEV 278
T E T + APE+
Sbjct: 160 -FTHEVVTLWYRAPEI 174
|
Length = 294 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 18/155 (11%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
+ VAIK L N K +E+ +M+ + HKN++ + T +L EF
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQDVYL 99
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
+ + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ +K+ DFG+AR S +MT T + APEV
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-11
Identities = 40/128 (31%), Positives = 64/128 (50%), Gaps = 8/128 (6%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDFLHKQKGVFQLTSLLK 212
E I+ K+ + +V A +LC+V M G IY+ + G F
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACF 101
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGT 270
+ G+ +LHQ II+RDLK N+L+D +G V+++D G+A V+ + G + GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGT 160
Query: 271 YRWMAPEV 278
+MAPE+
Sbjct: 161 PGFMAPEL 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 6/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G L K + A+KVL+ + V E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +F+ G ++ L +++ + + A +++ + YLH NI++RD
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSINIVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEV 278
LK N+L+D G V + DFG+ + AQS T GT ++APEV
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 41/145 (28%), Positives = 81/145 (55%), Gaps = 4/145 (2%)
Query: 137 AIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSI 194
A+KV+K E VN + ++ Q E ++ + + + + +C + + L V E++ G +
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
+ +Q+ + + + A ++S +NYLH+ II+RDLK N+L+D G +K+ D+G+
Sbjct: 84 MFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142
Query: 255 ARVQAQSGVMTAE-TGTYRWMAPEV 278
+ + G T+ GT ++APE+
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E +I+R I H +++Q G T C++ + +Y +L ++ + + +L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNI-AICDILAIERS 190
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
V + + YLH+N IIHRD+K N+ ++ G V + DFG A
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 34/124 (27%), Positives = 67/124 (54%), Gaps = 3/124 (2%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ +V A +LC+V M G + Y + + ++ ++ +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
++ G+ +LH +I++RD+K N+L+D+ G +++D G+A V+ + G +T GT +M
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYM 161
Query: 275 APEV 278
APE+
Sbjct: 162 APEI 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 49/186 (26%), Positives = 84/186 (45%), Gaps = 34/186 (18%)
Query: 110 KQLKIECKVASGSYGDLY----KGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI 164
K +I +V G YG ++ K T + VA+K +K + ++ E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF---------LHKQKGVFQLTSLLKVAI 215
+ + +V+ + A L + E++ G DF L + F + + A+
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF-EAV 114
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT---AETGTYR 272
D LH+ IHRDLK N L+D +G +K+ DFG++ G++T + G+
Sbjct: 115 DA------LHELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPD 163
Query: 273 WMAPEV 278
+MAPEV
Sbjct: 164 YMAPEV 169
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 39/123 (31%), Positives = 68/123 (55%), Gaps = 3/123 (2%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+E+ ++ + +V F GA + I E M GS+ L + K + + L KV+I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 110
Query: 216 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
V +G+ YL + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169
Query: 275 APE 277
+PE
Sbjct: 170 SPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 42/149 (28%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 189
VA+K L N K +E+ +++ + HKN++ + T +L +V E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
++ +H + +++ LL + G+ +LH IIHRDLK +N+++ + +K+
Sbjct: 109 -DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEV 278
DFG+AR + +MT T + APEV
Sbjct: 165 LDFGLARTACTNFMMTPYVVTRYYRAPEV 193
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 14/170 (8%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G L K A+KVL+ + + E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +V+ + YLH NII+RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHSLNIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEV 278
LK N+L+D G V + DFG+ + GV ET GT ++APEV
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 40/166 (24%), Positives = 82/166 (49%), Gaps = 6/166 (3%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G + + + A+KVL+ + + E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +++ + YLH NII+RD
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLNIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEV 278
LK N+L+D G V + DFG+ + + S + GT ++APEV
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 30/82 (36%), Positives = 42/82 (51%), Gaps = 13/82 (15%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
L L+ + V++GM +L IHRDL N+L+ EN VVK+ DFG+AR V+
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 259 AQSGVMTAETGTYRWMAPEVAF 280
+ +WMAPE F
Sbjct: 232 KGDARL-----PLKWMAPESIF 248
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 40/152 (26%), Positives = 77/152 (50%), Gaps = 16/152 (10%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
+V +KVL P + ++ F + +MR++ HK++V G C R +V EF+ G +
Sbjct: 34 KVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
F+H++ V KVA ++ ++YL +++H ++ T N+L+ G+ +
Sbjct: 92 DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151
Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPE 277
K++D G+ V++ + R W+APE
Sbjct: 152 KLSDPGIPIT-----VLSRQECVERIPWIAPE 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+L +VT++M+ G + F H QK G F ++ + +LH+ +I++RDLK
Sbjct: 68 DSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
N+L+D G + + DFG+++ T GT ++APEV
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
GD+Y A+KV+K + E + F +E I+ + Q A NL
Sbjct: 26 GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76
Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
+V E+ G + L++ + F ++ ++ +HQ +HRD+K N+L+D
Sbjct: 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136
Query: 243 ENGVVKVADFG-VARVQAQSGVM-TAETGTYRWMAPEV 278
G +K+ADFG AR+ A V GT ++APEV
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 7/129 (5%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
L + T V +++ E E LK EV + RH N++ T L ++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 186 TEFMARGSIYDFL--HKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
+ FMA GS L + +G+ + + ++L A+ +G+NYLHQN IHR++K +++L+
Sbjct: 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASHILI 134
Query: 242 DENGVVKVA 250
+G+V ++
Sbjct: 135 SGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 33/82 (40%), Positives = 44/82 (53%), Gaps = 3/82 (3%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
K V L L+ + V+KGM +L IHRDL N+L+ EN VVK+ DFG+AR +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 260 QSGVMTAETG-TYRWMAPEVAF 280
V + +WMAPE F
Sbjct: 233 PDYVRKGDARLPLKWMAPETIF 254
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 121 GSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK------IRHKNVVQF 172
GS+G L + + A+KVLK + + L++ E + K H + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIH 231
P L V EF+ G + H QK F A +++ + +LH II+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
RDLK N+L+D G K+ADFG+ + +G T+ GT ++APE+
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 3/77 (3%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
LL V++GM +L N +HRDL N+L+ + +VK+ DFG+AR +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 267 ETGTY---RWMAPEVAF 280
+ T+ +WMAPE F
Sbjct: 296 KGSTFLPVKWMAPESIF 312
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 28/69 (40%), Positives = 41/69 (59%), Gaps = 7/69 (10%)
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWM 274
G+ Y+H N++HRDLK NLL++ + +K+ DFG+AR +G MT T RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175
Query: 275 -APEVAFTF 282
APE+ +F
Sbjct: 176 RAPEIMLSF 184
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 34/98 (34%), Positives = 57/98 (58%), Gaps = 2/98 (2%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A ++S G+ +LH+ II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
D G +K+ADFG+ + GV T GT ++APE+
Sbjct: 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 7e-10
Identities = 36/100 (36%), Positives = 57/100 (57%), Gaps = 4/100 (4%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
+L V EF+ G + F + KG F L A ++ G+ +LH II+RDLK N++
Sbjct: 70 HLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+D +G +K+ADFG+ + + G A T GT ++APE+
Sbjct: 129 LDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 7e-10
Identities = 34/130 (26%), Positives = 68/130 (52%), Gaps = 7/130 (5%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQ----FIGACTRPP 180
+YKG + ++EV I+ K ++L + E+ +R+I N+++ I P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANL 239
L ++ E+ RG + + L K+K + + L +AID KG+ L++ N +++L + +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154
Query: 240 LMDENGVVKV 249
L+ EN +K+
Sbjct: 155 LVTENYKLKI 164
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 11/119 (9%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVN 147
+++P D WE+ L + + SG++G + + T + +VA+K+LK +
Sbjct: 24 MQLPYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS 81
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
+E + E+ IM + H N+V +GACT+ + I+TE+ G + D+LH+ K F
Sbjct: 82 SEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 45/166 (27%), Positives = 88/166 (53%), Gaps = 6/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
+ GSY L + + A+KV+K E VN + ++ Q E ++ + + +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+C + + L V EF++ G + + +Q+ + + + A ++S +N+LH+ II+RD
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERGIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
LK N+L+D G +K+ D+G+ + + G T+ GT ++APE+
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 15/130 (11%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDF----LHKQKGVFQLT 208
E I+ K+ + VV A LC+V M G IY+ +Q+ +F
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--- 106
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
A ++ G+ L + I++RDLK N+L+D+ G ++++D G+A + +
Sbjct: 107 ----YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV 162
Query: 269 GTYRWMAPEV 278
GT +MAPEV
Sbjct: 163 GTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 27/74 (36%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
L+ + V+ GM +L N +HRDL N+L+ E +VK+ DFG+AR + ++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 270 TY---RWMAPEVAF 280
T+ +WMAPE F
Sbjct: 301 TFLPLKWMAPESIF 314
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 43/166 (25%), Positives = 87/166 (52%), Gaps = 6/166 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
+ GSY L + Q A+KV+K E V+ + ++ Q E ++ + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+C + + L +V E++ G + + +Q+ + + + A ++ +N+LH+ II+RD
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHERGIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
LK N+L+D +G +K+ D+G+ + G T+ GT ++APE+
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 29/99 (29%), Positives = 55/99 (55%), Gaps = 3/99 (3%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L ++ +++ G ++ L+ Q+ F + + ++ +++LHQ II+RD+K N+L+
Sbjct: 80 LHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 242 DENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
D G V + DFG+++ A + GT +MAPEV
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 29/163 (17%)
Query: 116 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
CKV G+YG +YK +E A+K ++ T + +E+ ++R+++H NV+
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVIA 62
Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
F+ R +L + +F R S + Q + SLL +D
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFH-RASKANKKPMQLPRSMVKSLLYQILD-- 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV 257
G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 52/186 (27%), Positives = 88/186 (47%), Gaps = 30/186 (16%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYI 160
D +K+ + G++G+ L + Q A+K+L EM+K F +E I
Sbjct: 44 DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLS----KFEMIKRSDSAFFWEERDI 96
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVA 214
M + +VQ A L +V E+M G + YD K + T+ + +A
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY--TAEVVLA 154
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYR 272
+D +H IHRD+K N+L+D++G +K+ADFG +G++ +T GT
Sbjct: 155 LDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208
Query: 273 WMAPEV 278
+++PEV
Sbjct: 209 YISPEV 214
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 26/66 (39%), Positives = 43/66 (65%), Gaps = 1/66 (1%)
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYR 272
A +V+ + +LH++ +I+RDLK N+L+D G K+ADFG+ + +GV T GT
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161
Query: 273 WMAPEV 278
++APE+
Sbjct: 162 YIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 28/74 (37%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
LL + V+KGM++L N IHRDL N+L+ + K+ DFG+AR ++ S +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 269 GTY--RWMAPEVAF 280
+WMAPE F
Sbjct: 276 ARLPVKWMAPESIF 289
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
D G +K+ADFG+ + G T GT ++APE+
Sbjct: 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 30/82 (36%), Positives = 43/82 (52%), Gaps = 13/82 (15%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
+ L+ + V++GM +L IHRDL N+L+ EN VVK+ DFG+AR V+
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 259 AQSGVMTAETGTYRWMAPEVAF 280
S + +WMAPE F
Sbjct: 233 KGSARL-----PLKWMAPESIF 249
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 49/226 (21%), Positives = 82/226 (36%), Gaps = 29/226 (12%)
Query: 48 PYDETEDLKNV----LAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDG-- 101
Y+ L +K+ K C + + V + ++ + TD
Sbjct: 18 GYEAIFSLTGGTDTSDSKDTTGDKFDDCDELGDSDDVTHATD--YDADEESLSPQTDVCQ 75
Query: 102 --------TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE 153
+D + Q I + GS G+++ T E KV+ K
Sbjct: 76 EPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KT 132
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+E+ I++ I H+ ++ I A +C+V D L L+
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTYVDRSGPLP--LEQ 186
Query: 214 AIDVSKGM----NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
AI + + + YLH IIHRD+KT N+ +DE + DFG A
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-09
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 2/98 (2%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
D G +K+ADFG+ + GV T GT ++APE+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 4e-09
Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 14 LTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYDETEDLKNV 58
+ L ++GLNI +A F+T DG++LD FVV DG P E E L +
Sbjct: 18 IAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARI 65
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 27/176 (15%)
Query: 118 VASGSYGDLYKGTY-CSQEV-AIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G++ + SQ+V A+K+L EM+K F +E IM VV
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 171 QFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
Q A L +V E+M G + YD K + +L ++ +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL--------ALDAI 158
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
H +IHRD+K N+L+D++G +K+ADFG ++G++ +T GT +++PEV
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 18/172 (10%)
Query: 118 VASGSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKN 168
+ GS+G ++ KGT +Q AIK LK + V ++ + + + +++ H
Sbjct: 3 LGKGSFGKVFLAELKGT--NQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQN 227
+ NL V E++ G + H Q F L A ++ G+ +LH
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV 278
I++RDLK N+L+D +G +K+ADFG+ + T GT ++APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 29/163 (17%)
Query: 116 CKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
CKV G+YG +YK ++ A+K ++ T + +E+ ++R+++H NV+
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVIS 62
Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
F+ R +L + +F R S + Q + SLL +D
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILD-- 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV 257
G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 11/120 (9%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQ---EVAIKVLKPECVN 147
+++P D WE L + + SG++G + +GT SQ +VA+K+LKP +
Sbjct: 24 MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
+E + E+ IM + H N+V +GACT+ + I+TE+ G + ++LHK + F
Sbjct: 82 SEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 7/79 (8%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
L LL+ + V++GM++L N IHRD+ N+L+ + V K+ DFG+AR + S +
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 266 AETGTYR----WMAPEVAF 280
G R WMAPE F
Sbjct: 271 --KGNARLPVKWMAPESIF 287
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-08
Identities = 40/172 (23%), Positives = 79/172 (45%), Gaps = 22/172 (12%)
Query: 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ G YG+L+K EV +KVL + + + F + +M ++ HK++V G
Sbjct: 15 IRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYGV 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C +V E++ GS+ +L K K + ++ L+VA ++ +++L + H ++
Sbjct: 68 CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC 127
Query: 236 TANLLMDENG--------VVKVADFGVARVQAQSGVMTAETGTYR--WMAPE 277
N+L+ +K++D G++ V+ E R W+ PE
Sbjct: 128 AKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPE 174
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 16/151 (10%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
V +KVL P + ++ F + +M ++ H ++ G C R +V EF+ G +
Sbjct: 47 VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VK 248
L K+KG + + VA ++ ++YL N++H ++ N+L+ G+ +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 249 VADFGVARVQAQSGVMTAETGTYR--WMAPE 277
++D GV+ ++ E R W+APE
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPE 190
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 23/174 (13%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G+ L + + A+K+L EM+K F +E IM VV
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQ 226
Q A L +V E+M G + + + +K T+ + +A+D +H
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHS 160
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
IHRD+K N+L+D++G +K+ADFG + G++ +T GT +++PEV
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 50/188 (26%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI----RHKNVVQ 171
+++G+YG +Y + Q A+K + +L+ Q+V++ R I + VV
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKI---NKQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL-TSLLKVAIDVSKGMNYLHQNNII 230
+ +LC+V E++ G L K G + + + A V + YLH I+
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL-ALEYLHNYGIV 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--------------------GT 270
HRDLK NLL+ G +K+ DFG++++ G+M+ T GT
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 271 YRWMAPEV 278
++APEV
Sbjct: 180 PEYIAPEV 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 33/123 (26%), Positives = 60/123 (48%), Gaps = 5/123 (4%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
YK T + V ++ + E EM+ E+++ + H N+V + L +VT
Sbjct: 21 YKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78
Query: 187 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
FMA GS D + H G+ +L + + V K ++Y+H +HR +K +++L+ +
Sbjct: 79 SFMAYGSAKDLICTHFMDGMSELA-IAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137
Query: 245 GVV 247
G V
Sbjct: 138 GKV 140
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 37/178 (20%), Positives = 78/178 (43%), Gaps = 25/178 (14%)
Query: 110 KQLKIEC--KVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY---IMR 162
K +I K+ G +G + K + K++K + N + E +M+
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AIEPMVHQLMK 66
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKG 220
+ N ++ + T ++ +++ G ++D L K+ +L+ K+ + +
Sbjct: 67 D--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEA 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGV-VKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+N LH++NIIH D+K N+L D + + D+G+ ++ GT + +PE
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY---DGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 31/118 (26%), Positives = 55/118 (46%), Gaps = 2/118 (1%)
Query: 137 AIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+KVL + + +K E I+ + H + + LC+V ++ G ++
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
L +Q G A +V + YLH I++RDLK N+L+ E+G + ++DF
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 54/188 (28%), Positives = 91/188 (48%), Gaps = 31/188 (16%)
Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIK-VLK-PECVNTEMLKEFSQEVYIMRKI 164
K K+ + +GS+G +Y+ C S++VAIK VL+ P+ N E+L IM+ +
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIKKVLQDPQYKNRELL--------IMKNL 116
Query: 165 RHKNVV----QFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI- 215
H N++ + C + L +V EF+ + +++ ++ L V +
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175
Query: 216 --DVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVAR--VQAQSGVMTAETGT 270
+ + + Y+H I HRDLK NLL+D N +K+ DFG A+ + Q V +
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 271 YRWMAPEV 278
YR APE+
Sbjct: 236 YR--APEL 241
|
Length = 440 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 25/67 (37%), Positives = 44/67 (65%), Gaps = 3/67 (4%)
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTY 271
I V ++++H ++IHRD+K+AN+L+ NG+VK+ DFG +++ A + V GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 272 RWMAPEV 278
++APE+
Sbjct: 210 YYVAPEI 216
|
Length = 496 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
D + LK+ + G++G+ L + A+K+L K + + E + E I+ +
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VV+ + NL ++ EF+ G + L K+ + + + +A + ++ +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSI 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGV 254
HQ IHRD+K NLL+D G VK++DFG+
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 2/101 (1%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
P L +V F+ G ++ L ++ G F L+ ++ + LH+ N+I+RDLK N
Sbjct: 65 PEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123
Query: 239 LLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEV 278
+L+D G + + DFG+ ++ GT ++APE+
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
D + LK+ + G++G+ L + A+K+L K + + E + E I+ +
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VV+ + NL ++ EF+ G + L K+ + + + +A V ++ +
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAI 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGV 254
HQ IHRD+K NLL+D G VK++DFG+
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 8e-07
Identities = 42/171 (24%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 169
+ +G+YG ++ G + A+KVLK + + + E ++ IR +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A L ++ +++ G ++ L Q+ F+ + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
I+RD+K N+L+D NG V + DFG+++ + V A + GT +MAP++
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 27/177 (15%)
Query: 118 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G++ K + A+K+L EMLK F +E ++ ++ +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDNQWIT 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 223
A NL +V ++ G + L K F L ++ +AID
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDS------ 117
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEV 278
+HQ + +HRD+K N+LMD NG +++ADFG + G + + GT +++PE+
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
WE +LK+ + G++G + + T + VA+K+LK ++E + E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSE 60
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
+ I+ I H NVV +GACT+P L ++ EF G++ ++L ++G F
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 105 WEIDAKQLKIECKVASGSYGDL--------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
WE +L++ + G++G + K + C VA+K+LK +E K
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLKEGATASEH-KALMS 59
Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
E+ I+ I H NVV +GACT+P L ++ EF G++ +FL ++ F
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 37/132 (28%), Positives = 59/132 (44%), Gaps = 14/132 (10%)
Query: 155 SQEVYIMRKIRHKNV-----VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
E ++R++ H V V+ +G T C+V R +Y +L + L
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLT-----CLVLP-KYRSDLYTYLGARLRPLGLAQ 261
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTA 266
+ VA + ++Y+H IIHRD+KT N+L++ + + DFG A R +
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 267 ETGTYRWMAPEV 278
GT APEV
Sbjct: 322 IAGTVDTNAPEV 333
|
Length = 461 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 24/151 (15%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G+ L + Q A+KVL+ +M+K E I+ +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKS----DMIKRNQIAHVRAERDILADADSPWIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAIDVSKGMNYL 224
+ + +L +V E+M G + + L + K VF + L +A+D +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALD------SV 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
H+ IHRD+K N+L+D +G +K+ADFG+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLC 148
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 40/171 (23%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQ-EVYIMRKIRHKN-V 169
+ +G+YG ++ G + A+KVL K V E ++ E ++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A L ++ ++++ G ++ L+ Q+ F + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEV 278
++RD+K N+L+D G V + DFG+++ + + + GT +MAPE+
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 47/201 (23%)
Query: 117 KVASGSYGDLY----KGT---YCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRH 166
K+ +G +G+++ K T +C + ++ + LK +E SQ EV +MR+++H
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--------REKSQLVIEVNVMRELKH 71
Query: 167 KNVVQFIGACTRPPN--LCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGM 221
KN+V++I N L I+ EF G + + +K G + +++ + + +
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 222 NYLHQ-------NNIIHRDLKTANLLMDE---------------NG--VVKVADFGVARV 257
Y H ++HRDLK N+ + NG + K+ DFG+++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 258 QAQSGVMTAETGTYRWMAPEV 278
+ + GT + +PE+
Sbjct: 192 IGIESMAHSCVGTPYYWSPEL 212
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 21/61 (34%), Positives = 38/61 (62%), Gaps = 2/61 (3%)
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPE 277
++ +HQ + +HRD+K N+L+D NG +++ADFG Q G + + GT +++PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 278 V 278
+
Sbjct: 174 I 174
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 23/79 (29%), Positives = 41/79 (51%), Gaps = 13/79 (16%)
Query: 181 NLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L ++ E++ G + D +++ F + + +AID +H+ IHRD+
Sbjct: 75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAID------SIHKLGYIHRDI 127
Query: 235 KTANLLMDENGVVKVADFG 253
K NLL+D G +K++DFG
Sbjct: 128 KPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 29/111 (26%), Positives = 52/111 (46%), Gaps = 13/111 (11%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTE---MLKEF 154
WE +L + +G++G + + T + VA+K+LKP TE ++ E
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
Y+ H N+V +GACT ++TE+ G + +FL +++ F
Sbjct: 90 KVLSYLGN---HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
+ WE L+ + +G++G + + T VA+K+LK +T+ +
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-AHTDEREALM 89
Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
E+ I+ + +HKN+V +GACT + ++TE+ G + +FL K+ F
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 22/60 (36%), Positives = 39/60 (65%), Gaps = 2/60 (3%)
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTA-ETGTYRWMAPEV 278
++ +HQ +HRD+K N+L+D+NG +++ADFG R+ A V + GT +++PE+
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 20/61 (32%), Positives = 39/61 (63%), Gaps = 3/61 (4%)
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPE 277
++ +H ++HRDLK+AN+ + G++K+ DFG ++ + S V ++ GT ++APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 278 V 278
+
Sbjct: 242 L 242
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 105 WEIDAKQLKIECKVASGSYG--------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
WE +LK+ + G++G + K C + VA+K+LK +E K
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLKEGATASEY-KALMT 59
Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLT 208
E+ I+ I H NVV +GACT+P L ++ E+ G++ ++L ++ F
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 23/75 (30%), Positives = 44/75 (58%), Gaps = 3/75 (4%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
NL V +++ G + L + G+F+ L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLL-IRLGIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 240 LMDENGVVKVADFGV 254
L+D +G +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-05
Identities = 45/196 (22%), Positives = 75/196 (38%), Gaps = 38/196 (19%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
+ G G++Y CS+ VA+K ++ + +LK+ F +E I + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL-------------LKVAIDVSKG 220
C+ V M Y K V+Q SL L + +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ------------AQSGVMTAE- 267
+ Y+H ++HRDLK N+L+ G V + D+G A + + + +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 268 ------TGTYRWMAPE 277
GT +MAPE
Sbjct: 186 TIPGKIVGTPDYMAPE 201
|
Length = 932 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 187 EFMARGS-IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
EFM G I D + + K + + V V G+ LH+ I+HRD+K NLL+ +G
Sbjct: 289 EFMMAGKKIPDNMPQDKR--DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346
Query: 246 VVKVADFGVA 255
VK+ DFG A
Sbjct: 347 QVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 23/75 (30%), Positives = 43/75 (57%), Gaps = 3/75 (4%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
NL V +++ G + L + G+F L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132
Query: 240 LMDENGVVKVADFGV 254
L+D +G +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 29/119 (24%), Positives = 62/119 (52%), Gaps = 2/119 (1%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K L K + +N + E I+ + ++ VV+ + NL V +++ G +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
L + + ++ + +A +++ + +H+ IHRD+K N+L+D +G +K+ DFG+
Sbjct: 90 SLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 14/47 (29%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
L+++ ++ + + LH IIH DL T+N+++ + + DFG+A
Sbjct: 97 ELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIY-LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 24/112 (21%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 207
+ + E+ + ++ H+N+++ N ++T+ +Y F++ + ++
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ-KYDFDLYSFMYDEAFDWKD 262
Query: 208 TSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
LLK + K + Y+H +IHRD+K N+ ++ +G + + DFG A
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 14/32 (43%), Positives = 24/32 (75%)
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
+H+ IHRD+K N+L+D G +K++DFG++
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.002
Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV-DGWPYDETEDLKNVLAKEILKS 66
++T +L ++GLNI +A ST +LDVF V D + L + + +
Sbjct: 16 DITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIARLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 284 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.98 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.67 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.56 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.56 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.53 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.52 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.51 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.38 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.32 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.28 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.27 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.14 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 99.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.06 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.87 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.81 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.79 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.75 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.73 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.72 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.45 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.26 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.22 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 98.08 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.06 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.02 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.0 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.99 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.95 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.9 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.72 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.56 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 97.53 | |
| PLN02236 | 344 | choline kinase | 97.39 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.18 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.92 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.84 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.69 | |
| cd04895 | 72 | ACT_ACR_1 ACT domain-containing protein which is c | 96.65 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.61 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.49 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.44 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.43 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.41 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 96.4 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 96.18 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=310.11 Aligned_cols=175 Identities=28% Similarity=0.545 Sum_probs=161.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..+|.+.++||.|+||+||+|++ ++..||||.+.....+....+.+..|+.+|+.++|||||.+++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788999999999999999988 4689999999877667788888999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC------CcEEEecccceeeecc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------GVVKVADFGVARVQAQ 260 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~------~~vkl~Dfg~a~~~~~ 260 (284)
|||.||+|.+|+++ .+.+++..++.++.|++.||++||+++||||||||+|||++.. -.+||+|||+|+....
T Consensus 89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999987 4689999999999999999999999999999999999999865 4689999999999887
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+.+|+|.||||||++.++|
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~Y 191 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQY 191 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccc
Confidence 777778899999999999988877
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=309.54 Aligned_cols=181 Identities=46% Similarity=0.806 Sum_probs=166.5
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEECCce-EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
....|.++..++.+.+.+|+|+||+||+|.+.++. ||||++..........+.|.+|+.+|.+++|||||+++|+|.++
T Consensus 32 ~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 32 ELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred cccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34678899999999999999999999999999988 99999987665555578999999999999999999999999998
Q ss_pred C-cEEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEecCCC-cEEEecccce
Q 023285 180 P-NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLMDENG-VVKVADFGVA 255 (284)
Q Consensus 180 ~-~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~-iiH~Dikp~NIli~~~~-~vkl~Dfg~a 255 (284)
. .+++|||||++|+|.+++++ .+..+++..++.++.||++||+|||+++ ||||||||+|||++.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 4788999999999999999999999999 99999999999999998 9999999999
Q ss_pred eeeccC-CceecCCCcccccchhcccc
Q 023285 256 RVQAQS-GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~-~~~~~~~gt~~y~aPEvl~~ 281 (284)
+..... ..++...||+.|||||++++
T Consensus 192 r~~~~~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 192 REKVISKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred eeeccccccccCCCCCccccChhhhcC
Confidence 987654 45666899999999999994
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=285.80 Aligned_cols=177 Identities=32% Similarity=0.476 Sum_probs=160.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc-
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN- 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 181 (284)
..+...+++....||+|+.|+||++.+ +++.+|+|.+.. ..++...+++.+|+++++.++||+||.+||+|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 345566888899999999999999998 478999999953 3467788899999999999999999999999999995
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
++|+||||++|||.+++.+. +++++..+.+++.+|++||.|||+ .+||||||||+|||++..|.|||||||+++....
T Consensus 153 isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999999999999999764 789999999999999999999995 8999999999999999999999999999998766
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+ .-.+.+||..|||||.+.+..|
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Y 254 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESY 254 (364)
T ss_pred h-hcccccccccccChhhhcCCcC
Confidence 6 4567899999999999999876
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=285.09 Aligned_cols=178 Identities=26% Similarity=0.476 Sum_probs=159.0
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++.+.||+|+||.||.++. +++.+|+|+++.... .....+....|..+|.+++||+||+++..|++..++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35577999999999999999999876 578999999975533 334567789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+|+||+.||.|...|.+ .+.|++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+|+..-..+
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999976 5889999999999999999999999999999999999999999999999999999654443
Q ss_pred -ceecCCCcccccchhccccccC
Q 023285 263 -VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...+.+||+.|||||++.+..|
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy 202 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGY 202 (357)
T ss_pred CccccccCCccccChHHHhcCCC
Confidence 3445699999999999998765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=285.37 Aligned_cols=174 Identities=25% Similarity=0.411 Sum_probs=154.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..+.|.+.+.||+|+||.|-+|.. +++.||||+++...... .......+|+++|++|+|||||+++++|..+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356788999999999999999976 67999999996542211 12233679999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEecccceee
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARV 257 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~---~~vkl~Dfg~a~~ 257 (284)
..|+||||++||+|.+++-. ++.+.+..-+.++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999977 5778899999999999999999999999999999999999866 6899999999999
Q ss_pred eccCCceecCCCcccccchhccccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
......+.+.+|||.|.||||+.+.
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~k 353 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASK 353 (475)
T ss_pred cccceehhhhcCCccccChhheecC
Confidence 8877788999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=287.60 Aligned_cols=173 Identities=29% Similarity=0.437 Sum_probs=157.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
...|+..+.||+|+|+.+|+++. +|+.||+|++..... .....+...+|++|.++|+|||||+++++|++.+++|||
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 46799999999999999999987 689999999965433 445667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
.|+|+.++|..++. ++..++++++..++.||+.||.|||+.+|||||||..|+|++++.+|||+|||+|...... ...
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 99999999999997 4688999999999999999999999999999999999999999999999999999887644 566
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
.+.+|||.|+||||+...
T Consensus 176 ~TlCGTPNYIAPEVl~k~ 193 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKS 193 (592)
T ss_pred ceecCCCcccChhHhccC
Confidence 778999999999999854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=286.55 Aligned_cols=174 Identities=27% Similarity=0.463 Sum_probs=158.5
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 183 (284)
....|..+++||+|.||.||+|+. +++.||+|.++.+...+.......+||.||++|.||||+++.+..+.. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345788899999999999999987 578899999988877777888899999999999999999999998876 6799
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+|+|||+. +|.-++....-.|++.+++.++.|++.||+|+|.+||+|||||.+|||||++|.+||+|||+|++.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999988 9999997765689999999999999999999999999999999999999999999999999999765443
Q ss_pred -ceecCCCcccccchhccccc
Q 023285 263 -VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~ 282 (284)
.+|..+-|.+|+|||+|+|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred cccccceEEeeccChHHhcCC
Confidence 57888999999999999985
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=287.47 Aligned_cols=179 Identities=38% Similarity=0.703 Sum_probs=161.0
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECCc-eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|+++++.+++.+.||+|.||.||.|.++++ .||+|.++..... ...|.+|+++|++|+|+|||+++++|..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 578999999999999999999999999999876 9999999876444 357889999999999999999999999988
Q ss_pred cEEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|||||||+.|+|.+||.. .++.+...+++.++.|||.||+||+++++|||||.++||||++++.+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 45789999999999999999999999999999999999999999999999999999554
Q ss_pred cCCceecCC---CcccccchhccccccC
Q 023285 260 QSGVMTAET---GTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~---gt~~y~aPEvl~~~~y 284 (284)
+.. .+... -...|.|||.++..+|
T Consensus 355 d~~-Y~~~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 355 DDE-YTASEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred CCc-eeecCCCCCCceecCHHHHhhCCc
Confidence 443 33332 3579999999998776
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=288.02 Aligned_cols=179 Identities=37% Similarity=0.740 Sum_probs=164.9
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
....|+|..+++.+.++||+|+||+||+|.|.| +||||+++.+..+++..+.|++|+..+++-+|.||+-+.|+|.+++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 447899999999999999999999999999988 8999999988888899999999999999999999999999999977
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA- 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~- 259 (284)
. .||+.+|+|.+|+.+++-.+..|...+.+.|+.||+.||.|||.++|||||||..||++.++++|||+|||++....
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 6 99999999999999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred --cCCceecCCCcccccchhcccc
Q 023285 260 --QSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 260 --~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.........|...|||||+++-
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRm 564 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRM 564 (678)
T ss_pred eccccccCCCccchhhhcHHHHhh
Confidence 2333455678999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=270.77 Aligned_cols=171 Identities=29% Similarity=0.417 Sum_probs=154.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|+...++|+|+||+||+++. +|+.||||.+.....++...+-.++|+++|++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3677888999999999999987 68999999997654455556668999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCCceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~~~~~ 266 (284)
|++. ++.+-+......++...+..++.|++.|+.|+|++++|||||||+|||++.+|.+||||||+|+... .....|.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9987 7777777766778999999999999999999999999999999999999999999999999999877 5556778
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
.+.|.+|+|||++.|
T Consensus 161 YVATRWYRaPELLvG 175 (396)
T KOG0593|consen 161 YVATRWYRAPELLVG 175 (396)
T ss_pred hhhhhhccChhhhcc
Confidence 899999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=272.76 Aligned_cols=177 Identities=25% Similarity=0.454 Sum_probs=157.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEe-EEEcCCc-EE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG-ACTRPPN-LC 183 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~ 183 (284)
...+|++.++||+|+||.||+++. ++..||.|.++-+.++....+....|+.+|++|+|||||++++ .+.+++. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 345899999999999999999976 6899999999987788888889999999999999999999999 4555555 89
Q ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEecCCCcEEEeccccee
Q 023285 184 IVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~--~~--iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||||++++|+|...+.. ++..++++.+++++.|+++||..+|+ .+ |+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998854 45789999999999999999999998 45 9999999999999999999999999999
Q ss_pred eeccCC-ceecCCCcccccchhccccccC
Q 023285 257 VQAQSG-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+..... ...+.+|||.||+||++.+..|
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y 205 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGY 205 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCC
Confidence 876543 3356799999999999998876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=262.05 Aligned_cols=174 Identities=27% Similarity=0.452 Sum_probs=158.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|++.+.||.|+||.|.+.+. ++..+|+|+++.. .......+...+|..+|+.+.||+++++++.|.+..++|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 355899999999999999998876 5789999999754 2344566778999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||||.+||.|..++++ .++++++.++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.|+..... .
T Consensus 122 vmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 9999999999999987 478999999999999999999999999999999999999999999999999999987654 5
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
.+.+|||.|+|||++.++.|
T Consensus 199 ~TlCGTPeYLAPEii~sk~y 218 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGY 218 (355)
T ss_pred EEecCCccccChHHhhcCCC
Confidence 67899999999999998765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=276.71 Aligned_cols=177 Identities=27% Similarity=0.531 Sum_probs=158.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 180 (284)
...+.|.+.+.||+|+||.|+.|.. ++..||+|++...... ......+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4466899999999999999999987 5799999987654221 134456778999999999 999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccceeee-
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQ- 258 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~~~- 258 (284)
.+|+||||+.||+|++++.+ .+++.+..+..++.|+++|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999988 7899999999999999999999999999999999999999999 99999999999987
Q ss_pred ccCCceecCCCcccccchhcccccc-C
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFF-F 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~-y 284 (284)
.........+||+.|+|||++.+.. |
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y 199 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTY 199 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCc
Confidence 4556677889999999999999876 5
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.91 Aligned_cols=173 Identities=28% Similarity=0.465 Sum_probs=155.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.+|...+++|+|.||.||+|+. +|+.||||.++.....+..-....+|++.|+.++|+||+.++++|.....+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999988 57999999999876555556678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
||+. +|...++...-.++...++.++.++++|++|||++.|+||||||.|+|++.+|.+||+|||+|+...... ..+.
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 9976 9999998877889999999999999999999999999999999999999999999999999999865443 3344
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
.+-|.+|+|||++.|.+
T Consensus 161 ~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSR 177 (318)
T ss_pred ceeeeeccChHHhccch
Confidence 58899999999998753
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=272.13 Aligned_cols=171 Identities=35% Similarity=0.640 Sum_probs=150.3
Q ss_pred cCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-cEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-NLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lV~ 186 (284)
.+.|.-...||+|+||.||+|...+ ..||||.+....... .++|.+|+.++.+++|||+|+++|+|.+.. ..++|+
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 3567777899999999999999965 899999887653322 456999999999999999999999999988 499999
Q ss_pred EcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEecCCCcEEEecccceeeecc-C
Q 023285 187 EFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S 261 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~---~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~ 261 (284)
|||++|+|.+.|+.... .++|..+.+|+.++|+||+|||.. .||||||||+|||+|++.++||+|||+|+..+. .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 99999999999998766 899999999999999999999985 399999999999999999999999999987665 3
Q ss_pred CceecC-CCcccccchhcccc
Q 023285 262 GVMTAE-TGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~~~~~~-~gt~~y~aPEvl~~ 281 (284)
...... .||.+|+|||.+.+
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred cceeeecCCCCccCChhhhcc
Confidence 333333 89999999999865
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=277.57 Aligned_cols=173 Identities=27% Similarity=0.431 Sum_probs=156.4
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC-cEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP-NLC 183 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~ 183 (284)
..++|.+.++||.|.||.||+|+. .+..||||.++.....-+ .-.-++|+..|+++. ||||+++.+++.++. .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 346899999999999999999986 578899999986644422 223478999999999 999999999998887 899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+|||||+. +|++++..++..|++..+..|+.||++||+|+|++|++|||+||+|||+..+..+||+|||+||.......
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999976 99999999888999999999999999999999999999999999999999899999999999999888888
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.|..+.|.+|+|||+++.-
T Consensus 166 YTeYVSTRWYRAPEvLLrs 184 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRS 184 (538)
T ss_pred cchhhhcccccchHHhhhc
Confidence 8999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=276.18 Aligned_cols=173 Identities=33% Similarity=0.583 Sum_probs=158.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|.+.+.||+|+||.||+|+. +.+.||+|.+......+...+.+.+|++|++.++||||+.++++|++..++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4788899999999999999976 45899999997766667778889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+.| +|..++.. ++.++++.+..++.++++||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+.... ..+.
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9987 99999966 6889999999999999999999999999999999999999999999999999999776543 3456
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..|||.|||||++.++.|
T Consensus 160 ikGtPlYmAPElv~e~py 177 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPY 177 (808)
T ss_pred ccCcccccCHHHHcCCCc
Confidence 689999999999998876
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=268.35 Aligned_cols=175 Identities=25% Similarity=0.491 Sum_probs=162.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
..+|.+.+.||+|.||.|-+|+. .++.||||.++.+.. +.+..-.+.+|++||..|+||||+++|.+|.+.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999976 579999999976644 345566789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|||..+|.|+||+.. .+.+++.++..+++||.+|+.|+|+++++|||||.+|||+|.++++||+|||++....+....+
T Consensus 132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999999999987 4789999999999999999999999999999999999999999999999999999888888888
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
+++|+|.|.+||+++|..|
T Consensus 211 TFCGSPLYASPEIvNG~PY 229 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPY 229 (668)
T ss_pred HhcCCcccCCccccCCCCC
Confidence 9999999999999999887
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=261.15 Aligned_cols=178 Identities=34% Similarity=0.543 Sum_probs=158.7
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..|.++.++|++.+.||.|..+.||+|+. .+..||||++..+..+.+ ...+.+|+..++.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45778899999999999999999999987 578999999988765554 788999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|+||.||.+||+.+.+... +..+++..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+-...
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999763 4569999999999999999999999999999999999999999999999999876544
Q ss_pred cCC-c----eecCCCcccccchhcccc
Q 023285 260 QSG-V----MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 260 ~~~-~----~~~~~gt~~y~aPEvl~~ 281 (284)
.++ . ....+||++|||||+++.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhh
Confidence 333 1 144589999999999654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=270.27 Aligned_cols=176 Identities=28% Similarity=0.461 Sum_probs=154.0
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
.-...+|++++.||+|+|++|++|+. +++.+|||++..... .+...+-...|-.+|.+| .||.|++++..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567899999999999999999987 578999999864422 233445578899999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+|+||.++|+|.++|++. +.|++..++.++.+|+.||+|||++|||||||||+|||+|.+++++|+|||.|+.....
T Consensus 149 LYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999885 88999999999999999999999999999999999999999999999999999865432
Q ss_pred Cc--------------eecCCCcccccchhccccc
Q 023285 262 GV--------------MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~--------------~~~~~gt~~y~aPEvl~~~ 282 (284)
.. ....+||-.|.+||+|...
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~ 262 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS 262 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCC
Confidence 11 1447899999999999865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=269.10 Aligned_cols=150 Identities=21% Similarity=0.371 Sum_probs=138.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++++.||+|+||.||+|+. +|..+|+|+++...+ ..........|..+|....+|+||+++..|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45678999999999999999999976 689999999975533 445677899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||||||++||++..+|.+ .+.+++..+..++.+++.|++-+|+.|+|||||||+|+|||..|++||+|||+|.
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999977 5889999999999999999999999999999999999999999999999999985
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=272.44 Aligned_cols=178 Identities=28% Similarity=0.429 Sum_probs=158.7
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 180 (284)
..+..++|.+.+.||+|+||+|+++.. +++.+|||+++.+. ..++..+..+.|.+|+.... ||.+++++..|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 456778999999999999999999987 45889999998763 45667788999999988886 999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA- 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~- 259 (284)
++|+||||..||++.... +.+.|++..+..+++.|+.||.|||++||||||||.+|||+|.+|++||+|||+|+...
T Consensus 443 ~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred eEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 999999999999944333 34789999999999999999999999999999999999999999999999999999755
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......+.+|||.|||||++.++.|
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Y 545 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSY 545 (694)
T ss_pred CCCccccccCChhhcChhhhccCcc
Confidence 4555667899999999999999887
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.15 Aligned_cols=182 Identities=34% Similarity=0.604 Sum_probs=160.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
..|++..++..+.++||+|+||.||+|++.- ..||||..+.. ....+...+|++|+++|++++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 5699999999999999999999999998731 23899999863 3567889999999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
+.....+++|||+|.||+|.++|.+..+.++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999987667999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCcee-cCCCcccccchhccccccC
Q 023285 256 RVQAQSGVMT-AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 256 ~~~~~~~~~~-~~~gt~~y~aPEvl~~~~y 284 (284)
+....-.... ...-..+|+|||.+....|
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCcc
Confidence 8654211111 2234679999999987655
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=256.88 Aligned_cols=174 Identities=27% Similarity=0.440 Sum_probs=152.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCC-----
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPP----- 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 180 (284)
...|...++||+|+||+||+|+. +|+.||+|.++.+...+.......+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45688888999999999999987 6789999999866443334566789999999999999 999999998877
Q ss_pred -cEEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 181 -NLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 181 -~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.+++|+||++. +|..++.... ..++...++.++.||+.||+|||+++|+||||||+|||++++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 79999999976 9999998865 357788999999999999999999999999999999999999999999999999
Q ss_pred eec-cCCceecCCCcccccchhcccccc
Q 023285 257 VQA-QSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~-~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
... .....+.+++|.+|+|||++.|..
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCC
Confidence 655 333467889999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=255.85 Aligned_cols=171 Identities=29% Similarity=0.502 Sum_probs=148.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC--cEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l 184 (284)
..++...+.||+|+||.||++... +...|||.+... +....+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 346778899999999999999985 589999998754 2222677999999999999999999999854444 6999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeecc---
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ--- 260 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~~--- 260 (284)
.|||+++|+|.+++.+..+.++++.+.+++.||+.||+|||++||+||||||+|||++. ++.+||+|||.++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999886558999999999999999999999999999999999999999 79999999999986552
Q ss_pred -CCceecCCCcccccchhcccc
Q 023285 261 -SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 -~~~~~~~~gt~~y~aPEvl~~ 281 (284)
........||+.|||||++.+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred cccccccccCCccccCchhhcC
Confidence 222345689999999999983
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.10 Aligned_cols=173 Identities=28% Similarity=0.441 Sum_probs=153.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 184 (284)
.++|+...+|++|+||.||+|+. +++.||+|.++.+.......-.-.+|+.+|.+++|||||.+-.+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35789999999999999999987 46899999998775444444567899999999999999999887754 356999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~ 263 (284)
|||||+. +|..++.+-+.+|...+++.++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+....+ ..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9999987 999999998889999999999999999999999999999999999999999999999999999976543 45
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
+|..+-|.+|+|||++.|.
T Consensus 234 ~T~lVVTLWYRaPELLLG~ 252 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGA 252 (419)
T ss_pred CcceEEEeeecCHHHhcCC
Confidence 7788899999999999875
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=257.99 Aligned_cols=174 Identities=24% Similarity=0.358 Sum_probs=149.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||||+++.... .......+.+|+.++++++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3689999999999999999987 468999999864321 2334567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC----
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---- 262 (284)
||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999976 4679999999999999999999999999999999999999999999999999987432110
Q ss_pred --------------------------------ceecCCCcccccchhccccccC
Q 023285 263 --------------------------------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 --------------------------------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+||+.|+|||++.+..|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 213 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC
Confidence 0123479999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=266.02 Aligned_cols=174 Identities=27% Similarity=0.451 Sum_probs=161.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+-|++++.||.|+-|.|-.|++ +|+.+|||++... .........+.+|+-+|+-+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3577899999999999999988 6899999999755 344455667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||++||.|++++-. ++.+++.++.+++.||+.|+.|+|..+|+|||+||+|+|+|.++++||+|||+|..........+
T Consensus 92 Eyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeT 170 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLET 170 (786)
T ss_pred EecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccccc
Confidence 99999999999977 58899999999999999999999999999999999999999999999999999999888777888
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
.+|+|.|.|||+++|.+|
T Consensus 171 SCGSPHYA~PEIV~G~pY 188 (786)
T KOG0588|consen 171 SCGSPHYAAPEIVSGRPY 188 (786)
T ss_pred cCCCcccCCchhhcCCCC
Confidence 899999999999999988
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=265.97 Aligned_cols=178 Identities=33% Similarity=0.598 Sum_probs=160.9
Q ss_pred ccCCCCCCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 96 ~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
+......+.|+|..+.+.-.+-||+|+.|.||+|+..++.||||.++. .-..+|+-|++|+|+||+.|.|+
T Consensus 110 e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 110 EHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred ehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeee
Confidence 344455678999999999999999999999999999999999998752 12357888999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
|+..+.+|||||||..|-|+..|.. ...++...+..+..+|+.||.|||.+.|||||||.-||||..+..|||+|||-+
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence 9999999999999999999999976 567899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.......+-.+.||..|||||+|+...
T Consensus 260 ~e~~~~STkMSFaGTVaWMAPEvIrneP 287 (904)
T KOG4721|consen 260 KELSDKSTKMSFAGTVAWMAPEVIRNEP 287 (904)
T ss_pred HhhhhhhhhhhhhhhHhhhCHHHhhcCC
Confidence 9877766667889999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=254.73 Aligned_cols=180 Identities=32% Similarity=0.600 Sum_probs=149.1
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 175 (284)
.|++..++|++.++||+|+||.||+|.+ .++.||||+++.. ........+.+|+.+++++ +||||++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 3788899999999999999999999974 2357999998743 2344456799999999999 89999999999
Q ss_pred EEcCC-cEEEEEEcCCCCCHHHHHHhcC----------------------------------------------------
Q 023285 176 CTRPP-NLCIVTEFMARGSIYDFLHKQK---------------------------------------------------- 202 (284)
Q Consensus 176 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------- 202 (284)
|.... .+++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 87644 5899999999999999997532
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCc
Q 023285 203 ---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGT 270 (284)
Q Consensus 203 ---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt 270 (284)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 2367788899999999999999999999999999999999999999999999986432211 1223456
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 240 ~~y~aPE~~~~~~~ 253 (338)
T cd05102 240 LKWMAPESIFDKVY 253 (338)
T ss_pred ccccCcHHhhcCCC
Confidence 88999999876543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=255.48 Aligned_cols=148 Identities=22% Similarity=0.342 Sum_probs=133.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|+. +++.||||+++... ........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3789999999999999999987 47899999997432 12344566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=253.85 Aligned_cols=176 Identities=27% Similarity=0.424 Sum_probs=152.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC---ceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..+..++|++.+.||+|+||.||+|.+.+ ..||+|.+.... ........+.+|+.+++.++||||+++++++..+.
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 45667789999999999999999998632 579999986432 12344567889999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+.+|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999976 45789999999999999999999999999999999999999999999999999986543
Q ss_pred CCceecCCCcccccchhcccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
. .....||+.|||||++.+..
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~ 204 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVG 204 (340)
T ss_pred C--cceecCChhhcCHHHHhCCC
Confidence 2 23457999999999987654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=244.92 Aligned_cols=174 Identities=22% Similarity=0.341 Sum_probs=150.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|+..+.||+|+||.||+|.. +++.||+|.+...... ......+.+|+.++++++|+||+++++.+..+..+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999986 5789999998654322 2334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
|+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999888653 34689999999999999999999999999999999999999999999999999987654434455
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..||+.|+|||++.+..|
T Consensus 161 ~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05631 161 RVGTVGYMAPEVINNEKY 178 (285)
T ss_pred CCCCCCccCHhhhcCCCC
Confidence 679999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=256.08 Aligned_cols=146 Identities=21% Similarity=0.335 Sum_probs=132.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||||++.... ...+....+.+|+.++++++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3689999999999999999987 57899999986432 23345567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.01 Aligned_cols=173 Identities=27% Similarity=0.422 Sum_probs=151.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|++.+.||+|+||.||+|+. +++.||+|+++.... .......+.+|+.++++++||||+++++++..+..+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 346899999999999999999988 468899999864321 22345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence 9999999999999976 467899999999999999999999999999999999999999999999999999865443 2
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 173 ~~~~gt~~y~aPE~~~~~~ 191 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKG 191 (329)
T ss_pred ceecCChhhcCHHHHcCCC
Confidence 3457999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=254.43 Aligned_cols=172 Identities=30% Similarity=0.473 Sum_probs=143.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------------HHHHHHHHHHHHHHhCCCCceeeEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------------EMLKEFSQEVYIMRKIRHKNVVQFI 173 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~~~ 173 (284)
-..+|++.+.||+|.||.|-+|+. .++.||||++....... .-.+...+|+.+|+++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 356899999999999999999987 56899999995432111 1135789999999999999999999
Q ss_pred eEEEcC--CcEEEEEEcCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEe
Q 023285 174 GACTRP--PNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250 (284)
Q Consensus 174 ~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~ 250 (284)
++..+. +.+|+|+|||..|.+...= .... +++.++++++.+++.||+|||.+|||||||||+|+|++.+|+|||+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999764 5799999999988875432 2233 8999999999999999999999999999999999999999999999
Q ss_pred cccceeeeccC------CceecCCCcccccchhcccc
Q 023285 251 DFGVARVQAQS------GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 251 Dfg~a~~~~~~------~~~~~~~gt~~y~aPEvl~~ 281 (284)
|||++....+. ......+|||.|||||...+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 99999765322 12234689999999999877
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.53 Aligned_cols=172 Identities=24% Similarity=0.395 Sum_probs=151.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.. +++.||||+++.... .......+.+|+.++++++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4789999999999999999988 468999999875422 2234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 99999999999976 46789999999999999999999999999999999999999999999999999976543 2345
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..||+.|+|||++.+..|
T Consensus 158 ~~gt~~y~aPE~~~~~~~ 175 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGY 175 (333)
T ss_pred cccCccccChhHhcCCCC
Confidence 579999999999987643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.20 Aligned_cols=171 Identities=29% Similarity=0.485 Sum_probs=151.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
..|.-..+||+|+.|.||.|+. +++.||||.+.... ....+-+.+|+.+|+..+|+|||.+++.|...+.+|.|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 4577788999999999999976 56889999986542 2334568899999999999999999999988899999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
||+||+|.|.+.. ..+++.++..|+.+++.||+|||.+||+|||||.+|||++.+|.+||+|||+|....... ...+
T Consensus 351 ym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred ecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999999976 459999999999999999999999999999999999999999999999999998766544 4456
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
-+|||+|||||++....|
T Consensus 429 mVGTPYWMAPEVvtrk~Y 446 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPY 446 (550)
T ss_pred ccCCCCccchhhhhhccc
Confidence 789999999999988766
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=254.82 Aligned_cols=145 Identities=21% Similarity=0.359 Sum_probs=131.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|++.+.||+|+||.||+|+. +++.||||+++... ........+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588999999999999999987 46899999996532 234456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
|++||+|.+++.+ .+.+++..+..++.||+.||+|||+.||+||||||+|||++.++++||+|||+++
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999976 4568999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=249.83 Aligned_cols=168 Identities=24% Similarity=0.420 Sum_probs=145.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
+.||+|+||.||++.. +++.||||+++.... .......+.+|+.++++++||||+++++++..+..+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999987 568999999975422 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCCcc
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTY 271 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~ 271 (284)
+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999976 467899999999999999999999999999999999999999999999999999754322 2234457999
Q ss_pred cccchhccccccC
Q 023285 272 RWMAPEVAFTFFF 284 (284)
Q Consensus 272 ~y~aPEvl~~~~y 284 (284)
.|+|||++.+..|
T Consensus 160 ~y~aPE~~~~~~~ 172 (323)
T cd05571 160 EYLAPEVLEDNDY 172 (323)
T ss_pred cccChhhhcCCCC
Confidence 9999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=248.09 Aligned_cols=171 Identities=24% Similarity=0.391 Sum_probs=149.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|... ++.||+|+++.... .......+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999874 78999999864322 2234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 99999999999976 467899999999999999999999999999999999999999999999999999865432 234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..||+.|+|||++.+..
T Consensus 158 ~~gt~~y~aPE~~~~~~ 174 (291)
T cd05612 158 LCGTPEYLAPEVIQSKG 174 (291)
T ss_pred ccCChhhcCHHHHcCCC
Confidence 57999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=254.12 Aligned_cols=145 Identities=21% Similarity=0.365 Sum_probs=131.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|.+.++||+|+||.||+|.. +++.||+|++.... ........+.+|+.++++++||||+++++.+.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 56889999986432 123455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
|+++|+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 99999999999763 678999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=248.20 Aligned_cols=166 Identities=30% Similarity=0.492 Sum_probs=142.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----cEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 183 (284)
.|.-.+.+|+|+||.||+|.. +++.||||..-.+. +--.+|+++|+.++|||||++.-+|.... ...
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 467788999999999999987 45899999876542 12246999999999999999998885432 457
Q ss_pred EEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccceeeec
Q 023285 184 IVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQA 259 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~~~~ 259 (284)
+|||||+. +|+++++. .+..++.-.++-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||+|+...
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999976 99999974 25678888899999999999999999999999999999999965 999999999999987
Q ss_pred cCCceecCCCcccccchhcccccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......+...|..|+|||++.|..
T Consensus 178 ~~epniSYicSRyYRaPELifga~ 201 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGAT 201 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCcc
Confidence 776667778899999999998753
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=253.36 Aligned_cols=175 Identities=23% Similarity=0.336 Sum_probs=150.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++.+.||+|+||.||++.. +++.||+|+++... ........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34456899999999999999999988 46889999986422 1233345688999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999965 358899999999999999999999999999999999999999999999999998754332
Q ss_pred c--eecCCCcccccchhccccc
Q 023285 263 V--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~--~~~~~gt~~y~aPEvl~~~ 282 (284)
. .....||+.|||||++.+.
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred ceecccCCCCcccCCHHHHhcc
Confidence 2 2345799999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=253.30 Aligned_cols=146 Identities=21% Similarity=0.359 Sum_probs=131.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+|++.+.||+|+||.||+|.. +++.||||++..... .......+.+|+.++++++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999987 468999999864321 2234566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||+++|+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=251.96 Aligned_cols=173 Identities=23% Similarity=0.382 Sum_probs=151.6
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|... ++.||||+++.... .......+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36899999999999999999985 78999999875422 2245567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC----
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---- 262 (284)
||+++++|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999775 679999999999999999999999999999999999999999999999999997654332
Q ss_pred --------------------------ceecCCCcccccchhcccccc
Q 023285 263 --------------------------VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 --------------------------~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 223456899999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=248.29 Aligned_cols=172 Identities=21% Similarity=0.331 Sum_probs=149.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+++. +++.||+|+++.. .........+.+|+.+++.++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999987 4689999998642 122334566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--e
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--~ 264 (284)
||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999977667799999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....||+.|||||++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 161 NVAVGTPDYISPEILQA 177 (331)
T ss_pred cceeccccccCHHHHhh
Confidence 23469999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=242.84 Aligned_cols=176 Identities=31% Similarity=0.566 Sum_probs=147.8
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 168 (284)
+..++|++.++||+|+||.||++.+. +..||+|+++... .......|.+|+.++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 34678999999999999999999752 2369999987643 3455678999999999999999
Q ss_pred eeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 023285 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------------------GVFQLTSLLKVAIDVSKGMNYLHQNNII 230 (284)
Q Consensus 169 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~~i~~~L~~LH~~~ii 230 (284)
|+++++++......++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986531 2367788999999999999999999999
Q ss_pred ecCCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 231 H~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||||||+|||++.++.+||+|||+++....... .....++..|||||++.+..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 999999999999999999999999976533221 12234578999999987654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=250.39 Aligned_cols=174 Identities=24% Similarity=0.362 Sum_probs=149.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||+|+++... ...+....+.+|+.++.+++|+||+++++.+.+...+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688999999999999999987 46899999986432 22345567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC----
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---- 262 (284)
||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ceecCCCcccccchhccccccC
Q 023285 263 --------------------------------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 --------------------------------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+||+.|+|||++.+..|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 0113469999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.60 Aligned_cols=172 Identities=20% Similarity=0.322 Sum_probs=149.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+++. +++.||+|+++... ........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 46789999986421 12334456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce--
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-- 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~-- 264 (284)
||++||+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999999876677899999999999999999999999999999999999999999999999999865443222
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....||+.|+|||++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 161 SVAVGTPDYISPEILQA 177 (331)
T ss_pred ccccCCcccCCHHHHhc
Confidence 23469999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=246.71 Aligned_cols=172 Identities=26% Similarity=0.376 Sum_probs=151.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||+|+++.... ..+....+.+|+.+++.++|+||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 3689999999999999999987 578999999975432 2345567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--e
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--~ 264 (284)
||+++|+|.+++.+..+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999999988667899999999999999999999999999999999999999999999999999986543322 2
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....||+.|+|||++.+
T Consensus 161 ~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 161 KLPVGTPDYIAPEVLTT 177 (330)
T ss_pred ecccCCccccCHHHhcc
Confidence 23468999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=246.77 Aligned_cols=168 Identities=23% Similarity=0.425 Sum_probs=144.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999987 578999999875422 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCcc
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY 271 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~ 271 (284)
+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99998866 45789999999999999999999999999999999999999999999999999875322 22233457999
Q ss_pred cccchhccccccC
Q 023285 272 RWMAPEVAFTFFF 284 (284)
Q Consensus 272 ~y~aPEvl~~~~y 284 (284)
.|+|||++.+..|
T Consensus 160 ~y~aPE~~~~~~~ 172 (323)
T cd05595 160 EYLAPEVLEDNDY 172 (323)
T ss_pred CcCCcccccCCCC
Confidence 9999999977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=250.71 Aligned_cols=176 Identities=23% Similarity=0.319 Sum_probs=151.3
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.++..++|++.+.||+|+||.||++.. +++.||+|++.... ........+.+|+.+++.++||||+++++.+..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 445667999999999999999999988 46889999986421 123344568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999965 35889999999999999999999999999999999999999999999999999875443
Q ss_pred Cc--eecCCCcccccchhccccc
Q 023285 262 GV--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~--~~~~~gt~~y~aPEvl~~~ 282 (284)
.. .....||+.|||||++.+.
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CcccccCcccCccccCHHHHhcc
Confidence 22 2345799999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=246.17 Aligned_cols=167 Identities=25% Similarity=0.430 Sum_probs=144.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999987 568999999975422 3345567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCcc
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY 271 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt~ 271 (284)
+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999866 46789999999999999999999999999999999999999999999999999875322 22234457999
Q ss_pred cccchhcccccc
Q 023285 272 RWMAPEVAFTFF 283 (284)
Q Consensus 272 ~y~aPEvl~~~~ 283 (284)
.|+|||++.+..
T Consensus 160 ~y~aPE~~~~~~ 171 (328)
T cd05593 160 EYLAPEVLEDND 171 (328)
T ss_pred CccChhhhcCCC
Confidence 999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=234.23 Aligned_cols=175 Identities=25% Similarity=0.411 Sum_probs=154.8
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|.+++.||+|-||.||.|+.. +..||+|++... ........++.+|++|-..|+||||.++|++|.++.+.|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3457999999999999999999884 578999998533 2233445679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
++||...|+++..|..+ ...+++.....++.|++.||.|+|.++||||||||+|+|++..|.+|++|||-+...+ .+.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK 178 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence 99999999999999854 3569999999999999999999999999999999999999999999999999997666 445
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
..+.+||..|.|||+..+..
T Consensus 179 R~tlcgt~dyl~pEmv~~~~ 198 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRG 198 (281)
T ss_pred ceeeecccccCCHhhcCCCC
Confidence 66789999999999998764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=250.43 Aligned_cols=177 Identities=23% Similarity=0.320 Sum_probs=151.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+++..++|++.+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 3456677999999999999999999987 468999999864321 2233455789999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||++||+|.+++.+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999999865 3588999999999999999999999999999999999999999999999999986543
Q ss_pred CCc--eecCCCcccccchhccccc
Q 023285 261 SGV--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~--~~~~~gt~~y~aPEvl~~~ 282 (284)
... .....||+.|+|||++.+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccC
Confidence 321 2345799999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=251.00 Aligned_cols=176 Identities=26% Similarity=0.435 Sum_probs=162.9
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
....|.+...||+|.|+.|..|++ ++..||||++.....+....+.+.+|+++|+.+.|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345799999999999999999987 679999999987776777777799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|||..+|.+++|+.+. ++..+..+..++.|+.++++|||+++|+|||||++|||++.+.++||+|||++.+........
T Consensus 134 ~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 9999999999999884 667779999999999999999999999999999999999999999999999999888776777
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
+.+|++.|.|||++.|..|
T Consensus 213 t~cgsppyAaPEl~~g~~y 231 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKY 231 (596)
T ss_pred ccCCCCCccChHhhcCccc
Confidence 8899999999999999876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=241.33 Aligned_cols=172 Identities=27% Similarity=0.457 Sum_probs=147.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.++||+|+||.||+|+. +++.||||+++.... ......+.+|+.+++.++||||+++++++..+...|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 35799999999999999999988 468999999874422 222345778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+. ++|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 9996 5898888776677999999999999999999999999999999999999999999999999999754322 2234
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...+|+.|+|||++.+.
T Consensus 162 ~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 162 NEVVTLWYRPPDVLLGS 178 (303)
T ss_pred CCcccCCCCChHHHcCC
Confidence 45789999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.55 Aligned_cols=166 Identities=22% Similarity=0.418 Sum_probs=143.9
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||+|+||.||+|.. +++.||+|+++... ........+.+|+.++++++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999988 46789999986432 2334456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCCcccc
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW 273 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y 273 (284)
.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++..... .......||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999976 467899999999999999999999999999999999999999999999999999864322 223345799999
Q ss_pred cchhccccccC
Q 023285 274 MAPEVAFTFFF 284 (284)
Q Consensus 274 ~aPEvl~~~~y 284 (284)
+|||++.+..|
T Consensus 160 ~aPE~~~~~~~ 170 (312)
T cd05585 160 LAPELLLGHGY 170 (312)
T ss_pred CCHHHHcCCCC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=243.34 Aligned_cols=168 Identities=24% Similarity=0.430 Sum_probs=144.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
+.||+|+||.||++.. +++.||+|+++.... .......+..|+++++.++||||+++++++..+..+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999986 578999999975422 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99998866 4578999999999999999999997 7999999999999999999999999999875332 2223345799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (325)
T cd05594 160 PEYLAPEVLEDNDY 173 (325)
T ss_pred cccCCHHHHccCCC
Confidence 99999999977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=252.47 Aligned_cols=175 Identities=26% Similarity=0.463 Sum_probs=159.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc-EEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lV~ 186 (284)
++|...+.+|+|+||.++..++ .+..+++|.+..........+...+|+.++++++|||||.+.+.|..++. +||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999886655 46789999998877777777789999999999999999999999998888 99999
Q ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 187 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
+|++||++.+.+.+++ ..++++.+..++.|++.|+.|||+++|+|||||+.||++..++.|+|.|||+|+...... ..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a 163 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA 163 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence 9999999999998876 579999999999999999999999999999999999999999999999999999876654 55
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
.+..||+.||+||++.+..|
T Consensus 164 ~tvvGTp~YmcPEil~d~pY 183 (426)
T KOG0589|consen 164 STVVGTPYYMCPEILSDIPY 183 (426)
T ss_pred heecCCCcccCHHHhCCCCC
Confidence 66789999999999999887
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=239.53 Aligned_cols=171 Identities=25% Similarity=0.449 Sum_probs=147.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.++||.|+||.||+|.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35799999999999999999987 468999999875422 223356788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+++ +|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99975 999999776667899999999999999999999999999999999999999999999999999764322 1233
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+++.|+|||++.+
T Consensus 162 ~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 162 NEVVTLWYRPPDVLLG 177 (288)
T ss_pred CceecccccChHHhcC
Confidence 4578999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=236.43 Aligned_cols=176 Identities=27% Similarity=0.509 Sum_probs=150.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
|+..+|++.+.||+|+||.||+|.+. +..||+|.++... .......+.+|+.++++++||||+++++++..+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 56778999999999999999999753 4689999987642 34445679999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++||||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999987653222
Q ss_pred Ccee--cCCCcccccchhcccccc
Q 023285 262 GVMT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~~--~~~gt~~y~aPEvl~~~~ 283 (284)
.... ...++..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~ 184 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHH 184 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCC
Confidence 1111 224567899999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=242.66 Aligned_cols=173 Identities=23% Similarity=0.365 Sum_probs=147.4
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCC-ceeeEEeEEEcCCcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lV~ 186 (284)
+|++.+.||+|+||.||+|... ++.||||+++.... .....+.+..|..+++.++|+ +|+.+++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999874 57899999875422 234456788999999999864 6888999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCCcee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~~~~ 265 (284)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999987532 222334
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 160 ~~~gt~~y~aPE~~~~~~~ 178 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPY 178 (324)
T ss_pred eecCCccccChhhhcCCCC
Confidence 4579999999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=246.81 Aligned_cols=174 Identities=26% Similarity=0.457 Sum_probs=155.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 184 (284)
...|++.+.||+|.||.||+++. +++.+|+|+++..... ......+.+|+.+|++++ ||||+++++++.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 45789999999999999999987 4789999999755332 334568999999999999 9999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----CcEEEecccceeeecc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQ 260 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~----~~vkl~Dfg~a~~~~~ 260 (284)
|||++.||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|.....
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999999999876 39999999999999999999999999999999999999633 4799999999998877
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......+||+.|+|||++....|
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y 215 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPY 215 (382)
T ss_pred CceEeeecCCccccCchhhcCCCC
Confidence 666778899999999999986554
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=243.66 Aligned_cols=167 Identities=26% Similarity=0.377 Sum_probs=144.4
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
+.||+|+||.||++.. +++.||+|+++...........+.+|+.++++++||||+++++++..+..+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998864 46889999997543333344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCC
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG 269 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~g 269 (284)
+|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... .......|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999976 457899999999999999999999999999999999999999999999999999765433 22345579
Q ss_pred cccccchhcccccc
Q 023285 270 TYRWMAPEVAFTFF 283 (284)
Q Consensus 270 t~~y~aPEvl~~~~ 283 (284)
|+.|+|||++.+..
T Consensus 161 ~~~y~aPE~~~~~~ 174 (318)
T cd05582 161 TVEYMAPEVVNRRG 174 (318)
T ss_pred ChhhcCHHHHcCCC
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=243.78 Aligned_cols=171 Identities=21% Similarity=0.330 Sum_probs=147.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.++||+|+||.||++... ++.+|+|++.... ........+.+|+.++..++|+||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 37899999999999999999874 5789999985321 12233455889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--e
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--~ 264 (284)
||+++|+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987667799999999999999999999999999999999999999999999999999975433222 2
Q ss_pred ecCCCcccccchhccc
Q 023285 265 TAETGTYRWMAPEVAF 280 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~ 280 (284)
....||+.|+|||++.
T Consensus 161 ~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 161 SVAVGTPDYISPEILQ 176 (332)
T ss_pred cccccCccccCHHHHh
Confidence 2357999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=240.03 Aligned_cols=171 Identities=25% Similarity=0.421 Sum_probs=150.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-----CCcE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-----PPNL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 182 (284)
..|...+.||.|+||.|..|.. +++.||||.+.....+.-..++..+|+++++.++|+||+.+.+++.. -..+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 3566689999999999999987 57999999987554456667889999999999999999999999866 3469
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc--
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-- 260 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-- 260 (284)
|+|+|+|+. +|...++. +..++...+..++.|+++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+....
T Consensus 102 YiV~elMet-DL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 102 YLVFELMET-DLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred EEehhHHhh-HHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999999954 99999876 35599999999999999999999999999999999999999999999999999998753
Q ss_pred -CCceecCCCcccccchhccccc
Q 023285 261 -SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 -~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.+.+|..+.|.+|.|||++...
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~ 202 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNS 202 (359)
T ss_pred cccchhcceeeeeecCHHHHhcc
Confidence 5567888999999999998653
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=251.14 Aligned_cols=173 Identities=31% Similarity=0.508 Sum_probs=153.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
..|+..+.||+|+||.||+|.. +++.||||++..+. ..+.+.++.+|+.++.+++++||.++|+.+..+..++++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 3677779999999999999987 46899999998764 34557889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-eec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~~ 266 (284)
||.||++.+.+.. ...+.+..+..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||++........ ..+
T Consensus 92 y~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9999999999965 34458888999999999999999999999999999999999999999999999987655433 367
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
.+|||.||||||+.+.-|
T Consensus 171 fvGTPfwMAPEVI~~~~Y 188 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGY 188 (467)
T ss_pred ccccccccchhhhccccc
Confidence 799999999999997655
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=242.86 Aligned_cols=168 Identities=24% Similarity=0.372 Sum_probs=144.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||++.. +++.||+|+++..... .+....+..|..+++++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999987 4689999999754322 33456788999999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++... .........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999998866 4679999999999999999999999999999999999999999999999999987532 22233445799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (329)
T cd05588 160 PNYIAPEILRGEDY 173 (329)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=247.99 Aligned_cols=180 Identities=29% Similarity=0.559 Sum_probs=151.2
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|+++.++|++.+.||+|+||.||+|++ .+..||||+++... .......+.+|+.+++.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 46788888999999999999999999974 23579999997543 233456789999999999 7999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcC----------------------------------------------------
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------- 202 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------- 202 (284)
+|......++||||+++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999996532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 203 ----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 203 ----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1367788999999999999999999999999999999999999999999999986543
Q ss_pred CCce---ecCCCcccccchhcccccc
Q 023285 261 SGVM---TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~---~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ....+++.|+|||++.+..
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 292 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCV 292 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCC
Confidence 3211 1233567899999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=236.01 Aligned_cols=173 Identities=23% Similarity=0.346 Sum_probs=149.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|++.+.||+|+||.||++.. +++.||+|++...... ......+.+|+.++++++||||+++++.+..+..+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999987 4689999998654322 2234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
|+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||+++..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988654 34689999999999999999999999999999999999999999999999999987544333345
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..|++.|+|||++.+..
T Consensus 161 ~~~~~~y~aPE~~~~~~ 177 (285)
T cd05605 161 RVGTVGYMAPEVVKNER 177 (285)
T ss_pred ccCCCCccCcHHhcCCC
Confidence 57899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=241.82 Aligned_cols=171 Identities=20% Similarity=0.362 Sum_probs=146.2
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcE
Q 023285 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL 182 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 182 (284)
+|++.+.||+|+||.||++.. +++.||+|+++.... .......+..|+.++++++ |+||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999875 468899999864321 2233456889999999995 89999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++||||+++|+|.+++.. +..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999976 456899999999999999999999999999999999999999999999999999754322
Q ss_pred -CceecCCCcccccchhccccc
Q 023285 262 -GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 -~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.......||+.|+|||++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred CCccccccCCccccCHHHhcCC
Confidence 122345799999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=247.37 Aligned_cols=169 Identities=27% Similarity=0.438 Sum_probs=151.3
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.+.||+|.||+||-|++ +|+.||||++............+.+|+.||+++.||.||.+...|+...+++.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 46899999999998876 689999999987766666678899999999999999999999999999999999999976
Q ss_pred CHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEecccceeeeccCCceecCC
Q 023285 193 SIYDF-LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGVMTAET 268 (284)
Q Consensus 193 sL~~~-l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~---~~vkl~Dfg~a~~~~~~~~~~~~~ 268 (284)
+..+. |....+++++...+.++.||+.||.|||-++|+|+||||+|||+... -++||||||.|+...........+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVV 727 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVV 727 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhc
Confidence 55555 45567899999999999999999999999999999999999999643 489999999999988877777889
Q ss_pred CcccccchhccccccC
Q 023285 269 GTYRWMAPEVAFTFFF 284 (284)
Q Consensus 269 gt~~y~aPEvl~~~~y 284 (284)
|||.|.|||+++.+-|
T Consensus 728 GTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 728 GTPAYLAPEVLRNKGY 743 (888)
T ss_pred CCccccCHHHHhhccc
Confidence 9999999999998755
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=241.93 Aligned_cols=167 Identities=29% Similarity=0.476 Sum_probs=142.4
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+.||+|+||.||+++. .++.||||+++.... .......+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999875 467899999874321 123345678999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.+ .+.+.+..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999976 4678889999999999999999999999999999999999999999999999987543222 22345
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.||+.|+|||++.+..
T Consensus 161 ~gt~~y~aPE~~~~~~ 176 (323)
T cd05584 161 CGTIEYMAPEILMRSG 176 (323)
T ss_pred CCCccccChhhccCCC
Confidence 7999999999987653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=250.86 Aligned_cols=169 Identities=27% Similarity=0.449 Sum_probs=150.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-C-----CceeeEEeEEEcCCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-H-----KNVVQFIGACTRPPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~ 181 (284)
.+|.+.+.||+|+||.|.+|.. +++.||||+++.. ....++-..|+.+|..++ | -|+|+++++|...++
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 4788999999999999999987 5799999999863 566777888999999997 4 589999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEecccceeee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQ 258 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~--~~vkl~Dfg~a~~~ 258 (284)
+|||+|.++- +|++++...+ ..++...+..++.||+.||.+||+.||||+||||+|||+.+- ..|||+|||+|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 9999998743 469999999999999999999999999999999999999744 47999999999987
Q ss_pred ccCCceecCCCcccccchhccccccC
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.+.-. ....+..|+|||||.|.+|
T Consensus 342 ~q~vy--tYiQSRfYRAPEVILGlpY 365 (586)
T KOG0667|consen 342 SQRVY--TYIQSRFYRAPEVILGLPY 365 (586)
T ss_pred CCcce--eeeeccccccchhhccCCC
Confidence 76533 6788999999999999987
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=240.12 Aligned_cols=173 Identities=23% Similarity=0.353 Sum_probs=146.9
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 186 (284)
+|.+.+.||+|+||.||+|... ++.||+|+++.... .......+..|..++..+. |++|+++++++.....+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999874 57899999875422 2334456777888888774 799999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCcee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~ 265 (284)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999876 36789999999999999999999999999999999999999999999999999975432 22234
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 160 ~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred cCCCChhhcCHHHhcCCCC
Confidence 5579999999999987653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=235.97 Aligned_cols=173 Identities=28% Similarity=0.491 Sum_probs=143.6
Q ss_pred CCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC---CCCceeeEEeEEE-----c
Q 023285 110 KQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----R 178 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~ 178 (284)
++|++.+.||+|+||.||+|.. .++.||+|.++...........+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3789999999999999999986 357899999875543333344566777777766 6999999999985 3
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
...+++||||+. ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999996 5999999764 34589999999999999999999999999999999999999999999999999987
Q ss_pred eccCCceecCCCcccccchhcccccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
...........||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSS 185 (290)
T ss_pred ccCCcccccccccccccChHHHhCCC
Confidence 65444445567899999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=246.34 Aligned_cols=181 Identities=30% Similarity=0.585 Sum_probs=151.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 173 (284)
.+.|.++.++|++.+.||+|+||.||+|+.. +..||+|+++... ..+....+.+|+.+++.+ +|+||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3578889999999999999999999998752 2479999997543 344456789999999999 899999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------------------------------------------
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK--------------------------------------------------- 202 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 202 (284)
++|......|+||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986431
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 203 ------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 203 ------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
..+++..+.+++.||+.||+|||++||+||||||+||++++++.++|+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 23677889999999999999999999999999999999999999999999999765432211
Q ss_pred ---ecCCCcccccchhcccccc
Q 023285 265 ---TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ---~~~~gt~~y~aPEvl~~~~ 283 (284)
....+++.|||||++.+..
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~ 290 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCV 290 (374)
T ss_pred eeccCCCCccceeCHHHhcCCC
Confidence 1223567899999987654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=236.62 Aligned_cols=174 Identities=25% Similarity=0.394 Sum_probs=148.7
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|+.. ++.||+|+++...........+.+|+.++++++||||+++++++..+..+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36899999999999999999884 6889999997654444556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--cee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~~~ 265 (284)
|++++.+..+ ......+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~~l~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELL-EEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9998666544 4445678999999999999999999999999999999999999999999999999998654322 223
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 160 ~~~~~~~y~aPE~~~~~~~ 178 (287)
T cd07848 160 EYVATRWYRSPELLLGAPY 178 (287)
T ss_pred ccccccccCCcHHHcCCCC
Confidence 4568999999999877543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=239.26 Aligned_cols=175 Identities=25% Similarity=0.392 Sum_probs=153.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+..++|++.+.||+|+||.||+++.. +..+|+|+++... .......+.+|++++++++||||+++++++..++..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999884 6789999987542 34556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||+++..... .
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 99999999999999763 5689999999999999999999986 6999999999999999999999999999765432 2
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~ 179 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHY 179 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCC
Confidence 344579999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=241.41 Aligned_cols=171 Identities=29% Similarity=0.470 Sum_probs=143.9
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHH---HhCCCCceeeEEeEEEcCCcEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIM---RKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
|++.+.||+|+||.||+|.. +++.||||+++.... .....+.+.+|++++ ++++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67889999999999999987 468999999975421 223345677776665 566799999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~ 264 (284)
|||+++++|..++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999988854 5699999999999999999999999999999999999999999999999999875332 2223
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
....|++.|||||++.+..|
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~ 178 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY 178 (324)
T ss_pred cccccCccccCHhHhcCCCC
Confidence 44579999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=240.88 Aligned_cols=168 Identities=24% Similarity=0.372 Sum_probs=143.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||+|+++.... .......+.+|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 468899999975432 234456688899988877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999998866 46799999999999999999999999999999999999999999999999999975322 2223345799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (329)
T cd05618 160 PNYIAPEILRGEDY 173 (329)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=239.92 Aligned_cols=169 Identities=24% Similarity=0.401 Sum_probs=143.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-----CcEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PNLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~ 183 (284)
+|++.+.||+|+||.||+|.. +++.||||.++...........+.+|+.++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 468999999875433344456789999999999999999999988543 2489
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999995 599999865 4568999999999999999999999999999999999999999999999999997543221
Q ss_pred ---ceecCCCcccccchhcccc
Q 023285 263 ---VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ---~~~~~~gt~~y~aPEvl~~ 281 (284)
......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhc
Confidence 1234578999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=254.28 Aligned_cols=168 Identities=33% Similarity=0.527 Sum_probs=150.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|.-.+.||.|+||.||-|+. +++.||||.+.-. ....+.++++..|++.|++++|||++.+-|+|-.+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 466678899999999999987 5689999998643 3346678899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
||-| |-.|++.-.+.++.+-++..|+.+.+.||.|||+.+.||||||+.|||+.+.|.|||+|||.|....+. .++
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---nsF 182 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NSF 182 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hcc
Confidence 9965 999998877788999999999999999999999999999999999999999999999999999876543 567
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
+|||+|||||||..+
T Consensus 183 vGTPywMAPEVILAM 197 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAM 197 (948)
T ss_pred cCCccccchhHheec
Confidence 999999999999754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=240.53 Aligned_cols=168 Identities=26% Similarity=0.410 Sum_probs=143.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||||+++.... .......+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3689999999999987 468899999875321 234456678888888877 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.+. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 9999998763 5789999999999999999999999999999999999999999999999999875322 2233445799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (320)
T cd05590 160 PDYIAPEILQEMLY 173 (320)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=244.22 Aligned_cols=181 Identities=31% Similarity=0.588 Sum_probs=152.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 173 (284)
...|+++.++|.+.+.||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.+++++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 35799999999999999999999999998632 369999997542 3444567999999999996 99999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------------------------------------------
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK--------------------------------------------------- 202 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 202 (284)
++|......|+||||+++|+|.+++....
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 99999999999999999999999986531
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 203 --------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 203 --------------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
..+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 236777889999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+++.++.+||+|||+++....... .....+++.|+|||++.+..
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC
Confidence 9999999999999999986533221 12234678899999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=240.06 Aligned_cols=168 Identities=24% Similarity=0.361 Sum_probs=143.0
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|+.. ++.||||+++.... ..+....+..|.+++..+ +||||+++++++..+..+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999874 57899999875422 234456678899998876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999876 467899999999999999999999999999999999999999999999999998754322 223445689
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (321)
T cd05591 160 PDYIAPEILQELEY 173 (321)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=258.48 Aligned_cols=183 Identities=30% Similarity=0.565 Sum_probs=158.6
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEE
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 173 (284)
.....+|...+.++.+.||+|+||+||+|...+ ..||||.+|.. .+.+...+|.+|++++..++|||||+++
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 345788999999999999999999999997643 56999999854 3455788999999999999999999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIl 240 (284)
|+|..++.+|+|+|||..|+|.+||.... ..++..+.+.|+.|||.||+||-++.++||||..+|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999997542 12778899999999999999999999999999999999
Q ss_pred ecCCCcEEEecccceeeeccCCceec---CCCcccccchhccccccC
Q 023285 241 MDENGVVKVADFGVARVQAQSGVMTA---ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 241 i~~~~~vkl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPEvl~~~~y 284 (284)
|.++-.|||+|||+++-......... ..-..+|||||-|+-.+|
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF 682 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF 682 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc
Confidence 99999999999999986544433322 234679999999987776
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=239.21 Aligned_cols=174 Identities=27% Similarity=0.423 Sum_probs=151.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+..++|++.++||+|+||.||++... +..+|+|+++... .......+.+|++++++++||||++++++|..++.+|+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 55678999999999999999999884 6789999987542 34556779999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||||+++++|.+++.+ .+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-c
Confidence 9999999999999976 45689999999999999999999975 7999999999999999999999999998754332 2
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....|++.|+|||++.+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~ 178 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTH 178 (333)
T ss_pred cccCCCCccccCHHHhcCCC
Confidence 23457899999999997754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=248.93 Aligned_cols=173 Identities=18% Similarity=0.281 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..|.+.+.||+|++|.||+|... ++.||+|.+... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 35999999999999999999763 567888876533 3444567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999999988642 3468899999999999999999999999999999999999999999999999998654332
Q ss_pred --ceecCCCcccccchhccccccC
Q 023285 263 --VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 --~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~ 248 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRY 248 (478)
T ss_pred cccccccCCCccccCHhHhCCCCC
Confidence 1234569999999999877643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=239.60 Aligned_cols=168 Identities=27% Similarity=0.426 Sum_probs=140.7
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||+|++..... .......+..|.. +++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999987 478999999864321 2233445556654 57789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~~~~~~~gt 270 (284)
|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++... .........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999998876 4678999999999999999999999999999999999999999999999999987532 22233455799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (325)
T cd05604 160 PEYLAPEVIRKQPY 173 (325)
T ss_pred hhhCCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=238.86 Aligned_cols=168 Identities=25% Similarity=0.408 Sum_probs=140.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|... ++.||||+++.... .......+..|..++... +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999874 57899999975422 223344566677777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999876 45799999999999999999999999999999999999999999999999999976432 2233455799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (316)
T cd05592 160 PDYIAPEILKGQKY 173 (316)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=241.36 Aligned_cols=172 Identities=25% Similarity=0.378 Sum_probs=147.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
.++|++.+.||+|+||.||++.. .++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999977 4689999999765445555677889999999999999999999986543
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 47999999976 67776643 478899999999999999999999999999999999999999999999999986544
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~ 199 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGY 199 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCC
Confidence 444455678999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=238.84 Aligned_cols=168 Identities=23% Similarity=0.358 Sum_probs=144.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||++.. +++.||+|+++.... ..+..+.+.+|+.++.++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999987 468899999975432 234556788999999988 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999998865 35799999999999999999999999999999999999999999999999999975322 2233456799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (327)
T cd05617 160 PNYIAPEILRGEEY 173 (327)
T ss_pred cccCCHHHHCCCCC
Confidence 99999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=239.30 Aligned_cols=168 Identities=25% Similarity=0.411 Sum_probs=140.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||||++..... .......+..|.. +++.++||||+++++.+......|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3689999999999988 578999999864322 1223344555554 56889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999976 46789999999999999999999999999999999999999999999999999875322 2233445799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (323)
T cd05575 160 PEYLAPEVLRKQPY 173 (323)
T ss_pred hhhcChhhhcCCCC
Confidence 99999999887643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=239.02 Aligned_cols=168 Identities=24% Similarity=0.398 Sum_probs=139.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|+. +++.||+|++..... .......+..|.. +++.++||||+++++.+......|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999988 468899999864322 2223344555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999998865 46789999999999999999999999999999999999999999999999999875322 2223445789
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (321)
T cd05603 160 PEYLAPEVLRKEPY 173 (321)
T ss_pred cccCCHHHhcCCCC
Confidence 99999999877543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=239.29 Aligned_cols=168 Identities=24% Similarity=0.431 Sum_probs=139.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHH-HHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||+|++..... .......+..|. .+++.++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999987 457899999864321 122233444444 457889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999976 46688999999999999999999999999999999999999999999999999975322 2233455799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (325)
T cd05602 160 PEYLAPEVLHKQPY 173 (325)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-34 Score=239.86 Aligned_cols=168 Identities=34% Similarity=0.535 Sum_probs=151.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
-|.+..+||+|+||.||+|.+ .|+.+|||.+..+ ...+++..|+.++++++.|++|++||.+.....+|+||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 477899999999999999977 5799999998643 3467899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
|..||..+.++.++..+++.++..++.+.++||+|||...-||||||+.|||++.+|.+||+|||+|...++.- ...+.
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 99999999999989999999999999999999999999999999999999999999999999999998765432 23456
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.|||.||||||+..-
T Consensus 190 IGTPFWMAPEVI~EI 204 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEI 204 (502)
T ss_pred ccCcccccHHHHHHh
Confidence 799999999998643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=249.06 Aligned_cols=179 Identities=23% Similarity=0.321 Sum_probs=152.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC---
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--- 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 180 (284)
+...++|++.+.||+|+||.||+|.. +++.||||++............+.+|+.++..++|+|+++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34567999999999999999999987 5789999999776666667778999999999999999999988775432
Q ss_pred -----cEEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 181 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 181 -----~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
.+++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 368999999999999999653 346899999999999999999999999999999999999999999999999
Q ss_pred cceeeeccC---CceecCCCcccccchhccccccC
Q 023285 253 GVARVQAQS---GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 253 g~a~~~~~~---~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|+++..... .......||+.|+|||++.+..|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 222 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCC
Confidence 999864322 12234579999999999987654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=238.24 Aligned_cols=173 Identities=24% Similarity=0.392 Sum_probs=146.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 186 (284)
+|.+.+.||+|+||.||+|.. +++.||+|+++.... .......+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999987 468999999875322 2334566888999998886 577888999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999866 4679999999999999999999999999999999999999999999999999987543222 223
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 160 ~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CccCCccccCHHHHcCCCC
Confidence 4568999999999987643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=237.52 Aligned_cols=154 Identities=23% Similarity=0.359 Sum_probs=140.5
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
....+..++|++.+.||+|.-|.||++...+ ..+|+|++..+.. ......+...|..||..++||.++.+|..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3456778899999999999999999999865 7899999976543 345667789999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
...|+|||||+||+|+.+++++. +.|++..++.++.+|+.||+|||-.|||+|||||+||||.++|++.|+||.++.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999999999998875 579999999999999999999999999999999999999999999999999974
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=243.24 Aligned_cols=168 Identities=26% Similarity=0.379 Sum_probs=145.2
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+....|++.+.||+|+||.||++.. +++.||+|.... ..+.+|+.++++++||||+++++++......++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4567899999999999999999987 468999997532 346789999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC--C
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--G 262 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~--~ 262 (284)
|+|++. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... .
T Consensus 161 v~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 999995 599998866 356899999999999999999999999999999999999999999999999999753221 1
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred ccccccCccCCCChhhhcCCCC
Confidence 2334579999999999977643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=229.80 Aligned_cols=172 Identities=25% Similarity=0.416 Sum_probs=152.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 180 (284)
..|...+.+|.|..+.|-++.+ ++..+|+|++..... ..+..+.-.+|+.||+++. ||+|+++.++++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3577788899999999988866 578999998853211 2234566788999999995 999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+++|+|.|+.|.|.|++.. .-.++++...+|+.|++.|++|||.++|+||||||+|||++++.++||+|||.|+....
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999977 46799999999999999999999999999999999999999999999999999998888
Q ss_pred CCceecCCCcccccchhccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.......+|||+|.|||.+.-.
T Consensus 176 GekLrelCGTPgYLAPEtikC~ 197 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCS 197 (411)
T ss_pred chhHHHhcCCCcccChhheeee
Confidence 7777888999999999998754
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=232.04 Aligned_cols=175 Identities=19% Similarity=0.335 Sum_probs=149.4
Q ss_pred eeeeccCCceee--eeeeecCceEEEEEEECCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--
Q 023285 104 VWEIDAKQLKIE--CKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-- 178 (284)
Q Consensus 104 ~~~i~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 178 (284)
.+.|+.++++.. ..|++|++|.||+|.++++.||||.++..... ....+.|.+|+.++++++||||+++++++.+
T Consensus 12 ~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 12 IKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91 (283)
T ss_pred ceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence 445556666655 67999999999999999999999999754332 3335778999999999999999999999876
Q ss_pred --CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccce
Q 023285 179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 179 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
...+++||||+++|+|.+++.+. +.+++.....++.+++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence 45789999999999999999764 5788999999999999999999984 9999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
+..... .....|++.|+|||++.+
T Consensus 171 ~~~~~~--~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 171 KILSSP--PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred hhhccc--cccccCcccccCHHHhhh
Confidence 865432 234578999999999875
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=230.27 Aligned_cols=173 Identities=24% Similarity=0.340 Sum_probs=149.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|+..+.||+|+||.||+|.. +++.+|+|.+...... ......+.+|+.++++++|+|++.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 367788999999999999988 4689999998654322 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
|+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999988654 34699999999999999999999999999999999999999999999999999976544333345
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..|+..|+|||++.+..
T Consensus 161 ~~g~~~~~aPE~~~~~~ 177 (285)
T cd05632 161 RVGTVGYMAPEVLNNQR 177 (285)
T ss_pred CCCCcCccChHHhcCCC
Confidence 57899999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=226.64 Aligned_cols=173 Identities=34% Similarity=0.580 Sum_probs=148.0
Q ss_pred ccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+.++|++.+.||+|+||.||++.+.. ..+|+|.++..... ...+.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 45689999999999999999998854 58999988644322 356889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce--
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-- 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~-- 264 (284)
||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999999765567899999999999999999999999999999999999999999999999998754332221
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....++..|+|||++.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSK 177 (256)
T ss_pred CCCCCchhhCChhhcccCc
Confidence 1224567899999987643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=230.24 Aligned_cols=174 Identities=24% Similarity=0.361 Sum_probs=149.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|+..+.||+|+||.||++.. +++.||+|.+...... ......+.+|+.++++++|+|++.+++.+...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367888999999999999987 4689999998654322 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 188 FMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
|++|++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999986532 4589999999999999999999999999999999999999999999999999976554433344
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..|++.|+|||++.+..|
T Consensus 161 ~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05630 161 RVGTVGYMAPEVVKNERY 178 (285)
T ss_pred CCCCccccChHHHcCCCC
Confidence 579999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=243.17 Aligned_cols=181 Identities=28% Similarity=0.538 Sum_probs=156.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
...++.++.+.+.++||+|-||.|..+...+ ..||||.++++. +....++|..|+++|.+++||||+.++|+|..+..
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 3567888999999999999999999998876 899999999764 45557899999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+|+|+|||++|+|.+|+.+... .+......+|+.||++||+||.+.+++||||.++|+|++.++++||+|||+++....
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 9999999999999999987532 235566778999999999999999999999999999999999999999999985443
Q ss_pred CCcee---cCCCcccccchhccccccC
Q 023285 261 SGVMT---AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~---~~~gt~~y~aPEvl~~~~y 284 (284)
..... ..+-..+|||||-|.-.+|
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkF 716 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKF 716 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccc
Confidence 33222 2245689999997765554
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=236.45 Aligned_cols=168 Identities=24% Similarity=0.398 Sum_probs=141.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||+|+++.... .......+..|..++... +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999988 468899999975321 123345567788887754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999876 46789999999999999999999999999999999999999999999999999875322 2233456799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (316)
T cd05620 160 PDYIAPEILQGLKY 173 (316)
T ss_pred cCccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=231.08 Aligned_cols=167 Identities=24% Similarity=0.352 Sum_probs=142.1
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||+|+||.||++.. +++.||+|.+...... ......+..|+.++++++|+||+++.+++.....+|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 68999999999987 4689999998644222 23446678899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-eecCCCc
Q 023285 195 YDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGT 270 (284)
Q Consensus 195 ~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~~~~gt 270 (284)
.+++.. ....+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+........ .....||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988754 235689999999999999999999999999999999999999999999999999976543322 2344789
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 161 ~~y~aPE~~~~~~~ 174 (280)
T cd05608 161 PGFMAPELLQGEEY 174 (280)
T ss_pred cCccCHHHhcCCCC
Confidence 99999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=239.10 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=147.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 180 (284)
.++|++.+.||+|+||.||++.. .++.||||.++...........+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999976 468999999976544555667788999999999999999999988653 3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 47999999976 77777743 478899999999999999999999999999999999999999999999999987655
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~ 195 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCC
Confidence 444455679999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=227.80 Aligned_cols=168 Identities=35% Similarity=0.581 Sum_probs=147.5
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|++.+.||+|+||.||++... ++.||+|++..............+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 688999999999999999985 467999999866433334444567999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee-ccCCceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~-~~~~~~~~~~ 268 (284)
++++|.+++.. .+.+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred ccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999984 467899999999999999999999999999999999999999999999999999763 3333445667
Q ss_pred Ccccccchhccc
Q 023285 269 GTYRWMAPEVAF 280 (284)
Q Consensus 269 gt~~y~aPEvl~ 280 (284)
+++.|+|||++.
T Consensus 160 ~~~~y~aPE~~~ 171 (260)
T PF00069_consen 160 GTPEYMAPEVLQ 171 (260)
T ss_dssp SSGGGSCHHHHT
T ss_pred cccccccccccc
Confidence 899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-32 Score=238.62 Aligned_cols=169 Identities=31% Similarity=0.512 Sum_probs=146.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC--CCCceeeEEeEEEcCC----
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP---- 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~---- 180 (284)
.+...+++.+.+|+|.||.||+|...++.||||++. .+..+.|.+|..|++-. +|+||++++++-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345677889999999999999999999999999986 44567788888888765 7999999999876655
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEecCCCcEEEec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVKVAD 251 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------~iiH~Dikp~NIli~~~~~vkl~D 251 (284)
.++||+||.+.|||.+||.. ..+++....+++..+++||+|||+. .|+|||||.+|||+.+|++..|+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 79999999999999999976 5799999999999999999999963 699999999999999999999999
Q ss_pred ccceeeeccCC---ceecCCCcccccchhccccc
Q 023285 252 FGVARVQAQSG---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 252 fg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~ 282 (284)
||+|....... ..-..+||.+|||||++.|.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 99998754321 22346899999999999874
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=235.28 Aligned_cols=168 Identities=25% Similarity=0.395 Sum_probs=141.1
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|... ++.||||+++.... .......+..|..+++. ++||||+++++++.+...+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999874 57899999975422 12334556778888876 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999976 35689999999999999999999999999999999999999999999999999875322 2223445799
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (316)
T cd05619 160 PDYIAPEILLGQKY 173 (316)
T ss_pred ccccCHHHHcCCCC
Confidence 99999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=245.29 Aligned_cols=182 Identities=29% Similarity=0.586 Sum_probs=161.8
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 174 (284)
+....++.++...+.++||.|-||.||+|.++. -.||||..|.+.. .+..+.|++|..+|++++||||++++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheee
Confidence 445688889999999999999999999999853 3599999987643 445788999999999999999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
+|.+. ..|||||.++-|.|..|+...+..++...+..++.||+.+|.|||+++.+||||..+|||+.....|||+|||+
T Consensus 459 v~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 459 VCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred eeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccch
Confidence 99985 58999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCC--cccccchhccccccC
Q 023285 255 ARVQAQSGVMTAETG--TYRWMAPEVAFTFFF 284 (284)
Q Consensus 255 a~~~~~~~~~~~~~g--t~~y~aPEvl~~~~y 284 (284)
++...+........| ...|||||-++-.+|
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrF 569 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRF 569 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcc
Confidence 998877766555544 568999999876654
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=233.33 Aligned_cols=175 Identities=28% Similarity=0.538 Sum_probs=147.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+...+|++.+.||+|+||.||+|++ .++ .||+|.++.. ......+++.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 4556899999999999999999986 233 4899998743 2345567899999999999999999999999875
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++|+||+.+|+|.+++......++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 57899999999999999987666789999999999999999999999999999999999999999999999999986543
Q ss_pred CCce---ecCCCcccccchhcccccc
Q 023285 261 SGVM---TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~---~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ....++..|+|||++.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~ 187 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRI 187 (316)
T ss_pred CCcceeccCCccceeecChHHhccCC
Confidence 2221 1223467899999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=231.41 Aligned_cols=175 Identities=21% Similarity=0.385 Sum_probs=155.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||+|.|+.||++.+ +|+.+|+|++..........+++.+|++|-+.|+||||+++.+.+......|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45789999999999999999866 6899999999766666667888999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
|+|.|++|..-+-.+ ..+++..+...+.||+.+|.|+|.+||||||+||+|+++. ...-+||+|||+|........
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 999999998766553 6688999999999999999999999999999999999995 345699999999998775555
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....|||.|||||+++.-+|
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred cccccCCCcccCHHHhhcCCC
Confidence 667899999999999987665
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=237.20 Aligned_cols=168 Identities=30% Similarity=0.470 Sum_probs=144.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
....+|++.++||+|+||.||+|+. +++.||||++.... .......+.+|+.++++++|+||+++++++.....+++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3456788999999999999999987 46899999986432 34456779999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-c
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-V 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~ 263 (284)
||||+++++|.+. ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 150 v~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 9999999998643 235677888999999999999999999999999999999999999999999998654322 2
Q ss_pred eecCCCcccccchhccc
Q 023285 264 MTAETGTYRWMAPEVAF 280 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~ 280 (284)
.....||..|+|||++.
T Consensus 225 ~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 CNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccccccCccccCccccc
Confidence 23457999999999874
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-31 Score=226.03 Aligned_cols=176 Identities=34% Similarity=0.637 Sum_probs=151.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|+|..++|++.++||+|+||.||+|... +..||+|.++... ...+.+.+|+.++++++|+||+++++.+......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 6788899999999999999999999874 5779999987542 23567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++|||+++++|.+++... ...+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999764 3568889999999999999999999999999999999999999999999999998754332
Q ss_pred ce--ecCCCcccccchhcccccc
Q 023285 263 VM--TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~--~~~~gt~~y~aPEvl~~~~ 283 (284)
.. ....++..|+|||.+.+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGS 180 (261)
T ss_pred eeccCCCccceecCCHHHhccCC
Confidence 11 2234567899999987653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=239.02 Aligned_cols=168 Identities=22% Similarity=0.378 Sum_probs=146.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
....|++.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++|+||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3457999999999999999999984 478999985432 235689999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
||++. ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.++.........
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 99995 59999998767789999999999999999999999999999999999999999999999999997644433344
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 215 ~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKY 233 (357)
T ss_pred cccccccccCCeecCCCCC
Confidence 5679999999999987654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=250.71 Aligned_cols=180 Identities=34% Similarity=0.575 Sum_probs=161.4
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..||+....++.+.||.|.||.|++|+.. ...||||.+|.. ..+...++|+.|+.||.+.+||||+++.|+.+.
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 35789999999999999999999999873 257999999865 456678899999999999999999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
....+||+|||++|+|+.||++..+.|+.-++..+++.|+.||.||-+.|++||||.++|||++.+-..|++|||+++..
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999987
Q ss_pred ccCC--ceecCCC--cccccchhccccccC
Q 023285 259 AQSG--VMTAETG--TYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~--~~~~~~g--t~~y~aPEvl~~~~y 284 (284)
.+.. ..++.-| ..+|.|||.|...+|
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhccc
Confidence 5443 2222222 479999999988776
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=224.76 Aligned_cols=174 Identities=38% Similarity=0.666 Sum_probs=152.7
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
|.++.++|++.+.||+|+||.||+|...++.||+|.++.... ..+++.+|+.++++++|+||+++++++......++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 456778999999999999999999999999999999975422 46779999999999999999999999999899999
Q ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999999997643 368999999999999999999999999999999999999999999999999998664322
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....+..|+|||.+.+..
T Consensus 157 -~~~~~~~~~~ape~~~~~~ 175 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKK 175 (256)
T ss_pred -ccCCCcccccCchhhcCCc
Confidence 2334567899999886543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=235.86 Aligned_cols=166 Identities=31% Similarity=0.611 Sum_probs=143.9
Q ss_pred cCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC--CCCceeeEEeEEEcCC----cE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP----NL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~ 182 (284)
+++..+.+.||+|.||.||+|.|+|+.||||++... ..+.+.+|.+|++.+ +|+||+.++++-..++ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 467899999999999999999999999999998632 235688888888775 8999999998865543 48
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEecCCCcEEEecccc
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
|+|++|-+.|||+|||.. ..++....++++..++.||++||-. .|.|||||..|||+..+|...|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999976 6789999999999999999999953 599999999999999999999999999
Q ss_pred eeeeccCC-----ceecCCCcccccchhcccc
Q 023285 255 ARVQAQSG-----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~~-----~~~~~~gt~~y~aPEvl~~ 281 (284)
|-...... ..+..+||.+|||||+|..
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 97655432 2456789999999999864
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=237.76 Aligned_cols=172 Identities=27% Similarity=0.382 Sum_probs=147.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 180 (284)
.++|++.+.||+|+||.||++.. .++.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999987 468899999976544455567788999999999999999999987643 3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++ +|.+++.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 57999999975 78887743 478899999999999999999999999999999999999999999999999987655
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........+|+.|+|||++.+..|
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~ 202 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGY 202 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCC
Confidence 444455679999999999987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=234.58 Aligned_cols=168 Identities=24% Similarity=0.397 Sum_probs=142.9
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||++.. +++.||||+++.... ..+....+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999988 457899999874321 233456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt 270 (284)
|+|.+++.+ .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..... .......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999999876 357999999999999999999999999999999999999999999999999998753222 222344689
Q ss_pred ccccchhccccccC
Q 023285 271 YRWMAPEVAFTFFF 284 (284)
Q Consensus 271 ~~y~aPEvl~~~~y 284 (284)
+.|+|||++.+..|
T Consensus 160 ~~y~aPE~~~~~~~ 173 (318)
T cd05570 160 PDYIAPEILSYQPY 173 (318)
T ss_pred ccccCHHHhcCCCC
Confidence 99999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=225.24 Aligned_cols=175 Identities=33% Similarity=0.549 Sum_probs=150.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+.++|++.+.||+|+||.||+|.+. ...||||.++... .......|.+|+.++++++||||+++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 4668999999999999999999873 2479999987543 344566799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++||||+++++|.+++....+.+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||.++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999876678999999999999999999999999999999999999999999999999999876421
Q ss_pred Ccee--cCCCcccccchhcccccc
Q 023285 262 GVMT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~~--~~~gt~~y~aPEvl~~~~ 283 (284)
.... ...+++.|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~ 184 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRK 184 (266)
T ss_pred cceeccCCCCCccccChhhhccCC
Confidence 1111 223467899999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=227.13 Aligned_cols=178 Identities=26% Similarity=0.498 Sum_probs=148.6
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
|++..++|++.+.||+|+||.||+|... +..||||.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6677889999999999999999998763 3569999986432 3344567899999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
.....++||||+++++|.+++.+.. ..++...+..++.|++.||+|||+.|++|+||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9999999999999999999997632 2356778899999999999999999999999999999999999999
Q ss_pred EecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 249 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+|||+++....... .....+++.|||||++.+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 197 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC
Confidence 999999875432211 11234578899999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=224.68 Aligned_cols=173 Identities=35% Similarity=0.611 Sum_probs=148.3
Q ss_pred ccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+.++|++.+.||+|+||.||+|.+.+ ..+|||.++..... ...+.+|+.++++++||||+++++++......++||
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 45689999999999999999998755 46999998754322 356899999999999999999999999988999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee-
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT- 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~- 265 (284)
||+.+++|.+++......+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||.++.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999999997755578999999999999999999999999999999999999999999999999987654332211
Q ss_pred -cCCCcccccchhcccccc
Q 023285 266 -AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 -~~~gt~~y~aPEvl~~~~ 283 (284)
...++..|+|||++.+..
T Consensus 159 ~~~~~~~~y~~pe~~~~~~ 177 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSK 177 (256)
T ss_pred CCCccChhhCCHHHHhcCc
Confidence 224567899999987543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=258.00 Aligned_cols=179 Identities=35% Similarity=0.610 Sum_probs=154.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
.++.+...++.+.||+|+||.||+|++.+ ..||||.++.. .+.+...+|.+|..+|++++||||++++|+|.
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34678899999999999999999998843 24899998754 35677889999999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEec
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~D 251 (284)
+....+|++|||+||+|..||++. ...++...++.++.|||+|+.||+++++|||||.++|+|++....|||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999886 56789999999999999999999999999999999999999999999999
Q ss_pred ccceeeeccCCcee--cC-CCcccccchhccccccC
Q 023285 252 FGVARVQAQSGVMT--AE-TGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 252 fg~a~~~~~~~~~~--~~-~gt~~y~aPEvl~~~~y 284 (284)
||+|+-........ .. .-..+|||||.|+.+.|
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF 881 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF 881 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhccc
Confidence 99999433322221 11 23479999999997655
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=224.32 Aligned_cols=173 Identities=35% Similarity=0.644 Sum_probs=148.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE-cCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 183 (284)
|.++..+|++.+.||+|+||.||++...+..||+|.++.. ...+.+.+|+.++++++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 5677889999999999999999999999999999998643 23467899999999999999999999764 456789
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+++++|.+++.+.. ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999999997643 348899999999999999999999999999999999999999999999999987543321
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
....++..|+|||++.+..
T Consensus 157 --~~~~~~~~y~aPE~~~~~~ 175 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKK 175 (256)
T ss_pred --CCCccceeecCHHHHccCC
Confidence 2334567899999987653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=226.31 Aligned_cols=169 Identities=36% Similarity=0.652 Sum_probs=143.4
Q ss_pred eeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 113 KIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++.+.||.|+||.||+|.+. +..|+||.++.. ...+....|.+|++.+++++||||++++|++......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 56789999999999999987 578999999653 34556788999999999999999999999999888899999
Q ss_pred EcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce-
Q 023285 187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM- 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~- 264 (284)
||+++|+|.+++... ...+++..+..++.||+.||.|||+++++|+||+++||+++.++.+||+|||++.........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 567999999999999999999999999999999999999999999999999999876322211
Q ss_pred --ecCCCcccccchhccccc
Q 023285 265 --TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 --~~~~gt~~y~aPEvl~~~ 282 (284)
........|+|||.+.+.
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~ 180 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDG 180 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHS
T ss_pred cccccccccccccccccccc
Confidence 233467899999998764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=253.65 Aligned_cols=174 Identities=22% Similarity=0.389 Sum_probs=147.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.++||+|+||.||+|.. +++.||||+++.... .....+++.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999987 478999999975433 2345567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 187 EFMARGSIYDFLHKQ----------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 187 e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||++||+|.+++... ....+...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 1234567788999999999999999999999999999999999999999999997
Q ss_pred eeccCC-------------------ceecCCCcccccchhcccccc
Q 023285 257 VQAQSG-------------------VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~-------------------~~~~~~gt~~y~aPEvl~~~~ 283 (284)
...... ......||+.|||||++.+..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~ 207 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP 207 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC
Confidence 652110 011246999999999988754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=240.16 Aligned_cols=176 Identities=23% Similarity=0.389 Sum_probs=162.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+-|.+.+.||+|.|..|-+|++ +|..||||++.....+.-....+.+|++.|+.++|||||++|++...+..+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34789999999999999998876 8999999999877777767778999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEecccceeeeccCCcee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|.-++|+|+||+-+....+.+..+.+++.||+.|+.|+|+..++||||||+|+.+- +-|-|||.|||++.........+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999999999888899999999999999999999999999999999998775 66899999999998777777778
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
+.+|+..|.|||+++|-.|
T Consensus 177 TsCGSLAYSAPEILLGDsY 195 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSY 195 (864)
T ss_pred cccchhhccCchhhhcCcc
Confidence 8999999999999999766
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=237.98 Aligned_cols=170 Identities=26% Similarity=0.424 Sum_probs=146.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----cEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 183 (284)
+|++.+.||+|+||.||++.. +++.||||.+..........+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477899999999999999986 5789999998654334455678899999999999999999999998776 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 9999996 488888865 4678999999999999999999999999999999999999999999999999998654322
Q ss_pred -ceecCCCcccccchhccccc
Q 023285 263 -VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~ 282 (284)
..+...+|+.|+|||++.+.
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC
Confidence 23345689999999998764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=243.15 Aligned_cols=170 Identities=25% Similarity=0.393 Sum_probs=140.2
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC----
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP---- 179 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---- 179 (284)
.....+|++.+.||+|+||.||+|.. +++.||||.+.... ....+|+.++++++||||+++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34456899999999999999999987 56899999885431 2245799999999999999999876432
Q ss_pred ----CcEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEec
Q 023285 180 ----PNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVAD 251 (284)
Q Consensus 180 ----~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~D 251 (284)
..+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 247799999975 78777753 346789999999999999999999999999999999999998665 799999
Q ss_pred ccceeeeccCCceecCCCcccccchhccccc
Q 023285 252 FGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 252 fg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
||+|+............||+.|+|||++.+.
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCC
Confidence 9999866544444456789999999998763
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=235.23 Aligned_cols=164 Identities=24% Similarity=0.410 Sum_probs=137.6
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
||+|+||.||+|.. +++.||||++..... .......+..|..++... .||||+++++.+.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 478999999853221 222344556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCceecCCCc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~~~~~gt 270 (284)
|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999876 46799999999999999999999999999999999999999999999999999875322 2223345799
Q ss_pred ccccchhccccc
Q 023285 271 YRWMAPEVAFTF 282 (284)
Q Consensus 271 ~~y~aPEvl~~~ 282 (284)
+.|+|||++.+.
T Consensus 160 ~~y~aPE~~~~~ 171 (330)
T cd05586 160 TEYLAPEVLLDE 171 (330)
T ss_pred ccccCHHHHcCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=223.64 Aligned_cols=176 Identities=37% Similarity=0.651 Sum_probs=150.3
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|+++.++|++.+.||+|++|.||+|... ++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..|
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 5778889999999999999999999874 57899999875432 2456889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999998765322
Q ss_pred cee--cCCCcccccchhcccccc
Q 023285 263 VMT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~--~~~gt~~y~aPEvl~~~~ 283 (284)
... ....+..|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNR 180 (261)
T ss_pred ccccCCCcCceeccCccccccCC
Confidence 111 112345899999887643
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=231.24 Aligned_cols=171 Identities=24% Similarity=0.455 Sum_probs=147.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|.+.++||+|+||.||+|+. +++.||+|.++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 35799999999999999999987 467899999875432 223345778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 99975 9999987766678999999999999999999999999999999999999999999999999997643322 223
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+|+.|+|||++.+
T Consensus 163 ~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 163 NEVVTLWYRPPDVLLG 178 (309)
T ss_pred cccccccccCCHHHhC
Confidence 4568999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=238.49 Aligned_cols=181 Identities=31% Similarity=0.577 Sum_probs=152.0
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 173 (284)
...|++..++|.+.+.||+|+||.||+|++.+ ..||+|+++... .......+.+|+.++.++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 34699999999999999999999999998643 579999997542 3334457899999999997 99999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------------------------------------------
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK--------------------------------------------------- 202 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------- 202 (284)
+++..+...++||||+++|+|.+++++..
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999997532
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 023285 203 ----------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236 (284)
Q Consensus 203 ----------------------------------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp 236 (284)
..+++..+..++.|++.||+|||+++++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 1256667888999999999999999999999999
Q ss_pred CCEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 237 ANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 237 ~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+|||++.++.++|+|||+++....... .....+++.|||||.+.+..
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 317 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL 317 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC
Confidence 999999999999999999986432211 12335678999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=224.90 Aligned_cols=176 Identities=38% Similarity=0.680 Sum_probs=151.1
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
|+++..+|.+.+.||+|+||.||+|.+ .++.||+|.++.. ......+.+|++++++++|+||+++++++..+..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 678888999999999999999999987 4688999998743 23356789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+++|||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999997643 45889999999999999999999999999999999999999999999999999765433
Q ss_pred Ccee--cCCCcccccchhcccccc
Q 023285 262 GVMT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~~--~~~gt~~y~aPEvl~~~~ 283 (284)
.... ...+++.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~ 181 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNK 181 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCC
Confidence 2111 223467899999987653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=228.00 Aligned_cols=172 Identities=27% Similarity=0.477 Sum_probs=142.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEc-----CC
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR-----PP 180 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~ 180 (284)
+|++.+.||+|+||.||+|.. +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999987 468999999875433333334456677777665 69999999998864 24
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 58999999975 8999887643 458999999999999999999999999999999999999999999999999998765
Q ss_pred cCCceecCCCcccccchhcccccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.........+|..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~ 183 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQST 183 (288)
T ss_pred CcccCCCccccccccCchHhhCCC
Confidence 444444567899999999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=225.91 Aligned_cols=166 Identities=22% Similarity=0.353 Sum_probs=141.7
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||+|+||.||++.. +++.||+|.+...... ......+..|+.++++++||||+++++.+..+..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999986 4789999998643222 12234566799999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccc
Q 023285 195 YDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273 (284)
Q Consensus 195 ~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y 273 (284)
.+++... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.............|++.|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 9888653 235888999999999999999999999999999999999999999999999999876544444556799999
Q ss_pred cchhcccccc
Q 023285 274 MAPEVAFTFF 283 (284)
Q Consensus 274 ~aPEvl~~~~ 283 (284)
+|||++.+..
T Consensus 161 ~aPE~~~~~~ 170 (277)
T cd05607 161 MAPEILKEEP 170 (277)
T ss_pred cCHHHHccCC
Confidence 9999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=234.74 Aligned_cols=178 Identities=31% Similarity=0.584 Sum_probs=148.2
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 176 (284)
|+++.++|++.+.||+|+||.||+|... ++.||+|+++... ..+....+.+|+.+++++ +|+||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 7888999999999999999999999642 3679999987542 334456788999999999 799999999988
Q ss_pred Ec-CCcEEEEEEcCCCCCHHHHHHhcC-----------------------------------------------------
Q 023285 177 TR-PPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------- 202 (284)
Q Consensus 177 ~~-~~~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------- 202 (284)
.. ...++++|||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 65 456899999999999999986432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCccc
Q 023285 203 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYR 272 (284)
Q Consensus 203 -------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~ 272 (284)
..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++....... .....++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578889999999999999999999999999999999999999999999999986533211 122345678
Q ss_pred ccchhcccccc
Q 023285 273 WMAPEVAFTFF 283 (284)
Q Consensus 273 y~aPEvl~~~~ 283 (284)
|+|||++.+..
T Consensus 241 y~aPE~~~~~~ 251 (337)
T cd05054 241 WMAPESIFDKV 251 (337)
T ss_pred ccCcHHhcCCC
Confidence 99999887654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=224.57 Aligned_cols=173 Identities=31% Similarity=0.572 Sum_probs=145.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 180 (284)
..+|++.+.||+|+||.||++.+ .+..||+|.++.. .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45789999999999999999874 3578999998754 45556789999999999999999999998754 34
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+++||||+++++|.+++.+....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999977656789999999999999999999999999999999999999999999999999986543
Q ss_pred CCce----ecCCCcccccchhcccccc
Q 023285 261 SGVM----TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~----~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ....++..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESK 187 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCC
Confidence 3211 1123345699999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=220.42 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=152.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|.+.+.||+|++|.||+|+. +++.|++|.+............+.+|++++++++|||++++++.+......|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478899999999999999987 568999999876555566677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
+++++|.+++... ...++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999774 4578899999999999999999999999999999999999999999999999988654432 2234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..|++.|+|||++.+..
T Consensus 161 ~~~~~~y~aPE~~~~~~ 177 (256)
T cd08529 161 IVGTPYYLSPELCEDKP 177 (256)
T ss_pred cccCccccCHHHhcCCC
Confidence 46889999999987653
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=223.11 Aligned_cols=173 Identities=35% Similarity=0.579 Sum_probs=147.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+..+|++.+.||+|+||.||+|.+. +..+|+|+++..... ...+.+|+.++++++||||+++++++......|+||
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 4567899999999999999999875 458999998644322 246888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee-
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT- 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~- 265 (284)
||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++.........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999999998766678999999999999999999999999999999999999999999999999997654322111
Q ss_pred -cCCCcccccchhcccccc
Q 023285 266 -AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 -~~~gt~~y~aPEvl~~~~ 283 (284)
...++..|+|||++.+..
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~ 177 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSR 177 (256)
T ss_pred CCCCCCccccCHHHhccCC
Confidence 123446899999987654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=225.36 Aligned_cols=176 Identities=29% Similarity=0.527 Sum_probs=147.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
++..+|++.+.||+|+||.||+|.. .+..+++|.++... ..+....+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 3456899999999999999999985 34689999987542 3455678999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~ 244 (284)
..|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999986431 247788899999999999999999999999999999999999
Q ss_pred CcEEEecccceeeeccCC---ceecCCCcccccchhcccccc
Q 023285 245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.+||+|||+++...... ......++..|+|||++.+..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence 999999999997643221 122334577899999987543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=223.77 Aligned_cols=175 Identities=34% Similarity=0.554 Sum_probs=149.0
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+..+|++.+.||+|+||.||+|... +..+|+|.++... .......+.+|+.++++++||||+++++++..+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4568999999999999999999762 2369999987543 344567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999999999999998766678999999999999999999999999999999999999999999999999998654322
Q ss_pred c--ee--cCCCcccccchhcccccc
Q 023285 263 V--MT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~--~~--~~~gt~~y~aPEvl~~~~ 283 (284)
. .+ ...++..|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCc
Confidence 1 11 122356899999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=226.32 Aligned_cols=176 Identities=31% Similarity=0.604 Sum_probs=148.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
++..+|++.+.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345689999999999999999998633 469999987442 345567799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~ 244 (284)
...|++|||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 99999999999999999997632 457888999999999999999999999999999999999999
Q ss_pred CcEEEecccceeeeccCC---ceecCCCcccccchhcccccc
Q 023285 245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.++|+|||+++...... ......+++.|+|||.+.+..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK 202 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc
Confidence 999999999997643322 122345678999999887543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=227.84 Aligned_cols=180 Identities=31% Similarity=0.610 Sum_probs=151.2
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 172 (284)
..|++..++|.+.+.||+|+||.||++...+ ..+|+|.++... .......+.+|+.+++++ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4678888999999999999999999997532 469999987643 344456788999999999 79999999
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
++++......|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 24788899999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++.++.++|+|||.++....... .....+++.|+|||++.+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence 99999999999999999875432211 11223457899999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=225.89 Aligned_cols=178 Identities=26% Similarity=0.482 Sum_probs=148.3
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
|+++.++|++.+.||+|+||.||+|... +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7888999999999999999999998653 3479999886442 2334456889999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
.+...|+||||+++|+|.+++.+.. ...+...+..++.|++.||.|||+++|+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999997532 2345677889999999999999999999999999999999999999
Q ss_pred EecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 249 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+|||+++....... .....++..|+|||.+.+..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 197 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCC
Confidence 999999975433211 12234567899999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=262.99 Aligned_cols=177 Identities=23% Similarity=0.318 Sum_probs=155.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..+.+++|.+.+.||+|+||.|...+. +++.+|.|++....+- .....-|..|..+|..-..+-|++++-+|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 456778999999999999999999887 4688999998643221 2233458899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+|||||+||+|..++.+.. .++++.+..++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-.+...
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999999999999998875 8999999999999999999999999999999999999999999999999999766544
Q ss_pred Cc--eecCCCcccccchhccccc
Q 023285 262 GV--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~--~~~~~gt~~y~aPEvl~~~ 282 (284)
+. ....+|||.|+|||++..+
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhh
Confidence 42 3456899999999999753
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=236.87 Aligned_cols=179 Identities=22% Similarity=0.348 Sum_probs=158.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..+.|+.-+.||+|+||.||-++. +|+.+|.|.+..... ........++|..+|.++..+.||.+--+|.+.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45567788899999999999997655 688999998743322 233445678999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 183 CIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
|+|+..|.||+|.-.|.+. ++.|+++.+..++.+|+-||++||+.+|++||+||+|||+|++|+++|+|+|+|...+..
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999998888764 357999999999999999999999999999999999999999999999999999998888
Q ss_pred CceecCCCcccccchhccccccC
Q 023285 262 GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......+||.+||||||+....|
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y 363 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVY 363 (591)
T ss_pred CccccccCcccccCHHHHcCCcc
Confidence 77888899999999999998876
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-32 Score=212.16 Aligned_cols=172 Identities=26% Similarity=0.468 Sum_probs=154.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|.-.++||+|.||+||+|+. +.+.||+|.++.+..++.......+|+-+++.++|+|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999987 458899999987766666677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
|.. +|..|....++.++.+.+..++.|+++||.++|+.+++|||+||.|+||+.+|.+|++|||+|+...-+- ....+
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 976 9999999999999999999999999999999999999999999999999999999999999998654332 45677
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
+-|.+|.+|.++-|.+
T Consensus 162 vvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAK 177 (292)
T ss_pred eeeeeccCcceeeeee
Confidence 8899999999987753
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=227.77 Aligned_cols=176 Identities=32% Similarity=0.543 Sum_probs=146.1
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
+..++|++.+.||+|+||.||+|.+. +. .+++|.++.. ........+.+|+.++.++ +|+||+++++++..++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999863 33 4677776532 2345567889999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 182 LCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
+|+||||+++++|.+++.+.. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999997532 25788999999999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCCceecCCCcccccchhcccccc
Q 023285 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+||+|||+++............++..|+|||++.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccC
Confidence 9999999986432221222234567899999886643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=218.65 Aligned_cols=172 Identities=21% Similarity=0.394 Sum_probs=151.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||.|+||.||.++. +++.+++|.+.....+......+.+|+.++++++|+||+++++++......+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 488999999999998887765 578899999876555566677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
+++++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||.++...... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999775 4568999999999999999999999999999999999999999999999999998654433 2344
Q ss_pred CCCcccccchhccccc
Q 023285 267 ETGTYRWMAPEVAFTF 282 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~ 282 (284)
..+++.|+|||++.+.
T Consensus 161 ~~~~~~y~ape~~~~~ 176 (256)
T cd08221 161 VVGTPYYMSPELCQGV 176 (256)
T ss_pred cCCCccccCHhhcCCC
Confidence 5789999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=227.57 Aligned_cols=180 Identities=31% Similarity=0.603 Sum_probs=151.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 172 (284)
..|.+..++|.+.+.||+|+||.||+++.. ...+|+|.++... .......+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 457888899999999999999999999752 3569999987542 345567799999999999 59999999
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
++++.....+|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 999999999999999999999999997632 34788899999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++.++.+||+|||.++....... .....+++.|||||++.+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV 212 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC
Confidence 99999999999999999986543211 11223456899999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=226.51 Aligned_cols=179 Identities=31% Similarity=0.608 Sum_probs=150.7
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 173 (284)
.|++...+|.+.+.||+|+||.||+|+.. +..||+|.++... .....+.+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 47788899999999999999999999752 2469999987432 344567899999999999 799999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
+++......|+||||+++|+|.+++.... ..++...+..++.||+.||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997642 246778899999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+++.++.+||+|||.++....... .....+++.|+|||++.+..
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV 215 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC
Confidence 9999999999999999986543221 12234567899999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=221.83 Aligned_cols=174 Identities=38% Similarity=0.688 Sum_probs=146.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|++..++|++.++||+|+||.||+|+..+ ..||+|.++..... ...+.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 56778899999999999999999998743 57999998754332 3568999999999999999999998754 5689
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+++++|+||||+||++++++.++|+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997643 457889999999999999999999999999999999999999999999999997654332
Q ss_pred ce--ecCCCcccccchhccccc
Q 023285 263 VM--TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~--~~~~gt~~y~aPEvl~~~ 282 (284)
.. ....++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~ 178 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYG 178 (262)
T ss_pred cccccCCcccceecCHhHhccC
Confidence 21 123456789999988654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=224.53 Aligned_cols=180 Identities=32% Similarity=0.608 Sum_probs=152.4
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|+++.++|++.+.||+|+||.||++...+ ..+|+|.++... .......+.+|+.+++++ +|+||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4578889999999999999999999998632 579999987543 344556799999999999 7999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NI 239 (284)
++..+..++++|||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 24688899999999999999999999999999999999
Q ss_pred EecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+++.++.+||+|||.++....... .....+++.|+|||++.+..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 210 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV 210 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC
Confidence 999999999999999986543221 12223567899999886643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=224.31 Aligned_cols=170 Identities=28% Similarity=0.466 Sum_probs=149.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||+|+++.... .......+.+|++++++++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3689999999999999999987 468999999864322 2344567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 999999999999774 67899999999999999999999999999999999999999999999999999865443 334
Q ss_pred CCCcccccchhccccc
Q 023285 267 ETGTYRWMAPEVAFTF 282 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~ 282 (284)
..+++.|+|||.+.+.
T Consensus 158 ~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 158 LCGTPEYLAPEIILSK 173 (290)
T ss_pred CCCCccccChhhhcCC
Confidence 5689999999988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=222.33 Aligned_cols=177 Identities=28% Similarity=0.508 Sum_probs=150.2
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
|+++.++|++.+.||+|+||.||+|...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 67888999999999999999999998642 679999986442 3344567899999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
.....++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+|
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999997532 2367788999999999999999999999999999999999999999
Q ss_pred EecccceeeeccCC---ceecCCCcccccchhccccc
Q 023285 249 VADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 249 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~ 282 (284)
|+|||.++...... ......++..|+|||.+.+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence 99999987543322 12234567899999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=222.04 Aligned_cols=175 Identities=30% Similarity=0.538 Sum_probs=147.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+...+|++.++||+|+||.||+|++ +++ .||+|+++... .......+.+|+.+++.+.||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 4566899999999999999999986 333 48999987542 445567799999999999999999999999764
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++++||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999987667799999999999999999999999999999999999999999999999999986543
Q ss_pred CCce---ecCCCcccccchhcccccc
Q 023285 261 SGVM---TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~---~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ....+++.|+|||.+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRR 187 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCC
Confidence 3221 1223467899999987653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=232.20 Aligned_cols=178 Identities=33% Similarity=0.604 Sum_probs=146.5
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 176 (284)
|++..++|++.+.||+|+||.||+|.+ .++.||||+++... ..+....+.+|+.++.++ +||||+++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 778888999999999999999999974 35789999997543 334456788999999999 589999999988
Q ss_pred EcC-CcEEEEEEcCCCCCHHHHHHhcC-----------------------------------------------------
Q 023285 177 TRP-PNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------- 202 (284)
Q Consensus 177 ~~~-~~~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------- 202 (284)
... ..+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999986532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---eec
Q 023285 203 -------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTA 266 (284)
Q Consensus 203 -------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~ 266 (284)
..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 2357778889999999999999999999999999999999999999999999976432211 112
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||++.+..
T Consensus 241 ~~~~~~y~aPE~~~~~~ 257 (343)
T cd05103 241 ARLPLKWMAPETIFDRV 257 (343)
T ss_pred CCCCcceECcHHhcCCC
Confidence 23567899999986653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=220.49 Aligned_cols=173 Identities=23% Similarity=0.458 Sum_probs=149.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|+. +++.||||.++.. .........+.+|+.++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4789999999999999999987 5789999988643 234455667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998854 234588899999999999999999999999999999999999999999999999886543221
Q ss_pred -eecCCCcccccchhccccc
Q 023285 264 -MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 -~~~~~gt~~y~aPEvl~~~ 282 (284)
.....+++.|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~ 181 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred HHhcCCCCccccChhhhccC
Confidence 2234688999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=219.30 Aligned_cols=167 Identities=28% Similarity=0.536 Sum_probs=141.9
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gs 193 (284)
+.||+|+||.||+|+. +++.+|+|.+... ...+....+.+|+.++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999987 5788999987643 245566789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce---ecCCCc
Q 023285 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGT 270 (284)
Q Consensus 194 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt 270 (284)
|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......... .....+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999775567899999999999999999999999999999999999999999999999998754322111 111234
Q ss_pred ccccchhcccccc
Q 023285 271 YRWMAPEVAFTFF 283 (284)
Q Consensus 271 ~~y~aPEvl~~~~ 283 (284)
..|+|||.+.+..
T Consensus 160 ~~y~aPE~~~~~~ 172 (252)
T cd05084 160 VKWTAPEALNYGR 172 (252)
T ss_pred eeecCchhhcCCC
Confidence 5799999987653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=239.03 Aligned_cols=167 Identities=24% Similarity=0.322 Sum_probs=144.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
...|.+.+.||+|+||.||+|... ++.||||.... ..+.+|++++++++|+||+++++++......++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999884 57899996431 23578999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--- 263 (284)
|++. ++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9995 599999877666799999999999999999999999999999999999999999999999999986533211
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCC
Confidence 223469999999999987643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=223.14 Aligned_cols=170 Identities=28% Similarity=0.470 Sum_probs=146.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|++|.||+|+. +++.||+|.++...........+.+|+.++++++||||+++++++..+..+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478899999999999999987 478999999875443344456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 189 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
++ ++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 97 58999886533 56899999999999999999999999999999999999999999999999999754322 2223
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+++.|+|||++.+
T Consensus 160 ~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 160 HEVVTLWYRAPEVLLG 175 (285)
T ss_pred CCcccccccChHHhcC
Confidence 4567899999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=223.35 Aligned_cols=171 Identities=26% Similarity=0.456 Sum_probs=151.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|++|.||+|+. +++.||+|++............+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999987 578999999976554455567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--ceec
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~~~~ 266 (284)
+ +++|.+++......+++..+..++.||+.+|+|||+.|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 999999998766779999999999999999999999999999999999999999999999999998654432 1334
Q ss_pred CCCcccccchhccccc
Q 023285 267 ETGTYRWMAPEVAFTF 282 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~ 282 (284)
..++..|+|||++.+.
T Consensus 160 ~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 160 QVATRWYRAPELLYGA 175 (286)
T ss_pred ccCcccccCceeeecc
Confidence 5789999999998653
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.73 Aligned_cols=178 Identities=25% Similarity=0.445 Sum_probs=150.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEE-E
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC-T 177 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-~ 177 (284)
...++|...++++.+.|.+|||+.||.|+.. + ..||+|++-.. +....+...+|+.+|++|+ |+|||.+++.. .
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 3678899999999999999999999999884 3 79999998644 6778899999999999998 99999999932 1
Q ss_pred c---C---CcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEE
Q 023285 178 R---P---PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 178 ~---~---~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~vk 248 (284)
. . -.++|+||||.||+|-|++.++ ...|++.++++|+.|+++|+.+||... |||||||-+|||++.+|+.|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 1 1 2378999999999999999864 345999999999999999999999887 99999999999999999999
Q ss_pred EecccceeeeccCCcee----------cCCCcccccchhcccc
Q 023285 249 VADFGVARVQAQSGVMT----------AETGTYRWMAPEVAFT 281 (284)
Q Consensus 249 l~Dfg~a~~~~~~~~~~----------~~~gt~~y~aPEvl~~ 281 (284)
|||||.|.......... ....|+.|+|||+|--
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 99999997543322111 1136899999999853
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=232.70 Aligned_cols=172 Identities=26% Similarity=0.466 Sum_probs=145.6
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-- 179 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 179 (284)
.|++ .++|++.+.||+|+||.||+|.. +++.||||.++...........+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3444 46899999999999999999986 467899999875433334456688999999999999999999987543
Q ss_pred ----CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 180 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
...|+++|++ +++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3479999998 6799888753 56999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
+..... .....||+.|+|||++.+
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred eecCCC--cCCccccccccCchHhcC
Confidence 865432 345578999999999876
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=223.52 Aligned_cols=175 Identities=28% Similarity=0.517 Sum_probs=148.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
|++.+|.+.+.||+|+||.||++.. .+..+|+|.+... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5677899999999999999999974 2346899987643 345567799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~v 247 (284)
..+++||||+++++|.+++.... ..+++..+..++.|++.+|+|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997532 248999999999999999999999999999999999999999999
Q ss_pred EEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 248 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 248 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+|+|||.++....... .....+++.|+|||++.+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 198 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 198 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCC
Confidence 9999999975433221 12234577899999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=223.22 Aligned_cols=174 Identities=29% Similarity=0.558 Sum_probs=147.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 180 (284)
...|++.+.||+|+||.||++.+ ++..||+|.++... .......+.+|+.++++++|||++++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 44678999999999999999874 35789999987543 344567899999999999999999999998875 5
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||++|++|.+++.+....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 68999999999999999977555689999999999999999999999999999999999999999999999999986543
Q ss_pred CCc----eecCCCcccccchhcccccc
Q 023285 261 SGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
... .....++..|+|||++.+..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~ 188 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSK 188 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCC
Confidence 221 12345677899999987653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=244.22 Aligned_cols=171 Identities=25% Similarity=0.483 Sum_probs=147.5
Q ss_pred eeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------cEEE
Q 023285 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------NLCI 184 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l 184 (284)
...+.||+|+||.||+|++ +|+.||||.++... .....+...+|++++++++|+|||+++++=.+.. .-.+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3456899999999999986 68999999998654 3445677899999999999999999998765433 4679
Q ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCC--cEEEecccceeee
Q 023285 185 VTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADFGVARVQ 258 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~--~~~--~vkl~Dfg~a~~~ 258 (284)
|||||.||||+..+.+.. ..+++.+++.++.+++.||.|||++||+||||||.||++- .+| ..||+|||.|+..
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 999999999999997642 4599999999999999999999999999999999999995 333 4799999999999
Q ss_pred ccCCceecCCCcccccchhcccc-ccC
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFT-FFF 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~-~~y 284 (284)
++....++..||..|.+||++.. ++|
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y 201 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKY 201 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCc
Confidence 98888889999999999999985 443
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=220.54 Aligned_cols=175 Identities=33% Similarity=0.547 Sum_probs=148.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+...|++.+.||+|+||.||+|... + ..||||.++.. ........|..|+.++++++||||+++++++..+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3457899999999999999999873 2 36999998754 2455567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++||||+++++|.+++....+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999998766778999999999999999999999999999999999999999999999999987543322
Q ss_pred c---eecCC---Ccccccchhcccccc
Q 023285 263 V---MTAET---GTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~---~~~~~---gt~~y~aPEvl~~~~ 283 (284)
. ..... .+..|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRK 187 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCc
Confidence 1 11111 245799999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=241.34 Aligned_cols=269 Identities=26% Similarity=0.404 Sum_probs=196.0
Q ss_pred HHHHHHHH--HHHHhhhh--cCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHHHHhhcccCCCCCCCCCCC
Q 023285 5 CWVLMKVG--ELTSLLGE--IGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGV 80 (284)
Q Consensus 5 ~~~~~~l~--~~~~~~~~--~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 80 (284)
.|+|-||+ ||..-.++ ..||++-+.-|+-+.--.|+.. |...-+...|..++++-...-...+|.++--.--.
T Consensus 10 ~wLleLLr~aqL~qf~s~lr~~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~ 86 (1039)
T KOG0199|consen 10 DWLLELLRKAQLDQFISQLRFLLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGAD 86 (1039)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCC
Confidence 59999997 55555554 5788888887886654444322 44444455555555443332222222222111001
Q ss_pred CCCccccccCCCCccccCCCCCCeeeeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHH
Q 023285 81 PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFS 155 (284)
Q Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~ 155 (284)
+....... ... ..+....--|..+++++.++||+|+||.|++|.|+. -.||||+++.+.... ....|.
T Consensus 87 p~h~~~t~-----~~~-~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddfl 159 (1039)
T KOG0199|consen 87 PSHPAQTN-----SVA-NPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFL 159 (1039)
T ss_pred cccccccc-----CCC-CcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHH
Confidence 11111100 001 112223345677889999999999999999999953 469999998775544 678899
Q ss_pred HHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023285 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (284)
Q Consensus 156 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di 234 (284)
+|+.+|.+|+|+|++++||+..+ ....+|||+++.|||.+.|++ ....|....+..++.||+.||.||.+++.|||||
T Consensus 160 rEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL 238 (1039)
T KOG0199|consen 160 REASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL 238 (1039)
T ss_pred HHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence 99999999999999999999988 678999999999999999988 4567888999999999999999999999999999
Q ss_pred CCCCEEecCCCcEEEecccceeeeccCCceec----CCCcccccchhccccccC
Q 023285 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTA----ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 235 kp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~----~~gt~~y~aPEvl~~~~y 284 (284)
..+|+|+-....|||+|||+.+.......+.. ..-...|+|||-|++.+|
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc
Confidence 99999999999999999999987655443322 223568999999999876
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=232.35 Aligned_cols=170 Identities=24% Similarity=0.395 Sum_probs=144.8
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.+...+|.+.+.||+|+||.||++... +..||+|.+... ....+|+.++++++||||+++++++.....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 344568999999999999999998763 367999987643 235689999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+|||++. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 161 ~~lv~e~~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEehhcC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 999999996 589999844 567999999999999999999999999999999999999999999999999999764432
Q ss_pred Cc---eecCCCcccccchhccccccC
Q 023285 262 GV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. .....||+.|+|||++.+..|
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred cccccccccccccCccCHhHhcCCCC
Confidence 21 224579999999999987543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=220.29 Aligned_cols=169 Identities=34% Similarity=0.566 Sum_probs=147.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|+. +++.||+|+++... ......+.+|+.++++++||||+++++.+.....+++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 45799999999999999999987 56889999986442 233456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++...... ...
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 86 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999875 4678999999999999999999999999999999999999999999999999998654321 223
Q ss_pred cCCCcccccchhccc
Q 023285 266 AETGTYRWMAPEVAF 280 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~ 280 (284)
...+++.|+|||.+.
T Consensus 165 ~~~~~~~y~~PE~~~ 179 (267)
T cd06646 165 SFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCccccCHhHcc
Confidence 456889999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=219.68 Aligned_cols=175 Identities=36% Similarity=0.658 Sum_probs=148.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|++..++|++.++||+|+||.||+|... +..+|+|.++..... ...+.+|+.++++++|+|++++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 6778889999999999999999999874 578999998765433 3468999999999999999999998754 5689
Q ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++|||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999764 3458999999999999999999999999999999999999999999999999998654332
Q ss_pred ce--ecCCCcccccchhcccccc
Q 023285 263 VM--TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~--~~~~gt~~y~aPEvl~~~~ 283 (284)
.. ....++..|+|||++.+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~ 179 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred cccccCCCCCccccChHHHhcCC
Confidence 11 1223567899999886543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=224.34 Aligned_cols=171 Identities=26% Similarity=0.414 Sum_probs=149.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||++.. ++..+|+|.++.. ...+....+.+|++++++++||||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 4678999998754 234556678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
|+++++|.+++.+. +.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 99999999999764 678999999999999999999997 59999999999999999999999999998755332 2234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||++.+..
T Consensus 158 ~~~~~~~~aPE~~~~~~ 174 (308)
T cd06615 158 FVGTRSYMSPERLQGTH 174 (308)
T ss_pred CCCCcCccChhHhcCCC
Confidence 57899999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=223.75 Aligned_cols=175 Identities=32% Similarity=0.557 Sum_probs=148.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEECC------------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYCS------------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 169 (284)
..++|++.+.||+|+||.||+|.... ..||+|.+.... .......+.+|++++++++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45689999999999999999987632 458999987543 34566789999999999999999
Q ss_pred eeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 023285 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (284)
Q Consensus 170 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NI 239 (284)
+++++++..+...++|||++++++|.+++.+.. ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997643 2688999999999999999999999999999999999
Q ss_pred EecCCCcEEEecccceeeeccCC---ceecCCCcccccchhcccccc
Q 023285 240 LMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+++.++.++|+|||.++...... ......+++.|+|||.+.+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence 99999999999999997643322 122334678899999987643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=249.40 Aligned_cols=177 Identities=21% Similarity=0.403 Sum_probs=150.4
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CC
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 180 (284)
.+....+|.+.+.||.|+||.||++.. .+..||+|++............+..|+.++++++||||++++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 445567899999999999999999987 45789999997665566667789999999999999999999998854 35
Q ss_pred cEEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEecC-------
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-------NIIHRDLKTANLLMDE------- 243 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~-------~iiH~Dikp~NIli~~------- 243 (284)
.+|+||||+++|+|.+++... .+.+++..++.|+.||+.||.|||+. +||||||||+|||++.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999753 35799999999999999999999984 4999999999999964
Q ss_pred ----------CCcEEEecccceeeeccCCceecCCCcccccchhcccc
Q 023285 244 ----------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 244 ----------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.+.+||+|||++.............||+.|+|||++.+
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc
Confidence 23589999999987654444445679999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-30 Score=221.94 Aligned_cols=176 Identities=26% Similarity=0.519 Sum_probs=145.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+..++|++.+.||+|+||.||+|.+ +++ .+++|.+... .......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 3456889999999999999999987 343 4788887532 223445678889999999999999999998764 5
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++++||+++|+|.+++....+.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||.++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999987667899999999999999999999999999999999999999999999999999986533
Q ss_pred CCc---eecCCCcccccchhccccccC
Q 023285 261 SGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
... .....++..|+|||.+.+..|
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~ 188 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY 188 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc
Confidence 221 123346778999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=223.79 Aligned_cols=170 Identities=29% Similarity=0.471 Sum_probs=149.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||.|+||.||++.. ++..+|+|.++.. .......+.+|+.++++++||||+++++.+..+...|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 34689999999999999999987 4688999998744 4555678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+++++|.+++......+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999999999876667999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred cCCCcccccchhccc
Q 023285 266 AETGTYRWMAPEVAF 280 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~ 280 (284)
...+++.|+|||++.
T Consensus 162 ~~~~~~~y~~PE~~~ 176 (280)
T cd06611 162 TFIGTPYWMAPEVVA 176 (280)
T ss_pred eeecchhhcCHHHHh
Confidence 446899999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=223.69 Aligned_cols=174 Identities=32% Similarity=0.514 Sum_probs=144.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--C--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 183 (284)
+++|++.+.||+|+||.||+|... + ..+++|.++.. ......+.+.+|+.+++++ +||||+++++++.....+|
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 357999999999999999999873 2 34788887632 2344567799999999999 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 184 IVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
+|+||+++++|.+++.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 2478899999999999999999999999999999999999999999
Q ss_pred EecccceeeeccCCceecCCCcccccchhcccccc
Q 023285 249 VADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 249 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+|||++..............+..|+|||++.+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 194 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV 194 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCC
Confidence 99999986433221122223456799999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=224.50 Aligned_cols=179 Identities=31% Similarity=0.603 Sum_probs=151.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 175 (284)
.|++..++|.+.+.||+|+||.||+|+. .+..||+|.++... .......+.+|+.+++++ +||||+++++.
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4778888999999999999999999975 23479999987542 234456799999999999 79999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
+...+..|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 3489999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCc---eecCCCcccccchhcccccc
Q 023285 255 ARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
++....... .....+++.|+|||.+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 975443221 12234678899999886653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=215.67 Aligned_cols=172 Identities=25% Similarity=0.441 Sum_probs=148.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.||++.. +++.+|+|.++... .....+.+.+|+.+++.++|+||+++++.+..+..+|+||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 478899999999999999987 46889999986432 234556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-eec
Q 023285 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~~ 266 (284)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||++++++.++++|||.++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999999998653 34588999999999999999999999999999999999999999999999999986544322 234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||++.+..
T Consensus 160 ~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 160 YVGTPYYVPPEIWENMP 176 (255)
T ss_pred ccCCccccCHHHHccCC
Confidence 56899999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=221.00 Aligned_cols=167 Identities=30% Similarity=0.456 Sum_probs=145.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||+|++.... ..+..+.+.+|+.++++++||||+++++.+......++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3678899999999999999986 56889999986542 34455679999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
|+++++|..+ ..+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 9999999754 24688889999999999999999999999999999999999999999999999765432 23445
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.||..|+|||++.+..
T Consensus 154 ~~~~~y~aPE~~~~~~ 169 (279)
T cd06619 154 VGTNAYMAPERISGEQ 169 (279)
T ss_pred CCChhhcCceeecCCC
Confidence 7899999999987653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=224.45 Aligned_cols=180 Identities=24% Similarity=0.402 Sum_probs=159.1
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.-.+.-++|.+.+.||+|.||.|-+++- +++.+|+|+++.+.. ..+....-..|-++|+..+||.+..+--.|+.+.
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 4456678899999999999999998876 578999999987643 4555667888999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee-c
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-A 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~-~ 259 (284)
++|+||||..||.|+-.|.+ ...++++....+..+|++||.|||+++||+||||.+|+|+|.+|++||+|||+|+.. .
T Consensus 242 rlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred eEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999988866 467999999999999999999999999999999999999999999999999999863 4
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
....+.+.+|||.|.||||+...-|
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDY 345 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDY 345 (516)
T ss_pred ccceeccccCChhhcCchhhccccc
Confidence 4445678899999999999976544
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=217.99 Aligned_cols=175 Identities=39% Similarity=0.688 Sum_probs=150.5
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|+++.++|.+.++||+|+||.||+|... ++.||||.+..... ....+.+|+.++++++|+||+++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 6788899999999999999999999874 47899999875433 2356889999999999999999999999989999
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+++++|.+++.... ..+++..+..++.+++.|+.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999987654321
Q ss_pred c--eecCCCcccccchhccccc
Q 023285 263 V--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~--~~~~~gt~~y~aPEvl~~~ 282 (284)
. .....++..|+|||.+.+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~ 179 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYG 179 (261)
T ss_pred hhhhhccCCCccccCHHHhccC
Confidence 1 1122345789999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=227.25 Aligned_cols=180 Identities=31% Similarity=0.603 Sum_probs=151.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 172 (284)
..|++...+|++.+.||+|+||.||+|... +..||+|.++.. ........+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 468898999999999999999999999752 136899988743 2345567899999999999 79999999
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
+++|......++++||+++|+|.+++.... ..++...+..++.|++.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 24777888999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++.++.+||+|||.++....... .....++..|+|||++.+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 212 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC
Confidence 99999999999999999976543221 12223457899999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=246.74 Aligned_cols=169 Identities=30% Similarity=0.481 Sum_probs=147.8
Q ss_pred ceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
+.|+..||.|+||.||+|.... --.|-|++... ..+...+|+-|+.||..++||+|+.++++|...+.++|+.|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4456679999999999998753 34577877533 5677889999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCCceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~~~~~~~ 268 (284)
.||-.+..+-.....+++.++..+++|++.||.|||+++|||||||+.|||+.-+|.++|+|||++.... .......+.
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI 191 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI 191 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence 9999999988888899999999999999999999999999999999999999999999999999875432 223446779
Q ss_pred Ccccccchhccccc
Q 023285 269 GTYRWMAPEVAFTF 282 (284)
Q Consensus 269 gt~~y~aPEvl~~~ 282 (284)
|||+||||||.+-.
T Consensus 192 GTPYWMAPEVvmCE 205 (1187)
T KOG0579|consen 192 GTPYWMAPEVVMCE 205 (1187)
T ss_pred CCcccccchheeec
Confidence 99999999998754
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=222.51 Aligned_cols=177 Identities=31% Similarity=0.580 Sum_probs=149.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
+..++|.+.+.||+|+||.||+|+.. ++.||||.++... ..+....+.+|++++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34568999999999999999999762 3679999987542 344567899999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
...++||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997532 34788899999999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++|+|||+++...... ......+++.|+|||++.+..|
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc
Confidence 9999999997543221 1223346789999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=217.34 Aligned_cols=172 Identities=36% Similarity=0.576 Sum_probs=151.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.+++|++... ..+..+.+.+|+.++++++||||+++++.+.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 45799999999999999999987 4678999998754 2335678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 9999999999997765789999999999999999999999999999999999999999999999999987654322 233
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...++..|+|||++.+.
T Consensus 160 ~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 160 SFIGTPYWMAPEVAAVE 176 (262)
T ss_pred cccCCccccCchhhccc
Confidence 45788899999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=223.86 Aligned_cols=176 Identities=28% Similarity=0.538 Sum_probs=146.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEECC----------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCcee
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCS----------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 170 (284)
+...+|++.+.||+|+||.||++...+ ..||+|.++... .......+.+|++++++++|+|++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456689999999999999999987532 248999987542 345566799999999999999999
Q ss_pred eEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 023285 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (284)
Q Consensus 171 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NI 239 (284)
++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999996532 1367888999999999999999999999999999999
Q ss_pred EecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+++.++.+||+|||++........ .....+++.|+|||++.+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 207 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK 207 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC
Confidence 999999999999999975432221 12234567899999887643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=224.23 Aligned_cols=176 Identities=25% Similarity=0.493 Sum_probs=147.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
++..+|++.+.||+|+||.||+|... ++.||+|+++... .......+.+|+.++++++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 45567889999999999999999863 3679999987442 344556789999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~ 244 (284)
...++++||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 1347888899999999999999999999999999999999999
Q ss_pred CcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 245 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.+||+|||+++....... .....+++.|+|||.+.+..
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK 202 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCC
Confidence 9999999999876433221 12334578999999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=220.22 Aligned_cols=174 Identities=30% Similarity=0.559 Sum_probs=147.6
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--C----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--S----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+...+|++.+.||+|+||.||+|... + ..+|+|.++... .......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45678999999999999999999863 2 368999886543 34556779999999999999999999999987 7
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999988667799999999999999999999999999999999999999999999999999986543
Q ss_pred CCcee---cCCCcccccchhccccc
Q 023285 261 SGVMT---AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~~~---~~~gt~~y~aPEvl~~~ 282 (284)
..... ...++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHR 186 (279)
T ss_pred cccceecCCCcccccccCHHHhhcC
Confidence 22111 12235689999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=224.37 Aligned_cols=171 Identities=26% Similarity=0.475 Sum_probs=147.7
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.||+|+. +++.||+|.++...........+.+|+.++++++||||+++++++.+...+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478899999999999999988 578999999875543444445678899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~ 267 (284)
+++ +|.+++....+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++..... ......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 975 899888766677999999999999999999999999999999999999999999999999999754322 222345
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.+++.|+|||++.+.
T Consensus 160 ~~~~~y~aPE~~~~~ 174 (284)
T cd07839 160 VVTLWYRPPDVLFGA 174 (284)
T ss_pred ccccCCcChHHHhCC
Confidence 678999999998663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=221.58 Aligned_cols=172 Identities=28% Similarity=0.479 Sum_probs=150.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
..+.|++.++||.|+||.||+|.. +++.+++|.+... ..+....+.+|+.++++++|+||+++++.+..+..+|+|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 345799999999999999999987 4688999998654 455677899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|||+++++|..++.+....+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||.+...... ...
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 167 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccccc
Confidence 9999999999988766677899999999999999999999999999999999999999999999999998754322 222
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....+++.|+|||++.+
T Consensus 168 ~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 168 DSFIGTPYWMAPEVVMC 184 (292)
T ss_pred ceecCCccccCceeecc
Confidence 34568899999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=208.06 Aligned_cols=176 Identities=28% Similarity=0.438 Sum_probs=152.1
Q ss_pred eeeccCCceeeeeeeecCceEEE--EEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy--~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
++++.+++.-+..||+|++|.|- +-..+|...|+|.++... +.+...+.+.|+.+..+. .+|.+|.+||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 77888888889999999999865 445588999999998654 455566778888876554 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.++.||.|+- ||..|-.+ ..+.+++..+-+|+..+..||+|||++ .+||||+||+|||++.+|+||+||||.+..
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999976 88777543 467899999999999999999999976 999999999999999999999999999998
Q ss_pred eccCCceecCCCcccccchhccccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
..++-..+...|...|||||.+...
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPE 223 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcc
Confidence 8777667778999999999998653
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=216.26 Aligned_cols=173 Identities=22% Similarity=0.377 Sum_probs=151.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.||++.. +++.+|+|.+.......+....+.+|+.++++++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999876 568999999876655566678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccceeeeccCCceec
Q 023285 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
+++++|.+++.... ..+++..+..++.+++.+|+|||++|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997753 458999999999999999999999999999999999999855 4689999999987655444445
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..++..|+|||.+.+..
T Consensus 161 ~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 161 VVGTPCYISPELCEGKP 177 (256)
T ss_pred cccCCcccCchhccCCC
Confidence 57899999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=218.46 Aligned_cols=171 Identities=29% Similarity=0.495 Sum_probs=144.0
Q ss_pred ceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc-----
Q 023285 112 LKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----- 181 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 181 (284)
|++.+.||+|+||.||+|... +..||+|.++...........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999863 2679999998665556667789999999999999999999998866554
Q ss_pred -EEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 182 -LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 182 -~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.++++||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||.+
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999998543 235889999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCc---eecCCCcccccchhccccc
Q 023285 256 RVQAQSGV---MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~~~~---~~~~~gt~~y~aPEvl~~~ 282 (284)
+....... .....++..|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADR 190 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccC
Confidence 86543321 1122356789999998654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=223.71 Aligned_cols=172 Identities=25% Similarity=0.451 Sum_probs=147.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|.+.++||+|+||.||+|.. +++.||+|.++.... ......+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 45799999999999999999987 468899999875432 222345778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++ +|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 99974 9999998766778999999999999999999999999999999999999999999999999997543222 223
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...+++.|+|||++.+.
T Consensus 163 ~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 163 NEVVTLWYRPPDILLGS 179 (301)
T ss_pred ccceeecccCcHHHhCC
Confidence 44678999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=216.97 Aligned_cols=173 Identities=29% Similarity=0.458 Sum_probs=147.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+.|++.+.||+|++|.||+|.. +++.+|+|.++..... ......+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 5789999998654322 2234678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
|+||+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.++........
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999999763 56889999999999999999999999999999999999999999999999998754322111
Q ss_pred ----ecCCCcccccchhcccccc
Q 023285 265 ----TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ----~~~~gt~~y~aPEvl~~~~ 283 (284)
....++..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred cccccCCCcCccccCcceeccCC
Confidence 2346788999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=220.60 Aligned_cols=171 Identities=26% Similarity=0.413 Sum_probs=146.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|++|.||+|.. +++.||+|++..........+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 3688999999999999999987 46899999986443233344568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+++++|..++.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9999888777654 4568999999999999999999999999999999999999999999999999998765433 2234
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..++..|+|||++.+
T Consensus 160 ~~~~~~~~aPE~~~~ 174 (286)
T cd07847 160 YVATRWYRAPELLVG 174 (286)
T ss_pred cccccccCCHHHHhC
Confidence 467889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=217.44 Aligned_cols=165 Identities=31% Similarity=0.535 Sum_probs=138.3
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.||+|+||.||+|.+. +..||+|+++... .......+.+|+.++++++||||+++++++.. ...++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999763 3469999987542 34455679999999999999999999998864 5789999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc----eecCC
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET 268 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~----~~~~~ 268 (284)
+|.+++......+++..+++++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... .+...
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999987667899999999999999999999999999999999999999999999999999975433211 11223
Q ss_pred Ccccccchhcccccc
Q 023285 269 GTYRWMAPEVAFTFF 283 (284)
Q Consensus 269 gt~~y~aPEvl~~~~ 283 (284)
+++.|+|||.+.+..
T Consensus 160 ~~~~y~aPE~~~~~~ 174 (257)
T cd05115 160 WPLKWYAPECINFRK 174 (257)
T ss_pred CCcccCCHHHHccCC
Confidence 357899999887543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=214.98 Aligned_cols=173 Identities=26% Similarity=0.408 Sum_probs=148.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lV~e 187 (284)
.|++.+.||.|++|.||++.. +++.||+|.+..........+.+.+|+.++++++|+|++++++.+.. +..+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999987 46789999987655455566779999999999999999999998764 446899999
Q ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
|+++++|.+++... ...+++.++..++.+++.|+++||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999764 3468999999999999999999999999999999999999999999999999998654322 223
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...+++.|+|||++.+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~ 178 (257)
T cd08223 161 TLIGTPYYMSPELFSNKP 178 (257)
T ss_pred cccCCcCccChhHhcCCC
Confidence 456899999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=216.78 Aligned_cols=166 Identities=39% Similarity=0.661 Sum_probs=145.7
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
+.||+|+||.||+|... +..|++|.++...... ..+.+.+|+++++.++|+|++++++++.....+++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46899999999999885 6789999997654333 56789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 191 RGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 191 ~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+++|.+++... ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999875 4779999999999999999999999999999999999999999999999999998765432
Q ss_pred ---ceecCCCcccccchhccccc
Q 023285 263 ---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ---~~~~~~gt~~y~aPEvl~~~ 282 (284)
......+++.|+|||.+.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred ccccccCCCcCccccCHHHhccC
Confidence 12344678899999988764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=219.45 Aligned_cols=164 Identities=29% Similarity=0.491 Sum_probs=135.9
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.||+|+||.||+|... ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.....+|+||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 5899999999999752 2568888876432 3445567899999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---ee
Q 023285 193 SIYDFLHKQKG----VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MT 265 (284)
Q Consensus 193 sL~~~l~~~~~----~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~ 265 (284)
+|.+++..... ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence 99999976432 346778899999999999999999999999999999999999999999999875432211 12
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+++.|+|||++..
T Consensus 161 ~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 161 CHAVPLRWLAPELVEI 176 (269)
T ss_pred CCCCcccccCHHHHhh
Confidence 2345678999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=216.23 Aligned_cols=174 Identities=34% Similarity=0.633 Sum_probs=148.6
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|++..++|++.++||+|+||.||++... +..+++|.++.. ......+.+|+.++++++|+||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 7788999999999999999999999874 467999988743 3345678999999999999999999999887 7789
Q ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++|||+++++|.+++.+. ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999764 3457888999999999999999999999999999999999999999999999997654322
Q ss_pred c--eecCCCcccccchhccccc
Q 023285 263 V--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~--~~~~~gt~~y~aPEvl~~~ 282 (284)
. .....++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~ 178 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFG 178 (260)
T ss_pred cccccCCcccccccCHhHhccC
Confidence 1 1223456789999998754
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=219.04 Aligned_cols=161 Identities=25% Similarity=0.498 Sum_probs=137.5
Q ss_pred eeeeecCceEEEEEEECC--------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 116 CKVASGSYGDLYKGTYCS--------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
+.||+|+||.||+|+... ..|++|.+... ..+....+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998532 25899987653 34445678999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-------EEEecccc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VKVADFGV 254 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~-------vkl~Dfg~ 254 (284)
.++||||+++++|..++......+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999999876677999999999999999999999999999999999999987664 89999999
Q ss_pred eeeeccCCceecCCCcccccchhcccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
+..... .....++..|+|||.+.+
T Consensus 159 ~~~~~~---~~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 159 PITVLS---RQECVERIPWIAPECVED 182 (262)
T ss_pred CccccC---cccccccccccChhhhcC
Confidence 865432 233467889999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=221.01 Aligned_cols=175 Identities=29% Similarity=0.534 Sum_probs=147.6
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
+...+|.+.+.||+|+||.||+|... +..+++|.++.. .....+.+.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34567899999999999999999752 346899987643 344456799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~ 244 (284)
...++||||+++++|.+++.... +.+++..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997532 347889999999999999999999999999999999999999
Q ss_pred CcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 245 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.++|+|||++........ .....+++.|+|||.+.+..
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 201 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 201 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC
Confidence 9999999999975433221 22345678999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=220.26 Aligned_cols=169 Identities=36% Similarity=0.603 Sum_probs=147.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||+|.++.. .......+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 45889999999999999999987 5689999998754 2333456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 99999999999866 467999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred cCCCcccccchhccc
Q 023285 266 AETGTYRWMAPEVAF 280 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~ 280 (284)
...|++.|+|||++.
T Consensus 165 ~~~~~~~y~aPE~~~ 179 (267)
T cd06645 165 SFIGTPYWMAPEVAA 179 (267)
T ss_pred cccCcccccChhhhc
Confidence 457899999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=216.65 Aligned_cols=174 Identities=32% Similarity=0.592 Sum_probs=148.2
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|+|..++|++.++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++|+|++++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 678889999999999999999999987 4588999998754332 357889999999999999999999875 45689
Q ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++|||+.+++|.+++... ...++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998764 3468899999999999999999999999999999999999999999999999997655322
Q ss_pred ce--ecCCCcccccchhccccc
Q 023285 263 VM--TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~--~~~~gt~~y~aPEvl~~~ 282 (284)
.. ....++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~ 178 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYG 178 (260)
T ss_pred cccccCCcccccccCHHHhccC
Confidence 21 223456789999988654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=215.08 Aligned_cols=173 Identities=35% Similarity=0.634 Sum_probs=148.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+..+|++.+.||+|+||.||+|.+. +..+|+|.++..... ...+.+|++++++++|||++++++++......++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4568999999999999999999874 688999998754333 346889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--e
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--~ 264 (284)
||+++++|.+++....+.+++..+..++.|++.+++|||+.+++|+||||+||+++.++.++|+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999987667789999999999999999999999999999999999999999999999999876533221 1
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....++..|+|||.+.+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~ 177 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSK 177 (256)
T ss_pred CCCccchhhcCHhHhccCC
Confidence 1223567899999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=223.45 Aligned_cols=172 Identities=27% Similarity=0.423 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV 185 (284)
++|++.+.||+|+||.||+|+.. ++.+++|.++...........+.+|+.++++++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47899999999999999999984 68899999975543444445678899999999999999999998877 889999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|||+++ +|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+...... ...
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 999975 999999876667999999999999999999999999999999999999999999999999999865443 223
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
....+++.|+|||++.+.
T Consensus 164 ~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 164 TQLVVTLWYRAPELLLGA 181 (293)
T ss_pred ccccccccccCchhhcCC
Confidence 345678999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=220.15 Aligned_cols=176 Identities=35% Similarity=0.622 Sum_probs=150.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+-...+|++.++||.|+||.||+|... +..+++|.++.. .......+..|+.+++.++|+||+++++++......++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 344568999999999999999999874 588999998754 23345678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999764 34689999999999999999999999999999999999999999999999999976543221
Q ss_pred -eecCCCcccccchhcccccc
Q 023285 264 -MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 -~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....+++.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~ 180 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGT 180 (261)
T ss_pred cccCCCCceEecCHHHHccCC
Confidence 22334677899999987643
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=216.01 Aligned_cols=174 Identities=24% Similarity=0.424 Sum_probs=150.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.. +++.||+|.++.... .......+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 4799999999999999999988 478999999874322 3344678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
||+++++|.+++... ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998642 3458899999999999999999999999999999999999999999999999987654322
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......+++.|+|||.+.+..
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~ 182 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred ccceecCCccccCHHHhccCC
Confidence 223346889999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=221.51 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=147.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+|++.+.||+|++|.||+|.. +++.||||.++..... ......+..|+.++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 4689999999765433 33445678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
|||+ +++|.+++......+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||+++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999997644479999999999999999999999999999999999999999999999999998654432 23
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....+++.|+|||.+.+
T Consensus 160 ~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 160 THQVVTRWYRAPELLFG 176 (298)
T ss_pred cccccceeeeCHHHHhC
Confidence 34467889999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=216.49 Aligned_cols=164 Identities=28% Similarity=0.540 Sum_probs=139.4
Q ss_pred eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.||+|+||.||+|.+ ++..+|+|+++.........+.+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999975 35789999987665555667789999999999999999999998864 5678999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce----ecCC
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TAET 268 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~----~~~~ 268 (284)
+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++........ ....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999976 357899999999999999999999999999999999999999999999999999765433211 1223
Q ss_pred Ccccccchhccccc
Q 023285 269 GTYRWMAPEVAFTF 282 (284)
Q Consensus 269 gt~~y~aPEvl~~~ 282 (284)
+++.|+|||.+.+.
T Consensus 160 ~~~~y~aPE~~~~~ 173 (257)
T cd05116 160 WPVKWYAPECMNYY 173 (257)
T ss_pred CCccccCHhHhccC
Confidence 45799999988654
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=217.20 Aligned_cols=171 Identities=33% Similarity=0.624 Sum_probs=146.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
-+..++|++.+.||+|+||.||++...++.||+|.++.. .....+.+|+.++++++|||++++++++..+ ..++|
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred cccHHHceeeeeeccCCCCceEecccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 345678999999999999999999999999999998643 2235788999999999999999999998764 57999
Q ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 186 TEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||.++..... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999997643 35889999999999999999999999999999999999999999999999999764332 2
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
.....+..|+|||.+.+..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~ 173 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKK 173 (254)
T ss_pred CCCCCCceecCHHHhccCC
Confidence 2234467899999887543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-29 Score=233.56 Aligned_cols=172 Identities=21% Similarity=0.405 Sum_probs=139.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC------CceeeEEeEEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACT 177 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 177 (284)
++..++|++.+.||+|+||.||+|.. .++.||||+++.. ....+.+..|+.+++.++| .+++.+++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34457899999999999999999987 4688999998642 2233456677777777755 45888999887
Q ss_pred cC-CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCC----------
Q 023285 178 RP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG---------- 245 (284)
Q Consensus 178 ~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~---------- 245 (284)
.. ..+|+|||++ |++|.+++.+. +.+++..+..++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 64 5689999988 66999998763 679999999999999999999998 5999999999999998765
Q ss_pred ------cEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 246 ------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 246 ------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.+||+|||.+..... ..+...||+.|||||++.+..|
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCC
Confidence 499999998864332 2345689999999999988654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-29 Score=215.51 Aligned_cols=173 Identities=30% Similarity=0.477 Sum_probs=145.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 182 (284)
.+|++.+.||+|+||.||+|.. ++..||||.+..... .......+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999987 468999998864321 233456789999999999999999999988763 468
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++||||+++++|.+++.+. ..+++..+..++.|++.+|+|||+++++|+||||+||+++.++.++|+|||.++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 8999999999999999764 56888999999999999999999999999999999999999999999999998754321
Q ss_pred ---CceecCCCcccccchhcccccc
Q 023285 262 ---GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ---~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.......++..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEG 185 (265)
T ss_pred ccccccccCCCCccccChhhhcCCC
Confidence 1223446889999999987643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=216.40 Aligned_cols=176 Identities=30% Similarity=0.519 Sum_probs=148.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
|...+|+..+.||+|+||.||+|... + ..+++|.++... .....+.+.+|+.++++++|+|++++.+++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45668899999999999999999873 2 369999986542 34456779999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++||||+++++|.+++....+.+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999876678899999999999999999999999999999999999999999999999998765332
Q ss_pred Cce--e--cCCCcccccchhcccccc
Q 023285 262 GVM--T--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~--~--~~~gt~~y~aPEvl~~~~ 283 (284)
... . ....++.|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRK 186 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCC
Confidence 111 1 112346799999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=216.71 Aligned_cols=176 Identities=30% Similarity=0.527 Sum_probs=147.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
++...+|.+.+.||+|+||.||+|.+.+ ..|+||...... ..+..+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4567789999999999999999998632 368999886542 34556789999999999999999999999876 4
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|+||||+++++|.+++.+....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999987556789999999999999999999999999999999999999999999999999986544
Q ss_pred CCcee--cCCCcccccchhcccccc
Q 023285 261 SGVMT--AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~--~~~gt~~y~aPEvl~~~~ 283 (284)
..... ...+++.|+|||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~ 184 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRR 184 (270)
T ss_pred ccceecCCCCccccccChhhhccCC
Confidence 32221 223456899999886543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=218.02 Aligned_cols=170 Identities=30% Similarity=0.450 Sum_probs=142.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHH-HHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||++.. +++.||+|.++....... ...+..|+.+ ++.+.||||+++++++..+...|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 3689999999999999999987 478999999876533333 3445556554 67778999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
||++ |+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.+.......
T Consensus 80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9997 5898887652 34689999999999999999999997 99999999999999999999999999998654433
Q ss_pred ceecCCCcccccchhcccc
Q 023285 263 VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~ 281 (284)
..+...++..|+|||++.+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 159 AKTIDAGCKPYMAPERINP 177 (283)
T ss_pred ccccccCCccccChhhcCC
Confidence 3344578999999998854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=217.32 Aligned_cols=172 Identities=27% Similarity=0.485 Sum_probs=142.1
Q ss_pred ceeeeeeeecCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------Cc
Q 023285 112 LKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PN 181 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 181 (284)
+.+.+.||+|+||.||+|.+.. ..+|+|.++...........+.+|+.+++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998743 2589999876655566678899999999999999999999987432 24
Q ss_pred EEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 182 LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.+++|||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999999987432 2357899999999999999999999999999999999999999999999999998
Q ss_pred eeccCCc---eecCCCcccccchhcccccc
Q 023285 257 VQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
....... .....+++.|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 190 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRV 190 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCC
Confidence 6543221 12234677899999987653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=235.85 Aligned_cols=173 Identities=26% Similarity=0.392 Sum_probs=151.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC------CHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEc
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTR 178 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 178 (284)
.+|...+.+|+|+||.|+.|+++ ...|+||.+..+.. .+......-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45899999999999999999985 47899999876532 1222334667999999998 9999999999999
Q ss_pred CCcEEEEEEcCC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 179 PPNLCIVTEFMA-RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 179 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
++++|++||--. |.+|++++.. +..+++.++..|+.||+.|+++||+.||||||||-+|+.++.+|.+||+|||.|..
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999754 4499999966 57899999999999999999999999999999999999999999999999999975
Q ss_pred eccCCceecCCCcccccchhccccccC
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. ++.....+||..|.|||++.|.+|
T Consensus 720 ~k-sgpfd~f~gtv~~aapevl~g~~y 745 (772)
T KOG1152|consen 720 TK-SGPFDVFVGTVDYAAPEVLGGEKY 745 (772)
T ss_pred hc-CCCcceeeeeccccchhhhCCCcc
Confidence 43 456778899999999999999887
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=218.77 Aligned_cols=171 Identities=23% Similarity=0.391 Sum_probs=151.1
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|++.+.||.|+||.||+|... ++.||+|++..... .....+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999884 78999999865432 23556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
|+.|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+............
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999764 67899999999999999999999999999999999999999999999999998865544334456
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.|+..|+|||++.+.
T Consensus 160 ~~~~~y~~PE~~~~~ 174 (258)
T cd05578 160 SGTPGYMAPEVLCRQ 174 (258)
T ss_pred CCChhhcCHHHHccc
Confidence 788999999998764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=215.99 Aligned_cols=174 Identities=38% Similarity=0.696 Sum_probs=145.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|++..++|.+.++||+|++|.||+|...+ ..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 56777889999999999999999998754 5799998865432 23568899999999999999999998754 5688
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||.++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997643 357899999999999999999999999999999999999999999999999997654322
Q ss_pred ce--ecCCCcccccchhccccc
Q 023285 263 VM--TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~--~~~~gt~~y~aPEvl~~~ 282 (284)
.. ....++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~ 178 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred ccccCCCccchhhCCHHHhccC
Confidence 11 123456789999988654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=220.12 Aligned_cols=160 Identities=24% Similarity=0.471 Sum_probs=135.4
Q ss_pred eeeecCceEEEEEEEC--------------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCcee
Q 023285 117 KVASGSYGDLYKGTYC--------------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 170 (284)
.||+|+||.||+|... ...|++|++... ..+....+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 5899999999998741 134899988643 234456788999999999999999
Q ss_pred eEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-----
Q 023285 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----- 245 (284)
Q Consensus 171 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----- 245 (284)
++++++..+...++||||+++|+|..++.+..+.+++..+..++.||+.||+|||++||+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999977667889999999999999999999999999999999999997654
Q ss_pred --cEEEecccceeeeccCCceecCCCcccccchhcccc
Q 023285 246 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 246 --~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.++++|||.+..... .....++..|+|||.+.+
T Consensus 160 ~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 160 SPFIKLSDPGVSFTALS---REERVERIPWIAPECVPG 194 (274)
T ss_pred cceeeecCCcccccccc---ccccccCCcccCchhhcC
Confidence 489999998864322 123457888999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=224.73 Aligned_cols=163 Identities=25% Similarity=0.471 Sum_probs=133.7
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcEEEEEEc
Q 023285 115 ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF 188 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~ 188 (284)
.++||+|+||.||+|... ++.||+|.++.... ...+.+|+.++++++||||+++++++.. +..+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 458999999999999853 47899999875432 2346789999999999999999999854 4568999999
Q ss_pred CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEeccccee
Q 023285 189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (284)
Q Consensus 189 ~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli----~~~~~vkl~Dfg~a~ 256 (284)
+.+ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 965 898887532 1258889999999999999999999999999999999999 456789999999998
Q ss_pred eeccCC----ceecCCCcccccchhccccc
Q 023285 257 VQAQSG----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPEvl~~~ 282 (284)
...... ......||+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCC
Confidence 654321 22345789999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=217.99 Aligned_cols=167 Identities=32% Similarity=0.517 Sum_probs=146.0
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|++.+.||+|+||.||+|... +..+++|.+... .......+.+|+.+++.++|||++++++.+..+...++|+||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 578889999999999999884 578899988643 3455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~ 268 (284)
++++|..++.+....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...... .......
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 164 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccccc
Confidence 999999988765667999999999999999999999999999999999999999999999999998754322 1223456
Q ss_pred Ccccccchhccc
Q 023285 269 GTYRWMAPEVAF 280 (284)
Q Consensus 269 gt~~y~aPEvl~ 280 (284)
+++.|+|||++.
T Consensus 165 ~~~~y~aPE~~~ 176 (282)
T cd06643 165 GTPYWMAPEVVM 176 (282)
T ss_pred ccccccCHhhcc
Confidence 899999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-29 Score=212.95 Aligned_cols=167 Identities=34% Similarity=0.566 Sum_probs=142.0
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
+.||+|+||.||+|.. .++.+|+|.++... ..+....+.+|+.++++++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999986 45789999987543 344456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce--ecCCCccc
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYR 272 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~--~~~~gt~~ 272 (284)
.+++......+++..+..++.|++.+|.|||++|++|+||||+||+++.++.++|+|||++......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9999776667899999999999999999999999999999999999999999999999999754332111 12234678
Q ss_pred ccchhcccccc
Q 023285 273 WMAPEVAFTFF 283 (284)
Q Consensus 273 y~aPEvl~~~~ 283 (284)
|+|||++.+..
T Consensus 160 y~aPE~~~~~~ 170 (250)
T cd05085 160 WTAPEALNYGR 170 (250)
T ss_pred ccCHHHhccCC
Confidence 99999987653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-29 Score=217.55 Aligned_cols=175 Identities=29% Similarity=0.524 Sum_probs=148.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
+++.+|.+.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5677899999999999999999864 2457899987643 455567899999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~ 245 (284)
...+++|||+++++|.+++.... ..+++..+..++.|++.|++|||++|++||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997642 2478899999999999999999999999999999999999999
Q ss_pred cEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 246 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
.++|+|||+++....... .....+++.|+|||.+.+..
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 999999999975433221 11223567899999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-29 Score=216.51 Aligned_cols=165 Identities=26% Similarity=0.445 Sum_probs=137.3
Q ss_pred eeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|... +..+|+|.++... .......+.+|+.++++++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 35899999999999763 3579999887543 233445789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---e
Q 023285 192 GSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M 264 (284)
Q Consensus 192 gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~ 264 (284)
|+|.+++.... ...++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||.++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999997532 2456677889999999999999999999999999999999999999999999975433221 1
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....+++.|+|||++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 160 DQLWVPLRWIAPELVDE 176 (269)
T ss_pred CCcCCcccccCHhHhcc
Confidence 23356789999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=216.71 Aligned_cols=160 Identities=26% Similarity=0.476 Sum_probs=137.1
Q ss_pred eeeeecCceEEEEEEECCc------------eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 116 CKVASGSYGDLYKGTYCSQ------------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+.||+|+||.||+|...+. .+++|.++... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4689999999999988532 37888776432 125788999999999999999999999988 7789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-------cEEEeccccee
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-------VVKVADFGVAR 256 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-------~vkl~Dfg~a~ 256 (284)
+||||+++|+|.+++......++...+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||.+.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999987655789999999999999999999999999999999999999887 79999999998
Q ss_pred eeccCCceecCCCcccccchhccccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.... .....++..|+|||++.+.
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNG 179 (259)
T ss_pred cccc---ccccccCCCccChhhhcCC
Confidence 6543 2334567889999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=236.79 Aligned_cols=175 Identities=39% Similarity=0.721 Sum_probs=156.3
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+.|++++.++...++||-|.||.||.|.|.. -.||||.++.+ .....+|+.|+.+|+.++|||+|+++|+|+.+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 7899999999999999999999999999964 68999999854 334678999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|||+|||..|+|.+||++++. .++.-.++.++.||.+||+||..+++|||||.++|+|+.++..||++|||+++++.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999999998753 46666788999999999999999999999999999999999999999999999887
Q ss_pred cCCceecCCC---cccccchhcccc
Q 023285 260 QSGVMTAETG---TYRWMAPEVAFT 281 (284)
Q Consensus 260 ~~~~~~~~~g---t~~y~aPEvl~~ 281 (284)
... .+...| ...|.|||-+--
T Consensus 417 gDT-YTAHAGAKFPIKWTAPEsLAy 440 (1157)
T KOG4278|consen 417 GDT-YTAHAGAKFPIKWTAPESLAY 440 (1157)
T ss_pred CCc-eecccCccCcccccCcccccc
Confidence 653 444444 578999997754
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=217.24 Aligned_cols=176 Identities=31% Similarity=0.542 Sum_probs=145.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
+..++|++.+.||+|++|.||+|.+. +..|++|.++.. ........|.+|+.++++++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 44568999999999999999999874 367899987643 2344456799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEe
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVA 250 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~ 250 (284)
...++||||++|++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997643 2588999999999999999999999999999999999998655 69999
Q ss_pred cccceeeeccCCce---ecCCCcccccchhcccccc
Q 023285 251 DFGVARVQAQSGVM---TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 251 Dfg~a~~~~~~~~~---~~~~gt~~y~aPEvl~~~~ 283 (284)
|||.++........ .....+..|+|||++.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI 197 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCC
Confidence 99999865322211 1223356899999987653
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=213.68 Aligned_cols=171 Identities=34% Similarity=0.535 Sum_probs=151.2
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|... ++.+++|.++.. .....+.+|++++++++|+||+++++.+.....+|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 357899999999999999999884 588999998643 22678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 9999999999998766788999999999999999999999999999999999999999999999999998655433 233
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...++..|+|||++.+..
T Consensus 158 ~~~~~~~y~~PE~~~~~~ 175 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIG 175 (256)
T ss_pred cccCCccccCHHHHhcCC
Confidence 446889999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=219.10 Aligned_cols=170 Identities=27% Similarity=0.463 Sum_probs=145.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|++|.||+|.. +++.||||.+..... ......+.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 5799999999999999999987 468999999875422 2223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
|+.+ +|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++..... .....
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 9985 999999876667899999999999999999999999999999999999999999999999998754322 12233
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..++..|+|||++.+
T Consensus 163 ~~~~~~~~aPE~~~~ 177 (291)
T cd07844 163 EVVTLWYRPPDVLLG 177 (291)
T ss_pred cccccccCCcHHhhc
Confidence 457889999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=214.82 Aligned_cols=172 Identities=30% Similarity=0.543 Sum_probs=146.6
Q ss_pred CceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+|++.+.||+|+||.||+|.. +++.+|+|.++.... ..+....+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999987 568899999875422 123446689999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC----
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---- 261 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~---- 261 (284)
+||+++++|.+++.+. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999763 56889999999999999999999999999999999999999999999999998753211
Q ss_pred ---CceecCCCcccccchhcccccc
Q 023285 262 ---GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ---~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.......++..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~ 184 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESG 184 (265)
T ss_pred cccccccccCCCccccChhhhcCCC
Confidence 1122346889999999987653
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=223.62 Aligned_cols=168 Identities=20% Similarity=0.357 Sum_probs=142.0
Q ss_pred eeeeeeec--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 114 IECKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 114 ~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
+.+.||+| +||.||++.. +++.||+|.++......+..+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7789999987 5789999999766555566677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC------
Q 023285 190 ARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG------ 262 (284)
Q Consensus 190 ~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~------ 262 (284)
++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+......+
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999653 3458999999999999999999999999999999999999999999999998754322111
Q ss_pred --ceecCCCcccccchhcccc
Q 023285 263 --VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 --~~~~~~gt~~y~aPEvl~~ 281 (284)
......++..|+|||++.+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred ccccccccceecccChHHhhc
Confidence 1122356778999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=216.93 Aligned_cols=168 Identities=31% Similarity=0.562 Sum_probs=140.8
Q ss_pred ceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEE
Q 023285 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 183 (284)
|++.+.||+|+||.||++.+ .+..||+|.++... .......+.+|+.++++++||||+++++++... ..++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 48899999999999988654 35689999987542 234456788999999999999999999988653 3589
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||++++++.++|+|||+++.......
T Consensus 85 lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 99999999999999976 3589999999999999999999999999999999999999999999999999986543221
Q ss_pred ----eecCCCcccccchhccccc
Q 023285 264 ----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ----~~~~~gt~~y~aPEvl~~~ 282 (284)
.....++..|+|||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~ 185 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKEN 185 (283)
T ss_pred hhccCCCCCCCceeeCHhHhccc
Confidence 1223456789999988654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=218.73 Aligned_cols=176 Identities=31% Similarity=0.558 Sum_probs=147.8
Q ss_pred eccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
++..+|++.+.||+|+||.||+|.. .+..||+|.++.. ........+.+|+.++++++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999976 3478999998744 2345567799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK---------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997532 236788899999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+++.++.++|+|||.+........ ......+..|+|||++.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR 208 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC
Confidence 9999999999999999875432211 12234567899999887654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=220.16 Aligned_cols=174 Identities=23% Similarity=0.337 Sum_probs=148.9
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|++|.||+|... ++.||+|.+....... ...+.+.+|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36899999999999999999884 6899999997654332 45667999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--
Q 023285 187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-- 263 (284)
||+.+++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999764 35689999999999999999999999999999999999999999999999999865322110
Q ss_pred ----------------------------eecCCCcccccchhcccccc
Q 023285 264 ----------------------------MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ----------------------------~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....||..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 208 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence 11235788999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=218.81 Aligned_cols=175 Identities=28% Similarity=0.518 Sum_probs=144.9
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 169 (284)
..++|++.++||+|+||.||++... ...||+|.++.. ........+.+|+.++++++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 4567999999999999999988542 236899998754 234456789999999999999999
Q ss_pred eeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 023285 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (284)
Q Consensus 170 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NI 239 (284)
+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997632 2366778999999999999999999999999999999
Q ss_pred EecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+++.++.++|+|||+++....... .....+++.|+|||+..+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 208 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK 208 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC
Confidence 999999999999999975433221 11223467899999876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=219.12 Aligned_cols=172 Identities=29% Similarity=0.421 Sum_probs=148.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|++|.||+|.. +++.||+|.++...........+.+|++++++++|+||+++++.+..+...++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999987 46899999987654445556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--cee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~~~ 265 (284)
|++++.+..+..+ ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9998666655543 4668999999999999999999999999999999999999999999999999998654433 233
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 160 DYVATRWYRAPELLVGD 176 (288)
T ss_pred CcccccCCcCCchhcCC
Confidence 45678999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=224.35 Aligned_cols=171 Identities=27% Similarity=0.383 Sum_probs=146.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 180 (284)
.++|++.+.||+|+||.||+|.. +++.||||.+............+.+|+.++++++|+||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46899999999999999999987 578999999865444455566788999999999999999999988644 3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|+||||+.+ +|.+.+... ++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.++....
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 57999999965 898888542 88999999999999999999999999999999999999999999999999987655
Q ss_pred CCceecCCCcccccchhcccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
........+++.|+|||++.+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~ 193 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMG 193 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCC
Confidence 44444557889999999987754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=213.44 Aligned_cols=171 Identities=26% Similarity=0.507 Sum_probs=150.2
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.||+|.. +++.|++|.++.........+.+.+|+.++++++|+||+++++.+.....+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 478899999999999999987 568999999986654455778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce----
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---- 264 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~---- 264 (284)
+++++|.+++.. ...+++..+..++.+++.||.|||+.|++|+||+|+||++++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999976 356889999999999999999999999999999999999999999999999999865433221
Q ss_pred -ecCCCcccccchhccccc
Q 023285 265 -TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 -~~~~gt~~y~aPEvl~~~ 282 (284)
....+++.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred ccCCcCCcCccChhhccCC
Confidence 124678899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=212.56 Aligned_cols=171 Identities=34% Similarity=0.555 Sum_probs=149.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+|+..+.||+|++|.||+|.. +++.|++|.+.... ...+..+.+.+|+.++++++|+||+++++++.....+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 467788999999999999987 47899999986432 2244667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
+||+++++|.+++.+. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+..........
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 9999999999999764 568899999999999999999999999999999999999999999999999998755443344
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...+++.|+|||.+.+.
T Consensus 160 ~~~~~~~y~~pe~~~~~ 176 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQ 176 (258)
T ss_pred ccCCCcceeCHHHhcCC
Confidence 56789999999987654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=218.51 Aligned_cols=170 Identities=28% Similarity=0.460 Sum_probs=147.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.+|++.+.||+|+||.||+|.. +++.|++|.+..... .....+.+|+.+++.++|+|++++++.+..+...|+|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5899999999999999999986 568999999875432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+++++|.+++.+ ..+++.++..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9999999999865 457899999999999999999999999999999999999999999999999987543322 2234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||.+.+..
T Consensus 176 ~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 176 MVGTPYWMAPEVVTRKA 192 (296)
T ss_pred ccCCccccCHHHHcCCC
Confidence 57899999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=219.66 Aligned_cols=171 Identities=27% Similarity=0.448 Sum_probs=148.0
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||++... ++.||+|.++.. ........+.+|+.++++++|+||+++++.+..++.+|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 36889999999999999999884 789999988654 234455789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 188 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
|+++++|..++... ...+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+...... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 99999999998763 2378999999999999999999996 59999999999999999999999999998765332 22
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
....+++.|+|||.+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 159 KTNIGCQSYMAPERIKSG 176 (286)
T ss_pred ccCCCccCccCcchhcCC
Confidence 345688899999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=217.78 Aligned_cols=171 Identities=27% Similarity=0.551 Sum_probs=142.9
Q ss_pred CceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+|++.+.||+|+||.||+|.... ..+++|.++... .......+.+|+.+++.++||||+++++.+..+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47888999999999999998632 468999887543 3344577999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEE
Q 023285 184 IVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIl 240 (284)
+|+||+.+++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999986521 24778889999999999999999999999999999999
Q ss_pred ecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccc
Q 023285 241 MDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 241 i~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~ 282 (284)
+++++.++|+|||+++....... .....++..|+|||.+.+.
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 99999999999999975432211 1223456789999987654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=212.88 Aligned_cols=170 Identities=39% Similarity=0.688 Sum_probs=146.0
Q ss_pred ceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+++.+.||.|+||.||++.... ..||+|.++... ..+....+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999998854 789999997553 233567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
|||+++++|.+++...... +++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999999765444 899999999999999999999999999999999999999999999999999865443221
Q ss_pred e--cCCCcccccchhccccc
Q 023285 265 T--AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~--~~~gt~~y~aPEvl~~~ 282 (284)
. ...+++.|+|||.+.+.
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~ 179 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDG 179 (258)
T ss_pred ccccCCCcccccChHHhccC
Confidence 1 23367899999988543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=213.44 Aligned_cols=174 Identities=28% Similarity=0.494 Sum_probs=145.8
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+++...+.....||+|+||.||+|.. ++..|++|.++.. .....+.+.+|+.++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34444555667899999999999986 4578999988644 3445678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeecc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ 260 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~~ 260 (284)
+|+||+++++|.+++......+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999998654455 78889999999999999999999999999999999986 67999999999875432
Q ss_pred CC-ceecCCCcccccchhcccc
Q 023285 261 SG-VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~-~~~~~~gt~~y~aPEvl~~ 281 (284)
.. ......+++.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred CCCccccCCCCccccChhhhcc
Confidence 22 2233468999999999854
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=217.90 Aligned_cols=170 Identities=28% Similarity=0.467 Sum_probs=147.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++.+..+...|+|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 5899999999999999999986 57899999986542 2234668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+++++|.+++.+ ..+++..+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||.+....... ....
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9999999999865 457889999999999999999999999999999999999999999999999987654332 2234
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||.+.+..
T Consensus 175 ~~~~~~y~aPE~~~~~~ 191 (297)
T cd06656 175 MVGTPYWMAPEVVTRKA 191 (297)
T ss_pred ccCCccccCHHHHcCCC
Confidence 56889999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=216.82 Aligned_cols=170 Identities=26% Similarity=0.430 Sum_probs=144.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 5799999999999999999976 478999999865422 2223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+. ++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++...... ....
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 996 68888876655668888999999999999999999999999999999999999999999999987543322 2233
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..+++.|+|||++.+
T Consensus 163 ~~~~~~y~aPE~~~~ 177 (291)
T cd07870 163 EVVTLWYRPPDVLLG 177 (291)
T ss_pred ccccccccCCceeec
Confidence 457899999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=235.15 Aligned_cols=175 Identities=17% Similarity=0.294 Sum_probs=137.6
Q ss_pred cCCceeeeeeeecCceEEEEEEECC---ceEEEEEe---------------cCCCCCHHHHHHHHHHHHHHHhCCCCcee
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVL---------------KPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~---------------~~~~~~~~~~~~~~~E~~~l~~l~h~niv 170 (284)
.++|++.++||+|+||.||++.... ...++|.+ +...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3689999999999999999986532 22222211 11111233456788999999999999999
Q ss_pred eEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 171 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
++++++......|+|+|++. ++|.+++.... .......+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 99999999999999999995 48888875432 23345678889999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCCc--eecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQSGV--MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPEvl~~~~y 284 (284)
+||+|||+++....... .....||+.|+|||++.+..|
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC
Confidence 99999999986543321 224579999999999987654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=216.32 Aligned_cols=173 Identities=23% Similarity=0.446 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.. +++.++||.+.... ........+.+|+.+++.++|+||+++++.+..+...+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999986 57899999876432 23345567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
||+++++|.+++.. ....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999999864 23568999999999999999999999999999999999999999999999999987654322
Q ss_pred ceecCCCcccccchhccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~ 282 (284)
......++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~ape~~~~~ 181 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred ccccccCCcCccCHHHhcCC
Confidence 22344688999999998664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=213.57 Aligned_cols=172 Identities=31% Similarity=0.593 Sum_probs=145.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
+|.+.+.||+|++|.||+|.. .++.+|+|.+...... .+....+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999987 4688999988654322 1234678899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++||||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 99999999999999999764 67889999999999999999999999999999999999999999999999998765421
Q ss_pred C-------ceecCCCcccccchhcccccc
Q 023285 262 G-------VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~-------~~~~~~gt~~y~aPEvl~~~~ 283 (284)
. ......|+..|+|||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 188 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTS 188 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCC
Confidence 1 112235788999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=214.97 Aligned_cols=176 Identities=23% Similarity=0.417 Sum_probs=148.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-C
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-P 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 179 (284)
++.++|++.+.||+|+||.||+|.+. +..|++|.++.. ........+.+|+.++++++|+||+++++++.. +
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 56789999999999999999999874 478999988643 345556789999999999999999999998776 4
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
...++++||+++++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 67899999999999999997642 45889999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 253 GVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 253 g~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+++....... .....++..|+|||++.+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 195 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE 195 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCC
Confidence 99985433221 12234677899999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=217.76 Aligned_cols=172 Identities=24% Similarity=0.383 Sum_probs=145.6
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
+|++.+.||+|+||.||++... ++.|++|.++.... .......+.+|+.+++.++||||+++++.+..+..+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6889999999999999999874 57899999875432 23345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC------
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------ 261 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~------ 261 (284)
|++|++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++.....
T Consensus 82 ~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 82 YVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999764 67899999999999999999999999999999999999999999999999998642110
Q ss_pred ----------CceecCCCcccccchhcccccc
Q 023285 262 ----------GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ----------~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.......++..|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCC
Confidence 0011235788999999986643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=212.37 Aligned_cols=172 Identities=23% Similarity=0.404 Sum_probs=149.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~ 186 (284)
+|++.+.||.|+||.||++.. +++.||+|.++...........+.+|+.++++++|+||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478899999999999999977 56889999987655556667789999999999999999999998764 45689999
Q ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLH-----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 187 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH-----~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999764 467899999999999999999999 899999999999999999999999999999876
Q ss_pred ccCCc-eecCCCcccccchhccccc
Q 023285 259 AQSGV-MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~~~-~~~~~gt~~y~aPEvl~~~ 282 (284)
..... .....+++.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~ 185 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHM 185 (265)
T ss_pred cCCcccccccccCCCccChhhhcCC
Confidence 54432 3345789999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=211.53 Aligned_cols=173 Identities=24% Similarity=0.421 Sum_probs=149.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.+|+++. +++.||+|.+............+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999877 568999999875444455567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-eec
Q 023285 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~~ 266 (284)
+.+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997643 3578999999999999999999999999999999999999999999999999976543322 123
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..|++.|+|||++.+..
T Consensus 161 ~~~~~~~~~pe~~~~~~ 177 (256)
T cd08218 161 CIGTPYYLSPEICENRP 177 (256)
T ss_pred ccCCccccCHHHhCCCC
Confidence 45888999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=215.35 Aligned_cols=173 Identities=29% Similarity=0.578 Sum_probs=147.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 180 (284)
.++|++.+.||+|+||.||+|.+. +..+|||.++..... .....|.+|+.++++++|+||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 457888999999999999999863 578999999765332 456789999999999999999999999887 55
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||+++++|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 79999999999999999987666799999999999999999999999999999999999999999999999999986653
Q ss_pred CCce----ecCCCcccccchhccccc
Q 023285 261 SGVM----TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~~----~~~~gt~~y~aPEvl~~~ 282 (284)
.... ....++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~ 187 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTS 187 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccC
Confidence 2111 122445679999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=214.36 Aligned_cols=172 Identities=29% Similarity=0.511 Sum_probs=146.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+|+..+.||+|++|.||+|.. +++.||+|.++.... .....+.+.+|+.++++++|+||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999976 678999999864321 12345789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~~ 263 (284)
|+||+++++|.+++.+ .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999976 35789999999999999999999999999999999999998775 699999999976543211
Q ss_pred -----eecCCCcccccchhcccccc
Q 023285 264 -----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 -----~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....++..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~ 184 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQ 184 (268)
T ss_pred cCCccccccccccceeCHhHhccCC
Confidence 12346789999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=214.22 Aligned_cols=166 Identities=33% Similarity=0.558 Sum_probs=137.2
Q ss_pred eeeecCceEEEEEEEC--C--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 117 KVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
.||+|+||.||+|... + ..+++|.++.. ........+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 5899999999999874 3 35788887633 2345567899999999999 799999999999999999999999999
Q ss_pred CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 192 GSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 192 gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997532 247889999999999999999999999999999999999999999999999986
Q ss_pred eeccCCceecCCCcccccchhcccccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.............+..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~ 187 (270)
T cd05047 161 GQEVYVKKTMGRLPVRWMAIESLNYSV 187 (270)
T ss_pred ccchhhhccCCCCccccCChHHHccCC
Confidence 432221122223466899999986654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=214.93 Aligned_cols=171 Identities=32% Similarity=0.499 Sum_probs=150.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||.|++|.||+|.. +++.||+|.+.... .......+.+|+.+++.++|+|++++++.+..+...|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688899999999999999987 46899999987543 23445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
|+++++|.+++... .+++..+..++.|++.+|.|||+++++|+||+|+||++++++.++|+|||+++..... .....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999999763 7899999999999999999999999999999999999999999999999999876543 22344
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||++.+..
T Consensus 158 ~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 158 FVGTPFWMAPEVIKQSG 174 (274)
T ss_pred ccCCccccChhhhccCC
Confidence 57889999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=218.84 Aligned_cols=173 Identities=26% Similarity=0.472 Sum_probs=146.4
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 183 (284)
..++|++.+.||+|+||.||+|.. +++.||+|.++...........+.+|+.++++++|+|++++++++... ..++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 346899999999999999999987 478999999875433333334567899999999999999999998765 4689
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-C
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~ 262 (284)
+||||+.+ +|.+++......+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+...... .
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999975 899998776677999999999999999999999999999999999999999999999999999865432 2
Q ss_pred ceecCCCcccccchhcccc
Q 023285 263 VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~ 281 (284)
..+...+++.|+|||++.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CCCcccccccccChhhhcC
Confidence 2333456889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=209.53 Aligned_cols=173 Identities=25% Similarity=0.474 Sum_probs=153.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||.|+||.||++... ++.|++|++.......+....+.+|++++++++|+|++++.+.+......++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788999999999999999985 78999999986655556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 189 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 189 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
+++++|.+++... ...+++..+..++.+++.||.|||++|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999875 3779999999999999999999999999999999999999999999999999998654433 22
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....|++.|+|||.+.+..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~ 179 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKP 179 (258)
T ss_pred cceeeeecccChhHhccCC
Confidence 3456889999999876653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=218.12 Aligned_cols=173 Identities=29% Similarity=0.494 Sum_probs=144.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
.++|++.++||+|+||.||+|.. +++.||||.+............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999987 4789999998654333333445678999999999999999999987654
Q ss_pred --cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 181 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..++||||+.+ +|.+++.+....+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+...
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 35999999965 899888776667999999999999999999999999999999999999999999999999999765
Q ss_pred ccCC-----ceecCCCcccccchhccccc
Q 023285 259 AQSG-----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~~-----~~~~~~gt~~y~aPEvl~~~ 282 (284)
.... ......++..|+|||++.+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCC
Confidence 3321 11234578899999987653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=218.05 Aligned_cols=171 Identities=31% Similarity=0.455 Sum_probs=147.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||+|.+..........+.+.+|++++++++||||+++++++..+...|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999998 46899999986544344455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+++++|.++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....... ..+.
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999888887654 4568999999999999999999999999999999999999999999999999998654322 2234
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..++..|+|||++.+
T Consensus 160 ~~~~~~y~aPE~~~~ 174 (286)
T cd07846 160 YVATRWYRAPELLVG 174 (286)
T ss_pred ccceeeccCcHHhcc
Confidence 568899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=216.22 Aligned_cols=171 Identities=27% Similarity=0.469 Sum_probs=148.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..+|++.+.||.|++|.||+|.. +++.|++|.+.... ......+.+|+.+++.++|||++++++.+.....+|+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35799999999999999999985 57899999986432 233567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-ee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~ 265 (284)
||+++++|.+++.. ..+++..+..++.+++.||+|||+.|++|+||||+||+++.++.++|+|||++........ ..
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99999999999865 4589999999999999999999999999999999999999999999999999875433221 23
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...+++.|+|||.+.+..
T Consensus 174 ~~~~~~~y~aPE~~~~~~ 191 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKA 191 (296)
T ss_pred CcCCCccccCcchhcCCC
Confidence 446889999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=212.46 Aligned_cols=165 Identities=25% Similarity=0.383 Sum_probs=144.5
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||.|++|.||+++.. ++.+|+|++..... .....+.+.+|+.++++++||||+++++.+.++...|+|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999986 78999999865432 234557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCccccc
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~ 274 (284)
.+++.+. ..++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.++............+++.|+
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 9999764 568999999999999999999999999999999999999999999999999998765543334457899999
Q ss_pred chhcccccc
Q 023285 275 APEVAFTFF 283 (284)
Q Consensus 275 aPEvl~~~~ 283 (284)
|||.+.+..
T Consensus 160 ~PE~~~~~~ 168 (262)
T cd05572 160 APEIILNKG 168 (262)
T ss_pred ChhHhcCCC
Confidence 999986543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=210.22 Aligned_cols=167 Identities=34% Similarity=0.605 Sum_probs=142.8
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
++||+|+||.||++... ++.|++|.++.... .+....+.+|+.++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46899999999999875 78999999875533 24567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce---ecCCCcc
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGTY 271 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~---~~~~gt~ 271 (284)
.+++.+....++...+..++.+++.+++|||+++++||||+|+||+++.++.++|+|||.++........ .....+.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9999776567899999999999999999999999999999999999999999999999999765422111 1123356
Q ss_pred cccchhcccccc
Q 023285 272 RWMAPEVAFTFF 283 (284)
Q Consensus 272 ~y~aPEvl~~~~ 283 (284)
.|+|||++.+..
T Consensus 160 ~y~~PE~~~~~~ 171 (251)
T cd05041 160 KWTAPEALNYGR 171 (251)
T ss_pred ccCChHhhccCC
Confidence 799999987653
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=213.82 Aligned_cols=174 Identities=24% Similarity=0.418 Sum_probs=146.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..++|++.+.||+|+||.||+|+.. .+.|++|.+.... .......+.+|++++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4568999999999999999999862 3579999875432 2335677999999999999999999999999989
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK--------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~--------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
..|+||||+++++|.+++.... ..+++..+..++.|++.+|.|||+++|+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997643 15899999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCC--ceecCCCcccccchhccccc
Q 023285 253 GVARVQAQSG--VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 253 g~a~~~~~~~--~~~~~~gt~~y~aPEvl~~~ 282 (284)
|+++...... ......++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccC
Confidence 9987433221 22334567889999987654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=216.14 Aligned_cols=171 Identities=31% Similarity=0.448 Sum_probs=150.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|++|.||++... ++.+++|.+.... ..+....+.+|+.++++++||||+++++.+..+..+++++||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 6788899999999999999885 7899999987653 245567799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
+++++|.+++......+++..+..++.|++.+|+|||+ .|++|+||||+||++++++.++|+|||.+......... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 159 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-TF 159 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-cc
Confidence 99999999998755788999999999999999999999 99999999999999999999999999998765432222 26
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.++..|+|||.+.+..
T Consensus 160 ~~~~~y~~PE~~~~~~ 175 (265)
T cd06605 160 VGTSSYMAPERIQGND 175 (265)
T ss_pred cCChhccCHHHHcCCC
Confidence 7889999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=238.03 Aligned_cols=171 Identities=26% Similarity=0.449 Sum_probs=149.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.++||.|+||.||+|... ++.||||+++... ........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 357999999999999999999985 7899999997542 2345567789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
|||+.|++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 mEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~ 161 (669)
T cd05610 83 MEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161 (669)
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence 9999999999999763 568999999999999999999999999999999999999999999999999998654332 23
Q ss_pred ecCCCcccccchhccc
Q 023285 265 TAETGTYRWMAPEVAF 280 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~ 280 (284)
....+|+.|++||...
T Consensus 162 ~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 162 MDILTTPSMAKPKNDY 177 (669)
T ss_pred cccccCccccCccccc
Confidence 3457899999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=210.94 Aligned_cols=173 Identities=29% Similarity=0.459 Sum_probs=145.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 182 (284)
.+|+..+.||+|+||.||+|.. ++..|++|.++.... ..+....+.+|+.++++++||||+++++.+.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999986 568999999864422 22345678999999999999999999998875 3568
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++++||+++++|.+++.+. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 8999999999999999763 56889999999999999999999999999999999999999999999999998754321
Q ss_pred ---CceecCCCcccccchhcccccc
Q 023285 262 ---GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ---~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.......++..|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEG 185 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCC
Confidence 1122345889999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=214.23 Aligned_cols=171 Identities=29% Similarity=0.461 Sum_probs=143.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEE-----c
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT-----R 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~ 178 (284)
...++|++.+.||+|+||.||++.. +++.+|+|+++.. ......+.+|+.+++++ +||||+++++++. .
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3456899999999999999999987 5688999987643 22235678899999999 6999999999884 3
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
+...++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||.+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 45689999999999999988642 356888999999999999999999999999999999999999999999999999
Q ss_pred eeeccCC-ceecCCCcccccchhccc
Q 023285 256 RVQAQSG-VMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 256 ~~~~~~~-~~~~~~gt~~y~aPEvl~ 280 (284)
+...... ......|++.|+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred eecccCCCccccccCCCcccChhhhc
Confidence 8654322 223446899999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=210.85 Aligned_cols=172 Identities=33% Similarity=0.510 Sum_probs=149.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||.|+||.||+|.. ++..+++|++....... ....+.+|+.+++.++|+|++++++.+......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3689999999999999999987 56889999987543333 56789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce-
Q 023285 188 FMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM- 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~- 264 (284)
++++++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 999999999997642 46899999999999999999999999999999999999999999999999998765433221
Q ss_pred ----ecCCCcccccchhccccc
Q 023285 265 ----TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ----~~~~gt~~y~aPEvl~~~ 282 (284)
....|+..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccCChhhcChHHHccc
Confidence 234688999999998654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=210.68 Aligned_cols=172 Identities=30% Similarity=0.510 Sum_probs=145.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 182 (284)
.+|++.+.||+|+||.||+|.. +++.||+|.+.... ...+....+.+|+.++++++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999986 57899999875321 1234556799999999999999999999998764 458
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++|+||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 8999999999999999764 45889999999999999999999999999999999999999999999999999754321
Q ss_pred ---CceecCCCcccccchhccccc
Q 023285 262 ---GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ---~~~~~~~gt~~y~aPEvl~~~ 282 (284)
...+...++..|+|||.+.+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred ccCccccccCCcccccCHhhhcCC
Confidence 112345689999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=218.95 Aligned_cols=163 Identities=26% Similarity=0.477 Sum_probs=133.0
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcEEEEEEc
Q 023285 115 ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF 188 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lV~e~ 188 (284)
..+||+|+||.||+|+.. +..||+|.++.... ...+.+|+.++++++||||+++++++.. +..+++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 357999999999999863 36899999875422 2357789999999999999999998854 5678999999
Q ss_pred CCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEeccccee
Q 023285 189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (284)
Q Consensus 189 ~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli----~~~~~vkl~Dfg~a~ 256 (284)
+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 965 888887532 2347888999999999999999999999999999999999 566799999999998
Q ss_pred eeccCC----ceecCCCcccccchhccccc
Q 023285 257 VQAQSG----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPEvl~~~ 282 (284)
...... ......+|+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCC
Confidence 654321 12345689999999998763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=211.82 Aligned_cols=166 Identities=32% Similarity=0.569 Sum_probs=142.1
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 116 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
+.||+|++|.||+|.+.. ..||||.++..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998732 36999999766433 667889999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc----ee
Q 023285 191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MT 265 (284)
Q Consensus 191 ~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~----~~ 265 (284)
+++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||.++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997754 5689999999999999999999999999999999999999999999999999986543211 12
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...++..|+|||.+.+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~ 176 (257)
T cd05040 159 HLKVPFAWCAPESLRTRT 176 (257)
T ss_pred CCCCCceecCHHHhcccC
Confidence 235678999999987654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=217.18 Aligned_cols=175 Identities=31% Similarity=0.566 Sum_probs=145.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+...+|+..+.||+|+||.||+|.+ .+. .||+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 3456788999999999999999986 333 57999886542 334455789999999999999999999998764
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++++||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 57799999999999999987666789999999999999999999999999999999999999999999999999986543
Q ss_pred CCc---eecCCCcccccchhcccccc
Q 023285 261 SGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
... .....++..|+|||.+.+..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRK 187 (303)
T ss_pred cccccccCCCccccccCCHHHhccCC
Confidence 221 11233567899999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=224.12 Aligned_cols=180 Identities=23% Similarity=0.342 Sum_probs=158.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP 179 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 179 (284)
.....+....|++.++||+||.+.||++... .+.+|+|.+.....+.....-|.+|+.+|.+|+ |.+|++++++-..+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3578899999999999999999999999875 477888888766678888999999999999997 89999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
+.+|+||||-+- +|..+|.+.....+...++.+..||+.++.++|+.||||.||||+|+|+ -.|.+||+|||+|....
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 999999998754 9999998876666656899999999999999999999999999999999 57899999999998765
Q ss_pred cCC---ceecCCCcccccchhcccccc
Q 023285 260 QSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
... .....+||+.|||||.+....
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~ 537 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMS 537 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhcc
Confidence 432 345678999999999987654
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=214.16 Aligned_cols=172 Identities=24% Similarity=0.429 Sum_probs=143.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|++|.||+|.. +++.||+|.++...........+.+|+.++++++||||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999987 46889999986544344445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeeccC-Cce
Q 023285 188 FMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|+++ +|.+++..... .+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||.+...... ...
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 9964 88888765432 3678888999999999999999999999999999999985 567999999999754322 122
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
+...+++.|+|||++.+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 161 THEVVTLWYRAPEILLGS 178 (294)
T ss_pred ccCceeecccCHHHHhCC
Confidence 344678999999988653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=222.19 Aligned_cols=178 Identities=24% Similarity=0.383 Sum_probs=154.3
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 181 (284)
.|...+|.+...||.|+||.|-+|...+ +-+|||+++.+.. +++..+--+.|-++|.... -|.+++++..|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 5778899999999999999999998755 6799999987643 3444455567777877664 5889999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||+.||+|.-.+++ -+.+.++.+..++.+|+-||-+||++|||+||||.+||++|.+|++||+|||+++..--.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999888865 588999999999999999999999999999999999999999999999999999875443
Q ss_pred C-ceecCCCcccccchhccccccC
Q 023285 262 G-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+ ...+.+|||.|+|||++.-+.|
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPY 527 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPY 527 (683)
T ss_pred CcceeeecCCCcccccceEEeccc
Confidence 3 3446789999999999998876
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=212.02 Aligned_cols=164 Identities=24% Similarity=0.457 Sum_probs=135.1
Q ss_pred eeeecCceEEEEEEEC-C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYGDLYKGTYC-S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.||+|+||.||+|... + ..+++|.++... .....+.+.+|+.+++.++||||+++++.|......|+||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999752 2 346677765432 2345678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---ceec
Q 023285 193 SIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTA 266 (284)
Q Consensus 193 sL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~ 266 (284)
+|.+++.+.. ...+...+..++.||+.||+|||+++++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997632 345667788999999999999999999999999999999999999999999986432211 1234
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..++..|+|||++.+
T Consensus 161 ~~~~~~y~aPE~~~~ 175 (268)
T cd05086 161 KCVPLRWLAPELVGE 175 (268)
T ss_pred CcCcccccCchhccc
Confidence 467899999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=233.72 Aligned_cols=167 Identities=28% Similarity=0.486 Sum_probs=142.5
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCC--CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc--EEEE
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE--CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIV 185 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lV 185 (284)
.++...||+|+|-+||+|.+. |-.||--.++.. ...++..++|..|+.+|+.|+||||+++|..+.+..+ +.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 477889999999999999873 555554333322 2245567899999999999999999999999987665 8899
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEec-CCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+|.|..|+|..|+.+. +.++.+.++.|++||++||.|||++ -|||||||.+||+|+ ..|.|||+|+|+|.....+.
T Consensus 122 TEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999999874 6789999999999999999999988 699999999999997 66899999999999877654
Q ss_pred ceecCCCcccccchhccc
Q 023285 263 VMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~ 280 (284)
.. ...|||-|||||+..
T Consensus 201 ak-svIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 201 AK-SVIGTPEFMAPEMYE 217 (632)
T ss_pred cc-eeccCccccChHHHh
Confidence 33 378999999999976
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=216.26 Aligned_cols=173 Identities=29% Similarity=0.473 Sum_probs=149.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+...+|++.+.||+|+||.||++... ++.||+|++.... .......+.+|+++++.++||||+++++.+.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 34568999999999999999999874 7889999886542 34456789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||||+++++|.+++.+ .+.+++..+..++.+++.+|.|||+ .+++||||+|+||++++++.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-c
Confidence 9999999999999876 4578999999999999999999997 59999999999999999999999999998754322 1
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.....|+..|+|||++.+.
T Consensus 159 ~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred cCccccCcccCCHHHHccC
Confidence 2345789999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=213.75 Aligned_cols=166 Identities=25% Similarity=0.358 Sum_probs=142.2
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||+|+||.||++.. +++.||+|.+...... ......+..|+.++++++|||++++++.+......|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 4789999998643222 23345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccc
Q 023285 195 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273 (284)
Q Consensus 195 ~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y 273 (284)
.+++.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997643 36899999999999999999999999999999999999999999999999998765443334455788899
Q ss_pred cchhcccccc
Q 023285 274 MAPEVAFTFF 283 (284)
Q Consensus 274 ~aPEvl~~~~ 283 (284)
+|||++.+..
T Consensus 161 ~~PE~~~~~~ 170 (277)
T cd05577 161 MAPEVLQGEV 170 (277)
T ss_pred CCHHHhcCCC
Confidence 9999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=209.86 Aligned_cols=167 Identities=31% Similarity=0.500 Sum_probs=137.6
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE-cCCcEEEEEEcC
Q 023285 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLCIVTEFM 189 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lV~e~~ 189 (284)
+.||+|+||.||+|... +..||||.+... ........+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999862 257999987532 23445678899999999999999999999876 455689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-----e
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----M 264 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-----~ 264 (284)
.+++|.+++.+.....++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 99999999987656678888899999999999999999999999999999999999999999999975432211 1
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....+++.|+|||.+.+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~ 178 (262)
T cd05058 160 TGAKLPVKWMALESLQTQK 178 (262)
T ss_pred ccCcCCccccChhHhccCc
Confidence 1234577899999886543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=212.93 Aligned_cols=169 Identities=27% Similarity=0.475 Sum_probs=146.6
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEEEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTE 187 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~e 187 (284)
|++.+.||+|++|.||+|... ++.+|+|.++...........+.+|+.++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999874 58999999976543344556788999999999999999999999988 78999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--cee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~~~ 265 (284)
|+++ +|.+++......+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+....... ..+
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9975 9999987755679999999999999999999999999999999999999999999999999998665433 233
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...++..|+|||.+.+
T Consensus 160 ~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 160 NRVITLWYRPPELLLG 175 (287)
T ss_pred ccccccccCCceeeEc
Confidence 4467889999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=212.73 Aligned_cols=169 Identities=33% Similarity=0.565 Sum_probs=143.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP------ 179 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------ 179 (284)
.+.|++.+.||+|+||.||+|.. .++.||+|++.... .....+.+|+.+++++ +|+|++++++.+...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34688889999999999999987 46889999986432 2235688999999998 699999999998753
Q ss_pred CcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||++++++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4589999999999999999764 356899999999999999999999999999999999999999999999999999865
Q ss_pred ccC-CceecCCCcccccchhccc
Q 023285 259 AQS-GVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 259 ~~~-~~~~~~~gt~~y~aPEvl~ 280 (284)
... .......|++.|+|||++.
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred ccccccCCcccccccccCHhHhc
Confidence 432 2233457899999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=209.31 Aligned_cols=165 Identities=32% Similarity=0.542 Sum_probs=138.0
Q ss_pred eeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 116 CKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
++||+|+||.||+|.+. + ..+|+|.++..... ...+.+.+|+.+++++.|+|++++++++.. ...++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46999999999999863 2 57999998765433 456779999999999999999999998764 56899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce----ec
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TA 266 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~----~~ 266 (284)
+++|.+++.+. ..+++..+..++.|++.+|+|||+.+++|+||||+||+++.++.+||+|||.++........ ..
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999764 47899999999999999999999999999999999999999999999999999865332211 11
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..++..|+|||.+.+..
T Consensus 158 ~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 158 GRWPLKWYAPECINYGK 174 (257)
T ss_pred ccccccccCHHHhcCCC
Confidence 22356899999887653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=208.45 Aligned_cols=170 Identities=32% Similarity=0.464 Sum_probs=150.0
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|++|.||+|+.. ++.|++|++...... .....+.+|+..+.+++|+|++++++++......++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 6888999999999999999884 789999998765322 5567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee-c
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT-A 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~-~ 266 (284)
+++++|.+++... ..+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 9999999999764 678999999999999999999999 999999999999999999999999999998665433222 4
Q ss_pred CCCcccccchhccccc
Q 023285 267 ETGTYRWMAPEVAFTF 282 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~ 282 (284)
..++..|+|||.+.+.
T Consensus 160 ~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 160 FVGTVTYMSPERIQGE 175 (264)
T ss_pred eeecccccCHhhhCCC
Confidence 4678999999988664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=214.05 Aligned_cols=170 Identities=22% Similarity=0.382 Sum_probs=144.8
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcE
Q 023285 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 182 (284)
.|++.+.||.|+||.||++.. +++.||+|+++.... .....+.+.+|+.+++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999876 568899999875322 122346688999999999 589999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 9999999999999999764 568899999999999999999999999999999999999999999999999997643321
Q ss_pred --ceecCCCcccccchhcccc
Q 023285 263 --VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 --~~~~~~gt~~y~aPEvl~~ 281 (284)
......|+..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred ccccccccCCcccCChhhccC
Confidence 1223468899999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-28 Score=211.68 Aligned_cols=167 Identities=26% Similarity=0.418 Sum_probs=141.8
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcC--CcEEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP--PNLCIVT 186 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lV~ 186 (284)
|++.++||+|+||.||+|.. +++.||+|.++........ ....+|+.+++++. |+|++++++++.++ ..+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999987 5689999998754322222 34457888999886 99999999999987 8899999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+++ +|.+++......+++..+..++.|++.||+|||+.|++||||+|+||+++. +.+||+|||.++........+.
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 99975 899988776667999999999999999999999999999999999999999 9999999999986654444445
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..+++.|+|||++.+
T Consensus 158 ~~~~~~y~aPE~~~~ 172 (282)
T cd07831 158 YISTRWYRAPECLLT 172 (282)
T ss_pred CCCCcccCChhHhhc
Confidence 568999999997643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=205.45 Aligned_cols=171 Identities=32% Similarity=0.510 Sum_probs=152.4
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~ 186 (284)
+|+..+.||+|++|.||+|... ++.|++|++..........+.+.+|+.++++++|+||+++++.+... ..+++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999885 78999999876654456678899999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--- 263 (284)
||+++++|.+++.+. ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999775 4889999999999999999999999999999999999999999999999999987665543
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.....++..|+|||.+.+.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred ccCCCCCccccCHhhhcCC
Confidence 3456789999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=211.51 Aligned_cols=171 Identities=32% Similarity=0.547 Sum_probs=147.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
..|+..+.||.|+||.||+|.. +++.||||+++... .......+.+|+.+++++.|+||+++++.+.++...|+|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577888999999999999987 46899999987442 24456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|+++++|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999999864 468899999999999999999999999999999999999999999999999997654332 1233
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..++..|+|||++.+..
T Consensus 161 ~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 161 FVGTPFWMAPEVIQQSA 177 (277)
T ss_pred ccCcccccCHhHhccCC
Confidence 46788999999987653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=211.23 Aligned_cols=171 Identities=30% Similarity=0.531 Sum_probs=145.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+|.+.+.||+|+||.||+|.. +++.+|+|.++.... .....+.+.+|+.++++++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999976 578999998863211 1123456889999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||+++++|.+++.+. +.++...+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999774 6789999999999999999999999999999999999999999999999999975432
Q ss_pred CC---ceecCCCcccccchhccccc
Q 023285 261 SG---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~---~~~~~~gt~~y~aPEvl~~~ 282 (284)
.. ......++..|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSY 185 (272)
T ss_pred cccccccccccCCccccCHHHhccc
Confidence 21 12234588999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-28 Score=205.58 Aligned_cols=171 Identities=35% Similarity=0.582 Sum_probs=151.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|++|.||++.. .++.|++|.+............+.+|++++++++|+|++++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478899999999999999987 467899999987655556677899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-eecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-~~~~ 267 (284)
+++++|.+++... +.+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9999999999764 6789999999999999999999999999999999999999999999999999987654322 2345
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.++..|+|||.+.+.
T Consensus 160 ~~~~~y~~pe~~~~~ 174 (254)
T cd06627 160 VGTPYWMAPEVIEMS 174 (254)
T ss_pred ccchhhcCHhhhcCC
Confidence 688999999987654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=213.76 Aligned_cols=171 Identities=24% Similarity=0.400 Sum_probs=142.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCc-----
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN----- 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 181 (284)
++|++.+.||+|+||.||+|.. +++.||||.++...........+.+|+.+++++. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688999999999999999987 4689999998754333334467888999999996 6999999999887665
Q ss_pred EEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEeccccee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR 256 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~ 256 (284)
.|+||||+++ +|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+||+++. ++.++|+|||.++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 8999886532 35799999999999999999999999999999999999998 8999999999987
Q ss_pred eeccC-CceecCCCcccccchhcccc
Q 023285 257 VQAQS-GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 257 ~~~~~-~~~~~~~gt~~y~aPEvl~~ 281 (284)
..... ...+...+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhC
Confidence 54322 22334467889999998865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=216.08 Aligned_cols=171 Identities=26% Similarity=0.456 Sum_probs=142.2
Q ss_pred CceeeeeeeecCceEEEEEEE----CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 183 (284)
+|++.++||+|+||.||+|.. .++.||+|.+.... ........+.+|+.++++++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999987 45899999997642 1223345678899999999999999999999988 7899
Q ss_pred EEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC----CCcEEEecccce
Q 023285 184 IVTEFMARGSIYDFLHKQ----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----NGVVKVADFGVA 255 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~----~~~vkl~Dfg~a 255 (284)
+||||+++ +|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777776532 136889999999999999999999999999999999999999 899999999999
Q ss_pred eeeccCCc----eecCCCcccccchhccccc
Q 023285 256 RVQAQSGV----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~~~~----~~~~~gt~~y~aPEvl~~~ 282 (284)
+....... .....+++.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCC
Confidence 86533221 2234678899999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=215.85 Aligned_cols=173 Identities=25% Similarity=0.460 Sum_probs=146.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----- 180 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 180 (284)
..++|++.+.||+|+||.||+|.. +++.||+|.++...........+.+|+.++++++|||++++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456899999999999999999998 4688999999765433444456788999999999999999999987655
Q ss_pred -----cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 181 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.+++|+||+++ ++.+++......+++..+..++.|++.||.|||+.||+|+||||+||++++++.+||+|||.+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 79999999976 888888765567999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCC--ceecCCCcccccchhcccc
Q 023285 256 RVQAQSG--VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~--~~~~~~gt~~y~aPEvl~~ 281 (284)
....... ......++..|+|||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcC
Confidence 8654332 1223356788999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=214.82 Aligned_cols=166 Identities=25% Similarity=0.399 Sum_probs=139.9
Q ss_pred cee-eeeeeecCceEEEEEE--ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEE
Q 023285 112 LKI-ECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 112 ~~~-~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e 187 (284)
|++ .+.||+|+|+.|--+. .++.++|||++... ......+..+|++++.+++ |+||++++++|.++.++|+|||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE 156 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE 156 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence 444 3578999999988664 47899999998654 3445678899999999997 9999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEecccceeeeccC---
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQS--- 261 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~Dfg~a~~~~~~--- 261 (284)
-|.||+|...+.++ ..|++.++.++..+|+.||.|||.+||.|||+||+|||....+ -||||||.++.-+...
T Consensus 157 Km~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred cccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999999999874 6799999999999999999999999999999999999997554 4899999987643211
Q ss_pred -----CceecCCCcccccchhccc
Q 023285 262 -----GVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 262 -----~~~~~~~gt~~y~aPEvl~ 280 (284)
....+.+|+-.||||||..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCccccCcccchhhcchhHHh
Confidence 1223457888999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=214.39 Aligned_cols=161 Identities=22% Similarity=0.401 Sum_probs=137.2
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+.||+|+||.||+|... ...+++|.+... .....+.+.+|+.+++.++|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36899999999999763 234888887533 2344567899999999999999999999999989999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--------EEEecccceeee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------VKVADFGVARVQ 258 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~--------vkl~Dfg~a~~~ 258 (284)
||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876667899999999999999999999999999999999999987765 699999988654
Q ss_pred ccCCceecCCCcccccchhcccc
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.. .....+++.|+|||++.+
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 159 LP---KEILLERIPWVPPECIEN 178 (258)
T ss_pred CC---chhccccCCccCchhccC
Confidence 32 233467889999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=213.67 Aligned_cols=171 Identities=25% Similarity=0.468 Sum_probs=146.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||.|++|.||+|.. +++.||||.++...........+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 578999999875544444456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 189 ~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
+. ++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 5899988664 356899999999999999999999999999999999999999999999999998754322 12233
Q ss_pred CCCcccccchhccccc
Q 023285 267 ETGTYRWMAPEVAFTF 282 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~ 282 (284)
..+++.|+|||++.+.
T Consensus 160 ~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 160 EVVTLWYRAPEILLGC 175 (284)
T ss_pred ccccccccCCeEEecC
Confidence 4578899999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=228.68 Aligned_cols=165 Identities=28% Similarity=0.517 Sum_probs=145.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCC
Q 023285 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gs 193 (284)
-.||+|.||+||-|+.. ....|||-+... +.+..+-+..|+.+-++++|.|||+++|.+..++.+-|.||-.+|||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 37999999999999874 456789987533 44556779999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEecccceeeeccCC-ceecCCC
Q 023285 194 IYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSG-VMTAETG 269 (284)
Q Consensus 194 L~~~l~~~~~~~--~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~~-~~~~~~g 269 (284)
|.+++...-+++ ++.++..+..||+.||.|||++.|+|||||-+|+|++ ..|.+||+|||-++....-. ...+.+|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 999998877777 7889999999999999999999999999999999997 78999999999998765433 4457799
Q ss_pred cccccchhccccc
Q 023285 270 TYRWMAPEVAFTF 282 (284)
Q Consensus 270 t~~y~aPEvl~~~ 282 (284)
|..|||||+|-..
T Consensus 739 TLQYMAPEvIDqG 751 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQG 751 (1226)
T ss_pred chhhhChHhhccC
Confidence 9999999998654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=210.94 Aligned_cols=169 Identities=27% Similarity=0.509 Sum_probs=144.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.++||.|++|.||+|+. +++.||||.++.... ......+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 488999999999999999998 478899999875432 22345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 189 ~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||.++..... ....
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 985 8999886543 46899999999999999999999999999999999999999999999999999754332 1223
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+++.|+|||++.+
T Consensus 159 ~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 159 NEVVTLWYRAPDVLLG 174 (284)
T ss_pred cccccccccChHHhcC
Confidence 4567889999998865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=212.83 Aligned_cols=167 Identities=31% Similarity=0.509 Sum_probs=145.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+.|++.+.||+|+||.||+|.. +++.||+|.+.... ...+..+.+.+|+.+++.++|||++++++++......|+|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4688999999999999999987 57899999986432 23445567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+.| ++.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 99974 888888765667999999999999999999999999999999999999999999999999998765432 34
Q ss_pred CCCcccccchhccc
Q 023285 267 ETGTYRWMAPEVAF 280 (284)
Q Consensus 267 ~~gt~~y~aPEvl~ 280 (284)
..+++.|+|||++.
T Consensus 171 ~~~~~~y~aPE~~~ 184 (307)
T cd06607 171 FVGTPYWMAPEVIL 184 (307)
T ss_pred ccCCccccCceeee
Confidence 56889999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=216.22 Aligned_cols=174 Identities=25% Similarity=0.411 Sum_probs=145.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPN 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 181 (284)
...|+....||+|.||.||+|... ...+|||.++.+...........+|+.+++.++|||++.+..++-+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 347889999999999999999542 2379999998764333344567889999999999999999998877 778
Q ss_pred EEEEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----CcEEEeccc
Q 023285 182 LCIVTEFMARGSIYDFLHKQ----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFG 253 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~----~~vkl~Dfg 253 (284)
+++++||.+. +|...++-. ...++...++.|+.||+.|+.|||++=|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999987 999988643 2468899999999999999999999999999999999999876 899999999
Q ss_pred ceeeeccCCc----eecCCCcccccchhcccccc
Q 023285 254 VARVQAQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 254 ~a~~~~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
+|+....+-. ....+-|.+|+|||++.|.+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 9997554321 12335799999999999864
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=204.08 Aligned_cols=170 Identities=36% Similarity=0.599 Sum_probs=150.6
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|.+.+.||+|++|.||++... ++.+++|++..... .....+.+|+.++++++|+|++++++.+..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999984 78899999875432 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 268 (284)
+++++|.+++......+++..+..++.|++.+|.+||++|++|+||+|+||++++++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99999999998765679999999999999999999999999999999999999999999999999998765443234557
Q ss_pred Ccccccchhccccc
Q 023285 269 GTYRWMAPEVAFTF 282 (284)
Q Consensus 269 gt~~y~aPEvl~~~ 282 (284)
++..|+|||.+.+.
T Consensus 159 ~~~~~~~PE~~~~~ 172 (253)
T cd05122 159 GTPYWMAPEVINGK 172 (253)
T ss_pred cCCcccCHHHHcCC
Confidence 88999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-28 Score=209.13 Aligned_cols=169 Identities=33% Similarity=0.559 Sum_probs=146.1
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
-|++.+.||.|+||.||+|.. ++..||||++.... .......+.+|+.++++++||||+++++.+..+...|+||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 477888999999999999976 46899999986432 234456799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. ..+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999864 468999999999999999999999999999999999999999999999999987654322 12334
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.++..|+|||.+.+.
T Consensus 162 ~~~~~y~~PE~~~~~ 176 (277)
T cd06641 162 VGTPFWMAPEVIKQS 176 (277)
T ss_pred cCCccccChhhhccC
Confidence 688899999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=209.84 Aligned_cols=168 Identities=29% Similarity=0.541 Sum_probs=146.0
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV 185 (284)
.|++.+.||+|+||.||+|.. +++.||+|.++... .......+.+|+.++++++ |||++++++++......|+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477888999999999999987 56899999987542 3344567889999999997 99999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
|||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999999999999865 468999999999999999999999999999999999999999999999999998654432 23
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....|+..|+|||.+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 159 STFVGTPYWMAPEVITE 175 (277)
T ss_pred ccccCCcceeCHHHhcc
Confidence 34578999999998864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=209.74 Aligned_cols=167 Identities=26% Similarity=0.371 Sum_probs=141.3
Q ss_pred Cceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEc----CCcE
Q 023285 111 QLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PPNL 182 (284)
Q Consensus 111 ~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~ 182 (284)
+|++. ++||-|-.|.|-.+.. +++.+|+|++... ....+|+++--.. .|||||++++++.+ ...+
T Consensus 62 dY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 62 DYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 44443 4789999999998866 5789999998632 3456788875544 59999999998865 3468
Q ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeee
Q 023285 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQ 258 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~ 258 (284)
.+|||+|+||.|++-+..++ ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|.. .|..+||+|||+|+..
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 89999999999999998753 4699999999999999999999999999999999999996 4568999999999987
Q ss_pred ccCCceecCCCcccccchhccccccC
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......+.+.||.|.|||++...+|
T Consensus 215 ~~~~~L~TPc~TPyYvaPevlg~eKy 240 (400)
T KOG0604|consen 215 QEPGDLMTPCFTPYYVAPEVLGPEKY 240 (400)
T ss_pred CCCccccCCcccccccCHHHhCchhc
Confidence 76667778899999999999988876
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=208.06 Aligned_cols=172 Identities=28% Similarity=0.492 Sum_probs=150.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.++||+|+||.||++.. +++.+++|.++...........+.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478899999999999999977 468899999876554555667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 189 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 189 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9999999998662 356889999999999999999999999999999999999999999999999999876554 333
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...+++.|+|||.+.+..
T Consensus 160 ~~~~~~~~~~Pe~~~~~~ 177 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRP 177 (256)
T ss_pred cccCCccccCHHHHCCCC
Confidence 456889999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=213.66 Aligned_cols=170 Identities=32% Similarity=0.547 Sum_probs=146.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.|+..+.||+|+||.||+|.. +++.||+|.++... .......+.+|+.++++++||||+++++.+..+...|+||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 577788899999999999987 46789999987442 234556799999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++....... .....
T Consensus 84 ~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 84 LGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999999854 568999999999999999999999999999999999999999999999999997654332 12234
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.++..|+|||.+.+..
T Consensus 162 ~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 162 VGTPFWMAPEVIKQSA 177 (277)
T ss_pred cCcccccCHHHhCcCC
Confidence 6889999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=216.06 Aligned_cols=169 Identities=28% Similarity=0.455 Sum_probs=143.9
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.|.....||+|+||.||++.. ++..||||.+... .......+.+|+.++++++|+|++++++.+...+..|+||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344467799999999999987 5789999998643 334456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||++++++.++|+|||++....... .....
T Consensus 101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 999999998854 458999999999999999999999999999999999999999999999999987543221 22335
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.+++.|+|||++.+..
T Consensus 179 ~~~~~y~aPE~~~~~~ 194 (292)
T cd06658 179 VGTPYWMAPEVISRLP 194 (292)
T ss_pred ecCccccCHHHHccCC
Confidence 6889999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=208.45 Aligned_cols=171 Identities=29% Similarity=0.417 Sum_probs=145.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lV~ 186 (284)
+|...++||.|++|.||++.. +++.+|+|.+.... .......+.+|++++++++||||+++++++... ..+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 688899999999999999988 46899999987542 234567799999999999999999999988653 4689999
Q ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 99999999998754 24568899999999999999999999999999999999999999999999999987544322
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....++..|+|||.+.+..
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~ 179 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKP 179 (287)
T ss_pred cccccCCccccCHHHhcCCC
Confidence 22446788999999987654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=211.47 Aligned_cols=178 Identities=25% Similarity=0.408 Sum_probs=149.9
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP 179 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 179 (284)
..|.++.++|++.+.||+|+||.||+|.+. ++.||||.++.... ......+..|+.++.+.. |+||+++++++...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 356777889999999999999999999985 78999999875432 233455667777666665 99999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...|+||||+.+ ++.+++....+.+++..+..++.|++.||.|||+ .||+||||+|+||++++++.++|+|||.+...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999854 8888887656688999999999999999999997 59999999999999999999999999999765
Q ss_pred ccCCceecCCCcccccchhccccc
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
..........+++.|+|||.+.+.
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCC
Confidence 544444455688899999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-28 Score=209.40 Aligned_cols=163 Identities=26% Similarity=0.409 Sum_probs=133.9
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCHH-HHHHHHHHHHHHH---hCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMR---KIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
.||+|+||.||++.. +++.+|+|.+........ ....+.+|..+++ ...|||++.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 468999999865433222 2233445554444 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCc
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 270 (284)
+++|.+++.. .+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence 9999999876 456999999999999999999999999999999999999999999999999998754332 22345689
Q ss_pred ccccchhcccc
Q 023285 271 YRWMAPEVAFT 281 (284)
Q Consensus 271 ~~y~aPEvl~~ 281 (284)
+.|+|||.+.+
T Consensus 159 ~~y~aPE~~~~ 169 (279)
T cd05633 159 HGYMAPEVLQK 169 (279)
T ss_pred cCccCHHHhcC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=211.42 Aligned_cols=171 Identities=29% Similarity=0.476 Sum_probs=147.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||++.. ++..|++|.+... .......+.+|+.++++++|||++++++.+......|+|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 36899999999999999999976 5688999998643 2233467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99999999999865 357889999999999999999999999999999999999999999999999887543322 223
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...+++.|+|||.+.+..
T Consensus 174 ~~~~~~~y~~PE~~~~~~ 191 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKA 191 (293)
T ss_pred cccCChhhcCchhhccCC
Confidence 346889999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=207.65 Aligned_cols=170 Identities=31% Similarity=0.492 Sum_probs=145.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCC-----
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP----- 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~----- 180 (284)
.++|++.+.||+|++|.||+|.. +++.+++|++.... .....+.+|+.+++++ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46899999999999999999988 45789999987542 2346789999999999 6999999999997644
Q ss_pred -cEEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 181 -NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 181 -~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.+|+||||+++++|.+++... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999999998653 3678999999999999999999999999999999999999999999999999987
Q ss_pred eeccCC-ceecCCCcccccchhcccc
Q 023285 257 VQAQSG-VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPEvl~~ 281 (284)
...... ......++..|+|||++..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcc
Confidence 654322 2234568999999998754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=216.38 Aligned_cols=162 Identities=17% Similarity=0.196 Sum_probs=128.2
Q ss_pred eccCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCceee-EEeEEEcC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQ-FIGACTRP 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~ 179 (284)
.-...|.+.+.||+|+||.||+|.+ +++.||||++..... .......|.+|++++++++|+|++. +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 4456899999999999999999987 356789998753311 2334567999999999999999985 4432
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di-kp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...|+||||++|++|.. +.. . . ...++.+++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+..
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~~-~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-ARP-H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CCcEEEEEccCCCCHHH-hCc-c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 45799999999999963 211 1 1 1467889999999999999999999 999999999999999999999865
Q ss_pred ccCCce---------ecCCCcccccchhccc
Q 023285 259 AQSGVM---------TAETGTYRWMAPEVAF 280 (284)
Q Consensus 259 ~~~~~~---------~~~~gt~~y~aPEvl~ 280 (284)
...+.. +...+++.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 443311 2345788899999875
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=207.41 Aligned_cols=173 Identities=23% Similarity=0.434 Sum_probs=147.0
Q ss_pred CceeeeeeeecCceEEEEEEEC---CceEEEEEecCCC--------CCHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPEC--------VNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR 178 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 178 (284)
.|++.+.||+|+||.||+|... ++.+|+|.+.... .......++.+|+.++++ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 3778899999999999999874 4789999885332 233455678889998875 789999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccc
Q 023285 179 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
++..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998854 34568999999999999999999996 6899999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.............++..|+|||.+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 189 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEP 189 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCC
Confidence 98765544445667899999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-28 Score=210.70 Aligned_cols=170 Identities=26% Similarity=0.453 Sum_probs=145.2
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|++.+.||.|++|.||+|.. +++.||+|++............+.+|+.++++++|||++++++++......|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999987 5789999998755433444567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecC
Q 023285 190 ARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (284)
Q Consensus 190 ~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~ 267 (284)
+ ++|.+++.... ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.++..... ......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 5 59999997643 36899999999999999999999999999999999999999999999999999754322 122334
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.+++.|+|||++.+.
T Consensus 160 ~~~~~~~aPE~~~~~ 174 (283)
T cd07835 160 VVTLWYRAPEILLGS 174 (283)
T ss_pred ccccCCCCCceeecC
Confidence 678899999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=215.07 Aligned_cols=172 Identities=28% Similarity=0.469 Sum_probs=145.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP- 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 180 (284)
.|.+ .++|++.+.||+|+||.||+|.. ++..||||+++...........+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3544 45799999999999999999986 4689999998654434445567889999999999999999999987654
Q ss_pred -----cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 181 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999 6799988854 56899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
...... .....+++.|+|||++.+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhC
Confidence 765432 234467899999998865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-28 Score=215.15 Aligned_cols=168 Identities=26% Similarity=0.505 Sum_probs=141.6
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----cE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 182 (284)
++|++.+.||+|+||.||+|.. +++.||||.++... .......+.+|+.++++++|+||+++++++.... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 5799999999999999999986 57899999986432 2344567889999999999999999999876543 47
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+|+||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 999999975 88888754 468999999999999999999999999999999999999999999999999997643322
Q ss_pred ----ceecCCCcccccchhcccc
Q 023285 263 ----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ----~~~~~~gt~~y~aPEvl~~ 281 (284)
......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhC
Confidence 1223468899999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-27 Score=208.14 Aligned_cols=170 Identities=31% Similarity=0.485 Sum_probs=143.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcC-----C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP-----P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~ 180 (284)
.++|.+.+.||+|+||.||++.. +++.+|+|++... ......+.+|+.+++++ +|||++++++++... .
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 46799999999999999999987 4689999998643 22235677899999999 799999999998753 3
Q ss_pred cEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 181 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
..|+||||+++++|.+++.. ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 58999999999999998864 245689999999999999999999999999999999999999999999999999876
Q ss_pred eccCC-ceecCCCcccccchhcccc
Q 023285 258 QAQSG-VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 258 ~~~~~-~~~~~~gt~~y~aPEvl~~ 281 (284)
..... ......|+..|+|||++.+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred cccccccccCccCCccccChhhhcC
Confidence 44322 2234468899999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-27 Score=207.26 Aligned_cols=171 Identities=26% Similarity=0.478 Sum_probs=144.3
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEcCCc-----
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPN----- 181 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 181 (284)
|++.+.||+|+||.||+|... ++.||+|.++...........+.+|+.+++++ +|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999984 68999999975543344445677788877766 59999999999988776
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
++++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 8999887643 3689999999999999999999999999999999999999999999999999987655
Q ss_pred CCceecCCCcccccchhcccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
........++..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~ 182 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSS 182 (287)
T ss_pred CcccccccccccccChHHhccCC
Confidence 44334456789999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=214.78 Aligned_cols=169 Identities=28% Similarity=0.420 Sum_probs=143.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.|.....||+|+||.||+|.. +++.||+|.+.... ......+.+|+.+++.++|||++++++.+..+...|+|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 344455799999999999976 57899999986432 22345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 177 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 177 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence 999999998754 458999999999999999999999999999999999999999999999999987543321 22345
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.+++.|+|||++.+..
T Consensus 178 ~~~~~y~aPE~~~~~~ 193 (297)
T cd06659 178 VGTPYWMAPEVISRTP 193 (297)
T ss_pred ecCccccCHHHHccCC
Confidence 6899999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-28 Score=226.06 Aligned_cols=169 Identities=33% Similarity=0.538 Sum_probs=145.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEc-----CCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR-----PPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-----~~~ 181 (284)
..+.|.+.||.|.+|.||+++. +++.+|+|++.+.. +...+...|..+++... |||++.++|++.. ++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3567899999999999998865 67899999987653 33356778889998885 8999999999853 467
Q ss_pred EEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+|+|||||.|||.-|++.+. ..++.+..+..|++.++.|+.+||++.+||||||-.|||++.++.|||+|||++...+.
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999999774 46799999999999999999999999999999999999999999999999999876543
Q ss_pred -CCceecCCCcccccchhcccc
Q 023285 261 -SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 -~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.....+.+|||.||||||+.-
T Consensus 176 T~grRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred ccccccCcCCCcccccceeeec
Confidence 334566789999999999853
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=207.12 Aligned_cols=171 Identities=29% Similarity=0.489 Sum_probs=141.6
Q ss_pred ceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 112 LKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
|++.+.||+|+||.||+|.. +++.||||+++.........+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 2578999999876656666778999999999999999999999886532
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
..++++||+.+|+|.+++... ...++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247899999999999887532 124788899999999999999999999999999999999999999999999999
Q ss_pred eeeccCC---ceecCCCcccccchhccccc
Q 023285 256 RVQAQSG---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~~~---~~~~~~gt~~y~aPEvl~~~ 282 (284)
+...... ......+++.|++||.+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADN 190 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcC
Confidence 8643221 11233456789999987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=206.08 Aligned_cols=172 Identities=27% Similarity=0.484 Sum_probs=146.5
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
+|++.+.||+|+||.||+|.. .+..+|+|.+..........+.+.+|+.++++++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999988 468899999865433334456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCCc-ee
Q 023285 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-MT 265 (284)
Q Consensus 189 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~~-~~ 265 (284)
+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||++++++ .++|+|||.+........ ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999997643 3578999999999999999999999999999999999999876 569999999876543321 22
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...|++.|+|||++.+.
T Consensus 161 ~~~~~~~~~ape~~~~~ 177 (257)
T cd08225 161 TCVGTPYYLSPEICQNR 177 (257)
T ss_pred ccCCCccccCHHHHcCC
Confidence 34689999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=215.85 Aligned_cols=170 Identities=26% Similarity=0.419 Sum_probs=144.7
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-----CcE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PNL 182 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 182 (284)
.+|++.+.||+|+||.||+|.. +++.||||.++...........+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999987 478999999875433344456778899999999999999999988654 348
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
|+|+||+. ++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 99999996 599998865 467999999999999999999999999999999999999999999999999999865433
Q ss_pred CceecCCCcccccchhcccc
Q 023285 262 GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~ 281 (284)
.......++..|+|||++.+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccccccccccCccChHHHhc
Confidence 23344568899999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=207.93 Aligned_cols=163 Identities=26% Similarity=0.383 Sum_probs=134.0
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHH---HHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVY---IMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
.||+|+||.||+|.. +++.||+|.+....... .....+..|.. +++...||||+.+++.+......|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999876 46899999986543321 22222344443 4445679999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCc
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt 270 (284)
|++|.+++.. .+.+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++...... ......|+
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence 9999998865 467999999999999999999999999999999999999999999999999998754332 22345789
Q ss_pred ccccchhcccc
Q 023285 271 YRWMAPEVAFT 281 (284)
Q Consensus 271 ~~y~aPEvl~~ 281 (284)
..|+|||++.+
T Consensus 159 ~~y~aPE~~~~ 169 (278)
T cd05606 159 HGYMAPEVLQK 169 (278)
T ss_pred cCCcCcHHhcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=223.75 Aligned_cols=150 Identities=21% Similarity=0.378 Sum_probs=133.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
..+...|..++.||-|+||.|.+++. +...+|.|.++.. ..........+.|..||..-+.+-||++|..|++..++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 34556788899999999999998865 4567899988543 33445566788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
|+||||++||++..+|.+ .+.|.+..+..++.++.-|+++.|+.|+|||||||+|||||.+|++||.|||+|.
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999987 5889999999999999999999999999999999999999999999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=208.93 Aligned_cols=168 Identities=29% Similarity=0.451 Sum_probs=144.5
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEc
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
|++.+.||+|++|.||+|.. +++.|+||.+...... .......+|+..+++++ |+|++++++++..+...++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999998 4688999998654322 22334567999999999 99999999999999999999999
Q ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.++........+..
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 779999987754 47899999999999999999999999999999999999999999999999999876554444556
Q ss_pred CCcccccchhcccc
Q 023285 268 TGTYRWMAPEVAFT 281 (284)
Q Consensus 268 ~gt~~y~aPEvl~~ 281 (284)
.++..|+|||++.+
T Consensus 159 ~~~~~~~aPE~~~~ 172 (283)
T cd07830 159 VSTRWYRAPEILLR 172 (283)
T ss_pred CCcccccCceeeec
Confidence 78999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=204.36 Aligned_cols=174 Identities=27% Similarity=0.432 Sum_probs=150.3
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
...+.+++++...||.|+.|.|+++++. +...|||.+.... +.+..++++..+.++... ..|+||+.+|+|..+..
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 3445567778889999999999999985 4889999997653 455567777777776655 48999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.++.||.|.. -+..++..-.+++++..+-++...+++||.||.++ ||||||+||+|||+|+.|++||||||++....+
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999954 67777776678899999999999999999999965 999999999999999999999999999998888
Q ss_pred CCceecCCCcccccchhccc
Q 023285 261 SGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~ 280 (284)
+...+...|.+.|||||.+-
T Consensus 245 SkAhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 245 SKAHTRSAGCAAYMAPERID 264 (391)
T ss_pred ccccccccCCccccCccccC
Confidence 87888889999999999874
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=206.81 Aligned_cols=169 Identities=28% Similarity=0.447 Sum_probs=144.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.|.-.+.||+|++|.||++.. .++.+++|.++.. .....+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567899999999999986 4688999988643 333456688999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. +.++...+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+....... .....
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 999999999876 568999999999999999999999999999999999999999999999999887543321 22334
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.|++.|+|||++.+..
T Consensus 176 ~~~~~y~aPE~~~~~~ 191 (285)
T cd06648 176 VGTPYWMAPEVISRLP 191 (285)
T ss_pred cCCccccCHHHhcCCC
Confidence 6899999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=207.55 Aligned_cols=172 Identities=32% Similarity=0.486 Sum_probs=149.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||+|++|.||+|... ++.|++|+++.... ....+.+|++++++++|+|++++++.+......|+|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 346888899999999999999885 78999999875422 4567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||+++++|.+++......++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 9999999999998754479999999999999999999999999999999999999999999999999886543321 223
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...+++.|+|||++.+..
T Consensus 175 ~~~~~~~y~~PE~~~~~~ 192 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKD 192 (286)
T ss_pred cccCCcccCCHhHhcCCC
Confidence 345788999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=215.80 Aligned_cols=170 Identities=26% Similarity=0.434 Sum_probs=144.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----CCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 183 (284)
.+|++.+.||+|+||.||+|.. +++.||+|++............+.+|+.++++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5789999999999999999986 57899999987554334456678889999999999999999998753 34689
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999996 599999865 3568999999999999999999999999999999999999999999999999997653321
Q ss_pred ----ceecCCCcccccchhcccc
Q 023285 263 ----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ----~~~~~~gt~~y~aPEvl~~ 281 (284)
......++..|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred CCCcccccccccccccChHHhcC
Confidence 1223478899999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=211.85 Aligned_cols=170 Identities=22% Similarity=0.348 Sum_probs=145.0
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.+.+.+|.|+++.||++..+++.||||+++......+....+.+|+.++++++|+||+++++++..+...+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34556667778888888888899999999976544566778899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--------
Q 023285 192 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-------- 262 (284)
Q Consensus 192 gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-------- 262 (284)
++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999764 3468899999999999999999999999999999999999999999999999987543221
Q ss_pred ceecCCCcccccchhcccc
Q 023285 263 VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~ 281 (284)
......++..|+|||++.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred ccccccccccccCHHHhcC
Confidence 1233457789999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=209.28 Aligned_cols=167 Identities=32% Similarity=0.523 Sum_probs=145.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..|+..+.||+|+||.||+|.. ++..||+|.+.... ...+....+.+|+.++++++|||++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3578889999999999999987 56899999986442 23445667999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+.| +|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ...
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 99975 88888876667789999999999999999999999999999999999999999999999999875432 234
Q ss_pred CCCcccccchhccc
Q 023285 267 ETGTYRWMAPEVAF 280 (284)
Q Consensus 267 ~~gt~~y~aPEvl~ 280 (284)
..+++.|+|||++.
T Consensus 181 ~~~~~~y~aPE~~~ 194 (317)
T cd06635 181 FVGTPYWMAPEVIL 194 (317)
T ss_pred ccCCccccChhhhh
Confidence 56889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=210.29 Aligned_cols=180 Identities=26% Similarity=0.388 Sum_probs=152.4
Q ss_pred CCCCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEE
Q 023285 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (284)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 176 (284)
+....|.+..++++-...||.|+||+|++-.+ .++..|||.++.... ....++++.|.....+- +.||||++||++
T Consensus 54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 34467888888898899999999999999877 578999999986543 34556788888765554 689999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEec
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLH---K-QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVAD 251 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~D 251 (284)
..++..|+.||.|+- ||..+-. . ++..+++..+..|..-.+.||+||... .|||||+||+|||++..|.+||||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 999999999999965 7655432 1 356799999999999999999999965 899999999999999999999999
Q ss_pred ccceeeeccCCceecCCCcccccchhcccc
Q 023285 252 FGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 252 fg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
||.+.....+-..+...|...|||||.+..
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p 241 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDP 241 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCC
Confidence 999988777767788899999999998753
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=206.84 Aligned_cols=166 Identities=36% Similarity=0.593 Sum_probs=138.1
Q ss_pred eeeecCceEEEEEEECC--------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 117 KVASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.||+|+||.||+|+... +.+|||.+.... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998642 579999876432 234466789999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-----cEEEecccceee
Q 023285 189 MARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARV 257 (284)
Q Consensus 189 ~~~gsL~~~l~~~------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-----~vkl~Dfg~a~~ 257 (284)
+++++|.+++... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+++.
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999753 23478899999999999999999999999999999999999887 899999999975
Q ss_pred eccCCc---eecCCCcccccchhcccccc
Q 023285 258 QAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 258 ~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
...... .....++..|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGK 189 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCC
Confidence 432211 11234568899999987643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-30 Score=227.46 Aligned_cols=176 Identities=27% Similarity=0.390 Sum_probs=160.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECCce--EEEEEecCC-CCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
++...+++....||-|+||.|=+...+++. +|+|+++.. ..+....+....|..+|..++.|.||++|..|.++.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345667888899999999999998887655 899998654 44566677889999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|++||-|-||.|+..++. ++.|+...+..++..++.|++|||++|||+|||||+|++++.+|-+||.|||+|+......
T Consensus 496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999999977 5889999999999999999999999999999999999999999999999999999988887
Q ss_pred ceecCCCcccccchhccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~ 282 (284)
..-+.+|||.|.|||+++.+
T Consensus 575 KTwTFcGTpEYVAPEIILnK 594 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNK 594 (732)
T ss_pred ceeeecCCcccccchhhhcc
Confidence 77889999999999999864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=209.16 Aligned_cols=172 Identities=29% Similarity=0.423 Sum_probs=143.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV 185 (284)
.++|...+.||+|+||.||++.. +++.||+|.+..... ......+.+|+.++.++. |+||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 34677788999999999999987 468999999875432 244567899999999996 99999999999999999999
Q ss_pred EEcCCCCCHHHHHH---h-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 186 TEFMARGSIYDFLH---K-QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 186 ~e~~~~gsL~~~l~---~-~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
|||+.+ ++.++.. . ....+++..+..++.+++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 6655432 2 236789999999999999999999975 999999999999999999999999999976544
Q ss_pred CCceecCCCcccccchhccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
........|+..|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred CCccccccCccCccCHHHhccc
Confidence 4334455789999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=211.71 Aligned_cols=172 Identities=28% Similarity=0.497 Sum_probs=142.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
.++|++.++||+|+||.||+|.. +++.+|||.+............+.+|+.++++++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999987 4688999998654333333446788999999999999999999875433
Q ss_pred --cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 181 --~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.+++|+||+.+ +|.+.+......+++..+..++.|+++||.|||++|++|+||||+||++++++.++|+|||+++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 46999999975 888888765668999999999999999999999999999999999999999999999999999754
Q ss_pred ccCCc------------eecCCCcccccchhcccc
Q 023285 259 AQSGV------------MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 259 ~~~~~------------~~~~~gt~~y~aPEvl~~ 281 (284)
..... .+...+++.|+|||++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 32211 123356888999998765
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=207.74 Aligned_cols=170 Identities=27% Similarity=0.456 Sum_probs=148.4
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|++.+.||+|++|.||+|.. +++.+++|.++...........+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999987 4788999998765544455678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 268 (284)
++ +|.+++......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 76 9999887766789999999999999999999999999999999999999999999999999998665433 233456
Q ss_pred Ccccccchhccccc
Q 023285 269 GTYRWMAPEVAFTF 282 (284)
Q Consensus 269 gt~~y~aPEvl~~~ 282 (284)
++..|+|||.+.+.
T Consensus 160 ~~~~~~~PE~~~~~ 173 (283)
T cd05118 160 VTRWYRAPELLLGD 173 (283)
T ss_pred CcccccCcHHHhcC
Confidence 88899999998764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=214.29 Aligned_cols=170 Identities=26% Similarity=0.442 Sum_probs=147.6
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----cEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 183 (284)
+|++.+.||+|++|.||+|+.. ++.||||.+..........+.+.+|+.++++++|+||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999874 689999998765433455678999999999999999999999988765 789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+++ +|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999975 89998865 3579999999999999999999999999999999999999999999999999998765542
Q ss_pred ---ceecCCCcccccchhccccc
Q 023285 263 ---VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ---~~~~~~gt~~y~aPEvl~~~ 282 (284)
......++..|+|||++.+.
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred ccccccccccccCcCCceeeecc
Confidence 23445688999999998765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=212.65 Aligned_cols=167 Identities=23% Similarity=0.390 Sum_probs=139.5
Q ss_pred eeeeec--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
..||.| +||.||++.. +++.||+|+++......+..+.+.+|+.+++.++||||++++++|..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999987 679999999986655566667899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc-------
Q 023285 192 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------- 263 (284)
Q Consensus 192 gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~------- 263 (284)
++|.+++.+. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999998764 24588999999999999999999999999999999999999999999999986533211110
Q ss_pred -eecCCCcccccchhccccc
Q 023285 264 -MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 -~~~~~gt~~y~aPEvl~~~ 282 (284)
.....++..|+|||++.+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccccccCccCccChhhhcCC
Confidence 0112356679999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=206.56 Aligned_cols=169 Identities=32% Similarity=0.551 Sum_probs=142.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEc------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR------P 179 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~ 179 (284)
.+.|++.+.||.|+||.||+|.. .++.+|+|++... ......+..|+.+++++ +|+|++++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 45788999999999999999988 4688999998543 33446688999999999 69999999999853 4
Q ss_pred CcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+|++|||+++|+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 5689999999999999999764 345888889999999999999999999999999999999999999999999998754
Q ss_pred ccC-CceecCCCcccccchhccc
Q 023285 259 AQS-GVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 259 ~~~-~~~~~~~gt~~y~aPEvl~ 280 (284)
... .......|++.|+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred hccccCCCcccccccccCHhhcC
Confidence 322 1233456899999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-30 Score=214.47 Aligned_cols=178 Identities=28% Similarity=0.487 Sum_probs=150.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---- 178 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---- 178 (284)
+.++.+.|.-..+||+|.||.||+|+. .++.||+|++-.+...........+|+++|..++|+|++.+++.|..
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 445667888889999999999999976 45778998764433333445567899999999999999999988843
Q ss_pred ----CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 179 ----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 179 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
...+|+|+++|+. +|..++.+...++++.++.+++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 2348999999987 99999988778899999999999999999999999999999999999999999999999999
Q ss_pred eeeeccC-----CceecCCCcccccchhcccccc
Q 023285 255 ARVQAQS-----GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~-----~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
++....+ ...+..+-|.+|.+||.+.|.+
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 9754332 2356677899999999999864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=203.13 Aligned_cols=164 Identities=27% Similarity=0.385 Sum_probs=136.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHH-HHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.||+|+||.||+|.. +++.||+|.++..... ......+..|..+ ....+|+|++++++.+.....+|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999987 5689999998643221 2233345555544 4455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 271 (284)
++|.+++... +.+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||+++.... .....+++
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 9999999763 5689999999999999999999999999999999999999999999999999875433 23346889
Q ss_pred cccchhcccccc
Q 023285 272 RWMAPEVAFTFF 283 (284)
Q Consensus 272 ~y~aPEvl~~~~ 283 (284)
.|+|||.+.+..
T Consensus 158 ~y~~pe~~~~~~ 169 (260)
T cd05611 158 DYLAPETILGVG 169 (260)
T ss_pred CccChhhhcCCC
Confidence 999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=205.28 Aligned_cols=164 Identities=28% Similarity=0.450 Sum_probs=141.7
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||.|+||.||++... ++.+++|+++.... .......+.+|+.++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 688999999999984 78999999875432 234567799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---------cee
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---------VMT 265 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---------~~~ 265 (284)
.+++.+. +.+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999774 478999999999999999999999999999999999999999999999999987543321 123
Q ss_pred cCCCcccccchhccccc
Q 023285 266 AETGTYRWMAPEVAFTF 282 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~ 282 (284)
...++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~Pe~~~~~ 176 (265)
T cd05579 160 RIVGTPDYIAPEVILGQ 176 (265)
T ss_pred CcccCccccCHHHhcCC
Confidence 34678899999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=207.93 Aligned_cols=170 Identities=26% Similarity=0.471 Sum_probs=147.1
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|++.+.||+|++|.||+|+.. ++.||+|+++...........+.+|+.++++++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567788999999999999884 689999999765434445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 268 (284)
++ +|.+++.+....+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||.++...... ......
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 75 9999998765679999999999999999999999999999999999999999999999999998654332 233445
Q ss_pred Ccccccchhccccc
Q 023285 269 GTYRWMAPEVAFTF 282 (284)
Q Consensus 269 gt~~y~aPEvl~~~ 282 (284)
++..|+|||.+.+.
T Consensus 160 ~~~~~~aPE~~~~~ 173 (282)
T cd07829 160 VTLWYRAPEILLGS 173 (282)
T ss_pred cCcCcCChHHhcCC
Confidence 67889999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=206.70 Aligned_cols=172 Identities=24% Similarity=0.431 Sum_probs=148.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV 185 (284)
++|.+.+.||+|+||.||+|.. +++.||+|++..... .......+.+|+.++++++ |+||+++++++......++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3689999999999999999987 578999999865322 3344567889999999999 99999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--- 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--- 262 (284)
||++++++|.+++.+. +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 9999999999999774 579999999999999999999999999999999999999999999999999987543321
Q ss_pred ------------------ceecCCCcccccchhccccc
Q 023285 263 ------------------VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ------------------~~~~~~gt~~y~aPEvl~~~ 282 (284)
......++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 197 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK 197 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCC
Confidence 11233578899999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=211.66 Aligned_cols=168 Identities=26% Similarity=0.437 Sum_probs=142.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 180 (284)
.++|.+.+.||+|+||.||+|.. +++.||+|+++.........+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 46799999999999999999976 578999999875433344456788999999999999999999988643 3
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 478888887 6799888754 4589999999999999999999999999999999999999999999999999876433
Q ss_pred CCceecCCCcccccchhcccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~ 281 (284)
. .....++..|+|||++.+
T Consensus 173 ~--~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 173 E--MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred c--ccccccCCCccCHHHHhC
Confidence 2 234568899999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-30 Score=214.36 Aligned_cols=171 Identities=26% Similarity=0.427 Sum_probs=146.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-----cEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 183 (284)
+.+..+.||.|+||.||..++ .++.||+|.+..-..+-..-+++.+|++++...+|.|+...+++.+... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 445567899999999998887 5799999998654334445678999999999999999999988876543 368
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc--C
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--S 261 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~--~ 261 (284)
.++|.|.. +|...+-. ...++.+.++-+.+||++||.|||+.+|+||||||.|+|++.|..+||||||+|+.... .
T Consensus 134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 89999965 88888765 57799999999999999999999999999999999999999999999999999997544 3
Q ss_pred CceecCCCcccccchhcccccc
Q 023285 262 GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
..++.++-|.+|+|||+++|.+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGAR 233 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcch
Confidence 4577888999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=213.72 Aligned_cols=170 Identities=25% Similarity=0.451 Sum_probs=142.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcC--CcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP--PNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~ 183 (284)
.++|++.+.||+|+||.||+|.. +++.+|+|.+............+.+|+.+++++ +||||+++++++... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 35789999999999999999987 468899998864433344456678899999999 999999999998653 3589
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+++ +|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.++......
T Consensus 86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999975 999988653 68888999999999999999999999999999999999999999999999997543321
Q ss_pred -----ceecCCCcccccchhcccc
Q 023285 263 -----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 -----~~~~~~gt~~y~aPEvl~~ 281 (284)
......|++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred cccCcchhcccccccccCceeeec
Confidence 2223468899999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=210.32 Aligned_cols=169 Identities=24% Similarity=0.395 Sum_probs=139.9
Q ss_pred CceeeeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEc----CCc
Q 023285 111 QLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PPN 181 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~ 181 (284)
+|++.+.||+|+||.||++... +..||+|.+..........+.+.+|+.+++++ +||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999884 56899999875433344456788999999999 49999999987543 245
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+++|++. ++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 789999986 599999865 467899999999999999999999999999999999999999999999999999764322
Q ss_pred C-----ceecCCCcccccchhcccc
Q 023285 262 G-----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~-----~~~~~~gt~~y~aPEvl~~ 281 (284)
. ......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred cccccccccCcccCccccCcHHHhC
Confidence 1 1233468999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=198.93 Aligned_cols=179 Identities=21% Similarity=0.311 Sum_probs=152.5
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
.....|+.++|++.+.||+|+|.-||.++. ++..+|+|.+.-. ..+..+..++|++..++++|||++++++....+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 346679999999999999999999998874 6788999998754 356778899999999999999999999877544
Q ss_pred Cc-----EEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEE
Q 023285 180 PN-----LCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKV 249 (284)
Q Consensus 180 ~~-----~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~vkl 249 (284)
.. .|++++|+..|+|.+.+... ...+++.+++.|+.+|++||++||+.. +.||||||.|||+.+.+.++|
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 33 99999999999999999764 246999999999999999999999998 999999999999999999999
Q ss_pred ecccceeeeccC----------CceecCCCcccccchhccccc
Q 023285 250 ADFGVARVQAQS----------GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 250 ~Dfg~a~~~~~~----------~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.|||.++...-. .....+..|..|+|||++.-+
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk 213 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK 213 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence 999999753321 112344679999999998644
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=205.34 Aligned_cols=178 Identities=18% Similarity=0.258 Sum_probs=133.3
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCH--HH-------HHHHHHHHHHHHhCCCCcee
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT--EM-------LKEFSQEVYIMRKIRHKNVV 170 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~--~~-------~~~~~~E~~~l~~l~h~niv 170 (284)
.++..++|++.+.||+|+||.||+|...+ ..+|+|+........ +. ......+...+..+.|+|++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 45667899999999999999999998743 466777643322111 10 11123344456677899999
Q ss_pred eEEeEEEcCC----cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 171 QFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 171 ~~~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
++++.+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 9999765543 34788888754 777777553 44678889999999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCC--------ceecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++|+|||+|+...... ......||+.|+|||++.+..|
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~ 210 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV 210 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC
Confidence 9999999997643211 1223469999999999887653
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=208.64 Aligned_cols=168 Identities=26% Similarity=0.436 Sum_probs=142.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lV 185 (284)
.++|++.+.||.|+||.||+|.. +++.||||.+..........+.+.+|+.++++++||||+++++++.. ....|+|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 45799999999999999999976 56889999886543334455678899999999999999999999865 5678999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
+||+ +++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~ 163 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MT 163 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cC
Confidence 9999 5599988854 45788889999999999999999999999999999999999999999999998754322 23
Q ss_pred cCCCcccccchhcccc
Q 023285 266 AETGTYRWMAPEVAFT 281 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~ 281 (284)
...+++.|+|||++.+
T Consensus 164 ~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 164 GYVSTRYYRAPEIMLT 179 (328)
T ss_pred CCcccccccCceeeec
Confidence 4467889999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=206.96 Aligned_cols=168 Identities=29% Similarity=0.435 Sum_probs=143.0
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|....+||+|+||.||++.. +++.||||.+... .......+.+|+.+++.++|+|++++++.+..+...++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 33446799999999999987 5689999987533 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecCC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~~ 268 (284)
++++|.+++.. +.+++..+..++.|++.+|+|||++|++|+||+|+||++++++.++|+|||.+....... ......
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 99999998754 458999999999999999999999999999999999999999999999999987543321 223456
Q ss_pred Ccccccchhcccccc
Q 023285 269 GTYRWMAPEVAFTFF 283 (284)
Q Consensus 269 gt~~y~aPEvl~~~~ 283 (284)
+++.|+|||.+.+..
T Consensus 178 ~~~~y~~pE~~~~~~ 192 (292)
T cd06657 178 GTPYWMAPELISRLP 192 (292)
T ss_pred cCccccCHHHhcCCC
Confidence 889999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-27 Score=202.45 Aligned_cols=163 Identities=21% Similarity=0.403 Sum_probs=134.2
Q ss_pred Cceeeeee--eecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKV--ASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV 185 (284)
.|.+.+.+ |+|+||.||++.. ++..+|+|.++....... |+.....+ +|||++++++.+..++.+|+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 45555555 9999999999986 568899999875422211 22222222 699999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCCce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~~~ 264 (284)
|||+++++|.+++... ..+++..+..++.|+++||.|||+.|++||||||+||+++.++ .++|+|||.++.....
T Consensus 88 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 9999999999999764 4799999999999999999999999999999999999999988 9999999998765433
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
....++..|+|||++.+..|
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred ccCCCCCcccChhhhcCCCC
Confidence 23468999999999977543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=209.83 Aligned_cols=170 Identities=25% Similarity=0.415 Sum_probs=140.9
Q ss_pred Cc-eeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHH------------HHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 111 QL-KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------------MLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 111 ~~-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
+| .+.+.||+|+||.||+|.. .++.||||.++....... ....+.+|+.++++++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 45 4567899999999999986 478999999864422210 11257889999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
+......|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 999999999999997 599999865 456899999999999999999999999999999999999999999999999999
Q ss_pred eeecc---------------CCceecCCCcccccchhccccc
Q 023285 256 RVQAQ---------------SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~---------------~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
..... ........+++.|+|||++.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 76441 1112233568899999998753
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=205.47 Aligned_cols=171 Identities=23% Similarity=0.365 Sum_probs=144.2
Q ss_pred CceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcE
Q 023285 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 182 (284)
+|++.+.||+|++|.||+++. .++.||||+++.... .......+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999875 357899999864322 123446688999999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||+++++|.+++... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 9999999999999999763 568999999999999999999999999999999999999999999999999987643322
Q ss_pred c--eecCCCcccccchhccccc
Q 023285 263 V--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~--~~~~~gt~~y~aPEvl~~~ 282 (284)
. .....|+..|+|||.+.+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred ccccccccCCccccCHHHhcCC
Confidence 1 1234588999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=234.78 Aligned_cols=173 Identities=25% Similarity=0.421 Sum_probs=141.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc---------
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------- 178 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 178 (284)
.+|...+.||+|+||.||+++. .|+.+|||.+.... +......+.+|+..+.+|+|||||+++.++.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4677788999999999999987 69999999997665 66677889999999999999999998854400
Q ss_pred --------------------------------------------------------------------------------
Q 023285 179 -------------------------------------------------------------------------------- 178 (284)
Q Consensus 179 -------------------------------------------------------------------------------- 178 (284)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ----------------------C--------CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 023285 179 ----------------------P--------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228 (284)
Q Consensus 179 ----------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 228 (284)
+ ..+||=||||+.-.|.++++.....-....+++++++|+.||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0 1268899999986777777553221147789999999999999999999
Q ss_pred ceecCCCCCCEEecCCCcEEEecccceeeec-------------------cCCceecCCCcccccchhcccccc
Q 023285 229 IIHRDLKTANLLMDENGVVKVADFGVARVQA-------------------QSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 229 iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
||||||||.||++++++.|||+|||+|+... ..+..|..+||.-|+|||++.+..
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9999999999999999999999999997511 112346678999999999987653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=207.82 Aligned_cols=181 Identities=23% Similarity=0.340 Sum_probs=158.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhC-CCCceeeEEeEEEc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKI-RHKNVVQFIGACTR 178 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 178 (284)
..|.+..++|.+.+.||+|+|..|-.++. +.+.+|+|+++.+..++ +.+.=.+.|-.+..+. +||.+|-++..|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 46778889999999999999999998877 46889999998876654 3445566777777776 48999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+.++++|.||.+||+|.-.++++ ..++++.+..+..+|+.+|.|||+.|||+||||.+|+|+|..|++||.|+|.++..
T Consensus 323 esrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999999999998777664 57999999999999999999999999999999999999999999999999999975
Q ss_pred ccCC-ceecCCCcccccchhccccccC
Q 023285 259 AQSG-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
-.++ ...+.+|||.|+|||+++|..|
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred CCCCcccccccCCCcccchhhhccccc
Confidence 4444 4456799999999999999776
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=205.00 Aligned_cols=165 Identities=31% Similarity=0.528 Sum_probs=143.3
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
|...++||+|+||.||+|+. +++.|++|.+..... .......+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999987 578999999864422 344556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 268 (284)
+. +++.+++......+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~ 178 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence 96 488888877667789999999999999999999999999999999999999999999999999864322 23457
Q ss_pred Ccccccchhccc
Q 023285 269 GTYRWMAPEVAF 280 (284)
Q Consensus 269 gt~~y~aPEvl~ 280 (284)
|+..|+|||++.
T Consensus 179 ~~~~y~aPE~~~ 190 (313)
T cd06633 179 GTPYWMAPEVIL 190 (313)
T ss_pred ccccccChhhcc
Confidence 899999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-27 Score=217.46 Aligned_cols=175 Identities=23% Similarity=0.344 Sum_probs=134.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE------------------CCceEEEEEecCCCCCHHHHH--------------
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY------------------CSQEVAIKVLKPECVNTEMLK-------------- 152 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~-------------- 152 (284)
.....++|++.++||+|+||.||+|.. .++.||||.++... ....+
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~--~~~~~~fl~e~~~~~~~~e 217 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDR--QGVRQDFLKTGTLAKGSAE 217 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccc--hhhHHHHHhhhhhhhcccc
Confidence 345678999999999999999999964 23579999986432 11222
Q ss_pred HHHHHHHHHHhCCCCce-----eeEEeEEEc--------CCcEEEEEEcCCCCCHHHHHHhcCC----------------
Q 023285 153 EFSQEVYIMRKIRHKNV-----VQFIGACTR--------PPNLCIVTEFMARGSIYDFLHKQKG---------------- 203 (284)
Q Consensus 153 ~~~~E~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~---------------- 203 (284)
.+..|+.++.+++|.++ ++++++|.. ....++||||+++++|.++++...+
T Consensus 218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l 297 (507)
T PLN03224 218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI 297 (507)
T ss_pred hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence 23457777778876654 667777653 3468999999999999999875321
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee--cCCCccccc
Q 023285 204 -------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT--AETGTYRWM 274 (284)
Q Consensus 204 -------~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~--~~~gt~~y~ 274 (284)
.+++..+..++.|++.+|.|||+.+|+||||||+||+++.++.+||+|||+++......... ...+|+.|+
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 23456788999999999999999999999999999999999999999999997543322222 224578999
Q ss_pred chhcccc
Q 023285 275 APEVAFT 281 (284)
Q Consensus 275 aPEvl~~ 281 (284)
|||++..
T Consensus 378 aPE~l~~ 384 (507)
T PLN03224 378 PPEELVM 384 (507)
T ss_pred ChhhhcC
Confidence 9999854
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=239.72 Aligned_cols=170 Identities=26% Similarity=0.444 Sum_probs=146.1
Q ss_pred ceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
.+-...||.|.||.||-|.. +|.-.|+|-++.............+|..++..++|||+|+++|+=.+....+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 34466899999999999976 5788999988766544555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-----ce
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VM 264 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-----~~ 264 (284)
+||+|.+.+.. .+..++.....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|.....+. ..
T Consensus 1317 ~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1317 EGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred ccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99999999865 4556777778889999999999999999999999999999999999999999998754432 12
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
....||+.|||||+|.+-
T Consensus 1396 ~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred HhhcCCchhcCchhhccc
Confidence 344799999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=210.12 Aligned_cols=172 Identities=27% Similarity=0.464 Sum_probs=143.7
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..|++. .+|.+.+.||+|+||.||+|.. +++.||||.++...........+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 356664 4899999999999999999986 5789999998754333444566889999999999999999999987543
Q ss_pred ------cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 181 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
.+|+|+||+.. +|.+++ ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999965 777765 24589999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
++..... .....+++.|+|||++.+
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 164 ARHADAE--MTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CcCCCCC--CCCceeeecccChhhhcC
Confidence 8754322 234467889999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=224.60 Aligned_cols=180 Identities=32% Similarity=0.615 Sum_probs=157.2
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~ 173 (284)
.|+++.+.+++.+.||+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 89999999999999999999999999752 357999999866444 66788999999999996 99999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
|+|+..+.+++|+||+..|+|.+|++..+ ..++...++.++.||+.||+||++.++|||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998865 348889999999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCCceecC--C--CcccccchhccccccC
Q 023285 239 LLMDENGVVKVADFGVARVQAQSGVMTAE--T--GTYRWMAPEVAFTFFF 284 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~~~~~~--~--gt~~y~aPEvl~~~~y 284 (284)
||+..+..+||+|||+|+........... . -...|||||-+....|
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 99999999999999999965554433322 2 2457999999987655
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-26 Score=204.34 Aligned_cols=167 Identities=35% Similarity=0.549 Sum_probs=144.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..|+..+.||+|+||.||+|+. +++.+|+|.+.... .......++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3577788999999999999987 56889999986432 23445667889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+. |++.+++......+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||.+...... ..
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~ 170 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NX 170 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---cc
Confidence 9996 5888888766667899999999999999999999999999999999999999999999999998765432 34
Q ss_pred CCCcccccchhccc
Q 023285 267 ETGTYRWMAPEVAF 280 (284)
Q Consensus 267 ~~gt~~y~aPEvl~ 280 (284)
..+++.|+|||.+.
T Consensus 171 ~~~~~~y~aPE~~~ 184 (308)
T cd06634 171 FVGTPYWMAPEVIL 184 (308)
T ss_pred ccCCccccCHHHHh
Confidence 56889999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=197.99 Aligned_cols=164 Identities=29% Similarity=0.442 Sum_probs=143.0
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
||+|+||.||++... ++.+++|+++.... .......+..|+.++++++|+|++++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999874 68999999875433 233567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecCCCcccc
Q 023285 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW 273 (284)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~~gt~~y 273 (284)
.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999764 46899999999999999999999999999999999999999999999999999865443 223455788999
Q ss_pred cchhccccc
Q 023285 274 MAPEVAFTF 282 (284)
Q Consensus 274 ~aPEvl~~~ 282 (284)
+|||.+.+.
T Consensus 160 ~~Pe~~~~~ 168 (250)
T cd05123 160 LAPEVLLGK 168 (250)
T ss_pred cChHHhCCC
Confidence 999998664
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=209.61 Aligned_cols=172 Identities=27% Similarity=0.478 Sum_probs=145.9
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.|++ .++|++.+.||+|++|.||+|.. +++.||||++............+.+|+.++++++|||++++++++.....
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3444 45799999999999999999988 46889999987543344455678889999999999999999988766554
Q ss_pred ------EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 182 ------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 5699999865 46899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
...... .....++..|+|||++.+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhC
Confidence 765432 334567889999998864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=198.96 Aligned_cols=171 Identities=27% Similarity=0.438 Sum_probs=141.2
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+|.+.+.||+|+||.||++... +..+++|+++... ........+..|+.++++++||||+++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999874 3456667665322 2233345677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 2456899999999999999999999999999999999999974 679999999987654322
Q ss_pred -ceecCCCcccccchhccccc
Q 023285 263 -VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~ 282 (284)
......+++.|+|||.+.+.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~ 180 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQ 180 (260)
T ss_pred ccccCCCCCcCccCHHHHccC
Confidence 22345688999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=206.08 Aligned_cols=168 Identities=24% Similarity=0.439 Sum_probs=139.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------- 179 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 179 (284)
..+|.+.+.||.|+||.||+|.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999987 46899999986542 24456788999999999999999999776543
Q ss_pred -------CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEec
Q 023285 180 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD 251 (284)
Q Consensus 180 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~D 251 (284)
...|+||||+++ +|.+++.. +.+++..+..++.||+.||.|||+.|++||||||+||+++ .++.++|+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357999999974 99988854 4689999999999999999999999999999999999997 456789999
Q ss_pred ccceeeeccCC----ceecCCCcccccchhcccc
Q 023285 252 FGVARVQAQSG----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 252 fg~a~~~~~~~----~~~~~~gt~~y~aPEvl~~ 281 (284)
||.++...... ......++..|+|||++.+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhC
Confidence 99997643221 1223467889999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-28 Score=224.06 Aligned_cols=168 Identities=36% Similarity=0.586 Sum_probs=149.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
..+|.+..++|+|.||.|||++. +++..|+|+++.+. .+......+|+-+++..+||||+.++|.+-....++++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 45899999999999999999987 57899999998763 445677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+.||+|.+.-+. -+.+++.++..++++.+.||+|||+.|-+|||||-.||++++.|.+|++|||.+..+... ....
T Consensus 92 EycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk 170 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK 170 (829)
T ss_pred EecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence 99999999987655 578999999999999999999999999999999999999999999999999998754432 2334
Q ss_pred cCCCcccccchhcc
Q 023285 266 AETGTYRWMAPEVA 279 (284)
Q Consensus 266 ~~~gt~~y~aPEvl 279 (284)
...||++||||||-
T Consensus 171 sfiGtpywmapEva 184 (829)
T KOG0576|consen 171 SFIGTPYWMAPEVA 184 (829)
T ss_pred cccCCccccchhHH
Confidence 66899999999984
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=191.87 Aligned_cols=152 Identities=20% Similarity=0.244 Sum_probs=128.9
Q ss_pred cCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHH
Q 023285 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 198 (284)
Q Consensus 121 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l 198 (284)
|.+|.||++.. +++.||+|.++... .+.+|...+....||||+++++++......|+||||++||+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999987 57899999987532 2344555666667999999999999999999999999999999999
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhc
Q 023285 199 HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278 (284)
Q Consensus 199 ~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEv 278 (284)
.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 764 46899999999999999999999999999999999999999999999999987654432 233456778999998
Q ss_pred cccc
Q 023285 279 AFTF 282 (284)
Q Consensus 279 l~~~ 282 (284)
+.+.
T Consensus 154 ~~~~ 157 (237)
T cd05576 154 GGIS 157 (237)
T ss_pred cCCC
Confidence 8654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=211.39 Aligned_cols=165 Identities=27% Similarity=0.418 Sum_probs=134.5
Q ss_pred ceeeeeeeecCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|.-.+.+|.|+.|+ ||+|.+.++.||||++-. +......+|+..++.-+ ||||+++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34456789999985 899999999999999753 33456789999999885 999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---C--CcEEEecccceeeeccC
Q 023285 190 ARGSIYDFLHKQ--KGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---N--GVVKVADFGVARVQAQS 261 (284)
Q Consensus 190 ~~gsL~~~l~~~--~~~~-~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~--~~vkl~Dfg~a~~~~~~ 261 (284)
.. +|.+++... .... ..-....+..|+++||++||+.+||||||||.||||+. + ..++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 76 999999773 1111 11345778899999999999999999999999999975 3 47899999999876543
Q ss_pred C----ceecCCCcccccchhccccc
Q 023285 262 G----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~----~~~~~~gt~~y~aPEvl~~~ 282 (284)
. ......||.+|+|||++...
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcc
Confidence 2 12345799999999999764
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=195.08 Aligned_cols=170 Identities=24% Similarity=0.371 Sum_probs=144.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--C----ceeeEEeEEEcC
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--K----NVVQFIGACTRP 179 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~ 179 (284)
...+|.+...+|+|.||.|-.+... +..||||+++.. ....+..+-|++++.++.+ | -++++.++|.-.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3678999999999999999988764 578999999843 3444567789999999953 2 378999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---------------
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--------------- 243 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~--------------- 243 (284)
++.|||+|.| |-|+++++.+.+ .+++...+..++.|++.++++||+.+++|.||||+|||+..
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999999 569999997743 47999999999999999999999999999999999999942
Q ss_pred -----CCcEEEecccceeeeccCCceecCCCcccccchhcccccc
Q 023285 244 -----NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 244 -----~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+-.|+|+|||.|+...+. .+..+.|..|+|||||+|.-
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLG 285 (415)
T ss_pred eccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccC
Confidence 236999999999977654 36678899999999999853
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-24 Score=181.82 Aligned_cols=167 Identities=33% Similarity=0.584 Sum_probs=146.2
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|.+.+.||+|++|.||++... ++.+++|.+...... .....+.+|+..+++++|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999885 589999998755322 25678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--ceecC
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAE 267 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~~~~~ 267 (284)
++++|.+++......+++..+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999999997754338899999999999999999999999999999999999999999999999998765542 23445
Q ss_pred CCcccccchhcc
Q 023285 268 TGTYRWMAPEVA 279 (284)
Q Consensus 268 ~gt~~y~aPEvl 279 (284)
.++..|++||.+
T Consensus 160 ~~~~~~~~pe~~ 171 (225)
T smart00221 160 KGTPFYLAPEVL 171 (225)
T ss_pred eccCCcCCHhHh
Confidence 678899999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=185.00 Aligned_cols=141 Identities=17% Similarity=0.198 Sum_probs=109.8
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHH------------------------HHHHHHHHHHHHhCCCCce
Q 023285 115 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM------------------------LKEFSQEVYIMRKIRHKNV 169 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 169 (284)
...||+|++|.||+|.. +|+.||||++++....... .....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5899999999765321111 1123459999999988776
Q ss_pred eeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEEecCCCcEE
Q 023285 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 170 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~iiH~Dikp~NIli~~~~~vk 248 (284)
......... ..++||||++|+++...... .+.++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 443332222 23899999998877655433 35789999999999999999999 799999999999999998 58899
Q ss_pred Eecccceeeec
Q 023285 249 VADFGVARVQA 259 (284)
Q Consensus 249 l~Dfg~a~~~~ 259 (284)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=221.92 Aligned_cols=160 Identities=21% Similarity=0.343 Sum_probs=133.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.++..+.||+|+||.||+|.. .+..||||.++.... ....|++.+++++||||++++++|.++...|+||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 456677899999999999986 578999999864321 123468899999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH---~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
+++|+|.++++. +++..+.+++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+..... ..
T Consensus 765 ~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 999999999953 788999999999999999999 6799999999999999998888775 665543322 12
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...+|+.|||||++.+..|
T Consensus 837 ~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 837 KCFISSAYVAPETRETKDI 855 (968)
T ss_pred CccccccccCcccccCCCC
Confidence 3468899999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=182.24 Aligned_cols=167 Identities=26% Similarity=0.357 Sum_probs=141.0
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 182 (284)
.|-.++|++.++||+|+||.+|.|.. .++.||||+-..... ...+..|.++++.+++ ..|+.+..++.+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 46678999999999999999999976 689999998654322 2357789999999986 7888888888988899
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceeeec
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQA 259 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~~~ 259 (284)
.+|||.+ |.||.+++.-+...++..+++.++.|++.-++|+|.++.|||||||+|+|+.- ...+.|+|||+|+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 67999999888899999999999999999999999999999999999999973 3579999999998643
Q ss_pred cCC--------ceecCCCcccccchh
Q 023285 260 QSG--------VMTAETGTYRWMAPE 277 (284)
Q Consensus 260 ~~~--------~~~~~~gt~~y~aPE 277 (284)
+.. .....+||.+|.+--
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred cccccccCccccCCccceeeeehhhh
Confidence 321 123457899998743
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-24 Score=175.48 Aligned_cols=163 Identities=35% Similarity=0.668 Sum_probs=142.6
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHH
Q 023285 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~ 195 (284)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999986 7999999997653222 4567999999999999999999999999999999999999989999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeeccCC-ceecCCCcccc
Q 023285 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VMTAETGTYRW 273 (284)
Q Consensus 196 ~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y 273 (284)
+++......++...+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999775456899999999999999999999999999999999999999 8999999999998665432 13345678899
Q ss_pred cchhcccc
Q 023285 274 MAPEVAFT 281 (284)
Q Consensus 274 ~aPEvl~~ 281 (284)
++||.+.+
T Consensus 160 ~~pe~~~~ 167 (215)
T cd00180 160 MAPEVLLG 167 (215)
T ss_pred cChhHhcc
Confidence 99998865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=208.40 Aligned_cols=169 Identities=17% Similarity=0.290 Sum_probs=120.6
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE----
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA---- 175 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~---- 175 (284)
....++|.+.+.||+|+||.||+|+.. +..||||.++.... .+.+..| .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 345678999999999999999999873 57899998764321 1111111 1111122222222111
Q ss_pred --EEcCCcEEEEEEcCCCCCHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023285 176 --CTRPPNLCIVTEFMARGSIYDFLHKQKGV-------------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (284)
Q Consensus 176 --~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di 234 (284)
+.....+++|+||+++++|.+++...... .....+..++.||+.||+|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 24566799999999999999998753211 112346679999999999999999999999
Q ss_pred CCCCEEecC-CCcEEEecccceeeeccC--CceecCCCcccccchhccc
Q 023285 235 KTANLLMDE-NGVVKVADFGVARVQAQS--GVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 235 kp~NIli~~-~~~vkl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPEvl~ 280 (284)
||+|||++. ++.+||+|||+|+..... .......+|+.|||||.+.
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 999999985 689999999999754322 2234557899999999764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-26 Score=211.57 Aligned_cols=173 Identities=30% Similarity=0.524 Sum_probs=148.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--C----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--C----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
..++..++||+|+||+||+|.| . +-+||||++... ...+.-.+++.|+.+|.+++|||+++++++|..+. +.
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3566778999999999999988 2 257999998643 34556678999999999999999999999998866 88
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||++||++|+|.||++..++.+..+..+.|+.||++||.|||+++++||||.++|+|+..-..+|+.|||+|+.......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999998654432
Q ss_pred -eecCC--CcccccchhccccccC
Q 023285 264 -MTAET--GTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 -~~~~~--gt~~y~aPEvl~~~~y 284 (284)
..... -.+.|||=|.++...|
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCC
Confidence 22222 3568999998877655
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=197.32 Aligned_cols=170 Identities=21% Similarity=0.401 Sum_probs=141.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-----HHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-----TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 181 (284)
++|-+...||+|+|+.||+|.. .++.||||+-...... ....+...+|.+|-+.|+||.||++|++|.- ...
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 4577788999999999999976 4688999987543221 2234568899999999999999999999865 456
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEecC---CCcEEEeccccee
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE---NGVVKVADFGVAR 256 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~ 256 (284)
+|-|+||++|.+|+-||.. ...++++++..|+.||+.+|.||.+. .|||-||||.|||+-+ -|.+||.|||+++
T Consensus 543 FCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 8999999999999888865 57899999999999999999999976 6999999999999953 4689999999999
Q ss_pred eeccCCc--------eecCCCcccccchhccc
Q 023285 257 VQAQSGV--------MTAETGTYRWMAPEVAF 280 (284)
Q Consensus 257 ~~~~~~~--------~~~~~gt~~y~aPEvl~ 280 (284)
.++.... .....||++|.+||-|.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceee
Confidence 8765432 23457999999999764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=180.58 Aligned_cols=159 Identities=36% Similarity=0.587 Sum_probs=139.3
Q ss_pred CceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHH
Q 023285 122 SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 199 (284)
Q Consensus 122 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~ 199 (284)
+||.||+|... ++.+++|++........ .+.+.+|++.+++++|+|++++++.+......++++|++++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999984 58999999875533221 5789999999999999999999999999899999999999999999997
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhcc
Q 023285 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVA 279 (284)
Q Consensus 200 ~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl 279 (284)
... .++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.............+++.|+|||.+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 643 3899999999999999999999999999999999999999999999999999877655445566789999999988
Q ss_pred ccc
Q 023285 280 FTF 282 (284)
Q Consensus 280 ~~~ 282 (284)
.+.
T Consensus 159 ~~~ 161 (244)
T smart00220 159 LGK 161 (244)
T ss_pred ccC
Confidence 643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=182.71 Aligned_cols=167 Identities=20% Similarity=0.422 Sum_probs=144.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC--cE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NL 182 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~ 182 (284)
..++|++.+++|+|.++.||.|.. +++.++||++++. ..+.+.+|+.||+.|. ||||+.++++..++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 456899999999999999999984 6789999999864 2467899999999998 999999999987643 46
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeeccC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~~~ 261 (284)
-+|+||..+.+...+. +.++...+..++.++++||.|+|+.||.|||+||.|++||. .-.++|+|+|+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 7999999887766554 34788889999999999999999999999999999999994 457999999999988877
Q ss_pred CceecCCCcccccchhcccccc
Q 023285 262 GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......+.+..|--||++-..+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQ 208 (338)
T ss_pred ceeeeeeehhhcCCchheeech
Confidence 7778888899999999987654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-25 Score=197.11 Aligned_cols=173 Identities=21% Similarity=0.365 Sum_probs=147.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC------CceeeEEeEEEc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACTR 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~~ 178 (284)
+-..+|.+..-.|+|-|+.|.+|.. .++.||||+|.. ++-+.+.=+.|+++|++|.. .++++++..|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3446788888999999999999987 468999999974 34456677889999999963 589999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccce
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVA 255 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a 255 (284)
.+++|+|+|-+.- +|.+.|.+.. -.+....+..++.|++.||..|-+.||+|.||||+||||++. ..+||||||.|
T Consensus 506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 9999999999954 9999998753 357788999999999999999999999999999999999965 46899999999
Q ss_pred eeeccCCceecCCCcccccchhccccccC
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... ..+...-+..|.|||+|+|..|
T Consensus 585 ~~~~en-eitPYLVSRFYRaPEIiLG~~y 612 (752)
T KOG0670|consen 585 SFASEN-EITPYLVSRFYRAPEIILGLPY 612 (752)
T ss_pred cccccc-cccHHHHHHhccCcceeecCcc
Confidence 876554 3455566789999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=175.74 Aligned_cols=142 Identities=17% Similarity=0.188 Sum_probs=111.5
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCCH----------------------H--HHHHHHHHHHHHHhCCCCce
Q 023285 115 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------------E--MLKEFSQEVYIMRKIRHKNV 169 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------------------~--~~~~~~~E~~~l~~l~h~ni 169 (284)
...||+|++|.||+|.. +|+.||||++++..... . ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987 48999999998652210 0 01224679999999999987
Q ss_pred eeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEE
Q 023285 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 170 v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vk 248 (284)
.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 544443333 24899999998755443222 3457888999999999999999999 9999999999999998 89999
Q ss_pred Eecccceeeecc
Q 023285 249 VADFGVARVQAQ 260 (284)
Q Consensus 249 l~Dfg~a~~~~~ 260 (284)
|+|||+|+....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-25 Score=188.35 Aligned_cols=171 Identities=25% Similarity=0.361 Sum_probs=145.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
..+|.=.+.+|.|.- .|..+-. .+++||+|.+.....+....++..+|..++..+.|+||++++.+|+-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 446777778888887 4554543 5799999988655555666788899999999999999999999997653
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|+|||+|.. +|...+.. .++-..+..+..|++.|+.|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus 95 e~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 48999999976 99988863 367888999999999999999999999999999999999999999999999987665
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.-.++..+.|..|.|||++.|..|
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred ccccCchhheeeccCchheeccCC
Confidence 556788899999999999998754
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=181.16 Aligned_cols=166 Identities=20% Similarity=0.346 Sum_probs=141.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 183 (284)
+-+-.|+++++||+|+||.++.|+. ++++||||.-..... .-++..|.+.++.|. .++|++.|-+...+.+-.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 4466899999999999999999975 899999997543222 234677888999886 699999999999988899
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-----CCcEEEecccceeee
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARVQ 258 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-----~~~vkl~Dfg~a~~~ 258 (284)
+|+|.+ |.||.|++.-+...|+.+++..+|.|++.-++|+|++.+|+|||||+|+||.. .+.+.++|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 66999999999999999999999999999999999999999999999999973 346999999999975
Q ss_pred ccCC--------ceecCCCcccccchh
Q 023285 259 AQSG--------VMTAETGTYRWMAPE 277 (284)
Q Consensus 259 ~~~~--------~~~~~~gt~~y~aPE 277 (284)
.++. ......||-+||+-.
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSIN 206 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSIN 206 (449)
T ss_pred cCccccccCccccccccccceeeeEee
Confidence 4432 234557999999843
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.4e-24 Score=194.14 Aligned_cols=166 Identities=21% Similarity=0.367 Sum_probs=137.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV 185 (284)
.+.|.+...+|.|+|+.|-++.. +++..++|++.... .+..+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 56888999999999999998876 56889999986541 2234566555544 699999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe-cCCCcEEEecccceeeeccCCce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli-~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||.+.|+-+.+-+...+ .+. ..+..|+.+|+.++.|||++||+||||||+|||+ +..++++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 99999998888776632 233 7778899999999999999999999999999999 68999999999999876654 3
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
...+-|..|.|||++....|
T Consensus 471 ~tp~~t~~y~APEvl~~~~y 490 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEY 490 (612)
T ss_pred cccchhhcccChhhhccCCC
Confidence 34467889999999986554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=167.81 Aligned_cols=136 Identities=16% Similarity=0.260 Sum_probs=105.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCceeeEEeEEEcCC---cEE-EE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQFIGACTRPP---NLC-IV 185 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lV 185 (284)
.+.||+|+||.||..... ...+||++.... ....+.+.+|+.+++++ .||||++++|++.++. .++ +|
T Consensus 7 ~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPED-AQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEECCCC-cCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 467999999999963223 334799886542 22346799999999999 5799999999998864 333 78
Q ss_pred EEc--CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEecCC----CcEEEec-ccceee
Q 023285 186 TEF--MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM-NYLHQNNIIHRDLKTANLLMDEN----GVVKVAD-FGVARV 257 (284)
Q Consensus 186 ~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~iiH~Dikp~NIli~~~----~~vkl~D-fg~a~~ 257 (284)
+|| +.+++|.+++.+ +.+++. ..++.+++.++ +|||+++|+||||||+|||++.. +.++|+| ||.+..
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence 999 447899999965 345555 35678888887 99999999999999999999743 3899999 666554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=177.47 Aligned_cols=168 Identities=24% Similarity=0.387 Sum_probs=135.5
Q ss_pred CceeeeeeeecCceEEEEEEECC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC----CceeeEEeEE-EcCCcE
Q 023285 111 QLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH----KNVVQFIGAC-TRPPNL 182 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~ 182 (284)
+|++.++||+|+||.||.+...+ ..+|+|......... ...+..|..++..+.. ++++.+++.+ ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998754 468999876432111 1257788888888873 6899999999 577789
Q ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-----CcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-----~~vkl~Dfg~a~ 256 (284)
|+||+.+ |.+|.++..... +.++..++.+++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||+|+
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999988 679999886654 789999999999999999999999999999999999999865 469999999998
Q ss_pred --eec-cCC-------c-eecCCCcccccchhcccc
Q 023285 257 --VQA-QSG-------V-MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 257 --~~~-~~~-------~-~~~~~gt~~y~aPEvl~~ 281 (284)
... ..+ . .....||.+|+++..-.+
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 321 111 0 123459999999986554
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=164.44 Aligned_cols=137 Identities=23% Similarity=0.393 Sum_probs=117.1
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
+.||+|++|.||+|.+.+..|++|+..+...... ....+.+|+.++..+.|++++....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5689999999999999999999998765433221 1245788999999999999887777777777889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+|++|.+++.... . .+..++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999986532 2 7889999999999999999999999999999998 789999999998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=161.26 Aligned_cols=135 Identities=17% Similarity=0.185 Sum_probs=109.0
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
....|++|+||+||.+...+..++.+.+.....- .-....+.+|+++|+++. |+++++++++ ...+++|||+.
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 4567999999999988888889998887644321 112335889999999996 4889999886 45799999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEecCCCcEEEecccceeeecc
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di-kp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
|.+|...... . ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 82 G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 82 GAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred CccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9998754321 1 1357789999999999999999999 79999999999999999999985443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-22 Score=178.43 Aligned_cols=139 Identities=23% Similarity=0.414 Sum_probs=123.7
Q ss_pred CCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 183 (284)
..|...++||+|+|+.||+|+. .++.||+|.+.... ...+...|+++|..+. +.||+.+.+++..++...
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4688999999999999999965 34789999987542 2356889999999996 899999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEeccccee
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR 256 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~ 256 (284)
+|+||++.....++... ++...+..++..++.||.++|.+|||||||||.|+|.+ ..+.-.|+|||+|.
T Consensus 112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999999988854 67899999999999999999999999999999999998 55788999999996
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-21 Score=165.66 Aligned_cols=169 Identities=33% Similarity=0.571 Sum_probs=146.8
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHHHHHHHHHHHhCCCC-ceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678889999999999999887 8899999976644443 577899999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCC----
Q 023285 190 ARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG---- 262 (284)
Q Consensus 190 ~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~---- 262 (284)
.++++.+++.... ..+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997776543 2689999999999999999999999999999999999999888 79999999998554332
Q ss_pred ---ceecCCCcccccchhcccc
Q 023285 263 ---VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ---~~~~~~gt~~y~aPEvl~~ 281 (284)
......||..|+|||.+.+
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccCCHHHhcC
Confidence 2356689999999999876
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-21 Score=162.19 Aligned_cols=141 Identities=15% Similarity=0.227 Sum_probs=117.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHH------HHHHHHHHHhCCCCceeeEEeEEEcC-
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKE------FSQEVYIMRKIRHKNVVQFIGACTRP- 179 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~- 179 (284)
-.++|+..+.+|.|+||.||.....+..+|||++++.....+ .... +.+|+..+.++.|++|+.+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 467899999999999999999877778999999986644333 2233 67999999999999999998886533
Q ss_pred -------CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 180 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 180 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
+..++||||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|+||+++.+| ++|+||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 35899999999999988732 232 3456999999999999999999999999999988 999999
Q ss_pred cceeee
Q 023285 253 GVARVQ 258 (284)
Q Consensus 253 g~a~~~ 258 (284)
|..+..
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=160.81 Aligned_cols=133 Identities=20% Similarity=0.359 Sum_probs=109.7
Q ss_pred eeecCceEEEEEEECCceEEEEEecCCCCCH------HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
||+|+||.||+|.+.+..|++|......... ....++.+|+++++.++|+++.....++......++||||++|
T Consensus 2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g 81 (199)
T TIGR03724 2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG 81 (199)
T ss_pred CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence 7999999999999999999999975432211 1235678999999999988765555555556677999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
++|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.++...
T Consensus 82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 82 KPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred ccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999998755211 7899999999999999999999999999998 8999999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-22 Score=167.37 Aligned_cols=165 Identities=20% Similarity=0.329 Sum_probs=133.0
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeE-EEcCCcEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA-CTRPPNLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~lV 185 (284)
+.|.+.+.+|+|.||.+-++.++ ++.+++|.+... ....++|.+|...--.|. |.||+.-|++ |+..+.++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 57899999999999999999885 478999998654 234577888888766675 8999988864 7777888999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCCcEEEecccceeeeccCCc
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~--~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||++.|+|.+-+.. ..+-+...++++.|+++|++|+|+++++|||||.+||||- +..+|||||||..+.....
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-- 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-- 176 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence 999999999987744 4578888999999999999999999999999999999994 4458999999998743321
Q ss_pred eecCCCcccccchhcccc
Q 023285 264 MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~ 281 (284)
-...-.+-.|.|||+...
T Consensus 177 V~~~~~~~~y~~pe~~~~ 194 (378)
T KOG1345|consen 177 VKYLEYVNNYHAPELCDT 194 (378)
T ss_pred ehhhhhhcccCCcHHHhh
Confidence 111224567889998653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=166.22 Aligned_cols=144 Identities=17% Similarity=0.184 Sum_probs=113.3
Q ss_pred CceeeeeeeecCceEEEEEE---ECCceEEEEEecCCCCC--------------------H--HHHHHHHHHHHHHHhCC
Q 023285 111 QLKIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVN--------------------T--EMLKEFSQEVYIMRKIR 165 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~---~~~~~vavK~~~~~~~~--------------------~--~~~~~~~~E~~~l~~l~ 165 (284)
.|++.+.||+|++|.||+|. .+++.||||+++..... . .....+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999998 36899999998754211 0 01234678999999997
Q ss_pred CC--ceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEec
Q 023285 166 HK--NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLMD 242 (284)
Q Consensus 166 h~--niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-iiH~Dikp~NIli~ 242 (284)
+. .++++++. ...++||||++|++|..+... ........+..++.|++.++.+||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 63 34455543 235899999999888765433 234566677899999999999999999 99999999999999
Q ss_pred CCCcEEEecccceeeecc
Q 023285 243 ENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 243 ~~~~vkl~Dfg~a~~~~~ 260 (284)
++.++|+|||.|.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 88999999999985544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=179.95 Aligned_cols=138 Identities=21% Similarity=0.316 Sum_probs=115.6
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCC-H-----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-T-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
|...+.||+|+||.||+|.+.+..+++|+....... . ....++.+|+++++.++|++++....++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 355889999999999999998877777654322111 1 1235688999999999999998888777777788999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
|||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++...
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999885 346789999999999999999999999999999 67899999999998654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=155.27 Aligned_cols=139 Identities=16% Similarity=0.172 Sum_probs=109.3
Q ss_pred CceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCH--------------------HHHHHHHHHHHHHHhCCCC--
Q 023285 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT--------------------EMLKEFSQEVYIMRKIRHK-- 167 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~h~-- 167 (284)
.|.+.+.||+|+||.||++.. +++.||||+++...... .....+..|..++.++.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377788999999999999987 58999999876432110 0112367889999999877
Q ss_pred ceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q 023285 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (284)
Q Consensus 168 niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~v 247 (284)
.++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.|++|+||+|+||++++++.+
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44555542 345899999999998765421 3456788999999999999999999999999999999999
Q ss_pred EEecccceeeecc
Q 023285 248 KVADFGVARVQAQ 260 (284)
Q Consensus 248 kl~Dfg~a~~~~~ 260 (284)
+|+|||.+.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=161.82 Aligned_cols=133 Identities=23% Similarity=0.443 Sum_probs=113.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----C---CceeeEEeEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----H---KNVVQFIGACT 177 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~ 177 (284)
...+|.+.++||-|.|++||++..+ ++.||+|+.+.. ....+..+.||++|++++ | ..||++++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 4478999999999999999999874 588999999853 344566889999999995 2 46999999996
Q ss_pred c----CCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCC
Q 023285 178 R----PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDEN 244 (284)
Q Consensus 178 ~----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~ 244 (284)
. +.++|+|+|++ |.+|..++...+ +.++...+++|+.||+.||.|||.+ ||||.||||+|||+..+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 5 45799999999 669999997743 5699999999999999999999965 99999999999999543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-20 Score=162.13 Aligned_cols=179 Identities=20% Similarity=0.382 Sum_probs=146.5
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..+...++++...+-+|.||.||+|.+. .+.|.+|.++.. .++-....+++|.-++..+.|||+.++.+++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 3445567778888999999999999653 256888888743 35556778999999999999999999999886
Q ss_pred c-CCcEEEEEEcCCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q 023285 178 R-PPNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249 (284)
Q Consensus 178 ~-~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl 249 (284)
. ....+.++.++.-|+|..|+..++ +.++..++..++.|++.||+|||+.||||.||.++|.+||+.-+|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 5 445788899999999999998432 34677788899999999999999999999999999999999999999
Q ss_pred ecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 250 ADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 250 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
+|=.+++-..+... ...+-....|||||.+.+..|
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 99999986544332 234456789999999877655
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=146.07 Aligned_cols=138 Identities=20% Similarity=0.256 Sum_probs=99.9
Q ss_pred eeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHH----------------------HHHHHHHHHhCCCC--ce
Q 023285 115 ECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE----------------------FSQEVYIMRKIRHK--NV 169 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~h~--ni 169 (284)
.+.||+|+||.||+|... +++||||++++.......... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 899999998764322211111 13566666666543 34
Q ss_pred eeEEeEEEcCCcEEEEEEcCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcE
Q 023285 170 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV 247 (284)
Q Consensus 170 v~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~v 247 (284)
++.++. ...++||||++++.+.. .+.... . ...+..++.+++.++.++|. .||+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 555543 23589999999854321 111111 1 15678899999999999999 9999999999999999 8999
Q ss_pred EEecccceeeecc
Q 023285 248 KVADFGVARVQAQ 260 (284)
Q Consensus 248 kl~Dfg~a~~~~~ 260 (284)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=140.64 Aligned_cols=134 Identities=15% Similarity=0.176 Sum_probs=114.8
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.+.||+|.++.||++...+..+++|..+.... ...+.+|+.+++.++| .++++++++...++..+++|||++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 356799999999999999888999999865422 4578899999999987 5899999998888889999999998
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
+++..+ +......++.+++.++.++|.. +++|+|++|+||++++.+.++++|||.++..+
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~ 140 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence 776543 4456677889999999999985 79999999999999998999999999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-18 Score=147.53 Aligned_cols=138 Identities=13% Similarity=0.149 Sum_probs=107.7
Q ss_pred eeee-ecCceEEEEEEECCceEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhCCCCce--eeEEeEEEcCCc
Q 023285 116 CKVA-SGSYGDLYKGTYCSQEVAIKVLKPECV-----------NTEMLKEFSQEVYIMRKIRHKNV--VQFIGACTRPPN 181 (284)
Q Consensus 116 ~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~ 181 (284)
..|| .|+.|+||.....+..++||.+..... .......+.+|+.++.+++|+++ +..+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 788899999888889999998853211 11233568899999999998775 677776543222
Q ss_pred ----EEEEEEcCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 182 ----LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 182 ----~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.++|||+++| .+|.+++.. ..++.. .+.+++.++.+||++||+||||||.|||++.++.++|+|||.++
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 2599999997 699988854 345543 35689999999999999999999999999999999999999987
Q ss_pred eec
Q 023285 257 VQA 259 (284)
Q Consensus 257 ~~~ 259 (284)
...
T Consensus 191 ~~~ 193 (239)
T PRK01723 191 LRT 193 (239)
T ss_pred cCC
Confidence 644
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.8e-19 Score=172.85 Aligned_cols=175 Identities=21% Similarity=0.277 Sum_probs=139.3
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTR 178 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 178 (284)
...++....|.|.+.||+|+||.||+|+. +++.||+|+-++....+-.+ =.+++.+|+ -+.|..+..+..-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYI-----CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeee-----hHHHHHhhchhhhcchHHHHHHHcc
Confidence 46788899999999999999999999987 57899999988765432111 122334444 2455566666666
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-------CCCcEEEec
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-------ENGVVKVAD 251 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-------~~~~vkl~D 251 (284)
.+..++|+||.+.|+|.+++.. .+.+++..+..++.|++..++.||..+|||+||||+|+|+. ++--++|+|
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 6778999999999999999974 67899999999999999999999999999999999999994 234699999
Q ss_pred ccceee---eccCCceecCCCcccccchhcccccc
Q 023285 252 FGVARV---QAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 252 fg~a~~---~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
||.+.- ..+.......++|-.+-.+|+..|..
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp 879 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP 879 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCC
Confidence 999853 33444555667888999999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.6e-20 Score=181.23 Aligned_cols=121 Identities=13% Similarity=0.156 Sum_probs=91.7
Q ss_pred hCCC-CceeeEEeEE-------EcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023285 163 KIRH-KNVVQFIGAC-------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (284)
Q Consensus 163 ~l~h-~niv~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di 234 (284)
.++| +||++++++| .....++.++|++ +++|.+++......+++..++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5788888877 2334678889988 45999999765567999999999999999999999999999999
Q ss_pred CCCCEEecC-------------------CCcEEEecccceeeeccC-----------------CceecCCCcccccchhc
Q 023285 235 KTANLLMDE-------------------NGVVKVADFGVARVQAQS-----------------GVMTAETGTYRWMAPEV 278 (284)
Q Consensus 235 kp~NIli~~-------------------~~~vkl~Dfg~a~~~~~~-----------------~~~~~~~gt~~y~aPEv 278 (284)
||+|||++. ++.+|++|||+++..... .......||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 445666677766532110 00112357899999999
Q ss_pred cccccC
Q 023285 279 AFTFFF 284 (284)
Q Consensus 279 l~~~~y 284 (284)
+.+..|
T Consensus 187 ~~~~~~ 192 (793)
T PLN00181 187 DNGSSS 192 (793)
T ss_pred hccCCC
Confidence 987665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.4e-18 Score=141.68 Aligned_cols=174 Identities=28% Similarity=0.574 Sum_probs=143.6
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..|+.+++.+..+|.+...|..|+|+|.+.+++.|+++.........++|..|.-.++-..||||+.++|+|..++++.+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 45677888899999999999999999999999999998666666667889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC-Cceec-CCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 185 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN-NIIHR-DLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~-Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+..||+.|||+..++.+.+ .++..++.+++.+|++||+|||+. .+|-| -|+...+++|++.+.+|. .+-+++..+.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe 343 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE 343 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeec
Confidence 9999999999999998643 467788999999999999999987 34433 688999999998877764 2222222111
Q ss_pred CceecCCCcccccchhccccc
Q 023285 262 GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~ 282 (284)
....-.|.||+||.+..+
T Consensus 344 ---~gr~y~pawmspealqrk 361 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRK 361 (448)
T ss_pred ---cccccCcccCCHHHHhcC
Confidence 122457899999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-18 Score=161.07 Aligned_cols=170 Identities=23% Similarity=0.346 Sum_probs=132.5
Q ss_pred eeeeeeeecCceEEEEEEEC--CceEEEEEec----CCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 113 KIECKVASGSYGDLYKGTYC--SQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~----~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.....+|.|++|.|+..... ...++.|..+ +..........+..|..+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 56778999999977766542 2333444322 22222222333778888899999999988877777666666669
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC----
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---- 262 (284)
||+++ +|+.++.. .+.+....+..++.|++.|+.|+|+.||.|||+|++|+++..+|.+||+|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 99999976 3578999999999999999999999999999999999999999999999999997643322
Q ss_pred -ceecCCCcccccchhccccccC
Q 023285 263 -VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......|+..|+|||++.+..|
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~y 501 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEY 501 (601)
T ss_pred hhhcCcccCCcCcCccccccccc
Confidence 2345579999999999988776
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-18 Score=157.71 Aligned_cols=160 Identities=24% Similarity=0.387 Sum_probs=134.2
Q ss_pred eeecCceEEEEEE-----ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 118 VASGSYGDLYKGT-----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 118 lg~G~~g~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+|+|+||.|+..+ ..+.-+|.|+.+..............|..++..++ ||.++++.-.++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998643 34567888887654332222236677888999887 99999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 271 (284)
|.|..-+.+ ...+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++....... .+||+
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt~ 157 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGTY 157 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccch
Confidence 999887765 46688888889999999999999999999999999999999999999999999986554322 28999
Q ss_pred cccchhcccc
Q 023285 272 RWMAPEVAFT 281 (284)
Q Consensus 272 ~y~aPEvl~~ 281 (284)
-|||||++++
T Consensus 158 eymApEI~~g 167 (612)
T KOG0603|consen 158 EYRAPEIING 167 (612)
T ss_pred hhhhhHhhhc
Confidence 9999999983
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.9e-16 Score=143.07 Aligned_cols=142 Identities=18% Similarity=0.274 Sum_probs=99.1
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCH---H-------------------------H----------HHHHHH
Q 023285 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT---E-------------------------M----------LKEFSQ 156 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~---~-------------------------~----------~~~~~~ 156 (284)
+.||+|++|.||+|+. +|+.||||+.++..... + . .-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 68999999998753110 0 0 012455
Q ss_pred HHHHHHhCC----CCceeeEEeEE-EcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCce
Q 023285 157 EVYIMRKIR----HKNVVQFIGAC-TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-GMNYLHQNNII 230 (284)
Q Consensus 157 E~~~l~~l~----h~niv~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~-~L~~LH~~~ii 230 (284)
|...+.+++ +.+-+.+-.++ ......++||||++|++|.++........+ ...++..++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 665555553 22222222222 123346899999999999888754222222 3445666655 47889999999
Q ss_pred ecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 231 HRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 231 H~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
|+|++|.||+++.++.++++|||++...+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-15 Score=119.21 Aligned_cols=129 Identities=16% Similarity=0.214 Sum_probs=98.4
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEEcCCCCC
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMARGS 193 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~~~gs 193 (284)
.+.++.|.++.||+++..+..+++|+...... ....+..|+.+++.+.+.++ ++++.... ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35688999999999999999999999764321 12346789999998875544 45555443 23579999999987
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEecCCCcEEEecccceeee
Q 023285 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-----IHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 194 L~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i-----iH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+...
T Consensus 78 l~~~-----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 78 LLTE-----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc-----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 7543 0 1 113456789999999999885 9999999999998 678999999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=140.30 Aligned_cols=148 Identities=17% Similarity=0.225 Sum_probs=92.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC----------------------------H----HHHHH--
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN----------------------------T----EMLKE-- 153 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----------------------------~----~~~~~-- 153 (284)
..|.. +.||+|++|.||+|+.. |+.||||++++.... . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 78999999999999983 799999999865210 0 11111
Q ss_pred ----HHHHHHHHHhCC----CCceeeEEeEEEc-CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 023285 154 ----FSQEVYIMRKIR----HKNVVQFIGACTR-PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224 (284)
Q Consensus 154 ----~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~L 224 (284)
+.+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+++.++-.-.....+...+.+...+ .-+..+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qi 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQV 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHH
Confidence 344444444442 3332322222221 34567999999999998753211122232222221111 112334
Q ss_pred HhCCceecCCCCCCEEecCCC----cEEEecccceeeecc
Q 023285 225 HQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQAQ 260 (284)
Q Consensus 225 H~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~~~ 260 (284)
...|++|+|++|.||+++.+| +++++|||++...+.
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 568999999999999999888 999999999986543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.8e-14 Score=123.55 Aligned_cols=167 Identities=16% Similarity=0.250 Sum_probs=107.6
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCC----------CceeeEEeEE-
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRH----------KNVVQFIGAC- 176 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~- 176 (284)
.+...+.||.|+++.||.+++ +++++|+|+..... ......+.+.+|......+.+ -.++-.++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 567788999999999999999 46999999875332 223456778888766665433 1121112211
Q ss_pred --------EcC---C-----cEEEEEEcCCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 023285 177 --------TRP---P-----NLCIVTEFMARGSIYDFLHK---QKGV---FQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (284)
Q Consensus 177 --------~~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~~---~~~~~~~~i~~~i~~~L~~LH~~~iiH~Di 234 (284)
... . +.+++|+-+.+ +|.+++.. .... ........+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 1 35789998865 88887643 2221 222334566689999999999999999999
Q ss_pred CCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhccc
Q 023285 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 235 kp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
+|+|++++.+|.++|+||+........ ......+..|.+||+..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELES 215 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce--eeccCCCcccCChhhhh
Confidence 999999999999999999887654332 12144567899999764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.6e-15 Score=131.11 Aligned_cols=175 Identities=21% Similarity=0.339 Sum_probs=122.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-------------------------------------ceEEEEEecCCCC-
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------------------------------------QEVAIKVLKPECV- 146 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------------------------------------~~vavK~~~~~~~- 146 (284)
..+..++|.|++.||+|....||.|+..+ -+.|||.+-.-..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34556789999999999999999875311 0246666532111
Q ss_pred --CHHHHHHHHHHHH--------------HHHh--------CCCCceeeEEeEEEcC-----------------------
Q 023285 147 --NTEMLKEFSQEVY--------------IMRK--------IRHKNVVQFIGACTRP----------------------- 179 (284)
Q Consensus 147 --~~~~~~~~~~E~~--------------~l~~--------l~h~niv~~~~~~~~~----------------------- 179 (284)
+....+..-+|.- ..+. -+|||||++.++|.++
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1112233333321 1122 2599999999988542
Q ss_pred ----CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCC--cEEEec
Q 023285 180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVAD 251 (284)
Q Consensus 180 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~--~~~--~vkl~D 251 (284)
..+|+||..++. +|.+|+..+ ..+.....-++.|+++|..|||++||.|||+|.+|||+. +++ .+.|+|
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaD 388 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVAD 388 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcc
Confidence 248999999976 999999764 356777788999999999999999999999999999995 333 689999
Q ss_pred ccceeeeccC-------CceecCCCcccccchhccccc
Q 023285 252 FGVARVQAQS-------GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 252 fg~a~~~~~~-------~~~~~~~gt~~y~aPEvl~~~ 282 (284)
||.|--.... ......-|.-.-||||+....
T Consensus 389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred cceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9988532221 112233577889999998653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.6e-14 Score=116.79 Aligned_cols=138 Identities=17% Similarity=0.210 Sum_probs=101.1
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCC-----------C---------HHHHHHH----HHHHHHHHh
Q 023285 116 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECV-----------N---------TEMLKEF----SQEVYIMRK 163 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~E~~~l~~ 163 (284)
..||.|--+.||.|... +..+|||+.+.... + ......+ .+|.+.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899999863211 0 0011223 389999999
Q ss_pred CCC--CceeeEEeEEEcCCcEEEEEEcCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCE
Q 023285 164 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANL 239 (284)
Q Consensus 164 l~h--~niv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~iiH~Dikp~NI 239 (284)
+.. -+++..+++ ..-++||||+.+..+.. .+. ...++...+..+..+++.+|..| |+.|++|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 964 567777765 45689999997754422 222 12355566778889999999998 899999999999999
Q ss_pred EecCCCcEEEecccceeeecc
Q 023285 240 LMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~ 260 (284)
+++ ++.+.|+|||.|-....
T Consensus 157 L~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEE-CCcEEEEECCCceeCCC
Confidence 996 57899999999875544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7e-16 Score=149.49 Aligned_cols=168 Identities=16% Similarity=0.242 Sum_probs=133.0
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
++...+.||++.|=+|.+|++.+-.|+||++-... .+-+...+...|++ ....++||.+++.-+-..+...|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 78889999999999999999987779999985332 23333344444555 5666899999999888888888999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee----ccCCce
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----AQSGVM 264 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~----~~~~~~ 264 (284)
... +|+|-+.. +.-+..-+.+.|+.|++.|+.-+|+.||.|+|||.+||||..-+-+.|+||...+.. +.+...
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 966 99999976 355777788899999999999999999999999999999999999999999987642 122222
Q ss_pred e----cCCCcccccchhcccc
Q 023285 265 T----AETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~----~~~gt~~y~aPEvl~~ 281 (284)
+ +...-.+|.|||.|..
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred eEEEecCCceeeecChHhhhc
Confidence 1 2233458999998864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.8e-14 Score=115.66 Aligned_cols=81 Identities=21% Similarity=0.308 Sum_probs=71.4
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcc
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~ 271 (284)
|+|.+++......+++..+..++.|++.||.|||+++ ||+|||++.++.+++ ||.++..... ...||+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6899999876667999999999999999999999998 999999999999999 9999876543 236899
Q ss_pred cccchhccccccC
Q 023285 272 RWMAPEVAFTFFF 284 (284)
Q Consensus 272 ~y~aPEvl~~~~y 284 (284)
.|||||++.+..|
T Consensus 69 ~y~aPE~~~~~~~ 81 (176)
T smart00750 69 YFMAPEVIQGQSY 81 (176)
T ss_pred cccChHHhcCCCC
Confidence 9999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-13 Score=109.20 Aligned_cols=134 Identities=22% Similarity=0.296 Sum_probs=103.2
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCC
Q 023285 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~ 190 (284)
.+++|+-+.+|.+.+-+.++++|.=.+...... ...+..+|++++.+++--.|...+-+..+.....|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 578899999999988888888886544433221 12347789999999986666555555666677889999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
|..|.+++... . ..++..+-.-+.-||.+||+|+||.++||++..+ .+.++|||++....
T Consensus 83 G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 83 GELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred ChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 99999898663 2 3455566666777999999999999999999654 49999999998543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-13 Score=107.57 Aligned_cols=145 Identities=22% Similarity=0.268 Sum_probs=111.0
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCH-----H-HHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-----E-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~-----~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
....+.+|+-+.|+++.+.|+...||.-.+..... . ...+..+|++++.++.--.|.-..-++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 45678899999999999999999998654332221 1 24568899999999976565544445556666789999
Q ss_pred cCCC-CCHHHHHHhcCCCCCHHH-HHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEecccceeee
Q 023285 188 FMAR-GSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQ 258 (284)
Q Consensus 188 ~~~~-gsL~~~l~~~~~~~~~~~-~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~Dfg~a~~~ 258 (284)
|++| .++.+++......-..+. ...++.+|-..+.-||.++|||+||..+||++..++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 488888877543333333 378888999999999999999999999999997655 4589999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-12 Score=108.82 Aligned_cols=140 Identities=18% Similarity=0.254 Sum_probs=106.4
Q ss_pred eeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcC---CcEEEEEEcC
Q 023285 116 CKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRP---PNLCIVTEFM 189 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lV~e~~ 189 (284)
+.|+.|.++.+|+++..+ +.+++|+....... .....+.+|..+++.+.+ .++++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998865 89999997543211 134568899999999976 4467778777654 2678999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------- 226 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------- 226 (284)
+|.++.+.+.. ..++......++.++++.|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99887765421 345666677777777777777773
Q ss_pred -------------CCceecCCCCCCEEecC--CCcEEEecccceeee
Q 023285 227 -------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQ 258 (284)
Q Consensus 227 -------------~~iiH~Dikp~NIli~~--~~~vkl~Dfg~a~~~ 258 (284)
..++|+|+.|.||+++. ++.+.|+||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23699999999999998 667899999988754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.4e-14 Score=135.66 Aligned_cols=172 Identities=25% Similarity=0.406 Sum_probs=139.9
Q ss_pred CceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~ 186 (284)
.|.+.+.||+|+|+.+-.... ....+|.|.+...............|..+-+.+. |+|++.+++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 567777799999999876654 2345677766544333445556677888888887 999999999999999999999
Q ss_pred EcCCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCC-cEEEecccceeeecc-CC
Q 023285 187 EFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ-SG 262 (284)
Q Consensus 187 e~~~~gsL~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~-~~ 262 (284)
++..|+++.+.+ .......+...+..+..|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|..... .+
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999999988 443325677788899999999999999 99999999999999999999 999999999987655 32
Q ss_pred c---eecCCC-cccccchhccccc
Q 023285 263 V---MTAETG-TYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~---~~~~~g-t~~y~aPEvl~~~ 282 (284)
. .....| ++.|+|||+..+.
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~ 204 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGK 204 (601)
T ss_pred cceeeecccCCCCCCCCcccccch
Confidence 2 234568 9999999998874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-11 Score=106.31 Aligned_cols=135 Identities=16% Similarity=0.112 Sum_probs=99.8
Q ss_pred CceEEEEEEECCceEEEEEecCCCCCHHHH----------HHHHHHHHHHHhCCCCce--eeEEeEEEc-----CCcEEE
Q 023285 122 SYGDLYKGTYCSQEVAIKVLKPECVNTEML----------KEFSQEVYIMRKIRHKNV--VQFIGACTR-----PPNLCI 184 (284)
Q Consensus 122 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~----------~~~~~E~~~l~~l~h~ni--v~~~~~~~~-----~~~~~l 184 (284)
....|++....|+.+.||........ +.. ..+.+|...+.++...+| +..++++.. ....++
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33446677888889999977433211 111 147899999988864443 444555432 234789
Q ss_pred EEEcCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-------CCcEEEecccce
Q 023285 185 VTEFMARG-SIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVADFGVA 255 (284)
Q Consensus 185 V~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-------~~~vkl~Dfg~a 255 (284)
|||++++. +|.+++... ....+......++.+++..+.-||++||+|+|+++.|||++. +..+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999886 899988532 234566777899999999999999999999999999999975 468999999988
Q ss_pred ee
Q 023285 256 RV 257 (284)
Q Consensus 256 ~~ 257 (284)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 64
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-12 Score=120.16 Aligned_cols=122 Identities=31% Similarity=0.553 Sum_probs=104.9
Q ss_pred HHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCE
Q 023285 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-IHRDLKTANL 239 (284)
Q Consensus 161 l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i-iH~Dikp~NI 239 (284)
|+.+.|.|+.+++|.+.+++..+.|.+|+..|+|.|.+......++......++++|+.||+|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 467899999999999999999999999999999999998866678888888999999999999998765 9999999999
Q ss_pred EecCCCcEEEecccceeeeccC---CceecCCCcccccchhccccc
Q 023285 240 LMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 240 li~~~~~vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPEvl~~~ 282 (284)
++|..-.+||+|||+....... .......-..-|.|||++++.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 9999999999999998766421 112222345789999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.9e-13 Score=127.99 Aligned_cols=135 Identities=30% Similarity=0.473 Sum_probs=94.4
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.+|..++.|..|+||.||..+++ .+++|+|+-+... ..+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----ilRn------ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----ILRN------ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch----hhhc------cccccCCccee-----------------
Confidence 46888999999999999999775 6889997643211 1110 23333334333
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC------
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------ 261 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~------ 261 (284)
|+....+.. .+.++.. ++.+++|||+.||+|||+||+|.+|..-|++|+.|||+++...-.
T Consensus 136 ----gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 ----GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred ----chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 455555543 2344433 378899999999999999999999999999999999998742110
Q ss_pred -C---------ceecCCCcccccchhccccccC
Q 023285 262 -G---------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 -~---------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+ .-...+|||.|+||||+..+-|
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy 235 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY 235 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhcc
Confidence 0 0122379999999999987643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.2e-13 Score=120.83 Aligned_cols=101 Identities=25% Similarity=0.477 Sum_probs=88.6
Q ss_pred cEEEEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
++||.|+++...+|.+++..+ ....+....+.++.|++.+++| ++.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 588999999999999999643 2356777889999999999999 99999999999999999999999999998876
Q ss_pred ccCC-------ceecCCCcccccchhccccccC
Q 023285 259 AQSG-------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~-------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .++..+||..||+||-|.|..|
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y 439 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY 439 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhh
Confidence 5544 5677899999999999998766
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.6e-11 Score=96.65 Aligned_cols=128 Identities=20% Similarity=0.246 Sum_probs=84.2
Q ss_pred EEEEEEE-CCceEEEEEecCCCC-----------------------CH-HHHHHHHHHHHHHHhCCCC--ceeeEEeEEE
Q 023285 125 DLYKGTY-CSQEVAIKVLKPECV-----------------------NT-EMLKEFSQEVYIMRKIRHK--NVVQFIGACT 177 (284)
Q Consensus 125 ~Vy~~~~-~~~~vavK~~~~~~~-----------------------~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 177 (284)
.||.|.. .+..+|||+.+.... .. -......+|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4888887 578999999864311 00 1134478899999999865 567777553
Q ss_pred cCCcEEEEEEcCC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 178 RPPNLCIVTEFMA--RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY-LHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 178 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
..++||||++ |..+..+... .++......++.+++..+.. +|+.||+|+|+.+.||+++++ .+.++|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~---~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV---DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC---GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhc---cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555544322 12244556777788885555 579999999999999999876 999999999
Q ss_pred eeeecc
Q 023285 255 ARVQAQ 260 (284)
Q Consensus 255 a~~~~~ 260 (284)
+.....
T Consensus 153 av~~~~ 158 (188)
T PF01163_consen 153 AVDSSH 158 (188)
T ss_dssp EEETTS
T ss_pred ceecCC
Confidence 875543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-10 Score=94.80 Aligned_cols=108 Identities=17% Similarity=0.250 Sum_probs=86.1
Q ss_pred HHHHHHHHHHHHhCCCC--ceeeEEeEEEcC----CcEEEEEEcCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 023285 151 LKEFSQEVYIMRKIRHK--NVVQFIGACTRP----PNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223 (284)
Q Consensus 151 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~ 223 (284)
.....+|...+..+... .++..+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 34678888888888643 345566665542 2358999999884 7999987632 26667788999999999999
Q ss_pred HHhCCceecCCCCCCEEecCCC---cEEEecccceeeec
Q 023285 224 LHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQA 259 (284)
Q Consensus 224 LH~~~iiH~Dikp~NIli~~~~---~vkl~Dfg~a~~~~ 259 (284)
||++||+|+|+++.|||++.++ .+.++||+.++...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999999999999887 89999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.9e-11 Score=111.67 Aligned_cols=174 Identities=25% Similarity=0.286 Sum_probs=137.3
Q ss_pred ccCCceeeeeeee--cCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC
Q 023285 108 DAKQLKIECKVAS--GSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (284)
Q Consensus 108 ~~~~~~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 180 (284)
....+.+.+.+|. |.+|.+|.+.. .+..+|+|.-+.....+.....=.+|+..-+++. |+|.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3445677889999 99999998866 3577899884433222222233355676777775 899999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEecCC-CcEEEecccce
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVA 255 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a 255 (284)
..++=+|++. .+|.++.+.....++...+.....+... |+.++|..+++|-|+||+||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999985 6999998876566888889999999999 9999999999999999999999988 88999999998
Q ss_pred eeeccCCce------ecCCCcccccchhccccc
Q 023285 256 RVQAQSGVM------TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~~~~~------~~~~gt~~y~aPEvl~~~ 282 (284)
......... ....|...|++||++++.
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l 303 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL 303 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc
Confidence 876544311 122577899999998764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.6e-10 Score=95.30 Aligned_cols=138 Identities=18% Similarity=0.234 Sum_probs=104.1
Q ss_pred ceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCC-------H-------------HHHHHHHHHHHHHHhCCCC--c
Q 023285 112 LKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVN-------T-------------EMLKEFSQEVYIMRKIRHK--N 168 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-------~-------------~~~~~~~~E~~~l~~l~h~--n 168 (284)
..++.+||.|--+.||.|... +.++|||.-+....+ . -......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 457789999999999999884 899999976533210 0 1234477899999999754 7
Q ss_pred eeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 169 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
++..+++ ++-.+|||+++|-.|...- ++......++..|+.-+.-+-..|+||+|+++-||+++++|.+.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 7777765 5678999999996665432 23344455666666666666689999999999999999999999
Q ss_pred Eecccceeeec
Q 023285 249 VADFGVARVQA 259 (284)
Q Consensus 249 l~Dfg~a~~~~ 259 (284)
++||-.+....
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99998876443
|
|
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-10 Score=76.15 Aligned_cols=55 Identities=58% Similarity=0.925 Sum_probs=52.2
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~~ 63 (284)
.|+++++.+|+..|+||.+|.+|+|.|||.+|.|+|.+|..+++++|..++++.+
T Consensus 13 gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 13 KLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred chHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 4789999999999999999999999999999999999999999999999998765
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.9e-09 Score=86.34 Aligned_cols=139 Identities=14% Similarity=0.087 Sum_probs=103.3
Q ss_pred eecCceEEEEEEECCceEEEEEecCCCC---C-HHHHHHHHHHHHHHHhCCCC--ceeeEEeEEEc----CCcEEEEEEc
Q 023285 119 ASGSYGDLYKGTYCSQEVAIKVLKPECV---N-TEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR----PPNLCIVTEF 188 (284)
Q Consensus 119 g~G~~g~Vy~~~~~~~~vavK~~~~~~~---~-~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~----~~~~~lV~e~ 188 (284)
|+||.+-|++-...|+.+-+|.-..... . +-....|.+|...+.++... .+++....... .-.-+||+|-
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~ 106 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED 106 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence 5577788998888887888887542111 1 22456799999999999642 34555422211 1236899998
Q ss_pred CCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--EEEecccceee
Q 023285 189 MAR-GSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARV 257 (284)
Q Consensus 189 ~~~-gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~--vkl~Dfg~a~~ 257 (284)
++| .+|.+++.+.. ...+......+..+++..+.-||+.|+.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 864 48988885532 34567777899999999999999999999999999999987777 99999998864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.5e-09 Score=98.03 Aligned_cols=121 Identities=16% Similarity=0.278 Sum_probs=101.1
Q ss_pred CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHH
Q 023285 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211 (284)
Q Consensus 132 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~ 211 (284)
.+.+|.|...+... ........+-++-++.++||||++++..+..++.+|+|+|.+. .|..++.+. ....+.
T Consensus 36 ~~~~vsVF~~~~~~--~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSN--GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL----GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCC--chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh----HHHHHH
Confidence 45778888776542 2444557778889999999999999999999999999999985 788888663 356677
Q ss_pred HHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 212 KVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 212 ~i~~~i~~~L~~LH-~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.-+.||+.||.||| +.+++|++|..+.|+++..|..||++|..+...+.
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 78899999999998 67999999999999999999999999998865433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.1e-09 Score=98.06 Aligned_cols=141 Identities=18% Similarity=0.281 Sum_probs=94.5
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCCH--------------------------------HH------HHHHHH
Q 023285 116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNT--------------------------------EM------LKEFSQ 156 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~--------------------------------~~------~~~~~~ 156 (284)
+.|+.++-|.||+|+.. |+.||||+.+|..... +. .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 67999999999999996 8999999998763211 00 111334
Q ss_pred HHHHHHhCC-----CCc--eeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023285 157 EVYIMRKIR-----HKN--VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229 (284)
Q Consensus 157 E~~~l~~l~-----h~n--iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i 229 (284)
|..-+.+++ .++ |++++.-+ .+.-.++|||++|-.+.+........++.+.+.....++. +..+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~--t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEY--TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhc--cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 444444442 122 23333222 2446799999999999888543334566554444333322 333445799
Q ss_pred eecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 230 iH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+|.|..|.||+++.+|.+.+.|||.....+.
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.8e-08 Score=81.29 Aligned_cols=140 Identities=16% Similarity=0.189 Sum_probs=92.8
Q ss_pred ccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHH------HHHHHHHHHhCC---CCceeeEEeEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKE------FSQEVYIMRKIR---HKNVVQFIGACT 177 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~---h~niv~~~~~~~ 177 (284)
-..+|++.+.+-......|.+-...+..+++|.-++.....+ .... ..+++..+.+++ -.....++.+..
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 346788888888877777888788899999998765432211 1111 122333333332 233333333332
Q ss_pred c-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 178 R-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 178 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
. ....+++|||++|..|.++.. +++ .++..+..++.-+|+.|+.|+|..|.|++++++ .++++||
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 2 234678999999988766532 222 244567778999999999999999999999854 5999999
Q ss_pred cceee
Q 023285 253 GVARV 257 (284)
Q Consensus 253 g~a~~ 257 (284)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 87653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-09 Score=99.67 Aligned_cols=149 Identities=18% Similarity=0.178 Sum_probs=120.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 183 (284)
...+|.+...||.|.|+.++.... .+..+++|-+............-..|+.+...+. |.+++..+..+....+.|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 346788999999999999998765 3567888877655443333333456777777774 888998888777777888
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccceee
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARV 257 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~~ 257 (284)
+-.||++++++.... .....+++...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 999999999887666 334568888899999999999999999999999999999999876 7889999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.81 E-value=9.4e-08 Score=80.95 Aligned_cols=137 Identities=17% Similarity=0.255 Sum_probs=87.1
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc--eeeEEeEEEcCCcEEEEEEcCCCCC
Q 023285 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTEFMARGS 193 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~~~~gs 193 (284)
..||+|..+.||+. .+..+++|...+.. . .....+|.++++.+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 56899999999984 35578889876432 1 234688999999987433 5788888888888899999999963
Q ss_pred -HHHH---------------------HHhcC-CCCCHHHHH-HHHH----------HHHH-HHHHHH----hCCceecCC
Q 023285 194 -IYDF---------------------LHKQK-GVFQLTSLL-KVAI----------DVSK-GMNYLH----QNNIIHRDL 234 (284)
Q Consensus 194 -L~~~---------------------l~~~~-~~~~~~~~~-~i~~----------~i~~-~L~~LH----~~~iiH~Di 234 (284)
+... ++... ......... .+-. ++.. ...+|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 11110 011111110 1100 0111 122222 125789999
Q ss_pred CCCCEEecCCCcEEEecccceeeec
Q 023285 235 KTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 235 kp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.|.||++++++ +.++||+.+...+
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcCC
Confidence 99999999888 9999999987543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.8e-08 Score=91.46 Aligned_cols=141 Identities=16% Similarity=0.237 Sum_probs=95.1
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCH-----------------------------HH------HHHHHHHHH
Q 023285 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT-----------------------------EM------LKEFSQEVY 159 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-----------------------------~~------~~~~~~E~~ 159 (284)
+.||..+.|.||+|+. +|+.||||+-++..... +. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999998 57889999988764211 00 112444544
Q ss_pred HHHhC----CCCc------eeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 023285 160 IMRKI----RHKN------VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229 (284)
Q Consensus 160 ~l~~l----~h~n------iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~i 229 (284)
-..++ +|-+ |++++--++ ..-.++||||+|..+.|.-.-.+..++...+..-+.+...-+ +=..|.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhcCC
Confidence 43333 3544 555554444 346899999999877665433345577775554444433322 334689
Q ss_pred eecCCCCCCEEecC----CCcEEEecccceeeecc
Q 023285 230 IHRDLKTANLLMDE----NGVVKVADFGVARVQAQ 260 (284)
Q Consensus 230 iH~Dikp~NIli~~----~~~vkl~Dfg~a~~~~~ 260 (284)
+|+|=.|.||+++. ++.+.+.|||+....+.
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999984 67899999999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-07 Score=78.75 Aligned_cols=141 Identities=18% Similarity=0.253 Sum_probs=86.7
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC--ceeeEEeEEEc---CCcEEEEEEcC
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR---PPNLCIVTEFM 189 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~---~~~~~lV~e~~ 189 (284)
.+.++.|..+.||+....+..+++|..... .....+.+|..+++.+... .+++++..... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467899999999999998889999997532 4556788899999888643 35677764433 33478999999
Q ss_pred CCCCHHH----------------HHH---hcC-C--CCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 023285 190 ARGSIYD----------------FLH---KQK-G--VFQLTS---------LLKV------------AIDVSK-GMNYLH 225 (284)
Q Consensus 190 ~~gsL~~----------------~l~---~~~-~--~~~~~~---------~~~i------------~~~i~~-~L~~LH 225 (284)
+|..+.. .+. ... . .+.... .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987776 111 110 0 001000 0000 111222 233333
Q ss_pred -------hCCceecCCCCCCEEec-CCCcEEEecccceeeec
Q 023285 226 -------QNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQA 259 (284)
Q Consensus 226 -------~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~ 259 (284)
...++|+|+.|.||+++ .++.+.|+||+.+...+
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~~ 199 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWGD 199 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEEE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceECC
Confidence 23699999999999999 66777899999987543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.3e-07 Score=75.79 Aligned_cols=136 Identities=20% Similarity=0.364 Sum_probs=99.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCC--------------CCHHHHHHHHHHHHHHHhCC------CCceeeEEe
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--------------VNTEMLKEFSQEVYIMRKIR------HKNVVQFIG 174 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------h~niv~~~~ 174 (284)
...||+|+.-.||.-- .+....||+.++.. ......++..+|+..+..+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 3468999999998632 34567899988764 11123566777877777776 788999999
Q ss_pred EEEcCCcEEEEEEcCCC------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---
Q 023285 175 ACTRPPNLCIVTEFMAR------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 245 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~--- 245 (284)
+.+++....+|+|.+.. .+|.+++.. +.++. .+.+. +-.-..||-+.+|+.+|++|.||++...+
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999999999998754 278898854 34555 33333 33445678889999999999999996332
Q ss_pred -cEEEec-ccceee
Q 023285 246 -VVKVAD-FGVARV 257 (284)
Q Consensus 246 -~vkl~D-fg~a~~ 257 (284)
.+.|+| ||....
T Consensus 159 ~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 159 FRLVLIDGLGEKEL 172 (199)
T ss_pred eEEEEEeCCCCccc
Confidence 588888 676554
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=86.75 Aligned_cols=135 Identities=16% Similarity=0.219 Sum_probs=105.3
Q ss_pred CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----CCcEEEEEEcCCC-CCH
Q 023285 122 SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIVTEFMAR-GSI 194 (284)
Q Consensus 122 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lV~e~~~~-gsL 194 (284)
...+.|++.. +|..|++|++.... .........-+++++++.|+|+|++.+++.. +..+++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r--~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDR--DQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccc--ccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3456888876 57899999984331 2222234456789999999999999998863 4468999999986 478
Q ss_pred HHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 195 YDFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 195 ~~~l~~~--------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+++-... +...++..++.++.|+..||.++|+.|...+-|.|.+||++.+.+++|..-|.....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7765321 234677899999999999999999999999999999999998888998877766543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.2e-07 Score=79.43 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=87.1
Q ss_pred eeeecCc-eEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcCCCCCH
Q 023285 117 KVASGSY-GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (284)
Q Consensus 117 ~lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~gsL 194 (284)
.|..|.+ ..||+....+..+.+|+..... ...+.+|+.+++.+. +--+++++++...++..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3555555 6799988777788999875432 235677999988885 45567888888776678999999999776
Q ss_pred HHHH-------------------HhcCC---CCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 023285 195 YDFL-------------------HKQKG---VFQLT--SLLKVAI--------------------DVSKGMNYLH----- 225 (284)
Q Consensus 195 ~~~l-------------------~~~~~---~~~~~--~~~~i~~--------------------~i~~~L~~LH----- 225 (284)
.... +.... .+... ....... .+...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5432 11000 01100 0000000 0111122221
Q ss_pred --hCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 226 --QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 226 --~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...++|+|+.|.||++++++.+.|+||+.|...
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 234899999999999998878899999998643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=75.43 Aligned_cols=136 Identities=21% Similarity=0.280 Sum_probs=97.9
Q ss_pred cCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e 187 (284)
....+..+.|++|.+|.||.|.+.+..+|+|+-+.+. ....+..|++++..++-.++ +++|.+..+ ++.||
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 3345567789999999999999999999999977543 34678899999999987655 556655443 45599
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC-C-CEEecCCCcEEEecccceeeeccC
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT-A-NLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp-~-NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
|+.|-+|.+..... +.+.+.. ++..---|-..||-|..|.- . ||++ .++.+.|+||..|+....+
T Consensus 93 ~i~G~~L~~~~~~~----~rk~l~~----vlE~a~~LD~~GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 93 YIDGRPLGKLEIGG----DRKHLLR----VLEKAYKLDRLGIEHGELSRPWKNVLV-NDRDVYIIDFDSATFKKKP 159 (201)
T ss_pred hhcCcchhhhhhcc----cHHHHHH----HHHHHHHHHHhccchhhhcCCceeEEe-cCCcEEEEEccchhhccCC
Confidence 99998888766431 3333333 33333345567999998863 3 5555 5559999999999865443
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-06 Score=71.76 Aligned_cols=127 Identities=20% Similarity=0.320 Sum_probs=93.7
Q ss_pred CCceeeeeeeecCc-eEEEEEEECCceEEEEEecC---CCC-------C-H--------HHHHHHHHHHHHHHhCC---C
Q 023285 110 KQLKIECKVASGSY-GDLYKGTYCSQEVAIKVLKP---ECV-------N-T--------EMLKEFSQEVYIMRKIR---H 166 (284)
Q Consensus 110 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~~~---~~~-------~-~--------~~~~~~~~E~~~l~~l~---h 166 (284)
.++++.+.||.|.- |.||++...|+.+|+|+++. ... . . .....|..|.+.+.+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 99999999999999999321 100 0 0 12345889999988886 3
Q ss_pred Cce--eeEEeEEEcC------------------CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 023285 167 KNV--VQFIGACTRP------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226 (284)
Q Consensus 167 ~ni--v~~~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~ 226 (284)
.++ ++.+|+..=. ...-||.||.+... .++. +-+.+|.+-|..+|+
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccch----hHHHHHHHHHHHHHH
Confidence 455 8999987211 22568888886632 1222 334567777889999
Q ss_pred CCceecCCCCCCEEecCCCcEEEecccce
Q 023285 227 NNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 227 ~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.||+-+|+++.|.. +| +|+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc---CC--EEEecccC
Confidence 99999999999996 22 89999975
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.1e-08 Score=84.64 Aligned_cols=118 Identities=24% Similarity=0.443 Sum_probs=89.9
Q ss_pred HHhCCCCceeeEEeEEEcC-----CcEEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--Cce
Q 023285 161 MRKIRHKNVVQFIGACTRP-----PNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN--NII 230 (284)
Q Consensus 161 l~~l~h~niv~~~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~--~ii 230 (284)
+-++.|.||++++.++.+. ....+++|||..|++..+|++- ...+......+|+.||+.||.|||+. -|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4455799999999988653 4578999999999999999763 24577888899999999999999987 699
Q ss_pred ecCCCCCCEEecCCCcEEEecccceeeecc-----CCceecCCCcccccchhc
Q 023285 231 HRDLKTANLLMDENGVVKVADFGVARVQAQ-----SGVMTAETGTYRWMAPEV 278 (284)
Q Consensus 231 H~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPEv 278 (284)
|+++..+.|++..+|-+|+.--.-...... .......++.++|.|||.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s 253 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPES 253 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCc
Confidence 999999999999999888753222221111 112233456788888874
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.3e-07 Score=77.29 Aligned_cols=138 Identities=18% Similarity=0.225 Sum_probs=93.3
Q ss_pred eeeecCceEEEEEEE-CCceEEEEEecCCCCCHH---------------------HHHH-HHHHHHHHHhCC--CCceee
Q 023285 117 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTE---------------------MLKE-FSQEVYIMRKIR--HKNVVQ 171 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~---------------------~~~~-~~~E~~~l~~l~--h~niv~ 171 (284)
.|++|--..||+|.. .+..+|||+++.....-. .... ...|+.-|+++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 666777778999876 578999999975422110 0111 345666677764 344555
Q ss_pred EEeEEEcCCcEEEEEEcCCCCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEE
Q 023285 172 FIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKV 249 (284)
Q Consensus 172 ~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl 249 (284)
.+++.. ..+||||+..... .-.|. .-.+....+..+..+++..+.-|-. .+++|+||+.=|||+. ++.+.+
T Consensus 135 Pi~~~~----nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 135 PIAFRN----NVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ceeecC----CeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 555533 4799999965311 00010 1122333577788889999988877 8999999999999998 899999
Q ss_pred ecccceeeeccC
Q 023285 250 ADFGVARVQAQS 261 (284)
Q Consensus 250 ~Dfg~a~~~~~~ 261 (284)
+|||.|....++
T Consensus 208 ID~~QaV~~~hp 219 (268)
T COG1718 208 IDVSQAVTIDHP 219 (268)
T ss_pred EECccccccCCC
Confidence 999998765543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.3e-06 Score=84.55 Aligned_cols=78 Identities=12% Similarity=0.209 Sum_probs=56.4
Q ss_pred eeeeeecCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCce--eeEEeEEEcC---CcEEE
Q 023285 115 ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV--VQFIGACTRP---PNLCI 184 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~l 184 (284)
.+.++.|.+..+|+.+..+ ..+++|+..+... ......+.+|+++++.+. |.++ ++++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4567889999999877643 4678887644321 112346889999999996 6654 8888888764 45789
Q ss_pred EEEcCCCCC
Q 023285 185 VTEFMARGS 193 (284)
Q Consensus 185 V~e~~~~gs 193 (284)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=5.1e-08 Score=95.59 Aligned_cols=178 Identities=21% Similarity=0.245 Sum_probs=123.2
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.....+.+.+.+.+-+|+++.++.+.-. +...++|+.+.... .....+....+-.++-...+|.++...-.+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3455667778888999999999877543 33445554432110 11112233334444444456777766655666778
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec--
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-- 259 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-- 259 (284)
.++|++|+.+++|...+++. +..+...+......+..++++||...+.|+|++|.|+++..++..++.|||......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999999999874 445656666777788999999999999999999999999999999999998432100
Q ss_pred -----c--------------C-----------CceecCCCcccccchhcccccc
Q 023285 260 -----Q--------------S-----------GVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 -----~--------------~-----------~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
. . .......||+.|.+||.+.|..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 0 0 0012235899999999998764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-06 Score=71.63 Aligned_cols=72 Identities=11% Similarity=0.163 Sum_probs=46.5
Q ss_pred eeeeecCce-EEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC---ceeeEEeEEEcC---CcEEEEEEc
Q 023285 116 CKVASGSYG-DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACTRP---PNLCIVTEF 188 (284)
Q Consensus 116 ~~lg~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lV~e~ 188 (284)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.++++.+... .++.+++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457766665 58875 346788875431 1234688999999888642 455556554432 234889999
Q ss_pred CCCCCH
Q 023285 189 MARGSI 194 (284)
Q Consensus 189 ~~~gsL 194 (284)
++|.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.8e-06 Score=69.79 Aligned_cols=99 Identities=19% Similarity=0.347 Sum_probs=79.9
Q ss_pred HHHHHHHHhCCC-CceeeEEeEEEcCCcEEEEEEcCCCCCHHHH---HHhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 023285 155 SQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYLHQ---N 227 (284)
Q Consensus 155 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~~~~~~~~i~~~i~~~L~~LH~---~ 227 (284)
..|.-+++.+++ +++++++|+|.. ++|+||...+++... +.. -...++..+.+|+.+++..+++|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999986 699999999953 578999987766421 111 1235889999999999999999997 3
Q ss_pred CceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 228 ~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.+.-.|++|+|+-+++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5778899999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.5e-06 Score=58.11 Aligned_cols=55 Identities=27% Similarity=0.416 Sum_probs=44.4
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCc--hHHHHHHHHHHH
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE--TEDLKNVLAKEI 63 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~--~~~l~~~l~~~~ 63 (284)
.||++++.+|++.|+||.+|.+|++.||+.+|+|.|.++.... .++....+++.+
T Consensus 13 gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L 69 (73)
T cd04900 13 GLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREAL 69 (73)
T ss_pred CHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHH
Confidence 4899999999999999999999999999999999998765542 334444555554
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.7e-05 Score=68.78 Aligned_cols=78 Identities=10% Similarity=0.020 Sum_probs=58.8
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC---CceeeEEeEEEcC---CcEEEEE
Q 023285 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP---PNLCIVT 186 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~---~~~~lV~ 186 (284)
.-.+.||.|..+.||+....+..+.+|..+... ....+..|...++.+.. -.+++++++|... +..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 335679999999999987766677888854311 12478899999999863 3688999888643 5689999
Q ss_pred EcCCCCCH
Q 023285 187 EFMARGSI 194 (284)
Q Consensus 187 e~~~~gsL 194 (284)
|+++|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.4e-05 Score=55.55 Aligned_cols=56 Identities=21% Similarity=0.234 Sum_probs=44.3
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCC-chHHHHHHHHHHHHh
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEILK 65 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~-~~~~l~~~l~~~~~~ 65 (284)
||++++.+|++.|+||..|.+++|.+|+.+|+|.|...... ..++-...+++.+.+
T Consensus 13 Lfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~~~~~~~~~~l~~~L~~ 69 (76)
T cd04927 13 LLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDARELLHTKKRREETYDYLRA 69 (76)
T ss_pred HHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCCCCCHHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999776544 233444445555533
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.4e-05 Score=64.18 Aligned_cols=137 Identities=19% Similarity=0.249 Sum_probs=80.5
Q ss_pred eeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
+.|..|-...+|+.... ++.|++|+.... ........+|+.+++.+.. .-.+++++.+.. .++|||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~---~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK---TELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCC---ccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCC
Confidence 45777888899998765 478899976532 1111233578888888853 334555554331 379999998
Q ss_pred CCHHH--------------HH---HhcCCCC----------CH-HHHHHHHH----------------------HHHHHH
Q 023285 192 GSIYD--------------FL---HKQKGVF----------QL-TSLLKVAI----------------------DVSKGM 221 (284)
Q Consensus 192 gsL~~--------------~l---~~~~~~~----------~~-~~~~~i~~----------------------~i~~~L 221 (284)
.++.. .+ +...... .. ..+..+.. .+...+
T Consensus 77 ~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 156 (235)
T cd05157 77 RTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEI 156 (235)
T ss_pred CcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHH
Confidence 65421 11 1111111 11 11111111 111111
Q ss_pred HHH----H----hCCceecCCCCCCEEecC-CCcEEEecccceeeec
Q 023285 222 NYL----H----QNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA 259 (284)
Q Consensus 222 ~~L----H----~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~ 259 (284)
..| - ..+++|+|+.+.|||++. ++.+.++||..|....
T Consensus 157 ~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~~ 203 (235)
T cd05157 157 SWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYNY 203 (235)
T ss_pred HHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcCc
Confidence 111 1 136899999999999997 5789999999887543
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.3e-06 Score=82.17 Aligned_cols=160 Identities=18% Similarity=0.150 Sum_probs=112.6
Q ss_pred ceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~e~~ 189 (284)
+.+-+-+++|+++.++|.+-.. +....+.+... ....-++++|.+++||| .+..++-++.+...+++++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 4445567889999999877643 23334544321 33456788999999999 777777788888899999999
Q ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecCC
Q 023285 190 ARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268 (284)
Q Consensus 190 ~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~ 268 (284)
.++ +-..-.....-.+...+...+...-.++++++|+.--+|+| ||+.. ++..+..||+.+...+.........
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCcccccccCC
Confidence 886 22221111112233344556667778899999988778998 77764 4788999999987766554456678
Q ss_pred Ccccccchhcccccc
Q 023285 269 GTYRWMAPEVAFTFF 283 (284)
Q Consensus 269 gt~~y~aPEvl~~~~ 283 (284)
+|+.|+|||+.....
T Consensus 392 ~~~~~~~pev~~~~~ 406 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENT 406 (829)
T ss_pred CCCCCCCchhhcccc
Confidence 999999999876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.6e-05 Score=67.49 Aligned_cols=140 Identities=21% Similarity=0.253 Sum_probs=82.9
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC--ceeeEEeEE------EcCCcEEEE
Q 023285 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGAC------TRPPNLCIV 185 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~------~~~~~~~lV 185 (284)
-.+.++.|....+|+....+..+++|+..... . ......|..+++.|... .+++++... ...+..+++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 34556777777899887666678899875421 1 22345667777777432 244444421 123557899
Q ss_pred EEcCCCCCHH-----------HH---HHhcCCCCC--------HH---HH--H----------HHHHHHHHHHHHHHh--
Q 023285 186 TEFMARGSIY-----------DF---LHKQKGVFQ--------LT---SL--L----------KVAIDVSKGMNYLHQ-- 226 (284)
Q Consensus 186 ~e~~~~gsL~-----------~~---l~~~~~~~~--------~~---~~--~----------~i~~~i~~~L~~LH~-- 226 (284)
+||++|..+. .. ++.....++ .. .. . .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999885321 11 121111110 00 00 0 011123334555542
Q ss_pred -----CCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 227 -----NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 227 -----~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5899999999999999888778999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00016 Score=63.50 Aligned_cols=138 Identities=17% Similarity=0.169 Sum_probs=84.1
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC--ceeeEEeE------EEcCCcEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA------CTRPPNLCIVT 186 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lV~ 186 (284)
.+.+..|....+|+....+..+++|+.... . ......|+.+++.+.+. .+++++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 445777777889988777778999987641 1 23466788888877533 24454432 12345678999
Q ss_pred EcCCCCCHHH-----------H---HHhcCCCCCH--------HHHH------------HHHHHHHHHHHHHHh------
Q 023285 187 EFMARGSIYD-----------F---LHKQKGVFQL--------TSLL------------KVAIDVSKGMNYLHQ------ 226 (284)
Q Consensus 187 e~~~~gsL~~-----------~---l~~~~~~~~~--------~~~~------------~i~~~i~~~L~~LH~------ 226 (284)
++++|..+.. . ++.....+.. .... .....+...+.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999865421 1 1111000000 0000 011112333444443
Q ss_pred -CCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 227 -NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 227 -~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999887789999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.0003 Score=62.58 Aligned_cols=137 Identities=15% Similarity=0.196 Sum_probs=76.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC--ceeeEEeE------EEcCCcEEEEEE
Q 023285 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA------CTRPPNLCIVTE 187 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lV~e 187 (284)
+.++.|....+|+....+..+++|+.. . ... .....|..+++.|... .+++.+.. ....+..++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCCcEEEEEec-c-CCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456677777899887766789999875 2 122 2333455555555321 23343321 122456789999
Q ss_pred cCCCCCH-----------HHHH---HhcCCCC--------C--H-HHH-HH-----------HHHH-HHHHHHHHH----
Q 023285 188 FMARGSI-----------YDFL---HKQKGVF--------Q--L-TSL-LK-----------VAID-VSKGMNYLH---- 225 (284)
Q Consensus 188 ~~~~gsL-----------~~~l---~~~~~~~--------~--~-~~~-~~-----------i~~~-i~~~L~~LH---- 225 (284)
|++|..+ .+.+ +.....+ . . ... .+ ...+ +...++.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 9998632 1111 1111111 0 0 010 00 1111 111222332
Q ss_pred ---hCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 226 ---QNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 226 ---~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
..+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 23899999999999998666668999999864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.4e-06 Score=72.21 Aligned_cols=135 Identities=16% Similarity=0.202 Sum_probs=94.4
Q ss_pred ceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCC-------HH-------------HHHHHHHHHHHHHhCCC--Cc
Q 023285 112 LKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVN-------TE-------------MLKEFSQEVYIMRKIRH--KN 168 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-------~~-------------~~~~~~~E~~~l~~l~h--~n 168 (284)
+.++..||-|.-+.||.+-+. |++.++|.-+....+ .+ ..-...+|...|+.+.. --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 557788999999999998774 788888865432211 00 11235678888888863 33
Q ss_pred eeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEE
Q 023285 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (284)
Q Consensus 169 iv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vk 248 (284)
++..+++ ++.|+|||++.|-.|...-+- -+.++ +...+..-+--|-..|+||+|++-=||++.+++.++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 4555543 557899999999777654322 23333 333444445567789999999999999999999999
Q ss_pred Eecccceee
Q 023285 249 VADFGVARV 257 (284)
Q Consensus 249 l~Dfg~a~~ 257 (284)
++||-.+-.
T Consensus 243 vIDFPQmvS 251 (465)
T KOG2268|consen 243 VIDFPQMVS 251 (465)
T ss_pred EeechHhhc
Confidence 999986643
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.8e-05 Score=64.19 Aligned_cols=134 Identities=15% Similarity=0.172 Sum_probs=79.0
Q ss_pred eeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEEEEEcCCCCCHHH
Q 023285 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGSIYD 196 (284)
Q Consensus 118 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~e~~~~gsL~~ 196 (284)
+..|-...+|+.+..++.+++|...... ....-...+|..+++.+.... .++++..+. -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 4567778899888778889999754321 111013577889999886433 345554432 268999999865431
Q ss_pred --------------HH---HhcC---CCCCHH-HHHHHHHH---------HHHHHHHHHh--------CCceecCCCCCC
Q 023285 197 --------------FL---HKQK---GVFQLT-SLLKVAID---------VSKGMNYLHQ--------NNIIHRDLKTAN 238 (284)
Q Consensus 197 --------------~l---~~~~---~~~~~~-~~~~i~~~---------i~~~L~~LH~--------~~iiH~Dikp~N 238 (284)
.+ +..+ ..++.. .+..+..+ +...+..+-. ..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 11 1111 111111 11121111 1111222221 258999999999
Q ss_pred EEecCCCcEEEecccceeee
Q 023285 239 LLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~ 258 (284)
|++++++ +.++||..|...
T Consensus 158 il~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEEeCCC-CEEEeccccCcC
Confidence 9998877 789999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00039 Score=63.63 Aligned_cols=75 Identities=12% Similarity=0.047 Sum_probs=53.1
Q ss_pred eeeeecCceEEEEEEECC--ceEEEEEecCCCC---C--HHHHHHHHHHHHHHHhCC---CCceeeEEeEEEcCCcEEEE
Q 023285 116 CKVASGSYGDLYKGTYCS--QEVAIKVLKPECV---N--TEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~---~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV 185 (284)
+.||.|.+..||+....+ +.|+||.-.+... . +-...++..|.+.|+.+. -.++++++.+. ....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEE
Confidence 468999999999998854 4899998543211 0 123456777888888764 24677787763 3557899
Q ss_pred EEcCCCC
Q 023285 186 TEFMARG 192 (284)
Q Consensus 186 ~e~~~~g 192 (284)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=65.92 Aligned_cols=162 Identities=15% Similarity=0.193 Sum_probs=106.9
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceee--------EEeEEEcCCcE
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQ--------FIGACTRPPNL 182 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~--------~~~~~~~~~~~ 182 (284)
..+...||+|+-+.+|---.- ..-+-|+......... . +-+..|.+. .||-+-. ++|. ..+...
T Consensus 13 i~~gr~LgqGgea~ly~l~e~-~d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV-RDQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchh-hchhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence 445678999999999942211 2334566643221111 1 112233333 3543322 1111 112237
Q ss_pred EEEEEcCCCC-CHHHHHHhc--C---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 183 CIVTEFMARG-SIYDFLHKQ--K---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~g-sL~~~l~~~--~---~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.+.|..+.|. ....+.... + ....++.+++.++.++.+.+-||..|.+-+|++++|+|+++++.|.|+|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7888888775 333333211 1 347788999999999999999999999999999999999999999999876665
Q ss_pred eeccCCceecCCCcccccchhccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
...........+|...|.+||.-.
T Consensus 166 i~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 166 INANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred eccCCceEecccCccccCCHHHhc
Confidence 555555667788999999999755
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00026 Score=62.39 Aligned_cols=137 Identities=19% Similarity=0.291 Sum_probs=81.1
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEEEE
Q 023285 116 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~ 186 (284)
+.+..|-...+|+.+.. ++.+++|+..... .......+|..+++.+.... .+++++.+.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 34555666688887764 3789999965431 22235678888888886433 4556665542 3589
Q ss_pred EcCCCCCHHHH-----------------HHhcCCCC------CHHHH----HH--------------------------H
Q 023285 187 EFMARGSIYDF-----------------LHKQKGVF------QLTSL----LK--------------------------V 213 (284)
Q Consensus 187 e~~~~gsL~~~-----------------l~~~~~~~------~~~~~----~~--------------------------i 213 (284)
||++|..+... ++...... ....+ .. +
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99988655321 11111110 00111 00 1
Q ss_pred HHHHHHHHHHHHh---------CCceecCCCCCCEEecCC----CcEEEecccceeeec
Q 023285 214 AIDVSKGMNYLHQ---------NNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA 259 (284)
Q Consensus 214 ~~~i~~~L~~LH~---------~~iiH~Dikp~NIli~~~----~~vkl~Dfg~a~~~~ 259 (284)
...+...+.++-. ..++|+|+.|.||+++++ +.++++||..|....
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 1122223334432 268999999999999875 889999999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00077 Score=60.38 Aligned_cols=142 Identities=20% Similarity=0.286 Sum_probs=95.0
Q ss_pred eeeeeeecCceEEEEEEE-CCceEEEEEecCCCC----------------------C-HHHHHH-HHHHHHHHHhCCCCc
Q 023285 114 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----------------------N-TEMLKE-FSQEVYIMRKIRHKN 168 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------------------~-~~~~~~-~~~E~~~l~~l~h~n 168 (284)
+..+|..|--..||.|+. .|..+|||+++.... + ...++. ...|++-|+++....
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 344677788889999987 578899999873311 1 122333 346788888887655
Q ss_pred eeeEEeEEEcCCcEEEEEEcCCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCCc
Q 023285 169 VVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 169 iv~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~iiH~Dikp~NIli~~~~~ 246 (284)
|+..--+.. ....|||+|+....... .| ..-.++...+..+-.+++.-|.-|. .+++||.||+-=|+|+ .+|.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 543222222 23579999996422111 11 1234667777777778888777665 5699999999999999 5789
Q ss_pred EEEecccceeeecc
Q 023285 247 VKVADFGVARVQAQ 260 (284)
Q Consensus 247 vkl~Dfg~a~~~~~ 260 (284)
+.++|.+.+-....
T Consensus 303 lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 303 LYIIDVSQSVEHDH 316 (520)
T ss_pred EEEEEccccccCCC
Confidence 99999988765443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00086 Score=59.44 Aligned_cols=142 Identities=18% Similarity=0.302 Sum_probs=85.4
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcCC--cEEEEEEcCCCC
Q 023285 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP--NLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lV~e~~~~g 192 (284)
.+..|-.-.+|.....++.++++ ..+............+|..+++.+.- --+...++.|..+. ..|.||+|.+|.
T Consensus 32 ~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 32 EISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred eccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 33334444566665567888888 33222334455667888999888864 34455666776655 669999999983
Q ss_pred CH------------------HHHHHhcC----------C---CCCHHHHHHHHHH--------------HHHHHHHHHhC
Q 023285 193 SI------------------YDFLHKQK----------G---VFQLTSLLKVAID--------------VSKGMNYLHQN 227 (284)
Q Consensus 193 sL------------------~~~l~~~~----------~---~~~~~~~~~i~~~--------------i~~~L~~LH~~ 227 (284)
.+ .++|..-. + .....++.++..+ ...-..|++.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 22 11221100 0 0011112222221 12234455543
Q ss_pred --------CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 228 --------NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 228 --------~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.++|+|+.+.|+++++++-+-++||+.+..-+
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 48999999999999999889999999997644
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0014 Score=57.85 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=26.3
Q ss_pred CCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 227 NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 227 ~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 47899999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00031 Score=48.46 Aligned_cols=38 Identities=26% Similarity=0.261 Sum_probs=34.3
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCC
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGW 47 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw 47 (284)
.||.+++.+|++.|+||.+|+.+ |.+|+.+|+|.|...
T Consensus 12 gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~d~ 49 (74)
T cd04925 12 GLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVRDE 49 (74)
T ss_pred CHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEEcC
Confidence 47899999999999999999999 569999999999644
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0018 Score=58.33 Aligned_cols=136 Identities=13% Similarity=0.244 Sum_probs=78.7
Q ss_pred eeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEEcC
Q 023285 117 KVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~ 189 (284)
.+..|-.-.+|+.... ++.|++|+.... ... .-...+|..+++.+...++ +++++.+... .|.+|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~--t~~-~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi 115 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG--VEL-FFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI 115 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC--CCe-eechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence 3444666678887652 257899986543 122 2234779999998875444 4566665432 589999
Q ss_pred CCCCHHHH-----------------HHhcCCC----CC-HHHHHHHHHH-----------------HHHHHHHH----H-
Q 023285 190 ARGSIYDF-----------------LHKQKGV----FQ-LTSLLKVAID-----------------VSKGMNYL----H- 225 (284)
Q Consensus 190 ~~gsL~~~-----------------l~~~~~~----~~-~~~~~~i~~~-----------------i~~~L~~L----H- 225 (284)
++.+|..- +|..+.. .. ...+..+..+ +...+..| .
T Consensus 116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~ 195 (344)
T PLN02236 116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG 195 (344)
T ss_pred CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence 87655311 1111100 11 1222222211 11112222 1
Q ss_pred ---hCCceecCCCCCCEEecC-CCcEEEecccceeeec
Q 023285 226 ---QNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA 259 (284)
Q Consensus 226 ---~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~ 259 (284)
...++|+|+++.||++++ ++.+.++||..|....
T Consensus 196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNP 233 (344)
T ss_pred cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccc
Confidence 225899999999999986 4789999999987544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.004 Score=55.82 Aligned_cols=142 Identities=17% Similarity=0.260 Sum_probs=79.8
Q ss_pred CCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~ 183 (284)
+.+++....| |=.-.+|+....+ ..|++|+.... .+..-...+|..+++.+...++ +++++++. ++
T Consensus 15 ~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~---t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 15 SDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPN---TDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred CceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCC---cCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 3444444433 5556788876543 37899986542 1122334678999998875544 45666553 22
Q ss_pred EEEEcCCCCCHHH--------------H---HHhcCCC----CC-HHHHHHHHHHH----------------------HH
Q 023285 184 IVTEFMARGSIYD--------------F---LHKQKGV----FQ-LTSLLKVAIDV----------------------SK 219 (284)
Q Consensus 184 lV~e~~~~gsL~~--------------~---l~~~~~~----~~-~~~~~~i~~~i----------------------~~ 219 (284)
+|.+|++|..|.. . +|..+.. .+ ...+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899998765421 1 1111100 11 12222222111 11
Q ss_pred HHHHHH----hC----CceecCCCCCCEEecC-CCcEEEecccceeeec
Q 023285 220 GMNYLH----QN----NIIHRDLKTANLLMDE-NGVVKVADFGVARVQA 259 (284)
Q Consensus 220 ~L~~LH----~~----~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~ 259 (284)
-+..+. .. -..|.|+.+.||++++ ++.++++||..|....
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd 215 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSY 215 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCc
Confidence 122211 11 2799999999999974 5789999999987543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.005 Score=53.77 Aligned_cols=32 Identities=28% Similarity=0.527 Sum_probs=26.5
Q ss_pred CceecCCCCCCEEecCCCc-EEEecccceeeec
Q 023285 228 NIIHRDLKTANLLMDENGV-VKVADFGVARVQA 259 (284)
Q Consensus 228 ~iiH~Dikp~NIli~~~~~-vkl~Dfg~a~~~~ 259 (284)
.++|+|+.|.||++++++. .-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999987555 5699999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0081 Score=55.10 Aligned_cols=75 Identities=15% Similarity=0.034 Sum_probs=51.6
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCC--CH---HHHHHHHHHHHHHHhCC---CCceeeEEeEEEcCCcEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.||.|..-.||+....+..++||.-.+... .. -...+-..|...|+.+. -.++++++.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 45689999999999887777899998652211 11 12334445566666654 2578889988874 467889
Q ss_pred EcCCC
Q 023285 187 EFMAR 191 (284)
Q Consensus 187 e~~~~ 191 (284)
|++++
T Consensus 115 E~L~~ 119 (418)
T PLN02756 115 RYLEP 119 (418)
T ss_pred eecCC
Confidence 99977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0065 Score=54.77 Aligned_cols=73 Identities=12% Similarity=0.017 Sum_probs=46.7
Q ss_pred eeeecCceEEEEEEECC--ceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhCC--CC-ceeeEEeEEEcCCcEEEEE
Q 023285 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lV~ 186 (284)
.||.|....||++...+ +.|+||.-.+-.. .+-...+..-|...|+... -| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47889999999998754 5899997532110 1222345567777777664 24 45555533 345567999
Q ss_pred EcCCC
Q 023285 187 EFMAR 191 (284)
Q Consensus 187 e~~~~ 191 (284)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99965
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.011 Score=51.84 Aligned_cols=75 Identities=16% Similarity=0.133 Sum_probs=49.5
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEcCCcEEEEEEcC
Q 023285 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
+-.+.++.|....+|+.+..++.+.||+-.. .....|..|..-|+.|. --.+++++++....+.-++||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3456788899999999887889999998652 22346788888888884 356889999988777789999999
Q ss_pred CCC
Q 023285 190 ARG 192 (284)
Q Consensus 190 ~~g 192 (284)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.029 Score=49.68 Aligned_cols=31 Identities=23% Similarity=0.295 Sum_probs=28.5
Q ss_pred CceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 228 ~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+++|+|+.++|++++.++.+.++||..+...
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d 227 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA 227 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence 7999999999999999999999999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0012 Score=63.07 Aligned_cols=67 Identities=19% Similarity=0.397 Sum_probs=50.6
Q ss_pred HHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeeccCCc-----e-----ecCCCcccccchhcccc
Q 023285 215 IDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-----M-----TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 215 ~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-----~-----~~~~gt~~y~aPEvl~~ 281 (284)
.+++.||.|+|+. ++||+.|.|++|.++.++..||+.|+.+........ . ........|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999965 999999999999999999999999998754332111 1 11124568999999865
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.017 Score=48.73 Aligned_cols=79 Identities=16% Similarity=0.231 Sum_probs=60.1
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC---CceeeEEeEEEcCCcEEEEEEc
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.+-.+.+.-|.--..|+..+...++.||+- ..+....|..|+.-|+.+.- -.+++++.+.....+.|+|+||
T Consensus 18 i~er~~v~gG~inea~~v~dg~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 18 IKEREEVSGGDINEAWRLRDGTDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred hhcccccCCccccceeEeecCCcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 344455666666667777777889999983 34556778999888887754 4578899999999999999999
Q ss_pred CCCCCHH
Q 023285 189 MARGSIY 195 (284)
Q Consensus 189 ~~~gsL~ 195 (284)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9986554
|
|
| >cd04895 ACT_ACR_1 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0069 Score=41.38 Aligned_cols=54 Identities=24% Similarity=0.298 Sum_probs=41.1
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCc--hHHHHHHHHHHH
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE--TEDLKNVLAKEI 63 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~--~~~l~~~l~~~~ 63 (284)
-||.+++++|.+.|++|.-|+ -+|-.+...|+|+|..-.... .++....+++.+
T Consensus 13 GLL~~i~~~l~~~gl~I~~Ak-IsT~Gerv~DvFyV~d~~g~kl~d~~~~~~l~~~L 68 (72)
T cd04895 13 GILLEAVQVLTDLDLCITKAY-ISSDGGWFMDVFHVTDQLGNKLTDDSLIAYIEKSL 68 (72)
T ss_pred CHHHHHHHHHHHCCcEEEEEE-EeecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHh
Confidence 489999999999999999999 799999999999996554321 123344454444
|
This CD includes the N-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0047 Score=51.50 Aligned_cols=32 Identities=34% Similarity=0.580 Sum_probs=22.8
Q ss_pred CceecCCCCCCEEe-cCCCcEEEecccceeeec
Q 023285 228 NIIHRDLKTANLLM-DENGVVKVADFGVARVQA 259 (284)
Q Consensus 228 ~iiH~Dikp~NIli-~~~~~vkl~Dfg~a~~~~ 259 (284)
.+.|+|+.|.||++ +.++.++++||..|....
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n~ 176 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYND 176 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEEE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhcc
Confidence 57899999999999 889999999999997543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.011 Score=53.23 Aligned_cols=75 Identities=20% Similarity=0.209 Sum_probs=57.2
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
..+.|++|++- |+++.-. .....+++..|+.+.+..++-+..+ ..=|||+...||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34567888875 4455321 2245677888888888877777765 788999999999999 99999999999996
Q ss_pred ecc
Q 023285 258 QAQ 260 (284)
Q Consensus 258 ~~~ 260 (284)
...
T Consensus 371 ~~~ 373 (488)
T COG5072 371 SYS 373 (488)
T ss_pred ccC
Confidence 543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.029 Score=51.31 Aligned_cols=75 Identities=11% Similarity=-0.005 Sum_probs=49.4
Q ss_pred eeeeeecCceEEEEEEEC--CceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCC--CC-ceeeEEeEEEcCCcEEEE
Q 023285 115 ECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lV 185 (284)
.+.||.|.-..||++... ++.|+||.-.+-.. .+-...+..-|..+|+... -| .+++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 456799999999999874 57899997532211 1223456677778888764 24 45566543 34556789
Q ss_pred EEcCCC
Q 023285 186 TEFMAR 191 (284)
Q Consensus 186 ~e~~~~ 191 (284)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.047 Score=49.97 Aligned_cols=71 Identities=17% Similarity=0.309 Sum_probs=43.0
Q ss_pred eeeecCceEEEEEEECC---ce-----EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEE
Q 023285 117 KVASGSYGDLYKGTYCS---QE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~---~~-----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e 187 (284)
.|..|-...+|++...+ .. |.++... . ..+..-.-.+|..+++.+...++ +++++.+.. ++|.|
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~--~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-T--YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEecc-C--CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 44457777888886532 12 4444321 1 12222334678999999975544 566666642 58999
Q ss_pred cCCCCCH
Q 023285 188 FMARGSI 194 (284)
Q Consensus 188 ~~~~gsL 194 (284)
|++|..|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 9998654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.082 Score=47.33 Aligned_cols=131 Identities=17% Similarity=0.250 Sum_probs=77.3
Q ss_pred ceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc------eeeEEe----EEEcCCcEEEEEEcCCCC
Q 023285 123 YGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIG----ACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 123 ~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~----~~~~~~~~~lV~e~~~~g 192 (284)
--.+|+....+..+++|+..+. ... .+...|...+..+.... +...-| ......+.+-+++|++|.
T Consensus 38 eN~~f~~~~~~g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 38 ENSNFRVQTEDGRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred cCceEEEEecCCCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 3458888777767799998765 232 34556777777664221 222222 222224778899999987
Q ss_pred CHHH------------HH---HhcCC-----------CCCHH----H---------HHHHHHHHHHHHHHHHh-------
Q 023285 193 SIYD------------FL---HKQKG-----------VFQLT----S---------LLKVAIDVSKGMNYLHQ------- 226 (284)
Q Consensus 193 sL~~------------~l---~~~~~-----------~~~~~----~---------~~~i~~~i~~~L~~LH~------- 226 (284)
.+.. ++ +.... ...+. . -.....++...++.+.+
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 6651 11 11000 01111 0 01123344444444443
Q ss_pred -CC--ceecCCCCCCEEecCCCc-EEEecccceee
Q 023285 227 -NN--IIHRDLKTANLLMDENGV-VKVADFGVARV 257 (284)
Q Consensus 227 -~~--iiH~Dikp~NIli~~~~~-vkl~Dfg~a~~ 257 (284)
.+ +||+|+.|.||+++.+.. +.++||+.|..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 23 999999999999998874 89999999864
|
|
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.013 Score=39.99 Aligned_cols=41 Identities=20% Similarity=0.280 Sum_probs=34.9
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCC
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD 50 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~ 50 (284)
-+|.+++.+|++.|+||..|.++. .+++.+|+|.|......
T Consensus 13 Gll~~i~~~l~~~~lnI~sa~i~t-~~~~~~d~f~v~~~~~~ 53 (72)
T cd04926 13 GLLSDVTRVFRENGLTVTRAEIST-QGDMAVNVFYVTDANGN 53 (72)
T ss_pred CHHHHHHHHHHHCCcEEEEEEEec-CCCeEEEEEEEECCCCC
Confidence 378999999999999999999974 58899999999765443
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.011 Score=59.94 Aligned_cols=43 Identities=19% Similarity=0.298 Sum_probs=38.9
Q ss_pred HHHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCc
Q 023285 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE 51 (284)
Q Consensus 9 ~~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~ 51 (284)
.|++.++.+|+..|+||.+|.+|+|.|||.+|+|+|.......
T Consensus 716 gLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~~ 758 (895)
T PRK00275 716 DFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEP 758 (895)
T ss_pred cHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCCC
Confidence 4789999999999999999999999999999999998766543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 284 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-41 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-40 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-35 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-34 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-33 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-33 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-33 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-33 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-33 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-33 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-32 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-32 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-32 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-32 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-32 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-32 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-32 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-32 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-32 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-32 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-32 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-32 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-32 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-31 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-31 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-31 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-31 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-31 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-31 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-31 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-31 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-31 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-31 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-31 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-31 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-31 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-31 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-31 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-31 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-31 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-31 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-31 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-30 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-30 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-30 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-30 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-30 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-30 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-30 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-30 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-30 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-30 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-30 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-30 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-30 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-30 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-30 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-30 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-30 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-29 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-29 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-29 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-29 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 7e-29 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-29 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-28 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-28 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-27 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-27 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-27 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-27 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-27 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-27 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-27 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-26 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-26 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-26 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-26 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-26 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-26 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-24 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-24 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-24 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-24 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-24 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-24 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-24 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-24 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-23 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-22 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-22 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-22 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-22 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-22 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-22 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-22 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-22 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-22 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-22 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-21 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-21 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-21 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-21 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-21 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-20 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-19 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-19 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-19 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-19 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-19 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-19 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-19 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-19 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-19 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-19 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-19 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-19 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-19 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-19 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-19 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-19 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-19 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-18 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-18 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-17 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-17 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-17 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-17 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-17 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-17 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-16 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-16 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-16 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-15 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-14 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-13 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 8e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-11 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-09 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 7e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-102
Identities = 84/200 (42%), Positives = 126/200 (63%), Gaps = 5/200 (2%)
Query: 84 SKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP 143
S I ++ N D +I L I+ K+ +GS+G +++ + +VA+K+L
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILME 70
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
+ + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y LHK
Sbjct: 71 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 204 VFQLT--SLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 259
QL L +A DV+KGMNYLH N I+HR+LK+ NLL+D+ VKV DFG++R++A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
Query: 260 QSGV-MTAETGTYRWMAPEV 278
+ + + GT WMAPEV
Sbjct: 191 STFLSSKSAAGTPEWMAPEV 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 3e-99
Identities = 69/186 (37%), Positives = 109/186 (58%), Gaps = 5/186 (2%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS 155
D D WEI Q+ + ++ SGS+G +YKG + +VA+K+L + L+ F
Sbjct: 10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFK 68
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
EV ++RK RH N++ F+G T P L IVT++ S+Y LH + F++ L+ +A
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYR 272
++GM+YLH +IIHRDLK+ N+ + E+ VK+ DFG+A +++ S +G+
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 273 WMAPEV 278
WMAPEV
Sbjct: 188 WMAPEV 193
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 285 bits (730), Expect = 4e-96
Identities = 64/195 (32%), Positives = 102/195 (52%), Gaps = 8/195 (4%)
Query: 90 SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 149
S P + W+I +QL+I + G +G +Y G + EVAI+++ E N +
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAIRLIDIERDNED 71
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
LK F +EV R+ RH+NVV F+GAC PP+L I+T ++Y + K V +
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK 131
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA------QSGV 263
++A ++ KGM YLH I+H+DLK+ N+ D NG V + DFG+ + +
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 264 MTAETGTYRWMAPEV 278
+ + G +APE+
Sbjct: 191 LRIQNGWLCHLAPEI 205
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 2e-92
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 15/189 (7%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
L + G +G K T+ + + + + E + F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
H NV++FIG + L +TE++ G++ + + + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------------QSGVMTAETG 269
H NIIHRDL + N L+ EN V VADFG+AR+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 270 TYRWMAPEV 278
WMAPE+
Sbjct: 185 NPYWMAPEM 193
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 3e-92
Identities = 50/179 (27%), Positives = 90/179 (50%), Gaps = 9/179 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
ID KQL K+ G+L+KG + ++ +KVLK +T ++F++E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 165 RHKNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGM 221
H NV+ +GAC PP + ++T +M GS+Y+ LH+ V + +K A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 222 NYLH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+LH + I L + ++++DE+ +++ V W+APE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEA 179
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 6e-92
Identities = 61/188 (32%), Positives = 103/188 (54%), Gaps = 16/188 (8%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIM 161
+ EID +L +E + G +G +Y+ + EVA+K + + ++ ++ QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
++H N++ G C + PNLC+V EF G + L ++ L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 222 NYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADFGVARVQAQSGVMTAETGT 270
NYLH IIHRDLK++N+L+ + N ++K+ DFG+AR ++ M+A G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 271 YRWMAPEV 278
Y WMAPEV
Sbjct: 178 YAWMAPEV 185
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 5e-89
Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN-----TEM 150
+ + + +++ E ++ G +G ++KG VAIK L E
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
+EF +EV+IM + H N+V+ G PP +V EF+ G +Y L + + +
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 211 LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGV 263
L++ +D++ G+ Y+ N I+HRDL++ N+ + KVADFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 264 MTAETGTYRWMAPEV 278
++ G ++WMAPE
Sbjct: 183 VSGLLGNFQWMAPET 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-86
Identities = 62/181 (34%), Positives = 98/181 (54%), Gaps = 14/181 (7%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
+ ID K++++E V G++G + K + +++VAIK ++ E K F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGM 221
+ H N+V+ GAC P +C+V E+ GS+Y+ LH + + T + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 222 NYLHQ---NNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
YLH +IHRDLK NLL+ G V+K+ DFG A MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 278 V 278
V
Sbjct: 174 V 174
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 250 bits (639), Expect = 3e-82
Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 80 VPMHSKL--LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVA 137
+P L LIE S + V AKQ+++ ++ G YG+++ G + ++VA
Sbjct: 5 IPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64
Query: 138 IKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----PNLCIVTEFMARGS 193
+KV +E E+Y +RH+N++ FI A + L ++T++ GS
Sbjct: 65 VKVFFTTEEA-SWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENG 245
+YD+L S+LK+A G+ +LH + I HRDLK+ N+L+ +NG
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 246 VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEV 278
+AD G+A GT R+M PEV
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 1e-79
Identities = 53/187 (28%), Positives = 94/187 (50%), Gaps = 22/187 (11%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
A+ + + V G YG++++G++ + VA+K+ +E E+Y +RH+N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-SWFRE--TELYNTVMLRHEN 63
Query: 169 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
++ FI + L ++T + GS+YD+L S L++ + ++ G+ +L
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121
Query: 225 H--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTY 271
H + I HRDLK+ N+L+ +NG +AD G+A + +QS GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 272 RWMAPEV 278
R+MAPEV
Sbjct: 182 RYMAPEV 188
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-77
Identities = 58/196 (29%), Positives = 99/196 (50%), Gaps = 22/196 (11%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
GT+ + L++ A G +G ++K ++ VA+K+ + + + EVY
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYS 71
Query: 161 MRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
+ ++H+N++QFIGA R + L ++T F +GS+ DFL V L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 217 VSKGMNYLHQN----------NIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGV 263
+++G+ YLH++ I HRD+K+ N+L+ N +ADFG+A +G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 264 MTAETGTYRWMAPEVA 279
+ GT R+MAPEV
Sbjct: 190 THGQVGTRRYMAPEVL 205
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-77
Identities = 51/192 (26%), Positives = 97/192 (50%), Gaps = 22/192 (11%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
V A+ + ++ + G +G++++G + +EVA+K+ +E E+Y
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFRE--AEIYQTVM 92
Query: 164 IRHKNVVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+RH+N++ FI A + L +V+++ GS++D+L++ + ++K+A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 220 GMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTA 266
G+ +LH I HRDLK+ N+L+ +NG +AD G+A +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 267 ETGTYRWMAPEV 278
GT R+MAPEV
Sbjct: 211 RVGTKRYMAPEV 222
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 8e-73
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 28/197 (14%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
+D LK+ + G YG +YKG+ + VA+KV + E + +Y + +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-NFINE--KNIYRVPLM 64
Query: 165 RHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
H N+ +FI R +V E+ GS+ +L S ++A V++
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTR 122
Query: 220 GMNYLH---------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------QS 261
G+ YLH + I HRDL + N+L+ +G ++DFG++ +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 262 GVMTAETGTYRWMAPEV 278
+E GT R+MAPEV
Sbjct: 183 NAAISEVGTIRYMAPEV 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 55/188 (29%), Positives = 95/188 (50%), Gaps = 8/188 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
D W ++ + L + ++ G++G+++ G + VA+K + ++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARI 165
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+++ H N+V+ IG CT+ + IV E + G FL + ++ +LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAP 276
M YL IHRDL N L+ E V+K++DFG++R GV A G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284
Query: 277 EVAFTFFF 284
E +
Sbjct: 285 EALNYGRY 292
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-62
Identities = 66/179 (36%), Positives = 104/179 (58%), Gaps = 8/179 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
W ID +L ++ SG +G ++ G + ++ +VAIK ++ ++ E +F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +VQ G C +C+VTEFM G + D+L Q+G+F +LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
L + +IHRDL N L+ EN V+KV+DFG+ R T+ TGT +W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVF 177
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-62
Identities = 62/187 (33%), Positives = 98/187 (52%), Gaps = 14/187 (7%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
W ++ K+LK+ + G +GD+ G Y +VA+K +K + + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMT 69
Query: 163 KIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
++RH N+VQ +G L IVTE+MA+GS+ D+L + V LLK ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M YL NN +HRDL N+L+ E+ V KV+DFG+ + + + + +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184
Query: 278 VAFTFFF 284
F
Sbjct: 185 ALREKKF 191
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-62
Identities = 64/187 (34%), Positives = 103/187 (55%), Gaps = 12/187 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
WEID K L ++ +G +G + G + Q +VAIK++K ++ + EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H+ +VQ G CT+ + I+TE+MA G + ++L + + FQ LL++ DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
YL +HRDL N L+++ GVVKV+DFG++R T+ G+ RW PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 279 A----FT 281
F+
Sbjct: 193 LMYSKFS 199
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 77 ALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
A G+ W ++ K+LK+ + G +GD+ G Y +V
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKV 219
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIY 195
A+K +K + + F E +M ++RH N+VQ +G L IVTE+MA+GS+
Sbjct: 220 AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
D+L + V LLK ++DV + M YL NN +HRDL N+L+ E+ V KV+DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 255 ARVQAQSGVMTAETGT---YRWMAPEVAF 280
+ + + + +W APE
Sbjct: 336 TKEAS-----STQDTGKLPVKWTAPEALR 359
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-60
Identities = 56/179 (31%), Positives = 98/179 (54%), Gaps = 8/179 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
E+ +++ + ++ SG +G + G + Q +VA+K++K ++ + EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +V+F G C++ + IVTE+++ G + ++L + + LL++ DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVA 279
L + IHRDL N L+D + VKV+DFG+ R + GT +W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVF 177
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-60
Identities = 60/188 (31%), Positives = 97/188 (51%), Gaps = 11/188 (5%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFS 155
+ I K L++ K+ GS+G + +G + + VA+K LKP+ ++ E + +F
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+EV M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---Y 271
V++GM YL IHRDL NLL+ +VK+ DFG+ R + + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 272 RWMAPEVA 279
W APE
Sbjct: 189 AWCAPESL 196
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 5e-60
Identities = 69/185 (37%), Positives = 103/185 (55%), Gaps = 10/185 (5%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVY 159
D WE++ + ++ K+ G YG++Y+G + VA+K LK + + E EF +E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAA 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVS 218
+M++I+H N+VQ +G CTR P I+TEFM G++ D+L + LL +A +S
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
M YL + N IHRDL N L+ EN +VKVADFG++R+ TA G +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 180
Query: 276 PEVAF 280
PE
Sbjct: 181 PESLA 185
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 1e-59
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 13/192 (6%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
G + I + + + + G +G++Y+G Y + + VA+K K +C ++F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFM 61
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
E IM+ + H ++V+ IG P I+ E G + +L + K ++ +L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
+ K M YL N +HRD+ N+L+ VK+ DFG++R A +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 274 MAPEVA----FT 281
M+PE FT
Sbjct: 181 MSPESINFRRFT 192
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-59
Identities = 63/186 (33%), Positives = 89/186 (47%), Gaps = 10/186 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
EI+A ++ IE + SG G++ G VAIK LK + ++F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM + H N+++ G TR IVTE+M GS+ FL G F + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
GM YL +HRDL N+L+D N V KV+DFG++R ++ TG RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 274 MAPEVA 279
APE
Sbjct: 221 TAPEAI 226
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-59
Identities = 59/183 (32%), Positives = 104/183 (56%), Gaps = 10/183 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WE+ + LK+ ++ +G +G+++ G Y +VA+K LK ++ + F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
++++H+ +V+ T+ P + I+TE+M GS+ DFL G + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M ++ + N IHRDL+ AN+L+ + K+ADFG+AR+ + TA G +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 278 VAF 280
Sbjct: 181 AIN 183
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-59
Identities = 61/192 (31%), Positives = 95/192 (49%), Gaps = 13/192 (6%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
T +EI +++++ + G +GD+++G Y S E VAIK K + + ++F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL 64
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
QE MR+ H ++V+ IG T P + I+ E G + FL +K L SL+ A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
+S + YL +HRD+ N+L+ N VK+ DFG++R S A G +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 274 MAPEVA----FT 281
MAPE FT
Sbjct: 184 MAPESINFRRFT 195
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-59
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 19/225 (8%)
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGT 130
+P L P EI + + + +G +G++YKG
Sbjct: 7 HHHHDYDIPTTENLYF--QGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGM 64
Query: 131 Y------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184
VAIK LK + +F E IM + H N+++ G ++ + I
Sbjct: 65 LKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123
Query: 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+TE+M G++ FL ++ G F + L+ + ++ GM YL N +HRDL N+L++ N
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183
Query: 245 GVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVA----FT 281
V KV+DFG++R ++ +G RW APE FT
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-59
Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 14/196 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 154
G+D + + + LK ++ G++G + Y + VA+K L+ L++F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+E+ I++ ++H N+V++ G C L ++ E++ GS+ D+L K K LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT- 270
+ KGM YL IHRDL T N+L++ VK+ DFG+ + + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 271 --YRWMAPEVAFTFFF 284
W APE F
Sbjct: 179 SPIFWYAPESLTESKF 194
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-58
Identities = 45/189 (23%), Positives = 89/189 (47%), Gaps = 11/189 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEV 158
+L+ + SG +G ++KG + + V IKV++ + + + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHM 66
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
+ + H ++V+ +G C L +VT+++ GS+ D + + +G LL + ++
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
KGM YL ++ ++HR+L N+L+ V+VADFGVA + + +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 276 PEVAFTFFF 284
E +
Sbjct: 186 LESIHFGKY 194
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 70/196 (35%), Positives = 108/196 (55%), Gaps = 10/196 (5%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT 148
+ I + D WE++ + ++ K+ G YG++Y+G + S VA+K LK +T
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DT 257
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQL 207
++EF +E +M++I+H N+VQ +G CTR P I+TEFM G++ D+L +
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
LL +A +S M YL + N IHR+L N L+ EN +VKVADFG++R+ TA
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 376
Query: 268 TGT---YRWMAPEVAF 280
G +W APE
Sbjct: 377 AGAKFPIKWTAPESLA 392
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-58
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEML 151
P D + + LK + G +G + Y ++VA+K LKPE +
Sbjct: 9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHI 67
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTS 209
+ +E+ I+R + H+N+V++ G CT + ++ EF+ GS+ ++L K K L
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
LK A+ + KGM+YL +HRDL N+L++ VK+ DFG+ + ++ T +
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 269 GT---YRWMAPEVAFTFFF 284
W APE F
Sbjct: 188 DRDSPVFWYAPECLMQSKF 206
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-58
Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 11/186 (5%)
Query: 103 DVWEIDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+D K L +E K SG++G + KG Y + VA+K+LK E + + E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
+M+++ + +V+ IG C +V E G + +L + + + +++++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 126
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
S GM YL ++N +HRDL N+L+ K++DFG+++ ++A A+T +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 274 MAPEVA 279
APE
Sbjct: 187 YAPECI 192
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 14/194 (7%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
D + + LK ++ G++G + Y VA+K L+ + ++F +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQR 73
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
E+ I++ + +V++ G P +L +V E++ G + DFL + + + LL +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--- 270
+ KGM YL +HRDL N+L++ VK+ADFG+A+ +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 271 YRWMAPEVAFTFFF 284
W APE F
Sbjct: 194 IFWYAPESLSDNIF 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-58
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 92 PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPEC 145
+ + D + + + LK ++ G++G + Y + VA+K L+
Sbjct: 23 QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKG 203
L++F +E+ I++ ++H N+V++ G C L ++ E++ GS+ D+L K K
Sbjct: 83 EEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 262
LL+ + KGM YL IHRDL T N+L++ VK+ DFG+ + +
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 263 VMTAETGT---YRWMAPEVAFTFFF 284
+ W APE F
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKF 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-58
Identities = 57/186 (30%), Positives = 89/186 (47%), Gaps = 10/186 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
E+DA + I+ V +G +G++ G VAIK LK + ++F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGE 96
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM + H N+++ G T+ + IVTE+M GS+ FL K F + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
+ GM YL +HRDL N+L++ N V KV+DFG+ R ++ G RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 274 MAPEVA 279
+PE
Sbjct: 217 TSPEAI 222
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 103 DVWEIDAKQLKI-ECKVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQE 157
+ L I + ++ G++G + +G Y + +VAIKVLK + +E +E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMRE 60
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM ++ + +V+ IG C L +V E G ++ FL ++ ++++ ++ V
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
S GM YL + N +HRDL N+L+ K++DFG+++ + A TA + +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 274 MAPEVA 279
APE
Sbjct: 180 YAPECI 185
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 9e-57
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 89 ESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLK 142
+ D + LK + G +G + Y + VA+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHK 200
+ + + QE+ I+R + H++++++ G C +L +V E++ GS+ D+L +
Sbjct: 70 ADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
L LL A + +GM YLH + IHRDL N+L+D + +VK+ DFG+A+ V
Sbjct: 129 HS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 260 QSGVMTAETGT---YRWMAPEVAFTFFF 284
W APE + F
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKF 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-56
Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 11/187 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + K + SG++G +YKG + + VAIK L+ KE E Y+
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + + +V + +G C + ++T+ M G + D++ + K LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPE 277
MNYL ++HRDL N+L+ VK+ DFG+A+ + A+ AE G +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 278 VAFTFFF 284
+
Sbjct: 190 SILHRIY 196
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-56
Identities = 66/183 (36%), Positives = 107/183 (58%), Gaps = 10/183 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + LK+E K+ +G +G+++ TY +VA+K +KP + ++ F E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+ ++H +V+ T+ P + I+TEFMA+GS+ DFL +G L L+ + +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M ++ Q N IHRDL+ AN+L+ + V K+ADFG+ARV + TA G +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 278 VAF 280
Sbjct: 356 AIN 358
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-55
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 13/245 (5%)
Query: 47 WPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWE 106
P E E + K K S +++++ E +P+ +E
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY--TMPST--RDYE 386
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIM 161
I +++++ + G +GD+++G Y S E VAIK K + + ++F QE M
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTM 445
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
R+ H ++V+ IG T P + I+ E G + FL +K L SL+ A +S +
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVA 279
YL +HRD+ N+L+ N VK+ DFG++R S A G +WMAPE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 280 FTFFF 284
F
Sbjct: 565 NFRRF 569
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-55
Identities = 74/187 (39%), Positives = 111/187 (59%), Gaps = 10/187 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + L++E K+ G +G+++ GT+ VAIK LKP T + F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 278 VAFTFFF 284
A F
Sbjct: 435 AALYGRF 441
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 7e-55
Identities = 74/187 (39%), Positives = 111/187 (59%), Gaps = 10/187 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + L++E K+ G +G+++ GT+ VAIK LKP T + F QE +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 233
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +A ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 278 VAFTFFF 284
A F
Sbjct: 352 AALYGRF 358
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-54
Identities = 43/199 (21%), Positives = 79/199 (39%), Gaps = 30/199 (15%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY---------CSQEVAIKVLKPECVNTEMLKEFS 155
+I + L + G++ ++KG EV +KVL N + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFF 60
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ +M K+ HK++V G C +V EF+ GS+ +L K K + L+VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMD--------ENGVVKVADFGVARVQAQSGVMTAE 267
++ M++L +N +IH ++ N+L+ +K++D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173
Query: 268 TGTY----RWMAPEVAFTF 282
W+ PE
Sbjct: 174 KDILQERIPWVPPECIENP 192
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-53
Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 18/193 (9%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+ ID L + + G +G + +G S +VA+K +K + + ++EF E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 158 VYIMRKIRHKNVVQFIGACTR-----PPNLCIVTEFMARGSIYDFL-----HKQKGVFQL 207
M+ H NV++ +G C P ++ FM G ++ +L L
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
+LLK +D++ GM YL N +HRDL N ++ ++ V VADFG+++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 268 TGT---YRWMAPE 277
+W+A E
Sbjct: 207 RIAKMPVKWIAIE 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-53
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 96 EIPTDGTDVWE-IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNT 148
E P + + + K + SG++G +YKG + + VAIK L+
Sbjct: 2 EAPNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
KE E Y+M + + +V + +G C + ++T+ M G + D++ + K
Sbjct: 60 AN-KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAE 267
LL + ++KGMNYL ++HRDL N+L+ VK+ DFG+A+ + A+ AE
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 268 TGTY--RWMAPEVAFTFFF 284
G +WMA E +
Sbjct: 178 GGKVPIKWMALESILHRIY 196
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-53
Identities = 48/194 (24%), Positives = 88/194 (45%), Gaps = 19/194 (9%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+ I +Q + + G +G + + +VA+K+LK + + + ++EF +E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 158 VYIMRKIRHKNVVQFIGACTR------PPNLCIVTEFMARGSIYDFL-----HKQKGVFQ 206
M++ H +V + +G R P ++ FM G ++ FL +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
L +L++ +D++ GM YL N IHRDL N ++ E+ V VADFG++R
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 267 ETGT---YRWMAPE 277
+ +W+A E
Sbjct: 196 GCASKLPVKWLALE 209
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-52
Identities = 53/231 (22%), Positives = 101/231 (43%), Gaps = 18/231 (7%)
Query: 65 KSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKI--------EC 116
+ + P + + +D E+ K+L + +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ G++G + +G Y + +VAIKVLK +E +E IM ++ + +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
IG C L +V E G ++ FL ++ ++++ ++ VS GM YL + N +HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVA 279
+L N+L+ K++DFG+++ + A TA + +W APE
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-52
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLK 152
G V I + + ++ ++ G++G ++ VA+K LK + K
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--K 62
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------------- 198
+F +E ++ ++H+++V+F G C L +V E+M G + FL
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 199 -HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
+ KG L+ +L +A ++ GM YL + +HRDL T N L+ N +VK+ DFG++R
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 258 QAQSGVMTAETGTY---RWMAPEVAFTFFF 284
+ T RWM PE F
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKF 212
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-52
Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 26/199 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQ 156
+ EI ++ ++ +G +YKG +Q VAIK LK + + +EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH 61
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------HKQ 201
E + +++H NVV +G T+ L ++ + + G +++FL
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
K + + + ++ GM YL ++++H+DL T N+L+ + VK++D G+ R +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 262 GVMTAETGTY---RWMAPE 277
+ RWMAPE
Sbjct: 182 DYYKLLGNSLLPIRWMAPE 200
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 56/251 (22%), Positives = 95/251 (37%), Gaps = 14/251 (5%)
Query: 38 SLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEI 97
+ + D + + ++ S+ G L +P ++
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLK 152
V + + + G +G +Y GT A+K L E+
Sbjct: 79 VQH--VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-S 135
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
+F E IM+ H NV+ +G C R + +V +M G + +F+ + + L+
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271
+ V+KGM +L +HRDL N ++DE VKVADFG+AR + T
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 272 -----RWMAPE 277
+WMA E
Sbjct: 256 AKLPVKWMALE 266
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-51
Identities = 51/185 (27%), Positives = 80/185 (43%), Gaps = 12/185 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEV 158
V + + + G +G +Y GT A+K L + + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEG 77
Query: 159 YIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM+ H NV+ +G C R + +V +M G + +F+ + + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----R 272
+KGM YL +HRDL N ++DE VKVADFG+AR + T +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 273 WMAPE 277
WMA E
Sbjct: 198 WMALE 202
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-51
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 36/220 (16%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
S + +I D WE K L + + G +G + K T VA+K+LK
Sbjct: 6 SVDAFKILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL----- 198
+E+ ++ E +++++ H +V++ GAC++ L ++ E+ GS+ FL
Sbjct: 64 NASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 199 ------------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
H + + L+ A +S+GM YL + ++HRDL N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
+ E +K++DFG++R + + +WMA E
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-51
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 14/193 (7%)
Query: 105 WEI--DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
I + + + G +G +Y G Y + AIK L ++ + F +E
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLRE 72
Query: 158 VYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
+MR + H NV+ IG P ++ +M G + F+ + + L+ +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY----- 271
V++GM YL + +HRDL N ++DE+ VKVADFG+AR + + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 272 RWMAPEVAFTFFF 284
+W A E T+ F
Sbjct: 193 KWTALESLQTYRF 205
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-51
Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPEC 145
+ ++P D WE +L + +G++G + + T + VA+K+LKP
Sbjct: 8 DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------ 198
TE + E+ ++ + H N+V +GACT ++TE+ G + +FL
Sbjct: 66 HLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 199 -----------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
+ L LL + V+KGM +L N IHRDL N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 248 KVADFGVARVQAQSGVMTAETGT---YRWMAPEVAF 280
K+ DFG+AR + +WMAPE F
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF 220
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-51
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 30/239 (12%)
Query: 70 SCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG 129
S S P G + I +P V I + + ++ ++ G++G ++
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 130 TY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
VA+K LK ++F +E ++ ++H+++V+F G CT L
Sbjct: 61 ECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 183 CIVTEFMARGSIYDFL--------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+V E+M G + FL G L LL VA V+ GM YL +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVAFTFFF 284
+HRDL T N L+ + VVK+ DFG++R + T RWM PE F
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-51
Identities = 55/194 (28%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D+ E+ K + + + G++G++Y+G +VA+K L C + + +F
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 81
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------HKQKGVFQLTS 209
E I+ K H+N+V+ IG + I+ E MA G + FL Q +
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTA 266
LL VA D++ G YL +N+ IHRD+ N L+ V K+ DFG+AR ++
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 267 ETGTY---RWMAPE 277
+WM PE
Sbjct: 202 GGCAMLPVKWMPPE 215
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-51
Identities = 48/194 (24%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D WE+ +++ + ++ GS+G +Y+G VAIK + + EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFL 76
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------HKQKGVFQ 206
E +M++ +VV+ +G ++ ++ E M RG + +L +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
L+ ++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+ R ++
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 267 ETGTY---RWMAPE 277
RWM+PE
Sbjct: 197 GGKGLLPVRWMSPE 210
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 9e-51
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 27/201 (13%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFS 155
D T +D +K + + G++G + K + AIK +K + ++F+
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFA 73
Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------H 199
E+ ++ K+ H N++ +GAC L + E+ G++ DFL +
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190
Query: 260 QSGVMTAETGT---YRWMAPE 277
V +T RWMA E
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIE 211
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 27/212 (12%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPEC 145
+ ++P + + WE L+ + +G++G + + T +VA+K+LK
Sbjct: 31 DPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
E + E+ IM + +H+N+V +GACT + ++TE+ G + +FL ++ V
Sbjct: 89 HADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 205 FQ-------------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
+ LL + V++GM +L N IHRD+ N+L+ V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 252 FGVARVQAQSGVMTAETGT---YRWMAPEVAF 280
FG+AR + +WMAPE F
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G++G + + VA+K+LK +
Sbjct: 23 ELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 79
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+ L+ +++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPE 277
DFG+AR T +WMAPE
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPE 229
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-50
Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 20/194 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D+ E+ K + + + G++G++Y+G +VA+K L C + + +F
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 122
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLTS 209
E I+ K H+N+V+ IG + I+ E MA G + FL + Q +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTA 266
LL VA D++ G YL +N+ IHRD+ N L+ G V K+ DFG+AR ++G
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 267 ETGTY---RWMAPE 277
+WM PE
Sbjct: 243 GGCAMLPVKWMPPE 256
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-50
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 31/210 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G +G + + VA+K+LK +
Sbjct: 69 ELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 125
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+ L+ +++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPE 277
DFG+AR T +WMAPE
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPE 275
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 5e-50
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 72 SKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY 131
+ + + E+P D WE+ +L + + G++G +
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90
Query: 132 ---------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181
+VA+K+LK + + L + E+ +M+ I +HKN++ +GACT+
Sbjct: 91 IGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149
Query: 182 LCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
L ++ E+ ++G++ ++L H + L+ A V++GM YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVAF 280
IHRDL N+L+ E+ V+K+ADFG+AR T +WMAPE F
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-49
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 88 IESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKV 140
+ +C +P D WE +LK+ + G++G + + + VA+K+
Sbjct: 6 LPLDEHCERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 141 LKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFL 198
LK + E+ I+ I H NVV +GACT+P L ++ EF G++ +L
Sbjct: 65 LKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 199 ---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
K L L+ + V+KGM +L IHRDL N+L+ E
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
VVK+ DFG+AR + + +WMAPE
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-49
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
+ E D WE + L+ + SG++G + T S +VA+K+LK
Sbjct: 28 YVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 85
Query: 144 ECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
+ ++E + E+ +M ++ H+N+V +GACT + ++ E+ G + ++L ++
Sbjct: 86 KADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 203 GVF--------------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
F LT LL A V+KGM +L + +HRDL N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVAF 280
+ VVK+ DFG+AR +WMAPE F
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLF 247
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-48
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 34/215 (15%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 148
+ E ++ + G++G +++ VA+K+LK E +
Sbjct: 33 LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SA 91
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------- 198
+M +F +E +M + + N+V+ +G C +C++ E+MA G + +FL
Sbjct: 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 199 -------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
L +A V+ GM YL + +HRDL T N L+ EN
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPE 277
VVK+ADFG++R + A+ RWM PE
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-45
Identities = 57/189 (30%), Positives = 94/189 (49%), Gaps = 16/189 (8%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
W I+ +++ + SG+ + ++VAIK + E T + E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMS 68
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVFQLTSLLKVAI----- 215
+ H N+V + + L +V + ++ GS+ D + KG + L + I
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------G 269
+V +G+ YLH+N IHRD+K N+L+ E+G V++ADFGV+ A G +T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 270 TYRWMAPEV 278
T WMAPEV
Sbjct: 189 TPCWMAPEV 197
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 89 ESSPNCIEIPTDGTDVWEID--AKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE 144
E + +I T + + LK + ++ GS+ +YKG T + EVA L+
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----CTRPPNLCIVTEFMARGSIYDFLHK 200
+ + F +E +++ ++H N+V+F + + +VTE M G++ +L +
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARV 257
V ++ L + KG+ +LH IIHRDLK N+ + G VK+ D G+A +
Sbjct: 123 F-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 258 QAQSGVMTAETGTYRWMAPEV 278
+ S GT +MAPE+
Sbjct: 182 KRASFAKA-VIGTPEFMAPEM 201
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-43
Identities = 41/201 (20%), Positives = 72/201 (35%), Gaps = 4/201 (1%)
Query: 81 PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAI 138
P E+S D + + + ++ GSYG+++K + A+
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 139 KVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF 197
K + EV K+ +H V+ A L + TE S+
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQH 146
Query: 198 LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
+ D + +LH ++H D+K AN+ + G K+ DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 258 QAQSGVMTAETGTYRWMAPEV 278
+G + G R+MAPE+
Sbjct: 207 LGTAGAGEVQEGDPRYMAPEL 227
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 48/165 (29%), Positives = 90/165 (54%), Gaps = 8/165 (4%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG +Y G S +AIK + ++ + +E+ + + ++HKN+VQ++G+ +
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-SLLKV-AIDVSKGMNYLHQNNIIHRDLK 235
+ I E + GS+ L + G + + + +G+ YLH N I+HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 236 TANLLMD-ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEV 278
N+L++ +GV+K++DFG + R+ + TGT ++MAPE+
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEI 194
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 8e-43
Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 82 MHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIK 139
M + P + D +++ K+ GS+G+++KG + VAIK
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTK-------LEKIGKGSFGEVFKGIDNRTQKVVAIK 53
Query: 140 VLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 199
++ E E +++ QE+ ++ + V ++ G+ + L I+ E++ GS D L
Sbjct: 54 IIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL- 111
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
+ G T + + ++ KG++YLH IHRD+K AN+L+ E+G VK+ADFGVA Q
Sbjct: 112 -EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQL 169
Query: 260 QSGVMTAET--GTYRWMAPEV 278
+ T GT WMAPEV
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEV 190
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 53/188 (28%), Positives = 91/188 (48%), Gaps = 14/188 (7%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
+ D +VWEI ++ G++G +YK A KV++ + + E L+
Sbjct: 11 VRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELE 61
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
++ E+ I+ H +V+ +GA L I+ EF G++ + + +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
V + + +N+LH IIHRDLK N+LM G +++ADFGV+ + + ++ GT
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGT 180
Query: 271 YRWMAPEV 278
WMAPEV
Sbjct: 181 PYWMAPEV 188
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 34/187 (18%), Positives = 72/187 (38%), Gaps = 13/187 (6%)
Query: 105 WEIDAKQLKIECKVASG--SYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + ++ + G + Y + V ++ + E + EM+ E+++
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK 219
+ H N+V + L +VT FMA GS D + ++ + V K
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--------RVQAQSGVMTAETGTY 271
++Y+H +HR +K +++L+ +G V ++ R +
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 272 RWMAPEV 278
W++PEV
Sbjct: 200 PWLSPEV 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-42
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 12/200 (6%)
Query: 87 LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE 144
+ S ++I + W+ A+ LK ++ G+YG + K + Q +A+K ++
Sbjct: 1 MSIESSGKLKISPE--QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 145 CVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK--- 200
V+ + K+ ++ + MR +VQF GA R + I E M+ S F
Sbjct: 59 -VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116
Query: 201 -QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258
V L K+ + K +N+L +N IIHRD+K +N+L+D +G +K+ DFG++
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 259 AQSGVMTAETGTYRWMAPEV 278
S T + G +MAPE
Sbjct: 177 VDSIAKTRDAGCRPYMAPER 196
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 59/188 (31%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
+ +V+++ K+ GSYG +YK + Q VAIK + E L+
Sbjct: 21 DSLTKQPEEVFDV-------LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQ 69
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
E +E+ IM++ +VV++ G+ + +L IV E+ GS+ D + + +
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
+ KG+ YLH IHRD+K N+L++ G K+ADFGVA Q + T GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGT 188
Query: 271 YRWMAPEV 278
WMAPEV
Sbjct: 189 PFWMAPEV 196
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 46/164 (28%), Positives = 90/164 (54%), Gaps = 6/164 (3%)
Query: 120 SGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G T ++ IK + ++++ +E +EV ++ ++H N+VQ+ +
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+L IV ++ G ++ ++ QKGV FQ +L + + + ++H I+HRD+K+
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
N+ + ++G V++ DFG+ARV S V A GT +++PE+
Sbjct: 154 QNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTPYYLSPEI 196
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-41
Identities = 60/164 (36%), Positives = 95/164 (57%), Gaps = 7/164 (4%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEM--LKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G +G +YKG + VA+K L T ++F QE+ +M K +H+N+V+ +G +
Sbjct: 42 GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+LC+V +M GS+ D L G L K+A + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 237 ANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPE 277
AN+L+DE K++DFG+AR AQ+ + + GT +MAPE
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-41
Identities = 55/170 (32%), Positives = 84/170 (49%), Gaps = 7/170 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
++ GS+G +Y + VAIK + + E ++ +EV ++K+RH N
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+Q+ G R +V E+ GS D L K Q + V +G+ YLH +N+
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVA 279
IHRD+K N+L+ E G+VK+ DFG A + + GT WMAPEV
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVI 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-41
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K + SG +G ++K + + IK +K E +EV + K+ H N+V
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIV 67
Query: 171 QFIGA----------------CTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKV 213
+ G ++ L I EF +G++ ++ K++G L++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273
++KG++Y+H +I+RDLK +N+ + + VK+ DFG+ G T GT R+
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 274 MAPEV 278
M+PE
Sbjct: 188 MSPEQ 192
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 9/180 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 162
E+ A L+ ++ G+YG + K + Q +A+K ++ VN++ K ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSK 219
+ V F GA R ++ I E M S Y + + L K+A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 220 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ +LH ++IHRD+K +N+L++ G VK+ DFG++ + G +MAPE
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 39/197 (19%), Positives = 76/197 (38%), Gaps = 22/197 (11%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
G V ID K K+ G + + +G + A+K + C + +E +E
Sbjct: 21 GHMVI-IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREA 77
Query: 159 YIMRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFL---HKQKGVFQLTSLL 211
+ R H N+++ + C R ++ F RG++++ + + +L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----------AQS 261
+ + + +G+ +H HRDLK N+L+ + G + D G
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 262 GVMTAETGTYRWMAPEV 278
A+ T + APE+
Sbjct: 198 QDWAAQRCTISYRAPEL 214
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 6/186 (3%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKE 153
T V E+ + ++ +G+ G ++K ++ +A K++ E + + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQ 77
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+E+ ++ + +V F GA + I E M GS+ L K+ G L KV
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKV 136
Query: 214 AIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+I V KG+ YL + I+HRD+K +N+L++ G +K+ DFGV+ S + GT
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRS 195
Query: 273 WMAPEV 278
+M+PE
Sbjct: 196 YMSPER 201
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 43/184 (23%), Positives = 83/184 (45%), Gaps = 6/184 (3%)
Query: 99 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
T G ++ + L+ ++ SG+ G ++K + +A+K ++ N E K
Sbjct: 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILM 72
Query: 157 EVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
++ + ++ +VQ G ++ I E M + +G L K+ +
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTV 131
Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
+ K + YL ++ +IHRD+K +N+L+DE G +K+ DFG++ G +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 275 APEV 278
APE
Sbjct: 192 APER 195
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-39
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 17/168 (10%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G++++ + A+K ++ E +E+ + +V GA
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVR 120
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
P + I E + GS+ + KQ G L +G+ YLH I+H D+K
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 238 NLLMDENGV-VKVADFGVARVQAQSGVMTAET------GTYRWMAPEV 278
N+L+ +G + DFG A G+ + GT MAPEV
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 49/174 (28%), Positives = 92/174 (52%), Gaps = 9/174 (5%)
Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ + G +G +YKG +VA+K PE +++ ++EF E+ + RH ++V I
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQNNII 230
G C + ++ ++M G++ L+ ++ L++ I ++G++YLH II
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFT 281
HRD+K+ N+L+DEN V K+ DFG+++ + + T GT ++ PE
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 35/166 (21%), Positives = 81/166 (48%), Gaps = 7/166 (4%)
Query: 120 SGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G + ++Y+ VA+K ++ + ++ + + +E+ +++++ H NV+++ +
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
L IV E G + + K + ++ K + + + ++H ++HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161
Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEV 278
+K AN+ + GVVK+ D G+ R +++ + GT +M+PE
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 9/173 (5%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
K+ K+ G+ G +Y + QEVAI+ + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+V ++ + L +V E++A GS+ D + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+IHRD+K+ N+L+ +G VK+ DFG Q T GT WMAPEV
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEV 187
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-39
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 9/173 (5%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
L K+ GS G + ++VA+K++ + + EV IMR +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
NVV+ + L ++ EF+ G++ D + + + V V + + YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+IHRD+K+ ++L+ +G VK++DFG Q V ++ GT WMAPEV
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEV 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-39
Identities = 59/178 (33%), Positives = 94/178 (52%), Gaps = 16/178 (8%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
++ V +G+YG +YKG + Q AIKV+ V + +E QE+ +++K H+N+
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNI 83
Query: 170 VQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMN 222
+ GA L +V EF GS+ D + K + + + ++ +G++
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+LHQ+ +IHRD+K N+L+ EN VK+ DFGV+ Q V T GT WMAPEV
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEV 200
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-38
Identities = 48/189 (25%), Positives = 82/189 (43%), Gaps = 33/189 (17%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + K + AIK ++ E L EV ++ + H+ VV++ A
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 178 RPPN-------------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
N L I E+ G++YD +H + Q ++ + + ++Y+
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------------QAQSGVMTAETG 269
H IIHRDLK N+ +DE+ VK+ DFG+A+ S +T+ G
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 270 TYRWMAPEV 278
T ++A EV
Sbjct: 193 TAMYVATEV 201
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-38
Identities = 40/191 (20%), Positives = 77/191 (40%), Gaps = 28/191 (14%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
K+ SG +G ++K AIK K + + +EVY + +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
V++ A ++ I E+ GS+ D + ++ F+ L + + V +G+ Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 227 NNIIHRDLKTANLLMDENGV-------------------VKVADFGVARVQAQSGVMTAE 267
+++H D+K +N+ + + K+ D G + E
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVE 190
Query: 268 TGTYRWMAPEV 278
G R++A EV
Sbjct: 191 EGDSRFLANEV 201
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 5e-38
Identities = 37/165 (22%), Positives = 77/165 (46%), Gaps = 9/165 (5%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEV 278
AN L+ +G++K+ DFG+A +Q + + ++ GT +M PE
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-37
Identities = 36/165 (21%), Positives = 76/165 (46%), Gaps = 9/165 (5%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEV 278
AN L+ +G++K+ DFG+A +Q + + ++ G +M PE
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-37
Identities = 37/165 (22%), Positives = 77/165 (46%), Gaps = 9/165 (5%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 98 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEV 278
AN L+ +G++K+ DFG+A +Q + + ++ GT +M PE
Sbjct: 156 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-36
Identities = 36/188 (19%), Positives = 78/188 (41%), Gaps = 30/188 (15%)
Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC- 176
G +G +++ AIK ++ ++ +EV + K+ H +V++ A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 177 -----------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNY 223
+ L I + + ++ D+++ + + + + L + + +++ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-------------QAQSGVMTAETGT 270
LH ++HRDLK +N+ + VVKV DFG+ T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 271 YRWMAPEV 278
+M+PE
Sbjct: 194 KLYMSPEQ 201
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
G+ ++++G + AIKV + +E +++K+ HKN+V+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
T + ++ EF GS+Y L + + L L V DV GMN+L +N I+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K N++ D V K+ DFG AR + GT ++ P++
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-35
Identities = 56/176 (31%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ + G +G +YKG VA+K LK E +F EV ++ H+N+++
Sbjct: 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQN--- 227
G C P +V +MA GS+ L + + L ++A+ ++G+ YLH +
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVAFT 281
IIHRD+K AN+L+DE V DFG+A++ + V TA GT +APE T
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 11/169 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
G+ ++++G + AIKV + +E +++K+ HKN+V+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
T + ++ EF GS+Y L + + L L V DV GMN+L +N I+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K N++ D V K+ DFG AR + GT ++ P++
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 45/173 (26%), Positives = 80/173 (46%), Gaps = 15/173 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
+GSYG K S + + K L + + EV ++R+++H N+V++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 178 RPPN--LCIVTEFMARGSIYDFL--HKQKGV-FQLTSLLKVAIDVSKGMNYLHQ-----N 227
N L IV E+ G + + ++ +L+V ++ + H+ +
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
++HRDLK AN+ +D VK+ DFG+AR+ A+T GT +M+PE
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQ 187
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 17/170 (10%)
Query: 120 SGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
G+ G +Y+G + +++VA+K + PEC +EV ++R+ H NV+++
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
I E A ++ +++ ++ + + + G+ +LH NI+HRDLK
Sbjct: 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147
Query: 238 NLLMDENG-----VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEV 278
N+L+ ++DFG+ + + + GT W+APE+
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-32
Identities = 46/173 (26%), Positives = 79/173 (45%), Gaps = 26/173 (15%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+ +Y+ EVAIK++ K M++ EV I +++H ++++
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E G + +L + F Q+ + GM YLH +
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----------GMLYLHSH 131
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
I+HRDL +NLL+ N +K+ADFG+A Q + T GT +++PE+
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEI 183
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 26/182 (14%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLK---------------PECVNTEMLKEFSQEVYIMRKIR 165
G + + ++ A+K + + +F E+ I+ I+
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK------ 219
++ + G T + I+ E+M SI F V + I V K
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 220 --GMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+Y+H + NI HRD+K +N+LMD+NG VK++DFG + + GTY +M P
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPP 219
Query: 277 EV 278
E
Sbjct: 220 EF 221
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 32/206 (15%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
G V E+ +L++ +A G + +Y + +E A+K L E + QEV
Sbjct: 20 GQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEV 76
Query: 159 YIMRKIR-HKNVVQFIGACTRPPN--------LCIVTEFMARGSIYDFL--HKQKGVFQL 207
M+K+ H N+VQF A + ++TE +G + +FL + +G
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSC 135
Query: 208 TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
++LK+ + + ++H+ IIHRDLK NLL+ G +K+ DFG A + +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 266 AET-------------GTYRWMAPEV 278
T + PE+
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEI 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 25/172 (14%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G + ++ + + A K++ K + ++ S E+ I R + H++VV F G
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E R S+ + LHK++ Q+ G YLH+N
Sbjct: 112 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 160
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEV 278
+IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 212
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 7e-31
Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI---- 173
+G +G + + ++VAIK + E ++ + + + E+ IM+K+ H NVV
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 174 --GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNI 229
+ E+ G + +L++ + L + + D+S + YLH+N I
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142
Query: 230 IHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
IHRDLK N+++ + K+ D G A+ Q + T GT +++APE+
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-31
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 25/172 (14%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G + ++ + + A K++ K + ++ S E+ I R + H++VV F G
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E R S+ + LHK++ Q+ G YLH+N
Sbjct: 86 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 134
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEV 278
+IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEV 186
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-29
Identities = 54/172 (31%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
+ V GSYG + K + VAIK + +M+K+ + E+ +++++RH+N+
Sbjct: 29 NLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENL 86
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V + C + +V EF+ +I D L + K + G+ + H +NI
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
IHRD+K N+L+ ++GVVK+ DFG AR A V E T YR APE+
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APEL 195
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 9e-29
Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G++Y + +A+KVL K + + + +EV I +RH N+++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ E+ G++Y L ++ F +++ ++Y H +IHRD+K
Sbjct: 80 DATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLL+ G +K+ADFG + V A S T GT ++ PE+
Sbjct: 139 NLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEM 178
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G++Y + +A+KVL K + + + +E+ I +RH N+++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ EF RG +Y L ++ G F +++ ++Y H+ +IHRD+K
Sbjct: 85 DRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLLM G +K+ADFG + V A S GT ++ PE+
Sbjct: 144 NLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEM 183
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 45/164 (27%), Positives = 84/164 (51%), Gaps = 6/164 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G++ K QE A+KV+ + +EV +++K+ H N+++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ IV E G ++D + ++ F ++ V G+ Y+H++NI+HRDLK
Sbjct: 92 DSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
N+L+ +++ +K+ DFG++ Q+ M GT ++APEV
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 24/178 (13%)
Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
+E K+ G+YG +YK E A+K ++ E E + +E+ I+++++H
Sbjct: 6 GLE-KIGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKH 59
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
N+V+ L +V E + D L +G + + + + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
H ++HRDLK NLL++ G +K+ADFG+AR T E T YR AP+V
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV 171
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 47/172 (27%), Positives = 87/172 (50%), Gaps = 11/172 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
KI K+ GSYG ++K Q VAIK + ++K+ + E+ ++++++H N+
Sbjct: 7 KIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNL 64
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V + R L +V E+ ++ L + + + + + +N+ H++N
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
IHRD+K N+L+ ++ V+K+ DFG AR+ S E T YR +PE+
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPEL 173
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-28
Identities = 33/198 (16%), Positives = 77/198 (38%), Gaps = 27/198 (13%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
++ +K + + + G++ +Y+ T Q+ +KV KP E Q +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLM 118
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVA 214
++ ++F A +V E + G++ + ++ K V ++ A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM-----------DENGVVKVADFGVA---RVQAQ 260
+ + + +H IIH D+K N ++ D + + + D G + ++ +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 261 SGVMTAETGTYRWMAPEV 278
+ TA+ T + E+
Sbjct: 239 GTIFTAKCETSGFQCVEM 256
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-28
Identities = 55/178 (30%), Positives = 88/178 (49%), Gaps = 24/178 (13%)
Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
K+E KV G+YG +YK VA+K ++ + E + +E+ +++++ H
Sbjct: 25 KLE-KVGEGTYGVVYKAKDSQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELHH 78
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
N+V I L +V EFM D L + K Q + + + +G+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
HQ+ I+HRDLK NLL++ +G +K+ADFG+AR T E T YR AP+V
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV 190
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-28
Identities = 52/185 (28%), Positives = 91/185 (49%), Gaps = 34/185 (18%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
K++ + G + +YK +Q VAIK +K + K+ + +E+ +++++
Sbjct: 14 KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLLQELS 70
Query: 166 HKNVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAID 216
H N++ + A N+ +V +FM + H + +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL-------- 122
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRW 273
+G+ YLHQ+ I+HRDLK NLL+DENGV+K+ADFG+A+ + + T + T YR
Sbjct: 123 --QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR- 179
Query: 274 MAPEV 278
APE+
Sbjct: 180 -APEL 183
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 53/195 (27%), Positives = 84/195 (43%), Gaps = 47/195 (24%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL------------------------KPECVNTEMLKEF 154
GSYG + + A+KVL +++
Sbjct: 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83
Query: 155 SQEVYIMRKIRHKNVVQF---IGACTRPPNLCIVTEFMARGSIYDFLHKQK-------GV 204
QE+ I++K+ H NVV+ + +L +V E + +G + + +
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
FQ D+ KG+ YLH IIHRD+K +NLL+ E+G +K+ADFGV+ S +
Sbjct: 143 FQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 265 TAET-GTYRWMAPEV 278
+ T GT +MAPE
Sbjct: 194 LSNTVGTPAFMAPES 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
K+E K+ G+YG ++K + VA+K ++ + E S +E+ ++++++
Sbjct: 6 KLE-KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMN 222
HKN+V+ L +V EF D + G + + KG+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
+ H N++HRDLK NLL++ NG +K+A+FG+AR +AE T YR P+V
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV 172
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 37/164 (22%), Positives = 77/164 (46%), Gaps = 6/164 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + + + E A K++ + ++ ++ +E I RK++H N+V+ +
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+V + + G +++ + + + + + + Y H N I+HR+LK
Sbjct: 76 EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 134
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLL+ + VK+ADFG+A S GT +++PEV
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 178
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG+ G++ ++VAI+++ + E+ I++K+ H +++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ IV E M G ++D + + + + + YLH+N IIH
Sbjct: 205 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
RDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 42/186 (22%), Positives = 78/186 (41%), Gaps = 34/186 (18%)
Query: 120 SGSYGDL-YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
GS G + ++G++ + VA+K + + E+ ++ + H NV+++ + T
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-------GMNYLHQNNII 230
L I E ++ D + + K V L+ + G+ +LH II
Sbjct: 80 TDRFLYIALELCN-LNLQDLV-ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 231 HRDLKTANLLMD-------------ENGVVKVADFGVARV-----QAQSGVMTAETGTYR 272
HRDLK N+L+ EN + ++DFG+ + + + +GT
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 273 WMAPEV 278
W APE+
Sbjct: 198 WRAPEL 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
+EVAIK++ +N L++ +EV IM+ + H N+V+ L ++ E+ + G
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 194 IYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
++D+L + F Q+ S + Y HQ I+HRDLK NLL+D +
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVS----------AVQYCHQKRIVHRDLKAENLLLDAD 150
Query: 245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+K+ADFG + G + A G + APE+
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 34/183 (18%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
K++ K+ G+Y +YKG VA+K ++ E ++E S +++ ++H
Sbjct: 6 KLD-KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHA 60
Query: 168 NVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
N+V +L +V E++ G+I + + + +FQL
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---------- 110
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMA 275
+G+ Y H+ ++HRDLK NLL++E G +K+ADFG+AR + E T YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--P 168
Query: 276 PEV 278
P++
Sbjct: 169 PDI 171
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 26/180 (14%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
K+E K+ G+YG +YK + VA+K ++ + E + +E+ +++++
Sbjct: 7 KVE-KIGEGTYGVVYKARNKLTGEVVALKKIR-----LDTETEGVPSTAIREISLLKELN 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLK-VAIDVSKGM 221
H N+V+ + L +V EF+ D F+ L+K + +G+
Sbjct: 61 HPNIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
+ H + ++HRDLK NLL++ G +K+ADFG+AR T E T YR APE+
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR--APEI 174
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 47/171 (27%), Positives = 87/171 (50%), Gaps = 6/171 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I C + GS+G++ K QE A+KV+ + +EV +++K+ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + IV E G ++D + ++ F ++ V G+ Y+H++NI+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 10/165 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
GS+G++ A K + K + + K QE+ IM+ + H N+++
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETF 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
++ +V E G +++ + K VF+ + ++ DV + Y H+ N+ HRDLK
Sbjct: 76 EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134
Query: 237 ANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
N L + +K+ DFG+A +M + GT +++P+V
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 46/165 (27%), Positives = 89/165 (53%), Gaps = 11/165 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
SG++ +++ + A+K + K L+ E+ +++KI+H+N+V
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V + ++ G ++D + ++GV+ V V + YLH+N I+HRDLK
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134
Query: 237 ANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLL +EN + + DFG+++++ Q+G+M+ GT ++APEV
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEV 178
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 48/171 (28%), Positives = 87/171 (50%), Gaps = 6/171 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ SG+YG++ E AIK+++ V+T + +EV +++ + H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ N +V E G ++D + + F + V G+ YLH++NI+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
HRDLK NLL+ +++ ++K+ DFG++ V M GT ++APEV
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 7/172 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
K + + GS+G++ QE A+KV+ K + + +EV +++++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
++ +V E G ++D + + F ++ V G+ Y+H+N I
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 230 IHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+HRDLK NLL+ ++ +++ DFG++ S M + GT ++APEV
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 42/170 (24%), Positives = 81/170 (47%), Gaps = 13/170 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG+ G++ ++VAIK++ + E+ I++K+ H +++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ IV E M G ++D + + + + + YLH+N IIH
Sbjct: 80 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
RDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 45/211 (21%), Positives = 87/211 (41%), Gaps = 38/211 (18%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEM 150
++ D CKV G+YG +YK ++ A+K ++ ++
Sbjct: 7 FKVKLSSERERVED-LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--VTEFMARGSIYD---FLHKQKGVF 205
+E + ++R+++H NV+ + + + ++ +D + +
Sbjct: 66 CRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASK 117
Query: 206 QLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFG 253
+++ + K G++YLH N ++HRDLK AN+L+ E G VK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 254 VARV-QAQSGVMTAETGT-----YRWMAPEV 278
AR+ + + YR APE+
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYR--APEL 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-27
Identities = 41/177 (23%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL------KPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG++G ++ +EV +K + + + L + + E+ I+ ++ H N+++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 172 FIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
+ +V E G ++ F+ + +F QL S A+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----AVG----- 144
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
YL +IIHRD+K N+++ E+ +K+ DFG A + + GT + APEV
Sbjct: 145 -YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 38/168 (22%), Positives = 84/168 (50%), Gaps = 10/168 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIR-HKNVV 170
G + + + + E A+K+++ E+ + +E +I+R++ H +++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I + + +V + M +G ++D+L +K + + + +++LH NNI+
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
HRDLK N+L+D+N ++++DFG + + GT ++APE+
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 37/164 (22%), Positives = 77/164 (46%), Gaps = 6/164 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + + + E A K++ + ++ ++ +E I RK++H N+V+ +
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+V + + G +++ + + + + + + Y H N I+HR+LK
Sbjct: 99 EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLL+ + VK+ADFG+A S GT +++PEV
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 33/170 (19%), Positives = 74/170 (43%), Gaps = 7/170 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I + G +G +++ S + K +K + + ++K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L ++ EF++ I++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H D++ N++ + +K+ +FG AR + APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 34/174 (19%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
I ++ SG++G +++ + + K + P ++ +K E+ IM ++ H +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKL 110
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQ 226
+ A + ++ EF++ G ++D + + ++ + ++ +G+ ++H+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---QACEGLKHMHE 167
Query: 227 NNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
++I+H D+K N++ + VK+ DFG+A ++ T T + APE+
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 42/169 (24%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE----FSQEVYIMRKI-RHKNV 169
G + + + +E A+K++ + E ++E +EV I+RK+ H N+
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+Q +V + M +G ++D+L +K K+ + + + LH+ NI
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNI 145
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+HRDLK N+L+D++ +K+ DFG + + GT ++APE+
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
++E K+ +G+Y +YKG + VA+K +K + + ++E S +M++++H+
Sbjct: 9 QLE-KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHE 63
Query: 168 NVVQFIGACTRPPNLCIVTEFMA---RGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNY 223
N+V+ L +V EFM + + +L+K + +G+ +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEV 278
H+N I+HRDLK NLL+++ G +K+ DFG+AR ++E T YR AP+V
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDV 179
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 31/167 (18%), Positives = 66/167 (39%), Gaps = 15/167 (8%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
++ + + + + S ++ M KN V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 187 EFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+ + ++ D+++++ + L + I +++ + +LH ++HRDLK +N+ +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 245 GVVKVADFGVARV-------------QAQSGVMTAETGTYRWMAPEV 278
VVKV DFG+ T + GT +M+PE
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 16/173 (9%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEML--KEFSQEVYIMRKIRHKNVVQFIG 174
G + + + Q+ A+K++ + ++ L ++ +E I ++H ++V+ +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNI 229
+ L +V EFM + + + F + VA + + Y H NNI
Sbjct: 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDNNI 151
Query: 230 IHRDLKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
IHRD+K +L+ + + VK+ FGVA + V GT +MAPEV
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-26
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG++ + VA+K++ + + + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
+ E+ + G ++D + G+ F QL + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125
Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEV 278
I HRD+K NLL+DE +K++DFG V R + ++ GT ++APE+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 22/203 (10%), Positives = 59/203 (29%), Gaps = 37/203 (18%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 166
++LK+ + G ++ ++ A+KV + L+ + + ++
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 167 KNVVQFIGAC--------------------------TRPPNLCIVTEFMAR-----GSIY 195
++ + N ++ + S
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
DF++ +G + +L + + + L ++H NL + +G + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 256 RVQAQSGVMTAETGTYRWMAPEV 278
+ G + AP
Sbjct: 242 W---KVGTRGPASSVPVTYAPRE 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-26
Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 45/210 (21%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE 153
+ +DG + + + + +GS+G +++ S EVAIK + + K
Sbjct: 26 KVLASDGKTGEQREIAYTNCK-VIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KR 77
Query: 154 F-SQEVYIMRKIRHKNVVQFIGACTRPPN-------LCIVTEFM------------ARGS 193
F ++E+ IMR ++H NVV + A L +V E++
Sbjct: 78 FKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ 136
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADF 252
L + ++QL + + Y+H I HRD+K NLL+D GV+K+ DF
Sbjct: 137 TMPMLLIKLYMYQLL----------RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 253 GVARVQAQSGVMTAE--TGTYRWMAPEVAF 280
G A++ + + YR APE+ F
Sbjct: 187 GSAKILIAGEPNVSYICSRYYR--APELIF 214
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 49/178 (27%), Positives = 85/178 (47%), Gaps = 12/178 (6%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
++ + G +++ ++VA+KVL+ + + F +E + H +
Sbjct: 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 170 VQF--IGACTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
V G P IV E++ ++ D +H +G ++V D + +N+ H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH 133
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVA 279
QN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 40/170 (23%), Positives = 90/170 (52%), Gaps = 22/170 (12%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + G + +VA+K+L + + + +++ + +E+ ++ RH ++++ +
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P + +V E+++ G ++D++ K V F Q+ S ++Y H++
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------AVDYCHRHM 131
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
++HRDLK N+L+D + K+ADFG++ + + + G+ + APEV
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 56/191 (29%), Positives = 95/191 (49%), Gaps = 37/191 (19%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-F----SQEVYIMRKIR 165
K+ K+ G++G+++K Q+VA+K + E KE F +E+ I++ ++
Sbjct: 21 KLA-KIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLK 74
Query: 166 HKNVVQFIGACT--------RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVA 214
H+NVV I C ++ +V +F +D L F L+ + +V
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVM 130
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETG 269
+ G+ Y+H+N I+HRD+K AN+L+ +GV+K+ADFG+AR +Q T
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 270 T--YRWMAPEV 278
T YR PE+
Sbjct: 191 TLWYR--PPEL 199
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 37/167 (22%), Positives = 75/167 (44%), Gaps = 9/167 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
SG++GD++ S E IK + + +++ E+ +++ + H N+++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 178 RPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
N+ IV E G + + + + + ++ + + Y H +++H+DL
Sbjct: 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150
Query: 235 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
K N+L + +K+ DFG+A + T GT +MAPEV
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 33/165 (20%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + QE A ++ + ++ ++ +E I R ++H N+V+ + +
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ + + G +++ + + + + + + + HQ ++HR+LK
Sbjct: 81 EEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 238 NLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
NLL+ + VK+ADFG+A V+ + GT +++PEV
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 44/172 (25%), Positives = 84/172 (48%), Gaps = 6/172 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
KI K+ G +Y T + +VAIK + E LK F +EV+ ++ H+N+
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V I +V E++ ++ +++ G + + + + G+ + H I
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVA 279
+HRD+K N+L+D N +K+ DFG+A+ +++ + GT ++ +PE A
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 40/171 (23%), Positives = 81/171 (47%), Gaps = 8/171 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
I ++ +G++G +++ T + A K + P + E ++ +E+ M +RH +
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTL 216
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A + ++ EFM+ G +++ + + ++ V KG+ ++H+NN
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 230 IHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+H DLK N++ + +K+ DFG+ + TGT + APEV
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-25
Identities = 44/187 (23%), Positives = 82/187 (43%), Gaps = 19/187 (10%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVY 159
+ + + +K+L G + + + S QE A K LK + E E+
Sbjct: 27 NNFYILTSKEL------GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 160 IMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVF---QLTSLLKVA 214
++ + V+ + ++ E+ A G I+ + + + L+K
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-- 138
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTY 271
+ +G+ YLHQNNI+H DLK N+L+ G +K+ DFG++R + + GT
Sbjct: 139 -QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 272 RWMAPEV 278
++APE+
Sbjct: 198 EYLAPEI 204
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG++ + VA+K++ + + + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
+ E+ + G ++D + G+ F QL + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125
Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEV 278
I HRD+K NLL+DE +K++DFG V R + ++ GT ++APE+
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 42/164 (25%), Positives = 84/164 (51%), Gaps = 10/164 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+ +Y+ + A+KVLK + V+ ++++ E+ ++ ++ H N+++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFE 118
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
P + +V E + G ++D + +KG + + + + YLH+N I+HRDLK
Sbjct: 119 TPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NLL + +K+ADFG++++ +M GT + APE+
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 28/173 (16%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
SG++G + VA+K ++ E ++ +E+ R +RH N+V+F
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVIL 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
P +L I+ E+ + G +Y+ + G F QL S G++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS----------GVSYCHSM 135
Query: 228 NIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
I HRDLK N L+D + +K+ DFG ++ + GT ++APEV
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-25
Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 17/179 (9%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
++ ++ SG + + K +E A K +K +E +EV I+R+IRH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNY 223
N++ ++ ++ E ++ G ++DFL +K + T LK + G++Y
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLK---QILDGVHY 123
Query: 224 LHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
LH I H DLK N+++ N +K+ DFG+A GT ++APE+
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 40/170 (23%), Positives = 92/170 (54%), Gaps = 22/170 (12%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + G + +VA+K+L + + + +++ + +E+ ++ RH ++++ +
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P ++ +V E+++ G ++D++ K + F Q+ S G++Y H++
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------GVDYCHRHM 136
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
++HRDLK N+L+D + K+ADFG++ + + + G+ + APEV
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG + + K S E A K +K +E +EV I+R++ H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ ++ E ++ G ++DFL QK + G+NYLH I H D
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
LK N+++ +K+ DFG+A GT ++APE+
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 11/169 (6%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG + + K S E A K +K +E +EV I+R++ H NV+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ ++ E ++ G ++DFL QK + G+NYLH I H D
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
LK N+++ +K+ DFG+A GT ++APE+
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 28/186 (15%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKIR- 165
+ ++ G+YG +YK + VA+K ++ EV ++R++
Sbjct: 13 PVA-EIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALLRRLEA 70
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLK-VA 214
H NVV+ + C R + +V E + D +L K +K +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YR 272
+G+++LH N I+HRDLK N+L+ G VK+ADFG+AR+ + +T T YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 273 WMAPEV 278
APEV
Sbjct: 187 --APEV 190
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 42/175 (24%), Positives = 82/175 (46%), Gaps = 17/175 (9%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK-----------PECVNTEMLKEFSQEVYIMRKIRH 166
SG+YG++ + E AIKV+K + +E E+ +++ + H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
N+++ +VTEF G +++ + + F + + G+ YLH+
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHK 164
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+NI+HRD+K N+L+ + +K+ DFG++ ++ + GT ++APEV
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-24
Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 51/210 (24%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
GSYG + AIK++ K +N + ++ EV +M+K+ H N+ +
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL----------------------- 211
+C+V E G + D L+ +
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 212 ----------------KVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFG 253
+ + ++YLH I HRD+K N L +++ +K+ DFG
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 254 VARV-----QAQSGVMTAETGTYRWMAPEV 278
+++ + MT + GT ++APEV
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 47/188 (25%), Positives = 82/188 (43%), Gaps = 39/188 (20%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRH 166
+I K+ G+YG++YK + VAIK ++ E V ++E S ++++++H
Sbjct: 38 RIT-KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQH 92
Query: 167 KNVVQFIGACTRPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
+N+++ L ++ E+ + + ++QL
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI---------- 142
Query: 219 KGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARV-QAQSGVMTAETGT-- 270
G+N+ H +HRDLK NLL+ E V+K+ DFG+AR T E T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 271 YRWMAPEV 278
YR PE+
Sbjct: 203 YR--PPEI 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 4e-24
Identities = 41/211 (19%), Positives = 76/211 (36%), Gaps = 51/211 (24%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQ- 156
+ + + ++ ++SGSYG C+ VAIK + + + S
Sbjct: 17 LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 157 --------EVYIMRKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGS 193
E+ ++ H N++ + +VTE M +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ H Q ++ + G++ LH+ ++HRDL N+L+ +N + + DF
Sbjct: 130 VISPQHIQYFMYHIL----------LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 254 VARVQAQSGVMTAETGT--YRWMAPEVAFTF 282
+AR T YR APE+ F
Sbjct: 180 LAREDTADANKTHYVTHRWYR--APELVMQF 208
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-24
Identities = 46/170 (27%), Positives = 89/170 (52%), Gaps = 23/170 (13%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G + T+ Q+VA+K + + ++M +E+ ++ +RH ++++ T
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P ++ +V E+ A G ++D++ ++K + F Q+ + Y H++
Sbjct: 80 TPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC----------AIEYCHRHK 128
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
I+HRDLK NLL+D+N VK+ADFG++ + + G+ + APEV
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 5e-24
Identities = 40/167 (23%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G +G ++K + ++A K++ + E +K E+ +M ++ H N++Q A
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAF 155
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ +V E++ G ++D + + +K + +G+ ++HQ I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212
Query: 234 LKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
LK N+L + +K+ DFG+AR + GT ++APEV
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-24
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 31/179 (17%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQF---I 173
GSYG + + A+K+LK + + +E+ ++R++RHKNV+Q +
Sbjct: 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75
Query: 174 GACTRPPNLCIVTEFMARGS--IYDFLHKQK-------GVF-QLTSLLKVAIDVSKGMNY 223
+ +V E+ G + D + +++ G F QL G+ Y
Sbjct: 76 YNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------GLEY 124
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVA 279
LH I+H+D+K NLL+ G +K++ GVA A G+ + PE+A
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA 183
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-24
Identities = 37/169 (21%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC 176
GS+ K + Q A+K ++ M +E+ ++ H N+V+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ +V E + G +++ + K+K F + + +++ + ++++H ++HRD
Sbjct: 76 HDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRD 131
Query: 234 LKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
LK NLL ++N +K+ DFG AR + + T + APE+
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-24
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 17/172 (9%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
SG + + K S + A K + + + + +E +EV I+++I+H NV+
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNII 230
++ ++ E +A G ++DFL +K + T LK + G+ YLH I
Sbjct: 81 EVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK---QILNGVYYLHSLQIA 136
Query: 231 HRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H DLK N+++ +K+ DFG+A GT ++APE+
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 9e-24
Identities = 48/192 (25%), Positives = 86/192 (44%), Gaps = 42/192 (21%)
Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTE------------MLKEFSQE 157
+ ++ G+YG ++K + VA+K ++ + E +L+
Sbjct: 15 CVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRH---- 67
Query: 158 VYIMRKIRHKNVVQFI-----GACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTS 209
+ H NVV+ R L +V E + D +L K T
Sbjct: 68 ---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTE 120
Query: 210 LLK-VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+K + + +G+++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 269 GT--YRWMAPEV 278
T YR APEV
Sbjct: 181 VTLWYR--APEV 190
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 52/244 (21%), Positives = 91/244 (37%), Gaps = 51/244 (20%)
Query: 67 KDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL---KIECKVASGSY 123
+ +QP+ S + T D Q + +GS+
Sbjct: 11 AESCKPVQQPS---AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSF 67
Query: 124 GDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPP 180
G +Y+ C + VAIK + + K F E+ IMRK+ H N+V+ +
Sbjct: 68 GVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVR-LRYFFYSS 119
Query: 181 N-------LCIVTEFM------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
L +V +++ ++ + ++QL + +
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----------RSL 169
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEV 278
Y+H I HRD+K NLL+D + V+K+ DFG A+ + + + YR APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APEL 227
Query: 279 AFTF 282
F
Sbjct: 228 IFGA 231
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 19/174 (10%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA 175
G++ + QE A+K++ K + +EV ++ + + H+NV++ I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEF 79
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
+V E M GSI +HK + F V DV+ +++LH I HRDLK
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 236 TANLLM---DENGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPEV 278
N+L ++ VK+ DF + + + G+ +MAPEV
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 32/172 (18%), Positives = 67/172 (38%), Gaps = 6/172 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNV 169
++ V G GD+Y+ T + VA+K++ + + + +E +++ +V
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V L + + + L +++G + + + ++ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVA 279
HRD+K N+L+ + + DFG+A + GT +MAPE
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 34/192 (17%), Positives = 77/192 (40%), Gaps = 30/192 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
W + K+ G Y ++++ + ++V +K+LKP K+ +E+ I+
Sbjct: 31 EWGNQDDYQLVR-KLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKIL 84
Query: 162 RKIR-HKNVVQFIGACTRPPNLC---IVTEFMAR--GSIYDFL---HKQKGVFQLTSLLK 212
+R N++ P + + +Y L + ++++
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---- 140
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTY 271
K ++Y H I+HRD+K N+++D E+ +++ D+G+A +
Sbjct: 141 ------KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS- 193
Query: 272 RWM-APEVAFTF 282
R+ PE+ +
Sbjct: 194 RYFKGPELLVDY 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-22
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
WE+ A ++ V SG+YG + +VAIK L + K +E+ ++
Sbjct: 20 AWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ +RH+NV+ + T L +V FM + Q V+Q+
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 139 ----------KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 186
Query: 269 GTYRWM-APEVAFTF 282
T RW APEV +
Sbjct: 187 VT-RWYRAPEVILNW 200
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 3e-22
Identities = 24/194 (12%), Positives = 60/194 (30%), Gaps = 38/194 (19%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
+ T + + V E + +K+ +EV +R +R
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 166 --------------HKNVVQFIGACTRPPNLCIVTEFM-ARGSIYDFLH------KQKGV 204
K +++ L + + ++ F
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
+ L++ + V + + LH ++H L+ ++++D+ G V + F + G
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGAR 259
Query: 265 TAETGTYRWMAPEV 278
+ + + PE+
Sbjct: 260 VVSSVSRGFEPPEL 273
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 32/180 (17%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR----HKNV 169
G +G ++ G + +VAIKV+ V EV ++ K+ H V
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 170 VQFIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSK 219
++ + +V E ++D++ ++ + F Q+ + AI
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA----AIQ--- 153
Query: 220 GMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ H ++HRD+K N+L+D G K+ DFG + T GT + PE
Sbjct: 154 ---HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEW 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-22
Identities = 48/196 (24%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+ + + + + SG+ G + + VAIK L N K +E+ +M
Sbjct: 57 TFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ + HKN++ + T L +V E M + + ++Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQML 174
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 175 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 269 GT--YRWMAPEVAFTF 282
T YR APEV
Sbjct: 225 VTRYYR--APEVILGM 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-22
Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 30/195 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+WE+ + + V SG+YG + T VA+K L + K +E+ ++
Sbjct: 24 IWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ ++H+NV+ + T +L +VT M + H Q ++Q+
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + MT
Sbjct: 143 ----------RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYV 190
Query: 269 GTYRW-MAPEVAFTF 282
T RW APE+ +
Sbjct: 191 AT-RWYRAPEIMLNW 204
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
V+++ + + G+YG + VAIK + P E + + +E+ I
Sbjct: 22 VFDVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKI 78
Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
+ + RH+N++ I R P + IV + M + H ++Q+
Sbjct: 79 LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGV 263
+G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G
Sbjct: 138 L----------RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 264 MTAETGT--YRWMAPEVAFTF 282
+T T YR APE+
Sbjct: 188 LTEYVATRWYR--APEIMLNS 206
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-22
Identities = 42/178 (23%), Positives = 78/178 (43%), Gaps = 30/178 (16%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHK--NVVQ 171
SG +G +Y G S VAIK ++ + ++ EV +++K+ V++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 172 FIGACTRPPNLCIVTEFMA-RGSIYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
+ RP + ++ E ++DF+ ++ + F Q+ A+
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE----AVR----- 163
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ H ++HRD+K N+L+D N G +K+ DFG + + V T GT + PE
Sbjct: 164 -HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEW 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 8e-22
Identities = 35/175 (20%), Positives = 71/175 (40%), Gaps = 16/175 (9%)
Query: 113 KIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+++ +A G G +Y + V +K L + E E + ++ H ++
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 170 VQ---FIGACTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VQ F+ R + IV E++ S+ + + +++ ++YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVA 279
H +++ DLK N+++ E +K+ D G G + GT + APE+
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIV 249
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+ + + ++ + SG+ G + + VAIK L N K +E+ +M
Sbjct: 20 TFTVLKRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ + HKN++ + T +L IV E M + + ++Q+
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-ERMSYLLYQML 137
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 138 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 269 GTYRWM-APEVAFTF 282
T R+ APEV
Sbjct: 188 VT-RYYRAPEVILGM 201
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 31/196 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
WE+ V SG+YG + ++VAIK L + K +E+ ++
Sbjct: 19 AWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ ++H+NV+ + T +L +V FM + Q V+Q+
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-KIQYLVYQML 136
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
KG+ Y+H ++HRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 137 ----------KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184
Query: 269 GTYRW-MAPEVAFTFF 283
T RW APEV ++
Sbjct: 185 VT-RWYRAPEVILSWM 199
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 40/170 (23%), Positives = 83/170 (48%), Gaps = 21/170 (12%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGAC 176
GSY + + + E A+K ++ ++E+ I+ + +H N++
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDP-TEEIEILLRYGQHPNIITLKDVY 85
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ +VTE M G + D + + + F + +++L ++K + YLH ++HRD
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLF---TITKTVEYLHAQGVVHRD 141
Query: 234 LKTANLLM----DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
LK +N+L +++ DFG A+ ++A++G++ T ++APEV
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 40/174 (22%), Positives = 75/174 (43%), Gaps = 27/174 (15%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
G G + + + Q+ A+K+L + QEV + ++V +
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
L I+ E M G ++ + + +G T +++ D+ + +LH +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSH 147
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NI HRD+K NLL +++ V+K+ DFG A+ + + T ++APEV
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 47/199 (23%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIK--VLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
++E G++G + G S VAIK + P N E+ Q + + + H N
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVLHHPN 80
Query: 169 VVQFIGACTRPPN--------LCIVTEFM------------ARGSIYDFLHKQKGVFQLT 208
+VQ + + L +V E++ R + + +FQL
Sbjct: 81 IVQ-LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 209 SLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 265
+ + LH N+ HRD+K N+L++ +G +K+ DFG A+ + S
Sbjct: 140 ----------RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 266 AETGT--YRWMAPEVAFTF 282
A + YR APE+ F
Sbjct: 190 AYICSRYYR--APELIFGN 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-21
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 28/175 (16%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175
G G + + ++ A+K+L +EV + + + ++V+ +
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELHWRASQCPHIVRIVDV 123
Query: 176 C----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQ 226
L IV E + G ++ + +G T ++K + + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMK---SIGEAIQYLHS 179
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NI HRD+K NLL N ++K+ DFG A+ +T T ++APEV
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 234
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 94 CIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECV 146
C +P D WE +LK+ + G++G + + + VA+K+LK
Sbjct: 7 CERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
++E + E+ I+ I H NVV +GACT+P L ++ EF G++ +L ++
Sbjct: 66 HSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
F +G +Y+ I DLK
Sbjct: 125 FVPYKTKGA--RFRQGKDYV---GAIPVDLK 150
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 38/166 (22%), Positives = 65/166 (39%), Gaps = 6/166 (3%)
Query: 122 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181
+G+L S+ K + K++ + + K R ++ + +
Sbjct: 110 KFGNLST-YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
+ + L+K L L+ + V+KGM +L IHRDL N+L+
Sbjct: 169 EEKSLSDVEEEEAPEDLYK--DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVAFTFFF 284
E VVK+ DFG+AR + + +WMAPE F +
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 23/194 (11%), Positives = 60/194 (30%), Gaps = 38/194 (19%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
+ T + + V E + +K+ +EV +R +R
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 166 -----------HKNVVQFIGACTRPPNLCIVTEFM----ARGSIYDFLH------KQKGV 204
+ I ++ +++ F + ++ F
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
+ L++ + V + + LH ++H L+ ++++D+ G V + F + +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAV 266
Query: 265 TAETGTYRWMAPEV 278
+ + PE
Sbjct: 267 SPIGRGF--APPET 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 40/152 (26%), Positives = 73/152 (48%), Gaps = 20/152 (13%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K + K +CV ++ +E+ IM+ + H +V + ++ +V + + G +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102
Query: 196 DFLH-KQKGVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 246
H +Q F+ + K ++YL IIHRD+K N+L+DE+G
Sbjct: 103 -RYHLQQNVHFK--------EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH 153
Query: 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
V + DF +A + + +T GT +MAPE+
Sbjct: 154 VHITDFNIAAMLPRETQITTMAGTKPYMAPEM 185
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 4e-20
Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 30/171 (17%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
W+I + +I + +GSYG + + + VAIK + + K +E+ I+
Sbjct: 48 DWQIPDR-YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQ 206
++ H +VV+ + P ++ +V E + + H + ++
Sbjct: 107 NRLNHDHVVK-VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-HIKTLLYN 164
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
L G+ Y+H I+HRDLK AN L++++ VKV DFG+AR
Sbjct: 165 LL----------VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-20
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++ K + A+K+L K E + F +E ++ K + A
Sbjct: 85 GAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
NL +V ++ G + L K + + + +AID +HQ +
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQLHY 196
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+HRD+K N+LMD NG +++ADFG + G + + GT +++PE+
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 45/208 (21%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
V+ I + +++ + G+YG + T+ + VAIK ++P + +E+ I
Sbjct: 6 VYNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKI 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
++ +H+N++ I RP + I+ E M + H Q ++Q
Sbjct: 63 LKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 257
+ + LH +N+IHRDLK +NLL++ N +KV DFG+AR+
Sbjct: 122 L----------RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 258 -QAQSGVMTAETGT--YRWMAPEVAFTF 282
Q M T YR APEV T
Sbjct: 172 PTGQQSGMVEFVATRWYR--APEVMLTS 197
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 27/174 (15%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+ + T S+E AIK+L K + + ++E +M ++ H V+
Sbjct: 41 GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYLHQN 227
L + G + ++ K G F ++ + YLH
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRKI-GSFD--------ETCTRFYTAEIVSALEYLHGK 149
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET--GTYRWMAPEV 278
IIHRDLK N+L++E+ +++ DFG A + +S A + GT ++++PE+
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 8e-19
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++ ++ K T Q A+K++ K + + + F +E ++ + + Q A
Sbjct: 72 GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
L +V E+ G + L K + + +AID +H+
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID------SVHRLGY 183
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+HRD+K N+L+D G +++ADFG G + + GT +++PE+
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-19
Identities = 42/190 (22%), Positives = 73/190 (38%), Gaps = 30/190 (15%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
+ I+ + GSYG +Y + VAIK + + K +E+ I+
Sbjct: 22 VHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 163 KIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQL 207
+++ +++ P +L IV E + + H + ++ L
Sbjct: 81 RLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-HIKTILYNL 138
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
G N++H++ IIHRDLK AN L++++ VKV DFG+AR
Sbjct: 139 L----------LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 268 TGTYRWMAPE 277
P
Sbjct: 189 NDLEENEEPG 198
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 47/210 (22%), Positives = 90/210 (42%), Gaps = 47/210 (22%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+++ ++ + G G ++ C + VAIK + + + +K +E+ I+
Sbjct: 6 GFDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKII 62
Query: 162 RKIRHKNVVQFIGACTRPPNLC---------------IVTEFMA-------RGSIYDFLH 199
R++ H N+V+ + P IV E+M H
Sbjct: 63 RRLDHDNIVK-VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV- 257
+ ++QL +G+ Y+H N++HRDLK ANL ++ E+ V+K+ DFG+AR+
Sbjct: 122 ARLFMYQLL----------RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 258 ---QAQSGVMTAETGT--YRWMAPEVAFTF 282
+ G ++ T YR +P + +
Sbjct: 172 DPHYSHKGHLSEGLVTKWYR--SPRLLLSP 199
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++ K T + A+K+L K E + F +E IM VVQ A
Sbjct: 80 GAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V E+M G + +V ++ +H IHRD+K
Sbjct: 138 FQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
N+L+D++G +K+ADFG + G++ +T GT +++PEV
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 40/234 (17%), Positives = 81/234 (34%), Gaps = 77/234 (32%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMR 162
E +K+ + + +GS+G + + + A+K + + + E+ IM+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMK 55
Query: 163 KIRHKNVVQ--------------------------------FIGACTRPPN------LCI 184
+ H N+++ + N L +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 185 VTEFM-------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ E++ + SI ++QL + + ++H I H
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPM-NLISIYIYQLF----------RAVGFIHSLGICH 164
Query: 232 RDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEVAFTF 282
RD+K NLL++ ++ +K+ DFG A+ S A + YR APE+
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGA 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-18
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 61/216 (28%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
+ K ++ K+ G+YG + VA+K + N+ + +E
Sbjct: 5 RHVLRK-YELVKKLGKGAYG-----IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 158 VYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGVFQ 206
+ I+ ++ H+N+V + R N + +V ++M R +I + +HKQ V+Q
Sbjct: 59 IMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 257
L K + YLH ++HRD+K +N+L++ VKVADFG++R
Sbjct: 118 LI----------KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 258 -------------QAQSGVMTAETGT--YRWMAPEV 278
++T T YR APE+
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYR--APEI 201
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 26/151 (17%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
G G + + ++ A+K+L+ + + EV + + + ++V+ +
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQ----DCPKARR---EVELHWRASQCPHIVRIVDVY 80
Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
L IV E + G ++ + + +G T ++K + + + YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMK---SIGEAIQYLHSI 136
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVA 255
NI HRD+K NLL N ++K+ DFG A
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 18/152 (11%)
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIM--RKI-------RHKNVVQFIGACTRPPNLCIVTE 187
A+K L + +K E + R + +V A P L + +
Sbjct: 218 AMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 188 FMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246
M G + H Q GVF + A ++ G+ ++H +++RDLK AN+L+DE+G
Sbjct: 273 LMNGGDL--HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
V+++D G+A A GT+ +MAPEV
Sbjct: 331 VRISDLGLA-CDFSKKKPHASVGTHGYMAPEV 361
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+L K + V + ++ E I++ + +V+ + NL +V E++A G ++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L + G F A + YLH ++I+RDLK NLL+D+ G ++V DFG A
Sbjct: 130 SHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 256 RVQAQSGVMTAET--GTYRWMAPEV 278
+ T GT +APE+
Sbjct: 189 KRVKG----RTWTLCGTPEALAPEI 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 48/173 (27%), Positives = 82/173 (47%), Gaps = 23/173 (13%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
G +G+++ K T + A K L + + + E I+ K+ + +V
Sbjct: 196 GGFGEVFACQMKAT--GKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVSL 250
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
A +LC+V M G I H + FQ + + G+ +LHQ
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
NII+RDLK N+L+D++G V+++D G+A V+ ++G + GT +MAPE+
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPEL 360
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 18/169 (10%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
G +G++ + T + A K L+ + + M E I+ K+ + VV
Sbjct: 195 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVSL 249
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
A LC+V M G + H + F + A ++ G+ LH+ I
Sbjct: 250 AYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
++RDLK N+L+D++G ++++D G+A + + GT +MAPEV
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G + K T + A+K+L K + + + E +++ RH + A
Sbjct: 16 GTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
LC V E+ G + F H + VF ++ + YLH ++++RD+
Sbjct: 74 FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
K NL++D++G +K+ DFG+ + G T GT ++APEV
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEV 176
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 26/154 (16%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+KVL K V + ++ + E ++ + H +++ G + ++ +++ G +
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93
Query: 196 DFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 246
F +K F V+K + YLH +II+RDLK N+L+D+NG
Sbjct: 94 -FSLLRKSQRF--------PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 144
Query: 247 VKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+K+ DFG A+ T GT ++APEV
Sbjct: 145 IKITDFGFAKYVPD----VTYTLCGTPDYIAPEV 174
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-16
Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 14/167 (8%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G + K T + A+K+L K V + + E +++ RH + +
Sbjct: 159 GTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
LC V E+ G + F H + VF ++ ++YLH + N+++RD
Sbjct: 217 FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
LK NL++D++G +K+ DFG+ + + G T GT ++APEV
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEV 320
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 38/179 (21%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + KGT + A+K+LK EC E +++
Sbjct: 352 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 397
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
+ + Q L V E++ G + H Q+ G F+ + A +++ G+
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+L II+RDLK N+++D G +K+ADFG+ + GV T T GT ++APE+
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEI 513
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 22/153 (14%)
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
A+KVLK + E I+ ++ H +V+ A L ++ +F+ G +
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 197 FLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGVV 247
F K +F + K +++LH II+RDLK N+L+DE G +
Sbjct: 114 FTRLSKEVMFTE--------EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165
Query: 248 KVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
K+ DFG+++ + GT +MAPEV
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEV 197
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 55/179 (30%), Positives = 77/179 (43%), Gaps = 38/179 (21%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + K T A+KVLK EC TE ++I
Sbjct: 34 GSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTE------------KRILSL 79
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
H + Q P L V EF+ G + H QK F A ++ +
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+LH II+RDLK N+L+D G K+ADFG+ + +GV TA T GT ++APE+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFCGTPDYIAPEI 195
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
L V E++ G + H Q+ + ++S +NYLH+ II+RDLK N+L
Sbjct: 85 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+D G +K+ D+G+ + + G T+ T GT ++APE+
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEI 181
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
L V E++ G + H Q+ + ++S +NYLH+ II+RDLK N+L
Sbjct: 128 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+D G +K+ D+G+ + + G T+ T GT ++APE+
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEI 224
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTE--MLKEFSQEVYIMRKIR 165
GS+G + +K T +Q AIK LK EC E +L
Sbjct: 28 GSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLS---------LAWE 76
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYL 224
H + NL V E++ G + H Q F L+ A ++ G+ +L
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
H I++RDLK N+L+D++G +K+ADFG+ + T T GT ++APE+
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEI 189
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 35/179 (19%)
Query: 121 GSYG-------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVV 170
G YG T + A+KVLK + K+ + E I+ +++H +V
Sbjct: 28 GGYGKVFQVRKVTGANT--GKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSK--------GM 221
I A L ++ E+++ G + F+ ++ G+F D + +
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME--------DTACFYLAEISMAL 134
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+LHQ II+RDLK N++++ G VK+ DFG+ + G +T T GT +MAPE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEI 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 48/179 (26%), Positives = 80/179 (44%), Gaps = 38/179 (21%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + KGT + A+K+LK EC E +++
Sbjct: 31 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 76
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
+ + Q L V E++ G + H Q+ G F+ + A +++ G+
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
+L II+RDLK N+++D G +K+ADFG+ + GV T T GT ++APE+
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEI 192
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 39/195 (20%), Positives = 88/195 (45%), Gaps = 39/195 (20%)
Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+ K+ G + D+ T+ VA+K+++ + V TE ++ E+ +++++
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEAAED---EIKLLQRVND 74
Query: 166 ----------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQKGV-FQLTSL 210
++++ + + PN + +V E + ++ + K + L +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 211 LKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDE------NGVVKVADFGVARVQAQSGV 263
+++ + G++Y+H+ IIH D+K N+LM+ +K+AD G A +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 264 MTAETGTYRWMAPEV 278
+ +T YR +PEV
Sbjct: 194 NSIQTREYR--SPEV 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 24/156 (15%)
Query: 137 AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEFMARGS 193
A+KVLK + + + E ++ IR +V A L ++ +++ G
Sbjct: 86 AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145
Query: 194 IYDFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDEN 244
+ F H + F + + +LH+ II+RD+K N+L+D N
Sbjct: 146 L--FTHLSQRERFTE--------HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 195
Query: 245 GVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
G V + DFG+++ A GT +MAP++
Sbjct: 196 GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-15
Identities = 17/146 (11%), Positives = 49/146 (33%), Gaps = 6/146 (4%)
Query: 114 IECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVV 170
+ ++ T ++VA+ + P+ V + +L+E + +I V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + +V E++ GS+ + ++ ++ + H+ +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA---IRAMQSLAAAADAAHRAGVA 151
Query: 231 HRDLKTANLLMDENGVVKVADFGVAR 256
+ + + +G V +A
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 87 LIESSPNCIEIPTDGTDVWEIDAKQLKIEC----KV-ASGSYGDLY----KGTYCSQEVA 137
L+ ++P P+ ++ K KV GS+G + K A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE--EVFYA 67
Query: 138 IKVLKPECVNTEMLKEFSQEVYIM-------RKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
+KVL+ + + + +E +IM + ++H +V + L V +++
Sbjct: 68 VKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
G + F H Q+ F A +++ + YLH NI++RDLK N+L+D G + +
Sbjct: 123 GGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 250 ADFGVARVQAQSGVMTAET--GTYRWMAPEV 278
DFG+ + + T+ T GT ++APEV
Sbjct: 181 TDFGLCKENIEHNSTTS-TFCGTPEYLAPEV 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 23/173 (13%)
Query: 120 SGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------N 168
GS+G + K Q VA+K+++ ++ ++E+ I+ +R + N
Sbjct: 107 KGSFGQVVK---AYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQN 227
V+ + T ++C+ E ++ ++Y+ + K K F L + K A + + ++ LH+N
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 228 NIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
IIH DLK N+L+ + G +KV DFG + + Q ++ YR APEV
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEV 270
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 38/178 (21%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
+G + +++ Q + K+ SG +G +Y ++ A V+K E L E
Sbjct: 27 EGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SE 83
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVT-----EFMARGSIYDF------------LHK 200
+ +++ K+ ++ + L I +G Y F +
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVAR 256
Q G F+ +++L++ I + + Y+H+N +H D+K ANLL+ +V AD+G++
Sbjct: 144 QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HK 167
++ K+ SGS+G++Y GT ++EVAIK+ E V T+ L E I R ++
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLL---YESKIYRILQGGT 63
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ +V + + S+ D + L ++L +A + + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVAR 256
+ +HRD+K N LM V + DFG+A+
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 13/152 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
++ K+ G++G+L G + VAIK+ E + + + E +++ +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA-PQLHLEYRFYKQLGSGDGI 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
Q +V E + S+ D F L ++L +AI + M Y+H N+
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR 256
I+RD+K N L+ G V+ + DF +A+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRH-K 167
++ K+ SGS+GD+Y GT + +EVAIK+ ECV T+ L E I + ++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLH---IESKIYKMMQGGV 65
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ +V E + S+ D + F L ++L +A + + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVAR--VQAQSGVMTAE------TGTYRWM 274
N IHRD+K N LM + +V + DFG+A+ A++ TGT R+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-13
Identities = 29/152 (19%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
K+ ++ GS+G +++GT Q+VAIK E ++ + E + + +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDA-PQLRDEYRTYKLLAGCTGI 68
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+ +V + + S+ D L F + ++ A + + +H+ ++
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR 256
++RD+K N L+ ++ V DFG+ +
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 34/208 (16%), Positives = 72/208 (34%), Gaps = 37/208 (17%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGT----------YCSQEVAIKVLKPECVNTE 149
GT + + +Q K++ + G LY+ Q+ ++K+ + +
Sbjct: 32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGR 88
Query: 150 MLKEFS-----------QEVYIMRKIRHKNVVQFIGACTRPPNL-CIVTEFMARGSIYDF 197
+ E + + + + +G +V + R S+
Sbjct: 89 LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA 147
Query: 198 LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGV 254
L K V S+L+VA + + +LH+N +H ++ N+ +D +V A +G
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 255 AR--------VQAQSGVMTAETGTYRWM 274
A V G + G ++
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 25/182 (13%)
Query: 113 KIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH- 166
+I+ + GS+G + K + VAIK++K L + EV ++ +
Sbjct: 57 EIDSLIGKGSFGQVVK---AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKH 110
Query: 167 -----KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
+V +LC+V E ++ ++YD L L K A +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 221 MNYLHQN--NIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +L +IIH DLK N+L+ + +K+ DFG + Q ++ YR +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SP 227
Query: 277 EV 278
EV
Sbjct: 228 EV 229
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 2e-11
Identities = 32/192 (16%), Positives = 65/192 (33%), Gaps = 48/192 (25%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVL---KPECVNTEM---LKEFSQEVYIMRKI 164
+L+ K+ G +G++++ VAIK++ P+ VN +E E+ I +++
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 165 ---------RHKNVVQFIGAC----TRPPNLC--------------------------IV 185
R + + + PP L IV
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDEN 244
EF G D + + L + + ++ + + HRDL N+L+ +
Sbjct: 141 LEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 245 GVVKVADFGVAR 256
+ K+ +
Sbjct: 199 SLKKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 34/149 (22%), Positives = 64/149 (42%), Gaps = 28/149 (18%)
Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+ K+ G + D+ + VA+KV+K TE + E+ +++ +R
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKF----VAMKVVKSAEHYTETALD---EIRLLKSVRN 92
Query: 166 -------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKV 213
+ VVQ + N +C+V E + + ++ K L + K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 214 AIDVSKGMNYLH-QNNIIHRDLKTANLLM 241
V +G++YLH + IIH D+K N+L+
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILL 180
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 29/179 (16%), Positives = 70/179 (39%), Gaps = 23/179 (12%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC--VNTEM 150
G + ++ A K+ + G +G +Y S +KV + + TE+
Sbjct: 25 VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL 84
Query: 151 --LKEFSQEVYIMRKIRHKNV-------VQFIGACTRPPNL--CIVTEFMARGSIYDFLH 199
+ ++ I + IR + + G + ++ + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYE 143
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVAR 256
F ++L++++ + + Y+H++ +H D+K +NLL++ +V D+G+A
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 48/179 (26%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIVT 186
+VA+K+++ N +E ++ E+ +++KI+ K V ++CI
Sbjct: 46 SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 187 EFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
E + + + ++FL + + L + +A + + +LH+N + H DLK N+L +
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160
Query: 246 V-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEV 278
++VADFG S E T YR PEV
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEV 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 48/180 (26%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIV 185
+ VA+K++K N + E ++ E+ ++ + VQ + ++CIV
Sbjct: 40 GRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95
Query: 186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
E + S YDF+ + + F+L + K+A + K +N+LH N + H DLK N+L ++
Sbjct: 96 FELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154
Query: 245 GV-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEV 278
+KV DFG S E + YR APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 8e-11
Identities = 39/185 (21%), Positives = 77/185 (41%), Gaps = 55/185 (29%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRH-----KNVVQFIGACTRPPNLCIVTE 187
+ A+KV++ N + ++ E I++KI++ N+V++ G ++C++ E
Sbjct: 61 KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 188 FMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
+ S+Y+ + + G F + + I++ K +NYL + ++ H DLK N+L+D+
Sbjct: 117 PLGP-SLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 246 V-------------------------VKVADFGVARVQAQSGVMTAETGT-------YRW 273
+K+ DFG ++ YR
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226
Query: 274 MAPEV 278
APEV
Sbjct: 227 -APEV 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 53/296 (17%), Positives = 94/296 (31%), Gaps = 95/296 (32%)
Query: 6 WVLMKVGELTSLLGEIGLNIQEA----HAFSTVDGFSLDVFVVDG----------WPYDE 51
W + +LT+++ E LN+ E F L VF W
Sbjct: 347 WKHVNCDKLTTII-ESSLNVLEPAEYRKMF-----DRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 52 TEDLKNVLAKEILKS------KDQSCS--------KRQPALGVPMHSKLLIESSPNCIEI 97
D+ V+ K S K+ + S K + +H ++ + I
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV-----DHYNI 455
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
P D ++ L D Y ++ LK + E + F
Sbjct: 456 P-KTFDSDDLIPPYL------------DQYFYSHIGHH-----LK-NIEHPERMTLFRM- 495
Query: 158 VY-----IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY-DFLHKQKGVF-QLTSL 210
V+ + +KIRH + A N +F Y ++ + +L +
Sbjct: 496 VFLDFRFLEQKIRHDSTAW--NASGSILNTLQQLKF------YKPYICDNDPKYERLVNA 547
Query: 211 LKVAIDVSKGMNYLHQ--NNII---HRDL-KTANLLMDENGVVKVADFGVARVQAQ 260
+ +++L + N+I + DL + A LM E+ + F A Q Q
Sbjct: 548 I---------LDFLPKIEENLICSKYTDLLRIA--LMAEDEAI----FEEAHKQVQ 588
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 284 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.4 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.97 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.9 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.88 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.65 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.65 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 98.03 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.92 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.75 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.73 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 97.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.47 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 94.2 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 91.68 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 89.54 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 88.53 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 88.21 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.74 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 82.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=331.88 Aligned_cols=179 Identities=40% Similarity=0.708 Sum_probs=157.4
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
...|+|+.+++++.++||+|+||.||+|++.+ .||||+++....+.+..+.|.+|+.++++++|||||+++|++.+ +.
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 35799999999999999999999999998765 69999998766677778899999999999999999999998865 56
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+|||||+||+|.++++..++.+++..+..|+.||+.||+|||+++||||||||+|||+++++++||+|||+|+.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999887788999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CceecCCCcccccchhccccc
Q 023285 262 ---GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ---~~~~~~~gt~~y~aPEvl~~~ 282 (284)
...+..+||+.|||||++.+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~ 209 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQ 209 (307)
T ss_dssp --------CCCCTTSCCHHHHHCC
T ss_pred CcceeecccccCCCccCHHHhhcc
Confidence 223456899999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=331.86 Aligned_cols=176 Identities=24% Similarity=0.428 Sum_probs=153.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
-++|++.+.||+|+||.||+|++ +++.||||+++.........+.+.+|+.++++++|||||++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999987 4789999999877667777888999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 187 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
||++||+|.+++...+ ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9999999999997643 467999999999999999999999999999999999999999999999999998764432 23
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
+..+||+.|||||++.+..|
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y 202 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPY 202 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCC
T ss_pred cccCCCccccCHHHHCCCCC
Confidence 45579999999999998766
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=326.36 Aligned_cols=176 Identities=23% Similarity=0.391 Sum_probs=155.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|++.+.||+|+||.||+|+. +++.||||+++.... +....+.+.+|++++++++|||||++++++.++..+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999998 578999999964321 12235679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-- 262 (284)
||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999976 4679999999999999999999999999999999999999999999999999999764322
Q ss_pred -ceecCCCcccccchhccccccC
Q 023285 263 -VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+||+.|||||++.+..|
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y 211 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA 211 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB
T ss_pred ccccCcccCcccCCHHHHcCCCC
Confidence 3445689999999999988765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=323.19 Aligned_cols=179 Identities=28% Similarity=0.530 Sum_probs=156.2
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
.+.|+.++|.+.++||+|+||.||+|++. +..||||+++.. +.+..++|.+|++++++++|||||+++|+|
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 35688889999999999999999999863 567999999754 566678899999999999999999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQ------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~ 244 (284)
.+++.+|+|||||++|+|.+++++. ...+++..+..++.||+.||+|||+++||||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 9999999999999999999999763 2469999999999999999999999999999999999999999
Q ss_pred CcEEEecccceeeeccCCce---ecCCCcccccchhccccccC
Q 023285 245 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPEvl~~~~y 284 (284)
+.+||+|||+|+........ ....||++|||||++.+..|
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 207 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 207 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC
Confidence 99999999999865433222 12358999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=323.45 Aligned_cols=180 Identities=31% Similarity=0.535 Sum_probs=152.9
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
..+.|+.+++.+.++||+|+||.||+|++. ++.||||+++.. +....++|.+|++++++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 456788899999999999999999999863 578999999754 56667889999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli 241 (284)
|.++..+|+|||||++|+|.+++++.. +.+++.++..|+.||+.||+|||+++||||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997642 458999999999999999999999999999999999999
Q ss_pred cCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 242 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 242 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+.++.+||+|||+|+...... ..+...||+.|||||++.+..|
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 237 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC
Confidence 999999999999998654332 2234579999999999998765
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=314.25 Aligned_cols=173 Identities=23% Similarity=0.477 Sum_probs=139.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.. +++.||||+++..... .+....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999987 4789999999755433 334567999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+ +|+|.+++.+ ++.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+..........
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 6799999976 47899999999999999999999999999999999999999999999999999987766655667
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
.+||+.|||||++.+..|
T Consensus 171 ~~GT~~Y~APE~~~~~~y 188 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLY 188 (275)
T ss_dssp ----CTTSCHHHHSSSSC
T ss_pred eeECcccCChhhhcCCCC
Confidence 789999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=320.62 Aligned_cols=180 Identities=27% Similarity=0.509 Sum_probs=156.7
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
.++|+..++++.++||+|+||.||+|.+. ++.||||+++... .....++|.+|+.++++++|||||+++|+|
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45678889999999999999999999873 4789999997543 334457899999999999999999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli 241 (284)
.++..+|+|||||++|+|.++|.... ..+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 99999999999999999999996532 458999999999999999999999999999999999999
Q ss_pred cCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 242 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 242 ~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++++++||+|||+|+...... ..+...||++|||||++.+..|
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~ 224 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence 999999999999998654322 2344579999999999988765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=324.52 Aligned_cols=172 Identities=27% Similarity=0.420 Sum_probs=153.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.++||+|+||.||+|++ +++.||||+++.... ...+.+.+|+.++++++|||||++++++.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999998 478999999964422 22356889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
|||+||+|.+++.+ +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...+
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999999976 46999999999999999999999999999999999999999999999999999876543 3455
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
..+||+.|||||++.+..|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCB
T ss_pred ccccCcCcCCHHHHCCCCC
Confidence 6789999999999988765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=325.25 Aligned_cols=178 Identities=26% Similarity=0.373 Sum_probs=149.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+++++|++.+.||+|+||.||+|+. +++.||||+++...........+.+|+.++++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45667899999999999999999986 3578999999754333333346889999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999977 46799999999999999999999999999999999999999999999999999986433
Q ss_pred -CCceecCCCcccccchhccccccC
Q 023285 261 -SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 -~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......+||+.|||||++.+..|
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y 203 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGH 203 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCC
T ss_pred CCccccccccCcccCCHHHhccCCC
Confidence 333456789999999999988765
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=311.77 Aligned_cols=169 Identities=30% Similarity=0.519 Sum_probs=149.9
Q ss_pred ceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----CCcEEEE
Q 023285 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCIV 185 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lV 185 (284)
|++.++||+|+||.||+|.+. +..||||++..........+.|.+|+.++++++|||||+++++|.+ +..+|+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 488899999999999999984 6889999997666667777889999999999999999999999865 3458999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEec-CCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~~ 262 (284)
||||+||+|.+++.+ .+.+++..+..++.||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|+.....
T Consensus 108 mEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999976 467999999999999999999999998 99999999999997 4799999999999865443
Q ss_pred ceecCCCcccccchhccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~ 282 (284)
.....+||+.|||||++.+.
T Consensus 186 ~~~~~~GTp~YmAPE~~~~~ 205 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp SBEESCSSCCCCCGGGGGTC
T ss_pred ccCCcccCccccCHHHcCCC
Confidence 34567899999999998763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=326.46 Aligned_cols=172 Identities=27% Similarity=0.420 Sum_probs=153.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.++||+|+||.||+|++ +++.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC--SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35799999999999999999998 478999999975432 22356889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
|||+||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ...+
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999999999965 46999999999999999999999999999999999999999999999999999876543 3445
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
..+||+.|||||++.+..|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y 324 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPY 324 (423)
T ss_dssp CCEECTTTCCHHHHTTCCB
T ss_pred ccccCcCcCCHHHHCCCCC
Confidence 6789999999999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=317.05 Aligned_cols=171 Identities=24% Similarity=0.365 Sum_probs=148.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
......|++.++||+|+||.||+|++ +++.||||+++.+.. ..+|+.++++++|||||++++++.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 33456789999999999999999998 478999999976532 246999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~ 262 (284)
||||||+||+|.+++.+. +.+++..+..++.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+......
T Consensus 127 ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999999999764 6799999999999999999999999999999999999999887 69999999998754332
Q ss_pred c------eecCCCcccccchhccccccC
Q 023285 263 V------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~------~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ....+||+.|||||++.+..|
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y 233 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPC 233 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCC
T ss_pred cccceecCCccccCccccCHHHHCCCCC
Confidence 1 123479999999999998766
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=308.49 Aligned_cols=174 Identities=21% Similarity=0.374 Sum_probs=140.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-------
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------- 180 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 180 (284)
++|++.+.||+|+||.||+|++ +++.||||+++... .....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3689999999999999999987 47899999997542 3455678999999999999999999999986543
Q ss_pred -----cEEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccc
Q 023285 181 -----NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (284)
Q Consensus 181 -----~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg 253 (284)
.+|+||||++||+|.+++.... ...+...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 3799999999999999997642 234556688999999999999999999999999999999999999999999
Q ss_pred ceeeeccCC-------------ceecCCCcccccchhccccccC
Q 023285 254 VARVQAQSG-------------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 254 ~a~~~~~~~-------------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+|+...... ..+..+||+.|||||++.+..|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y 207 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCC
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC
Confidence 998654321 1234579999999999998766
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=316.09 Aligned_cols=182 Identities=31% Similarity=0.581 Sum_probs=157.5
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~ 173 (284)
.+.|+|+.++|++.+.||+|+||.||+|++.+ +.||||.++... .....+.|.+|+.++++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35699999999999999999999999998743 579999997543 44556789999999999976 8999999
Q ss_pred eEEEcC-CcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 174 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 174 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
|+|.++ ..+|+|||||++|+|.++|++.. ..+++..+..++.||++||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 56899999999999999997632 34889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
|||+++++.+||+|||+|+....... .+...||+.|||||++.+..|
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 99999999999999999986543322 234468999999999988766
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=303.81 Aligned_cols=168 Identities=29% Similarity=0.560 Sum_probs=141.7
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC----cEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lV 185 (284)
++|.+.++||+|+||.||+|+++++.||||+++.. ......+..|+..+.+++|||||+++++|..++ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46899999999999999999999999999999643 222223445666777899999999999998654 58999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEecCCCcEEEecccceee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
||||++|+|.++++. ..++++.+.+++.|++.||+|||++ +||||||||+|||++.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999976 4589999999999999999999987 999999999999999999999999999987
Q ss_pred eccCCce-----ecCCCcccccchhccccc
Q 023285 258 QAQSGVM-----TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~~~-----~~~~gt~~y~aPEvl~~~ 282 (284)
....... ....||+.|||||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred ccCCCCceeeecccccccccccCHHHhccc
Confidence 6543322 234799999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=310.52 Aligned_cols=173 Identities=25% Similarity=0.423 Sum_probs=151.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc------CC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~ 180 (284)
.++|++.+.||+|+||.||+|++ +++.||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999998 57999999998765566667889999999999999999999998764 35
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+|||||+ |+|.+++.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 7899999996 589999976 56899999999999999999999999999999999999999999999999999986432
Q ss_pred -----CCceecCCCcccccchhcccccc
Q 023285 261 -----SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 -----~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
....+..+||+.|||||++.+..
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~ 238 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLH 238 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCS
T ss_pred CccccccccccceeChHhcCHHHhcCCC
Confidence 22345678999999999998754
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=312.55 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=157.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999998 5789999998754 34455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEecccceeeeccCCcee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~--~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
||+||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999997766789999999999999999999999999999999999999854 899999999999877666667
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
..+||+.|||||++.+..|
T Consensus 315 ~~~GT~~y~APEv~~~~~y 333 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPV 333 (573)
T ss_dssp EECSSGGGCCHHHHTTCCB
T ss_pred eeEECccccCHHHhCCCCC
Confidence 7789999999999998765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=311.25 Aligned_cols=173 Identities=24% Similarity=0.380 Sum_probs=149.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+..++|++.+.||+|+||.||+|+. +++.||||+++.... ..........++.+++.++|||||+++++|.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4457899999999999999999998 578999999963311 1222333344567778889999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999977 47799999999999999999999999999999999999999999999999999987654
Q ss_pred CCceecCCCcccccchhcccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~ 281 (284)
. ...+.+||+.|||||++.+
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHST
T ss_pred C-CCCCccCCcCccCHHHHhC
Confidence 4 3456789999999999964
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=292.74 Aligned_cols=166 Identities=23% Similarity=0.375 Sum_probs=142.9
Q ss_pred CCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 183 (284)
++|++.++||+|+||.||+|+. +++.||||.+.... ...++.+|+++++.+ .||||+++++++.+++++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4799999999999999999976 25789999986542 234678999999998 5999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||++||+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999999983 48999999999999999999999999999999999999876 899999999997543211
Q ss_pred -----------------------------ceecCCCcccccchhcccccc
Q 023285 263 -----------------------------VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 -----------------------------~~~~~~gt~~y~aPEvl~~~~ 283 (284)
..+..+||+.|||||++.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 123457999999999998753
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.98 Aligned_cols=176 Identities=26% Similarity=0.446 Sum_probs=160.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
..++|++.+.||+|+||.||+|.+ +++.||||++.....+....+.+.+|+.++++++||||+++++++.....+|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999997 578999999976666677778899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|||++||+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 9999999999999764 679999999999999999999999999999999999999999999999999998766655566
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 172 ~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCC
T ss_pred cccCCcceeCcccccCCCc
Confidence 7789999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=265.86 Aligned_cols=178 Identities=31% Similarity=0.473 Sum_probs=157.6
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+.+..++|++.+.||+|+||.||+|.+. ++.||+|.+... +....+.+.+|+.++++++||||+++++++.++...
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4567889999999999999999999984 789999998643 566778899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999998654322
Q ss_pred ce---------------ecCCCcccccchhccccccC
Q 023285 263 VM---------------TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~---------------~~~~gt~~y~aPEvl~~~~y 284 (284)
.. ....||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCC
Confidence 11 14579999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=269.77 Aligned_cols=183 Identities=43% Similarity=0.702 Sum_probs=153.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
...+++...+|++.+.||+|+||.||+|+..++.||||++.......+..+.+.+|+.++++++||||+++++++.....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 35678889999999999999999999999999999999998776667777889999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999997642 23899999999999999999999999 99999999999999999999999999986
Q ss_pred eccCC-ceecCCCcccccchhccccccC
Q 023285 258 QAQSG-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
..... ......||+.|+|||++.+..|
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 216 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPS 216 (309)
T ss_dssp -------------CCTTSCHHHHTTCCC
T ss_pred ccccccccccCCCCccccChhhhcCCCC
Confidence 44332 2345579999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=272.12 Aligned_cols=177 Identities=22% Similarity=0.411 Sum_probs=154.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|++.+.||+|+||.||+|+. +++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4467899999999999999999988 478999999864311 1223467889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cCC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~~ 262 (284)
+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+... ...
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999976 4679999999999999999999999999999999999999999999999999998643 233
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~ 182 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY 182 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB
T ss_pred cccccccChhhCChhhhcCCCC
Confidence 3456689999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.78 Aligned_cols=179 Identities=23% Similarity=0.354 Sum_probs=154.4
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCC
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 180 (284)
..+..++|++.+.||+|+||.||+|+.. ++.||+|+++..... ......+.+|..+++++ +||||+++++++.+..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 4566789999999999999999999884 688999999754332 33445688999999887 8999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee-c
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-A 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~-~ 259 (284)
.+|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.. .
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999999999764 67999999999999999999999999999999999999999999999999999863 3
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........+||+.|+|||++.+..|
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~ 230 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDY 230 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCB
T ss_pred CCCccccccCCcccCCchhhcCCCC
Confidence 3334456789999999999987654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=258.92 Aligned_cols=178 Identities=34% Similarity=0.631 Sum_probs=156.5
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..|.++.++|++.+.||+|+||.||+|.+ .++.||+|+++...... +.+.+|+.++++++||||+++++++.++..
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 46889999999999999999999999998 56889999998654333 568999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++||||+++++|.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999887778999999999999999999999999999999999999999999999999999755332
Q ss_pred C--ceecCCCcccccchhcccccc
Q 023285 262 G--VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 262 ~--~~~~~~gt~~y~aPEvl~~~~ 283 (284)
. ......+|+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~ 183 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSR 183 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCC
T ss_pred ccccccCcccccccCCHHHhcCCC
Confidence 1 123345678899999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=270.28 Aligned_cols=181 Identities=30% Similarity=0.605 Sum_probs=156.7
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 172 (284)
..|++..++|++.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.+++++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 457788899999999999999999999862 246999999755 3455677899999999999 89999999
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
++++.....+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999998643 34789999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..|
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence 9999999999999999998654322 1233467889999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=274.89 Aligned_cols=176 Identities=22% Similarity=0.403 Sum_probs=156.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..+..++|++.+.||+|+||.||++.. +++.||+|+++.... .....+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 456778999999999999999999988 468899999864311 12234678899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||+.||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999999976 467999999999999999999999999999999999999999999999999999987666
Q ss_pred CceecCCCcccccchhcccc
Q 023285 262 GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~ 281 (284)
.......||+.|+|||++.+
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCC
T ss_pred CceeccCCCccccCCeeecc
Confidence 66677889999999999964
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=268.72 Aligned_cols=175 Identities=24% Similarity=0.377 Sum_probs=154.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+.|++.+.||+|+||.||+|+. +++.||+|+++...... .....+.+|+.++++++||||+++++++.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35799999999999999999998 47899999997543221 1346789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEecccceeee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~ 258 (284)
|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999966 46799999999999999999999999999999999999998777 7999999999877
Q ss_pred ccCCceecCCCcccccchhccccccC
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
..........||+.|+|||++.+..|
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~ 195 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPL 195 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCC
T ss_pred CCCCccccCCCCccEECchHHcCCCC
Confidence 66555566789999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=268.40 Aligned_cols=175 Identities=21% Similarity=0.384 Sum_probs=156.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||+|+++.........+.+.+|+.++++++||||+++++++.+....|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999988 4789999999876666677788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~---~~vkl~Dfg~a~~~~~~~~ 263 (284)
||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999976 4679999999999999999999999999999999999999865 4599999999987765555
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCC
T ss_pred cccCCCCccccCHHHHccCCC
Confidence 556789999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-36 Score=266.73 Aligned_cols=177 Identities=23% Similarity=0.361 Sum_probs=155.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 182 (284)
+..++|++.+.||+|+||.||+|+.. ++.||+|+++.... .....+.+.+|..+++++ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45678999999999999999999984 68999999975533 445667789999999988 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec-cC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QS 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~-~~ 261 (284)
|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+... ..
T Consensus 86 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999999999764 679999999999999999999999999999999999999999999999999998643 22
Q ss_pred CceecCCCcccccchhccccccC
Q 023285 262 GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......||+.|+|||++.+..|
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~ 187 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDY 187 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CcccccCCCccccCccccCCCCC
Confidence 33456689999999999987653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=271.95 Aligned_cols=178 Identities=24% Similarity=0.384 Sum_probs=147.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
.+..++|++.+.||+|+||.||+|+. +++.||||+++.... .......+.+|..+++.+ +||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45667899999999999999999988 468999999874311 223356688999999998 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~- 260 (284)
+|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999774 6799999999999999999999999999999999999999999999999999986332
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......+||+.|+|||++.+..|
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~ 201 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLY 201 (353)
T ss_dssp --------CCGGGCCHHHHHHHHC
T ss_pred CccccccCCCcCeEChhhcCCCCc
Confidence 223445679999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=273.31 Aligned_cols=180 Identities=29% Similarity=0.552 Sum_probs=158.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+.|+++.++|++.+.||+|+||.||+|++. ++.||||+++.. ...+....|.+|+.++++++||||+++++++..+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 468899999999999999999999999984 789999998754 34556677999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999987666799999999999999999999999999999999999999999999999999986543
Q ss_pred CCcee---cCCCcccccchhcccccc
Q 023285 261 SGVMT---AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~---~~~gt~~y~aPEvl~~~~ 283 (284)
..... ...+++.|+|||++.+..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred CceeecCCCCCCCcCcCCHhHhccCC
Confidence 32111 123577899999987653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=263.68 Aligned_cols=172 Identities=18% Similarity=0.291 Sum_probs=154.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||+|+++.. ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 35899999999999999999988 4689999998743 334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CCcEEEecccceeeeccCCce
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~--~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999999776667999999999999999999999999999999999999987 789999999999887665555
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~ 179 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp EEEESCGGGSCHHHHTTCE
T ss_pred ccccCChhhcCcHHhcCCC
Confidence 6678999999999997753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=264.36 Aligned_cols=179 Identities=35% Similarity=0.521 Sum_probs=154.4
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..++..++|++.+.||+|+||.||+|.+. +..||||+++.. ......+.+.+|+.++++++||||+++++++.+
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 35678899999999999999999999883 345999999754 345566789999999999999999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
....|+||||+++++|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999876678999999999999999999999999999999999999999999999999999875
Q ss_pred ccCCc----eecCCCcccccchhcccccc
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
..... .....+|+.|+|||++.+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCE
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCC
Confidence 43221 12234678999999987653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=257.71 Aligned_cols=173 Identities=25% Similarity=0.461 Sum_probs=154.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||||+++...........+.+|+.++++++||||+++++++.++..+++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998 46899999998765566667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
|+++ ++.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9976 777777776788999999999999999999999999999999999999999999999999999875432 23445
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..||+.|+|||++.+..
T Consensus 161 ~~~t~~y~aPE~~~~~~ 177 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp CCSCGGGCCHHHHTTCS
T ss_pred CccccCCcChHHHcCCC
Confidence 67899999999987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=266.55 Aligned_cols=178 Identities=19% Similarity=0.314 Sum_probs=154.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEE-------ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCceee
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 171 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~ 171 (284)
...+++..++|.+.+.||+|+||.||+|. ..++.||||+++.. . ..++..|+.+++.++ |+||+.
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~---~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--N---PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--C---HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--C---hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 35788889999999999999999999993 25789999999754 2 346778888888887 899999
Q ss_pred EEeEEEcCCcEEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC----
Q 023285 172 FIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---- 243 (284)
Q Consensus 172 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---- 243 (284)
+++++..++..|+||||+++|+|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999975 2467999999999999999999999999999999999999998
Q ss_pred -------CCcEEEecccceeeec---cCCceecCCCcccccchhccccccC
Q 023285 244 -------NGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 244 -------~~~vkl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++.+||+|||+|+... .....+...||+.|||||++.+..|
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 8999999999997543 2233456689999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=260.78 Aligned_cols=179 Identities=31% Similarity=0.576 Sum_probs=151.2
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..++..++|++.+.||+|+||.||+|++ +++.||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 4 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 4 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3467788999999999999999999985 4688999999754 4666778999999999999999999999986
Q ss_pred c--CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 178 R--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 178 ~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
. ...+++||||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 5 35689999999999999999887667999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCC----ceecCCCcccccchhccccccC
Q 023285 256 RVQAQSG----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 256 ~~~~~~~----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+...... ......+++.|+|||++.+..|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCC
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCC
Confidence 8654332 1233457888999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=274.23 Aligned_cols=176 Identities=21% Similarity=0.323 Sum_probs=152.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..+..++|++.++||+|+||.||+|+.. ++.||+|+++..... ......+.+|+.+++.++||||++++++|.++..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 3456779999999999999999999984 588999998632110 1112338899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||++||+|.+++.+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999999876544
Q ss_pred Cce--ecCCCcccccchhccc
Q 023285 262 GVM--TAETGTYRWMAPEVAF 280 (284)
Q Consensus 262 ~~~--~~~~gt~~y~aPEvl~ 280 (284)
... +..+||+.|+|||++.
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHH
T ss_pred CCcccccccCCcCeeChHHHh
Confidence 332 3457999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.93 Aligned_cols=179 Identities=26% Similarity=0.433 Sum_probs=145.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..+..++|++.+.||+|+||.||+++. +++.||+|+++.... .......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 346678999999999999999999986 468999999976432 2234556889999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
....+|+||||++|++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999999999763 6789999999999999999999999999999999999999999999999999976
Q ss_pred eccC-CceecCCCcccccchhccccccC
Q 023285 258 QAQS-GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~-~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .......||+.|+|||++.+..|
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 198 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGH 198 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC
T ss_pred cccCCccccccCCCcCccCHhhCcCCCC
Confidence 4332 23345679999999999977643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=273.98 Aligned_cols=176 Identities=35% Similarity=0.640 Sum_probs=154.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-c
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-N 181 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~ 181 (284)
..|+++.++|++.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.++++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4589999999999999999999999999999999999998643 3467999999999999999999999987765 7
Q ss_pred EEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+|+||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999987543 479999999999999999999999999999999999999999999999999985443
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. .....+++.|+|||++.+..|
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCC
T ss_pred c--ccCCCCCcceeCHHHhcCCCC
Confidence 2 223367899999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=263.97 Aligned_cols=175 Identities=26% Similarity=0.445 Sum_probs=153.1
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|++.+.||+|+||.||+|+. +++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3456899999999999999999988 478999999864311 1123456889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999999999976 467999999999999999999999999999999999999999999999999999875432
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~ 180 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPY 180 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCB
T ss_pred cccccCCccccCHhHhcCCCC
Confidence 345689999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=259.65 Aligned_cols=175 Identities=28% Similarity=0.430 Sum_probs=150.8
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
+.-.++|++.++||+|+||.||+|+. .++.||+|+++...........+.+|+.++++++||||+++++++.++..+++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34457899999999999999999998 57899999997654445556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cc
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~ 263 (284)
||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999985 899999877677999999999999999999999999999999999999999999999999999875432 23
Q ss_pred eecCCCcccccchhcccc
Q 023285 264 MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~ 281 (284)
.+...||+.|+|||++.+
T Consensus 176 ~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp --CCCCCCTTCCHHHHTT
T ss_pred ccCCcccCCcCCHHHhcC
Confidence 445678999999999876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=258.57 Aligned_cols=174 Identities=21% Similarity=0.259 Sum_probs=149.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 183 (284)
+-.++|++.++||+|+||.||+|... ++.||||++............+..|+..+.++ +||||++++++|.+...+|
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34568999999999999999999984 78999999876555555555666666666655 8999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999999 6699999988777899999999999999999999999999999999999999999999999999987766555
Q ss_pred eecCCCcccccchhcccc
Q 023285 264 MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~ 281 (284)
.....||+.|+|||++.+
T Consensus 213 ~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp --CCCCCGGGCCGGGGGT
T ss_pred CcccCCCccccCHhHhcC
Confidence 566679999999999876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=259.09 Aligned_cols=172 Identities=27% Similarity=0.465 Sum_probs=151.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||||++...... ..+.+.+|+.++++++||||+++++++..+..+|+||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 45899999999999999999986 5789999998654322 2456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-cee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~ 265 (284)
||++||+|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 97 e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999999763 58999999999999999999999999999999999999999999999999998755432 334
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|+|||++.+..|
T Consensus 175 ~~~gt~~y~aPE~~~~~~~ 193 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAY 193 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCB
T ss_pred CccCCcCccChhhhcCCCC
Confidence 5679999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=257.47 Aligned_cols=177 Identities=25% Similarity=0.408 Sum_probs=150.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+-.++|++.+.||+|+||.||+|.. .++.||+|++.... ...+..+.+.+|+.++++++||||+++++++..+..+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3456899999999999999999987 46899999985443 34566778999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||++|++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 88 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 999999999999999764 679999999999999999999999999999999999999999999999999997654332
Q ss_pred -ceecCCCcccccchhccccccC
Q 023285 263 -VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~ 189 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEAT 189 (294)
T ss_dssp --------CCSSCCHHHHHTCCC
T ss_pred cccCccccCccccCHhHhcCCCC
Confidence 2234569999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=257.62 Aligned_cols=179 Identities=34% Similarity=0.615 Sum_probs=154.3
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
...|+++.++|++.+.||+|+||.||+|.+.+ ..||||+++...... +.+.+|+.++++++||||+++++++.+..
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 35688999999999999999999999999854 689999998654333 56889999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999987667799999999999999999999999999999999999999999999999999975533
Q ss_pred CC--ceecCCCcccccchhcccccc
Q 023285 261 SG--VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~--~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.. ......+|+.|+|||++.+..
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSK 197 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCC
T ss_pred cccccccCCccCcccCCHHHhccCC
Confidence 21 122345678999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=257.75 Aligned_cols=179 Identities=38% Similarity=0.728 Sum_probs=146.6
Q ss_pred CCCCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
...+.++|..++|++.++||+|+||.||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++ ..
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 4456789999999999999999999999998765 599999987766777788899999999999999999999965 45
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
...++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 67899999999999999998777789999999999999999999999999999999999999999999999999997543
Q ss_pred c---CCceecCCCcccccchhccc
Q 023285 260 Q---SGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 260 ~---~~~~~~~~gt~~y~aPEvl~ 280 (284)
. ........||+.|+|||++.
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ------------CCCTTCCHHHHC
T ss_pred cccccccccccCCCccccCchhhc
Confidence 2 22234457999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=265.72 Aligned_cols=182 Identities=30% Similarity=0.604 Sum_probs=158.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceee
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQ 171 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 171 (284)
...|++..++|++.+.||+|+||.||+|...+ ..||||+++.. ........+.+|+.+++++ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 35688999999999999999999999998632 57999999765 3456678899999999999 8999999
Q ss_pred EEeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 023285 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236 (284)
Q Consensus 172 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp 236 (284)
+++++..+...++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999998753 3589999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 237 ANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 237 ~NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+|||++.++.+||+|||+|+...... ......+|+.|+|||++.+..|
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 99999999999999999998654322 2334467899999999877643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=278.65 Aligned_cols=180 Identities=23% Similarity=0.407 Sum_probs=145.3
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
...+..++|++.+.||+|+||.||+|.. +++.||||+++... ........+.+|+.++++++||||+++++++....
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 3456678899999999999999999987 47899999987432 12334567889999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|+||||+++|+|.+++... +.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999999999764 679999999999999999999998 999999999999999999999999999998633
Q ss_pred c-CCceecCCCcccccchhccccccC
Q 023285 260 Q-SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~-~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ........||+.|+|||++.+..|
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~ 326 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDY 326 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCC
T ss_pred CCCcccccccCCccccCHhhcCCCCC
Confidence 2 233456789999999999987654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.21 Aligned_cols=176 Identities=32% Similarity=0.527 Sum_probs=154.3
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+...+.+..++|++.+.||+|+||.||+|++.++.||||+++.. ......+.+|+.++++++||||+++++++....
T Consensus 15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 44568899999999999999999999999999999999999643 334455677999999999999999999998744
Q ss_pred ----cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCEEecCCCc
Q 023285 181 ----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN----------NIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 181 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~----------~iiH~Dikp~NIli~~~~~ 246 (284)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 37999999999999999976 4589999999999999999999999 9999999999999999999
Q ss_pred EEEecccceeeeccCCc---eecCCCcccccchhcccc
Q 023285 247 VKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~ 281 (284)
+||+|||+|+....... .....||+.|+|||++.+
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhccc
Confidence 99999999987544322 233579999999999876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=266.54 Aligned_cols=178 Identities=24% Similarity=0.420 Sum_probs=152.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
.+..++|++.+.||+|+||.||+|+. +++.||||+++.... ..+....+..|..+++.+ +||||+++++++.+...
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45677999999999999999999998 478999999964311 112345678899999887 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~- 260 (284)
+|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999764 6799999999999999999999999999999999999999999999999999986432
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~ 195 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKY 195 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CCcccCCCCCcccCChhhhcCCCC
Confidence 223456689999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=271.97 Aligned_cols=175 Identities=18% Similarity=0.323 Sum_probs=153.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||+|+++.........+.+.+|+.++++++||||+++++++.++...|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 35799999999999999999987 5789999999876555666778999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeeeccCC-
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~~~~~- 262 (284)
||+.||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+......
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999977 46799999999999999999999999999999999999998 46789999999997655432
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~ 190 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPY 190 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCB
T ss_pred eeecccCCcccCCHHHhcCCCC
Confidence 2345689999999999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=252.46 Aligned_cols=176 Identities=31% Similarity=0.558 Sum_probs=155.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+++..++|++.+.||+|+||.||+|...+ ..||+|+++..... ...+.+|+.++++++||||+++++++..+...+
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 56788899999999999999999998854 58999999865433 356899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.++.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999999999999988666799999999999999999999999999999999999999999999999999987654432
Q ss_pred e--ecCCCcccccchhcccccc
Q 023285 264 M--TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~--~~~~gt~~y~aPEvl~~~~ 283 (284)
. ....+|+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~ 181 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFK 181 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSE
T ss_pred hcccCCCcCcccCCHHHHhccC
Confidence 2 2335677899999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=267.41 Aligned_cols=178 Identities=21% Similarity=0.346 Sum_probs=152.3
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 181 (284)
.+..++|++.+.||+|+||.||+|+.. ++.||||+++.... .......+..|..+++.+ +||||+++++++.+...
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456779999999999999999999985 57899999864311 112345688999999988 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~- 260 (284)
+|+||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999764 5799999999999999999999999999999999999999999999999999986432
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~ 198 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPY 198 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CcccccccCCccccChhhhcCCCc
Confidence 223455689999999999987653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=259.52 Aligned_cols=174 Identities=22% Similarity=0.398 Sum_probs=146.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-------
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------- 180 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 180 (284)
++|++.+.||+|+||.||+|+. +++.||||+++... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4789999999999999999998 47899999997543 3445678999999999999999999999986543
Q ss_pred --------------------------------------------------cEEEEEEcCCCCCHHHHHHhcC--CCCCHH
Q 023285 181 --------------------------------------------------NLCIVTEFMARGSIYDFLHKQK--GVFQLT 208 (284)
Q Consensus 181 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~--~~~~~~ 208 (284)
..++||||+++++|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2899999999999999997743 235566
Q ss_pred HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-------------ceecCCCcccccc
Q 023285 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-------------VMTAETGTYRWMA 275 (284)
Q Consensus 209 ~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-------------~~~~~~gt~~y~a 275 (284)
.+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765432 2234579999999
Q ss_pred hhccccccC
Q 023285 276 PEVAFTFFF 284 (284)
Q Consensus 276 PEvl~~~~y 284 (284)
||++.+..|
T Consensus 245 PE~~~~~~~ 253 (332)
T 3qd2_B 245 PEQIHGNNY 253 (332)
T ss_dssp HHHHHCCCC
T ss_pred hHHhcCCCC
Confidence 999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=260.72 Aligned_cols=174 Identities=23% Similarity=0.358 Sum_probs=153.9
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+.|++.+.||+|+||.||+|... ++.||+|+++...... .....+.+|+.++++++||||+++++++.....++
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 47999999999999999999984 7899999987543221 13567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEecccceeeec
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA 259 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~~ 259 (284)
+||||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999965 46799999999999999999999999999999999999999887 89999999998776
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.........||+.|+|||++.+..|
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (326)
T 2y0a_A 170 FGNEFKNIFGTPEFVAPEIVNYEPL 194 (326)
T ss_dssp TTSCCCCCCSCTTTCCHHHHTTCCC
T ss_pred CCCccccccCCcCcCCceeecCCCC
Confidence 5555566789999999999987653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=273.81 Aligned_cols=176 Identities=19% Similarity=0.296 Sum_probs=153.5
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..+..++|++.+.||+|+||.||+++. +++.||||+++.... .......+.+|..++.+++||||+++++++.+...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 345677999999999999999999998 478999999863211 11223458899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999876568999999999999999999999999999999999999999999999999999876544
Q ss_pred Cce--ecCCCcccccchhccc
Q 023285 262 GVM--TAETGTYRWMAPEVAF 280 (284)
Q Consensus 262 ~~~--~~~~gt~~y~aPEvl~ 280 (284)
... ...+||+.|+|||++.
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHH
T ss_pred CccccceeccccCcCCHHHHh
Confidence 332 3458999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=269.91 Aligned_cols=176 Identities=23% Similarity=0.316 Sum_probs=152.0
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
..+..++|++.+.||+|+||.||+|+. +++.||+|+++.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 345677899999999999999999998 468899999863210 01112347899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999976 46899999999999999999999999999999999999999999999999999876554
Q ss_pred Cc--eecCCCcccccchhccccc
Q 023285 262 GV--MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~--~~~~~gt~~y~aPEvl~~~ 282 (284)
.. ....+||+.|+|||++.+.
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~ 244 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQ 244 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTT
T ss_pred CcccccCCcCCccccCHHHhhcc
Confidence 32 2356899999999999764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=265.44 Aligned_cols=173 Identities=18% Similarity=0.333 Sum_probs=154.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||+|+||.||+|.. +++.||+|++... .......+.+|+.++++++||||+++++++.+...+++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999988 4689999998754 3444567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC--CCcEEEecccceeeeccCCce
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~--~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999999776567999999999999999999999999999999999999974 578999999999987665555
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 208 ~~~~gt~~y~aPE~~~~~~ 226 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREP 226 (387)
T ss_dssp EEECSSGGGCCHHHHTTCC
T ss_pred eeeccCCCccCchhccCCC
Confidence 6668999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=263.99 Aligned_cols=178 Identities=19% Similarity=0.331 Sum_probs=157.4
Q ss_pred eeeeccCCceeeeeeeec--CceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 104 VWEIDAKQLKIECKVASG--SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
.+..+.++|++.+.||+| +||.||+|+.. ++.||||+++......+..+.+.+|+.++++++||||+++++++..+
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 345567899999999999 99999999984 78999999987666677778899999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+...
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999999999774 356999999999999999999999999999999999999999999999999998654
Q ss_pred ccCC--------ceecCCCcccccchhcccc
Q 023285 259 AQSG--------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 259 ~~~~--------~~~~~~gt~~y~aPEvl~~ 281 (284)
.... ......||+.|+|||++.+
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred ccccccccccccccccccccccccCHHHHhc
Confidence 3221 1223478999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=267.56 Aligned_cols=177 Identities=22% Similarity=0.396 Sum_probs=145.1
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHH-HHhCCCCceeeEEeEEEcCCcE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+..++|++.+.||+|+||.||+|+.. ++.||||+++.... .......+.+|..+ ++.++||||+++++++.+...+
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 45678999999999999999999984 67899999975433 23344567777776 5778999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-C
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~ 261 (284)
|+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999999976 36789999999999999999999999999999999999999999999999999986332 2
Q ss_pred CceecCCCcccccchhccccccC
Q 023285 262 GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......+||+.|+|||++.+..|
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~ 216 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPY 216 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCC
T ss_pred CccccccCCccccCHHHhCCCCC
Confidence 33456689999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.23 Aligned_cols=173 Identities=25% Similarity=0.480 Sum_probs=152.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|.+ +++.||||++...... .+....+.+|+.+++.++||||+++++++..+...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 5789999998632111 11235688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|||+ +|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 9999 67999998764 679999999999999999999999999999999999999999999999999998766655556
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...||+.|+|||++.+..
T Consensus 166 ~~~gt~~y~aPE~~~~~~ 183 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKL 183 (336)
T ss_dssp CCTTSTTTSCGGGSCCSG
T ss_pred cccCCcCcCCHHHHcCCC
Confidence 678999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=251.04 Aligned_cols=174 Identities=21% Similarity=0.367 Sum_probs=157.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|... ++.||+|++..........+.+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 458999999999999999999874 689999999876666777788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~---vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||.+........
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999998764 67999999999999999999999999999999999999986655 99999999987766655
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~ 183 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDP 183 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCC
T ss_pred ccCCCCCcCCcCchhhcCCC
Confidence 56678999999999988764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=263.84 Aligned_cols=174 Identities=25% Similarity=0.407 Sum_probs=143.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
...++|++.+.||+|+||.||+++. +++.||||++...... ...+.+|+.++++++||||+++++++.....+|+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 4567899999999999999999998 5789999999754322 2457899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--EEEecccceeeeccCC
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSG 262 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~--vkl~Dfg~a~~~~~~~ 262 (284)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 94 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 94 IMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999763 57999999999999999999999999999999999999987765 9999999998654444
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp --------CTTSCHHHHHCSSC
T ss_pred CCCCCcCCCCcCChhhhcCCCC
Confidence 4556689999999999977653
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=260.99 Aligned_cols=179 Identities=30% Similarity=0.543 Sum_probs=155.3
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
.+++..++|++.+.||+|+||.||+|+..+ +.||||+++... ..+..+.+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356778899999999999999999999854 789999997543 455677899999999999999999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~D 233 (284)
......|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999997642 5689999999999999999999999999999
Q ss_pred CCCCCEEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhcccccc
Q 023285 234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 234 ikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
|||+||+++.++.+||+|||+++...... ......+|+.|+|||++.+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 99999999999999999999997643221 223456889999999987654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=263.42 Aligned_cols=182 Identities=31% Similarity=0.588 Sum_probs=155.0
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 173 (284)
...|++..++|++.+.||+|+||.||+|.+. ++.||||+++.. ......+.+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4578999999999999999999999999852 378999999754 3455567899999999999 789999999
Q ss_pred eEEEcCCc-EEEEEEcCCCCCHHHHHHhcCC-------------------------------------------------
Q 023285 174 GACTRPPN-LCIVTEFMARGSIYDFLHKQKG------------------------------------------------- 203 (284)
Q Consensus 174 ~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------- 203 (284)
+++..... +++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 8999999999999999976432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---ce
Q 023285 204 ----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (284)
Q Consensus 204 ----------------~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~ 264 (284)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 18899999999999999999999999999999999999999999999999998653322 22
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
....||+.|+|||++.+..|
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp --CEECGGGCCHHHHHHCCC
T ss_pred cccCCCceeEChhhhcCCCC
Confidence 34568899999999876543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=265.78 Aligned_cols=180 Identities=32% Similarity=0.534 Sum_probs=147.1
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..+++..+|++.+.||+|+||.||+|+.. +..||||+++... .....+.|.+|+.++++++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 35678889999999999999999999864 5679999997542 45567789999999999999999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
....++||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999876678999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCc----eecCCCcccccchhccccccC
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~y 284 (284)
..... .....+|+.|+|||++.+..|
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp ----------------CTTSCHHHHHHCCC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCc
Confidence 43321 112245778999999876543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=264.26 Aligned_cols=174 Identities=25% Similarity=0.382 Sum_probs=152.7
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|++.+.||+|+||.||+|+. +++.||||+++.... .....+.+.+|+.++++++||||+++++++.+...+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 356899999999999999999998 478999999864311 11234678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCce
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 119 v~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 99999999999999774 57999999999999999999999999999999999999999999999999999876443 3
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
....||+.|+|||++.+..|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~ 215 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGY 215 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCB
T ss_pred ccccCCccccCHHHhcCCCC
Confidence 45679999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=256.46 Aligned_cols=172 Identities=26% Similarity=0.440 Sum_probs=148.1
Q ss_pred CCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
++|++.+.||+|+||.||+|+.. ++.||+|+++...........+.+|+.++++++||||+++++++.....+++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999984 78999999976543333446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-CceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~~ 267 (284)
+++ +|.+++....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 986 999999877678999999999999999999999999999999999999999999999999999764422 223455
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
.||+.|+|||++.+.
T Consensus 161 ~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGS 175 (288)
T ss_dssp -CCCTTCCHHHHTTC
T ss_pred cccccccCchheeCC
Confidence 789999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=261.66 Aligned_cols=169 Identities=24% Similarity=0.400 Sum_probs=145.6
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
..+.||+|+||.||+|.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.....+++||||+++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 367899999999999987 4789999999764 334567899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe--cCCCcEEEecccceeeeccCCceecCCC
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETG 269 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli--~~~~~vkl~Dfg~a~~~~~~~~~~~~~g 269 (284)
++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++............|
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~g 250 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCS
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccC
Confidence 99999998766679999999999999999999999999999999999999 5678999999999998766555556689
Q ss_pred cccccchhccccccC
Q 023285 270 TYRWMAPEVAFTFFF 284 (284)
Q Consensus 270 t~~y~aPEvl~~~~y 284 (284)
|+.|+|||++.+..|
T Consensus 251 t~~y~aPE~~~~~~~ 265 (373)
T 2x4f_A 251 TPEFLAPEVVNYDFV 265 (373)
T ss_dssp SCTTCCHHHHTTCBC
T ss_pred CCcEeChhhccCCCC
Confidence 999999999876543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=251.11 Aligned_cols=174 Identities=29% Similarity=0.499 Sum_probs=156.7
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC--CcE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 182 (284)
++++.++|++.+.||+|+||.||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 567788999999999999999999999999999999987766677778899999999999999999999999887 788
Q ss_pred EEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 183 CIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
++||||+++|+|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999987543 5899999999999999999999999 9999999999999999999999998875422
Q ss_pred cCCceecCCCcccccchhccccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.....||+.|+|||++.+.
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~ 183 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKK 183 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSC
T ss_pred ----ccCccCCccccChhhhccC
Confidence 2345789999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=253.08 Aligned_cols=180 Identities=30% Similarity=0.509 Sum_probs=145.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..+++..++|++.+.||+|+||.||+|.+. +..||+|+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 457888999999999999999999999873 346999998754 24556678999999999999999999999985
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
++..|+||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 4678999999999999999987666799999999999999999999999999999999999999999999999999986
Q ss_pred eccCCc--eecCCCcccccchhccccccC
Q 023285 258 QAQSGV--MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~--~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... .....+|+.|+|||++.+..|
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCC
T ss_pred cCcccccccccCCCcccccChhhcccCCC
Confidence 544322 223457789999999876543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=253.91 Aligned_cols=178 Identities=29% Similarity=0.554 Sum_probs=151.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..+....|++.+.||+|+||.||+|++ +++.||||+++... .......+.+|+.++++++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345677899999999999999999984 46899999997543 23345779999999999999999999999987
Q ss_pred C--CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 179 P--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 179 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
. ..+++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 66899999999999999997767789999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCc----eecCCCcccccchhcccccc
Q 023285 257 VQAQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
....... .....||..|+|||++.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCC
Confidence 7654332 23446888999999987653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=274.20 Aligned_cols=176 Identities=22% Similarity=0.497 Sum_probs=156.1
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|.+.+.||+|+||.||+|+. +++.||||+++..... .+....+.+|+.+++.++||||+++++++.....+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4457899999999999999999988 4789999998643111 123467899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999999965 46799999999999999999999999999999999999999999999999999998766555
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....||+.|+|||++.+..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~ 191 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRL 191 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCC
T ss_pred ccccCCCcCeEChhhccCCC
Confidence 56678999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=255.31 Aligned_cols=173 Identities=25% Similarity=0.399 Sum_probs=151.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC--cE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL 182 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 182 (284)
+..++|++.+.||+|+||.||+|... ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44668999999999999999999985 78999999975322 223567889999999999999999999998765 78
Q ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli----~~~~~vkl~Dfg~a~ 256 (284)
|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 238999999999999999999999999999999999999 788889999999999
Q ss_pred eeccCCceecCCCcccccchhccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
............||+.|+|||++.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred ecCCCCceeecccCCCccCHHHhh
Confidence 876665556678999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=263.72 Aligned_cols=176 Identities=23% Similarity=0.340 Sum_probs=150.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
.+.|++.+.||+|+||.||+|.. +++.||||+++... ......+.+.+|+.++++++||||+++++++..+..+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45799999999999999999987 47899999985321 01112467899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEecccceee
Q 023285 184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV 257 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~---vkl~Dfg~a~~ 257 (284)
+||||++|++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 235899999999999999999999999999999999999986654 99999999987
Q ss_pred eccCCc-eecCCCcccccchhccccccC
Q 023285 258 QAQSGV-MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~-~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... .....||+.|+|||++.+..|
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 210 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPY 210 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCB
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCC
Confidence 654432 345679999999999987643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=259.23 Aligned_cols=172 Identities=24% Similarity=0.414 Sum_probs=148.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||||++..... .+..+.+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 5899999999999999999987 478999999864422 2334668899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---ce
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~ 264 (284)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred cCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999999865 4579999999999999999999999999999999999999999999999999998653322 23
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~ 183 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRRE 183 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSS
T ss_pred CCCccCcCccCcHHhccCC
Confidence 4567999999999997654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=249.39 Aligned_cols=177 Identities=35% Similarity=0.638 Sum_probs=155.8
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.|.++.++|++.+.||+|+||.||+|.+ .++.||+|+++..... .+.+.+|+.++++++||||+++++++..+...
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4788999999999999999999999998 5678999999865433 35789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998876789999999999999999999999999999999999999999999999999997653321
Q ss_pred --ceecCCCcccccchhcccccc
Q 023285 263 --VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 --~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......+++.|+|||++.+..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~ 181 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSR 181 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCC
T ss_pred ccccccccccccccChhhhcCCC
Confidence 122345778999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=276.94 Aligned_cols=177 Identities=23% Similarity=0.348 Sum_probs=156.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|++.+.||+|+||.||+|+. +++.||||+++.... .......+.+|+.++++++||||+++++++.+...+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5677899999999999999999998 578999999864311 1122456889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999997643 359999999999999999999999999999999999999999999999999998876655
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......||+.|+|||++.+..
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~ 361 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNER 361 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCE
T ss_pred cccccCCCccccCHHHHcCCC
Confidence 556678999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=270.14 Aligned_cols=170 Identities=25% Similarity=0.383 Sum_probs=137.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-----CCc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-----PPN 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~ 181 (284)
.++|++.+.||+|+||.||+|.. +++.||||++..........+.+.+|+.++++++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36899999999999999999987 47899999997665566677889999999999999999999999944 356
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999999985 699999965 467999999999999999999999999999999999999999999999999999865321
Q ss_pred C----------------------------ceecCCCcccccchhccc
Q 023285 262 G----------------------------VMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 262 ~----------------------------~~~~~~gt~~y~aPEvl~ 280 (284)
. ..+..+||+.|+|||++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 1 234457899999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=272.05 Aligned_cols=179 Identities=36% Similarity=0.671 Sum_probs=157.2
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
.+.|++...+|++.+.||+|+||.||+|.+. +..||||+++..... .+.|.+|+.++++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3579999999999999999999999999985 689999999765332 46799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999874 356899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCce--ecCCCcccccchhcccccc
Q 023285 259 AQSGVM--TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~~--~~~~gt~~y~aPEvl~~~~ 283 (284)
...... ....+++.|+|||++.+..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 395 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNK 395 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCE
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCC
Confidence 443221 2234678999999987653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=253.58 Aligned_cols=180 Identities=29% Similarity=0.574 Sum_probs=156.9
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|++..++|++.+.||+|+||.||+|++ .++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 56889999999999999999999999985 34789999997543 345567899999999999 8999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
++..+...++||||+++|+|.+++..... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 99999999999999999999999987533 4899999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++.++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 223 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC
Confidence 99999999999999999986544322 22345788999999987654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=264.89 Aligned_cols=171 Identities=25% Similarity=0.390 Sum_probs=147.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-----Cc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 181 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.........+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45899999999999999999987 468899999986655666778899999999999999999999999776 56
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 105 ~~lv~e~~~~-~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEEECCSE-EHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEEecCCc-CHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999999964 99999965 467999999999999999999999999999999999999999999999999999875432
Q ss_pred C-----------------------ceecCCCcccccchhcccc
Q 023285 262 G-----------------------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~-----------------------~~~~~~gt~~y~aPEvl~~ 281 (284)
. ..+..+||+.|+|||++.+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 1 2356689999999998743
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=259.18 Aligned_cols=181 Identities=30% Similarity=0.559 Sum_probs=153.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|++..++|++.+.||+|+||.||+|++ .+..||||+++... .......+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 46889999999999999999999999986 23579999997542 334457799999999999 8999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKG----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~L~~LH~~~iiH~ 232 (284)
++......++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999977533 37889999999999999999999999999
Q ss_pred CCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 233 Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
||||+||+++.++.+||+|||+++....... .....+|+.|+|||++.+..|
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 9999999999999999999999986543322 223457889999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.57 Aligned_cols=172 Identities=26% Similarity=0.378 Sum_probs=145.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
.++|++.+.||+|+||.||+|.. +++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999987 4789999999765556667788999999999999999999999997653
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 57999999976 6777774 3489999999999999999999999999999999999999999999999999987766
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
....+...||+.|+|||++.+..|
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~ 240 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGY 240 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCC
T ss_pred CcccCCCcccccccCHHHHcCCCC
Confidence 555667789999999999988755
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=262.66 Aligned_cols=181 Identities=30% Similarity=0.519 Sum_probs=154.4
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
+.+++..++|++.+.||+|+||.||+|++. ++.||||+++.. ........+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 346778899999999999999999999853 467999998743 345566789999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---c
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---V 246 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~ 246 (284)
+......|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999998743 4589999999999999999999999999999999999999555 5
Q ss_pred EEEecccceeeeccC---CceecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQS---GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+||+|||+|+..... .......||+.|+|||++.+..|
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 263 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC
Confidence 999999999754222 12234567999999999876543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=259.26 Aligned_cols=172 Identities=25% Similarity=0.458 Sum_probs=135.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
-.+.|++.+.||+|+||.||+|+.. ++.||||+++... ..+.+.+|+.++++++||||+++++++......++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 3567999999999999999999984 5789999997532 245688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~~~~~~ 262 (284)
|||+++++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp ECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999999999999976 467999999999999999999999999999999999999975 8899999999998765544
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~ 227 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAY 227 (349)
T ss_dssp -------CGGGSCHHHHTTCCC
T ss_pred ccccccCCCCccCHHHhcCCCC
Confidence 4556689999999999987653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=268.28 Aligned_cols=179 Identities=35% Similarity=0.637 Sum_probs=154.7
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|++..++|++.+.||+|+||.||+|.+. +..||||+++.... ..+.|.+|+.++++++||||+++++++. ..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 3579999999999999999999999999985 67899999986533 3567999999999999999999999987 56
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 7899999999999999997542 368899999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ceecCCCcccccchhccccccC
Q 023285 260 QSG--VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~--~~~~~~gt~~y~aPEvl~~~~y 284 (284)
... ......+|+.|+|||++.+..|
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 362 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSF 362 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCC
T ss_pred CCceeccCCCcccccccCHHHhccCCC
Confidence 321 1123356789999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=251.83 Aligned_cols=171 Identities=24% Similarity=0.382 Sum_probs=146.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|... ++.||||++..........+.+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999984 7899999997665556667789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
|+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++..... .....
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999988865 467999999999999999999999999999999999999999999999999999875533 23345
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..||+.|+|||++.+
T Consensus 162 ~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 162 EVATRWYRSPELLVG 176 (311)
T ss_dssp ----GGGCCHHHHHT
T ss_pred CcCCccccChHHHhc
Confidence 679999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=269.80 Aligned_cols=170 Identities=17% Similarity=0.257 Sum_probs=143.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhCC---------CCceee
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR---------HKNVVQ 171 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~ 171 (284)
+..++|++.+.||+|+||.||+|+++++.||||+++.... .....+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4467899999999999999999999999999999975432 2233467889999998886 777777
Q ss_pred EEeEEE------------------------------cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 023285 172 FIGACT------------------------------RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221 (284)
Q Consensus 172 ~~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L 221 (284)
+.+++. ....+|+||||+++|++.+.+.+ +.+++..+..++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776642 26789999999999977766643 5689999999999999999
Q ss_pred HHHH-hCCceecCCCCCCEEecCCC--------------------cEEEecccceeeeccCCceecCCCcccccchhccc
Q 023285 222 NYLH-QNNIIHRDLKTANLLMDENG--------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 222 ~~LH-~~~iiH~Dikp~NIli~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
+||| ++||+||||||+|||++.++ .+||+|||+|+..... ...||+.|||||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999887 9999999999876543 237999999999998
Q ss_pred cc
Q 023285 281 TF 282 (284)
Q Consensus 281 ~~ 282 (284)
+.
T Consensus 251 g~ 252 (336)
T 2vuw_A 251 GD 252 (336)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=252.01 Aligned_cols=180 Identities=28% Similarity=0.553 Sum_probs=156.4
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
..|++..++|++.+.||+|+||.||+|... ++.||||+++.. ......+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 457888999999999999999999999862 378999999754 345667889999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~ 232 (284)
+......++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999998643 238899999999999999999999999999
Q ss_pred CCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 233 Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||||+||+++.++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 9999999999999999999999987644332 22345788999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=258.06 Aligned_cols=173 Identities=23% Similarity=0.341 Sum_probs=150.8
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|++.+.||+|+||.||+|.. +++.||||++..... ...+.+|+.+++++ +||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 3457899999999999999999996 578999999875422 23588999999999 8999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-----EEEecccceeee
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARVQ 258 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~-----vkl~Dfg~a~~~ 258 (284)
+||||+ +++|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 88999999876678999999999999999999999999999999999999998887 999999999875
Q ss_pred ccCCc--------eecCCCcccccchhccccccC
Q 023285 259 AQSGV--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
..... .....||+.|+|||++.+..|
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ 194 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC
Confidence 43321 235679999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=253.29 Aligned_cols=174 Identities=29% Similarity=0.444 Sum_probs=145.4
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------------------------HHHHHHHHHHHH
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------------------------EMLKEFSQEVYI 160 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~ 160 (284)
+..++|++.+.||+|+||.||+|.. +++.||||+++...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3456899999999999999999987 46899999986543211 123568999999
Q ss_pred HHhCCCCceeeEEeEEEc--CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 161 MRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 161 l~~l~h~niv~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
+++++||||+++++++.. ...+|+||||+++++|.+++. ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 567999999999999988653 3579999999999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCC-ceecCCCcccccchhccccc
Q 023285 239 LLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPEvl~~~ 282 (284)
|+++.++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 212 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET 212 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccC
Confidence 999999999999999998765432 33456799999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=253.49 Aligned_cols=172 Identities=24% Similarity=0.425 Sum_probs=150.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
.++..++|++.+.||+|+||.||+|.... ..||+|+++.. .....+.+.+|+.++++++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 35677899999999999999999998742 46999998643 33445779999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--------E
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------V 247 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~--------v 247 (284)
+..+...++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999886666999999999999999999999999999999999999998887 9
Q ss_pred EEecccceeeeccCCceecCCCcccccchhcccc
Q 023285 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 248 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
||+|||.+...... ....||+.|+|||++.+
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIEN 191 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHC
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCC
Confidence 99999998644322 23457899999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=272.98 Aligned_cols=178 Identities=24% Similarity=0.352 Sum_probs=154.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+..++|.+.+.||+|+||.||+|+. +++.||+|+++..... ......+.+|+.++++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999998 4789999998643211 123467889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999764 34699999999999999999999999999999999999999999999999999987654
Q ss_pred CCc-eecCCCcccccchhccccccC
Q 023285 261 SGV-MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~-~~~~~gt~~y~aPEvl~~~~y 284 (284)
... .....||+.|+|||++.+..|
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~ 366 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEY 366 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCB
T ss_pred CCcccccccCCccccChhhhcCCCC
Confidence 433 234589999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=260.64 Aligned_cols=173 Identities=23% Similarity=0.384 Sum_probs=152.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
++|++.+.||+|+||.||+|.. +++.||||+++...... .....+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 5799999999999999999986 57899999997653222 134467889999999999999999999999999
Q ss_pred EEEEEEcCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+++||||+.+| +|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999777 99999976 46799999999999999999999999999999999999999999999999999987766
Q ss_pred CCceecCCCcccccchhcccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
........||+.|+|||++.+..
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~ 205 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNP 205 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCC
T ss_pred CCceeccCCCccccChhhhcCCC
Confidence 55555668999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=254.35 Aligned_cols=180 Identities=31% Similarity=0.522 Sum_probs=151.0
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
.+++...+|++.+.||+|+||.||+|.... ..||||+++... .......+.+|+.++++++||||+++++++.
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 357888999999999999999999998742 359999997543 4555678999999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.....++||||+++++|.+++....+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999999988767899999999999999999999999999999999999999999999999999986
Q ss_pred eccCCc----eecCCCcccccchhccccccC
Q 023285 258 QAQSGV----MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~----~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... .....+|+.|+|||++.+..|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCC
T ss_pred hccccccccccCCCCccccccCchhcccCCC
Confidence 543221 122346789999999876543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-35 Score=255.92 Aligned_cols=175 Identities=27% Similarity=0.425 Sum_probs=145.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc----
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN---- 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 181 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... .......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 56899999999999999999996 578999999976543 34556789999999999999999999999876543
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+||||++|++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 49999999999999999764 67999999999999999999999999999999999999999999999999999865432
Q ss_pred C----ceecCCCcccccchhccccccC
Q 023285 262 G----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ......||+.|+|||++.+..|
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSV 196 (311)
T ss_dssp ------------CCTTCCHHHHHTCCC
T ss_pred ccccccccccCcCcccCCHHHhcCCCC
Confidence 2 1223468999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=259.54 Aligned_cols=170 Identities=24% Similarity=0.435 Sum_probs=139.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCC--cEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~ 183 (284)
.++|++.+.||+|+||.||+|.. +++.||||++............+.+|+.+++++. ||||+++++++..++ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999987 4789999999765556667788999999999997 999999999997544 689
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc---
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--- 260 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~--- 260 (284)
+||||+++ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999974 99999976 4689999999999999999999999999999999999999999999999999986432
Q ss_pred -------------------CCceecCCCcccccchhcccc
Q 023285 261 -------------------SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 -------------------~~~~~~~~gt~~y~aPEvl~~ 281 (284)
....+...||+.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 112344579999999999976
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=253.72 Aligned_cols=175 Identities=25% Similarity=0.379 Sum_probs=154.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+.|++.+.||+|+||.||+|+. +++.||||+++...... .....+.+|+.++++++||||+++++++.....+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45799999999999999999998 47899999997543221 1356799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEecccceeee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~ 258 (284)
++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999976 46789999999999999999999999999999999999999888 7999999999877
Q ss_pred ccCCceecCCCcccccchhccccccC
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
..........||+.|+|||++.+..|
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~ 195 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPL 195 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCC
T ss_pred CccccccccCCCCCccCcccccCCCC
Confidence 65555556679999999999987643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=253.07 Aligned_cols=181 Identities=27% Similarity=0.498 Sum_probs=156.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEe
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 174 (284)
.+.|++..++|++.+.||+|+||.||+|.+. ++.||||+++.. ........+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3568899999999999999999999999764 478999998754 24455667999999999999999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~ 245 (284)
++......++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999997632 4578999999999999999999999999999999999999999
Q ss_pred cEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 246 ~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCC
Confidence 999999999986543321 12335688999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=252.95 Aligned_cols=175 Identities=26% Similarity=0.501 Sum_probs=153.2
Q ss_pred eccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--c
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--R 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~ 178 (284)
++.++|++.+.||+|+||.||+|++ .++.||||+++.. .....+.+.+|+.++++++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 5678999999999999999999985 4688999999754 4566678999999999999999999999987 4
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
....|+||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 55699999999999999999876667999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----eecCCCcccccchhcccccc
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
..... .....+|+.|+|||++.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNI 206 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred ccCCccceeeccCCccccccCHHHhccCC
Confidence 44332 23346888999999987653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.89 Aligned_cols=176 Identities=34% Similarity=0.664 Sum_probs=142.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+++.++|++.+.||+|+||.||+|.+.++.||||+++..... ....+.+.+|+.+++.++||||+++++++..+...+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 567789999999999999999999999999999998754222 233567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEecC--------CCcEEEecc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADF 252 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---iiH~Dikp~NIli~~--------~~~vkl~Df 252 (284)
+||||+++++|.+++.. +.+++..+..++.|++.||.|||++| |+||||||+||+++. ++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999999854 57999999999999999999999999 999999999999986 778999999
Q ss_pred cceeeeccCCceecCCCcccccchhccccccC
Q 023285 253 GVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|.++...... .....||+.|+|||++.+..|
T Consensus 161 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 191 (271)
T 3dtc_A 161 GLAREWHRTT-KMSAAGAYAWMAPEVIRASMF 191 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCCC
T ss_pred Cccccccccc-ccCCCCccceeCHHHhccCCC
Confidence 9998654432 334579999999999876543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=253.81 Aligned_cols=180 Identities=30% Similarity=0.603 Sum_probs=156.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~ 172 (284)
..|++..++|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 468889999999999999999999999863 4679999997543 455677899999999999 89999999
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
++++.....+|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 24889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++.++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC
Confidence 99999999999999999987654322 23345788999999986643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=252.48 Aligned_cols=169 Identities=28% Similarity=0.420 Sum_probs=149.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.|...++||+|+||.||+|+. +++.||||+++... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 477788999999999999987 47899999997543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... .....
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999864 469999999999999999999999999999999999999999999999999998754432 33456
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.||+.|+|||++.+..
T Consensus 202 ~gt~~y~aPE~~~~~~ 217 (321)
T 2c30_A 202 VGTPYWMAPEVISRSL 217 (321)
T ss_dssp CSCGGGCCHHHHTTCC
T ss_pred cCCccccCHhhhcCCC
Confidence 7999999999997754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=254.22 Aligned_cols=181 Identities=27% Similarity=0.455 Sum_probs=139.4
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+.+..++|++.+.||+|+||.||+|++.. ..||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 456778899999999999999999998743 279999998765555667889999999999999999999999987
Q ss_pred CCcE------EEEEEcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcE
Q 023285 179 PPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (284)
Q Consensus 179 ~~~~------~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~v 247 (284)
.... ++||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999999996532 258999999999999999999999999999999999999999999
Q ss_pred EEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 248 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 248 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
||+|||+++....... .....+++.|+|||++.+..|
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCC
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCC
Confidence 9999999986543321 223456789999999877643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=246.69 Aligned_cols=171 Identities=25% Similarity=0.435 Sum_probs=152.1
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|... +..||+|.+..... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 347999999999999999999984 46899999865422 22567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||++ +.++.++|+|||.+........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99999999999976 4669999999999999999999999999999999999999 7889999999999987766555
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.....||+.|+|||++.+.
T Consensus 165 ~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC
T ss_pred hhccCCCCCccChHHhccc
Confidence 6667899999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=265.19 Aligned_cols=179 Identities=38% Similarity=0.683 Sum_probs=150.7
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.++++++||||+++++++.. .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 45799999999999999999999999999965 67999999865433 3578999999999999999999999876 6
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999753 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc--eecCCCcccccchhccccccC
Q 023285 260 QSGV--MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .....+++.|+|||++.+..|
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCC
T ss_pred CCceecccCCcccccccCHhHHhcCCC
Confidence 3221 223356789999999876543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=249.99 Aligned_cols=178 Identities=38% Similarity=0.675 Sum_probs=156.8
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+.|++...+|++.+.||+|+||.||+|.+. +..||+|+++.. ....+.+.+|+.++++++||||+++++++..+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 568899999999999999999999999985 688999999754 334577999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..|+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999874 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc--eecCCCcccccchhcccccc
Q 023285 260 QSGV--MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPEvl~~~~ 283 (284)
.... .....+|+.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 188 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNK 188 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCccccccCCccccCcCChhhhccCC
Confidence 4322 22335678999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=249.01 Aligned_cols=169 Identities=31% Similarity=0.567 Sum_probs=144.6
Q ss_pred eccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEc----CC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTR----PP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~ 180 (284)
+..++|++.+.||+|+||.||+|+++++.||||++... ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 34678999999999999999999999999999998643 23456667777666 789999999998654 34
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEecCCCcEEEecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
.+++||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 58999999999999999954 56999999999999999999999 999999999999999999999999999
Q ss_pred cceeeeccCCce-----ecCCCcccccchhccccc
Q 023285 253 GVARVQAQSGVM-----TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 253 g~a~~~~~~~~~-----~~~~gt~~y~aPEvl~~~ 282 (284)
|+|+........ ....||+.|+|||++.+.
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred CCeeecccccccccccccccccccceeChhhhcCc
Confidence 999875543322 234799999999999765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=248.41 Aligned_cols=174 Identities=27% Similarity=0.399 Sum_probs=139.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
+++..++|++.+.||+|+||.||+|.. +++.||||+++.........+.+.++...++.++||||+++++++..+...
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 467788999999999999999999998 678999999976544444445566666778899999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 183 CIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 98888754 356799999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCceecCCCcccccchhcc
Q 023285 259 AQSGVMTAETGTYRWMAPEVA 279 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl 279 (284)
..........||+.|+|||++
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp ---------CCCCCCSCHHHH
T ss_pred cccccccccCCCccccChhhc
Confidence 655555556899999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=268.16 Aligned_cols=171 Identities=28% Similarity=0.463 Sum_probs=147.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|+. ++..||||+++...........+.+|+.++++++||||+++++++.....+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 4799999999999999999998 46889999997654434445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEecccceeeeccCCce
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~---~~vkl~Dfg~a~~~~~~~~~ 264 (284)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|+........
T Consensus 117 ~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~ 195 (494)
T 3lij_A 117 CYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195 (494)
T ss_dssp CCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence 99999999998764 679999999999999999999999999999999999999754 45999999999887665556
Q ss_pred ecCCCcccccchhcccc
Q 023285 265 TAETGTYRWMAPEVAFT 281 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~ 281 (284)
....||+.|+|||++.+
T Consensus 196 ~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 196 KERLGTAYYIAPEVLRK 212 (494)
T ss_dssp CCCCSCTTTCCHHHHTT
T ss_pred cccCCCcCeeCHHHHcc
Confidence 67789999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=254.54 Aligned_cols=175 Identities=22% Similarity=0.348 Sum_probs=150.6
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~ 180 (284)
...+..++|++.+.||+|+||.||++.. +++.||||+++...........+.+|+.++++++| |||+++++++..+.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 3467788999999999999999999987 46789999998766667777889999999999987 99999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+|||+ .+++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999995 57799999987 46799999999999999999999999999999999999996 68899999999986543
Q ss_pred CC---ceecCCCcccccchhcccc
Q 023285 261 SG---VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~---~~~~~~gt~~y~aPEvl~~ 281 (284)
.. ......||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ----------CCCCSSCCHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhh
Confidence 32 2235579999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=246.43 Aligned_cols=177 Identities=28% Similarity=0.490 Sum_probs=153.8
Q ss_pred eeeeccCCceeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+.+..++|.+.+ .||+|+||.||+|.+ .+..||||+++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 4667788898887 999999999999986 4678999999764 24566778999999999999999999999995
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
....++||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45699999999999999999876677999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----eecCCCcccccchhccccc
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~ 282 (284)
..... .....+|+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred ccCcceeeccccccccccccCHHHhccC
Confidence 43322 1233568999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=253.46 Aligned_cols=172 Identities=27% Similarity=0.483 Sum_probs=135.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++... .......+.+|+.++++++||||+++++++..++.+|+||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35799999999999999999987 47899999997543 2223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 187 EFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
||+++ +|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99985 9999987642 45899999999999999999999999999999999999999999999999999875432
Q ss_pred -CceecCCCcccccchhccccc
Q 023285 262 -GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 -~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.......||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTC
T ss_pred cccCCCCcccccccCchHhhCC
Confidence 233456789999999998763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=251.97 Aligned_cols=174 Identities=23% Similarity=0.423 Sum_probs=152.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----CCceeeEEeEEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----HKNVVQFIGACT 177 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~ 177 (284)
..+-.++|++.++||+|+||.||+|+. +++.||||+++. .....+.+..|+.+++.++ ||||+++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 445577999999999999999999998 578999999974 3455667888999999997 999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-------------
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE------------- 243 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~------------- 243 (284)
.....|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 889999998753 45999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 244 ------------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 244 ------------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++.+||+|||+|+..... .....||+.|+|||++.+..|
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCC
T ss_pred cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCC
Confidence 789999999999865432 345679999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=252.27 Aligned_cols=180 Identities=29% Similarity=0.566 Sum_probs=155.7
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|++..++|++.+.||+|+||.||+|...+ ..||+|.++... ..+....+.+|+.+++++ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4688999999999999999999999998742 379999997543 455667899999999999 8999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQ-------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli 241 (284)
++..+..+++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999753 2457999999999999999999999999999999999999
Q ss_pred cCCCcEEEecccceeeeccCCc---eecCCCcccccchhcccccc
Q 023285 242 DENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 242 ~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~ 283 (284)
+.++.+||+|||+++....... .....+|+.|+|||++.+..
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 242 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC
Confidence 9999999999999986543322 12345678999999987654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=269.47 Aligned_cols=173 Identities=28% Similarity=0.510 Sum_probs=149.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++...........+.+|+.++++++||||+++++++.....+|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 45899999999999999999998 4789999998643222223567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 999999999999764 6799999999999999999999999999999999999995 456799999999987665555
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.....||+.|+|||++.+.
T Consensus 180 ~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp --CCTTGGGGCCGGGGGSC
T ss_pred cCCCcCCCCCCCHHHhCCC
Confidence 5667899999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=244.30 Aligned_cols=170 Identities=24% Similarity=0.392 Sum_probs=150.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.. +++.||||+++...........+.+|+..+.++ +||||+++++++..+...++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999998 478999999987655556677899999999999 8999999999999999999999
Q ss_pred EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-------------------
Q 023285 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------------------- 244 (284)
Q Consensus 187 e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~------------------- 244 (284)
||+++++|.+++... .+.+++..+..++.||+.||+|||++||+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999999764 2668999999999999999999999999999999999999844
Q ss_pred CcEEEecccceeeeccCCceecCCCcccccchhccccc
Q 023285 245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 245 ~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
..+||+|||.+...... ....||+.|+|||++.+.
T Consensus 171 ~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQEN 205 (289)
T ss_dssp CCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTC
T ss_pred eEEEEcccccccccCCc---cccCCCccccChhHhcCC
Confidence 47999999999876543 334699999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=254.86 Aligned_cols=176 Identities=28% Similarity=0.523 Sum_probs=152.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
...++|++.+.||+|+||.||+|.+. ++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 34578999999999999999999974 789999998765 334567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999986542 358999999999999999999999999999999999999999999999999998643321
Q ss_pred ---ceecCCCcccccchhccccccC
Q 023285 263 ---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGRL 218 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred ccccccccCCCccccCHHHhcCCCC
Confidence 2234468999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=246.14 Aligned_cols=178 Identities=25% Similarity=0.505 Sum_probs=151.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+.+..++|++.+.||+|+||.||+|.+.+ ..||+|+++... ..+..+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 466778899999999999999999998642 359999987542 45567789999999999999999999999875
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...|+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4578999999999999999887677999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC--ceecCCCcccccchhcccccc
Q 023285 259 AQSG--VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~--~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ......+|+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 190 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRR 190 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCC
T ss_pred ccccccccccCCCCcceeCchhhccCC
Confidence 4332 123446788999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=259.09 Aligned_cols=168 Identities=24% Similarity=0.370 Sum_probs=136.2
Q ss_pred CCceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEc----CCc
Q 023285 110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTR----PPN 181 (284)
Q Consensus 110 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~ 181 (284)
++|.+. +.||+|+||.||+|.. +++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 467776 7899999999999988 4688999998632 3567788887 45589999999999865 567
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~ 257 (284)
+|+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 899999999999999997643 46999999999999999999999999999999999999997 78999999999987
Q ss_pred eccCCceecCCCcccccchhccccccC
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...........||+.|+|||++.+..|
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~ 240 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKY 240 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCS
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCC
Confidence 665555566789999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=265.63 Aligned_cols=172 Identities=25% Similarity=0.472 Sum_probs=149.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-----------HHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----------EMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
.++|++.++||+|+||.||+|.. +++.||||+++...... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46899999999999999999998 46889999997543221 235678999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEecc
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADF 252 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~Df 252 (284)
+.+...+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 99999999999999999999999764 6799999999999999999999999999999999999998776 6999999
Q ss_pred cceeeeccCCceecCCCcccccchhcccc
Q 023285 253 GVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
|+|+............||+.|+|||++.+
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc
Confidence 99988766655667789999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=252.95 Aligned_cols=178 Identities=28% Similarity=0.533 Sum_probs=146.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
-.+..++|++.+.||+|+||.||+|++. ++ .||+|.++... .....+.+.+|+.++++++||||++++++|..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3456778999999999999999999873 33 36888876432 33445789999999999999999999999987
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+ ..++|+|++.+|+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 478999999999999999887788999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCc---eecCCCcccccchhccccccC
Q 023285 259 AQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
..... .....+|+.|+|||++.+..|
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCC
Confidence 43322 223456889999999887654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=245.18 Aligned_cols=174 Identities=24% Similarity=0.410 Sum_probs=148.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.++|++.+.||+|+||.||+|... ++.||+|+++...... ...+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999984 7899999987543221 1356799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEecccceeee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~ 258 (284)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+...
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999976 35799999999999999999999999999999999999998877 8999999999876
Q ss_pred ccCCceecCCCcccccchhcccccc
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
..........||+.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEP 187 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCC
T ss_pred cCCCcccccCCCcCccCcceecCCC
Confidence 5554455667999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=255.04 Aligned_cols=172 Identities=27% Similarity=0.377 Sum_probs=141.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 180 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++...........+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999987 4789999999765556667788999999999999999999999997765
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++ +|.+++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 68999999975 8888885 3489999999999999999999999999999999999999999999999999987655
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~ 203 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGY 203 (371)
T ss_dssp ----------CTTCCHHHHTTCCC
T ss_pred ccccCCceecCCccCHHHhcCCCC
Confidence 444556789999999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=249.25 Aligned_cols=174 Identities=24% Similarity=0.341 Sum_probs=153.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|.+.+.||+|+||.||++... ++.||+|++.... ......+.+.+|+.++++++||||+++++++.+...+|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 468999999999999999999984 6789999986543 2445667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|||+++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..... ...
T Consensus 120 ~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 120 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp ECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 999999999999876 367999999999999999999999999999999999999999999999999999875432 233
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 199 ~~~~gt~~y~aPE~~~~~~ 217 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKG 217 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSC
T ss_pred cccCCCccccCHHHhccCC
Confidence 4567999999999987654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=278.36 Aligned_cols=180 Identities=21% Similarity=0.329 Sum_probs=152.7
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP 179 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 179 (284)
...+..++|++.+.||+|+||.||+|+.. ++.||||+++.... .......+..|..++..+ +||||+++++++.+.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 34566789999999999999999999984 57899999874311 122345688899999988 699999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..+|+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999999874 679999999999999999999999999999999999999999999999999998643
Q ss_pred c-CCceecCCCcccccchhccccccC
Q 023285 260 Q-SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~-~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ........||+.|+|||++.+..|
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~ 519 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPY 519 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCB
T ss_pred cCCcccccccCCCcccCHhhhcCCCC
Confidence 3 333456689999999999987654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=250.92 Aligned_cols=177 Identities=27% Similarity=0.477 Sum_probs=145.7
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTR 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 178 (284)
+..++|++.+.||+|+||.||+|+. +++.||||+++.... .......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4466899999999999999999996 578999999864321 1112245667777777665 9999999999987
Q ss_pred CC-----cEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 179 PP-----NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 179 ~~-----~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
.. .+++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 48999999975 9999997753 34999999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCceecCCCcccccchhccccccC
Q 023285 253 GVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|+++............||+.|+|||++.+..|
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCC
Confidence 99987665555566789999999999977654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=255.69 Aligned_cols=172 Identities=28% Similarity=0.452 Sum_probs=145.9
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP- 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 180 (284)
.|++ .++|++.+.||+|+||.||+|.. +++.||||++..........+.+.+|+.++++++||||+++++++....
T Consensus 20 ~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 20 AWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp EECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred eeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 4444 46899999999999999999987 4789999999765555666778999999999999999999999998753
Q ss_pred -----cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 181 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
.+|+||||+ +++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7799999976 56899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
+.... ..+...+|+.|+|||++.+
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 176 RQADS--EMTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp EECCS--SCCSSCSCGGGCCTHHHHT
T ss_pred ccccc--ccCcCcCCCCcCCHHHHhC
Confidence 87543 2456689999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=254.61 Aligned_cols=173 Identities=28% Similarity=0.483 Sum_probs=149.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 178 (284)
.++|++.+.||+|+||.||+|+. +++.||||++............+.+|+.++++++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 47899999987654444445678899999999999999999999977
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.+.+|+||||+++ +|.+.+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 3468999999976 888888776678999999999999999999999999999999999999999999999999999865
Q ss_pred cc-----CCceecCCCcccccchhccccc
Q 023285 259 AQ-----SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~-----~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.. ........||+.|+|||++.+.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred cccccccccccCCcccccCccCchhhcCC
Confidence 42 2233456789999999998763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=245.37 Aligned_cols=176 Identities=31% Similarity=0.595 Sum_probs=152.2
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
+.|++..++|++.+.||+|+||.||+|...+ +.||||.++..... .+.+.+|+.++++++||||+++++++.. +.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 5689999999999999999999999999854 68999999765333 4578999999999999999999999875 56
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999999999999996532 2689999999999999999999999999999999999999999999999999987654
Q ss_pred CCce--ecCCCcccccchhccccc
Q 023285 261 SGVM--TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~~~~--~~~~gt~~y~aPEvl~~~ 282 (284)
.... ....+++.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~ 185 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYG 185 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHC
T ss_pred cccccccCCCCccCccChhhhccC
Confidence 3322 233567899999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=257.81 Aligned_cols=180 Identities=17% Similarity=0.288 Sum_probs=146.3
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHH---------HHHHHHHHHHHHhCCCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKIRHK 167 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~---------~~~~~~E~~~l~~l~h~ 167 (284)
..++..++|++.+.||+|+||.||+|.+. ++.||||++......... ...+.+|+..++.++||
T Consensus 29 i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp EECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred eeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 34466779999999999999999999873 368999998754211000 11244566677888999
Q ss_pred ceeeEEeEEEcC----CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-
Q 023285 168 NVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD- 242 (284)
Q Consensus 168 niv~~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~- 242 (284)
||+++++++... ...|+||||+ |++|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 999999998764 4589999999 8999999988667899999999999999999999999999999999999999
Q ss_pred -CCCcEEEecccceeeeccCCc--------eecCCCcccccchhccccccC
Q 023285 243 -ENGVVKVADFGVARVQAQSGV--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 243 -~~~~vkl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
.++.+||+|||+|+....... .....||+.|+|||++.+..|
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 238 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP 238 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC
Confidence 889999999999986543221 123459999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=246.86 Aligned_cols=178 Identities=28% Similarity=0.513 Sum_probs=148.9
Q ss_pred CeeeeccCCceeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 103 DVWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 103 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..+.++.++|++.+ .||+|+||.||+|.+ .++.||||+++.........+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34667888999998 999999999999965 247899999986654555677899999999999999999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.....++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 45678999999999999999977 46699999999999999999999999999999999999999999999999999987
Q ss_pred eccCCc----eecCCCcccccchhccccc
Q 023285 258 QAQSGV----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~~----~~~~~gt~~y~aPEvl~~~ 282 (284)
...... .....+|+.|+|||++.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred eccCCCcccccccCCCCceeeChHHhccC
Confidence 544322 1223567899999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.11 Aligned_cols=177 Identities=31% Similarity=0.567 Sum_probs=152.4
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
...+..++|++.+.||+|+||.||+|++ +++.||||+++.. ..+..+.+.+|+.++++++||||+++++++.
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 3456678899999999999999999985 4688999999754 4556678999999999999999999999987
Q ss_pred cCC--cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 178 RPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 178 ~~~--~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
... .+++||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999887677999999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCc----eecCCCcccccchhccccc
Q 023285 256 RVQAQSGV----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 256 ~~~~~~~~----~~~~~gt~~y~aPEvl~~~ 282 (284)
+....... .....++..|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred hhccccccccccccCCCCceeEECchhhcCC
Confidence 87654332 1234577889999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=256.20 Aligned_cols=175 Identities=21% Similarity=0.338 Sum_probs=151.3
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEcCC
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPP 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 180 (284)
...+....|++.+.||+|+||.||+|... ++.||||+++...........+.+|+.++++++ ||||+++++++..+.
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 45667778999999999999999999874 688999999876666777788999999999997 499999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||| +.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999999 5678999999874 5789999999999999999999999999999999999995 68999999999986543
Q ss_pred CC---ceecCCCcccccchhcccc
Q 023285 261 SG---VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~---~~~~~~gt~~y~aPEvl~~ 281 (284)
.. ......||+.|+|||++.+
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhh
Confidence 22 2345679999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=247.10 Aligned_cols=171 Identities=22% Similarity=0.382 Sum_probs=144.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|.+.++||+|+||.||++.. .+..||+|++..... ....+.+.+|+.++++++||||+++++++.+....|+|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999987 468999999875432 2235678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccC
Q 023285 188 FMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 188 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~ 261 (284)
|+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999998653 3679999999999999999999999999999999999999 45678999999999876555
Q ss_pred CceecCCCcccccchhcccc
Q 023285 262 GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~ 281 (284)
.......||+.|+|||++.+
T Consensus 181 ~~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ------CTTGGGCCHHHHTT
T ss_pred ccCcCcccccCcCChHHhcc
Confidence 45566789999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=245.90 Aligned_cols=177 Identities=21% Similarity=0.481 Sum_probs=145.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++.+.||+|+||.||+|.. +++.||||+++.... ..+....+.+|+.++++++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 34567899999999999999999988 478999999864311 112345789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999999764 568999999999999999999999999999999999999999999999999998765544
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......||+.|+|||++.+..
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp -----------CCTGGGTTSC
T ss_pred ceecccCCccccCHHHHcCCC
Confidence 445567999999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=253.22 Aligned_cols=173 Identities=24% Similarity=0.443 Sum_probs=140.6
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
..++|++.+.||+|+||.||+|.. +++.||||+++...........+.+|+.++++++||||+++++++..+..+|+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999987 578999999986655555567788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-----CCCcEEEecccceeeecc
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-----~~~~vkl~Dfg~a~~~~~ 260 (284)
|||+++ +|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 112 ~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999975 999999774 5699999999999999999999999999999999999994 555699999999976542
Q ss_pred C-CceecCCCcccccchhccccc
Q 023285 261 S-GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 ~-~~~~~~~gt~~y~aPEvl~~~ 282 (284)
. .......||+.|+|||++.+.
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~ 212 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGS 212 (329)
T ss_dssp ----------CCTTCCHHHHTTC
T ss_pred cccccCCCcCCccccCHHHhcCC
Confidence 2 233455789999999999764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=248.07 Aligned_cols=175 Identities=35% Similarity=0.631 Sum_probs=145.3
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-Cc
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PN 181 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~ 181 (284)
..|.++.++|++.+.||+|+||.||+|+..++.||||+++... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 4578889999999999999999999999999999999987542 356789999999999999999999997654 47
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 899999999999999997643 2388999999999999999999999999999999999999999999999999976543
Q ss_pred CCceecCCCcccccchhcccccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
. .....+++.|+|||++.+..
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~ 190 (278)
T 1byg_A 170 T--QDTGKLPVKWTAPEALREKK 190 (278)
T ss_dssp --------CCTTTSCHHHHHHCC
T ss_pred c--ccCCCccccccCHHHhCCCC
Confidence 3 23346789999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=243.19 Aligned_cols=174 Identities=24% Similarity=0.341 Sum_probs=153.4
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||++... ++.||+|++.... ......+.+.+|+.++++++||||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 457999999999999999999984 6889999986543 2345667899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++..... ...
T Consensus 94 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 94 LELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 999999999999876 367999999999999999999999999999999999999999999999999999875432 233
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~ 191 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKG 191 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSC
T ss_pred ccccCCCCcCCcchhccCC
Confidence 4567999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=246.63 Aligned_cols=175 Identities=25% Similarity=0.424 Sum_probs=135.8
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|+. +++.||||++...... .+..+.+.+|+.++++++||||+++++++......++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35799999999999999999987 5789999998633111 12246789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
|||+++++|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+....... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 99999999999998766789999999999999999999999999999999999999999999999999998654322 22
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~ 188 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSA 188 (278)
T ss_dssp -------------------
T ss_pred eeccCCCCcCCcchhcCCC
Confidence 3457899999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=246.21 Aligned_cols=174 Identities=18% Similarity=0.279 Sum_probs=151.3
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++.+.||+|+||.||+|.. +++.||||+++.... ...+.+|+.+++++ +|+|++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45577899999999999999999995 679999999864422 23578899999999 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc-----EEEecccceee
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARV 257 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~-----vkl~Dfg~a~~ 257 (284)
++||||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 88999999876667999999999999999999999999999999999999987776 99999999987
Q ss_pred eccCCc--------eecCCCcccccchhccccccC
Q 023285 258 QAQSGV--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... .....||+.|+|||++.+..|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 195 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 195 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCC
Confidence 554321 234579999999999987653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.87 Aligned_cols=167 Identities=35% Similarity=0.551 Sum_probs=149.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
+.|++.+.||+|+||.||+|+. +++.||||++...... .+..+.+.+|+.++++++||||+++++++..+...++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4689999999999999999986 5789999999755333 445678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+. |+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~ 209 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 209 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---Cc
Confidence 9997 5899998776778999999999999999999999999999999999999999999999999999865432 34
Q ss_pred CCCcccccchhccc
Q 023285 267 ETGTYRWMAPEVAF 280 (284)
Q Consensus 267 ~~gt~~y~aPEvl~ 280 (284)
..||+.|+|||++.
T Consensus 210 ~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 210 FVGTPYWMAPEVIL 223 (348)
T ss_dssp CCSCGGGCCHHHHH
T ss_pred ccCCcceeCHhhhc
Confidence 57999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=258.34 Aligned_cols=174 Identities=25% Similarity=0.396 Sum_probs=151.2
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC--cE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL 182 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 182 (284)
+..++|++.+.||+|+||.||+|.+. ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44668999999999999999999985 78999999975322 223567889999999999999999999998755 78
Q ss_pred EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli----~~~~~vkl~Dfg~a~ 256 (284)
|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999997643 238999999999999999999999999999999999999 777889999999998
Q ss_pred eeccCCceecCCCcccccchhcccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
............||+.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHH
T ss_pred EccCCCccccccCCccccCHHHhhc
Confidence 7766555556789999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=265.81 Aligned_cols=174 Identities=26% Similarity=0.446 Sum_probs=153.9
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+-.++|++.+.||+|+||.||+|.. +++.||||++...... ......+.+|+.++++++||||+++++++.....+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3356899999999999999999988 4789999998654322 334577999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeecc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~ 260 (284)
+||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999976 4679999999999999999999999999999999999999 5678999999999987665
Q ss_pred CCceecCCCcccccchhcccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~ 281 (284)
........||+.|+|||++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT
T ss_pred ccccccCCCCccccCceeecC
Confidence 555566689999999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=250.11 Aligned_cols=178 Identities=28% Similarity=0.414 Sum_probs=151.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
......++|++.+.||+|+||.||+|... ++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 34455679999999999999999999984 7899999997665566667788999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+||||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888887654 467999999999999999999999999999999999999999999999999999765432
Q ss_pred -CceecCCCcccccchhccccc
Q 023285 262 -GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 -~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.......||+.|+|||++.+.
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp ------CCCCCTTCCHHHHTTC
T ss_pred ccccCCCcCCccccCcccccCC
Confidence 233456799999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=247.17 Aligned_cols=183 Identities=26% Similarity=0.452 Sum_probs=147.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
...+.++.++|++.+.||+|+||.||+|... ++.||||+++.........+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3556788899999999999999999999763 24799999987666677778899999999999999999999999
Q ss_pred EcCC-----cEEEEEEcCCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 177 TRPP-----NLCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 177 ~~~~-----~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
.... ..++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 8755 359999999999999999532 356999999999999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+||+|||+++...... ......+++.|+|||++.+..|
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 9999999998654322 1233457889999999877543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-34 Score=254.39 Aligned_cols=177 Identities=27% Similarity=0.435 Sum_probs=154.5
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.++..++|++.+.||+|+||.||+|.+. ++.||+|+++.. ......+.+.+|+.++++++||||+++++++..+...
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3456778999999999999999999985 789999999765 3456677899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999999999764 5799999999999999999999996 9999999999999999999999999999754332
Q ss_pred CceecCCCcccccchhccccccC
Q 023285 262 GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|+|||++.+..|
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~ 207 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHY 207 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCC
T ss_pred -cccCCCCCCCeECHHHHcCCCC
Confidence 2345579999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=250.51 Aligned_cols=163 Identities=23% Similarity=0.366 Sum_probs=126.7
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
+.||+|+||.||+|... ++.||||++... ....+.+|+.+++++. ||||+++++++.++...|+||||+++|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 68999999999999984 689999998632 3456789999999997 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEecccceeeeccCC-ceecCC
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSG-VMTAET 268 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~Dfg~a~~~~~~~-~~~~~~ 268 (284)
+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999977 46799999999999999999999999999999999999998766 89999999998654332 334567
Q ss_pred CcccccchhccccccC
Q 023285 269 GTYRWMAPEVAFTFFF 284 (284)
Q Consensus 269 gt~~y~aPEvl~~~~y 284 (284)
||+.|+|||++.+..|
T Consensus 171 ~t~~y~aPE~~~~~~~ 186 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGY 186 (325)
T ss_dssp -------------CCC
T ss_pred CCcCccCHHHhcCCCC
Confidence 8999999999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=242.40 Aligned_cols=175 Identities=30% Similarity=0.507 Sum_probs=152.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----C
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----P 179 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~ 179 (284)
..+...|++.+.||+|+||.||+|... +..||+|+++.........+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 344567899999999999999999884 5789999998766667778889999999999999999999999865 3
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEec-CCCcEEEeccccee
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVAR 256 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~-~~~~vkl~Dfg~a~ 256 (284)
..+++||||+++++|.+++... +.+++..+..++.|++.||.|||++| |+||||||+||+++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 5589999999999999999764 67899999999999999999999999 99999999999997 78999999999997
Q ss_pred eeccCCceecCCCcccccchhccccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
..... ......||+.|+|||++.+.
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGTC
T ss_pred ccccc-ccccccCCcCcCCHHHHhcc
Confidence 55443 33456799999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=245.43 Aligned_cols=175 Identities=25% Similarity=0.426 Sum_probs=148.2
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
...++|++.+.||+|+||.||+|... ++.||+|++...... ......+.+|+.++++++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 45578999999999999999999884 578999998643211 122456889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 86 lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~ 163 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-R 163 (279)
T ss_dssp EEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-c
Confidence 999999999999999764 56999999999999999999999999999999999999999999999999998654433 2
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~ 183 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRM 183 (279)
T ss_dssp ----CCCCTTCCHHHHTTCC
T ss_pred ccccCCCCCccCHhHhccCC
Confidence 34567999999999988754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=248.27 Aligned_cols=171 Identities=35% Similarity=0.626 Sum_probs=142.6
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++.++|++.+.||+|+||.||+|++.++.||||.++.. ...+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 467789999999999999999999999999999998643 345679999999999999999999998874 47999
Q ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEecCCCc-EEEecccceeeec
Q 023285 186 TEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQ---NNIIHRDLKTANLLMDENGV-VKVADFGVARVQA 259 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~---~~iiH~Dikp~NIli~~~~~-vkl~Dfg~a~~~~ 259 (284)
|||+++++|.+++..... .++...+..++.|++.||+|||+ +||+||||||+||+++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976432 47889999999999999999999 89999999999999998886 7999999997554
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. .....||+.|+|||++.+..|
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCC
T ss_pred cc--cccCCCCCceEChhhhCCCCC
Confidence 32 334569999999999987643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=246.60 Aligned_cols=174 Identities=29% Similarity=0.554 Sum_probs=149.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP- 179 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 179 (284)
++.+.|++.+.||+|+||.||++.+ +++.||||+++.. ......+.+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 4444569999999999999998875 4688999999865 3456677899999999999999999999999874
Q ss_pred -CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 180 -PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 180 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 5789999999999999999663 4899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----eecCCCcccccchhcccccc
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
..... .....+|+.|+|||++.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 213 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYK 213 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred cccccccccccCCCCCceeeChHHhcCCC
Confidence 54332 23346788999999987653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.69 Aligned_cols=170 Identities=25% Similarity=0.468 Sum_probs=141.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||||+++... .......+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 5799999999999999999998 47899999997542 12222345679999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~~ 266 (284)
|+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 9975 999999887777999999999999999999999999999999999999999999999999999865432 23345
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..||+.|+|||++.+
T Consensus 160 ~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 160 EVVTLWYRPPDILLG 174 (324)
T ss_dssp ---CGGGCCHHHHTT
T ss_pred ccCcccccChhhhcC
Confidence 578999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=241.86 Aligned_cols=171 Identities=31% Similarity=0.602 Sum_probs=148.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHH--HH---HHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE--ML---KEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~--~~---~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+..++|++.+.||+|+||.||+|+. +++.||||++........ .. +.+.+|+.++++++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45677999999999999999999998 578999999865433221 11 679999999999999999999999976
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCc-----EEEec
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV-----VKVAD 251 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~-----vkl~D 251 (284)
.. ++||||+++|+|.+++......+++..+..++.|++.||+|||++| |+||||||+||+++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 55 7999999999999999877778999999999999999999999999 999999999999988776 99999
Q ss_pred ccceeeeccCCceecCCCcccccchhccc
Q 023285 252 FGVARVQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 252 fg~a~~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
||+++.... ......||+.|+|||++.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSS
T ss_pred CCccccccc--cccccCCCccccCchhhc
Confidence 999975443 345568999999999984
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=253.60 Aligned_cols=176 Identities=26% Similarity=0.533 Sum_probs=146.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+..++|++.+.||+|+||.||+|.+. ++. ||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 45678999999999999999999873 333 7888875432 22233567889999999999999999999864 6
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..++||||+.+|+|.+++...++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 68999999999999999987667899999999999999999999999999999999999999999999999999986543
Q ss_pred CC---ceecCCCcccccchhccccccC
Q 023285 261 SG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. ......+|+.|+|||++.+..|
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred ccccccccCCCCcccccChHHhccCCC
Confidence 32 2234567889999999986543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-34 Score=268.56 Aligned_cols=179 Identities=38% Similarity=0.685 Sum_probs=154.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|++..++|++.++||+|+||.||+|.+.+ ..||||+++..... .+.|.+|+.++++++||||+++++++.. .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 45799999999999999999999999999965 67999999865433 3578999999999999999999999876 6
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|+||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999753 3568999999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ceecCCCcccccchhccccccC
Q 023285 260 QSG--VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~--~~~~~~gt~~y~aPEvl~~~~y 284 (284)
... ......++..|+|||++.+..|
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred CCceecccCCcCcccccCHHHhccCCC
Confidence 321 1123356789999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.43 Aligned_cols=181 Identities=31% Similarity=0.583 Sum_probs=154.2
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|++..++|++.+.||+|+||.||+|.+ .++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 46788899999999999999999999985 24789999997543 455567899999999999 6899999999
Q ss_pred EEEcCC-cEEEEEEcCCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 175 ACTRPP-NLCIVTEFMARGSIYDFLHKQKGV---------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 175 ~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
++...+ .+++||||+++++|.+++...... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988755 499999999999999999875332 7899999999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
|+++.++.+||+|||+++....... .....+|+.|+|||++.+..|
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 9999999999999999986543221 223457889999999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=244.53 Aligned_cols=175 Identities=29% Similarity=0.480 Sum_probs=147.9
Q ss_pred cCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE-cCCcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~ 182 (284)
..+|++.+.||+|+||.||+|+..+ ..+|+|.++.. ......+.+.+|+.++++++||||+++++++. .+...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 3468999999999999999998632 35899998753 34556778999999999999999999999864 45678
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++||||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999999998766779999999999999999999999999999999999999999999999999998654322
Q ss_pred -----ceecCCCcccccchhccccccC
Q 023285 263 -----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......+|+.|+|||++.+..|
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKF 209 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCC
T ss_pred hhccccccCCCCCccccChHHhcCCCC
Confidence 2234467889999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=257.12 Aligned_cols=176 Identities=21% Similarity=0.360 Sum_probs=151.2
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhC-CCCceeeEEeEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 176 (284)
..+..++|++.+.||+|+||.||+++. +++.||||+++.... .......+.+|+.+++++ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 345567999999999999999999987 578999999864321 112234577899999999 699999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.....+++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999999999764 579999999999999999999999999999999999999999999999999998
Q ss_pred eeccCC--ceecCCCcccccchhcccc
Q 023285 257 VQAQSG--VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 257 ~~~~~~--~~~~~~gt~~y~aPEvl~~ 281 (284)
...... ......||+.|+|||++.+
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred ecccCCCCcccCcccCcCccChhhhcC
Confidence 653322 2334579999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=269.26 Aligned_cols=179 Identities=27% Similarity=0.485 Sum_probs=149.1
Q ss_pred eeeeccCCceeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+.+...++.+.+ .||+|+||.||+|.+. +..||||+++... .....+.|.+|+.++++++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4566777777777 8999999999999873 4579999997652 33346789999999999999999999999987
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+|+||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999999999999876677999999999999999999999999999999999999999999999999999865
Q ss_pred ccCCc----eecCCCcccccchhccccccC
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~y 284 (284)
..... .....+|+.|+|||++.+..|
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~ 516 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKF 516 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCC
Confidence 33221 122345689999999976554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=251.16 Aligned_cols=171 Identities=22% Similarity=0.422 Sum_probs=152.3
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC--CH----HHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCC
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV--NT----EMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~--~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 180 (284)
++|++.+.||+|+||.||+|... ++.||||+++.... .. +..+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 57999999999999999999984 78999999975532 11 2345688999999999 7999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
..|+||||++|++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999976 36799999999999999999999999999999999999999999999999999987766
Q ss_pred CCceecCCCcccccchhcccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~ 281 (284)
........||+.|+|||++.+
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHH
T ss_pred CcccccCCCCCCccChhhccc
Confidence 555566789999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=249.91 Aligned_cols=177 Identities=32% Similarity=0.539 Sum_probs=147.6
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 180 (284)
.++.++|++.+.||+|+||.||+|+. ++. .+|||.++.. ......+.+.+|+.+++++ +||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 46678999999999999999999987 344 4599998743 2344556799999999999 8999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~ 245 (284)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997643 4689999999999999999999999999999999999999999
Q ss_pred cEEEecccceeeeccCCceecCCCcccccchhcccccc
Q 023285 246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 246 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.+||+|||+++............+++.|+|||++.+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhcccc
Confidence 99999999998544333334456788999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=243.97 Aligned_cols=166 Identities=18% Similarity=0.373 Sum_probs=148.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEc--CCc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPN 181 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~ 181 (284)
...++|++.+.||+|+||.||+|.. +++.||||+++... .+.+.+|+.++++++ ||||+++++++.. ...
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3457899999999999999999987 57899999997432 356889999999997 9999999999988 667
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeecc
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~ 260 (284)
.++||||+.+++|.+++.. +++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 108 ~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999999998743 88999999999999999999999999999999999999776 899999999987766
Q ss_pred CCceecCCCcccccchhcccc
Q 023285 261 SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~ 281 (284)
........||+.|+|||++.+
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTT
T ss_pred CCccccccccccccChhhhcC
Confidence 555666789999999999876
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=247.91 Aligned_cols=179 Identities=19% Similarity=0.303 Sum_probs=151.9
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-- 177 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-- 177 (284)
...+.++.++|++.+.||+|+||.||++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 98 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRE 98 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEE
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEec
Confidence 356788899999999999999999999996 5789999998643 4556778999999999999999999999987
Q ss_pred --cCCcEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 178 --RPPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 178 --~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
.....++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 99 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~df 178 (317)
T 2buj_A 99 RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDL 178 (317)
T ss_dssp ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEec
Confidence 34578999999999999999976 3467999999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCc----------eecCCCcccccchhccccc
Q 023285 253 GVARVQAQSGV----------MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 253 g~a~~~~~~~~----------~~~~~gt~~y~aPEvl~~~ 282 (284)
|.++....... .....||+.|+|||++.+.
T Consensus 179 g~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 218 (317)
T 2buj_A 179 GSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ 218 (317)
T ss_dssp SSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC
T ss_pred CcchhcccccccccccccccccccccCCcccCCHhHhccC
Confidence 99875432110 1223579999999998753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=253.24 Aligned_cols=179 Identities=31% Similarity=0.480 Sum_probs=152.6
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
..++..++|++.+.||+|+||.||+|.. +++.||||+++.... ......+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 4556678999999999999999999987 478999999875432 12223689999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEecCCCcEEEeccccee
Q 023285 183 CIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~~i~~~L~~LH~~---~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999997643 3489999999999999999999999 99999999999999999999999999998
Q ss_pred eeccCC--ceecCCCcccccchhcccccc
Q 023285 257 VQAQSG--VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~--~~~~~~gt~~y~aPEvl~~~~ 283 (284)
...... ......||+.|+|||++.+..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSE
T ss_pred ccCcccccccccccCCcCccCHHHhccCC
Confidence 754332 233456999999999986643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=243.82 Aligned_cols=170 Identities=26% Similarity=0.465 Sum_probs=149.5
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 178 (284)
..+|++.+.||+|+||.||+|... ++.||+|+++... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 457999999999999999999984 7899999997542 356789999999999999999998854
Q ss_pred --------CCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEE
Q 023285 179 --------PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249 (284)
Q Consensus 179 --------~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl 249 (284)
...+++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 34589999999999999999764 357999999999999999999999999999999999999999999999
Q ss_pred ecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 250 ADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 250 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+|||+++............||+.|+|||++.+..|
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY 198 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCC
Confidence 99999987766555556679999999999877543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=243.82 Aligned_cols=171 Identities=33% Similarity=0.525 Sum_probs=148.9
Q ss_pred ceeeeeeeecCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEcC
Q 023285 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
|...+.||+|+||.||+|..+++.||||++.... ...+..+.+.+|+.++++++||||+++++++......++||||+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 4456899999999999999999999999986532 23455678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---e
Q 023285 190 ARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M 264 (284)
Q Consensus 190 ~~gsL~~~l~~~--~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~ 264 (284)
++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 999999999753 34689999999999999999999999999999999999999999999999999986543221 2
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
....||+.|+|||++.+.
T Consensus 193 ~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp SSCCSCGGGCCHHHHTTE
T ss_pred cccCCCcCcCChHHhcCC
Confidence 334789999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=270.06 Aligned_cols=179 Identities=28% Similarity=0.518 Sum_probs=149.2
Q ss_pred eeeeccCCceeee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
.+.++...+.+.. .||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.++++++||||+++++++..
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4566666777654 899999999999966 24789999998765556667889999999999999999999999975
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..+++||||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 442 -~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 442 -ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp -SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred -CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 468999999999999999976 467999999999999999999999999999999999999999999999999999865
Q ss_pred ccCC----ceecCCCcccccchhccccccC
Q 023285 259 AQSG----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... ..+...+|+.|+|||++.+..|
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~ 549 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKF 549 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCC
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCC
Confidence 4322 1233456789999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=251.08 Aligned_cols=173 Identities=29% Similarity=0.456 Sum_probs=144.6
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH---HHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
.++|++.+.||+|+||.||+|+.. ++.||||+++...... ...+.+.+|+.++++++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 468999999999999999999884 7899999987542221 22346889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-C
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~ 262 (284)
+||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999986 999999876677999999999999999999999999999999999999999999999999999865432 2
Q ss_pred ceecCCCcccccchhccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~ 282 (284)
......||+.|+|||++.+.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~ 187 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGA 187 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTC
T ss_pred cCCcccccccccCchHhhCC
Confidence 34456799999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=244.41 Aligned_cols=174 Identities=18% Similarity=0.303 Sum_probs=144.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... .....+.+.+|+.++++++||||+++++++..+...|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 56899999999999999999987 478999999875432 344567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--c
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--V 263 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~--~ 263 (284)
|||+++++|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 9999999999999764 679999999999999999999999999999999999999999999999999997654332 2
Q ss_pred eecCCCcccccchhcccccc
Q 023285 264 MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~ 283 (284)
.....||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~ 211 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESH 211 (309)
T ss_dssp -----CCGGGCCGGGTCC--
T ss_pred ccccCCCcCccCHHHHcCCC
Confidence 23457899999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=242.21 Aligned_cols=177 Identities=22% Similarity=0.429 Sum_probs=142.9
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
..++|++.+.||+|+||.||+|.. +++.||||+++... ........+.+|+.++++++||||+++++++......++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346899999999999999999987 57899999997543 345567789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 185 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999865 3466899999999999999999999999999999999999999999999999999765433
Q ss_pred C-ceecCCCcccccchhccccccC
Q 023285 262 G-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ......||+.|+|||++.+..|
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp ---------CCSSCCHHHHTTCCC
T ss_pred CccccccCCCeeEeChHHhCCCCC
Confidence 2 2234578999999999877543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=243.19 Aligned_cols=176 Identities=24% Similarity=0.425 Sum_probs=152.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.+..++|++.+.||+|+||.||+|... ++.||||++...... ......+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345678999999999999999999984 578999998643111 11245789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999999999764 57999999999999999999999999999999999999999999999999999765433
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......||+.|+|||++.+..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~ 188 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKT 188 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC
T ss_pred ccccccCCCCcCCHHHhccCC
Confidence 234567999999999988754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=246.45 Aligned_cols=168 Identities=32% Similarity=0.562 Sum_probs=142.3
Q ss_pred cCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC--CCCceeeEEeEEEcC----CcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRP----PNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~ 182 (284)
.++|++.+.||+|+||.||+|++.++.||||++... . ...+..|.+++... +||||+++++++... ...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 468999999999999999999999999999998632 1 23445566665554 899999999999877 679
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEecCCCcEEEecccc
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 999999999999999976 4689999999999999999999998 999999999999999999999999999
Q ss_pred eeeeccCCc-----eecCCCcccccchhcccccc
Q 023285 255 ARVQAQSGV-----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~~~-----~~~~~gt~~y~aPEvl~~~~ 283 (284)
++....... .....||+.|+|||++.+..
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 222 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhccccc
Confidence 976543221 12457999999999987653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-33 Score=240.98 Aligned_cols=171 Identities=24% Similarity=0.376 Sum_probs=152.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---C----HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---N----TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR 178 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 178 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 46899999999999999999998 468999999975431 1 233567889999999996 9999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+...++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||.+...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999999976 367999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCceecCCCcccccchhccc
Q 023285 259 AQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
..........||+.|+|||++.
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHH
T ss_pred CCCcccccccCCccccCHHHhc
Confidence 6555556678999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=249.16 Aligned_cols=171 Identities=31% Similarity=0.507 Sum_probs=140.6
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHH--HHhCCCCceeeEEeEEEc---
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI--MRKIRHKNVVQFIGACTR--- 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~--- 178 (284)
.+.++.++|++.+.||+|+||.||+|+.+++.||||+++.. ....+..|..+ +..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 34577889999999999999999999999999999998643 12334444444 456899999999986532
Q ss_pred --CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEecCCCcE
Q 023285 179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVV 247 (284)
Q Consensus 179 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------~iiH~Dikp~NIli~~~~~v 247 (284)
...+++||||+++|+|.+++... ..++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred CCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 23579999999999999999763 358899999999999999999999 99999999999999999999
Q ss_pred EEecccceeeeccCC---------ceecCCCcccccchhcccc
Q 023285 248 KVADFGVARVQAQSG---------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 248 kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPEvl~~ 281 (284)
||+|||+++...... ......||+.|+|||++.+
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 999999998654321 2234579999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=253.28 Aligned_cols=173 Identities=27% Similarity=0.473 Sum_probs=134.3
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP- 179 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 179 (284)
..|++. ++|++.+.||+|+||.||+|.. +++.||||++..........+.+.+|+.++++++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456664 6899999999999999999987 578999999976555566678899999999999999999999999764
Q ss_pred -----CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 180 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 180 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
..+|+|+|++ +++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 6799998865 5699999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
++..... .+...||+.|+|||++.+
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp --------------CCCTTCCHHHHTT
T ss_pred ccccccc--CCCcCcCcCccChHHHcC
Confidence 9865432 345689999999999876
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=259.08 Aligned_cols=171 Identities=23% Similarity=0.428 Sum_probs=137.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.++|.+.+.||+|+||.||+|.. +++.||||++..... .......+.+|+.++++++||||+++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 46899999999999999999988 468999999865321 11223358899999999999999999999865 4
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC---cEEEecccceee
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARV 257 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~---~vkl~Dfg~a~~ 257 (284)
.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999998865 46799999999999999999999999999999999999997544 599999999987
Q ss_pred eccCCceecCCCcccccchhcccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
...........||+.|+|||++.+
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp CC-----------CTTCCTTTTC-
T ss_pred cCCCccccccCCCCCccCceeeec
Confidence 665555566789999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=249.55 Aligned_cols=167 Identities=23% Similarity=0.416 Sum_probs=144.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... ...+|+.++.++ +||||+++++++.++..+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 45799999999999999999998 478999999975432 235688888888 799999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC----CcEEEecccceeeeccC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQS 261 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~----~~vkl~Dfg~a~~~~~~ 261 (284)
|||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.++ +.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 95 TELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp ECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999999976 4679999999999999999999999999999999999998533 35999999999875443
Q ss_pred -CceecCCCcccccchhccccc
Q 023285 262 -GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 -~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.......||+.|+|||++.+.
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHH
T ss_pred CCceeccCCCccccCHHHhcCC
Confidence 234456799999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=251.50 Aligned_cols=170 Identities=20% Similarity=0.329 Sum_probs=143.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-----
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----- 178 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 178 (284)
+...++|++.+.||+|+||.||+|.. +++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 45567899999999999999999987 578999999865421 23479999999999999999999843
Q ss_pred ---------------------------------CCcEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Q 023285 179 ---------------------------------PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMN 222 (284)
Q Consensus 179 ---------------------------------~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~ 222 (284)
...+++||||+++ +|.+.+.. ....+++..+..++.||+.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3348999999985 88877753 3567999999999999999999
Q ss_pred HHHhCCceecCCCCCCEEec-CCCcEEEecccceeeeccCCceecCCCcccccchhccccc
Q 023285 223 YLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 223 ~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
|||++||+||||||+||+++ .++.+||+|||+|+............||+.|+|||++.+.
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC
Confidence 99999999999999999998 6899999999999977665556677899999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=249.30 Aligned_cols=176 Identities=22% Similarity=0.369 Sum_probs=148.3
Q ss_pred cCCceee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEE
Q 023285 109 AKQLKIE-CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 184 (284)
.+.|.+. +.||+|+||.||+|... ++.||||+++...........+.+|+.+++++. ||||+++++++......|+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3467776 88999999999999884 789999999765444555678999999999996 6999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceeeecc
Q 023285 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQ 260 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~~~~ 260 (284)
||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998543 367999999999999999999999999999999999999987 78999999999987765
Q ss_pred CCceecCCCcccccchhccccccC
Q 023285 261 SGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
........||+.|+|||++.+..|
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~ 210 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPI 210 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCC
T ss_pred ccccccccCCcCccCCeeecCCCC
Confidence 545556689999999999987653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=242.87 Aligned_cols=170 Identities=28% Similarity=0.463 Sum_probs=143.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc---------
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--------- 178 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 178 (284)
++|++.+.||+|+||.||+|+. +++.||||+++. .....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4799999999999999999997 578999999864 34556789999999999999999999998864
Q ss_pred ----CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 179 ----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 179 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
....|+||||+++++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 3568999999999999999987666788899999999999999999999999999999999999999999999999
Q ss_pred eeeeccC---------------CceecCCCcccccchhccccc
Q 023285 255 ARVQAQS---------------GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 255 a~~~~~~---------------~~~~~~~gt~~y~aPEvl~~~ 282 (284)
+...... .......||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 9754321 122345689999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=244.27 Aligned_cols=174 Identities=32% Similarity=0.488 Sum_probs=147.3
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+...++|++.+.||+|+||.||+|... ++.||||+++... ....+.+|+.++++++||||+++++++.....+|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 445678999999999999999999984 7899999997542 2356889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+++++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999999999998666789999999999999999999999999999999999999999999999999998654432
Q ss_pred ceecCCCcccccchhcccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~ 283 (284)
......||+.|+|||++.+..
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~ 201 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIG 201 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSC
T ss_pred ccCccCCCCCccChhhcCCCC
Confidence 234557999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=241.38 Aligned_cols=173 Identities=32% Similarity=0.543 Sum_probs=152.3
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
..+.|++.+.||+|+||.||+|.. +++.||||+++.... ....+.+.+|+.++++++||||+++++++......|+|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 345799999999999999999987 478999999975532 33467799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~ 264 (284)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... ..
T Consensus 99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999999864 568999999999999999999999999999999999999999999999999998755432 23
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~ 195 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSA 195 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCC
T ss_pred CccCCCcCccCHHHHhcCC
Confidence 4557999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=245.16 Aligned_cols=176 Identities=28% Similarity=0.487 Sum_probs=138.3
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEE-
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACT- 177 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~- 177 (284)
...+++...+|++.+.||+|+||.||+|.+ +++.||||++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 357788889999999999999999999998 6789999998643 4556678999999999996 999999999994
Q ss_pred -------cCCcEEEEEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEecCCCc
Q 023285 178 -------RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV 246 (284)
Q Consensus 178 -------~~~~~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~~~~~ 246 (284)
....+++||||+. |+|.+++.. ..+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3445899999996 599999865 3467999999999999999999999999 999999999999999999
Q ss_pred EEEecccceeeeccCCce-------------ecCCCcccccchhccc
Q 023285 247 VKVADFGVARVQAQSGVM-------------TAETGTYRWMAPEVAF 280 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPEvl~ 280 (284)
+||+|||+++........ ....||+.|+|||++.
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 999999999865432211 1345899999999983
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=240.24 Aligned_cols=172 Identities=24% Similarity=0.413 Sum_probs=150.8
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.. +++.||||+++... ..+..+.+.+|+.++++++||||+++++++..+...|+|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 4799999999999999999988 47899999986543 23445779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---ce
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~ 264 (284)
|+++++|.+++.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||.+....... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999865 4579999999999999999999999999999999999999999999999999998654322 23
Q ss_pred ecCCCcccccchhcccccc
Q 023285 265 TAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~ 283 (284)
....||+.|+|||++.+..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~ 183 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRRE 183 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSS
T ss_pred cCCccccCccChHHHhcCC
Confidence 4557899999999997653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-34 Score=247.52 Aligned_cols=178 Identities=30% Similarity=0.528 Sum_probs=133.6
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..|.+..++|++.+.||+|+||.||+|.. +++.||||++.... .....+.+.+|+.++++++||||+++++++....
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 86 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD 86 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence 35778899999999999999999999986 57899999986542 2334567899999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccc
Q 023285 181 NLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg 253 (284)
..++||||+++++|.+++.. ..+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 99999999999999999974 24568999999999999999999999999999999999999999999999999
Q ss_pred ceeeeccCC------ceecCCCcccccchhcccc
Q 023285 254 VARVQAQSG------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 254 ~a~~~~~~~------~~~~~~gt~~y~aPEvl~~ 281 (284)
.+....... ......||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 987543221 1234468999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=243.99 Aligned_cols=172 Identities=26% Similarity=0.472 Sum_probs=148.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+++. +++.||+|+++... ......+.+|+.++++++||||+++++++.....+|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 35799999999999999999998 47899999997542 223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+++..... .
T Consensus 86 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 86 QLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I 163 (304)
T ss_dssp CCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred EcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence 999999999999764 578999999999999999999999999999999999999 78899999999999754432 2
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSC
T ss_pred cccccCCCCccChHHhccCCC
Confidence 334568999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-33 Score=248.87 Aligned_cols=173 Identities=23% Similarity=0.376 Sum_probs=140.3
Q ss_pred ccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCC---------CHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV---------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..++|++.+.||+|+||.||+|.. .++.||||++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 356899999999999999999987 478999999864322 2334578999999999999999999999984
Q ss_pred c-----CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 178 R-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 178 ~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
. ...+|+||||++ |+|.+++...+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 346899999997 5999999876678999999999999999999999999999999999999999999999999
Q ss_pred cceeeeccCCceecCCCcccccchhcccc
Q 023285 253 GVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
|+++............||+.|+|||++.+
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TC---------------CGGGCCHHHHTT
T ss_pred CcccccccccccceecccceecCcHHhcC
Confidence 99986655555566789999999999876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=239.83 Aligned_cols=173 Identities=29% Similarity=0.514 Sum_probs=148.3
Q ss_pred CceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE-EE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL-CI 184 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~l 184 (284)
.|++.+.||+|+||.||+|.+. + ..||+|+++.. ......+.+.+|+.++++++||||+++++++...... ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4667799999999999999862 2 36999998753 3455677899999999999999999999999876665 99
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC---
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS--- 261 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~--- 261 (284)
||||+.+++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 99999999999999876678999999999999999999999999999999999999999999999999999754322
Q ss_pred --CceecCCCcccccchhccccccC
Q 023285 262 --GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 --~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.......+|+.|+|||++.+..|
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~ 205 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRF 205 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCC
T ss_pred ccccCcCCCCCccccChhhhccCCC
Confidence 12234467899999999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=246.05 Aligned_cols=179 Identities=29% Similarity=0.495 Sum_probs=149.8
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
..++..++|++.+.||+|+||.||+|++ .++.||||++... ........+.+|+.++++++||||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 4567888999999999999999999984 3468999999643 3455667899999999999999999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcE
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVV 247 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~v 247 (284)
......|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++. +..+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998753 35889999999999999999999999999999999999984 4469
Q ss_pred EEecccceeeeccCC---ceecCCCcccccchhcccccc
Q 023285 248 KVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 248 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+|||+++...... ......+|+.|+|||++.+..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 221 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCC
Confidence 999999997543222 123346789999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=246.30 Aligned_cols=177 Identities=28% Similarity=0.542 Sum_probs=144.8
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
.+..++|++.+.||+|+||.||+|.+. ++. ||+|.++... .....+.+.+|+.++++++||||+++++++..+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 456789999999999999999999873 443 5777775432 334457799999999999999999999999875
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
. .++|+|++.+|+|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 889999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred cCCc---eecCCCcccccchhccccccC
Q 023285 260 QSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .....+|+.|+|||++.+..|
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCC
Confidence 3221 223456889999999887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=253.32 Aligned_cols=174 Identities=29% Similarity=0.484 Sum_probs=139.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 183 (284)
..|++.+.||+|+||.||+|++. + ..||||.++.. ......+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35788999999999999999863 2 36899998753 344567889999999999999999999998754 45789
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~- 262 (284)
+||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999999998766778999999999999999999999999999999999999999999999999998643321
Q ss_pred ----ceecCCCcccccchhccccccC
Q 023285 263 ----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......+|+.|+|||++.+..|
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~ 273 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKF 273 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCC
T ss_pred ccccccCCCCCcccccChHHhcCCCC
Confidence 1233457889999999877653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=242.36 Aligned_cols=175 Identities=25% Similarity=0.398 Sum_probs=150.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--cCCcEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 184 (284)
.++|++.+.||+|+||.||+|.. +++.||+|+++.........+.+.+|+.++++++||||+++++++. ....+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45899999999999999999998 4789999999876666777788999999999999999999999874 3567999
Q ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEecCCCcEEEeccccee
Q 023285 185 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~~i~~~L~~LH~~~-----iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||||+++++|.+++... ...+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999763 245899999999999999999999999 9999999999999999999999999997
Q ss_pred eeccCCc-eecCCCcccccchhcccccc
Q 023285 257 VQAQSGV-MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 257 ~~~~~~~-~~~~~gt~~y~aPEvl~~~~ 283 (284)
....... .....||+.|+|||++.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMS 192 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-
T ss_pred eeccccccccccCCCccccChHHhccCC
Confidence 6543321 22346899999999987754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=253.40 Aligned_cols=178 Identities=35% Similarity=0.655 Sum_probs=152.3
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
...|++..++|++.+.||+|+||.||+|.+.+ .+|+|+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35788999999999999999999999999865 59999997654444445668899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~- 260 (284)
+++||||+++++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999999987666799999999999999999999999999999999999998 68999999999875421
Q ss_pred -----CCceecCCCcccccchhcccc
Q 023285 261 -----SGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 261 -----~~~~~~~~gt~~y~aPEvl~~ 281 (284)
........||+.|+|||++.+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccCCCcccccChHHhhh
Confidence 112234468999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=250.45 Aligned_cols=173 Identities=27% Similarity=0.433 Sum_probs=143.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
.++|++.+.||+|+||.||+|.. +++.||+|+++... ......+.+.+|+.++++++||||+++++++.+....|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 45899999999999999999988 46789999986431 13345678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 023285 184 IVTEFMARGSIYDFLHKQ---------------------------------------KGVFQLTSLLKVAIDVSKGMNYL 224 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~L~~L 224 (284)
+||||++||+|.+++... ...+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 11235677889999999999999
Q ss_pred HhCCceecCCCCCCEEecCCC--cEEEecccceeeeccCC-----ceecCCCcccccchhcccc
Q 023285 225 HQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 225 H~~~iiH~Dikp~NIli~~~~--~vkl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPEvl~~ 281 (284)
|++||+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 999999999999999998776 89999999998653321 2345679999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.47 Aligned_cols=167 Identities=29% Similarity=0.584 Sum_probs=147.8
Q ss_pred cCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--CCCCceeeEEeEEEcCC----cE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTRPP----NL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~ 182 (284)
.++|++.+.||+|+||.||+|+++++.||||+++.. ....+.+|.++++. ++||||+++++++.... ..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 468999999999999999999999999999998642 24567889999887 78999999999998876 79
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH--------~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
|+||||+++|+|.+++.+ ..+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999999999999976 45899999999999999999999 89999999999999999999999999999
Q ss_pred eeeeccCCc-----eecCCCcccccchhccccc
Q 023285 255 ARVQAQSGV-----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 255 a~~~~~~~~-----~~~~~gt~~y~aPEvl~~~ 282 (284)
++....... .....||+.|+|||++.+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred ceeccccccccccccccCCcCcccCCHhhhccc
Confidence 987654432 2445799999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=244.37 Aligned_cols=170 Identities=26% Similarity=0.404 Sum_probs=141.9
Q ss_pred cCCceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEE
Q 023285 109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 184 (284)
.+.|++. +.||+|+||.||+|.. +++.||||+++... ......+.+|+.+++++ +||||+++++++..+..+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3478885 7899999999999986 57899999997542 23356789999999985 79999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEecccceeeeccC
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS 261 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~---vkl~Dfg~a~~~~~~ 261 (284)
||||+++++|.+++... +.+++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999774 57899999999999999999999999999999999999998776 999999998754321
Q ss_pred C--------ceecCCCcccccchhcccc
Q 023285 262 G--------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~--------~~~~~~gt~~y~aPEvl~~ 281 (284)
. ......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp --------------CCSGGGCCHHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhc
Confidence 1 1223469999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=247.63 Aligned_cols=172 Identities=28% Similarity=0.489 Sum_probs=147.6
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..|++. ++|.+.+.||+|+||.||+|.. +++.||||+++...........+.+|+.++++++||||+++++++....
T Consensus 36 ~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 36 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred ceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 456664 6999999999999999999987 4789999999876656667788999999999999999999999998876
Q ss_pred cE------EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 181 NL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 181 ~~------~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
.. |+||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred CcccceeEEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 54 99999997 48888773 4499999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
++..... .....||+.|+|||++.+
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSC
T ss_pred ccccccC--cCCcccCccccCHHHhcC
Confidence 9865432 345678999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=246.28 Aligned_cols=170 Identities=24% Similarity=0.416 Sum_probs=143.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... .......+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35799999999999999999988 468999999875422 1123345889999999999999999999997754
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEecccceee
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV 257 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~---vkl~Dfg~a~~ 257 (284)
+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||+++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999999999999965 467999999999999999999999999999999999999987664 99999999987
Q ss_pred eccCCceecCCCcccccchhccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
...........||+.|+|||++.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHH
T ss_pred cccccccccccCCcCccCchhhc
Confidence 65543344557999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=243.02 Aligned_cols=170 Identities=29% Similarity=0.490 Sum_probs=144.8
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||+|+||.||+|... ++.||+|++... .......+.+|+.++++++||||+++++++..+...++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 468999999999999999999984 789999998754 2334567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ....
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999999999999876678999999999999999999999999999999999999999999999999997643211 1223
Q ss_pred cCCCcccccchhccc
Q 023285 266 AETGTYRWMAPEVAF 280 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~ 280 (284)
...||+.|+|||++.
T Consensus 176 ~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVM 190 (302)
T ss_dssp ---CCGGGCCHHHHH
T ss_pred cccCChhhcCCeeec
Confidence 457899999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=265.10 Aligned_cols=180 Identities=30% Similarity=0.510 Sum_probs=152.5
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
..+++..++|++.+.||+|+||.||+|.+. +..||||.++.. ......+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 457788899999999999999999999873 256999998753 24556678999999999999999999999985
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
+ +..|+||||+++|+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 568999999999999999987666799999999999999999999999999999999999999999999999999986
Q ss_pred eccCCc--eecCCCcccccchhccccccC
Q 023285 258 QAQSGV--MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~--~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... .....+|+.|+|||++.+..|
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCC
Confidence 544322 223456789999999876543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=254.56 Aligned_cols=170 Identities=14% Similarity=0.188 Sum_probs=140.9
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHH---HHHHhCCCCceeeEE-------e
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEV---YIMRKIRHKNVVQFI-------G 174 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~ 174 (284)
..++|++.+.||+|+||.||+|+. +++.||||+++... ......+.+.+|+ +++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 456899999999999999999986 47899999997442 2344567899999 555566799999998 6
Q ss_pred EEEcCC-----------------cEEEEEEcCCCCCHHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHHhCCce
Q 023285 175 ACTRPP-----------------NLCIVTEFMARGSIYDFLHKQKGVFQL-------TSLLKVAIDVSKGMNYLHQNNII 230 (284)
Q Consensus 175 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~~~~~-------~~~~~i~~~i~~~L~~LH~~~ii 230 (284)
++..++ ..|+||||+ +|+|.+++... +.+++ ..+..++.||+.||+|||++||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 666553 289999999 57999999764 23444 77888999999999999999999
Q ss_pred ecCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhccccc
Q 023285 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 231 H~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhccc
Confidence 999999999999999999999999986433 3455677 999999998765
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=244.00 Aligned_cols=177 Identities=30% Similarity=0.453 Sum_probs=134.8
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCceeeEEeEEEc
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~ 178 (284)
...|.+..++|++.+.||+|+||.||+|... ++.||||+++... .......+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4678899999999999999999999999985 7899999997653 3444455666665 7788899999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEeccc
Q 023285 179 PPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFG 253 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg 253 (284)
++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999986 88888753 246789999999999999999999999 99999999999999999999999999
Q ss_pred ceeeeccCCceecCCCcccccchhccc
Q 023285 254 VARVQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 254 ~a~~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
+++............||+.|+|||++.
T Consensus 172 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 172 ISGQLVDSIAKTRDAGCRPYMAPERID 198 (327)
T ss_dssp SSCC-----------------------
T ss_pred CceecccccccccCCCCccccCceeec
Confidence 998765544445557999999999983
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=241.55 Aligned_cols=178 Identities=35% Similarity=0.607 Sum_probs=142.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC---C--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC---S--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~--~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..+..++|++.+.||+|+||.||+|++. + ..||||+++.... ..+..+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4567789999999999999999999862 2 2689999876533 34566789999999999999999999999987
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+. .++||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 64 89999999999999999876677999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCc----eecCCCcccccchhcccccc
Q 023285 259 AQSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
..... .....+|+.|+|||++.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred cccccchhhhccCCCCceeeCchhhcCCC
Confidence 44322 12345788999999987643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-33 Score=240.70 Aligned_cols=173 Identities=28% Similarity=0.506 Sum_probs=151.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|+. +++.||||+++...........+.+|+.++++++||||+++++++......++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 46899999999999999999998 4789999999755444445677999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC---CcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~---~~vkl~Dfg~a~~~~~~~~ 263 (284)
||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 999999999998764 579999999999999999999999999999999999999754 4799999999986654444
Q ss_pred eecCCCcccccchhccccc
Q 023285 264 MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~ 282 (284)
.....||+.|+|||++.+.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC
T ss_pred cccccCcccccChHHhcCC
Confidence 4455689999999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=244.24 Aligned_cols=175 Identities=27% Similarity=0.491 Sum_probs=147.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC---CCCceeeEEeEEE-----
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT----- 177 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~----- 177 (284)
.++|++.+.||+|+||.||+|.. .++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46899999999999999999987 357899999865433222233466777777766 8999999999987
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 5567999999998 59999998753 458999999999999999999999999999999999999999999999999998
Q ss_pred eeccCCceecCCCcccccchhccccccC
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
............||+.|+|||++.+..|
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 196 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSY 196 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCC
T ss_pred cccCCCCccccccccceeCHHHHhcCCC
Confidence 7655444556789999999999877543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=252.33 Aligned_cols=170 Identities=11% Similarity=0.129 Sum_probs=130.1
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhC--CCCceeeEE-------eEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI--RHKNVVQFI-------GAC 176 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 176 (284)
..+|++.+.||+|+||.||+|++ +++.||||+++..... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34699999999999999999997 4789999999876442 34556678885554444 699988755 444
Q ss_pred EcC-----------------CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecC
Q 023285 177 TRP-----------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL------LKVAIDVSKGMNYLHQNNIIHRD 233 (284)
Q Consensus 177 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~~i~~~L~~LH~~~iiH~D 233 (284)
..+ ..+|+||||++ |+|.+++...+..+....+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 433 33899999998 7999999875445566666 78889999999999999999999
Q ss_pred CCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhcccc
Q 023285 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 234 ikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
|||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccC
Confidence 9999999999999999999999865432 225567799999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-32 Score=244.22 Aligned_cols=170 Identities=25% Similarity=0.443 Sum_probs=147.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-----Cc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 181 (284)
..+|++.+.||+|+||.||+|.. +++.||||++... ......+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35899999999999999999987 4688999999753 2455667899999999999999999999999765 36
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+||||+.+ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 8999999975 99999976 46999999999999999999999999999999999999999999999999999875433
Q ss_pred Cc----eecCCCcccccchhccccc
Q 023285 262 GV----MTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~----~~~~~gt~~y~aPEvl~~~ 282 (284)
.. .....||+.|+|||++.+.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred CCccccccccccccCCCCCHHhcCC
Confidence 22 2345799999999987543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=250.49 Aligned_cols=175 Identities=25% Similarity=0.420 Sum_probs=153.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCH---------------HHHHHHHHHHHHHHhCCCCceee
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT---------------EMLKEFSQEVYIMRKIRHKNVVQ 171 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~ 171 (284)
+..++|++.+.||+|+||.||+|..+++.||||++....... .....+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 446799999999999999999999999999999986431111 11277999999999999999999
Q ss_pred EEeEEEcCCcEEEEEEcCCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecC
Q 023285 172 FIGACTRPPNLCIVTEFMARGSIYDF------LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDE 243 (284)
Q Consensus 172 ~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~ 243 (284)
+++++......|+||||+++++|.++ +... ...+++..+..++.|++.||.|||+ +||+||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5442 4679999999999999999999999 99999999999999999
Q ss_pred CCcEEEecccceeeeccCCceecCCCcccccchhccccc
Q 023285 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 244 ~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
++.+||+|||.+...... ......||+.|+|||++.+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSC
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCC
Confidence 999999999999876443 44566899999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=247.03 Aligned_cols=178 Identities=20% Similarity=0.288 Sum_probs=142.8
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHH---------HHHHHHHHHHHHHhCCCCcee
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTE---------MLKEFSQEVYIMRKIRHKNVV 170 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv 170 (284)
.++..++|++.+.||+|+||.||+|... +..||||++........ ....+.+|+..++.++||||+
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 4456789999999999999999999983 47899999875422110 112367888999999999999
Q ss_pred eEEeEEEc----CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-
Q 023285 171 QFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG- 245 (284)
Q Consensus 171 ~~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~- 245 (284)
++++++.. ....|+||||+ +++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 99999987 67899999999 88999999764 4799999999999999999999999999999999999999887
Q ss_pred -cEEEecccceeeeccCC--------ceecCCCcccccchhccccccC
Q 023285 246 -VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 246 -~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.+||+|||+|+...... ......||+.|+|||++.+..|
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 237 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL 237 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC
Confidence 99999999998653321 1134579999999999987643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-32 Score=249.34 Aligned_cols=172 Identities=27% Similarity=0.449 Sum_probs=149.1
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC------CCCceeeEEeEEEc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI------RHKNVVQFIGACTR 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~ 178 (284)
....+|++.+.||+|+||.||+|... ++.||||+++.. ....+.+.+|+.+++.+ .|+||+++++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 34568999999999999999999874 689999999753 44556788899998887 46799999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc--EEEecccce
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVA 255 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~--vkl~Dfg~a 255 (284)
...+|+||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999996 59999997753 45999999999999999999999999999999999999999887 999999999
Q ss_pred eeeccCCceecCCCcccccchhccccccC
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+..... .....||+.|+|||++.+..|
T Consensus 250 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 276 (429)
T 3kvw_A 250 CYEHQR--VYTYIQSRFYRAPEVILGARY 276 (429)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHHTBCC
T ss_pred eecCCc--ccccCCCCCccChHHHhCCCC
Confidence 765432 345689999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-32 Score=236.60 Aligned_cols=176 Identities=27% Similarity=0.481 Sum_probs=149.2
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.+.+...++.....||+|+||.||+|.. +++.||||.++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 4556667777778999999999999997 4688999998754 33445779999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeee
Q 023285 182 LCIVTEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQ 258 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~ 258 (284)
.++||||+++++|.+++....+ .+++..+..++.|++.||+|||++||+|+||||+||+++. ++.+||+|||.++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999987533 4668889999999999999999999999999999999987 899999999999865
Q ss_pred ccCC-ceecCCCcccccchhcccc
Q 023285 259 AQSG-VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 259 ~~~~-~~~~~~gt~~y~aPEvl~~ 281 (284)
.... ......||+.|+|||++.+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHH
T ss_pred CCCCCcccccCCCccccChhhhcC
Confidence 4322 2345579999999999865
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=251.09 Aligned_cols=167 Identities=25% Similarity=0.383 Sum_probs=140.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC------C
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 180 (284)
..+|++.+.||+|+||.||+|++ +++.||||++.... +.+.+|+.++++++||||+++++++... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 34799999999999999999998 47899999986432 1234799999999999999999988532 2
Q ss_pred cEEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-CcEEEeccccee
Q 023285 181 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVAR 256 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-~~vkl~Dfg~a~ 256 (284)
.+++||||+++ +|.+.+.. ....+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 37799999976 77776643 35679999999999999999999999999999999999999955 678999999999
Q ss_pred eeccCCceecCCCcccccchhccccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
............||+.|+|||++.+.
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTC
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCC
Confidence 76555555567899999999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-32 Score=241.27 Aligned_cols=171 Identities=33% Similarity=0.547 Sum_probs=143.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEc-----
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----- 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----- 178 (284)
...++|++.+.||+|+||.||+|+. +++.||||++..... ....+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 4567899999999999999999998 678999999875432 235788999999999 79999999999976
Q ss_pred -CCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEeccccee
Q 023285 179 -PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 179 -~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
...+++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence 467999999999999999998743 568999999999999999999999999999999999999999999999999987
Q ss_pred eeccC-CceecCCCcccccchhccc
Q 023285 257 VQAQS-GVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 257 ~~~~~-~~~~~~~gt~~y~aPEvl~ 280 (284)
..... .......||+.|+|||++.
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp -------------CCGGGCCHHHHC
T ss_pred ecCcCccccccccCCccccChhhhc
Confidence 65432 2234457999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-32 Score=238.71 Aligned_cols=172 Identities=26% Similarity=0.452 Sum_probs=149.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc------eeeEEeEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACT 177 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~ 177 (284)
+-.++|++.+.||+|+||.||+|.. .++.||||+++.. ......+.+|+.+++.++|++ ++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 4467999999999999999999986 4689999999743 455677899999999998765 999999999
Q ss_pred cCCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-------------
Q 023285 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE------------- 243 (284)
Q Consensus 178 ~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~------------- 243 (284)
.....|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 789999997753 36899999999999999999999999999999999999987
Q ss_pred ------CCcEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 244 ------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 244 ------~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
++.+||+|||+++..... .....||+.|+|||++.+..|
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 211 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGW 211 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCC
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCC
Confidence 668999999999865432 345679999999999987653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=247.54 Aligned_cols=171 Identities=19% Similarity=0.271 Sum_probs=145.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC----------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceee----
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC----------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ---- 171 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---- 171 (284)
....++|++.+.||+|+||.||+|+.. ++.||||+++.. ..+.+|+.++++++||||++
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~ 110 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKK 110 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhh
Confidence 344689999999999999999999874 578999998743 35889999999999999887
Q ss_pred -----------EEeEEEc-CCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 172 -----------FIGACTR-PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 172 -----------~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
+++++.. +...|+||||+ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 6777765 67899999999 89999999874 3679999999999999999999999999999999999
Q ss_pred EEecCCC--cEEEecccceeeeccCC--------ceecCCCcccccchhccccccC
Q 023285 239 LLMDENG--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 239 Ili~~~~--~vkl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
||++.++ .+||+|||+++...... ......||+.|+|||++.+..|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 9999998 99999999997654321 1234479999999999987643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-32 Score=234.43 Aligned_cols=171 Identities=27% Similarity=0.408 Sum_probs=145.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE-EcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|+. +++.||||++...... ..+.+|+.+++.++|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999996 5789999998754322 3588999999999988766655555 566778999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999 889999998766789999999999999999999999999999999999999 488999999999998755432
Q ss_pred c--------eecCCCcccccchhccccccC
Q 023285 263 V--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
. .....||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCC
T ss_pred cccccccccccccccccccCChhhhcCCCC
Confidence 2 234579999999999987643
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=236.85 Aligned_cols=171 Identities=27% Similarity=0.402 Sum_probs=142.7
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE-EcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|+. +++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 35899999999999999999996 578999998764322 23588899999999988776666655 667778999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 889999998766789999999999999999999999999999999999999 789999999999998754432
Q ss_pred c--------eecCCCcccccchhccccccC
Q 023285 263 V--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
. .....||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCC
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCC
Confidence 1 234579999999999987653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-32 Score=246.29 Aligned_cols=172 Identities=24% Similarity=0.378 Sum_probs=147.0
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--------CCceeeEEeEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--------HKNVVQFIGAC 176 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~ 176 (284)
+-.++|++.++||+|+||.||+|+. +++.||||+++. .......+.+|+.++++++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3357899999999999999999987 468999999974 3455677899999999996 78899999998
Q ss_pred E----cCCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCC-----
Q 023285 177 T----RPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG----- 245 (284)
Q Consensus 177 ~----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~----- 245 (284)
. ....+|+||||+ +++|.+++... .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 566799999999 55777776554 36799999999999999999999998 999999999999999775
Q ss_pred --------------------------------------------cEEEecccceeeeccCCceecCCCcccccchhcccc
Q 023285 246 --------------------------------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 246 --------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.+||+|||.|+..... .+...||+.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHT
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcC
Confidence 7999999999876543 345679999999999987
Q ss_pred ccC
Q 023285 282 FFF 284 (284)
Q Consensus 282 ~~y 284 (284)
..|
T Consensus 268 ~~~ 270 (397)
T 1wak_A 268 SGY 270 (397)
T ss_dssp SCC
T ss_pred CCC
Confidence 654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-32 Score=248.49 Aligned_cols=168 Identities=27% Similarity=0.395 Sum_probs=140.3
Q ss_pred ccCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc-----
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----- 181 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 181 (284)
...+|++.+.||+|+||.||+|+. .+..||+|.+..... ...+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 345799999999999999999998 446689988754321 12369999999999999999999955433
Q ss_pred -EEEEEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEeccccee
Q 023285 182 -LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR 256 (284)
Q Consensus 182 -~~lV~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg~a~ 256 (284)
+++||||+++ ++.+.+. .....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8899999987 4444433 2356799999999999999999999999999999999999999 79999999999999
Q ss_pred eeccCCceecCCCcccccchhccccc
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
............||+.|+|||++.+.
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGA 216 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTC
T ss_pred cccCCCCCcccccCcCccCHHHHcCC
Confidence 87655556677899999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-32 Score=240.16 Aligned_cols=169 Identities=26% Similarity=0.421 Sum_probs=145.3
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC-----Cc
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 181 (284)
.++|++.+.||+|+||.||+|+.. ++.||||+++.. ........+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 468999999999999999999985 789999999753 2455567789999999999999999999988764 67
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.|+||||+. ++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 999999997 499999976 46899999999999999999999999999999999999999999999999999865432
Q ss_pred C-----------ceecCCCcccccchhcccc
Q 023285 262 G-----------VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 262 ~-----------~~~~~~gt~~y~aPEvl~~ 281 (284)
. ......||+.|+|||++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHS
T ss_pred cccccCccccccchhhccccccccCCeeecc
Confidence 1 1223468999999998764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=238.66 Aligned_cols=177 Identities=22% Similarity=0.386 Sum_probs=137.9
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..+.+..++|++.+.||+|+||.||+|.. +++.||||+++.........+.+.++..+++.++||||+++++++..+.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 46778888999999999999999999998 4789999999765443444455666667888999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..++||||+ ++.+..+.....+.+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 5567666665567899999999999999999999995 99999999999999999999999999998665
Q ss_pred cCCceecCCCcccccchhccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~ 280 (284)
.........||+.|+|||++.
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERID 197 (318)
T ss_dssp ----------CCTTCCHHHHC
T ss_pred CCccccccCCCccccChhhcc
Confidence 544445567999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.8e-32 Score=236.86 Aligned_cols=176 Identities=22% Similarity=0.344 Sum_probs=149.8
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEcC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP 179 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 179 (284)
....+..++|++.+.||+|+||.||++... ++.||||++............+.+|+.++++++ |+||+++++++..+
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 456788889999999999999999999874 688999999876666777788999999999998 49999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
...|+||| +.+++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++ ++.+||+|||+++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 99999999 557799999977 46789999999999999999999999999999999999996 5899999999998654
Q ss_pred cCC---ceecCCCcccccchhcccc
Q 023285 260 QSG---VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 260 ~~~---~~~~~~gt~~y~aPEvl~~ 281 (284)
... ......||+.|+|||++.+
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp ------------CCGGGCCHHHHTT
T ss_pred CccccccccCCCCCCCcCCHHHHhh
Confidence 322 1234578999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=250.72 Aligned_cols=174 Identities=25% Similarity=0.410 Sum_probs=142.9
Q ss_pred CCeeeeccCCceeeeeeeecCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP 179 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 179 (284)
...+.+...+|.+.+.||+|+||. +|++..+++.||||++..... ..+.+|+.+++++ +||||+++++++.+.
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 346778888999999999999998 566777899999999975432 2356899999999 799999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-----CcEEEecccc
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGV 254 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-----~~vkl~Dfg~ 254 (284)
...|+||||+. |+|.+++........+..+..++.||+.||+|||++||+||||||+|||++.+ ..+||+|||+
T Consensus 91 ~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 99999999996 49999998766666777788999999999999999999999999999999532 3688999999
Q ss_pred eeeeccC----CceecCCCcccccchhcccc
Q 023285 255 ARVQAQS----GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 255 a~~~~~~----~~~~~~~gt~~y~aPEvl~~ 281 (284)
|+..... .......||+.|+|||++.+
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSC
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 9865432 12344579999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=241.00 Aligned_cols=178 Identities=22% Similarity=0.321 Sum_probs=142.3
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhC----CCCceeeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKI----RHKNVVQFI 173 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~~~ 173 (284)
..+.-.++|++.+.||+|+||.||+|.. +++.||||+++...... .....+.+|+.+++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3445567899999999999999999987 56899999997543322 1234467899999999 899999999
Q ss_pred eEEEcCCcEEEEEEc-CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEec
Q 023285 174 GACTRPPNLCIVTEF-MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD 251 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~D 251 (284)
+++......++|||+ +.+++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+||+++ .++.+||+|
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 999999999999999 788999999977 35799999999999999999999999999999999999999 889999999
Q ss_pred ccceeeeccCCceecCCCcccccchhcccccc
Q 023285 252 FGVARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 252 fg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
||+++..... ......||+.|+|||++.+..
T Consensus 184 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 214 (312)
T 2iwi_A 184 FGSGALLHDE-PYTDFDGTRVYSPPEWISRHQ 214 (312)
T ss_dssp CSSCEECCSS-CBCCCCSCTTTSCHHHHHHSC
T ss_pred cchhhhcccC-cccccCCcccccCceeeecCC
Confidence 9999876543 345567999999999987543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=261.15 Aligned_cols=162 Identities=12% Similarity=0.130 Sum_probs=126.5
Q ss_pred eeeecCceEEEEEE--ECCceEEEEEecCCCC----C----HHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEE
Q 023285 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECV----N----TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~----~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV 185 (284)
..+.|+.|....++ +.++.+++|++..... . ....++|.+|+++|+++ .|+||+++++++.++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667776666543 3689999999965421 1 23456799999999999 699999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Cce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~ 264 (284)
|||++|++|.+++.. .+.++.. +|+.||+.||+|+|++|||||||||+|||++.+|++||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999976 4666654 58899999999999999999999999999999999999999999865443 234
Q ss_pred ecCCCcccccchhccccc
Q 023285 265 TAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~ 282 (284)
+..+||+.|||||++.+.
T Consensus 397 ~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp HHHHHHHHHHHHHHC---
T ss_pred cCceechhhccHHHhCCC
Confidence 456799999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=242.14 Aligned_cols=171 Identities=28% Similarity=0.489 Sum_probs=145.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
.|++ .++|.+.+.||+|+||.||+|.. +++.||||++..........+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~l-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 19 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccc-CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 4555 35899999999999999999987 47899999997665566667889999999999999999999999987654
Q ss_pred ------EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 182 ------~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
+|+||||+. ++|.+++. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred cccceeEEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 48887763 35899999999999999999999999999999999999999999999999999
Q ss_pred eeeccCCceecCCCcccccchhcccc
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
+..... .....||+.|+|||++.+
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TC----------CCSBCCSCHHHHSC
T ss_pred cCCCCC--ccccccCcCcCCHHHHhC
Confidence 765432 345578999999999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.4e-32 Score=236.47 Aligned_cols=172 Identities=24% Similarity=0.425 Sum_probs=144.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--cCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 183 (284)
++|++.+.||+|+||.||++.. +++.||+|+++.... .......+.+|+.++++++||||+++++++. .....|
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 5899999999999999999988 468999999864321 1234567999999999999999999999984 456799
Q ss_pred EEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc--
Q 023285 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-- 260 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-- 260 (284)
+||||++++ |.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+.....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999875 77777653 45799999999999999999999999999999999999999999999999999986542
Q ss_pred -CCceecCCCcccccchhccccc
Q 023285 261 -SGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 261 -~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
........||+.|+|||++.+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCC
T ss_pred cccccccCCCCCCCcChhhccCc
Confidence 2223455799999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-31 Score=235.13 Aligned_cols=168 Identities=25% Similarity=0.438 Sum_probs=138.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE---------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--------- 177 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--------- 177 (284)
.++|++.+.||+|+||.||+|... ++.||||++... +....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 568999999999999999999985 789999998754 4566788999999999999999999999874
Q ss_pred -----cCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEec
Q 023285 178 -----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD 251 (284)
Q Consensus 178 -----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~D 251 (284)
.....|+||||++ |+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++ +++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999997 599999964 5689999999999999999999999999999999999997 567999999
Q ss_pred ccceeeeccC----CceecCCCcccccchhcccc
Q 023285 252 FGVARVQAQS----GVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 252 fg~a~~~~~~----~~~~~~~gt~~y~aPEvl~~ 281 (284)
||+++..... .......+|+.|+|||++.+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcC
Confidence 9999865322 12234467999999998865
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.8e-32 Score=262.16 Aligned_cols=168 Identities=21% Similarity=0.274 Sum_probs=144.8
Q ss_pred eccCCceeeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc--
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-- 181 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 181 (284)
+-.++|++.+.||+|+||.||+|.+ +++.||||++... ...+....+.+|+.++++++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 4457999999999999999999987 3689999998653 245566789999999999999999999999987665
Q ss_pred ---EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 182 ---LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 182 ---~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.|+||||++|++|.+++.. .+++..+..++.||+.||+|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999988743 68999999999999999999999999999999999999875 9999999999876
Q ss_pred ccCCceecCCCcccccchhccccc
Q 023285 259 AQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
... ....||+.|+|||++.+.
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHC
T ss_pred ccC---CccCCCccccCHHHHcCC
Confidence 543 455799999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=241.01 Aligned_cols=178 Identities=24% Similarity=0.376 Sum_probs=150.7
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCC--CCceeeEEeE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGA 175 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~ 175 (284)
..+.-.++|++.+.||+|+||.||+|.. +++.||||+++...... .....+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445577899999999999999999987 57899999997543221 12245778999999996 5999999999
Q ss_pred EEcCCcEEEEEEcCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec-CCCcEEEeccc
Q 023285 176 CTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFG 253 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~-~~~~vkl~Dfg 253 (284)
+..+...++|||++.+ ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++ +++.+||+|||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999999986 899999976 46799999999999999999999999999999999999999 78999999999
Q ss_pred ceeeeccCCceecCCCcccccchhcccccc
Q 023285 254 VARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 254 ~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
+++..... ......||+.|+|||++.+..
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 224 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHR 224 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHHSC
T ss_pred cccccccc-cccCCCCCccCCChHHhccCC
Confidence 99876543 344567999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=247.49 Aligned_cols=171 Identities=23% Similarity=0.361 Sum_probs=146.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.++||+|+||.||+|.+ +++.||||+++..... ..+.+|+.+++.++| ++++.+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 56899999999999999999997 4789999998654322 347889999999987 5666777777788889999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe---cCCCcEEEecccceeeeccCC
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 889999998767789999999999999999999999999999999999999 688999999999998765432
Q ss_pred c--------eecCCCcccccchhccccccC
Q 023285 263 V--------MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~--------~~~~~gt~~y~aPEvl~~~~y 284 (284)
. .....||+.|+|||++.+..|
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQ 190 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred cccccccccccccCCCccccCHHHhcCCCC
Confidence 2 125579999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=247.12 Aligned_cols=167 Identities=25% Similarity=0.477 Sum_probs=128.6
Q ss_pred Ccee-eeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE--cCCcEE
Q 023285 111 QLKI-ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLC 183 (284)
Q Consensus 111 ~~~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 183 (284)
.|.+ .++||+|+||.||+|++. ++.||||+++..... ..+.+|+.++++++||||+++++++. ....+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 4555 457999999999999964 578999999755333 35788999999999999999999995 467899
Q ss_pred EEEEcCCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----cCCCcEEEec
Q 023285 184 IVTEFMARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVAD 251 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli----~~~~~vkl~D 251 (284)
+||||+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 888888632 1248999999999999999999999999999999999999 6788999999
Q ss_pred ccceeeeccC----CceecCCCcccccchhccccc
Q 023285 252 FGVARVQAQS----GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 252 fg~a~~~~~~----~~~~~~~gt~~y~aPEvl~~~ 282 (284)
||+|+..... .......||+.|+|||++.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCC
Confidence 9999865432 223445789999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=234.90 Aligned_cols=171 Identities=23% Similarity=0.435 Sum_probs=147.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc------eeeEEeEEEc
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACTR 178 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~ 178 (284)
-.++|++.+.||+|+||.||+|... + +.||||+++. .......+.+|+.++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3679999999999999999999873 3 6899999974 3455677889999999998766 9999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEe----------------
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---------------- 241 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli---------------- 241 (284)
...+|+||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 567878776643 579999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 242 ---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 242 ---~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+.++.+||+|||+++..... .....||+.|+|||++.+..|
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 216 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGW 216 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCC
T ss_pred ccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCC
Confidence 56789999999999865432 345689999999999987643
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=239.92 Aligned_cols=173 Identities=22% Similarity=0.305 Sum_probs=134.7
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc--
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-- 181 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 181 (284)
....++|++.+.||+|+||.||+|+.. ++.||||++..... ....+.+|+..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR---FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT---CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc---ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 344578999999999999999999984 78999998864322 22356778888899999999999999865433
Q ss_pred -----EEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEecC-CCcEEEe
Q 023285 182 -----LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMDE-NGVVKVA 250 (284)
Q Consensus 182 -----~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH--~~~iiH~Dikp~NIli~~-~~~vkl~ 250 (284)
+++||||+++ +|.+.+.. ....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999987 66555442 3567899999999999999999999 999999999999999996 8999999
Q ss_pred cccceeeeccCCceecCCCcccccchhccccc
Q 023285 251 DFGVARVQAQSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 251 Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
|||+++............||+.|+|||++.+.
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCC
Confidence 99999877666555667899999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.46 Aligned_cols=170 Identities=25% Similarity=0.405 Sum_probs=146.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CC-----ceeeEEeEEEcCC
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HK-----NVVQFIGACTRPP 180 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~ 180 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++. .......+..|+.+++.++ |+ +|+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 57899999999999999999987 468899999974 3455677888999998886 44 4999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEec--CCCcEEEecccce
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMD--ENGVVKVADFGVA 255 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH--~~~iiH~Dikp~NIli~--~~~~vkl~Dfg~a 255 (284)
..|+||||+++ +|.+++.... +.+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|||+|
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999999965 9999998754 56899999999999999999999 57999999999999995 4788999999999
Q ss_pred eeeccCCceecCCCcccccchhccccccC
Q 023285 256 RVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
+..... .....||+.|+|||++.+..|
T Consensus 209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~ 235 (382)
T 2vx3_A 209 CQLGQR--IYQYIQSRFYRSPEVLLGMPY 235 (382)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHTTCCC
T ss_pred eecccc--cccccCCccccChHHHcCCCC
Confidence 876432 345689999999999987654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=237.26 Aligned_cols=173 Identities=18% Similarity=0.345 Sum_probs=147.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----------CCceeeE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQF 172 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~ 172 (284)
.+..++|++.+.||+|+||.||+|.. +++.||||+++. .......+.+|+.++++++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45677999999999999999999997 578999999974 3445567889999999887 7899999
Q ss_pred EeEEEcCC----cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEec----
Q 023285 173 IGACTRPP----NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMD---- 242 (284)
Q Consensus 173 ~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~-~iiH~Dikp~NIli~---- 242 (284)
++++.... .+++|||++ +++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987644 789999999 78999999874 35699999999999999999999998 999999999999995
Q ss_pred --CCCcEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 243 --ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 243 --~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
..+.+||+|||+++..... .....||+.|+|||++.+..|
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC
T ss_pred CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCC
Confidence 3448999999999876543 345579999999999987654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=233.63 Aligned_cols=168 Identities=22% Similarity=0.325 Sum_probs=121.6
Q ss_pred cCCceeee-eeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----CCc
Q 023285 109 AKQLKIEC-KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPN 181 (284)
Q Consensus 109 ~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 181 (284)
.++|.+.+ .||+|+||.||+|... ++.||||++... .... .+....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 45788855 6999999999999985 789999998643 2222 223334667799999999999876 445
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~ 257 (284)
+++||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 899999999999999998753 46999999999999999999999999999999999999976 45699999999986
Q ss_pred eccCCceecCCCcccccchhcccccc
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.... ......||+.|+|||++.+..
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~ 205 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPEK 205 (336)
T ss_dssp C-----------------------CH
T ss_pred cccc-ccccCCCCcCccChhhhCCCC
Confidence 5543 334567899999999986643
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=256.30 Aligned_cols=174 Identities=25% Similarity=0.399 Sum_probs=150.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc------CCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 181 (284)
++|++.+.||+|+||.||+|.. +++.||||+++.. ........+.+|+.++++++||||+++++++.. ...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999987 5789999998754 356667789999999999999999999998765 667
Q ss_pred EEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc---EEEeccccee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVAR 256 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~---vkl~Dfg~a~ 256 (284)
.|+||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||.++
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997643 26899999999999999999999999999999999999997765 9999999998
Q ss_pred eeccCCceecCCCcccccchhccccccC
Q 023285 257 VQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
............||+.|+|||++.+..|
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 200 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKY 200 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCC
T ss_pred ccccccccccccCCcccCChHHhccCCC
Confidence 7766555566789999999999987654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=239.83 Aligned_cols=166 Identities=23% Similarity=0.352 Sum_probs=130.2
Q ss_pred CCceeeeeeeecCceEEE-EEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLY-KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy-~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lV~e 187 (284)
+.|.+.+.||+|+||+|| .+..+++.||||++... ..+.+.+|+.+++++ +||||+++++++.++..+|+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 356667899999999996 44557899999998643 234678899999886 89999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC-------------CcEE
Q 023285 188 FMARGSIYDFLHKQKGV------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-------------GVVK 248 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~------~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~-------------~~vk 248 (284)
|+. |+|.+++...... .++..+..++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 996 5999999764221 1233457899999999999999999999999999999754 4899
Q ss_pred EecccceeeeccCCc-----eecCCCcccccchhcccc
Q 023285 249 VADFGVARVQAQSGV-----MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 249 l~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPEvl~~ 281 (284)
|+|||+|+....... .....||+.|+|||++.+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 999999987654321 234579999999999975
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-31 Score=247.17 Aligned_cols=158 Identities=19% Similarity=0.216 Sum_probs=125.8
Q ss_pred eeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
...+.||+|+||.||+|+..++.+++|.......... ..+++.+|++++++++||||+++..++......|+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3467899999999999988999999998755433211 2455899999999999999996655555667789999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--- 263 (284)
||++|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 99999999999865 5689999999999999999999999999999998 999999999997654321
Q ss_pred -----eecCCCcccccchhcccc
Q 023285 264 -----MTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 264 -----~~~~~gt~~y~aPEvl~~ 281 (284)
.....||+.|||||++.+
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHH
T ss_pred chhhhhhhhcCCCCcCCHHHHHH
Confidence 134579999999999976
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=215.10 Aligned_cols=146 Identities=12% Similarity=0.160 Sum_probs=131.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
+-.++|++.+.||+|+||.||+|... ++.||||+++.... ..+..+.+.+|+.++++++||||+++++++..++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999985 78999999986544 3556688999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccce
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a 255 (284)
+||||++|++|.+++.. + .....+.+++.|++.||+|||++||+||||||+|||++.+|.+||+++|..
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999954 2 466678999999999999999999999999999999999999999987764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=229.21 Aligned_cols=169 Identities=16% Similarity=0.196 Sum_probs=129.2
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCC-Cce--------------
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNV-------------- 169 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~ni-------------- 169 (284)
....|++.+.||+|+||.||+|++. ++.||||+++.... .....+.+.+|+.+++.++| +|.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3446889999999999999999985 89999999874322 22335779999999999987 221
Q ss_pred -------eeEEeEEEc-----CCcEEEEEEcCCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 023285 170 -------VQFIGACTR-----PPNLCIVTEFMARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231 (284)
Q Consensus 170 -------v~~~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~------~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH 231 (284)
..+..++.. ...++++|+++ +++|.+++.. ....+++..+..++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111111 23478888877 5699999852 2345778889999999999999999999999
Q ss_pred cCCCCCCEEecCCCcEEEecccceeeeccCCceecCCCcccccchhccc
Q 023285 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAF 280 (284)
Q Consensus 232 ~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~ 280 (284)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++.
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhh
Confidence 999999999999999999999999865443 445577 9999999983
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=209.64 Aligned_cols=143 Identities=24% Similarity=0.406 Sum_probs=126.1
Q ss_pred CCceee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHH-HhCCCCceeeEEeEEEc----CCc
Q 023285 110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTR----PPN 181 (284)
Q Consensus 110 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~ 181 (284)
++|.+. +.||+|+||.||+|.. +++.||||+++.. ..+.+|+.++ +..+||||+++++++.. ...
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 467776 7899999999999988 5789999998642 3567888887 66689999999999876 677
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~ 257 (284)
+++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999999998753 46999999999999999999999999999999999999997 78999999999976
Q ss_pred ec
Q 023285 258 QA 259 (284)
Q Consensus 258 ~~ 259 (284)
..
T Consensus 170 ~~ 171 (299)
T 3m2w_A 170 TT 171 (299)
T ss_dssp CT
T ss_pred cc
Confidence 54
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=206.79 Aligned_cols=147 Identities=14% Similarity=0.116 Sum_probs=117.6
Q ss_pred CCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCH----------------HHHHHHHHHHHHHHhCCCCceeeE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------EMLKEFSQEVYIMRKIRHKNVVQF 172 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~h~niv~~ 172 (284)
..|.+.+.||+|+||.||+|.+ +++.||||+++...... .....+.+|+.++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3566779999999999999998 47899999997542211 24567999999999999 4 556
Q ss_pred EeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecc
Q 023285 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (284)
Q Consensus 173 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Df 252 (284)
.+++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 655544 45699999999999987 42 123457999999999999999999999999999999 999999999
Q ss_pred cceeeeccCCceecCCCcccccchhcccc
Q 023285 253 GVARVQAQSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
|+|+. +..++|||++.+
T Consensus 237 G~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILER 253 (282)
T ss_dssp TTCEE------------TTSTTHHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHHH
Confidence 99973 335688888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.6e-24 Score=181.47 Aligned_cols=140 Identities=14% Similarity=0.204 Sum_probs=109.8
Q ss_pred CceeeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhC
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI 164 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 164 (284)
-|.+.+.||+|+||.||+|.. +++. ||||+++...... .....+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999988 7888 9999986542110 1123688999999999
Q ss_pred CCCce--eeEEeEEEcCCcEEEEEEcCCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCC
Q 023285 165 RHKNV--VQFIGACTRPPNLCIVTEFMAR-G----SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 236 (284)
Q Consensus 165 ~h~ni--v~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~iiH~Dikp 236 (284)
.|+++ +.+++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88754 444443 356899999942 3 77776432 235567899999999999999 99999999999
Q ss_pred CCEEecCCCcEEEecccceeeecc
Q 023285 237 ANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 237 ~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
+|||++. .++|+|||+|.....
T Consensus 200 ~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp TSEEESS--SEEECCCTTCEETTS
T ss_pred HHEEEcC--cEEEEECcccccCCC
Confidence 9999988 999999999986543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.2e-20 Score=163.94 Aligned_cols=138 Identities=13% Similarity=0.147 Sum_probs=101.2
Q ss_pred CceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC---------------HHH-----HHHHHHHHHHHHhCCCCce
Q 023285 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN---------------TEM-----LKEFSQEVYIMRKIRHKNV 169 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---------------~~~-----~~~~~~E~~~l~~l~h~ni 169 (284)
-|++..+||+|++|.||+|.. .|+.||||+++..... ... .-...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999987 5789999998643110 000 0112456777777755443
Q ss_pred --eeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC--
Q 023285 170 --VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-- 245 (284)
Q Consensus 170 --v~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-- 245 (284)
+..++. . ..++||||++|++|.++. ..+....++.|++.+|.+||++|||||||||.|||++++|
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 223322 1 237999999998875432 1233467889999999999999999999999999998877
Q ss_pred --------cEEEecccceeeec
Q 023285 246 --------VVKVADFGVARVQA 259 (284)
Q Consensus 246 --------~vkl~Dfg~a~~~~ 259 (284)
.+.|+||+.+-...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEETT
T ss_pred ccccccccceEEEEeCCcccCC
Confidence 38999999886543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=9.1e-15 Score=124.88 Aligned_cols=140 Identities=12% Similarity=0.050 Sum_probs=112.9
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcC
Q 023285 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
.|++...++.|+.+.||+....++.+++|+...... .....+.+|+.+++.+. +..++++++++...+..|+|||++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 578888889899999999988789999999864211 11235888999999985 677889999999888999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------- 226 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------- 226 (284)
+|.+|.+.+. +......++.+++.+|..||+
T Consensus 93 ~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 93 DGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred CCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 9999887531 122234778899999999998
Q ss_pred ----------------CCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 227 ----------------NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 227 ----------------~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
..++|+|++|.||++++++.+.|+||+.+...
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 45899999999999987666679999998654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=4.4e-13 Score=113.62 Aligned_cols=134 Identities=11% Similarity=0.108 Sum_probs=99.2
Q ss_pred ceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc--eeeEEeEEEcCCcEEEEEEc
Q 023285 112 LKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lV~e~ 188 (284)
+.+....+.|..+.||+.... ++.+++|+..... ...+.+|+.+++.+.+.+ +++++++...++..++||||
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 444433345666999998764 5779999976431 235788999999886544 56789988888889999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---------------------------------------- 228 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~---------------------------------------- 228 (284)
++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998873 211 12 2356677777788887643
Q ss_pred ------------------ceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 229 ------------------IIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 229 ------------------iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
++|+|++|.||++++++.+.|+||+.+...+
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999877667799999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=116.61 Aligned_cols=140 Identities=13% Similarity=0.201 Sum_probs=107.5
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEec--CCCCCHHHHHHHHHHHHHHHhCC--CCceeeEEeEEEcC---CcEEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP---PNLCIVTE 187 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lV~e 187 (284)
.+.++.|.++.+|+.+..+..+++|+.. +... ......+.+|..+++.+. +..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4568899999999998888899999875 3321 122346888999999997 45688999998876 44899999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ----------------------------------------- 226 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~----------------------------------------- 226 (284)
|++|..+.+.. ...++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99997774311 2346788888999999999999997
Q ss_pred -----------------CCceecCCCCCCEEecCCCc--EEEecccceeee
Q 023285 227 -----------------NNIIHRDLKTANLLMDENGV--VKVADFGVARVQ 258 (284)
Q Consensus 227 -----------------~~iiH~Dikp~NIli~~~~~--vkl~Dfg~a~~~ 258 (284)
..++|+|++|.||+++.++. +.|+||+.+...
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997653 699999999754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=2.1e-09 Score=93.53 Aligned_cols=133 Identities=18% Similarity=0.213 Sum_probs=99.5
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCc--eeeEEeEEEcCC---cEEEEEEcCC
Q 023285 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKN--VVQFIGACTRPP---NLCIVTEFMA 190 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lV~e~~~ 190 (284)
.++.|.+..||+.. ..+++|+-.. ......+.+|..+++.+. +.. ++.++....... ..|+|||+++
T Consensus 27 ~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred ecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 48899999999864 6799998542 345567899999999884 332 455655544433 3488999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 023285 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-------------------------------------------- 226 (284)
Q Consensus 191 ~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-------------------------------------------- 226 (284)
|.+|.+... ..++..+...++.+++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 988765332 236777777888888888888885
Q ss_pred --------------CCceecCCCCCCEEecC--CCcEEEecccceeeec
Q 023285 227 --------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQA 259 (284)
Q Consensus 227 --------------~~iiH~Dikp~NIli~~--~~~vkl~Dfg~a~~~~ 259 (284)
..++|+|++|.||++++ ++.+.|+||+.+...+
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 13799999999999998 5568899999987654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.97 E-value=2.4e-08 Score=87.11 Aligned_cols=134 Identities=16% Similarity=0.143 Sum_probs=95.0
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC---ceeeEEeEEE-cCCcEEEEEEcCCC
Q 023285 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACT-RPPNLCIVTEFMAR 191 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lV~e~~~~ 191 (284)
+.++.|....||+. +..+++|+-. .......+.+|..+++.+.+. .+++.+.++. ..+..++|||+++|
T Consensus 25 ~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788888899987 6789999843 344567799999999999752 3677777774 44567899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 023285 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-------------------------------------------- 227 (284)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------------------- 227 (284)
.++.+... ..++......++.++...|..||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88765321 1234444444555555555544432
Q ss_pred ----------------CceecCCCCCCEEecC---CCc-EEEecccceeeec
Q 023285 228 ----------------NIIHRDLKTANLLMDE---NGV-VKVADFGVARVQA 259 (284)
Q Consensus 228 ----------------~iiH~Dikp~NIli~~---~~~-vkl~Dfg~a~~~~ 259 (284)
.++|+|++|.||+++. ++. +.|+||+.+...+
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 4599999999999987 455 5899999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=4.6e-08 Score=83.31 Aligned_cols=133 Identities=16% Similarity=0.210 Sum_probs=95.8
Q ss_pred eeeecCce-EEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYG-DLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.+..|..| .||+... .+..+++|+-... ....+.+|...|+.+. +-.++++++++.+.+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34556655 5888655 3568999986532 3456888999999885 344788999999889999999999998
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------------------------------------------- 227 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------- 227 (284)
++.+..... ......++.++...|..||+.
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765331 122234455555555555531
Q ss_pred -------------CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 228 -------------NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 228 -------------~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.++|+|+.+.||+++.++.+-|+||+.+...+
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 26899999999999987777899999987543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=3.8e-08 Score=87.36 Aligned_cols=80 Identities=11% Similarity=0.012 Sum_probs=55.0
Q ss_pred eeee-eecCceEEEEEEEC--------CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCC---CceeeEEeEEEcC--
Q 023285 115 ECKV-ASGSYGDLYKGTYC--------SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP-- 179 (284)
Q Consensus 115 ~~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~-- 179 (284)
.+.| +.|....+|+.... ++.+++|+-.+... .......+.+|+.+++.+.. -.+++++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 78888999988765 67899998654210 00001346788888888853 3577888887665
Q ss_pred -CcEEEEEEcCCCCCH
Q 023285 180 -PNLCIVTEFMARGSI 194 (284)
Q Consensus 180 -~~~~lV~e~~~~gsL 194 (284)
+..++|||+++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.1e-07 Score=79.16 Aligned_cols=137 Identities=16% Similarity=0.157 Sum_probs=80.9
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEe------EEEcCCcEEEEEE
Q 023285 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIG------ACTRPPNLCIVTE 187 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lV~e 187 (284)
+.|+.|..+.+|+....+..+++|+.... . ..+..|..+++.+.. -.+++++. +....+..++||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 35666778899998887777999998752 2 233445566555532 13344443 1223567899999
Q ss_pred cCCCCCHH--------------HHHHhcCCCC-------------CHHH-------------------------------
Q 023285 188 FMARGSIY--------------DFLHKQKGVF-------------QLTS------------------------------- 209 (284)
Q Consensus 188 ~~~~gsL~--------------~~l~~~~~~~-------------~~~~------------------------------- 209 (284)
|++|.++. .-++.....+ .+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986431 1122211101 1110
Q ss_pred HHHHHHHHHHHHHHHH-------------hCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 210 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 210 ~~~i~~~i~~~L~~LH-------------~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+..+...+..++++|+ ..+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 0111122334566665 358999999999999988889999999998643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=4e-07 Score=82.03 Aligned_cols=76 Identities=11% Similarity=0.004 Sum_probs=49.8
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCC--CH---HHHHHHHHHHHHHHhCCC--C-ceeeEEeEEEcCCcEEE
Q 023285 115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIRH--K-NVVQFIGACTRPPNLCI 184 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~---~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 184 (284)
.+.+|.|.++.||+++. .++.++||...+... .. ....++..|..+++.+.. + .+++++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 35689999999999954 468899998754321 00 112456778888887742 3 455666543 345689
Q ss_pred EEEcCCCC
Q 023285 185 VTEFMARG 192 (284)
Q Consensus 185 V~e~~~~g 192 (284)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.25 E-value=6.5e-06 Score=71.89 Aligned_cols=75 Identities=16% Similarity=0.136 Sum_probs=61.1
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC---CCceeeEEeEEEcCCcEEEEEEcCCC
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lV~e~~~~ 191 (284)
.+.|+.|....+|+....+..+++|+.... ....+..|...|+.+. ...+++++.++...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456889999999998877889999986532 2456888999998885 36788999998888889999999998
Q ss_pred CCH
Q 023285 192 GSI 194 (284)
Q Consensus 192 gsL 194 (284)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.23 E-value=9.8e-06 Score=73.57 Aligned_cols=75 Identities=12% Similarity=0.035 Sum_probs=46.8
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCC--CHH-----HHHHHHHHHHHHH-hCCCCceeeEEeEEEcCCcEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--NTE-----MLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~-----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.+|.|....||+....++.++||...+... ... ....+..|+..+. ......+++++.+. .+..++||
T Consensus 39 i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 34578899999999987778899995432110 110 1223344443332 22335677777766 46678999
Q ss_pred EcC-CC
Q 023285 187 EFM-AR 191 (284)
Q Consensus 187 e~~-~~ 191 (284)
|++ +|
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.10 E-value=1.4e-05 Score=69.16 Aligned_cols=135 Identities=16% Similarity=0.209 Sum_probs=76.3
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEEcC-CCC
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFM-ARG 192 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~-~~g 192 (284)
.+.|+.|....+|+. ..+++|+..... .......+|..+++.+...++ +++++.+ ...-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 567888999999998 679999876431 111123568888877753222 5666543 33457899999 664
Q ss_pred CHHH------------------HHHhcCCCC----CH-HHHHHHHH--------------HHHHHHHH----HH----hC
Q 023285 193 SIYD------------------FLHKQKGVF----QL-TSLLKVAI--------------DVSKGMNY----LH----QN 227 (284)
Q Consensus 193 sL~~------------------~l~~~~~~~----~~-~~~~~i~~--------------~i~~~L~~----LH----~~ 227 (284)
++.. -++.....+ .. ..+..+.. .+...+.. +. ..
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 3321 111111111 11 11111110 11111111 11 12
Q ss_pred CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 228 ~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.++|+|+.|.||+ ..++.+.++||..+...+
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence 4899999999999 567788999999887543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=98.03 E-value=2e-05 Score=69.08 Aligned_cols=136 Identities=13% Similarity=0.126 Sum_probs=74.4
Q ss_pred eeeecCceE-EEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSYGD-LYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.|+.|.... +|+.+.. +..+++|...+... ..+..|+.+++.+.. -.+++++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 354454443 6676653 67788887544310 224456777766642 33566777644433 7899999876
Q ss_pred CHHHHHHhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH---
Q 023285 193 SIYDFLHKQK-------------------------GVFQLTSLL-------K-V------------AIDVSKGMNYL--- 224 (284)
Q Consensus 193 sL~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~L~~L--- 224 (284)
.+.+++.... ..++..... . + ...+...++.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7665443210 112221110 0 0 00111222333
Q ss_pred ---HhCCceecCCCCCCEEecCC----CcEEEecccceeeec
Q 023285 225 ---HQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA 259 (284)
Q Consensus 225 ---H~~~iiH~Dikp~NIli~~~----~~vkl~Dfg~a~~~~ 259 (284)
+...++|+|+.+.||+++.+ +.+.|+||+.+...+
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 23479999999999999874 789999999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.92 E-value=2e-05 Score=68.53 Aligned_cols=140 Identities=12% Similarity=0.133 Sum_probs=80.7
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc--eeeEEeE------EEcCCcEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT 186 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lV~ 186 (284)
.+.|+.|....+|+....+..+++|+..... ....+..|..+++.+...+ +++++.. ....+..++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 4567778888999988776789999986521 1234556777777775322 3344321 12235678999
Q ss_pred EcCCCCCHH-----------H---HHHhcCCCC--------CHHHHHH---------------HHHHHHHHHHHHHh---
Q 023285 187 EFMARGSIY-----------D---FLHKQKGVF--------QLTSLLK---------------VAIDVSKGMNYLHQ--- 226 (284)
Q Consensus 187 e~~~~gsL~-----------~---~l~~~~~~~--------~~~~~~~---------------i~~~i~~~L~~LH~--- 226 (284)
+|++|..+. . -++.....+ ....-.. +...+...++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 999985421 1 122211111 1000000 00113344555552
Q ss_pred ----CCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 227 ----NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 227 ----~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.+++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 37999999999999987766689999988653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.75 E-value=5.9e-05 Score=64.67 Aligned_cols=79 Identities=13% Similarity=0.133 Sum_probs=56.3
Q ss_pred cCCceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC---CceeeEEeEEEcCCcEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~l 184 (284)
..+..-.+.+|.|..+.||+.+. +|+.|++|+-..... .....|..|...|+.+.. -.+++++++. .-++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 44566678899999999999987 478999998654321 122357889999998853 2356666653 2378
Q ss_pred EEEcCCCCC
Q 023285 185 VTEFMARGS 193 (284)
Q Consensus 185 V~e~~~~gs 193 (284)
||||++++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00019 Score=65.40 Aligned_cols=70 Identities=11% Similarity=0.173 Sum_probs=47.9
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEE
Q 023285 115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI 184 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 184 (284)
.+.|+.|....+|+.... ++.+++|+..... . ...+..|..+++.+...+ .+++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 456788888899998864 4689999874321 1 134457989888886433 3667776542 38
Q ss_pred EEEcCCCC
Q 023285 185 VTEFMARG 192 (284)
Q Consensus 185 V~e~~~~g 192 (284)
|+||++|.
T Consensus 150 v~e~l~G~ 157 (429)
T 1nw1_A 150 LEEYIPSR 157 (429)
T ss_dssp EECCCCEE
T ss_pred EEEEeCCc
Confidence 99999863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=64.89 Aligned_cols=71 Identities=11% Similarity=0.162 Sum_probs=43.2
Q ss_pred eeeeecCceEEEEEEECC----------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEE
Q 023285 116 CKVASGSYGDLYKGTYCS----------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCI 184 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~l 184 (284)
+.++.|..-.+|+....+ ..+++|+.... .+.......|..+++.+...+ .+++++... -++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~ 111 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGR 111 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEecC----CcE
Confidence 456778778899887654 68889986532 111112467888888875333 456765542 268
Q ss_pred EEEcCCCCC
Q 023285 185 VTEFMARGS 193 (284)
Q Consensus 185 V~e~~~~gs 193 (284)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00045 Score=61.82 Aligned_cols=136 Identities=13% Similarity=0.193 Sum_probs=80.5
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEE
Q 023285 116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV 185 (284)
+.+..|-...+|+.... ++.+++|+.... ......+.+|..+++.+. +.-.+++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 34666777778887763 367999985321 112345668999998885 3334677776654 289
Q ss_pred EEcCCCCCHH--------------HH---HHhcCC----CCC--HHHHHHHHHHHHH-------------------HHHH
Q 023285 186 TEFMARGSIY--------------DF---LHKQKG----VFQ--LTSLLKVAIDVSK-------------------GMNY 223 (284)
Q Consensus 186 ~e~~~~gsL~--------------~~---l~~~~~----~~~--~~~~~~i~~~i~~-------------------~L~~ 223 (284)
|||++|..|. +. ++.... ... ..++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999985432 11 122111 111 2344445443321 2333
Q ss_pred HH----h----CCceecCCCCCCEEecCC----CcEEEecccceeee
Q 023285 224 LH----Q----NNIIHRDLKTANLLMDEN----GVVKVADFGVARVQ 258 (284)
Q Consensus 224 LH----~----~~iiH~Dikp~NIli~~~----~~vkl~Dfg~a~~~ 258 (284)
|. . ..++|+|+.+.||+++.+ +.+.++||..|...
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 32 2 258999999999999876 78999999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0013 Score=57.00 Aligned_cols=137 Identities=14% Similarity=0.134 Sum_probs=78.6
Q ss_pred eeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC--ceeeEEeE-----EEcCCcEEEEEEc
Q 023285 117 KVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGA-----CTRPPNLCIVTEF 188 (284)
Q Consensus 117 ~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lV~e~ 188 (284)
.++ |....||+.... ++.+++|+..+..... ..+..|..+++.+... .+++++.. ....+..++||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 355 777789987653 5689999987543332 3456688887777532 24444443 1223456889999
Q ss_pred CCCCCHH-----------HH---HHhc--C------CCCCHHHH----------------------HHHHHHHHHHHHHH
Q 023285 189 MARGSIY-----------DF---LHKQ--K------GVFQLTSL----------------------LKVAIDVSKGMNYL 224 (284)
Q Consensus 189 ~~~gsL~-----------~~---l~~~--~------~~~~~~~~----------------------~~i~~~i~~~L~~L 224 (284)
++|..+. .. ++.. . ...+.... ...+.+++..++-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9874321 11 1111 0 11121110 01111222222222
Q ss_pred ----HhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 225 ----HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 225 ----H~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
....++|+|+++.||+++ + .+.++||+.+....
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGP 225 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEEC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCc
Confidence 234689999999999998 4 89999999887543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0011 Score=60.82 Aligned_cols=72 Identities=21% Similarity=0.137 Sum_probs=47.3
Q ss_pred eeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce-eeEEeEEEcCCcEEEEEEcCCC
Q 023285 115 ECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMAR 191 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lV~e~~~~ 191 (284)
.+.|+.|-...+|+....+ ..+++|+..... .. .-...+|..+++.+...++ +++++.+. + ..||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4567788888999998876 789999874321 11 1112578999998875444 67777763 2 359999987
Q ss_pred CC
Q 023285 192 GS 193 (284)
Q Consensus 192 gs 193 (284)
.+
T Consensus 186 ~~ 187 (458)
T 2qg7_A 186 YA 187 (458)
T ss_dssp EE
T ss_pred cc
Confidence 43
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00086 Score=58.94 Aligned_cols=33 Identities=15% Similarity=0.352 Sum_probs=29.1
Q ss_pred CCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 227 ~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..++|+|+.+.||+++.++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 369999999999999988899999999887644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0013 Score=59.67 Aligned_cols=72 Identities=11% Similarity=0.146 Sum_probs=46.6
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEE
Q 023285 115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 184 (284)
.+.+..|-...+|+.... ++.+++|+..... +..-...+|..+++.+. +.-.+++++.+. -+.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 345666777889988875 5789999864321 11112457888888875 333466665442 278
Q ss_pred EEEcCCCCC
Q 023285 185 VTEFMARGS 193 (284)
Q Consensus 185 V~e~~~~gs 193 (284)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.47 E-value=0.13 Score=45.92 Aligned_cols=31 Identities=23% Similarity=0.393 Sum_probs=26.4
Q ss_pred ceecCCCCCCEEe------cCCCcEEEecccceeeec
Q 023285 229 IIHRDLKTANLLM------DENGVVKVADFGVARVQA 259 (284)
Q Consensus 229 iiH~Dikp~NIli------~~~~~vkl~Dfg~a~~~~ 259 (284)
++|+|+.+.||++ ++++.++++||..|....
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~ 282 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY 282 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence 5799999999999 456789999999997643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=94.20 E-value=0.003 Score=58.01 Aligned_cols=61 Identities=11% Similarity=0.050 Sum_probs=17.2
Q ss_pred eeeeeeecCceEEEEEEECC--ceEEE------EEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEE
Q 023285 114 IECKVASGSYGDLYKGTYCS--QEVAI------KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 177 (284)
+.+++| ||.||+|.+.+ .+||| |..+......+....|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 344565 99999999864 58888 777665555566677999999999999999999988764
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=91.68 E-value=0.13 Score=40.93 Aligned_cols=51 Identities=18% Similarity=0.257 Sum_probs=38.1
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHH
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKE 62 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~ 62 (284)
+++++|.+|++.|+||.++..|.+.++|.+ .++|.+- ....+.++..+.+.
T Consensus 19 iva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~~-~~~~~~l~~~L~~~ 69 (192)
T 1u8s_A 19 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISGS-PSNITRVETTLPLL 69 (192)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEEC-HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEecC-CCCHHHHHHHHHHH
Confidence 689999999999999999999999998888 5555432 12345555555543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=89.54 E-value=0.33 Score=38.76 Aligned_cols=35 Identities=17% Similarity=0.237 Sum_probs=31.1
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEec
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD 45 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~ 45 (284)
+.++++..|.+.|+||.++..|.+.++|.+- +.|.
T Consensus 18 iva~vs~~La~~g~NI~da~q~~~~~~f~m~-~~v~ 52 (195)
T 2nyi_A 18 IVHDFSWALKNISANVESSRMACLGGDFAMI-VLVS 52 (195)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEEE-EEEE
T ss_pred HHHHHHHHHHHCCCCEEEEEeEEECCeEEEE-EEEE
Confidence 6789999999999999999999999999994 4444
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=88.53 E-value=0.82 Score=31.14 Aligned_cols=55 Identities=18% Similarity=0.129 Sum_probs=40.6
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHHHHh
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILK 65 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~~~~ 65 (284)
+|+++|.+|++.|.||.+.+.+... |...-.+.++.-.....+.+...+.+-...
T Consensus 18 ila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~~~ 72 (91)
T 1zpv_A 18 IVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFGQT 72 (91)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHHHH
Confidence 6899999999999999998887765 665555555443355778888887654433
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=88.21 E-value=4.9 Score=34.86 Aligned_cols=148 Identities=13% Similarity=0.129 Sum_probs=81.6
Q ss_pred eeeeccCC---ceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE-----
Q 023285 104 VWEIDAKQ---LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----- 175 (284)
Q Consensus 104 ~~~i~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~----- 175 (284)
.-.|+++. ++..+....|+.|.++... ++..++||... .-..+.+..++...-.+.-|+..-+...
T Consensus 60 i~~i~w~~l~~v~~I~~s~~Gstgvff~~t-d~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~ 133 (342)
T 1cja_A 60 IGDINWKNLQQFKGIERSEKGTEGLFFVET-ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGT 133 (342)
T ss_dssp TTCCCTTCGGGEEEEEECCSTTSCEEEEEE-SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHH
T ss_pred ccccccccccCeeEEEeccCCCCCeEEEEe-CCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHH
Confidence 35677777 6677777888776555544 67889999431 1122334455555555555553222211
Q ss_pred ---------E--------EcCCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceec
Q 023285 176 ---------C--------TRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHR 232 (284)
Q Consensus 176 ---------~--------~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~-----iiH~ 232 (284)
- .....+.++|+|.+|..|.+.-... ...+..+....++ -+-+++.+..++ +-+.
T Consensus 134 e~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n 211 (342)
T 1cja_A 134 NMLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTN 211 (342)
T ss_dssp HHHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCS
T ss_pred HHHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccC
Confidence 0 0123577999999876554321110 0112222222211 133566666552 1122
Q ss_pred CCCCCCEEecCCC-cEEEecccceeeec
Q 023285 233 DLKTANLLMDENG-VVKVADFGVARVQA 259 (284)
Q Consensus 233 Dikp~NIli~~~~-~vkl~Dfg~a~~~~ 259 (284)
--.+.|||++.++ .+.++|-+.+...+
T Consensus 212 ~GN~~NIL~~~~n~~~~~IDhn~af~~~ 239 (342)
T 1cja_A 212 EGNLDNIMLSERGATVVPIDSKIIPLDA 239 (342)
T ss_dssp CCCGGGEEEESBTTCEEECSCCCCCCCS
T ss_pred CCChhheEEeCCCCeEEEEcCCccccCC
Confidence 3589999998655 49999999987543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.74 E-value=1.7 Score=35.36 Aligned_cols=85 Identities=11% Similarity=0.011 Sum_probs=59.6
Q ss_pred CCCceeeEEeEEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCceecCCCCCCEEecC
Q 023285 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN-YLHQNNIIHRDLKTANLLMDE 243 (284)
Q Consensus 165 ~h~niv~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~-~LH~~~iiH~Dikp~NIli~~ 243 (284)
.||++ --.+-.+++.+.+.++--+++.=...+. ..+....++++.+|+.... ++ ..-+|--+.|+||+++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 47777 2333356666777777654443333443 3678888999988877655 43 34577889999999999
Q ss_pred CCcEEEecccceee
Q 023285 244 NGVVKVADFGVARV 257 (284)
Q Consensus 244 ~~~vkl~Dfg~a~~ 257 (284)
++.+++.-.|+-..
T Consensus 120 ~~~p~i~hRGi~~~ 133 (219)
T 4ano_A 120 ALEPFFLHVGVKES 133 (219)
T ss_dssp TCCEEESCCEETTT
T ss_pred CCcEEEEEcCCccc
Confidence 99999998887543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.60 E-value=1 Score=36.58 Aligned_cols=84 Identities=8% Similarity=0.077 Sum_probs=59.2
Q ss_pred CCCceeeEEeEEEcCCcEEEEEEcCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC
Q 023285 165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243 (284)
Q Consensus 165 ~h~niv~~~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~ 243 (284)
.||++++. .+-...+.+.+.++.-+.+ ++.. + ...+....++++.+|+....+++ .=+|--+.|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 47888766 4555556666666654322 2222 2 33678888999999888775444 3477889999999999
Q ss_pred CCcEEEeccccee
Q 023285 244 NGVVKVADFGVAR 256 (284)
Q Consensus 244 ~~~vkl~Dfg~a~ 256 (284)
++.++++=.|+..
T Consensus 115 ~~~p~i~~RGik~ 127 (215)
T 4ann_A 115 DGLPIAKTRGLQN 127 (215)
T ss_dssp TSCEEESCCEETT
T ss_pred CCCEEEEEccCcc
Confidence 9999999888754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=82.11 E-value=3.7 Score=33.49 Aligned_cols=59 Identities=15% Similarity=0.138 Sum_probs=47.4
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEecCCCcEEEec
Q 023285 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVAD 251 (284)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH-~~~iiH~Dikp~NIli~~~~~vkl~D 251 (284)
||.+.|...+.++++++++.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.|...+
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 899999999999999999999999999987762 22222344567899999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 284 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-47 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-43 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-42 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-36 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-34 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-30 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-16 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-59
Identities = 69/182 (37%), Positives = 109/182 (59%), Gaps = 5/182 (2%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
D WEI Q+ + ++ SGS+G +YKG + +VA+K+L + L+ F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
K RH N++ F+G T P L IVT++ S+Y LH + F++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYRWMAPEVA 279
YLH +IIHRDLK+ N+ + E+ VK+ DFG+A V+++ S +G+ WMAPEV
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 280 FT 281
Sbjct: 179 RM 180
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-51
Identities = 62/179 (34%), Positives = 97/179 (54%), Gaps = 8/179 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ K+LK+ + G +GD+ G Y +VA+K +K N + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
RH N+VQ +G L IVTE+MA+GS+ D+L + + V LLK ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
YL NN +HRDL N+L+ E+ V KV+DFG+ + + + +W APE
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE 174
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-47
Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 12/190 (6%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLK 152
+ + D WEI + + G++G +YK S A KV+ + + E L+
Sbjct: 4 VTRDLNPEDFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELE 54
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
++ E+ I+ H N+V+ + A NL I+ EF A G++ + + + + +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTY 271
V +NYLH N IIHRDLK N+L +G +K+ADFGV+ ++ + GT
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174
Query: 272 RWMAPEVAFT 281
WMAPEV
Sbjct: 175 YWMAPEVVMC 184
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-47
Identities = 56/183 (30%), Positives = 102/183 (55%), Gaps = 8/183 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WE+ + LK+ ++ +G +G+++ G Y +VA+K LK ++ + F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
++++H+ +V+ T+ P + I+TE+M GS+ DFL G+ + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYRWMAPEV 278
M ++ + N IHRDL+ AN+L+ + K+ADFG+AR+ + +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 279 AFT 281
Sbjct: 182 INY 184
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 5e-47
Identities = 48/179 (26%), Positives = 89/179 (49%), Gaps = 6/179 (3%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
E+ + ++ +G+ G ++K ++ +A K++ E + + + +E+ ++ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+V F GA + I E M GS+ L K G L KV+I V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 224 LHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
L + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M+PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQG 177
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-47
Identities = 72/190 (37%), Positives = 110/190 (57%), Gaps = 10/190 (5%)
Query: 98 PTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEF 154
T G D WEI + L++E K+ G +G+++ GT+ VAIK LKP ++ E F
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AF 59
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKV 213
QE +M+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTY 271
A ++ GM Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ +
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 272 RWMAPEVAFT 281
+W APE A
Sbjct: 179 KWTAPEAALY 188
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-46
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 7/180 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIM 161
W ++ +I + G +G++Y +A+KVL + + + +EV I
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+RH N+++ G + ++ E+ G++Y L K F +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANAL 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
+Y H +IHRD+K NLL+ G +K+ADFG + A S T GT ++ PE+
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (391), Expect = 5e-46
Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 7/168 (4%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + VAIK + + E ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ + D L K Q + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
+K N+L+ E G+VK+ DFG A + A + GT WMAPEV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILA 185
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 3e-45
Identities = 67/184 (36%), Positives = 102/184 (55%), Gaps = 8/184 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
D WE++ + ++ K+ G YG++Y+G + S VA+K LK +T ++EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 66
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSK 219
M++I+H N+VQ +G CTR P I+TEFM G++ D+L + LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPE 277
M YL + N IHRDL N L+ EN +VKVADFG++R+ +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 278 VAFT 281
Sbjct: 187 SLAY 190
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-45
Identities = 58/178 (32%), Positives = 94/178 (52%), Gaps = 6/178 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID K L ++ +G +G + G + +VAIK++K ++ + EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H+ +VQ G CT+ + I+TE+MA G + ++L + + FQ LL++ DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPEVAFT 281
+HRDL N L+++ GVVKV+DFG++R RW PEV
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-45
Identities = 60/178 (33%), Positives = 98/178 (55%), Gaps = 6/178 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID +L ++ SG +G ++ G + + +VAIK ++ ++ E +F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G C +C+V EFM G + D+L Q+G+F +LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVAFT 281
+ +IHRDL N L+ EN V+KV+DFG+ R ++ +W +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-44
Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 11/181 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
D + LK + ++ GS+ +YKG EVA L+ + + F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 165 RHKNVVQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+H N+V+F + + +VTE M G++ +L + V ++ L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124
Query: 221 MNYLHQNN--IIHRDLKTAN-LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+ +LH IIHRDLK N + G VK+ D G+A ++ ++ A GT +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183
Query: 278 V 278
+
Sbjct: 184 M 184
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-44
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
WE + L+ + SG++G + T S +VA+K+LK + ++ + E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSE 90
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------- 202
+ +M ++ H+N+V +GACT + ++ E+ G + ++L ++
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 203 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
V LL A V+KGM +L + +HRDL N+L+ VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVAFT 281
AR +WMAPE F
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFE 240
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-44
Identities = 50/184 (27%), Positives = 91/184 (49%), Gaps = 11/184 (5%)
Query: 107 IDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+D K L +E K SG++G + KG Y + VA+K+LK E + + E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+++ + +V+ IG C + +V E G + +L + + + +++++ VS GM
Sbjct: 63 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPE 277
YL ++N +HRDL N+L+ K++DFG+++ + T +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 278 VAFT 281
Sbjct: 181 CINY 184
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-44
Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 11/186 (5%)
Query: 105 WEIDAKQLKI-ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVY 159
+ L I + ++ G++G + +G Y +VAIKVLK +E +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM ++ + +V+ IG C + L +V E G ++ FL ++ ++++ ++ VS
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMA 275
GM YL + N +HRDL N+L+ K++DFG+++ + +A +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 276 PEVAFT 281
PE
Sbjct: 181 PECINF 186
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 9e-44
Identities = 43/174 (24%), Positives = 82/174 (47%), Gaps = 7/174 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ + G+YG++ + VA+K++ + + + +E+ I + + H+NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+F G + E+ + G ++D + G + + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 231 HRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPEVAFT 281
HRD+K NLL+DE +K++DFG+A V + ++ GT ++APE+
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 3e-43
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC 145
+ ++P D WE +L + +G++G + + T VA+K+LKP
Sbjct: 8 DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS- 64
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-- 202
+ + E+ ++ + H N+V +GACT ++TE+ G + +FL +++
Sbjct: 65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 203 ---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
L LL + V+KGM +L N IHRDL N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 248 KVADFGVARVQAQSGVMTAET---GTYRWMAPEVAFT 281
K+ DFG+AR + +WMAPE F
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 148 bits (375), Expect = 3e-43
Identities = 39/171 (22%), Positives = 79/171 (46%), Gaps = 6/171 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I ++ +G++G +++ T + A K + + + +E+ M +RH +V
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLV 86
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
A + ++ EFM+ G +++ + + ++ V KG+ ++H+NN +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVA 279
H DLK N++ + +K+ DFG+ + TGT + APEVA
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 148 bits (375), Expect = 3e-43
Identities = 32/170 (18%), Positives = 77/170 (45%), Gaps = 6/170 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I ++ SG++G +++ + + K + E+ IM ++ H ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLI 89
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
A + ++ EF++ G ++D + + ++ +G+ ++H+++I+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H D+K N++ + + VK+ DFG+A ++ T T + APE+
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 199
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-42
Identities = 60/183 (32%), Positives = 95/183 (51%), Gaps = 11/183 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT-EMLKEFSQEVYI 160
I K L++ K+ GS+G + +G + + VA+K LKP+ ++ E + +F +EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+ V++G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAP 276
M YL IHRDL NLL+ +VK+ DFG+ R + + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 277 EVA 279
E
Sbjct: 184 ESL 186
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 9e-42
Identities = 61/185 (32%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVY 159
EID +KIE + +G +G++ G VAIK LK + ++F E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEAS 79
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM + H NV+ G T+ + I+TEFM GS+ FL + G F + L+ + ++
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------GTYRW 273
GM YL N +HRDL N+L++ N V KV+DFG++R T RW
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 274 MAPEV 278
APE
Sbjct: 200 TAPEA 204
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-41
Identities = 55/187 (29%), Positives = 91/187 (48%), Gaps = 11/187 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
EI + + + +G +G++YKG VAIK LK + +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEA 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
IM + H N+++ G ++ + I+TE+M G++ FL ++ G F + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWM 274
GM YL N +HRDL N+L++ N V KV+DFG++RV + + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 275 APEVAFT 281
APE
Sbjct: 181 APEAISY 187
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-41
Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 13/179 (7%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
++ + +GSYG K S + + K L + + EV ++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 171 QFIGACTRPPN--LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
++ N L IV E+ G + + K++ +L+V ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 226 Q-----NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
+ + ++HRDLK AN+ +D VK+ DFG+AR + + A GT +M+PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 4e-41
Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 9/184 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
+EI +++++ + G +GD+++G Y S E VAIK K C + + ++F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
MR+ H ++V+ IG T + I+ E G + FL +K L SL+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPE 277
+ YL +HRD+ N+L+ N VK+ DFG++R S A +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 278 VAFT 281
Sbjct: 180 SINF 183
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 9e-41
Identities = 46/171 (26%), Positives = 85/171 (49%), Gaps = 7/171 (4%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
K+ K+ G+ G +Y + QEVAI+ + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+V ++ + L +V E++A GS+ D + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPE 277
+IHRD+K+ N+L+ +G VK+ DFG + + + GT WMAPE
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 186
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-40
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 21/196 (10%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+D +K + + G++G + K + AIK +K + + ++F+ E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64
Query: 162 RKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVF 205
K+ H N++ +GAC L + E+ G++ DFL K
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 206 QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 266 AETGTYRWMAPEVAFT 281
RWMA E
Sbjct: 185 MGRLPVRWMAIESLNY 200
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-40
Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 22/190 (11%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
A+ + ++ + G +G++++G + +EVA+K+ E E+Y +RH+N
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHEN 58
Query: 169 VVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
++ FI A + L +V+++ GS++D+L++ + ++K+A+ + G+ +L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHL 116
Query: 225 HQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
H I HRDLK+ N+L+ +NG +AD G+A + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 272 RWMAPEVAFT 281
R+MAPEV
Sbjct: 177 RYMAPEVLDD 186
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 4e-40
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 34/213 (15%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
E ++ + G++G +++ VA+K+LK E + +M +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQRE 66
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-------------- 203
+M + + N+V+ +G C +C++ E+MA G + +FL
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 204 ---------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
L +A V+ GM YL + +HRDL T N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVAFTFFF 284
+R + A+ RWM PE F +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-39
Identities = 41/172 (23%), Positives = 78/172 (45%), Gaps = 7/172 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNV 169
K + GS+ + + +E AIK+L+ + E + ++E +M ++ H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ L + G + ++ K G F T ++ + YLH I
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEV 278
IHRDLK N+L++E+ +++ DFG A+V + + GT ++++PE+
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 4e-39
Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKP 143
S + +P D WE+ +++ + ++ GS+G +Y+G VAIK +
Sbjct: 5 SAADVYVP----DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
+ EF E +M++ +VV+ +G ++ ++ E M RG + +L +
Sbjct: 61 A-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119
Query: 204 V---------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
L+ ++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 255 ARVQAQSG---VMTAETGTYRWMAPEVAFT 281
R ++ RWM+PE
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKD 209
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 33/170 (19%), Positives = 74/170 (43%), Gaps = 7/170 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I + G +G +++ S + K +K + + ++K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L ++ EF++ I++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H D++ N++ + +K+ +FG AR + APEV
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (333), Expect = 9e-38
Identities = 41/176 (23%), Positives = 83/176 (47%), Gaps = 11/176 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-------EMLKEFSQEVYIMRK 163
+ + + G + + + +E A+K++ + E+ + +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 164 IR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
+ H N++Q +V + M +G ++D+L + K K+ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTE 149
+P D WE +LK+ + G++G + + + VA+K+LK ++E
Sbjct: 1 LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ------- 201
S+ ++ H NVV +GACT+P L ++ EF G++ +L +
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 202 --------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
K L L+ + V+KGM +L IHRDL N+L+ E VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 254 VARVQAQSGVMTAET---GTYRWMAPEVAFT 281
+AR + + +WMAPE F
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFD 210
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 6e-37
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 11/184 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + K + SG++G +YKG + VAIK L+ + + KE E Y+
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYV 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + + +V + +G C + ++T+ M G + D++ + K LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPE 277
MNYL ++HRDL N+L+ VK+ DFG+A++ + + +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 278 VAFT 281
Sbjct: 184 SILH 187
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (329), Expect = 8e-37
Identities = 41/171 (23%), Positives = 86/171 (50%), Gaps = 7/171 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ +G++ ++ + VAIK + + + + E+ ++ KI+H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIV 70
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+L ++ + ++ G ++D + + KG + ++ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 231 HRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
HRDLK NLL +DE+ + ++DFG+++++ V++ GT ++APEV
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-36
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
E+P D WE+ +L + + G++G + +VA+K+LK +
Sbjct: 1 ELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
++ + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 59 EKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ A V++GM YL IHRDL N+L+ E+ V+K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 251 DFGVARVQAQSGVMTA---ETGTYRWMAPEVAFT 281
DFG+AR +WMAPE F
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-36
Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 14/190 (7%)
Query: 105 WEIDAKQLKI--ECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQE 157
I L + + G +G +Y GT A+K L + + +F E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTE 78
Query: 158 VYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
IM+ H NV+ +G C R +V +M G + +F+ + + L+ +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
V+KGM +L +HRDL N ++DE VKVADFG+AR T
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 272 RWMAPEVAFT 281
+WMA E T
Sbjct: 199 KWMALESLQT 208
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (320), Expect = 2e-35
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 6/175 (3%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 166
+ +I + +GS+G ++ + A+KVLK E V + ++ + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+++ G + ++ +++ G L ++ F A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
+II+RDLK N+L+D+NG +K+ DFG A+ GT ++APEV T
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST 175
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 4e-35
Identities = 42/171 (24%), Positives = 77/171 (45%), Gaps = 6/171 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIM-RKIRHKN 168
+ + GS+G ++ + Q AIK LK + V + ++ E ++ H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ NL V E++ G + + F L+ A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEV 278
I++RDLK N+L+D++G +K+ADFG+ + GT ++APE+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (316), Expect = 1e-34
Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 8/172 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
+ + G +G++Y + A+K L + + + + + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+V A P L + + M G ++ L + GVF + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+++RDLK AN+L+DE+G V+++D G+A A GT+ +MAPEV
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEV 176
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 5e-34
Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 8/176 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHK 167
K++ + G + +YK + Q VAIK +K + + + +E+ +++++ H
Sbjct: 2 KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N++ + A N+ +V +FM + + V + + + +G+ YLHQ+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVAFTF 282
I+HRDLK NLL+DENGV+K+ADFG+A+ + + T + T + APE+ F
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 2e-33
Identities = 40/175 (22%), Positives = 75/175 (42%), Gaps = 10/175 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR- 165
++ + SG +G +Y G S VAIK ++ + ++ EV +++K+
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 166 -HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
V++ + RP + ++ E ++G Q V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 225 HQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
H ++HRD+K N+L+D N G +K+ DFG + + V T GT + PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEW 180
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-33
Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 14/188 (7%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
V+++ + + + G+YG + VAIK + P + + +E+ I+
Sbjct: 3 VFDVGPRYTNLS-YIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKIL 60
Query: 162 RKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
+ RH+N++ P + + +Y L Q + +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQI 118
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRW 273
+G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T T +
Sbjct: 119 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 274 MAPEVAFT 281
APE+
Sbjct: 179 RAPEIMLN 186
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 6e-33
Identities = 41/176 (23%), Positives = 77/176 (43%), Gaps = 11/176 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
++ SG + + K S + A K +K + ++ +EV I+++I+H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
NV+ ++ ++ E +A G ++DF +K + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 227 NNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
I H DLK N+++ + V +K+ DFG+A GT ++APE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-33
Identities = 44/180 (24%), Positives = 86/180 (47%), Gaps = 11/180 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RH 166
+ ++ G+YG ++K + VA+K ++ + M +EV ++R + H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 167 KNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
NVV+ CT L +V E + + + ++ + + +G+
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFT 281
++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+ T + APEV
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 3/169 (1%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G+YG +YK + VA+K ++ + + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + L +V EF+ + L + + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEV 278
HRDLK NLL++ G +K+ADFG+AR T E T + APE+
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 118 bits (297), Expect = 2e-32
Identities = 48/180 (26%), Positives = 84/180 (46%), Gaps = 12/180 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNV 169
++ + G +++ ++VA+KVL+ + + F +E + H +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 170 VQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
V P IV E++ ++ D +H + G ++V D + +N+ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH 128
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVAFT 281
QN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE A
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (296), Expect = 2e-32
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 2/166 (1%)
Query: 113 KIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
K+ G+YG +YK + A+K ++ E + + +E+ I+++++H N+V+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
L +V E + + L +G + + + + G+ Y H ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
RDLK NLL++ G +K+ADFG+AR W
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 3e-32
Identities = 38/176 (21%), Positives = 73/176 (41%), Gaps = 18/176 (10%)
Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVV 170
+ G G + + ++ A+K+L+ + +EV + + + ++V
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIV 68
Query: 171 QFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLH 225
+ + L IV E + G ++ + + F ++ + + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 226 QNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
NI HRD+K NLL N ++K+ DFG A+ +T T ++APEV
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-30
Identities = 45/171 (26%), Positives = 84/171 (49%), Gaps = 4/171 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G+YG ++K + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L +V EF + F G + + KG+ + H N++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVAF 280
HRDLK NLL++ NG +K+A+FG+AR +AE T + P+V F
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 3e-30
Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 16/181 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G++G+++K + Q+VA+K + E +E+ I++ ++H+NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 171 QFIGACTRPP--------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
I C ++ +V +F L F L+ + +V + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE 277
Y+H+N I+HRD+K AN+L+ +GV+K+ADFG+AR +Q T T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 278 V 278
+
Sbjct: 192 L 192
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 3e-30
Identities = 44/182 (24%), Positives = 79/182 (43%), Gaps = 17/182 (9%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
++ K+ SGS+GD+Y GT + +EVAIK+ + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I C + ++ + S+ D + F L ++L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGV--------MTAETGTYRWMAPEVA 279
HRD+K N LM + +V + DFG+A+ + TGT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 280 FT 281
Sbjct: 186 LG 187
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 6e-30
Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 14/188 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
WE+ + V SG+YG + +VAIK L + K +E+
Sbjct: 10 TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+++ +RH+NV+ + T + +V FM G+ L K +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-HEKLGEDRIQF 125
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+ + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRW 183
Query: 273 WMAPEVAF 280
+ APEV
Sbjct: 184 YRAPEVIL 191
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 8e-30
Identities = 39/170 (22%), Positives = 79/170 (46%), Gaps = 5/170 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
+ G++G + + + A+K+L+ E + + + E +++ RH +
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
A LC V E+ G ++ L +++ F ++ + YLH ++
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEV 278
++RD+K NL++D++G +K+ DFG+ + G M GT ++APEV
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (277), Expect = 5e-29
Identities = 43/169 (25%), Positives = 77/169 (45%), Gaps = 6/169 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
+ +GS+G + + A+K+L + V + ++ E I++ + +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ + NL +V E++A G ++ L + G F A + YLH ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
I+RDLK NLL+D+ G ++V DFG A+ GT +APE+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEI 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-29
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 21/198 (10%)
Query: 95 IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEML 151
+ P G D E+ K+ + +GS+G +Y+ C + VAIK + +
Sbjct: 7 VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLH--KQKG 203
+ ++E+ IMRK+ H N+V+ L +V +++ H + K
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262
+ + + + + Y+H I HRD+K NLL+D + V+K+ DFG A+ +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 263 VMTAETGTYRWMAPEVAF 280
+ + + APE+ F
Sbjct: 178 PNVSYICSRYYRAPELIF 195
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 7e-28
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 13/185 (7%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
G + + K+ + + SG+ G + + VAIK L N K +E+
Sbjct: 9 GDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+M+ + HKN++ + T ++ +V E M + +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 273 WMAPE 277
+ APE
Sbjct: 184 YRAPE 188
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (264), Expect = 1e-27
Identities = 31/181 (17%), Positives = 69/181 (38%), Gaps = 19/181 (10%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+ ++ GS+G +++GT Q+VAIK + E + + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + ++ + S+ D L F + ++ A + + +H+ +++
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 231 HRDLKTANLLMDE-----NGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPE 277
+RD+K N L+ ++ V DFG+ + +GT R+M+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 278 V 278
Sbjct: 184 T 184
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 9e-27
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 12/185 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
+WE+ + + V SG+YG + VA+K L + K +E+ +
Sbjct: 12 TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 161 MRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
++ ++H+NV+ + T N + + + + + QK + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+ +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR MT T + A
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRA 186
Query: 276 PEVAF 280
PE+
Sbjct: 187 PEIML 191
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (260), Expect = 9e-27
Identities = 33/192 (17%), Positives = 79/192 (41%), Gaps = 23/192 (11%)
Query: 101 GTDVWEIDAKQLK--------IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEM 150
+ W+ ++ ++ + K+ G Y ++++ + ++V +K+LKP
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K 72
Query: 151 LKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQL 207
K+ +E+ I+ +R N++ P + +V E +
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTD 128
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTA 266
+ ++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 267 ETGTYRWMAPEV 278
+ + PE+
Sbjct: 189 RVASRYFKGPEL 200
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-25
Identities = 40/176 (22%), Positives = 84/176 (47%), Gaps = 11/176 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR 165
++ + +G+YG ++ S + A+KVLK + + + E ++ IR
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 166 HK-NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+V A L ++ +++ G ++ L +++ F + ++ + +L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHL 145
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEV 278
H+ II+RD+K N+L+D NG V + DFG+++ V ++ GT +MAP++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 2e-17
Identities = 24/163 (14%), Positives = 52/163 (31%), Gaps = 26/163 (15%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLK--------EFSQE 157
+DA I + G ++ E +K K + + +K FS
Sbjct: 1 VDA----IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 158 VYIMRKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+ + + + G ++ E + +Y + +V
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEV 108
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
+ + + + I+H DL N+L+ E G + + DF +
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.6 bits (187), Expect = 1e-16
Identities = 32/193 (16%), Positives = 74/193 (38%), Gaps = 29/193 (15%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G + ++ VA+K+++ + V TE E+ +++++ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 171 QFIGACTRPP---------------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ ++ +V E + + + L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGV------VKVADFGVARVQAQSGVMTAET 268
+ G++Y+H + IIH D+K N+LM+ +K+AD G A + +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190
Query: 269 GTYRWMAPEVAFT 281
T + +PEV
Sbjct: 191 QTREYRSPEVLLG 203
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 284 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.91 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.29 | |
| d2f06a1 | 71 | Hypothetical protein BT0572 {Bacteroides thetaiota | 89.41 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 87.56 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 86.99 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 81.79 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 80.7 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=315.87 Aligned_cols=178 Identities=38% Similarity=0.699 Sum_probs=156.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
++|+|+.++|++.+.||+|+||.||+|++.+ .||||+++....+.+..+.|.+|+.++++++||||+++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4799999999999999999999999998765 69999998766667778899999999999999999999998765 568
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~- 261 (284)
++||||++||+|.+++...+..+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999887778999999999999999999999999999999999999999999999999999865432
Q ss_pred --CceecCCCcccccchhccccc
Q 023285 262 --GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 --~~~~~~~gt~~y~aPEvl~~~ 282 (284)
...+...||+.|||||++.+.
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp -------CCCCGGGCCHHHHTTC
T ss_pred CcccccccccCcccCCHHHHhcc
Confidence 223456799999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-44 Score=309.57 Aligned_cols=181 Identities=37% Similarity=0.686 Sum_probs=160.0
Q ss_pred CCCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
..+.|+|+.++|++.+.||+|+||.||+|++ +++.||||+++..... .++|.+|+.++++++||||++++++|.+
T Consensus 8 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3467999999999999999999999999998 4788999999765332 4579999999999999999999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
++.+|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999764 46789999999999999999999999999999999999999999999999999987
Q ss_pred eccCCce--ecCCCcccccchhccccccC
Q 023285 258 QAQSGVM--TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~~--~~~~gt~~y~aPEvl~~~~y 284 (284)
....... +...||+.|||||++.+..|
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cCCCCceeeccccccccccChHHHcCCCC
Confidence 6543322 23357899999999987665
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=306.81 Aligned_cols=173 Identities=25% Similarity=0.424 Sum_probs=150.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|++ +++.||||+++... ..+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4799999999999999999998 47899999997543 23344678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC---ce
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~ 264 (284)
|++||+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999999965 4679999999999999999999999999999999999999999999999999998754332 23
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
+..+||+.|||||++.+..|
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSB
T ss_pred cceeeCcCccCHhHhcCCCC
Confidence 45689999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=300.69 Aligned_cols=175 Identities=34% Similarity=0.626 Sum_probs=147.5
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
|++++|++.+.||+|+||.||+|.+. ++.||||+++..... .++|.+|++++++++||||++++|+|..++.+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 56789999999999999999999984 578999999765433 35799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-- 263 (284)
|||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999999988777899999999999999999999999999999999999999999999999999986544322
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|||||++.+..|
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~ 179 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRY 179 (263)
T ss_dssp ------CTTSCCHHHHTTCCC
T ss_pred ecceecCcccCChHHhcCCCC
Confidence 234578999999999988765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=312.48 Aligned_cols=176 Identities=27% Similarity=0.443 Sum_probs=155.5
Q ss_pred eeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
++..++|++.++||+|+||.||+|++ +++.||+|+++... .......+.+|+.++++++||||++++++|.++..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45677999999999999999999998 47899999997543 3445678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||++||+|.+++.+. +.+++..+..++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999999999764 679999999999999999999997 59999999999999999999999999999865433
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
..+..+||+.|||||++.+..|
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y 180 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHY 180 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCC
T ss_pred ccccccCCccccCchHHcCCCC
Confidence 2345689999999999998765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=301.08 Aligned_cols=174 Identities=25% Similarity=0.440 Sum_probs=154.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
.++|++.+.||+|+||.||+|+. +++.||+|+++..... ......+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999998 4689999998643211 22356789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCcee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|||++||+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 85 mEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~ 162 (263)
T d2j4za1 85 LEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT 162 (263)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred EeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence 9999999999999764 67999999999999999999999999999999999999999999999999999866543 345
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|||||++.+..|
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~ 181 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMH 181 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCC
T ss_pred ccCCCCcccCHHHHcCCCC
Confidence 5689999999999998765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-43 Score=303.66 Aligned_cols=171 Identities=27% Similarity=0.467 Sum_probs=152.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.++||+|+||.||+|.. +++.||||+++..... ..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999987 4799999998754222 24678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|++||+|.+++.+ +.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...... ....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999998865 469999999999999999999999999999999999999999999999999998765433 3456
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..||+.|||||++.+..|
T Consensus 176 ~~gt~~Y~aPE~~~~~~~ 193 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAY 193 (293)
T ss_dssp CCSCGGGCCHHHHSSSCB
T ss_pred cccCCCccChhhhcCCCC
Confidence 689999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-43 Score=300.30 Aligned_cols=179 Identities=31% Similarity=0.591 Sum_probs=156.1
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|+|+.++|++.+.||+|+||.||+|.+. ++.||||+++..... .+.|.+|+.++++++||||+++++++.+ +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 3679999999999999999999999999985 578999999765433 3579999999999999999999998865 5
Q ss_pred cEEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 6799999999999999876533 358999999999999999999999999999999999999999999999999999765
Q ss_pred cCCc--eecCCCcccccchhccccccC
Q 023285 260 QSGV--MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .+...||+.|||||++.+..|
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEE
T ss_pred CCccccccccCCcccccChHHHhCCCC
Confidence 4432 234578999999999987543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-42 Score=306.72 Aligned_cols=173 Identities=23% Similarity=0.372 Sum_probs=157.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4799999999999999999987 4789999999754 34456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCCcEEEecccceeeeccCCcee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~--~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|++||+|.+++.+..+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 9999999999977667899999999999999999999999999999999999996 46789999999999877666667
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|||||++.+..|
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~ 202 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPV 202 (350)
T ss_dssp EECSCTTTCCHHHHHTCCB
T ss_pred eecCcccccCHHHHcCCCC
Confidence 7889999999999988764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=299.04 Aligned_cols=176 Identities=25% Similarity=0.416 Sum_probs=145.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--CCcEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCI 184 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 184 (284)
.++|++.+.||+|+||.||+|+. +++.||||+++.....+...+.+.+|++++++++||||+++++++.+ +..+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 45799999999999999999988 47899999998776677777889999999999999999999999865 456899
Q ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEecCCCcEEEeccccee
Q 023285 185 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR 256 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----iiH~Dikp~NIli~~~~~vkl~Dfg~a~ 256 (284)
||||++||+|.+++.+ .++.+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999865 2467999999999999999999999876 9999999999999999999999999998
Q ss_pred eeccCC-ceecCCCcccccchhccccccC
Q 023285 257 VQAQSG-VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...... ......||+.|||||++.+..|
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 191 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSY 191 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCC
Confidence 755432 3345689999999999988765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-43 Score=302.85 Aligned_cols=176 Identities=23% Similarity=0.391 Sum_probs=152.0
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 184 (284)
.+++|++.+.||+|+||.||+|.. +++.||||+++.... .....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 346899999999999999999988 478999999864321 12234679999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC--
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-- 262 (284)
||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999876 4679999999999999999999999999999999999999999999999999998764322
Q ss_pred -ceecCCCcccccchhccccccC
Q 023285 263 -VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|||||++.+..|
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~ 187 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSA 187 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCC
T ss_pred cccccccCCccccCceeeccCCC
Confidence 2345679999999999988765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=301.75 Aligned_cols=170 Identities=32% Similarity=0.505 Sum_probs=151.5
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
+.|++.+.||+|+||.||+|++ +++.||||+++.. ..+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 3589999999999999999998 4689999999754 33445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
|++||+|.+++.+..+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 999999999987766789999999999999999999999999999999999999999999999999998654322 2345
Q ss_pred CCCcccccchhcccc
Q 023285 267 ETGTYRWMAPEVAFT 281 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~ 281 (284)
..||+.|||||++.+
T Consensus 170 ~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 170 FIGTPYWMAPEVVMC 184 (288)
T ss_dssp CCSCCTTCCHHHHTT
T ss_pred cccccccCCHHHHhh
Confidence 689999999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-42 Score=300.17 Aligned_cols=178 Identities=34% Similarity=0.548 Sum_probs=146.8
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
+++.++|++.+.||+|+||.||+|++. + ..||||.+... ......+.|.+|+.++++++|||||+++|+|..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 567789999999999999999999873 2 25889988654 34556678999999999999999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc
Q 023285 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~ 260 (284)
.+|+||||+++|+|.+++....+.+++..+..++.||++||+|||++||+||||||+|||++.++++||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988777899999999999999999999999999999999999999999999999999986543
Q ss_pred CCce------ecCCCcccccchhccccccC
Q 023285 261 SGVM------TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 261 ~~~~------~~~~gt~~y~aPEvl~~~~y 284 (284)
.... ....||+.|||||++.+..|
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 210 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCC
Confidence 2211 12357899999999987765
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=293.20 Aligned_cols=170 Identities=30% Similarity=0.512 Sum_probs=149.4
Q ss_pred CceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc----CCcEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCI 184 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 184 (284)
-|++.++||+|+||.||+|++. ++.||+|.++.........+.|.+|++++++++||||+++++++.. +..+|+
T Consensus 10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4588889999999999999984 6789999997665566677889999999999999999999999864 345899
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEec-CCCcEEEecccceeeeccC
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--iiH~Dikp~NIli~-~~~~vkl~Dfg~a~~~~~~ 261 (284)
||||+++|+|.+++.+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999999999764 67999999999999999999999998 99999999999996 5789999999999865443
Q ss_pred CceecCCCcccccchhccccc
Q 023285 262 GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~ 282 (284)
......||+.|||||++.+.
T Consensus 169 -~~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 169 -FAKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp -SBEESCSSCCCCCGGGGGTC
T ss_pred -ccCCcccCccccCHHHhCCC
Confidence 34566899999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-41 Score=303.66 Aligned_cols=173 Identities=18% Similarity=0.340 Sum_probs=156.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
+.|++.+.||+|+||.||+|+. +++.||||+++.. .......+.+|+.++++++||||+++++++.++..+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4799999999999999999997 4789999998754 33445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec--CCCcEEEecccceeeeccCCcee
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~--~~~~vkl~Dfg~a~~~~~~~~~~ 265 (284)
|++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999998877666799999999999999999999999999999999999998 67899999999999877666667
Q ss_pred cCCCcccccchhccccccC
Q 023285 266 AETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~y 284 (284)
...||+.|||||++.+..|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp EECSSGGGCCHHHHTTCCB
T ss_pred eccCcccccCHHHHcCCCC
Confidence 7789999999999988754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-42 Score=304.70 Aligned_cols=177 Identities=22% Similarity=0.410 Sum_probs=156.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
|..++|++.+.||+|+||.||+|+. +++.||||+++.... .....+.+.+|+.++++++||||+++++++.++..+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4456899999999999999999997 578999999964321 1223567899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~ 262 (284)
+||||++||+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999977 46799999999999999999999999999999999999999999999999999987543 33
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+||+.|||||++.+..|
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y 182 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDY 182 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB
T ss_pred ccccceeCHHHhhhhhccCCCC
Confidence 4456789999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-42 Score=301.41 Aligned_cols=174 Identities=23% Similarity=0.444 Sum_probs=136.6
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.+.|++.+.||+|+||.||+|+. +++.||||++...... .....+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35699999999999999999988 4789999999755332 23456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeeeccCCc
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~~~~~~ 263 (284)
||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+|+.......
T Consensus 87 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred eccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 99999999999976 56799999999999999999999999999999999999994 578999999999987766555
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
....+||+.|||||++.+..|
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~ 186 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPY 186 (307)
T ss_dssp -------CTTSCHHHHTTCCC
T ss_pred eeeeeeCccccCcHHHcCCCC
Confidence 566789999999999988765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=294.34 Aligned_cols=178 Identities=31% Similarity=0.537 Sum_probs=151.4
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
||+++.|++.+.||+|+||.||+|.+.+ ..||||+++.. ........|.+|+.++++++||||++++|++.+.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 6778899999999999999999998743 36999999754 3455567799999999999999999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
...++||||+.++++.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999998754
Q ss_pred cCC----ceecCCCcccccchhccccccC
Q 023285 260 QSG----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
... ......||+.|||||++.+..|
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKF 190 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCC
Confidence 322 1223468999999999988765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=302.72 Aligned_cols=181 Identities=29% Similarity=0.557 Sum_probs=153.8
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|+|+.++|++.+.||+|+||.||+|++.+ ..||+|.+.... .......+.+|+.+++++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4589999999999999999999999998742 259999986542 334456799999999998 8999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~ 232 (284)
++.+.+.+|+||||+++|+|.+++.... +.+++..++.++.||+.||+|||++||+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997643 247889999999999999999999999999
Q ss_pred CCCCCCEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 233 Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
||||+|||++.++.+||+|||+|+....... .....||+.|||||++.+..|
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 9999999999999999999999987554332 223457999999999987765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=290.50 Aligned_cols=175 Identities=34% Similarity=0.613 Sum_probs=156.3
Q ss_pred eccCCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEE
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV 185 (284)
+++++|++.++||+|+||+||+|++. ++.||||+++...... ++|.+|+.++++++||||++++|+|.+++.+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46779999999999999999999995 5689999998654443 5799999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc--
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~-- 263 (284)
|||+++|+|.+++......+++..+.+++.|+++||+|||++||+||||||+||+++.++.+||+|||+|+.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999999888778899999999999999999999999999999999999999999999999999986544332
Q ss_pred eecCCCcccccchhccccccC
Q 023285 264 MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 ~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~ 178 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKF 178 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCC
T ss_pred ecccCCCCCcCCcHHhcCCCC
Confidence 234578999999999987665
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=293.15 Aligned_cols=177 Identities=28% Similarity=0.480 Sum_probs=153.7
Q ss_pred eeeccCCceeeee-eeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 105 WEIDAKQLKIECK-VASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 105 ~~i~~~~~~~~~~-lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
+.+..++|.+.+. ||+|+||.||+|.+. +..||||+++.. ......++|.+|++++++++||||++++|++..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 4466778889884 999999999999763 347999999764 345667889999999999999999999999976
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
+.+|+||||+++|+|.+++...++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999997777789999999999999999999999999999999999999999999999999998765
Q ss_pred cCCc----eecCCCcccccchhcccccc
Q 023285 260 QSGV----MTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~~----~~~~~gt~~y~aPEvl~~~~ 283 (284)
.... .....||+.|||||++.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRK 188 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred ccccccccccccccCccccChHHHhCCC
Confidence 4322 22446899999999987654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-41 Score=293.39 Aligned_cols=174 Identities=22% Similarity=0.354 Sum_probs=155.3
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC----HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN----TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 183 (284)
++|++.+.||+|+||.||+|++ +++.||||+++..... ....+.+.+|+.++++++||||+++++++.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4799999999999999999998 4789999999654322 123577999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC----cEEEecccceeeec
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA 259 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~----~vkl~Dfg~a~~~~ 259 (284)
+||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 90 iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 999999999999999764 6799999999999999999999999999999999999998776 59999999999877
Q ss_pred cCCceecCCCcccccchhccccccC
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.........||+.|||||++.+..|
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~ 193 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPL 193 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCB
T ss_pred CCccccccCCCCcccCHHHHcCCCC
Confidence 6666667789999999999987654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-41 Score=296.14 Aligned_cols=167 Identities=32% Similarity=0.489 Sum_probs=149.4
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
.|+..+.||+|+||.||+|+. +++.||||+++..... .+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 599999999999999999987 4788999999765443 4456779999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceecC
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~~ 267 (284)
|+.+|+|..++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~~~~ 171 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---ANSF 171 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---BCCC
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---CCcc
Confidence 9999988776654 56799999999999999999999999999999999999999999999999999986543 2456
Q ss_pred CCcccccchhcccc
Q 023285 268 TGTYRWMAPEVAFT 281 (284)
Q Consensus 268 ~gt~~y~aPEvl~~ 281 (284)
.||+.|||||++.+
T Consensus 172 ~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 172 VGTPYWMAPEVILA 185 (309)
T ss_dssp CSCGGGCCHHHHTT
T ss_pred ccCccccCHHHHhc
Confidence 79999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=291.93 Aligned_cols=176 Identities=28% Similarity=0.531 Sum_probs=145.5
Q ss_pred eccCCceeee-eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 107 IDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 107 i~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
++.+.+.+.+ +||+|+||.||+|.+. ++.||||+++....+....++|.+|+.++++++||||++++++|.. +.
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~ 81 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 81 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC
Confidence 3445556654 6999999999999863 3679999998665556667789999999999999999999999976 46
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++||||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 7899999999999999976 467999999999999999999999999999999999999999999999999999875433
Q ss_pred Cc----eecCCCcccccchhccccccC
Q 023285 262 GV----MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~----~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. .....||+.|||||++.+..|
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~ 187 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKF 187 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred ccccccccccCCCceecCchhhcCCCC
Confidence 22 223468999999999977643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-41 Score=298.31 Aligned_cols=172 Identities=27% Similarity=0.455 Sum_probs=153.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|+. +++.||||+++.... .....+.+.+|+.++++++||||+++++++.++..+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999997 478999999864321 1223567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||++||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 84 E~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~ 160 (316)
T d1fota_ 84 DYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT 160 (316)
T ss_dssp CCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred eecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence 99999999998876 467899999999999999999999999999999999999999999999999999876543 346
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
.+||+.|||||++.+..|
T Consensus 161 ~~Gt~~Y~APE~l~~~~y 178 (316)
T d1fota_ 161 LCGTPDYIAPEVVSTKPY 178 (316)
T ss_dssp CCSCTTTCCHHHHTTCCB
T ss_pred ccCcccccCHHHHcCCCC
Confidence 789999999999988765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=293.29 Aligned_cols=179 Identities=38% Similarity=0.685 Sum_probs=151.2
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
.+.|+|+.++|++.+.||+|+||.||+|++.+ +.||||+++..... .+.|.+|+.++++++||||++++++|.+ .
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 46799999999999999999999999999854 68999999765433 3579999999999999999999999865 5
Q ss_pred cEEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
.+++||||+++|+|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 689999999999999998754 3569999999999999999999999999999999999999999999999999998654
Q ss_pred cCC--ceecCCCcccccchhccccccC
Q 023285 260 QSG--VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~--~~~~~~gt~~y~aPEvl~~~~y 284 (284)
... ..+...||+.|+|||++.+..|
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~ 191 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRF 191 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCC
T ss_pred CCCceeeccccccccccChHHHhCCCC
Confidence 332 2334578999999999987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-41 Score=289.25 Aligned_cols=179 Identities=31% Similarity=0.515 Sum_probs=147.1
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 178 (284)
+|+|+.++|++.+.||+|+||.||+|++.+ ..||||.++.. ......+.|.+|+.++++++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 489999999999999999999999998742 45889988643 345566789999999999999999999999964
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
+.+|+||||+++|+|.+++......+++..++.++.||+.||+|||+++|+||||||+||+++.++.+||+|||+|+..
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999998887788999999999999999999999999999999999999999999999999999875
Q ss_pred ccCC--ceecCCCcccccchhccccccC
Q 023285 259 AQSG--VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 259 ~~~~--~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... ..+...||+.|+|||++.+..|
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCC
T ss_pred cCCcceeccceecCcccchhhHhccCCC
Confidence 4332 2344568999999999987655
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-40 Score=284.68 Aligned_cols=171 Identities=24% Similarity=0.378 Sum_probs=154.1
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcC
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP 179 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 179 (284)
++|++.+.||+|+||+||+|+. +++.||||+++..... ......+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999998 5789999999654322 123456889999999997 99999999999999
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
..+|+||||++||+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999976 4679999999999999999999999999999999999999999999999999999877
Q ss_pred cCCceecCCCcccccchhcccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~ 281 (284)
.....+...||+.|+|||++.+
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHH
T ss_pred CCCceeeeeccCCCCCHHHhhc
Confidence 6656667789999999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-40 Score=296.79 Aligned_cols=172 Identities=26% Similarity=0.387 Sum_probs=153.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|.+ +++.||||+++.... .....+.+.+|+.++++++||||+++++++.....+++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999988 478999999864321 1223467899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCceec
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~~~~ 266 (284)
||+.||+|.+++.+. +.+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 121 e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 999999999999764 67999999999999999999999999999999999999999999999999999876543 345
Q ss_pred CCCcccccchhccccccC
Q 023285 267 ETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~y 284 (284)
..||+.|||||++.+..|
T Consensus 198 ~~Gt~~Y~APE~~~~~~~ 215 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGY 215 (350)
T ss_dssp CEECGGGCCHHHHTTCCB
T ss_pred ccCccccCCHHHHcCCCC
Confidence 689999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-40 Score=289.36 Aligned_cols=173 Identities=18% Similarity=0.289 Sum_probs=154.2
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (284)
.++|++.+.||+|+||.||+|.+ +++.||||+++.. ......+.+|+++|++++||||+++++++.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 35799999999999999999997 4789999999754 223456889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCC--CcEEEecccceeeeccCCce
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVM 264 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~--~~vkl~Dfg~a~~~~~~~~~ 264 (284)
||++||+|.+++......+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999999998766689999999999999999999999999999999999999854 48999999999887665556
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
....+|+.|+|||++.+..|
T Consensus 161 ~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEE
T ss_pred cccccccccccchhccCCCC
Confidence 66789999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=286.63 Aligned_cols=174 Identities=36% Similarity=0.653 Sum_probs=146.9
Q ss_pred eeeccCCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCcEE
Q 023285 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC 183 (284)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~ 183 (284)
|+|+.++|++.+.||+|+||.||+|+++++.||||+++.+ ...+.|.+|+.++++++||||++++|+|.+ ++.+|
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 8999999999999999999999999999999999999753 234678999999999999999999999865 45689
Q ss_pred EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+++|+|.+++.+.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999999997643 35899999999999999999999999999999999999999999999999999865443
Q ss_pred ceecCCCcccccchhccccccC
Q 023285 263 VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....+|+.|+|||++.+..|
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp ------CCTTTSCHHHHHHCCC
T ss_pred -CccccccccCCChHHHhCCCC
Confidence 334568999999999987654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-40 Score=285.89 Aligned_cols=182 Identities=31% Similarity=0.585 Sum_probs=146.4
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEE
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 173 (284)
.+.|+|+.++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|..++.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 3578999999999999999999999999863 2579999987543 445567788888888877 589999999
Q ss_pred eEEEcC-CcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 174 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 174 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
+++..+ ..+++||||+++|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 998764 46899999999999999997642 34889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|||++.++.+||+|||+|+...... ..+...||+.|||||++.+..|
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 9999999999999999998654332 2234579999999999987764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-39 Score=279.43 Aligned_cols=175 Identities=27% Similarity=0.423 Sum_probs=146.4
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC----c
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----N 181 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~ 181 (284)
.++|++.+.||+|+||.||+|.. +++.||||+++.... +.+....+.+|+.++++++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999997 478999999986544 3556678999999999999999999999987654 3
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||++|++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999999999999876 467999999999999999999999999999999999999999999999999998754332
Q ss_pred C----ceecCCCcccccchhccccccC
Q 023285 262 G----VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~----~~~~~~gt~~y~aPEvl~~~~y 284 (284)
. ......||+.|||||++.+..|
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 191 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSV 191 (277)
T ss_dssp --------------TTCCHHHHTTCCC
T ss_pred cccccccccccCcccccCHHHHcCCCC
Confidence 2 2345579999999999988765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-39 Score=283.81 Aligned_cols=180 Identities=30% Similarity=0.548 Sum_probs=155.6
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 176 (284)
.+|+..++|++.+.||+|+||.||+|++.+ +.||||+++.. ...+..++|.+|+.++++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 467788899999999999999999998743 67999999754 3455677899999999999999999999999
Q ss_pred EcCCcEEEEEEcCCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 023285 177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233 (284)
Q Consensus 177 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~D 233 (284)
......++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999997532 2378889999999999999999999999999
Q ss_pred CCCCCEEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 234 ikp~NIli~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
|||+|||++.++.+||+|||+|+...... ..+...||+.|||||++.+..|
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 99999999999999999999998643322 2234578999999999988765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-39 Score=289.61 Aligned_cols=171 Identities=24% Similarity=0.380 Sum_probs=147.0
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 182 (284)
.++|++.+.||+|+||.||+|+. +++.||||++..... .........+|+.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 46899999999999999999998 478999999863321 111222334457778888899999999999999999
Q ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC
Q 023285 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~ 262 (284)
|+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~- 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred EEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence 9999999999999999774 67899999999999999999999999999999999999999999999999999876543
Q ss_pred ceecCCCcccccchhcccc
Q 023285 263 VMTAETGTYRWMAPEVAFT 281 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~ 281 (284)
......||+.|||||++.+
T Consensus 161 ~~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp CCCSCCSCGGGCCHHHHST
T ss_pred cccccccccccchhHHhhc
Confidence 3455689999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=284.26 Aligned_cols=181 Identities=27% Similarity=0.511 Sum_probs=158.0
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeE
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 175 (284)
+.|+|+.++|++.++||+|+||.||+|.+. ++.||||+++.. ...+....|.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 569999999999999999999999999874 367999999754 345566779999999999999999999999
Q ss_pred EEcCCcEEEEEEcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCc
Q 023285 176 CTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (284)
Q Consensus 176 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~ 246 (284)
|..+...++||||+++|+|.+++.... ..+++..+..++.|+++||.|||+++|+||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 999999999999999999999986532 34688899999999999999999999999999999999999999
Q ss_pred EEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 247 VKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 247 vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
+||+|||+|+....... .....||+.|+|||.+.+..|
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence 99999999986543322 233468999999999987654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=284.68 Aligned_cols=174 Identities=24% Similarity=0.423 Sum_probs=150.2
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHH-hCCCCceeeEEeEEEcCCcEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lV 185 (284)
++|.+.+.||+|+||.||+|++ +++.||||+++.... ..+..+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 579999999964321 1222445666766654 78999999999999999999999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeecc-CCce
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVM 264 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~-~~~~ 264 (284)
|||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999976 46799999999999999999999999999999999999999999999999999986543 3344
Q ss_pred ecCCCcccccchhccccccC
Q 023285 265 TAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 265 ~~~~gt~~y~aPEvl~~~~y 284 (284)
+...||+.|+|||++.+..|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~ 180 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKY 180 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCB
T ss_pred cccCCCCCcCCHHHHcCCCC
Confidence 55689999999999998765
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=283.30 Aligned_cols=173 Identities=25% Similarity=0.460 Sum_probs=146.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.+.||+|+||.||+|.+ +++.||||+++...........+.+|++++++++||||+++++++.++..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4899999999999999999998 47899999997654444456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC-Ccee
Q 023285 188 FMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (284)
Q Consensus 188 ~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~-~~~~ 265 (284)
|+.+ ++.+++.. ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||.|+..... ....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 9976 55555543 4567999999999999999999999999999999999999999999999999999865443 2334
Q ss_pred cCCCcccccchhcccccc
Q 023285 266 AETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 266 ~~~gt~~y~aPEvl~~~~ 283 (284)
...||+.|+|||++....
T Consensus 161 ~~~gt~~y~apE~~~~~~ 178 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCK 178 (298)
T ss_dssp CCBCCCTTCCHHHHTTCS
T ss_pred eecccceeeehhhhcccc
Confidence 557999999999987654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=283.88 Aligned_cols=175 Identities=28% Similarity=0.546 Sum_probs=147.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCc
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 181 (284)
...+|++.+.||+|+||.||+|.+. ++ .||+|.++.. .+.+..+.|.+|+.++++++||||++++|+|.++ .
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 4457999999999999999999874 32 5899988643 2344567899999999999999999999999875 5
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
.++++|++.+|+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 78889999999999999887788999999999999999999999999999999999999999999999999999875433
Q ss_pred Cc---eecCCCcccccchhccccccC
Q 023285 262 GV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
.. .....||+.|||||++.+..|
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~ 190 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIY 190 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCC
T ss_pred cccccccccccCccccChHHHhcCCC
Confidence 22 223468999999999988765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-39 Score=280.92 Aligned_cols=180 Identities=31% Similarity=0.613 Sum_probs=153.0
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEE
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 173 (284)
.|+|+.++|.+.+.||+|+||.||+|+..+ ..||||+++.+. ......++.+|...+.++ +||||++++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 399999999999999999999999998632 369999997653 455567899999999888 799999999
Q ss_pred eEEEcCCcEEEEEEcCCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 023285 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (284)
Q Consensus 174 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~N 238 (284)
++|.++...++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 99999999999999999999999997643 358999999999999999999999999999999999
Q ss_pred EEecCCCcEEEecccceeeeccCC---ceecCCCcccccchhccccccC
Q 023285 239 LLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 239 Ili~~~~~vkl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPEvl~~~~y 284 (284)
||++.++.+||+|||+++...... ......||+.|+|||++.+..|
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y 214 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence 999999999999999998654432 2334578999999999987765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-39 Score=285.79 Aligned_cols=168 Identities=23% Similarity=0.369 Sum_probs=146.1
Q ss_pred CCceeee-eeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHh-CCCCceeeEEeEEEc----CCc
Q 023285 110 KQLKIEC-KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR----PPN 181 (284)
Q Consensus 110 ~~~~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~ 181 (284)
++|++.. .||+|+||.||+|++ +++.||||+++.. ..+.+|+.++.+ .+||||+++++++.+ +..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 5788875 599999999999997 4789999998642 356789988655 489999999999865 456
Q ss_pred EEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC---CCcEEEecccceee
Q 023285 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~---~~~vkl~Dfg~a~~ 257 (284)
+|+|||||+||+|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 899999999999999997643 46999999999999999999999999999999999999985 56799999999998
Q ss_pred eccCCceecCCCcccccchhccccccC
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...........||+.|||||++.+..|
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~y 190 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPEKY 190 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGGGG
T ss_pred ccCCCccccccCCcccCCcHHHcCCCC
Confidence 776666677789999999999988765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=279.83 Aligned_cols=178 Identities=35% Similarity=0.608 Sum_probs=143.9
Q ss_pred eeccCCceeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
-|+.++|++.+.||+|+||.||+|++.+ ..||||+++.... ..+..++|.+|+.++++++||||++++|+|.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 3667899999999999999999998732 3689999876543 34456789999999999999999999999976
Q ss_pred CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 180 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
+.+++||||+++|++.+++....+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 56889999999999999998877789999999999999999999999999999999999999999999999999999764
Q ss_pred cCCc----eecCCCcccccchhccccccC
Q 023285 260 QSGV----MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~~----~~~~~gt~~y~aPEvl~~~~y 284 (284)
.... .....||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCC
Confidence 4332 223357889999999987653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=283.13 Aligned_cols=178 Identities=32% Similarity=0.541 Sum_probs=150.1
Q ss_pred eeccCCceeeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEeEEEcCC
Q 023285 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (284)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 180 (284)
.|+.++|++.+.||+|+||.||+|++. +. .||||.++... ..+..+.|.+|+.+++++ +||||++++++|.+++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 467889999999999999999999884 33 57888875432 334566799999999999 6999999999999999
Q ss_pred cEEEEEEcCCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC
Q 023285 181 NLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (284)
Q Consensus 181 ~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~ 245 (284)
.+++||||+++|+|.+++++. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999753 35789999999999999999999999999999999999999999
Q ss_pred cEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 246 ~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.+||+|||+|+............||+.|+|||.+.+..|
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 203 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCC
Confidence 999999999987655444455679999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=279.16 Aligned_cols=181 Identities=29% Similarity=0.570 Sum_probs=158.1
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCceeeEEe
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 174 (284)
..|+|+.++|++.+.||+|+||.||+|++. ++.||||+++... .......|.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 369999999999999999999999999863 3579999998653 455567899999999999 6999999999
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~ 237 (284)
+|.++..+++||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++++||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997642 25889999999999999999999999999999999
Q ss_pred CEEecCCCcEEEecccceeeeccCCc---eecCCCcccccchhccccccC
Q 023285 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 238 NIli~~~~~vkl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPEvl~~~~y 284 (284)
||+++.++.+|++|||.++....... .+...||+.|+|||++.+..|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence 99999999999999999986543322 234578999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-39 Score=277.52 Aligned_cols=172 Identities=24% Similarity=0.398 Sum_probs=147.9
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhCC--CCceeeEEeEEEcCCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 181 (284)
++|++.+.||+|+||.||+|+. +++.||||+++...... ....++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 4799999999999999999998 47899999987543221 11234778999999997 8999999999999999
Q ss_pred EEEEEEcCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-CCcEEEecccceeeec
Q 023285 182 LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA 259 (284)
Q Consensus 182 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-~~~vkl~Dfg~a~~~~ 259 (284)
.|+||||+.+ +++.+++.+ ++.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999976 588888866 467999999999999999999999999999999999999985 4799999999998755
Q ss_pred cCCceecCCCcccccchhcccccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
.. ..+...||+.|||||++.+..
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~ 185 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHR 185 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSC
T ss_pred cc-cccccccCCCcCCHHHHcCCC
Confidence 43 345678999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=275.21 Aligned_cols=168 Identities=29% Similarity=0.559 Sum_probs=140.8
Q ss_pred CCceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC----cEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV 185 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lV 185 (284)
.+|.+.++||+|+||.||+|+++++.||||+++.. ......+..|+..+++++||||++++++|..+. .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 57899999999999999999999999999998643 222222334555667889999999999997654 58999
Q ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 186 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~--------~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
|||+++|+|.+++++ ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999976 358999999999999999999996 5999999999999999999999999999987
Q ss_pred eccCC-----ceecCCCcccccchhccccc
Q 023285 258 QAQSG-----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~-----~~~~~~gt~~y~aPEvl~~~ 282 (284)
..... ......||+.|||||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred ccCCCcceeccccceecccCcCChhhcccc
Confidence 65433 22345799999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=276.13 Aligned_cols=168 Identities=29% Similarity=0.435 Sum_probs=140.1
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
.++.||+|+||+||+|+. +++.||||+++..... ....+.+.+|+.++++++||||+++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999987 4789999998754322 12235689999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+.++++..+. ..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .....
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9886655544 446789999999999999999999999999999999999999999999999999998654432 33456
Q ss_pred CCcccccchhccccc
Q 023285 268 TGTYRWMAPEVAFTF 282 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~ 282 (284)
+||+.|||||++.+.
T Consensus 161 ~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGA 175 (299)
T ss_dssp CCCCTTCCHHHHTTC
T ss_pred ecChhhccHHHHccC
Confidence 799999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=277.53 Aligned_cols=176 Identities=26% Similarity=0.441 Sum_probs=148.7
Q ss_pred cCCceeeeeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhC---CCCceeeEEeEEEc----
Q 023285 109 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR---- 178 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 178 (284)
.++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 358999999999999999999873 46799999875443333334566777777766 79999999999853
Q ss_pred -CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 179 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
...++++||++.++++..........+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3468999999998777666655567799999999999999999999999999999999999999999999999999987
Q ss_pred eccCCceecCCCcccccchhccccccC
Q 023285 258 QAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...........||+.|||||++.+..|
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y 192 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSY 192 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCC
T ss_pred hcccccCCCcccChhhcCcchhcCCCC
Confidence 766666677889999999999988765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-38 Score=277.41 Aligned_cols=175 Identities=28% Similarity=0.458 Sum_probs=148.5
Q ss_pred CeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC
Q 023285 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (284)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 180 (284)
..|++ .++|++.++||+|+||.||+|+. +++.||||+++....+....+.+.+|+.+|++++||||++++++|....
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 34666 56899999999999999999997 4789999999876666777788999999999999999999999997654
Q ss_pred ------cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 181 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
.+|+||||+ +.+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 479999999 5588887754 5699999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
|+..... .+...||+.|+|||++.+..
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~~ 194 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNWM 194 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTTT
T ss_pred eeccCCc--cccccccccccCHHHHcCCC
Confidence 9876543 46678999999999987643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.1e-38 Score=271.61 Aligned_cols=173 Identities=25% Similarity=0.396 Sum_probs=147.2
Q ss_pred CCceeeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEEc
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e~ 188 (284)
++|++.++||+|+||.||+|++. ++.||||+++...........+.+|+.++++++||||+++++++..++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999884 68999999976654444567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceecC
Q 023285 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (284)
Q Consensus 189 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~~ 267 (284)
+.++.+..+ ....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.|....... .....
T Consensus 82 ~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHH-HTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHH-HhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 987555554 4556789999999999999999999999999999999999999999999999999998654332 23445
Q ss_pred CCcccccchhcccccc
Q 023285 268 TGTYRWMAPEVAFTFF 283 (284)
Q Consensus 268 ~gt~~y~aPEvl~~~~ 283 (284)
.+++.|+|||++.+..
T Consensus 161 ~~~~~y~~pE~~~~~~ 176 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSK 176 (286)
T ss_dssp -CCCTTCCHHHHTTCC
T ss_pred cccchhhhHHHHhCCC
Confidence 7899999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=270.30 Aligned_cols=171 Identities=30% Similarity=0.502 Sum_probs=147.5
Q ss_pred eeeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc-CCcEEEEE
Q 023285 113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVT 186 (284)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lV~ 186 (284)
.+.++||+|+||+||+|++.. ..||||.++.. .+....++|.+|++++++++||||++++|++.. ++.+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 457889999999999998732 35899998743 356667889999999999999999999999865 56799999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCCc---
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~~--- 263 (284)
||+++|+|.+++......+++..+++++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999999988777888999999999999999999999999999999999999999999999999986543321
Q ss_pred --eecCCCcccccchhccccccC
Q 023285 264 --MTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 264 --~~~~~gt~~y~aPEvl~~~~y 284 (284)
.....||+.|+|||++.+..|
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~ 211 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKF 211 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCC
T ss_pred eecccccccccccChHHHhcCCC
Confidence 223468999999999887654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-36 Score=268.71 Aligned_cols=165 Identities=18% Similarity=0.385 Sum_probs=144.9
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEc--CCcEE
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPNLC 183 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~ 183 (284)
.++|++.++||+|+||+||+|+. +++.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ...++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 45799999999999999999997 47899999997542 356889999999996 9999999999974 45699
Q ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeeccCC
Q 023285 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262 (284)
Q Consensus 184 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~~~~ 262 (284)
+||||+.+++|..+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999987653 4699999999999999999999999999999999999998655 69999999999876665
Q ss_pred ceecCCCcccccchhccccc
Q 023285 263 VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 263 ~~~~~~gt~~y~aPEvl~~~ 282 (284)
......+|+.|+|||++.+.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTC
T ss_pred cccccccCccccCcccccCC
Confidence 66777899999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=270.40 Aligned_cols=175 Identities=23% Similarity=0.422 Sum_probs=143.5
Q ss_pred eeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCC-
Q 023285 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP- 180 (284)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 180 (284)
.|+|.. +|++.++||+|+||+||+|.. +++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 3 ~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 3 VFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp CCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 455544 699999999999999999987 47999999997543 4556678999999999999999999999997643
Q ss_pred ---cEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 181 ---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 181 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
..+++++++.+|+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 23444455668899999975 4699999999999999999999999999999999999999999999999999986
Q ss_pred eccCC----ceecCCCcccccchhccccc
Q 023285 258 QAQSG----VMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 258 ~~~~~----~~~~~~gt~~y~aPEvl~~~ 282 (284)
..... ......||+.|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred ccCCCccceeeccccccceechHHHhhcC
Confidence 54322 23445799999999998554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=262.03 Aligned_cols=173 Identities=26% Similarity=0.427 Sum_probs=154.4
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcCCcEEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lV~e 187 (284)
++|++.++||+|+||+||+|++ +++.||||+++...........+.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4799999999999999999998 46889999998765566677889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccCC-ceec
Q 023285 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (284)
Q Consensus 188 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~~-~~~~ 266 (284)
++.+++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...... ....
T Consensus 82 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred ecccccccccccc-ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999888877754 5788999999999999999999999999999999999999999999999999998765433 3344
Q ss_pred CCCcccccchhcccccc
Q 023285 267 ETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 267 ~~gt~~y~aPEvl~~~~ 283 (284)
..+++.|+|||++.+..
T Consensus 161 ~~~~~~~~~pe~~~~~~ 177 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp CCSCGGGCCHHHHTTCS
T ss_pred eccccchhhhhHhccCC
Confidence 56789999999987654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-36 Score=264.43 Aligned_cols=172 Identities=19% Similarity=0.279 Sum_probs=148.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEcCCcEEE
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCI 184 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~l 184 (284)
-.++|++.+.||+|+||.||+|++ +++.||||+++..... ..+.+|++.++.++| +|++.+++++..+...++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 367899999999999999999997 4789999998644222 346788999999986 899999999999999999
Q ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecC-----CCcEEEecccceeeec
Q 023285 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARVQA 259 (284)
Q Consensus 185 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~-----~~~vkl~Dfg~a~~~~ 259 (284)
||||+ +++|.+++......++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67999999887778999999999999999999999999999999999999964 5789999999998754
Q ss_pred cCC--------ceecCCCcccccchhccccccC
Q 023285 260 QSG--------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 260 ~~~--------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
... ......||+.|||||++.+..|
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~ 190 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 190 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC
Confidence 321 1234579999999999988754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=269.70 Aligned_cols=177 Identities=24% Similarity=0.434 Sum_probs=150.0
Q ss_pred CCeeeeccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEcC
Q 023285 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (284)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 179 (284)
...|++ .++|++.++||+|+||+||+|+. +++.||||+++....+....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~ 89 (348)
T d2gfsa1 11 KTIWEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 89 (348)
T ss_dssp SSEEEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CccccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence 457887 46899999999999999999987 479999999987666667777899999999999999999999998643
Q ss_pred -----CcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 180 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 180 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
...+++++++.||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.
T Consensus 90 ~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 90 RSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred cccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccch
Confidence 334666777889999999954 5699999999999999999999999999999999999999999999999999
Q ss_pred eeeeccCCceecCCCcccccchhcccccc
Q 023285 255 ARVQAQSGVMTAETGTYRWMAPEVAFTFF 283 (284)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPEvl~~~~ 283 (284)
|...... .....||+.|+|||++.+..
T Consensus 168 a~~~~~~--~~~~~g~~~y~apE~~~~~~ 194 (348)
T d2gfsa1 168 ARHTDDE--MTGYVATRWYRAPEIMLNWM 194 (348)
T ss_dssp --CCTGG--GSSSCHHHHTSCHHHHTTCS
T ss_pred hcccCcc--cccccccccccCchhhcCCc
Confidence 9765432 34567999999999987654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=264.39 Aligned_cols=173 Identities=28% Similarity=0.469 Sum_probs=143.5
Q ss_pred cCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc--------
Q 023285 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (284)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 178 (284)
.++|++.++||+|+||+||+|++ +++.||||+++.....+....++.+|+.++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 46899999999999999999997 47899999987655445556778999999999999999999999865
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...+|+||||+.++.+. ........+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~~~~~iv~e~~~~~~~~-~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHH-HHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccc-hhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 34689999999875554 44444678999999999999999999999999999999999999999999999999999764
Q ss_pred ccC-----CceecCCCcccccchhccccc
Q 023285 259 AQS-----GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~-----~~~~~~~gt~~y~aPEvl~~~ 282 (284)
... .......||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred ccccccccccccceecCHHHhhHHHHcCC
Confidence 422 122345799999999998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-36 Score=267.95 Aligned_cols=166 Identities=25% Similarity=0.344 Sum_probs=140.3
Q ss_pred CceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc------CCcE
Q 023285 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPNL 182 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~ 182 (284)
+|+..++||+|+||+||+|++ +++.||||+++.+.. .+.+|+.++++++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999998 478999999975432 23479999999999999999999853 3358
Q ss_pred EEEEEcCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCC-cEEEecccceeeec
Q 023285 183 CIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQA 259 (284)
Q Consensus 183 ~lV~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~-~vkl~Dfg~a~~~~ 259 (284)
|+||||++++.+..+.. .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 99999998754333322 2356799999999999999999999999999999999999999775 89999999999876
Q ss_pred cCCceecCCCcccccchhccccc
Q 023285 260 QSGVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 260 ~~~~~~~~~gt~~y~aPEvl~~~ 282 (284)
.........||+.|+|||++.+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTC
T ss_pred CCcccccccccccccChHHhhcc
Confidence 66666677899999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-36 Score=268.86 Aligned_cols=171 Identities=26% Similarity=0.376 Sum_probs=139.0
Q ss_pred CCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCceeeEEeEEEc------CCc
Q 023285 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPN 181 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 181 (284)
++|++.++||+|+||+||+|.+ +++.||||+++....+.....++.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999998 47999999998776677777889999999999999999999999964 367
Q ss_pred EEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeeeccC
Q 023285 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (284)
Q Consensus 182 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~~~ 261 (284)
+|+||||+.+ ++.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++++|||.++.....
T Consensus 97 ~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 8999999976 5555553 45899999999999999999999999999999999999999999999999999877766
Q ss_pred CceecCCCcccccchhccccccC
Q 023285 262 GVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 262 ~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
...+...+|+.|+|||++.+..|
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~ 195 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_dssp --------CCTTCCHHHHTTCCC
T ss_pred cccccccccccccChhhhcCCCC
Confidence 66677789999999999988654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-35 Score=257.07 Aligned_cols=170 Identities=26% Similarity=0.375 Sum_probs=141.8
Q ss_pred CCceeeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCc-eeeEEeEEEcCCcEEEEE
Q 023285 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT 186 (284)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lV~ 186 (284)
++|++.+.||+|+||.||+|++. ++.||||+++..... .++..|++++++++|+| |+.+.+++......++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 47999999999999999999974 789999998754322 34788999999998766 555566667788899999
Q ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEec---CCCcEEEecccceeeeccCC-
Q 023285 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG- 262 (284)
Q Consensus 187 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~---~~~~vkl~Dfg~a~~~~~~~- 262 (284)
||+ +++|.+.+....+.+++..+..++.|++.||+|||++||+||||||+|||++ .+..++|+|||+|+......
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999 5588888777677899999999999999999999999999999999999986 45579999999998754322
Q ss_pred -------ceecCCCcccccchhccccccC
Q 023285 263 -------VMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 263 -------~~~~~~gt~~y~aPEvl~~~~y 284 (284)
......||+.|||||++.+..|
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 190 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQ 190 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCC
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCC
Confidence 1234579999999999988754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-36 Score=263.56 Aligned_cols=175 Identities=22% Similarity=0.366 Sum_probs=150.8
Q ss_pred eccCCceeeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCC-CceeeEEeEEEc
Q 023285 107 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTR 178 (284)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 178 (284)
+..++|++.+.||+|+||.||+|.. +++.||||+++.... +....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457899999999999999999976 357899999865422 12234568899999999987 899999999999
Q ss_pred CCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 179 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
...+++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999774 56789999999999999999999999999999999999999999999999999865
Q ss_pred ccC--CceecCCCcccccchhccccc
Q 023285 259 AQS--GVMTAETGTYRWMAPEVAFTF 282 (284)
Q Consensus 259 ~~~--~~~~~~~gt~~y~aPEvl~~~ 282 (284)
... .......|++.|+|||++.+.
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred cccccccccccccccccchhHHhhcC
Confidence 332 233456799999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.1e-29 Score=225.96 Aligned_cols=172 Identities=19% Similarity=0.357 Sum_probs=137.1
Q ss_pred ccCCceeeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-----------CCceeeEEe
Q 023285 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQFIG 174 (284)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~ 174 (284)
..++|++.++||+|+||+||+|+. +++.||||+++.. ....+.+.+|+.+++.+. |+||+++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 345799999999999999999987 5799999999753 344567888999988875 478999998
Q ss_pred EEEc--CCcEEEEEEcCCCCCH-HHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEecCCC----
Q 023285 175 ACTR--PPNLCIVTEFMARGSI-YDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG---- 245 (284)
Q Consensus 175 ~~~~--~~~~~lV~e~~~~gsL-~~~l-~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~iiH~Dikp~NIli~~~~---- 245 (284)
++.. ....+++++++..+.. .... ......+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8754 3456667766655433 2322 2334678999999999999999999997 8999999999999998665
Q ss_pred --cEEEecccceeeeccCCceecCCCcccccchhccccccC
Q 023285 246 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVAFTFFF 284 (284)
Q Consensus 246 --~vkl~Dfg~a~~~~~~~~~~~~~gt~~y~aPEvl~~~~y 284 (284)
.++++|||.|...... .....||+.|+|||++.+..|
T Consensus 168 ~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 206 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW 206 (362)
T ss_dssp EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC
T ss_pred cceeeEeecccccccccc--cccccccccccChhhccccCC
Confidence 4999999999865443 355689999999999887654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5e-26 Score=184.84 Aligned_cols=136 Identities=15% Similarity=0.155 Sum_probs=108.1
Q ss_pred ceeeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----------------HHHHHHHHHHHHHHHhCCCCceeeEEe
Q 023285 112 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----------------TEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (284)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~~~~ 174 (284)
+.+.++||+|+||.||+|+. +++.||||+++..... .........|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999986 6799999998643211 112234567899999999999999887
Q ss_pred EEEcCCcEEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEecCCCcEEEecccc
Q 023285 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (284)
Q Consensus 175 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~iiH~Dikp~NIli~~~~~vkl~Dfg~ 254 (284)
+.. .+++|||+++..+. .++...+..++.|++.++.|||++||+||||||+|||++++ .++|+|||.
T Consensus 82 ~~~----~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 82 WEG----NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EET----TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ecC----CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 642 37999999885542 24556677899999999999999999999999999999865 589999999
Q ss_pred eeeecc
Q 023285 255 ARVQAQ 260 (284)
Q Consensus 255 a~~~~~ 260 (284)
|.....
T Consensus 149 a~~~~~ 154 (191)
T d1zara2 149 SVEVGE 154 (191)
T ss_dssp CEETTS
T ss_pred cccCCC
Confidence 976543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.91 E-value=3.6e-09 Score=87.77 Aligned_cols=140 Identities=11% Similarity=0.058 Sum_probs=95.4
Q ss_pred CceeeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEEEEcC
Q 023285 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (284)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV~e~~ 189 (284)
.|++.+..+.++.+.||+....++.+++|+...... .....+.+|...++.+. +--+++++.++..++..++||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 566666555555678999888888899998764321 11234677888888775 444788888888888899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 023285 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------- 226 (284)
Q Consensus 190 ~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~------------------------------------------- 226 (284)
+|.++.+..... .. ...++.++...+..||+
T Consensus 93 ~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 998775543211 11 12223333333444442
Q ss_pred ----------C------CceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 227 ----------N------NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 227 ----------~------~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
. .++|+|+.|.||++++++.+-|+||+.+...
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccC
Confidence 1 2689999999999987766779999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.29 E-value=4.9e-06 Score=67.84 Aligned_cols=137 Identities=10% Similarity=0.095 Sum_probs=83.8
Q ss_pred eeeecCc-eEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC--CceeeEEeEEEcCCcEEEEEEcCCCC
Q 023285 117 KVASGSY-GDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG 192 (284)
Q Consensus 117 ~lg~G~~-g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lV~e~~~~g 192 (284)
.+..|.. +.||+.+.. +..+++|.-.+... ..+..|...++.+.. -.+++++.++.+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3455554 578988875 45688898765422 236677888777753 34678888888888899999999885
Q ss_pred CHHH--------------HHHhcC------CC--CCHHHHHHHHH--------------------HHHHHHHHHHhC---
Q 023285 193 SIYD--------------FLHKQK------GV--FQLTSLLKVAI--------------------DVSKGMNYLHQN--- 227 (284)
Q Consensus 193 sL~~--------------~l~~~~------~~--~~~~~~~~i~~--------------------~i~~~L~~LH~~--- 227 (284)
++.+ .+.+-. .. ........-.. .....+..+.+.
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 4421 111100 00 00000000000 011123333322
Q ss_pred ----CceecCCCCCCEEecCCCcEEEecccceeee
Q 023285 228 ----NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (284)
Q Consensus 228 ----~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~ 258 (284)
.++|+|+.|.||++++++.+-|+||+.+...
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g 206 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 206 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcccC
Confidence 3799999999999988777789999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=5e-06 Score=72.76 Aligned_cols=76 Identities=12% Similarity=0.031 Sum_probs=47.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhCC-C--CceeeEEeEEEcCCcEEEE
Q 023285 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIR-H--KNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lV 185 (284)
+.||.|....||+.+. .++.++||.-.+... .+....+...|...|+.+. + ..+++++.+. +...++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 3578899999999875 357899997543210 0111234556777777663 2 4567777654 3456789
Q ss_pred EEcCCCCC
Q 023285 186 TEFMARGS 193 (284)
Q Consensus 186 ~e~~~~gs 193 (284)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998753
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.00021 Score=60.40 Aligned_cols=131 Identities=15% Similarity=0.155 Sum_probs=74.2
Q ss_pred eEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCcee--eEE-----eEEEcCCcEEEEEEcCCCCCH-
Q 023285 124 GDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV--QFI-----GACTRPPNLCIVTEFMARGSI- 194 (284)
Q Consensus 124 g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~~~-----~~~~~~~~~~lV~e~~~~gsL- 194 (284)
=.||+.+. .|+.|++|+.++...+. .++..|...+..|....+. ..+ ..+...+..+.++++++|..+
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 36998876 57889999988764333 4566788888777532221 111 122345668899999987321
Q ss_pred ----HH---------HHHhc--------CCCCCH-------------------H---HHHHHHHHHHHHHHHHH----hC
Q 023285 195 ----YD---------FLHKQ--------KGVFQL-------------------T---SLLKVAIDVSKGMNYLH----QN 227 (284)
Q Consensus 195 ----~~---------~l~~~--------~~~~~~-------------------~---~~~~i~~~i~~~L~~LH----~~ 227 (284)
.. -++.. +...+. . .....+.++...+.-.- ..
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 11 11110 011111 1 11222222322222221 13
Q ss_pred CceecCCCCCCEEecCCCcEEEecccceeeec
Q 023285 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (284)
Q Consensus 228 ~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~~~ 259 (284)
++||+|+.+.|||+++ + ..++||+-|....
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~ 222 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARNGP 222 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCEEC
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhcccCc
Confidence 6899999999999964 3 4589999997543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.00055 Score=59.27 Aligned_cols=70 Identities=13% Similarity=0.182 Sum_probs=46.3
Q ss_pred eeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCceeeEEeEEEcCCcEEEE
Q 023285 116 CKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (284)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lV 185 (284)
+.|+.|-.=.+|+....+ +.|.+++.- .. .. .....+|..+++.+. +.-.+++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 457777777899887632 457777754 21 11 234567899998886 4444677877753 689
Q ss_pred EEcCCCCC
Q 023285 186 TEFMARGS 193 (284)
Q Consensus 186 ~e~~~~gs 193 (284)
+||++|..
T Consensus 120 ~efi~g~~ 127 (395)
T d1nw1a_ 120 EEYIPSRP 127 (395)
T ss_dssp ECCCCEEE
T ss_pred EEEecccc
Confidence 99998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.29 E-value=0.00032 Score=58.70 Aligned_cols=139 Identities=11% Similarity=0.033 Sum_probs=74.5
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCce--eeEEe------EEEcCCcEEEEE
Q 023285 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV--VQFIG------ACTRPPNLCIVT 186 (284)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~------~~~~~~~~~lV~ 186 (284)
.+.|..|.--+.|+.+..+..+++|+..... ....+..|..++..+...++ +..+- +.........++
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCCC----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 3455666667789988877889999986431 12345556777777653222 11110 112234456667
Q ss_pred EcCCCCCH--------------HHHHHhcCCC--------------------------CCHHHHHHHHHHHHHHHHHHHh
Q 023285 187 EFMARGSI--------------YDFLHKQKGV--------------------------FQLTSLLKVAIDVSKGMNYLHQ 226 (284)
Q Consensus 187 e~~~~gsL--------------~~~l~~~~~~--------------------------~~~~~~~~i~~~i~~~L~~LH~ 226 (284)
.++.|... ...++..... .........+..+...+.-.+.
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 77766321 0111110000 0011112222233333333332
Q ss_pred ----CCceecCCCCCCEEecCCCcEEEecccceee
Q 023285 227 ----NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (284)
Q Consensus 227 ----~~iiH~Dikp~NIli~~~~~vkl~Dfg~a~~ 257 (284)
.|+||+|+.++||+++.+...-|+||+.|..
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999888789999999874
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=89.41 E-value=0.31 Score=30.53 Aligned_cols=47 Identities=15% Similarity=0.198 Sum_probs=39.0
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHH
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKE 62 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~ 62 (284)
-|.+++++|++-|.||.-.++|.+. ++.+-+|.|+ +.+...++|.+.
T Consensus 12 ~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~~ 58 (71)
T d2f06a1 12 ALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKEK 58 (71)
T ss_dssp HHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHHC
Confidence 4788999999999999999999876 6888899986 677777776653
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=87.56 E-value=0.77 Score=29.35 Aligned_cols=54 Identities=19% Similarity=0.180 Sum_probs=39.4
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCC-CchHHHHHHHHHHHHh
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPY-DETEDLKNVLAKEILK 65 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~-~~~~~l~~~l~~~~~~ 65 (284)
+++.+|.+|++.|.||.|...+...+-|.+...+ + ++. .+.+.++..+.+-..+
T Consensus 15 iVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~~~v-~-~~~~~~~~~l~~~l~~la~~ 69 (83)
T d1zpva1 15 IVAGVSGKIAELGLNIDDISQTVLDEYFTMMAVV-S-SDEKQDFTYLRNEFEAFGQT 69 (83)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEE-E-ESSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCeEEEEEeEEeCCEEEEEEEE-E-EecCCCHHHHHHHHHHHHHH
Confidence 5789999999999999999988777766665544 3 433 3467777777654433
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=86.99 E-value=0.2 Score=32.68 Aligned_cols=52 Identities=15% Similarity=0.143 Sum_probs=35.7
Q ss_pred HHHHHHHhhhhcCcceeeccccccCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~dg~~~d~~~v~gw~~~~~~~l~~~l~~~~ 63 (284)
+++++|.+|++.|.||.+...+...+-|.+-..+ . ++....+.++..+.+--
T Consensus 18 iva~vt~~l~~~g~NI~d~~~~~~~~~~~~~~~v-~-~~~~~~~~l~~~L~~l~ 69 (86)
T d1u8sa1 18 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTLLMLI-S-GSPSNITRVETTLPLLG 69 (86)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEEEEEE-E-ECHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCeEEEeEeEEECCeeEEEEEE-E-cCcccHHHHHHHHHHHH
Confidence 6789999999999999999877666655554444 3 33334556665555433
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=81.79 E-value=2.1 Score=26.94 Aligned_cols=38 Identities=26% Similarity=0.308 Sum_probs=31.1
Q ss_pred HHHHHHHhhhhcCcceeeccccc-cCCCceeeEEEecCC
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFS-TVDGFSLDVFVVDGW 47 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fs-t~dg~~~d~~~v~gw 47 (284)
+|.+++++|++-|.||...++.- ..+|+..-++.+|+-
T Consensus 16 vi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~ 54 (78)
T d1ygya3 16 ALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQD 54 (78)
T ss_dssp HHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSC
T ss_pred HHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCC
Confidence 58999999999999999888765 456678888888763
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=80.70 E-value=1.7 Score=27.82 Aligned_cols=34 Identities=18% Similarity=0.289 Sum_probs=26.7
Q ss_pred HHHHHHHhhhhcCcceeeccccccCC-CceeeEEE
Q 023285 10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFV 43 (284)
Q Consensus 10 ~l~~~~~~~~~~~~~i~e~~~fst~d-g~~~d~~~ 43 (284)
+|.+++++|++-|.||.+-+.-+..+ ||.+-.+.
T Consensus 24 vla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i~ 58 (84)
T d1sc6a3 24 VLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIE 58 (84)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEEE
T ss_pred HHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEEE
Confidence 68999999999999999887777665 55554443
|